Citrus Sinensis ID: 048314
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 274 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.580 | 0.191 | 0.443 | 1e-40 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.583 | 0.193 | 0.413 | 4e-32 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.580 | 0.182 | 0.389 | 6e-31 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.587 | 0.202 | 0.387 | 5e-30 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.587 | 0.253 | 0.386 | 8e-30 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.583 | 0.194 | 0.395 | 1e-29 | |
| Q8VYT3 | 648 | Probable LRR receptor-lik | no | no | 0.587 | 0.248 | 0.392 | 3e-29 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.587 | 0.254 | 0.369 | 2e-28 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.587 | 0.253 | 0.375 | 3e-28 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.587 | 0.252 | 0.370 | 2e-27 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 166 bits (420), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 79/178 (44%), Positives = 112/178 (62%), Gaps = 19/178 (10%)
Query: 112 PYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168
P W R IA+ +A+GILYLH+EC I+HCDIKPQNIL+DE++T +ISDFGLAKLL
Sbjct: 626 PSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMN 685
Query: 169 ---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219
KG +APE ++ +PI+ K DVY YG++LLE +CC + ++++ + +IL
Sbjct: 686 QTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDLE----DNVIL 741
Query: 220 TNWVYKCFINRELNKLVRGTEV---DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
NW Y CF L L D + +E VK+ +WC+Q+E +RP+M+ V ML
Sbjct: 742 INWAYDCFRQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQML 799
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 138 bits (347), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 74/179 (41%), Positives = 100/179 (55%), Gaps = 19/179 (10%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
W R IAL AKGI YLH+EC I+HCDIKP+NIL+D+ + AK+SDFGLAKLL+ K
Sbjct: 579 WEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDN 638
Query: 172 -----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILT 220
G +APE PI+ K+DVY YG+VLLE + N ++ + K +
Sbjct: 639 RYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDV-SEKTNHKKFS 697
Query: 221 NWVYKCFINREL-----NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
W Y+ F +L VD + + +VK WC+Q++P RP+M VV ML
Sbjct: 698 IWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQML 756
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (338), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 69/177 (38%), Positives = 106/177 (59%), Gaps = 18/177 (10%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL----- 168
W R IA+ A+GI Y H++C I+HCDIKP+NIL+D+ + K+SDFGLAK++
Sbjct: 627 WRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHS 686
Query: 169 -------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
+G +APE PI+VKADVY YG++LLE + N+++ + E+
Sbjct: 687 HVVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM-SYDAEDFFYPG 745
Query: 222 WVYKCFIN----RELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
W YK N + ++K ++G +++ ++ L KV WC+QDE ++RPSM VV +L
Sbjct: 746 WAYKELTNGTSLKAVDKRLQGVAEEEEVVKAL-KVAFWCIQDEVSMRPSMGEVVKLL 801
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 131 bits (330), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 71/183 (38%), Positives = 100/183 (54%), Gaps = 22/183 (12%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
W R RIAL AKGI YLH+ C I+HCDIKP+NIL+D + AK+SDFGLAKLL
Sbjct: 556 WETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFS 615
Query: 172 ----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDA-------SKP 214
G +APE PI+ KADVY +G+ LLE I N+ +++ ++P
Sbjct: 616 RVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEP 675
Query: 215 EEIILTNWVYKCFINRELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVV 271
E+ W + I ++ +V E + + + + V +WC+QD +RP+M VV
Sbjct: 676 EKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVV 735
Query: 272 MML 274
ML
Sbjct: 736 KML 738
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 130 bits (328), Expect = 8e-30, Method: Compositional matrix adjust.
Identities = 68/176 (38%), Positives = 99/176 (56%), Gaps = 15/176 (8%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
WN R +IA+ A+G+ YLH++C+P I+H D+K NIL+DE++ A + DFGLAKLL+ +
Sbjct: 393 WNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDS 452
Query: 172 ----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
G +APE S K DV+G+GI+LLE I +E S ++ +
Sbjct: 453 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLE 512
Query: 222 WVYKCFINRELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
WV K ++ +LV GT D+ + +++V L C Q PA RP M VV ML
Sbjct: 513 WVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQML 568
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 130 bits (326), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 70/177 (39%), Positives = 104/177 (58%), Gaps = 17/177 (9%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169
W+ R IAL AKG+ YLH++C+ I+HCDIKP+NIL+D+ + AK+SDFGLAKL++
Sbjct: 589 WDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQS 648
Query: 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
+G +APE IS K+DVY YG+VLLE I +N + + E+ +
Sbjct: 649 HVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYD-PSETSEKCHFPS 707
Query: 222 WVYKCFINRELNKLVRG----TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
+ +K +L +V G +V + ++ +K LWC+Q++ RPSM VV ML
Sbjct: 708 FAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQML 764
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 129 bits (323), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 69/176 (39%), Positives = 99/176 (56%), Gaps = 15/176 (8%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
WN R RIA+ A+G+LYLH++C+P I+H D+K NIL+DE + A + DFGLAKLL+
Sbjct: 397 WNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHADS 456
Query: 172 ----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
G +APE S K DV+G+GI+LLE I +E + ++ +
Sbjct: 457 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGAMLE 516
Query: 222 WVYKCFINRELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
WV K ++ +L+ GT DK + +++V L C Q PA RP M VV+ML
Sbjct: 517 WVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLML 572
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (315), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 65/176 (36%), Positives = 102/176 (57%), Gaps = 15/176 (8%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
W++R +IA+ A+G++YLH++C+P I+H D+K NIL+DE + A + DFGLAKLL +
Sbjct: 399 WSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 458
Query: 172 ----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
G +APE S K DV+G+GI+LLE I + ++ S ++ ++ +
Sbjct: 459 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLD 518
Query: 222 WVYKCFINRELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
WV K +L +L+ + D+ LE +V+V L C Q P+ RP M V+ ML
Sbjct: 519 WVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKML 574
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (314), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 66/176 (37%), Positives = 97/176 (55%), Gaps = 15/176 (8%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
W R RIAL +G+LYLH++C+P I+H D+K NIL+D+++ A + DFGLAKLL +
Sbjct: 406 WGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFGLAKLLDHEES 465
Query: 172 ----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
G +APE S K DV+G+GI+LLE I +E + + + +
Sbjct: 466 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKAANQRGAILD 525
Query: 222 WVYKCFINRELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
WV K ++L ++V + D+ +E +V+V L C Q P RP M VV ML
Sbjct: 526 WVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKMSEVVRML 581
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 122 bits (307), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 66/178 (37%), Positives = 99/178 (55%), Gaps = 17/178 (9%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
W+ R RIA+ A+G++YLH++C+P I+H D+K NIL+D++ A + DFGLAKLL +
Sbjct: 406 WSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDS 465
Query: 172 ----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
G +APE S K DV+G+GI+LLE + E + ++ ++ +
Sbjct: 466 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLD 525
Query: 222 WVYKCFINRELNKLVRGTEVDKKN-----LENLVKVGLWCVQDEPALRPSMKCVVMML 274
WV K ++L LV + KK+ L+ +V+V L C Q P RP M VV ML
Sbjct: 526 WVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVRML 583
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 274 | ||||||
| 225431565 | 791 | PREDICTED: G-type lectin S-receptor-like | 0.635 | 0.219 | 0.647 | 1e-65 | |
| 359477052 | 767 | PREDICTED: G-type lectin S-receptor-like | 0.635 | 0.226 | 0.641 | 1e-65 | |
| 147867430 | 930 | hypothetical protein VITISV_038238 [Viti | 0.635 | 0.187 | 0.647 | 1e-65 | |
| 359477046 | 798 | PREDICTED: G-type lectin S-receptor-like | 0.635 | 0.218 | 0.647 | 4e-65 | |
| 224116044 | 313 | predicted protein [Populus trichocarpa] | 0.635 | 0.555 | 0.598 | 9e-61 | |
| 224105693 | 313 | predicted protein [Populus trichocarpa] | 0.635 | 0.555 | 0.593 | 2e-60 | |
| 357478041 | 854 | Receptor like kinase [Medicago truncatul | 0.635 | 0.203 | 0.588 | 2e-59 | |
| 224093336 | 755 | predicted protein [Populus trichocarpa] | 0.635 | 0.230 | 0.601 | 1e-58 | |
| 356546166 | 810 | PREDICTED: G-type lectin S-receptor-like | 0.627 | 0.212 | 0.607 | 2e-58 | |
| 357478045 | 928 | Kinase-like protein [Medicago truncatula | 0.605 | 0.178 | 0.573 | 6e-56 |
| >gi|225431565|ref|XP_002276127.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 256 bits (653), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 121/187 (64%), Positives = 148/187 (79%), Gaps = 13/187 (6%)
Query: 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159
LA I+F S R P W++RVRIALDVA+GILYLH+ECE PI+HCDIKPQNILMD+FWTAKI
Sbjct: 589 LADILFKSKTRPP-WDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILMDDFWTAKI 647
Query: 160 SDFGLAKLL------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
SDFGLAKLL +G +APE + PISVKADVY YGIVLLE +CC N+
Sbjct: 648 SDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLELVCCRRNL 707
Query: 208 EIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSM 267
E++ SKPEEI+L+NW YKCF+ EL KL+ G EV++K+LE +VK+GLWC+QDEPALRPS+
Sbjct: 708 EVNVSKPEEIVLSNWAYKCFVAGELYKLLGGEEVERKSLEEMVKLGLWCIQDEPALRPSI 767
Query: 268 KCVVMML 274
K +V+ML
Sbjct: 768 KSIVLML 774
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477052|ref|XP_002276297.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 256 bits (653), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 120/187 (64%), Positives = 149/187 (79%), Gaps = 13/187 (6%)
Query: 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159
LA I+F S R P W++RVRIALDVA+GILYLH+ECE PI+HCDIKPQNILMD+FWTAKI
Sbjct: 565 LADILFKSKTRPP-WDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILMDDFWTAKI 623
Query: 160 SDFGLAKLL------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
SDFGLAKLL +G +APE + PISVKADVY YGIVLLE +CC N+
Sbjct: 624 SDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLELVCCRRNL 683
Query: 208 EIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSM 267
E++ S+PEEI+L+NW YKCF+ EL+KL+ G EV++K+LE +VK+GLWC+QDEPALRPS+
Sbjct: 684 EVNVSEPEEIVLSNWAYKCFVAGELHKLLGGEEVERKSLEQMVKLGLWCIQDEPALRPSI 743
Query: 268 KCVVMML 274
K +V+ML
Sbjct: 744 KSIVLML 750
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147867430|emb|CAN78998.1| hypothetical protein VITISV_038238 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 255 bits (652), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 121/187 (64%), Positives = 148/187 (79%), Gaps = 13/187 (6%)
Query: 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159
LA I+F S R P W++RVRIALDVA+GILYLH+ECE PI+HCDIKPQNILMD+FWTAKI
Sbjct: 728 LADILFKSKTRPP-WDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILMDDFWTAKI 786
Query: 160 SDFGLAKLL------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
SDFGLAKLL +G +APE + PISVKADVY YGIVLLE +CC N+
Sbjct: 787 SDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLELVCCRRNL 846
Query: 208 EIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSM 267
E++ SKPEEI+L+NW YKCF+ EL KL+ G EV++K+LE +VK+GLWC+QDEPALRPS+
Sbjct: 847 EVNVSKPEEIVLSNWAYKCFVAGELYKLLGGEEVERKSLEEMVKLGLWCIQDEPALRPSI 906
Query: 268 KCVVMML 274
K +V+ML
Sbjct: 907 KSIVLML 913
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477046|ref|XP_002275786.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 253 bits (647), Expect = 4e-65, Method: Compositional matrix adjust.
Identities = 121/187 (64%), Positives = 145/187 (77%), Gaps = 13/187 (6%)
Query: 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159
LA ++F + R P+WN+RVRIALDVA+GILYLH+ECE PI+HCDIKPQNILMDEF AKI
Sbjct: 596 LANLLFNAGTR-PHWNERVRIALDVARGILYLHEECETPIIHCDIKPQNILMDEFLNAKI 654
Query: 160 SDFGLAKLL------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
SDFGLAKLL +G +APE + TPISVKAD+Y YGIVLLE +CC +NM
Sbjct: 655 SDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQRNTPISVKADIYSYGIVLLEIVCCRKNM 714
Query: 208 EIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSM 267
E+ PEEIIL+NWVY+C ++REL+KLV DKK LE +VKVGLWC+QDEPALRPSM
Sbjct: 715 EVQVKNPEEIILSNWVYQCMVSRELDKLVADEVADKKTLERMVKVGLWCIQDEPALRPSM 774
Query: 268 KCVVMML 274
K VV++L
Sbjct: 775 KSVVLIL 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116044|ref|XP_002332034.1| predicted protein [Populus trichocarpa] gi|222875259|gb|EEF12390.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 239 bits (610), Expect = 9e-61, Method: Compositional matrix adjust.
Identities = 112/187 (59%), Positives = 141/187 (75%), Gaps = 13/187 (6%)
Query: 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159
LA ++F ER P W+ RV+IALD+AKGILYLH+ECE PI+HCDIKPQNILMD+FW AKI
Sbjct: 111 LADLLF-RTERIPNWSHRVKIALDIAKGILYLHEECEAPIIHCDIKPQNILMDDFWNAKI 169
Query: 160 SDFGLAKLL------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
SDFGLAKLL +G +APE +K TPISVKADVY YG++LLE + C N+
Sbjct: 170 SDFGLAKLLVPDQTRTFTIVRGTRGYLAPEWHKNTPISVKADVYSYGVMLLEIVFCRRNI 229
Query: 208 EIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSM 267
E + S+PEE+ L+NW Y+ + REL+KL G +VD +NLE +V VG+WC+QDEP +RPSM
Sbjct: 230 ETNVSRPEEVQLSNWAYELLVERELDKLDLGEDVDLQNLEKMVMVGIWCIQDEPGIRPSM 289
Query: 268 KCVVMML 274
K VV+ML
Sbjct: 290 KSVVLML 296
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224105693|ref|XP_002333784.1| predicted protein [Populus trichocarpa] gi|222838485|gb|EEE76850.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 238 bits (607), Expect = 2e-60, Method: Compositional matrix adjust.
Identities = 111/187 (59%), Positives = 140/187 (74%), Gaps = 13/187 (6%)
Query: 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159
LA ++F ER P W+ RV+IALD+AKGILYLH+ECE PI+HCDIKPQNILMD+FW AKI
Sbjct: 111 LADLLF-RTERIPNWSHRVKIALDIAKGILYLHEECEAPIIHCDIKPQNILMDDFWNAKI 169
Query: 160 SDFGLAKLL------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
SDFGLAKLL +G +APE +K TPISVKADVY YG++LLE + C N+
Sbjct: 170 SDFGLAKLLVPDQTRTFTMVRGTRGYLAPEWHKNTPISVKADVYSYGVMLLEIVFCRRNI 229
Query: 208 EIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSM 267
E + S+PEE+ L+NW Y+ + REL+KL G +VD +N E +V VG+WC+QDEP +RPSM
Sbjct: 230 ETNVSRPEEVQLSNWAYELLVERELDKLDLGEDVDLQNFEKMVMVGIWCIQDEPGIRPSM 289
Query: 268 KCVVMML 274
K VV+ML
Sbjct: 290 KSVVLML 296
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357478041|ref|XP_003609306.1| Receptor like kinase [Medicago truncatula] gi|357478087|ref|XP_003609329.1| Receptor like kinase [Medicago truncatula] gi|355510361|gb|AES91503.1| Receptor like kinase [Medicago truncatula] gi|355510384|gb|AES91526.1| Receptor like kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 234 bits (598), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 110/187 (58%), Positives = 138/187 (73%), Gaps = 13/187 (6%)
Query: 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159
L ++F +R P WN+RVRIALD+A+GILYLH+EC+ PI+HCD+KPQNILMD+FWTAKI
Sbjct: 608 LGKLLF-GDQRRPDWNERVRIALDIARGILYLHEECDAPIIHCDLKPQNILMDKFWTAKI 666
Query: 160 SDFGLAKLL------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
SDFGLAKLL +G MAPE K ISVK DVY YGIVLLE +CC N+
Sbjct: 667 SDFGLAKLLMPDQTRTFTMVRGTRGYMAPEWNKNVAISVKTDVYSYGIVLLEILCCRRNL 726
Query: 208 EIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSM 267
+++ +PEEI+L W YKCFI ++NKLV +DK +EN+VKV LWC+QD+P LRP+M
Sbjct: 727 DVNVLEPEEILLAGWTYKCFIAGDVNKLVPSEAIDKNVMENMVKVALWCIQDDPFLRPTM 786
Query: 268 KCVVMML 274
K VV+ML
Sbjct: 787 KGVVLML 793
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224093336|ref|XP_002309887.1| predicted protein [Populus trichocarpa] gi|222852790|gb|EEE90337.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 232 bits (591), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 113/188 (60%), Positives = 140/188 (74%), Gaps = 14/188 (7%)
Query: 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159
LA ++F + ER P W+ RV+IALD+AKGILYLH+ECE PI+HCDIKPQNILMD+FWTAKI
Sbjct: 552 LANLLFRN-ERIPDWSDRVKIALDIAKGILYLHEECEAPIMHCDIKPQNILMDDFWTAKI 610
Query: 160 SDFGLAKLL------------SDKGCMAPECYK-RTPISVKADVYGYGIVLLETICCWEN 206
SDFGLAKLL G MAPE K TP SVK DVY YG+VLLE + C N
Sbjct: 611 SDFGLAKLLVPDQTRTLTIARGTPGYMAPEWTKISTPTSVKVDVYSYGVVLLEIVFCRRN 670
Query: 207 MEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPS 266
M+I+ SKPEE++L+ W Y+ + REL++L G +VD++ LE +V +G+WC+QDEP LRPS
Sbjct: 671 MKINVSKPEEVLLSKWAYELLVARELDRLDLGEDVDRQKLEKMVMIGIWCIQDEPGLRPS 730
Query: 267 MKCVVMML 274
MK VVMML
Sbjct: 731 MKTVVMML 738
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546166|ref|XP_003541502.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 232 bits (591), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 113/186 (60%), Positives = 138/186 (74%), Gaps = 14/186 (7%)
Query: 103 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162
I ++R P W++RVRIAL++AKGILYLH+ECE PI+HCDIKPQNILMDEFWTAKISDF
Sbjct: 608 IFGAQSQRRPGWDERVRIALEIAKGILYLHEECEAPIIHCDIKPQNILMDEFWTAKISDF 667
Query: 163 GLAKLL------------SDKGCMAPECYK-RTPISVKADVYGYGIVLLETICCWENMEI 209
GLAKLL +G +APE K PISVK DVY YGIVLLE +CC N+E+
Sbjct: 668 GLAKLLMPDQTRTITGARGTRGYVAPEWDKLNIPISVKVDVYSYGIVLLEILCCRRNIEV 727
Query: 210 DASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK-NLENLVKVGLWCVQDEPALRPSMK 268
S+PE +L+NW YKCF++ +LNKL VD K ++EN+VKV LWC+QDEP LRP+MK
Sbjct: 728 HVSEPEAALLSNWAYKCFVSGQLNKLFLWESVDNKTSVENIVKVALWCIQDEPFLRPTMK 787
Query: 269 CVVMML 274
VV+ML
Sbjct: 788 SVVLML 793
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357478045|ref|XP_003609308.1| Kinase-like protein [Medicago truncatula] gi|357478091|ref|XP_003609331.1| Kinase-like protein [Medicago truncatula] gi|355510363|gb|AES91505.1| Kinase-like protein [Medicago truncatula] gi|355510386|gb|AES91528.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 223 bits (568), Expect = 6e-56, Method: Compositional matrix adjust.
Identities = 102/178 (57%), Positives = 131/178 (73%), Gaps = 12/178 (6%)
Query: 109 ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168
+R P W++RVR+ALD+A+GI YLH+ECE PI+HCDIKPQNILMDEFWTAKISDFGLAKLL
Sbjct: 616 QRRPDWDERVRMALDIARGISYLHEECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 675
Query: 169 ------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEE 216
+G MAPE PIS+KADVY YGI+L E +CC N++++ +PEE
Sbjct: 676 MPDQTRTFTVVRGTRGYMAPEWNMNVPISLKADVYSYGIMLFEILCCRRNLDVNVLEPEE 735
Query: 217 IILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
I+L+ W YKC + ++N LV +D +EN+VKV LWC+QD+P LRP+MK VV+ML
Sbjct: 736 ILLSGWAYKCLVAGQVNNLVPWEVIDNNVMENMVKVALWCIQDDPFLRPTMKGVVLML 793
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 274 | ||||||
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.583 | 0.194 | 0.395 | 9.8e-27 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.321 | 0.100 | 0.47 | 3e-26 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.587 | 0.248 | 0.397 | 3.9e-25 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.587 | 0.253 | 0.386 | 4.7e-25 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.580 | 0.192 | 0.391 | 5.2e-25 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.748 | 0.328 | 0.353 | 7.4e-25 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.587 | 0.254 | 0.369 | 2.1e-24 | |
| TAIR|locus:2033577 | 425 | AT1G70740 [Arabidopsis thalian | 0.624 | 0.402 | 0.345 | 2.8e-24 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.580 | 0.408 | 0.396 | 5.3e-24 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.744 | 0.329 | 0.343 | 5.8e-24 |
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 311 (114.5 bits), Expect = 9.8e-27, P = 9.8e-27
Identities = 70/177 (39%), Positives = 104/177 (58%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169
W+ R IAL AKG+ YLH++C+ I+HCDIKP+NIL+D+ + AK+SDFGLAKL++
Sbjct: 589 WDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQS 648
Query: 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
+G +APE IS K+DVY YG+VLLE I +N + + E+ +
Sbjct: 649 HVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYD-PSETSEKCHFPS 707
Query: 222 WVYKCFINRELNKLVRG----TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
+ +K +L +V G +V + ++ +K LWC+Q++ RPSM VV ML
Sbjct: 708 FAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQML 764
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 229 (85.7 bits), Expect = 3.0e-26, Sum P(3) = 3.0e-26
Identities = 47/100 (47%), Positives = 63/100 (63%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD--- 170
W +R IAL A+G+ YLH C+ I+HCD+KP+NIL+ + + KISDFGL+KLL+
Sbjct: 610 WQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEES 669
Query: 171 ---------KGCMAPECYKRTPISVKADVYGYGIVLLETI 201
+G +APE IS KADVY YG+VLLE +
Sbjct: 670 SLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELV 709
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 294 (108.6 bits), Expect = 3.9e-25, P = 3.9e-25
Identities = 70/176 (39%), Positives = 100/176 (56%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--DK 171
WN R RIA+ A+G+LYLH++C+P I+H D+K NIL+DE + A + DFGLAKLL+ D
Sbjct: 397 WNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHADS 456
Query: 172 ----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
G +APE S K DV+G+GI+LLE I +E + ++ +
Sbjct: 457 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGAMLE 516
Query: 222 WVYKCFINRELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
WV K ++ +L+ GT DK + +++V L C Q PA RP M VV+ML
Sbjct: 517 WVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLML 572
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 293 (108.2 bits), Expect = 4.7e-25, P = 4.7e-25
Identities = 68/176 (38%), Positives = 99/176 (56%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
WN R +IA+ A+G+ YLH++C+P I+H D+K NIL+DE++ A + DFGLAKLL+ +
Sbjct: 393 WNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDS 452
Query: 172 ----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
G +APE S K DV+G+GI+LLE I +E S ++ +
Sbjct: 453 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLE 512
Query: 222 WVYKCFINRELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
WV K ++ +LV GT D+ + +++V L C Q PA RP M VV ML
Sbjct: 513 WVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQML 568
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 295 (108.9 bits), Expect = 5.2e-25, P = 5.2e-25
Identities = 70/179 (39%), Positives = 99/179 (55%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-D-- 170
W R +IAL A+G+ YLHDEC I+HCDIKP+NIL+D + K++DFGLAKL+ D
Sbjct: 590 WKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFS 649
Query: 171 ---------KGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEI-ILT 220
+G +APE I+ KADVY YG++L E + N E S+ E++
Sbjct: 650 RVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTE--QSENEKVRFFP 707
Query: 221 NWVYKCFI-NRELNKLV----RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
+W + ++ LV G VD + + KV WC+QDE + RP+M VV +L
Sbjct: 708 SWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQIL 766
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 291 (107.5 bits), Expect = 7.4e-25, P = 7.4e-25
Identities = 83/235 (35%), Positives = 120/235 (51%)
Query: 70 VSWTTDIEVSSVA-------MRG-SKPSTEAALDLPWDL-AYIIFCSAERNPY-----WN 115
+ + T++E+ S+A +RG TE L P+ + C ER P W
Sbjct: 342 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWP 401
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK---- 171
R RIAL A+G+ YLHD C+P I+H D+K NIL+DE + A + DFGLAKL+ K
Sbjct: 402 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 461
Query: 172 --------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDA-SKPEEIILTNW 222
G +APE S K DV+GYGI+LLE I ++ + ++++L +W
Sbjct: 462 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW 521
Query: 223 VYKCFINRELNKLVRG---TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
V ++L LV T +++ LE +++V L C Q P RP M VV ML
Sbjct: 522 VKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVRML 576
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 287 (106.1 bits), Expect = 2.1e-24, P = 2.1e-24
Identities = 65/176 (36%), Positives = 102/176 (57%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
W++R +IA+ A+G++YLH++C+P I+H D+K NIL+DE + A + DFGLAKLL +
Sbjct: 399 WSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 458
Query: 172 ----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
G +APE S K DV+G+GI+LLE I + ++ S ++ ++ +
Sbjct: 459 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLD 518
Query: 222 WVYKCFINRELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
WV K +L +L+ + D+ LE +V+V L C Q P+ RP M V+ ML
Sbjct: 519 WVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKML 574
|
|
| TAIR|locus:2033577 AT1G70740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 279 (103.3 bits), Expect = 2.8e-24, P = 2.8e-24
Identities = 65/188 (34%), Positives = 103/188 (54%)
Query: 103 IIFCSAERNPY-WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISD 161
++F S ++ W QR I +A+G+LYLH++ I+H DIK NIL+DE W KI+D
Sbjct: 146 VLFKSNRKSEIDWKQRFEIITGIARGLLYLHEDAPNCIIHRDIKAGNILLDEKWVPKIAD 205
Query: 162 FGLAKLLSD------------KGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEI 209
FG+A+L + G MAPE +SVKADV+ +G+++LE + +N
Sbjct: 206 FGMARLYQEDVTHVNTRVAGTNGYMAPEYVMHGVLSVKADVFSFGVLVLELVSGQKNSSF 265
Query: 210 DASKPEEIILTNWVYKCFIN-RELNKLVR--GTEVDKKNLENLVKVGLWCVQDEPALRPS 266
P++ +L W +K + R + L + D ++ V++GL CVQ +P RPS
Sbjct: 266 SMRHPDQTLL-EWAFKLYKKGRTMEILDQDIAASADPDQVKLCVQIGLLCVQGDPHQRPS 324
Query: 267 MKCVVMML 274
M+ V ++L
Sbjct: 325 MRRVSLLL 332
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 275 (101.9 bits), Expect = 5.3e-24, P = 5.3e-24
Identities = 71/179 (39%), Positives = 100/179 (55%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL------ 167
WN R+RIAL AKG+ YLH++ PP+++ D K NIL++ + AK+SDFGLAKL
Sbjct: 169 WNSRIRIALGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGDT 228
Query: 168 --LSDK-----GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKP-EEIIL 219
+S + G APE +K ++VK+DVY +G+VLLE I ID ++P E L
Sbjct: 229 QNVSSRVVGTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELIT--GKRVIDTTRPCHEQNL 286
Query: 220 TNWVYKCFI--NR--ELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
W F NR EL + E +K+L V + C+Q+EP +RP + VV L
Sbjct: 287 VTWAQPIFREPNRFPELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIVRPLISDVVTAL 345
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 269 (99.8 bits), Expect = 5.8e-24, Sum P(2) = 5.8e-24
Identities = 81/236 (34%), Positives = 122/236 (51%)
Query: 70 VSWTTDIEVSSVA-------MRG-SKPSTEAALDLPWDL-AYIIFCSAER---NPY--WN 115
+ + T++E+ S+A +RG TE L P+ + C ER NP W
Sbjct: 334 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWP 393
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--DK-- 171
+R IAL A+G+ YLHD C+ I+H D+K NIL+DE + A + DFGLAKL++ D
Sbjct: 394 KRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHV 453
Query: 172 --------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDA-SKPEEIILTNW 222
G +APE S K DV+GYG++LLE I + ++ + ++I+L +W
Sbjct: 454 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDW 513
Query: 223 VYKCFINRELNKLVRGTEVDKK----NLENLVKVGLWCVQDEPALRPSMKCVVMML 274
V + ++L LV E++ K +E L+++ L C Q RP M VV ML
Sbjct: 514 VKEVLKEKKLESLV-DAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRML 568
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00034882001 | SubName- Full=Chromosome chr4 scaffold_73, whole genome shotgun sequence; (774 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 274 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-23 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-20 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-17 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-17 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-15 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-11 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-10 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-09 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-09 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-08 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-08 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-07 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-05 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-04 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-04 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.001 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.001 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.001 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.001 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.001 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.002 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.002 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 0.002 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 0.002 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.003 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 0.003 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.004 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.004 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.004 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.004 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.004 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 0.004 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-23
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 16/99 (16%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKISDFGLAKLLSDK- 171
++ +RI L + +G+ YLH I+H D+KP+NIL+D K++DFGL+KLL+
Sbjct: 91 EDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147
Query: 172 ----------GCMAPECYK-RTPISVKADVYGYGIVLLE 199
MAPE + S K+D++ G++L E
Sbjct: 148 SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 2e-20
Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 13/91 (14%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
+ + YLH + I+H D+KP+NIL+DE K++DFGLA+ L
Sbjct: 101 FYLRQILSALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV 157
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE D++ G++L E
Sbjct: 158 GTPEYMAPEVLLGKGYGKAVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 2e-20
Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 41/179 (22%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG- 172
++ +IAL + +G+ YLH I+H D+KP+NIL+DE KI+DFGLAK L
Sbjct: 97 EDEAKKIALQILRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSS 153
Query: 173 -----C-----MAPE-CYKRTPISVKADVYGYGIVLLETIC---------CWENMEIDAS 212
MAPE K DV+ G++L E + + +++
Sbjct: 154 SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRR 213
Query: 213 KPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVV 271
+ + + E L++ C+ +P+ RP+ + ++
Sbjct: 214 ILGPPLEFDEPKWSSGSEEAKDLIK-----------------KCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 2e-17
Identities = 41/165 (24%), Positives = 65/165 (39%), Gaps = 28/165 (16%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----- 170
+ AL +A+G+ YL + +H D+ +N L+ E KISDFGL++ L D
Sbjct: 103 DLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYR 159
Query: 171 -KGC------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV 223
+G MAPE K + K+DV+ +G+ WE +P + V
Sbjct: 160 KRGGKLPIRWMAPESLKEGKFTSKSDVWSFGV------LLWEIFT-LGEQPYPGMSNEEV 212
Query: 224 YKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
+ N L + L C ++P RP+
Sbjct: 213 LEYLKNGYRLPQPPNCP------PELYDLMLQCWAEDPEDRPTFS 251
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 29/92 (31%), Positives = 41/92 (44%), Gaps = 16/92 (17%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------- 173
+ +G+ YLH I+H DIK NIL+D K++DFG AK L D
Sbjct: 107 TRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV 163
Query: 174 ------MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE + AD++ G ++E
Sbjct: 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIE 195
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 4e-17
Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 34/170 (20%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD--- 170
+ + AL +A+G+ YL + +H D+ +N L+ E KISDFGL++ L D
Sbjct: 102 LSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158
Query: 171 ---KGC------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
KG MAPE K + K+DV+ +G++L WE +P
Sbjct: 159 YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLL------WEIFT-LGEEP------- 204
Query: 222 WVYKCFINRE-LNKLVRGTEVDKKNL--ENLVKVGLWCVQDEPALRPSMK 268
Y N E L L +G + K L K+ L C ++P RP+
Sbjct: 205 --YPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFS 252
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 8e-16
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 22/103 (21%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-- 173
+++AL +AKG+ YL + +H D+ +N L+ E KISDFGL++ + +
Sbjct: 103 DLLQMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR 159
Query: 174 -----------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
MAPE K + K+DV+ +G++L WE
Sbjct: 160 KRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLL------WE 196
|
Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (178), Expect = 6e-15
Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 14/84 (16%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-----------MA 175
+ YLH ILH DIKPQNI + K+ DFG++K+LS ++
Sbjct: 115 ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171
Query: 176 PECYKRTPISVKADVYGYGIVLLE 199
PE + P + K+D++ G VL E
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 7e-15
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 22/105 (20%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
+ A+ +AKG+ YL +H D+ +N L+ E KISDFGL++ + D
Sbjct: 104 LKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160
Query: 174 -------------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
MAPE K + K+DV+ +G++L WE
Sbjct: 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLL------WE 199
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 9e-15
Identities = 32/90 (35%), Positives = 43/90 (47%), Gaps = 13/90 (14%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
+ ++ KG+ YLH I+H DIK NIL+ K+ DFGL+ LSD
Sbjct: 103 VCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG 159
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE P KAD++ GI +E
Sbjct: 160 TPYWMAPEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 17/98 (17%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-DKGCM 174
+ + + + KG+ YL + +H D+ +NIL++ KISDFGLAK+L DK
Sbjct: 110 RLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYY 166
Query: 175 -------------APECYKRTPISVKADVYGYGIVLLE 199
APEC + + S +DV+ +G+ L E
Sbjct: 167 YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-12
Identities = 48/185 (25%), Positives = 80/185 (43%), Gaps = 38/185 (20%)
Query: 99 DLAYIIFCSAE-RNPYWNQRV-RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 156
DL+ I + R Q + RI + + +G+ LH++ ILH D+K NIL+
Sbjct: 85 DLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDL 141
Query: 157 AKISDFGLAKLLSDKGC---------MAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
KI D G++K+L MAPE +K P S K+D++ G +L E
Sbjct: 142 VKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201
Query: 208 EIDASKPEEIILTNWVYKCFINRELNKLVRGT-----EVDKKNLENLVKVGLWCVQDEPA 262
E A +++ K+ RG + ++L+N ++ +Q +P
Sbjct: 202 E--ARSMQDL--------------RYKVQRGKYPPIPPIYSQDLQNFIR---SMLQVKPK 242
Query: 263 LRPSM 267
LRP+
Sbjct: 243 LRPNC 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-12
Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 11/90 (12%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK------G 172
+IA+ V KG+ YLH++ + I+H D+KP NIL++ K+ DFG++ L + G
Sbjct: 104 KIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVG 161
Query: 173 C---MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE + SVK+D++ G+ L+E
Sbjct: 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIE 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 6e-12
Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 14/91 (15%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
I KG+ YLH +H DIK NIL++E AK++DFG++ L+D
Sbjct: 104 ILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI 160
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE + + KAD++ GI +E
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 43/177 (24%), Positives = 83/177 (46%), Gaps = 15/177 (8%)
Query: 110 RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168
RN W +R +IA+ +AK + +LH C P ++ ++ P+ I++D + L LL
Sbjct: 775 RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833
Query: 169 SDKGC------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW 222
+D C +APE + I+ K+D+YG+G++L+E + + + I+ W
Sbjct: 834 TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV--EW 891
Query: 223 VYKCFINRELNKLV-----RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
C+ + L+ + V++ + ++ + L C +P RP V+ L
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 9e-12
Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 14/94 (14%)
Query: 117 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----- 170
+V+ ++ + YLH I+H DIKP NIL+DE I+DF +A ++
Sbjct: 101 QVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157
Query: 171 -----KGCMAPECYKRTPISVKADVYGYGIVLLE 199
G MAPE R SV D + G+ E
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYE 191
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 34/90 (37%), Positives = 47/90 (52%), Gaps = 12/90 (13%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
+IA V KG+ YLH I+H DIKP NIL+ K+ DFG++ L +
Sbjct: 109 KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG 165
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE + P S+ +DV+ G+ LLE
Sbjct: 166 TSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 35/175 (20%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168
+ +++A ++A G+ YL +H D+ +N ++ E T KI DFG+ + +
Sbjct: 120 KFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 169 -SDKGC-----MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW 222
KG MAPE K + K+DV+ +G+VL WE M A +P
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVL------WE-MATLAEQP-------- 221
Query: 223 VYKCFINRELNKLVRGTEVDKK--NLEN-LVKVGLWCVQDEPALRPSMKCVVMML 274
Y+ N E+ K V N + L+++ C Q P +RP+ +V L
Sbjct: 222 -YQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-11
Identities = 36/93 (38%), Positives = 54/93 (58%), Gaps = 13/93 (13%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-- 173
Q ++ +LDVA+G+ YL + ++H D+ +NIL+ E AK+SDFGLA++ S G
Sbjct: 101 QLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGS-MGVDN 156
Query: 174 -------MAPECYKRTPISVKADVYGYGIVLLE 199
APE K S K+DV+ YG++L E
Sbjct: 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWE 189
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 62.1 bits (149), Expect = 5e-11
Identities = 40/174 (22%), Positives = 63/174 (36%), Gaps = 26/174 (14%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKISDFGLAKLLSDKGC- 173
+ + I + + YLH + I+H DIKP+NIL+D K+ DFGLAKLL D G
Sbjct: 102 EALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158
Query: 174 ----------------MAPECYKRT---PISVKADVYGYGIVLLETICCWENMEIDASKP 214
MAPE S +D++ GI L E + E + +
Sbjct: 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS 218
Query: 215 EEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
+ + + L + + + + +P R S
Sbjct: 219 ATSQTLKIILELPTPSLASPLS--PSNPELISKAASDLLKKLLAKDPKNRLSSS 270
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 11/92 (11%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---DKG 172
Q++ ALDV +G+ YL E +H D+ +N+L+ E AK+SDFGLAK S D G
Sbjct: 103 QQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG 159
Query: 173 CM-----APECYKRTPISVKADVYGYGIVLLE 199
+ APE + S K+DV+ +GI+L E
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 14/87 (16%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---------- 173
V +G+ YLH++ ++H DIK NIL + K++DFG+A L+D
Sbjct: 108 VLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPY 164
Query: 174 -MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE + + S +D++ G ++E
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIE 191
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-10
Identities = 38/112 (33%), Positives = 56/112 (50%), Gaps = 16/112 (14%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
R + + G+ +LH + ILH DIK N+ +D + KI D G+AKLLSD
Sbjct: 105 RFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI 161
Query: 174 ------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219
++PE + P + K+DV+ G+VL E CC DA+ +IL
Sbjct: 162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYE--CCTGKHPFDANNQGALIL 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-10
Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 13/113 (11%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158
DL Y I+ ER + + + + GIL+LH I++ D+KP+N+L+D+ +
Sbjct: 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCR 135
Query: 159 ISDFGLAKLLSD----------KGCMAPECYKRTPISVKADVYGYGIVLLETI 201
+SD GLA L D G MAPE K P S D + G + E +
Sbjct: 136 LSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 7e-10
Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 22/106 (20%)
Query: 113 YWNQRVRIALDVAK--------GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164
+ ++ R + + A+ + YLH I++ D+KP+NIL+D K++DFGL
Sbjct: 83 HLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGL 139
Query: 165 AKLLSDKG------C-----MAPECYKRTPISVKADVYGYGIVLLE 199
AK LS +G C +APE D + G++L E
Sbjct: 140 AKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYE 185
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 14/91 (15%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-------SDKG 172
+A VA+G+ YL ++ +H D+ +NIL+ E K++DFGLA+L+ SDK
Sbjct: 109 MACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK 165
Query: 173 C----MAPECYKRTPISVKADVYGYGIVLLE 199
APE S K+DV+ +GI+L E
Sbjct: 166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYE 196
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 14/94 (14%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
+ +V +G+ YLH + ++H DIK NIL+ + + K++DFG A L+ +
Sbjct: 120 YVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176
Query: 174 ------MAPECYKRTPISVKADVYGYGIVLLETI 201
MAPE KR K D++ GI+ +E
Sbjct: 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 13/91 (14%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--SDKGC---- 173
IA + KG+ YLH + I+H DIKP N+L++ KI+DFG++K+L + C
Sbjct: 104 IARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV 161
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLE 199
M+PE + S AD++ G+ LLE
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 31/111 (27%), Positives = 43/111 (38%), Gaps = 24/111 (21%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
L + +G+ YLH I+H DIKP NI +D K+ DFG A L +
Sbjct: 103 VYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159
Query: 174 ----------MAPECYKRTPISVK---ADVYGYGIVLLETICC---WENME 208
MAPE AD++ G V+LE W ++
Sbjct: 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 25/75 (33%), Positives = 37/75 (49%), Gaps = 12/75 (16%)
Query: 139 ILHCDIKPQNILMDEFWTAKISDFGLAKLLSD-----KGC------MAPECYKRTPISVK 187
+LH D+KP NI +D K+ DFGLAK+L K M+PE K
Sbjct: 131 VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK 190
Query: 188 ADVYGYGIVLLETIC 202
+D++ G ++ E +C
Sbjct: 191 SDIWSLGCLIYE-LC 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-09
Identities = 35/91 (38%), Positives = 49/91 (53%), Gaps = 20/91 (21%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--------------SDK 171
KG+ YLH+ I+H DIK NIL+D KISDFG++K L S +
Sbjct: 117 KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 172 GC---MAPECYKRTPISVKADVYGYGIVLLE 199
G MAPE K+T + KAD++ G +++E
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVE 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-09
Identities = 41/155 (26%), Positives = 64/155 (41%), Gaps = 42/155 (27%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----------KGC 173
V +G+ YLH + ILH D+K N+L+D KISDFG++K D +G
Sbjct: 117 VLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 174 ---MAPECY--KRTPISVKADVYGYGIVLLETICC---WENME-------IDASK----- 213
MAPE S K D++ G V+LE W + E + +
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233
Query: 214 PEEIILT------NWVYKCFINRELNKLVRGTEVD 242
P ++ + +++ CF +N R T +
Sbjct: 234 PPDVSMNLSPVALDFLNACF---TINPDNRPTARE 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 19/92 (20%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---------- 173
V KG+ YLH + +H DIK NIL+ E + KI+DFG++ L+D G
Sbjct: 111 VLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167
Query: 174 -----MAPECYK-RTPISVKADVYGYGIVLLE 199
MAPE + KAD++ +GI +E
Sbjct: 168 GTPCWMAPEVMEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-09
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 18/108 (16%)
Query: 107 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
S NP + L VAKG+ YL +H D+ +N ++DE +T K++DFGLA+
Sbjct: 90 SETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
Query: 167 LLSDK---------------GCMAPECYKRTPISVKADVYGYGIVLLE 199
+ DK MA E + + K+DV+ +G++L E
Sbjct: 147 DIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 194
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 32/156 (20%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMA-------- 175
+ + Y+H ILH DIK NI + + K+ DFG++K+L + MA
Sbjct: 110 IVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166
Query: 176 ---PECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232
PE + + K+D++ G VL E + + DA+ P ++
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYE-LLTLKRT-FDATNPLNLV-------------- 210
Query: 233 NKLVRG--TEVDKKNLENLVKVGLWCVQDEPALRPS 266
K+V+G T V L+ + +Q +P RP+
Sbjct: 211 VKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 14/91 (15%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
I +V G+ YLH+E + +H DIK NIL+ E K++DFG++ L+
Sbjct: 103 ILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV 159
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE K++ KAD++ GI +E
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 11/90 (12%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD-------- 170
+I++ V +G+ YL ++ + I+H D+KP NIL++ K+ DFG++ L D
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160
Query: 171 -KGCMAPECYKRTPISVKADVYGYGIVLLE 199
+ M+PE + T +V++D++ G+ L+E
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (131), Expect = 2e-08
Identities = 19/44 (43%), Positives = 27/44 (61%), Gaps = 3/44 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169
+G+ Y H ILH D+KPQNIL++ K++DFGLA+
Sbjct: 109 RGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 2e-08
Identities = 26/115 (22%), Positives = 46/115 (40%), Gaps = 34/115 (29%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
A ++ + YLH + I+H D+KP+NIL+D+ KI+DFG AK+L
Sbjct: 107 YAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 174 -------------------------MAPECYKRTPISVKADVYGYGIVLLETICC 203
++PE P +D++ G ++ + +
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 18/96 (18%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG--------LAKLLSD 170
+IA+ + K + YLH + ++H D+KP N+L++ K+ DFG +AK + D
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI-D 163
Query: 171 KGC---MAPE----CYKRTPISVKADVYGYGIVLLE 199
GC MAPE + VK+DV+ GI ++E
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 35/97 (36%), Positives = 48/97 (49%), Gaps = 16/97 (16%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA-------K 166
WN V++ L + YLH E I+H D+ P NI++ E I+DFGLA K
Sbjct: 116 WNIFVQMVL----ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK 169
Query: 167 LLSDKGCM---APECYKRTPISVKADVYGYGIVLLET 200
L S G + PE K P KADV+ +G +L +
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 32/83 (38%), Positives = 46/83 (55%), Gaps = 11/83 (13%)
Query: 128 ILYLHDECEPPILHCDIKPQNILMDEFWT-AKISDFGLAKLLSDKG---------C-MAP 176
+L LH ILH D+K QNIL+D+ KI DFG++K+LS K C ++P
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISP 170
Query: 177 ECYKRTPISVKADVYGYGIVLLE 199
E + P + K+D++ G VL E
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYE 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 14/95 (14%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-- 173
Q I ++ KG+ YLH E + +H DIK N+L+ E K++DFG+A L+D
Sbjct: 102 QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158
Query: 174 ---------MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE K++ KAD++ GI +E
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 14/91 (15%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
I ++ KG+ YLH E + +H DIK N+L+ E K++DFG+A L+D
Sbjct: 106 ILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE K++ KAD++ GI +E
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 15/93 (16%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-------SDKG 172
IA+ K + YL +E + I+H D+KP NIL+D K+ DFG++ L D G
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG 169
Query: 173 C---MAPE---CYKRTPISVKADVYGYGIVLLE 199
C MAPE R V++DV+ GI L E
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYE 202
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-08
Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 11/90 (12%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
+IA+ V +G+ YL++ I+H DIKP NIL++ K+ DFG++ L +
Sbjct: 107 KIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVG 164
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLE 199
M+PE + +VK+DV+ GI ++E
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIE 194
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 31/85 (36%), Positives = 42/85 (49%), Gaps = 14/85 (16%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK-------LLSDKGC---MA 175
G+ YLHD +H DIK NIL+D K++DFG+AK S KG MA
Sbjct: 113 LGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMA 169
Query: 176 PECYKRT-PISVKADVYGYGIVLLE 199
PE + + AD++ G +LE
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLE 194
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-08
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 11/90 (12%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---DKGCM 174
++ +LDV + + YL +H D+ +N+L+ E AK+SDFGL K S D G +
Sbjct: 105 LKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 161
Query: 175 -----APECYKRTPISVKADVYGYGIVLLE 199
APE + S K+DV+ +GI+L E
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-08
Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 123 DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC--------- 173
++ KG+ YLH E + +H DIK N+L+ E K++DFG+A L+D
Sbjct: 109 EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP 165
Query: 174 --MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE +++ KAD++ GI +E
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 22/98 (22%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD-------K 171
++ + + K + YL ++ ++H D+KP NIL+D K+ DFG++ L D
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 172 GC---MAPECYKRTPIS-------VKADVYGYGIVLLE 199
GC MAPE R ++ADV+ GI L+E
Sbjct: 176 GCAAYMAPE---RIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 8e-08
Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 11/90 (12%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD-------- 170
++++ V +G+ YL ++ + I+H D+KP NIL++ K+ DFG++ L D
Sbjct: 107 KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 164
Query: 171 -KGCMAPECYKRTPISVKADVYGYGIVLLE 199
+ M+PE + T SV++D++ G+ L+E
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-08
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 13/91 (14%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK--------- 171
A + G+ +LH I++ D+KP+N+L+D+ +ISD GLA L
Sbjct: 101 AAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157
Query: 172 -GCMAPECYKRTPISVKADVYGYGIVLLETI 201
G MAPE + D + G L E I
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMI 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 15/99 (15%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM 174
Q V +A +A+G+ YL +H D+ +NIL+ E KI+DFGLA+L+ D
Sbjct: 103 PQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159
Query: 175 ------------APECYKRTPISVKADVYGYGIVLLETI 201
APE ++K+DV+ +GI+L E +
Sbjct: 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 23/63 (36%), Positives = 35/63 (55%), Gaps = 4/63 (6%)
Query: 109 ERNPYWNQRVR-IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167
E P +V+ + KG+ Y+H I+H D+KP N+L+ KI+DFGLA+L
Sbjct: 92 EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARL 148
Query: 168 LSD 170
S+
Sbjct: 149 FSE 151
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 13/91 (14%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK--------- 171
A ++ G+ LH E I++ D+KP+NIL+D++ +ISD GLA + +
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT 164
Query: 172 -GCMAPECYKRTPISVKADVYGYGIVLLETI 201
G MAPE K + D +G G ++ E I
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 16/116 (13%)
Query: 99 DLAYIIFCSAERNPYWNQ--RVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 156
DL Y I+ E NP + + + G+ +LH + I++ D+KP+N+L+D
Sbjct: 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGN 135
Query: 157 AKISDFGLAKLLSDK-----------GCMAPECYKRTPISVKADVYGYGIVLLETI 201
+ISD GLA L D G MAPE + D + G+ L E I
Sbjct: 136 VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 29/90 (32%), Positives = 53/90 (58%), Gaps = 11/90 (12%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD-------- 170
++++ V KG+ YL ++ + I+H D+KP NIL++ K+ DFG++ L D
Sbjct: 107 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 164
Query: 171 -KGCMAPECYKRTPISVKADVYGYGIVLLE 199
+ M+PE + T SV++D++ G+ L+E
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 26/72 (36%), Positives = 40/72 (55%), Gaps = 11/72 (15%)
Query: 139 ILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG------C-----MAPECYKRTPISVK 187
I++ D+KP+NIL+DE K++DFGL+K D C MAPE R +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 188 ADVYGYGIVLLE 199
AD + +G+++ E
Sbjct: 179 ADWWSFGVLMFE 190
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 13/88 (14%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL-------LSDKGCM-- 174
+ +G+ YLH + I+H D+K +NI +++ I D G A+ L G +
Sbjct: 166 ILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222
Query: 175 -APECYKRTPISVKADVYGYGIVLLETI 201
APE R + KAD++ GIVL E +
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 23/86 (26%), Positives = 37/86 (43%), Gaps = 15/86 (17%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM----------- 174
+G+ + H ILH D+KP+N+L++ K++DFGLA+
Sbjct: 109 QGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYR 165
Query: 175 APEC-YKRTPISVKADVYGYGIVLLE 199
APE S D++ G + E
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAE 191
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 18/41 (43%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
+G+ YLH ILH D+KP N+L+ K++DFGLA+
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 15/99 (15%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD---- 170
N+ + +A +A+G+ ++ +H D++ NIL+ E KI+DFGLA+L+ D
Sbjct: 102 NKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158
Query: 171 --KGC------MAPECYKRTPISVKADVYGYGIVLLETI 201
+G APE ++K+DV+ +GI+L E +
Sbjct: 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 15/98 (15%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK---- 171
Q + +A VA G+ YL + +H D+ +N+L+ E K++DFGLA+++ +
Sbjct: 104 QLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160
Query: 172 --------GCMAPECYKRTPISVKADVYGYGIVLLETI 201
APE S+K+DV+ +GI+L E +
Sbjct: 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 22/61 (36%), Positives = 33/61 (54%), Gaps = 10/61 (16%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPECYKRTPIS 185
+G+ +LH I+H D+KPQNIL+ KI+DFGLA++ S + T +
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-------MALTSVV 167
Query: 186 V 186
V
Sbjct: 168 V 168
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 30/99 (30%), Positives = 39/99 (39%), Gaps = 20/99 (20%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------------- 173
G+ YLH I+H DIK NIL D K+ DFG +K L
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 174 -MAPECYKRTPISVKADVYGYGIVLLETICC---WENME 208
M+PE KADV+ G ++E + W E
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 8e-07
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 14/96 (14%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM 174
NQ V + +A + YLH E ILH D+K QN+ + K+ D G+A++L ++ M
Sbjct: 102 NQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158
Query: 175 A-----------PECYKRTPISVKADVYGYGIVLLE 199
A PE + P + K+DV+ G + E
Sbjct: 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYE 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 8e-07
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 17/100 (17%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------ 168
+ RI V KG+ +L +E I+H D+KP N+L++ K+ DFG++ L
Sbjct: 102 DVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159
Query: 169 SDKGC---MAPECYK------RTPISVKADVYGYGIVLLE 199
++ GC MAPE K +V++DV+ G+ +LE
Sbjct: 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-07
Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 12/90 (13%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD-------- 170
RIA+ V KG+ YL ILH D+KP N+L++ K+ DFG++ L +
Sbjct: 99 RIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVG 155
Query: 171 -KGCMAPECYKRTPISVKADVYGYGIVLLE 199
MAPE + +DV+ GI +E
Sbjct: 156 TNAYMAPERISGEQYGIHSDVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-07
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 14/93 (15%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-------- 171
+ L V K + +LH + ++H DIK +IL+ K+SDFG +S +
Sbjct: 120 VCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176
Query: 172 GC---MAPECYKRTPISVKADVYGYGIVLLETI 201
G MAPE R P + D++ GI+++E +
Sbjct: 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 44/182 (24%), Positives = 86/182 (47%), Gaps = 41/182 (22%)
Query: 112 PYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD- 170
P + +++A ++A G+ YL+ + +H D+ +N ++ +T KI DFG+ + + +
Sbjct: 116 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172
Query: 171 -------KGC-----MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEII 218
KG MAPE K + +D++ +G+VL WE + A +P
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL------WEITSL-AEQP---- 221
Query: 219 LTNWVYKCFINRELNKLVR-GTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVM 272
Y+ N ++ K V G +D+ + + +L+++ C Q P +RP+ +V
Sbjct: 222 -----YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVN 273
Query: 273 ML 274
+L
Sbjct: 274 LL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 37/110 (33%), Positives = 55/110 (50%), Gaps = 23/110 (20%)
Query: 116 QRVRIALDVAKGILYLHDE-CEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM 174
Q V+ ALD A G+ YL + C +H D+ +N L+ E KISDFG+++ D G
Sbjct: 94 QLVKFALDAAAGMAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIY 148
Query: 175 APECYKRTPI-------------SVKADVYGYGIVLLET----ICCWENM 207
+ K+ PI S ++DV+ YGI+L ET +C + M
Sbjct: 149 SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 1e-06
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 11/81 (13%)
Query: 130 YLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC--------MAPECYKR 181
YLH I++ D+KP+N+L+D KI+DFG AK + + +APE
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILS 172
Query: 182 TPISVKADVYGYGIVLLETIC 202
D + GI++ E +
Sbjct: 173 KGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 19/94 (20%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKISDFGLAKLLSD-----K 171
V+I+L G+ ++HD ILH DIK QNI + + AK+ DFG+A+ L+D
Sbjct: 108 VQISL----GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160
Query: 172 GC------MAPECYKRTPISVKADVYGYGIVLLE 199
C ++PE + P + K D++ G VL E
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYE 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 19/92 (20%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL-AKLLSDK-------GC-- 173
+ + + +LH ++H D+K NIL+ K++DFG+ AK S G
Sbjct: 112 MLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY 168
Query: 174 -MAPE---C--YKRTPISVKADVYGYGIVLLE 199
MAPE C +K P KAD++ GI L+E
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 28/82 (34%), Positives = 45/82 (54%), Gaps = 14/82 (17%)
Query: 130 YLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD-----KGC------MAPEC 178
++HD ILH DIK QNI + + T K+ DFG+A++L+ + C ++PE
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172
Query: 179 YKRTPISVKADVYGYGIVLLET 200
+ P + K+D++ G VL E
Sbjct: 173 CENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 24/74 (32%), Positives = 40/74 (54%), Gaps = 7/74 (9%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIAL-DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 157
DL +II P + +R L + +G+ Y+H ++H D+KP N+L++E
Sbjct: 93 DLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCEL 146
Query: 158 KISDFGLAKLLSDK 171
+I DFG+A+ LS
Sbjct: 147 RIGDFGMARGLSSS 160
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 27/109 (24%), Positives = 48/109 (44%), Gaps = 22/109 (20%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMA---- 175
+ DV + + YL +H D+ +N L+ E K+SDFGLA+ + D +
Sbjct: 105 MCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161
Query: 176 --------PECYKRTPISVKADVYGYGIVLLETICC-------WENMEI 209
PE + + S K+DV+ +G+++ E + N E+
Sbjct: 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-06
Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 34/168 (20%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----- 170
Q V +A +A G+ Y+ +H D++ NIL+ E K++DFGLA+L+ D
Sbjct: 103 QLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159
Query: 171 -KGC------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV 223
+G APE ++K+DV+ +GI+L E + P
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE-------LTTKGRVP--------- 203
Query: 224 YKCFINRE-LNKLVRGTEV--DKKNLENLVKVGLWCVQDEPALRPSMK 268
Y +NRE L+++ RG + + E+L + C + EP RP+ +
Sbjct: 204 YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 3e-06
Identities = 19/48 (39%), Positives = 28/48 (58%), Gaps = 3/48 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
+G+ YLH ILH DIK NIL++ K++DFGLA+ + +
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 38/157 (24%), Positives = 67/157 (42%), Gaps = 28/157 (17%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM--------- 174
+A+G+ ++ +H D++ NIL+ KI+DFGLA+++ D
Sbjct: 111 IAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 167
Query: 175 ---APECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRE 231
APE ++K+DV+ +GI+L+E + S PE I R
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI------------RA 215
Query: 232 LNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
L + R + E L + + C ++ P RP+ +
Sbjct: 216 LERGYRMPRPENCP-EELYNIMMRCWKNRPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 31/100 (31%), Positives = 45/100 (45%), Gaps = 22/100 (22%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG-------- 172
+ +AKG+ YL E ++H D+ +N+L+ KI+DFGLAKLL
Sbjct: 115 CVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG 171
Query: 173 -----CMAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
MA E + K+DV+ YG+ WE M
Sbjct: 172 KVPIKWMALESILHRIYTHKSDVWSYGVT------VWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 30/113 (26%), Positives = 47/113 (41%), Gaps = 26/113 (23%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA---KISDFGLAKLLSDKGC- 173
+ + +G+ YLH+ I+H D+K N+L+D T +I+DFG A L+ KG
Sbjct: 106 INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTG 160
Query: 174 --------------MAPECYKRTPISVKADVYGYGIVLLETICC---WENMEI 209
MAPE + DV+ G V++E W +
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 25/66 (37%), Positives = 32/66 (48%), Gaps = 11/66 (16%)
Query: 115 NQRVR--------IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
N V+ L + +GI YLH+ ILH DIK NIL+D KI+DFGLA+
Sbjct: 107 NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
Query: 167 LLSDKG 172
Sbjct: 164 PYDGPP 169
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 13/85 (15%)
Query: 128 ILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-----DKG---C-----M 174
+L +H ++H DIK NIL+ K+ DFG +K+ + D G C +
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 175 APECYKRTPISVKADVYGYGIVLLE 199
APE ++R P S KAD++ G++L E
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYE 237
|
Length = 496 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 13/91 (14%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK--------- 171
A ++ G+ LH E ++ D+KP+NIL+D++ +ISD GLA + +
Sbjct: 108 AAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT 164
Query: 172 -GCMAPECYKRTPISVKADVYGYGIVLLETI 201
G MAPE ++ D +G G ++ E I
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 26/83 (31%), Positives = 38/83 (45%), Gaps = 13/83 (15%)
Query: 130 YLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG-----C-----MAPECY 179
YLH+ I++ D+KP+N+L+D K+ DFG AK L C +APE
Sbjct: 108 YLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEII 164
Query: 180 KRTPISVKADVYGYGIVLLETIC 202
D + GI+L E +
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 28/103 (27%), Positives = 46/103 (44%), Gaps = 24/103 (23%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGCM 174
R+ L V + H++ I+H D+KPQNI++ AK+ DFG+ LL
Sbjct: 82 GRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138
Query: 175 ------------------APECYKRTPISVKADVYGYGIVLLE 199
APE + P++ +D+Y +G++ LE
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 15/98 (15%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----- 170
V +A VA G+ Y+ +H D++ NIL+ + KI+DFGLA+L+ D
Sbjct: 103 NLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159
Query: 171 -KGC------MAPECYKRTPISVKADVYGYGIVLLETI 201
+G APE ++K+DV+ +GI+L E +
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 13/96 (13%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK-----LLSD 170
Q ++ A DVA G+ YL ++ +H D+ +N+L+ E +KI+DFGL++ +
Sbjct: 120 QLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKT 176
Query: 171 KG-----CMAPECYKRTPISVKADVYGYGIVLLETI 201
G MA E + + K+DV+ +G++L E +
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-06
Identities = 25/92 (27%), Positives = 46/92 (50%), Gaps = 15/92 (16%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM----- 174
+ LDV +G+ YL ++H D+ +N L+ E K+SDFG+ + + D
Sbjct: 105 MCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161
Query: 175 -------APECYKRTPISVKADVYGYGIVLLE 199
+PE + + S K+DV+ +G+++ E
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWE 193
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 34/167 (20%)
Query: 124 VAKGILYLHDE-CEPPILHCDIKPQNILMDEFWTAKISDFGLAK-LLSD-----KGC--- 173
VAKG+ +L + C +H D+ +N+L+ KI DFGLA+ +++D KG
Sbjct: 150 VAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN 229
MAPE + ++DV+ YGI+L WE + ++ + + + YK
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILL------WEIFSLGSNPYPGMPVDSKFYK---- 255
Query: 230 RELNKLVRGTEVDKKNL--ENLVKVGLWCVQDEPALRPSMKCVVMML 274
+ G + + + + C +P RP+ K +V ++
Sbjct: 256 ----LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 5e-06
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 14/97 (14%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK---- 171
Q + L V + + YLH++ ++H DIK +IL+ K+SDFG +S +
Sbjct: 119 QIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175
Query: 172 -------GCMAPECYKRTPISVKADVYGYGIVLLETI 201
MAPE R P + D++ GI+++E I
Sbjct: 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 14/84 (16%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMA----------- 175
G+ ++H++ +LH DIK +NI + + K+ DFG A+LL+ G A
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVP 168
Query: 176 PECYKRTPISVKADVYGYGIVLLE 199
PE ++ P + K+D++ G +L E
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 36/116 (31%), Positives = 57/116 (49%), Gaps = 13/116 (11%)
Query: 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155
L D A+ I S Q + A DVA+G+ YL + +H D+ +NIL+ E +
Sbjct: 105 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENY 161
Query: 156 TAKISDFGLAK-----LLSDKG-----CMAPECYKRTPISVKADVYGYGIVLLETI 201
AKI+DFGL++ + G MA E + + +DV+ YG++L E +
Sbjct: 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-06
Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 15/90 (16%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD------KGC---- 173
+A+G+ Y+ + +H D++ N+L+ E KI+DFGLA+++ D +G
Sbjct: 112 IAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI 168
Query: 174 --MAPECYKRTPISVKADVYGYGIVLLETI 201
APE ++K+DV+ +GI+L E +
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 7e-06
Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 38/166 (22%)
Query: 79 SSVAMR-GSKPSTEAALDLPWDLAYIIFCSAERNPYW----NQRVRIALDVAKGILYLHD 133
+ V MR S S++++ + W + +R + VA+G+ +L
Sbjct: 180 TYVEMRPVSSSSSQSSDSK---------DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS 230
Query: 134 E-CEPPILHCDIKPQNILMDEFWTAKISDFGLAK-LLSD-----KG-------CMAPECY 179
+ C +H D+ +N+L+ + AKI DFGLA+ +++D KG MAPE
Sbjct: 231 KNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 286
Query: 180 KRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225
+V++DV+ YGI+L WE + S I++ + YK
Sbjct: 287 FDCVYTVQSDVWSYGILL------WEIFSLGKSPYPGILVNSKFYK 326
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-06
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 15/98 (15%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----- 170
Q V +A +A G+ Y+ +H D++ NIL+ + KI+DFGLA+L+ D
Sbjct: 103 QLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159
Query: 171 -KGC------MAPECYKRTPISVKADVYGYGIVLLETI 201
+G APE ++K+DV+ +GI+L E +
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-06
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 13/91 (14%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK--------- 171
A ++ G+ ++H+ +++ D+KP NIL+DE +ISD GLA S K
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 159
Query: 172 GCMAPECYKR-TPISVKADVYGYGIVLLETI 201
G MAPE ++ T AD + G +L + +
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 9e-06
Identities = 40/173 (23%), Positives = 74/173 (42%), Gaps = 35/173 (20%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPE 177
VR +D+A G+ YL + +H D+ +N +++E T ++DFGL+K +
Sbjct: 116 VRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 178 CYKRTPI-------------SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
C + P+ + +DV+ +G+ + WE M + Y
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTM------WEIMTRGQTP----------Y 216
Query: 225 KCFINREL-NKLVRGTEVDK--KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
N E+ N L++G + + LE++ ++ C EP RPS + + L
Sbjct: 217 AGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 34/117 (29%), Positives = 55/117 (47%), Gaps = 17/117 (14%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168
Q + A + +G+ YLH + +H D+ +N+L+D KI DFGLAK +
Sbjct: 108 QLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164
Query: 169 --SDKG-----CMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEII 218
+ G A EC K S +DV+ +G+ L E + ++ + K EE+I
Sbjct: 165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 19/107 (17%)
Query: 107 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
S +R ++ + ALD YLH E +++ D+K +N+++D+ KI+DFGL K
Sbjct: 93 SEDRARFYGAEIVSALD------YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 144
Query: 167 L-LSDKGCM----------APECYKRTPISVKADVYGYGIVLLETIC 202
+ D M APE + D +G G+V+ E +C
Sbjct: 145 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 35/171 (20%)
Query: 112 PYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD- 170
P + +++A ++A G+ YL+ +H D+ +N ++ E +T KI DFG+ + + +
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 172
Query: 171 -------KGC-----MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEII 218
KG M+PE K + +DV+ +G+VL WE + A +P
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL------WEIATL-AEQP---- 221
Query: 219 LTNWVYKCFINRELNKLV-RGTEVDKKN--LENLVKVGLWCVQDEPALRPS 266
Y+ N ++ + V G +DK + + L ++ C Q P +RPS
Sbjct: 222 -----YQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 28/109 (25%), Positives = 41/109 (37%), Gaps = 32/109 (29%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA------------ 165
+ I + I Y+H + +LH D+KP NIL+ F I D+G A
Sbjct: 116 LSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 166 -----------------KLLSDKGCMAPECYKRTPISVKADVYGYGIVL 197
K++ MAPE P S D+Y G++L
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 30/107 (28%), Positives = 47/107 (43%), Gaps = 22/107 (20%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
Q V + +A G+ YL + +H D+ +NIL++ K+SDFGL++ L D
Sbjct: 105 VGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161
Query: 174 -------------MAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
APE + +DV+ +GIV+ WE M
Sbjct: 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVM------WEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 16/99 (16%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK-------L 167
+ ++++LD A G+ YL + +H D+ +N L+ E KISDFG+++
Sbjct: 93 KKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149
Query: 168 LSDK------GCMAPECYKRTPISVKADVYGYGIVLLET 200
+SD APE + ++DV+ YGI+L ET
Sbjct: 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 20/107 (18%)
Query: 107 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
S +R ++ + AL YLH C+ +++ D+K +N+++D+ KI+DFGL K
Sbjct: 93 SEDRARFYGAEIVSALG------YLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCK 143
Query: 167 L-LSDKGCM----------APECYKRTPISVKADVYGYGIVLLETIC 202
+SD M APE + D +G G+V+ E +C
Sbjct: 144 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 20/45 (44%), Positives = 25/45 (55%), Gaps = 7/45 (15%)
Query: 127 GILYLHDECEPPILHCDIKPQNILM----DEFWTAKISDFGLAKL 167
G+ YLH +LH D+KP NIL+ E KI D GLA+L
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 16/91 (17%)
Query: 122 LDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--------SDKG- 172
+ +AKG++YL E ++H D+ +N+L+ KI+DFGLA+LL +D G
Sbjct: 116 VQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGK 172
Query: 173 ----CMAPECYKRTPISVKADVYGYGIVLLE 199
MA EC + ++DV+ YG+ + E
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWE 203
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 26/93 (27%), Positives = 40/93 (43%), Gaps = 17/93 (18%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG-------- 172
A+ +A G+ YL + +H D+ +NIL+ KI DFGL + L
Sbjct: 103 AVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159
Query: 173 ------CMAPECYKRTPISVKADVYGYGIVLLE 199
APE + S +DV+ +G+ L E
Sbjct: 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWE 192
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 19/41 (46%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
+GI Y H +LH D+KPQN+L+D K++DFGLA+
Sbjct: 110 QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 29/89 (32%), Positives = 44/89 (49%), Gaps = 13/89 (14%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK--------- 171
A ++ G+ ++H+ +++ D+KP NIL+DE +ISD GLA S K
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 159
Query: 172 GCMAPECY-KRTPISVKADVYGYGIVLLE 199
G MAPE K AD + G +L +
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFK 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 17/93 (18%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--------SDKG 172
A VA G+ YL +H D+ +N+L+ AKISDFG+++ L +
Sbjct: 101 AHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157
Query: 173 ------CMAPECYKRTPISVKADVYGYGIVLLE 199
APEC S K+DV+ YG+ L E
Sbjct: 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 29/96 (30%), Positives = 45/96 (46%), Gaps = 16/96 (16%)
Query: 117 RVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA-KLLSDKGC-- 173
++ IA VA G+ YL + +H D+ +N L+ E KI+DFGL+ + S
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 174 ----------MAPECYKRTPISVKADVYGYGIVLLE 199
M PE + ++DV+ YG+VL E
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 224
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 25/84 (29%), Positives = 44/84 (52%), Gaps = 13/84 (15%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM----------A 175
+G+ +LH C I+H D+KP+NIL+ K++DFGLA++ S + + A
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 176 PECYKRTPISVKADVYGYGIVLLE 199
PE ++ + D++ G + E
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 19/47 (40%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG 172
+ I Y H I+H DIKP+NIL+ E K+ DFG A+ L +
Sbjct: 111 QAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-05
Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK-----LLSD 170
Q + A DVA+G+ YL + +H D+ +NIL+ E + AKI+DFGL++ +
Sbjct: 113 QLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 169
Query: 171 KG-----CMAPECYKRTPISVKADVYGYGIVLLETI 201
G MA E + + +DV+ YG++L E +
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 29/90 (32%), Positives = 41/90 (45%), Gaps = 17/90 (18%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---------- 173
V+ G+ YL +H D+ +N+L+ AKISDFGL+K L
Sbjct: 104 VSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLE 199
APEC S ++DV+ YGI + E
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 35/113 (30%), Positives = 53/113 (46%), Gaps = 13/113 (11%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158
DL + I+ E + V A ++ G+ LH E I++ D+KP+NIL+D+ +
Sbjct: 86 DLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIR 142
Query: 159 ISDFGLAKLLSDK----------GCMAPECYKRTPISVKADVYGYGIVLLETI 201
ISD GLA + + G MAPE K + D + G +L E I
Sbjct: 143 ISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 17/100 (17%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG--- 172
Q V + +A G+ YL D +H D+ +NIL++ K+SDFGL+++L D
Sbjct: 107 QLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163
Query: 173 -----------CMAPECYKRTPISVKADVYGYGIVLLETI 201
APE + +DV+ YGIV+ E +
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 10/84 (11%)
Query: 123 DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK--LLSDK-----GCMA 175
+V G+ LH I+H DIKP+N+L+D+ K++DFGL++ L + K +A
Sbjct: 105 EVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLA 161
Query: 176 PECYKRTPISVKADVYGYGIVLLE 199
PE +D + G V+ E
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFE 185
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 18/51 (35%), Positives = 30/51 (58%), Gaps = 3/51 (5%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
+ L + +G+ YLH+ I+H D+K N+L+ + KI+DFGLA+
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 29/90 (32%), Positives = 43/90 (47%), Gaps = 17/90 (18%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK------------ 171
V+ G+ YL E +H D+ +N+L+ AKISDFGL+K L
Sbjct: 104 VSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160
Query: 172 --GCMAPECYKRTPISVKADVYGYGIVLLE 199
APEC S K+DV+ +G+++ E
Sbjct: 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 20/50 (40%), Positives = 32/50 (64%), Gaps = 3/50 (6%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169
+A + GI YLH I+H DIKP N+L++ KI+DFG++++L+
Sbjct: 173 VARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219
|
Length = 353 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 27/80 (33%), Positives = 41/80 (51%), Gaps = 11/80 (13%)
Query: 130 YLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG---CMAPECYKRTPISV 186
YLH + I++ D+KP+N+L+D K++DFG AK + D+ C PE I
Sbjct: 133 YLH-SKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQS 189
Query: 187 KA-----DVYGYGIVLLETI 201
K D + G++L E I
Sbjct: 190 KGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 22/115 (19%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--SDKGC 173
Q V +A+ +A G+ YLH ++H DI +N ++DE KI+D L++ L D C
Sbjct: 118 QLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 174 -----------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEI 217
MA E S +DV+ +G++L WE M + + EI
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL------WELMTLGQTPYVEI 223
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 44/174 (25%), Positives = 68/174 (39%), Gaps = 40/174 (22%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKISDFGLAK-------- 166
+ A DVAKG YL E +H DI +N L+ AKI+DFG+A+
Sbjct: 119 LFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175
Query: 167 ------LLSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILT 220
+L K M PE + + K DV+ +G++ WE +
Sbjct: 176 RKGGRAMLPIK-WMPPEAFLDGIFTSKTDVWSFGVL------LWEIFSLGYMP------- 221
Query: 221 NWVYKCFINRE-LNKLVRGTEVDK-KNLENLV-KVGLWCVQDEPALRPSMKCVV 271
Y N+E + + G +D K V ++ C Q P RP+ ++
Sbjct: 222 ---YPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 38/171 (22%), Positives = 71/171 (41%), Gaps = 43/171 (25%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---- 173
+ A +++G+ YL E ++H D+ +N+L+ E KISDFGL++ + ++
Sbjct: 130 ISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR 186
Query: 174 ---------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDAS-----KPEEIIL 219
MA E + ++DV+ +G++ WE + + + PE
Sbjct: 187 SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVL------LWEIVTLGGNPYPGIAPE---- 236
Query: 220 TNWVYKCFINRELNKLVRGTEVDKKN--LENLVKVGLWCVQDEPALRPSMK 268
R N L G +++ E + + L C + EP RP+
Sbjct: 237 ----------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA 277
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 28/86 (32%), Positives = 38/86 (44%), Gaps = 13/86 (15%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPEC---YKRTP 183
GI +LH I+H D+KP NI++ T KI DFGLA+ M P Y R P
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 186
Query: 184 -------ISVKADVYGYGIVLLETIC 202
D++ G ++ E I
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 11/80 (13%)
Query: 128 ILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG---C-----MAPECY 179
+ YLH + I++ D+KP+NIL+D+ K++DFG AK L D+ C +APE
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVI 170
Query: 180 KRTPISVKADVYGYGIVLLE 199
+ + D + GI++ E
Sbjct: 171 QSKGHNKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 16/96 (16%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK-----LLSDKG 172
+++ + A G+ YL + +H D+ +N L+ E KISDFG+++ + + G
Sbjct: 97 IQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153
Query: 173 CM--------APECYKRTPISVKADVYGYGIVLLET 200
M APE S ++DV+ +GI+L E
Sbjct: 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEA 189
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 34/97 (35%), Positives = 43/97 (44%), Gaps = 16/97 (16%)
Query: 116 QRVRIA---LDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG 172
Q V IA +G+ YLH +H DIK NIL+ E T K++DFG A L+S
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169
Query: 173 C-------MAPE---CYKRTPISVKADVYGYGIVLLE 199
MAPE K DV+ GI +E
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 36/173 (20%), Positives = 71/173 (41%), Gaps = 35/173 (20%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD-----KG 172
++ +D+A G+ YL + +H D+ +N ++ E T ++DFGL+K + +G
Sbjct: 116 LKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG 172
Query: 173 C--------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
+A E + K+DV+ +G+ + WE + Y
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM------WEIATRGQTP----------Y 216
Query: 225 KCFINREL-NKLVRGTEVDKKN--LENLVKVGLWCVQDEPALRPSMKCVVMML 274
N E+ + L G + + L+ L + C + +P RP+ + +L
Sbjct: 217 PGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 6e-05
Identities = 34/109 (31%), Positives = 48/109 (44%), Gaps = 24/109 (22%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-SDKGCM-------- 174
+ KG+ YL +H D+ +NIL++ KI DFGL K+L DK
Sbjct: 117 ICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 175 -----APECYKRTPISVKADVYGYGIVLLE--TICCWENMEIDASKPEE 216
APE + SV +DV+ +G+VL E T + S P E
Sbjct: 174 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYS-----DKSCSPPAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 36/171 (21%)
Query: 121 ALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAK-LLSD-----KG- 172
+ VA+G+ +L +C +H D+ +NIL+ E KI DFGLA+ + D KG
Sbjct: 179 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 173 ------CMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226
MAPE + ++DV+ +G++L WE + AS +
Sbjct: 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLL------WEIFSLGASPYPGVQ-------- 280
Query: 227 FINREL-NKLVRGTEVDKKN--LENLVKVGLWCVQDEPALRPSMKCVVMML 274
I+ E +L GT + + + L C + P RP+ +V +L
Sbjct: 281 -IDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 6e-05
Identities = 19/40 (47%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
GIL+ H +LH D+KPQN+L+D K++DFGLA+
Sbjct: 113 GILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 7e-05
Identities = 30/103 (29%), Positives = 51/103 (49%), Gaps = 19/103 (18%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-SDKGCM 174
Q+++ A+ + KG+ YL +H D+ +N+L++ KI DFGL K + +DK
Sbjct: 110 QQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 166
Query: 175 -------------APECYKRTPISVKADVYGYGIVLLE--TIC 202
APEC ++ + +DV+ +G+ L E T C
Sbjct: 167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 7e-05
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL------LSDKGC- 173
A +VA I YLH I++ D+KP+NIL+D ++DFGL K + C
Sbjct: 102 AAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETI 201
+APE ++ P D + G VL E +
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 18/41 (43%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
+G+ Y H +LH D+KPQN+L+ E K++DFGLA+
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-05
Identities = 35/118 (29%), Positives = 52/118 (44%), Gaps = 19/118 (16%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK---- 171
Q V + +A G+ YL E +H D+ +NIL++ K+SDFGL++ L D
Sbjct: 107 QLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163
Query: 172 ------GC------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEI 217
G APE + +DV+ YGIV+ E + E D S + I
Sbjct: 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 7e-05
Identities = 18/41 (43%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
+G+ YLH ++H D+KP NIL++ KI DFGLA+
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 8e-05
Identities = 28/86 (32%), Positives = 39/86 (45%), Gaps = 13/86 (15%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPEC---YKRTP 183
GI +LH I+H D+KP NI++ T KI DFGLA+ M P Y R P
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 184 ISV-------KADVYGYGIVLLETIC 202
+ D++ G ++ E I
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 8e-05
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 16/95 (16%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--SDK---- 171
+ IA+ +A G+ YL +H D+ +N L+ E T KISDFGL++ + +D
Sbjct: 127 LHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 172 -------GCMAPECYKRTPISVKADVYGYGIVLLE 199
M PE + ++D++ +G+VL E
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 8e-05
Identities = 27/98 (27%), Positives = 41/98 (41%), Gaps = 22/98 (22%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL-LSDKGC--------- 173
+ + YLH I+H D+KP NIL+D K++DFGL+K+ L +
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 174 ---------MAPECYKRTPISVKADVYGYGIVLLETIC 202
+APE S D + G +L E +
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 9e-05
Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 14/97 (14%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK------LLS 169
Q V A +++ G+ +LH I++ D+K N+++D KI+DFG+ K + +
Sbjct: 102 QAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158
Query: 170 DKGC-----MAPECYKRTPISVKADVYGYGIVLLETI 201
C +APE P D + YG++L E +
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 9e-05
Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 20/107 (18%)
Query: 107 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
S +R ++ + ALD YLH I++ D+K +N+++D+ KI+DFGL K
Sbjct: 93 SEDRTRFYGAEIVSALD------YLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK 143
Query: 167 L-LSDKGCM----------APECYKRTPISVKADVYGYGIVLLETIC 202
++D M APE + D +G G+V+ E +C
Sbjct: 144 EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 24/73 (32%), Positives = 34/73 (46%), Gaps = 11/73 (15%)
Query: 115 NQRVRIALDVAK--------GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
N+ V+ L K G+ Y+H ILH D+K NIL+ + K++DFGLA+
Sbjct: 111 NKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
Query: 167 LLSDKGCMAPECY 179
S P Y
Sbjct: 168 AFSLSKNSKPNRY 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 14/89 (15%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA-----------KLLSDKG 172
V + + YLH + ++H DIK +IL+ K+SDFG L+
Sbjct: 126 VLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY 182
Query: 173 CMAPECYKRTPISVKADVYGYGIVLLETI 201
MAPE RTP + D++ GI+++E +
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 20/107 (18%)
Query: 107 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
+ ER ++ + AL+ YLH +++ DIK +N+++D+ KI+DFGL K
Sbjct: 93 TEERARFYGAEIVSALE------YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 143
Query: 167 L-LSDKGCM----------APECYKRTPISVKADVYGYGIVLLETIC 202
+SD M APE + D +G G+V+ E +C
Sbjct: 144 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 26/105 (24%), Positives = 49/105 (46%), Gaps = 15/105 (14%)
Query: 107 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
+ +Q + + DV +G+ YL + +H D+ +N L+D+ K+SDFGL++
Sbjct: 92 EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148
Query: 167 LLSDKGCM------------APECYKRTPISVKADVYGYGIVLLE 199
+ D PE + S K+DV+ +G+++ E
Sbjct: 149 YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE 193
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 15/103 (14%)
Query: 111 NPYWNQRVRI--ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168
NP ++++ I A ++ G+ L E I++ D+KP+NIL+D+ +ISD GLA +
Sbjct: 96 NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI 152
Query: 169 SDK----------GCMAPECYKRTPISVKADVYGYGIVLLETI 201
+ G MAPE + D +G G ++ E I
Sbjct: 153 PEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 14/93 (15%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK---LLSDKG---C- 173
A ++ G+ +LH E I++ D+K N+L+D KI+DFG+ K L C
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETIC 202
+APE P D + G++L E +
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA 191
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 27/95 (28%), Positives = 47/95 (49%), Gaps = 16/95 (16%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----KGC 173
V A VA+G+ +L + +H D+ +N+L+ E KI+DFGLA+ + +
Sbjct: 135 VSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 174 ---------MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE + ++DV+ +G++L E
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167
+G+ YLH ILH DIKP N+L++ KI DFGLA++
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 17/88 (19%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK--------GC---M 174
KG+ YLH E +H DIK NIL+ E K++DFG++ L+ G M
Sbjct: 112 KGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWM 168
Query: 175 APECY---KRTPISVKADVYGYGIVLLE 199
APE ++ K D++ GI +E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 17/114 (14%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG--- 172
Q V + +A G+ YL D +H D+ +NIL++ K+SDFGL+++L D
Sbjct: 108 QLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164
Query: 173 -----------CMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPE 215
APE + +DV+ +GIV+ E + E D S E
Sbjct: 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 28/97 (28%), Positives = 44/97 (45%), Gaps = 14/97 (14%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA---------- 165
Q + L V K + LH + ++H DIK +IL+ K+SDFG
Sbjct: 117 QIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173
Query: 166 -KLLSDKGCMAPECYKRTPISVKADVYGYGIVLLETI 201
L+ MAPE R P + D++ GI+++E +
Sbjct: 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 15/94 (15%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK------ 171
+ +A ++ + YL + +H D+ +N L+ E K++DFGL++L++
Sbjct: 107 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163
Query: 172 ------GCMAPECYKRTPISVKADVYGYGIVLLE 199
APE S+K+DV+ +G++L E
Sbjct: 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 197
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 17/41 (41%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
KG+ + H +LH D+KPQN+L+++ K++DFGLA+
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 17/90 (18%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKISDFGLAKLLSD--------KGC- 173
+ +G+ YLHD I+H DIK N+L++ + KISDFG +K L+ G
Sbjct: 117 ILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTL 173
Query: 174 --MAPECYKRTP--ISVKADVYGYGIVLLE 199
MAPE + P AD++ G ++E
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVE 203
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 19/41 (46%), Positives = 29/41 (70%), Gaps = 3/41 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
KGI + H E +LH D+KPQN+L+++ K++DFGLA+
Sbjct: 111 KGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 26/103 (25%), Positives = 48/103 (46%), Gaps = 12/103 (11%)
Query: 109 ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168
E++ + ++ +A+D KG+ L+ P + ++ + L+ E + KI GL K+L
Sbjct: 116 EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKIL 173
Query: 169 S-----DKGCMAPECYKR-----TPISVKADVYGYGIVLLETI 201
S + M YK + ++K D+Y G+VL E
Sbjct: 174 SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
|
Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 23/58 (39%), Positives = 33/58 (56%), Gaps = 4/58 (6%)
Query: 116 QRVRIAL-DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG 172
RVR L + +GI + H I+H DIKP+NIL+ + K+ DFG A+ L+ G
Sbjct: 100 SRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 20/44 (45%), Positives = 30/44 (68%), Gaps = 3/44 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169
+G+ Y H + ILH D+KPQN+L++E K++DFGLA+ S
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 18/45 (40%), Positives = 29/45 (64%), Gaps = 3/45 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
K + Y+H ++H D+KP NIL++ K++DFGLA+ LS+
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 36/171 (21%)
Query: 121 ALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAK-LLSD-----KGC 173
+ VA+G+ +L +C +H D+ +NIL+ E KI DFGLA+ + D KG
Sbjct: 180 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 174 -------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226
MAPE + ++DV+ +G++L WE + AS +
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLL------WEIFSLGASPYPGVQ-------- 281
Query: 227 FINRELNKLVR-GTEVDKKNLEN--LVKVGLWCVQDEPALRPSMKCVVMML 274
IN E + ++ GT + + ++ L C Q +P RP+ +V +L
Sbjct: 282 -INEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 26/97 (26%), Positives = 46/97 (47%), Gaps = 18/97 (18%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG-LAKLLSDKGC--------- 173
+A+ +L +H + +H DIKP+N+L+D K++DFG A+L ++K
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167
Query: 174 --MAPEC------YKRTPISVKADVYGYGIVLLETIC 202
+APE + V+ D + G++ E I
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY 204
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 18/104 (17%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC- 173
NQ + + G+ Y+H + ILH D+K +NI + KI DFG+++LL C
Sbjct: 106 NQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGS-CD 160
Query: 174 -----------MAPECYKRTPISVKADVYGYGIVLLETICCWEN 206
M+PE K K+D++ G +L E +CC +
Sbjct: 161 LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYE-MCCLAH 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 33/108 (30%), Positives = 50/108 (46%), Gaps = 27/108 (25%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-----TAKISDFGLAKLL--SD 170
+ I LDVAKG +YL +H D+ +N L+ E KI DFGLA+ + SD
Sbjct: 109 LDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD 165
Query: 171 ----KG-------CMAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
+G MAPE + ++DV+ +G++ WE +
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVL------MWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 26/103 (25%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--SDKGCMAPECYKR 181
+AKG+ YL + ++H ++ +NIL+ +I+DFG+A LL DK E +
Sbjct: 118 IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH--K 172
Query: 182 TPI-------------SVKADVYGYGIVLLETICCWENMEIDA 211
TPI + ++DV+ YG+ + WE M A
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTV------WEMMSYGA 209
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 35/115 (30%), Positives = 51/115 (44%), Gaps = 15/115 (13%)
Query: 105 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164
+ +A+RN + I V + I YLH E I+H DIK +NI ++ + DFG
Sbjct: 172 YLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGA 228
Query: 165 AKLLSD---------KGCMA---PECYKRTPISVKADVYGYGIVLLETICCWENM 207
A D G +A PE R P D++ GIVL E C +++
Sbjct: 229 ACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 16/89 (17%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL--------LSDKGCMA 175
+ +G+ Y+H ++H D+KP NIL++E KI DFGLA++ +S + A
Sbjct: 117 ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRA 173
Query: 176 PE---CYKRTPISVKADVYGYGIVLLETI 201
PE +++ V+ D++ G + E +
Sbjct: 174 PEIMLTWQK--YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 43/184 (23%), Positives = 75/184 (40%), Gaps = 33/184 (17%)
Query: 108 AERNP----YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG 163
AE N +Q + IA +A G++YL + +H D+ +N L+ E KI DFG
Sbjct: 109 AEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 165
Query: 164 LAKLLSDKG-------------CMAPECYKRTPISVKADVYGYGIVLLETICCWENMEID 210
+++ + M PE + ++DV+ G+VL WE
Sbjct: 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL------WEIFTY- 218
Query: 211 ASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCV 270
+P + N V +C + + R + + + L C Q EP +R ++K +
Sbjct: 219 GKQPWYQLSNNEVIECITQGRVLQRPRTCP------KEVYDLMLGCWQREPHMRLNIKEI 272
Query: 271 VMML 274
+L
Sbjct: 273 HSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG------C- 173
A ++A + YLH I++ D+KP+NIL+D ++DFGL K + C
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETI 201
+APE ++ P D + G VL E +
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 24/93 (25%), Positives = 43/93 (46%), Gaps = 17/93 (18%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD--------- 170
+ DV +G+ YL +H D+ +N L+ K+SDFG+ + + D
Sbjct: 105 MCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161
Query: 171 ----KGCMAPECYKRTPISVKADVYGYGIVLLE 199
K PE + + S K+DV+ +G+++ E
Sbjct: 162 KFPVKWS-PPEVFNFSKYSSKSDVWSFGVLMWE 193
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 13/88 (14%)
Query: 122 LDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM------- 174
+ +G+ +LH ++H D+KPQNIL+ K++DFGLA++ S + +
Sbjct: 117 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 173
Query: 175 ---APECYKRTPISVKADVYGYGIVLLE 199
APE ++ + D++ G + E
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 25/93 (26%), Positives = 41/93 (44%), Gaps = 20/93 (21%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---------- 173
+ G+ YLH+ C ++H DIK N+++ K+ DFG A+ L+ G
Sbjct: 111 ILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167
Query: 174 -------MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE + K+D++ G + E
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFE 200
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 14/90 (15%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK--LLSDKG----C- 173
A ++A G+ +LH + I++ D+K N+++D KI+DFG+ K + K C
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG 163
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLE 199
+APE P D + +G++L E
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 18/90 (20%)
Query: 124 VAKGILYLHDE-CEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD------KG---- 172
VAKG+ +L + C +H D+ +NIL+ KI DFGLA+ + + KG
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 173 ---CMAPECYKRTPISVKADVYGYGIVLLE 199
MAPE + ++DV+ YGI+L E
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWE 308
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 22/53 (41%), Positives = 34/53 (64%), Gaps = 4/53 (7%)
Query: 118 VRIAL-DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169
V+I L + +G+ Y H +LH D+KPQN+L++E K++DFGLA+ S
Sbjct: 106 VKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 20/47 (42%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG 172
+G+ Y+H +LH D+KP N+L++ KI DFGLA+ S+KG
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 19/44 (43%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169
+G+ Y H +LH D+KPQN+L++E K++DFGLA+ S
Sbjct: 115 RGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 35/110 (31%), Positives = 54/110 (49%), Gaps = 23/110 (20%)
Query: 122 LDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--------SDKG- 172
+ +AKG+ YL E ++H D+ +N+L+ KI+DFGLA+LL +D G
Sbjct: 116 VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172
Query: 173 ----CMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEII 218
MA E + ++DV+ YG+ + WE M A KP + I
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTV------WELMTFGA-KPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 18/41 (43%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
+G+ Y+H + ILH D+KPQN+L+ K++DFGLA+
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 16/41 (39%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
+G+ + H +LH D+KPQN+L++ K++DFGLA+
Sbjct: 111 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 23/106 (21%)
Query: 122 LDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--------SDKG- 172
+ +AKG+ YL + ++H D+ +N+L+ KI+DFGLAKLL ++ G
Sbjct: 116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 173 ----CMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKP 214
MA E + ++DV+ YG+ + WE M SKP
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTV------WELMTF-GSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 5e-04
Identities = 15/43 (34%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
+ +G+ ++H H D+KP+N+L+ KI+DFGLA+
Sbjct: 108 ILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 25/92 (27%), Positives = 46/92 (50%), Gaps = 14/92 (15%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK------LLSDKGC- 173
A ++A G+ +LH + I++ D+K N+++D KI+DFG+ K + + C
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCG 163
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETI 201
+APE P D + +G++L E +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 29/92 (31%), Positives = 41/92 (44%), Gaps = 17/92 (18%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK-----LLSDKGC----- 173
+ +G+ YLH I+H DIK NIL D K+ DFG +K LS G
Sbjct: 115 ILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETI 201
M+PE KAD++ G ++E +
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 19/92 (20%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL-AKLLSDKG---------- 172
+G+ YLH+ ++H DIK QNIL+ + K+ DFG+ A+L S G
Sbjct: 122 TLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178
Query: 173 CMAPE---C-YKRTP-ISVKADVYGYGIVLLE 199
MAPE C + ++DV+ GI +E
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 27/94 (28%), Positives = 41/94 (43%), Gaps = 12/94 (12%)
Query: 139 ILHCDIKPQNILMDEFWTAKISDFGLAK--------LLSDKGCMAPECYKRTPISVKADV 190
+H D+KP+N L+D K++DFGL+K ++ MAPE + D
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDY 181
Query: 191 YGYGIVLLETICCWENMEIDASKPEEII--LTNW 222
+ G +L E +C + S P E L W
Sbjct: 182 WSLGCMLYEFLCGFP--PFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 20/42 (47%), Positives = 28/42 (66%), Gaps = 4/42 (9%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTA-KISDFGLAK 166
+GI Y H +LH D+KPQN+L+D A K++DFGLA+
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 8e-04
Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK---LLSDKGC---- 173
A ++A + YLH I++ D+KP+NIL+D ++DFGL K SD
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETI 201
+APE ++ P D + G VL E +
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 8e-04
Identities = 28/84 (33%), Positives = 37/84 (44%), Gaps = 13/84 (15%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-------MAPE- 177
+G+ YLH ++H DIK NIL+ E K++DFG A S MAPE
Sbjct: 132 QGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEV 188
Query: 178 --CYKRTPISVKADVYGYGIVLLE 199
K DV+ GI +E
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIE 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 8e-04
Identities = 24/93 (25%), Positives = 44/93 (47%), Gaps = 14/93 (15%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------- 173
A ++ +++LHD+ I++ D+K N+L+D K++DFG+ K G
Sbjct: 102 AAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETIC 202
+APE + D + G++L E +C
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 9e-04
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 34/159 (21%)
Query: 124 VAKGILYLHDE-CEPPILHCDIKPQNILMDEFWTAKISDFGLAK-LLSD-----KGC--- 173
VA+G+ +L + C +H D+ +N+L+ + KI DFGLA+ ++ D KG
Sbjct: 246 VARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN 229
MAPE + +DV+ YGI+L WE + + +I+ + Y
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILL------WEIFSLGGTPYPGMIVDSTFY----- 350
Query: 230 RELNKLVRGTEVDKKN--LENLVKVGLWCVQDEPALRPS 266
NK+ G + K + + + + + C EP RPS
Sbjct: 351 ---NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 35/167 (20%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG----- 172
+ IA+ +A G+ YL +H D+ +NIL+ E KISD GL++ +
Sbjct: 127 LHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 173 --------CMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
M PE S +D++ +G+VL WE +P Y
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL------WEIFSF-GLQP---------Y 227
Query: 225 KCFINRELNKLVRGTEV---DKKNLENLVKVGLWCVQDEPALRPSMK 268
F N+E+ ++VR ++ + + + C Q+ P+ RP K
Sbjct: 228 YGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFK 274
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 18/41 (43%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
+G+ Y+H ILH D+KPQN+L+ + K++DFGLA+
Sbjct: 114 RGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 16/82 (19%)
Query: 131 LHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM-------------APE 177
+H ++H D+K NI + K+ DFG +K SD + APE
Sbjct: 185 VHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 178 CYKRTPISVKADVYGYGIVLLE 199
++R S KAD++ G++L E
Sbjct: 242 LWERKRYSKKADMWSLGVILYE 263
|
Length = 478 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.001
Identities = 24/77 (31%), Positives = 32/77 (41%), Gaps = 22/77 (28%)
Query: 139 ILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM----------APEC------YKRT 182
I H DIKP+NIL+ K++DFG + + K APEC Y
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY--- 176
Query: 183 PISVKADVYGYGIVLLE 199
K D++ G V E
Sbjct: 177 --GPKMDIWAVGCVFFE 191
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 18/40 (45%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
G+ +LHD ILH D+K N+L++ KI DFGLA+
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 29/86 (33%), Positives = 41/86 (47%), Gaps = 19/86 (22%)
Query: 130 YLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA----KLLSDKGC-------MAPEC 178
YLH I+H D+K N+L+ K++DFG++ K L + MAPE
Sbjct: 125 YLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEV 181
Query: 179 -----YKRTPISVKADVYGYGIVLLE 199
K TP KAD++ GI L+E
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 24/106 (22%)
Query: 121 ALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAK-LLSD-----KG- 172
+ VAKG+ +L +C +H D+ +NIL+ E KI DFGLA+ + D KG
Sbjct: 185 SFQVAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 173 ------CMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDAS 212
MAPE ++++DV+ +G++L WE + AS
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLL------WEIFSLGAS 280
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 27/85 (31%), Positives = 39/85 (45%), Gaps = 13/85 (15%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPEC---YKRTP 183
GI +LH I+H D+KP NI++ T KI DFGLA+ M P Y R P
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191
Query: 184 ISV-------KADVYGYGIVLLETI 201
+ D++ G ++ E +
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 25/87 (28%), Positives = 44/87 (50%), Gaps = 12/87 (13%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK--GCMAPECYKR 181
+ +G+ Y+H I+H D+KP N+ ++E KI DFGLA+ D+ G +A Y+
Sbjct: 129 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 185
Query: 182 TPI-------SVKADVYGYGIVLLETI 201
I + D++ G ++ E +
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELL 212
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 30/92 (32%), Positives = 41/92 (44%), Gaps = 17/92 (18%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-----SDKGC----- 173
+ +G+ YLH I+H DIK NIL D K+ DFG +K L S G
Sbjct: 115 ILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETI 201
M+PE KADV+ G ++E +
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 22/90 (24%), Positives = 37/90 (41%), Gaps = 14/90 (15%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---------- 173
+ + ++H I+H DIKP N+ + K+ D GL + S K
Sbjct: 115 LCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 174 -MAPECYKRTPISVKADVYGYGIVLLETIC 202
M+PE + K+D++ G +L E
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 13/80 (16%)
Query: 99 DLAYIIFCSAERNPYWNQRVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWT 156
DLA ++ E+ P + R+ + +G+ Y+H +LH D+KP N+ ++ E
Sbjct: 101 DLANVL----EQGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLV 153
Query: 157 AKISDFGLAKLL----SDKG 172
KI DFGLA+++ S KG
Sbjct: 154 LKIGDFGLARIVDPHYSHKG 173
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 16/98 (16%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD---- 170
Q + I + + + YLH I+H D+K +NI +DE A + DFG A L
Sbjct: 185 EQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 171 ------KGCM---APECYKRTPISVKADVYGYGIVLLE 199
G + +PE P K D++ G+VL E
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
|
Length = 392 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.002
Identities = 19/46 (41%), Positives = 28/46 (60%), Gaps = 3/46 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK 171
+G+ Y+H I+H D+KP NI ++E KI DFGLA+ D+
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 27/92 (29%), Positives = 41/92 (44%), Gaps = 14/92 (15%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK-----------LLS 169
A ++A + YLH I++ D+KP+NIL+D ++DFGL K
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158
Query: 170 DKGCMAPECYKRTPISVKADVYGYGIVLLETI 201
+APE + P D + G VL E +
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 26/84 (30%), Positives = 37/84 (44%), Gaps = 15/84 (17%)
Query: 130 YLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-----------MAPEC 178
Y+H + ++H DIK NIL+ K+ DFG+A LL+ MAPE
Sbjct: 116 YIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV 172
Query: 179 YKR-TPISVKADVYGYGIVLLETI 201
KAD++ GI + E
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 18/96 (18%)
Query: 118 VRIALDVAKGILYLHDE-CEPPILHCDIKPQNILMDEFWTAKISDFGLAK-LLSD----- 170
V + VA G+ +L + C +H D+ +N+L+ E KI DFGLA+ ++ D
Sbjct: 242 VGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS 297
Query: 171 KGC-------MAPECYKRTPISVKADVYGYGIVLLE 199
KG MAPE + +DV+ +GI+L E
Sbjct: 298 KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.003
Identities = 15/33 (45%), Positives = 21/33 (63%)
Query: 140 LHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG 172
+H DIKP NIL+D K++DFGL K ++
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.004
Identities = 17/40 (42%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
G+ Y+H +LH D+KP N+L++ KI DFGLA+
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 20/72 (27%), Positives = 32/72 (44%), Gaps = 11/72 (15%)
Query: 139 ILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-----------MAPECYKRTPISVK 187
++H DIKP N+ + K+ D GL + S K M+PE + K
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 188 ADVYGYGIVLLE 199
+D++ G +L E
Sbjct: 187 SDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 16/95 (16%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD------- 170
V A VA+G+ YL + +H D+ +N+L+ E KI+DFGLA+ + +
Sbjct: 137 VSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 171 ------KGCMAPECYKRTPISVKADVYGYGIVLLE 199
MAPE + ++DV+ +G++L E
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.004
Identities = 21/74 (28%), Positives = 35/74 (47%), Gaps = 11/74 (14%)
Query: 139 ILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-----------MAPECYKRTPISVK 187
++H DIK NIL+ + K++DFG ++ + MAPE R K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 188 ADVYGYGIVLLETI 201
D++ GI+ +E +
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.004
Identities = 26/112 (23%), Positives = 46/112 (41%), Gaps = 24/112 (21%)
Query: 109 ERNPYWNQRVRI---ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165
+ N Y + + ++ + YL + +H DI +N+L+ K+ DFGL+
Sbjct: 98 QVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS 154
Query: 166 KLLSDKGC------------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
+ L D+ MAPE + +DV+ +G +C WE
Sbjct: 155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG------VCMWE 200
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 37.8 bits (87), Expect = 0.004
Identities = 28/84 (33%), Positives = 38/84 (45%), Gaps = 13/84 (15%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-------MAPE- 177
+G+ YLH ++H DIK NIL+ E K++DFG A + S MAPE
Sbjct: 136 QGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEV 192
Query: 178 --CYKRTPISVKADVYGYGIVLLE 199
K DV+ GI +E
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIE 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 37.8 bits (87), Expect = 0.004
Identities = 22/74 (29%), Positives = 35/74 (47%), Gaps = 11/74 (14%)
Query: 139 ILHCDIKPQNILMDEFWTAKISDFGL-----------AKLLSDKGCMAPECYKRTPISVK 187
++H DIK NIL+ + K++DFG + ++ MAPE R K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 188 ADVYGYGIVLLETI 201
D++ GI+ +E I
Sbjct: 197 VDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 274 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.67 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.46 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.44 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.11 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.01 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.95 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.89 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.83 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.8 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.67 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.62 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.48 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.31 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.86 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.85 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.78 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.62 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.56 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.3 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.02 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.95 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.92 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.86 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.64 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.18 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 95.47 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.47 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.16 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.02 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.6 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 93.49 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 90.47 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 89.57 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 89.49 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 89.46 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 88.81 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 88.33 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 87.45 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 86.25 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 85.93 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 85.6 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 84.28 | |
| PTZ00384 | 383 | choline kinase; Provisional | 83.77 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 83.48 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 82.95 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 81.34 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 80.91 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-55 Score=382.14 Aligned_cols=263 Identities=29% Similarity=0.446 Sum_probs=228.5
Q ss_pred chhhhhhhHHHHhhhccccccCCCCCCCCcchhHH-----HHHHHHHhcCCCC--CCcHHHHHHHHhcCCCCccceEeEE
Q 048314 9 SAWIARSSLCTKLRNFCRSSLNDRNSPRSKSVWSC-----MRALMATVNSPYS--PSRPLTLTSIVSRVSWTTDIEVSSV 81 (274)
Q Consensus 9 ~~~~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~-----~~~~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~ 81 (274)
...|++.+|..+|++|+.++++|+|+| |.||+| ...++|....... ..+|.+|+.++++++|||+|+|+||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggf--g~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGF--GTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCC--eEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 455999999999999999999999999 999999 1222333333222 4569999999999999999999999
Q ss_pred EEeCC-cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEe
Q 048314 82 AMRGS-KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKIS 160 (274)
Q Consensus 82 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~ 160 (274)
|.+.+ +++||||||++|||.++|+......++|..+.+|+.++|.||+|||..+.++|+|||||++|||++.++.+|++
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99998 59999999999999999997433389999999999999999999999988899999999999999999999999
Q ss_pred ccccceec------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh
Q 048314 161 DFGLAKLL------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI 228 (274)
Q Consensus 161 d~g~~~~~------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (274)
|||+++.. ++.+|+|||+...+..+.++||||||++++|+++|+.+.+... +.....+..|.+....
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHHH
Confidence 99998644 4567999999999999999999999999999999999887543 3344458889888888
Q ss_pred hhhhhhhhcCC----ccCH-HHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 229 NRELNKLVRGT----EVDK-KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 229 ~~~~~~~~~~~----~~~~-~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
++.+.+++|+. ..+. .....+..+..+|++.+|.+||+|.||+++|
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 88999999987 2332 5778899999999999999999999998875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=336.58 Aligned_cols=225 Identities=22% Similarity=0.289 Sum_probs=192.2
Q ss_pred ccCCCCCCCCcchhHH-----HHHHHHHhcC-CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHH
Q 048314 28 SLNDRNSPRSKSVWSC-----MRALMATVNS-PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLA 101 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~-----~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 101 (274)
+-||.|.| |.|+.| ..+.+|.++. ..+.+.|.+|+++|++|+|+|||+++|+|..+...+||||||++|||.
T Consensus 212 ~~LG~G~F--G~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 212 RELGSGQF--GEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHhcCCcc--ceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 33999999 999999 3444444444 456788999999999999999999999999988899999999999999
Q ss_pred HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------------
Q 048314 102 YIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------------ 169 (274)
Q Consensus 102 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------------ 169 (274)
+||.......++-...+.++.|||+|++||.++ ++|||||..+|||++.+..+||+|||+++...
T Consensus 290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kf 366 (468)
T KOG0197|consen 290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKF 366 (468)
T ss_pred HHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCC
Confidence 999976667799999999999999999999999 99999999999999999999999999999654
Q ss_pred CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc-CC--ccCHHH
Q 048314 170 DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVR-GT--EVDKKN 245 (274)
Q Consensus 170 ~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~ 245 (274)
...|+|||.+..+.++.++|||||||+||||+| |+.||..- .+...-+.++ +. +.|..|
T Consensus 367 PIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-----------------sn~ev~~~le~GyRlp~P~~C 429 (468)
T KOG0197|consen 367 PIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-----------------SNEEVLELLERGYRLPRPEGC 429 (468)
T ss_pred CceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-----------------CHHHHHHHHhccCcCCCCCCC
Confidence 235999999999999999999999999999987 67776432 1111111122 22 578899
Q ss_pred HHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 246 LENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 246 ~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
++++.++|..||+.+|++|||++.+...|
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l 458 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLREVL 458 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHHHH
Confidence 99999999999999999999999887643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=333.85 Aligned_cols=230 Identities=27% Similarity=0.345 Sum_probs=189.2
Q ss_pred cccCCCCCCCCcchhHH----HH-HHHHHhcCC-CC---CCcHHHHHHHHhcCCCCccceEeEEEEeCC-cceEEEEeCC
Q 048314 27 SSLNDRNSPRSKSVWSC----MR-ALMATVNSP-YS---PSRPLTLTSIVSRVSWTTDIEVSSVAMRGS-KPSTEAALDL 96 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~----~~-~~~~~~~~~-~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 96 (274)
...+|.|+| |.||+| .. +++|.+... .+ .+.|.+|+.+|++++|||||+++|+|.+.. ..++||||++
T Consensus 46 ~~~iG~G~~--g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 46 EEVLGSGSF--GTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhcccCCc--eeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 455999999 999998 22 333333322 11 447999999999999999999999999987 7999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-cccCCCCCCceEEcCCC-cEEEeccccceecC-----
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP-ILHCDIKPQNILMDEFW-TAKISDFGLAKLLS----- 169 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~-i~h~dl~~~nil~~~~~-~~kl~d~g~~~~~~----- 169 (274)
+|+|.+++.......+++..++.++.||+.|+.|||++ + |||||||++|+|++.++ ++||+|||+++...
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 99999999875467899999999999999999999999 7 99999999999999997 99999999996432
Q ss_pred ------CCCcCCCcccc--cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 ------DKGCMAPECYK--RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 ------~~~~~ape~~~--~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
|+.|||||++. ...|+.|+||||||+++|||++|+.||..... .. ... .. ...-.+ ..+
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~--~~~---~v-----~~~~~R-p~~ 267 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQ--VAS---AV-----VVGGLR-PPI 267 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HH--HHH---HH-----HhcCCC-CCC
Confidence 66799999999 56899999999999999999999999975411 00 000 10 001111 135
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
|..++..+..+|.+||+.||+.||++.+++.+|
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence 566889999999999999999999999998765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=317.17 Aligned_cols=232 Identities=21% Similarity=0.225 Sum_probs=190.9
Q ss_pred hccccccCCCCCCCCcchhHH------HHHHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC-cceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC------MRALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS-KPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 92 (274)
+....+.+|.|.- |.|||+ ...+.|.+. .....++..+|++++++.+||+||++||.|..++ ...++|
T Consensus 80 dle~~~~lG~G~g--G~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNG--GTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCC--cEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 4455678999999 999999 222222221 1133455679999999999999999999999988 499999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEEecccccee----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL---- 167 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~---- 167 (274)
|||++|||++++.. -+.+++...-+++.++++||.|||. + +|+||||||+|+|+...+.+||+|||.+..
T Consensus 158 EYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999999986 3679999999999999999999996 6 999999999999999999999999999864
Q ss_pred -----cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCC-hhhHHHHHHHHHHHhhhhhhhhhcC--C
Q 048314 168 -----LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASK-PEEIILTNWVYKCFINRELNKLVRG--T 239 (274)
Q Consensus 168 -----~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~--~ 239 (274)
.+|..|||||.+.+..|+.++||||||+.++|+++|+.||...... .....+ +..++++ .
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L------------l~~Iv~~ppP 300 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL------------LCAIVDEPPP 300 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH------------HHHHhcCCCC
Confidence 4478899999999999999999999999999999999999754111 111111 1122221 1
Q ss_pred ccCHH-HHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 240 EVDKK-NLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 240 ~~~~~-~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..|.. +++++.+++..||++||.+|||+.|+++.
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 34554 88999999999999999999999999863
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=332.16 Aligned_cols=228 Identities=17% Similarity=0.234 Sum_probs=197.7
Q ss_pred hhccccccCCCCCCCCcchhHH----------HHHH-HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC----------MRAL-MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~----------~~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
..|...+++|+|+| .++|++ .+++ ++.+.+....+...+||++.++|+|||||+++++|++.+..||
T Consensus 18 ~~Y~~g~~LGkGgF--A~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGF--ARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcc--eEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 45888999999999 999988 2222 5555566778888999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
|+|+|.+++|..++++ .+.+++++++.+..||+.||.|||+. +|+|||||..|++++.+.++||+|||+|....
T Consensus 96 vLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999999984 56899999999999999999999999 99999999999999999999999999997654
Q ss_pred ----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 ----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 ----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
||.|.|||++....++..+||||+||++|.|+.|++||+.... +..+..+....
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v----------------kety~~Ik~~~ 234 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV----------------KETYNKIKLNE 234 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH----------------HHHHHHHHhcC
Confidence 8899999999998999999999999999999999999975411 11111111111
Q ss_pred -ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 -EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..|...+.+..+||..+|+.||.+|||+.+|+.
T Consensus 235 Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 356677788999999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=305.71 Aligned_cols=232 Identities=19% Similarity=0.225 Sum_probs=184.4
Q ss_pred ccccccCCCCCCCCcchhHH------HHHHHHHhcCC----C-----CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 24 FCRSSLNDRNSPRSKSVWSC------MRALMATVNSP----Y-----SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~~----~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
|-.++.+|.|.| |.|-++ ...++|++... . ......+|+++|++|+|||||++++++...+..
T Consensus 174 yii~~~LGsGaf--g~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 174 YIISKTLGSGAF--GLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred eEeeeeecCCce--eEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 334888999999 888777 11112222111 1 112235999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC---CcEEEeccccc
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF---WTAKISDFGLA 165 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~---~~~kl~d~g~~ 165 (274)
||||||+.||.|-+++-. ++.+.+..-+.++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||++
T Consensus 252 YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999986 56688888899999999999999999 99999999999999876 78999999999
Q ss_pred eecC----------CCCcCCCcccccCC---CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 166 KLLS----------DKGCMAPECYKRTP---ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 166 ~~~~----------~~~~~ape~~~~~~---~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
+..+ |+.|.|||++.... +..++|+||+||+||-+++|.+||.....+.. +.. .+..+
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l~e----QI~~G-- 397 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---LKE----QILKG-- 397 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---HHH----HHhcC--
Confidence 8764 78999999998754 34588999999999999999999975533321 111 11111
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+....+.....+++..+||.+||..||++|||++|+++
T Consensus 398 -~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 398 -RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111222355677889999999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=307.13 Aligned_cols=230 Identities=20% Similarity=0.184 Sum_probs=180.6
Q ss_pred hhhccccccCCCCCCCCcchhHH-------HHHHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC-------MRALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
.++|..++-||.|.| +.||+| .+++|.+..+ +...+....|+++|+.++|||||++++++++++..+|
T Consensus 9 ~~~y~~~~~iG~Gsf--avVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSF--AVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccceehhhccCcce--EEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 457777778999999 999999 2223222222 2345556799999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC------CcEEEecccc
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF------WTAKISDFGL 164 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~------~~~kl~d~g~ 164 (274)
|||||.||+|.+|++. .+.+++.+.+.++.|++.||++||++ +|+||||||.|||++.. -.+||+|||+
T Consensus 87 VMEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999999986 56899999999999999999999999 99999999999999765 5689999999
Q ss_pred ceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 165 AKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 165 ~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
++... ++.|||||++....|+.|+|+||.|+++|++++|+.||+... .. .+.. ..-.....
T Consensus 162 AR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t--~~--eL~~---~~~k~~~~-- 232 (429)
T KOG0595|consen 162 ARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET--PK--ELLL---YIKKGNEI-- 232 (429)
T ss_pred hhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC--HH--HHHH---HHhccccc--
Confidence 98765 678999999999999999999999999999999999997441 11 1111 10001000
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhh
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKC 269 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 269 (274)
+. ..+......+.+++...+..||.+|.+..+
T Consensus 233 -~~--~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 233 -VP--VLPAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred -cC--chhhhccCchhhhhhHHHhcCccccCchHH
Confidence 00 123333444556777777777777766554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=328.73 Aligned_cols=230 Identities=21% Similarity=0.232 Sum_probs=191.9
Q ss_pred ccccCCCCCCCCcchhHH------------HHHHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 26 RSSLNDRNSPRSKSVWSC------------MRALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 26 ~~~~~g~g~~~~g~vy~~------------~~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
...-+|+|.| |+||+| ++++|+..... +...+|.+|++.|..++|||||+|+|+|.+++..+||
T Consensus 490 ~~~eLGegaF--GkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 490 FKEELGEGAF--GKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred ehhhhcCchh--hhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 3456999999 999999 44444433332 3467899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEE
Q 048314 92 AALDLPWDLAYIIFCSA------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl 159 (274)
+|||.+|+|.+||..+. ...|+..+.+.++.|||.|+.||-++ .++||||-.+|||+.++..+||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEe
Confidence 99999999999998541 12288999999999999999999999 9999999999999999999999
Q ss_pred eccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHH
Q 048314 160 SDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYK 225 (274)
Q Consensus 160 ~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 225 (274)
+|||+++..- -.+||+||.+..++++.++|||||||+|||+++ |+.||... +..+.+ .
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl-Sn~EVI-------e 716 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL-SNQEVI-------E 716 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc-chHHHH-------H
Confidence 9999997543 246999999999999999999999999999986 88888644 111111 1
Q ss_pred HHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 226 CFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+.++... +.|..++.++.+||..||+.+|++|||++||-.+|
T Consensus 717 ~i~~g~lL------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L 759 (774)
T KOG1026|consen 717 CIRAGQLL------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRL 759 (774)
T ss_pred HHHcCCcc------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 22222221 47889999999999999999999999999997654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=300.12 Aligned_cols=224 Identities=20% Similarity=0.183 Sum_probs=192.5
Q ss_pred HHhhhccccccCCCCCCCCcchhHH----------HHHH-HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSC----------MRAL-MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~----------~~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
....+|...++||+|+| |+|+.+ ++++ |+.+....+.+...+|..+|.+++||.||++.-.|.+...
T Consensus 22 ~~~~dF~~lkviGkG~f--GkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSF--GKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred CChhheeeeeeeeccCC--ceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 34578999999999999 999988 5555 3344444567778899999999999999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
+|||+||+.||.|..+|++ ++.+++.....++.+|+.||.|||+. +|+||||||+|||++..|+++|+|||+++.
T Consensus 100 LylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchh
Confidence 9999999999999999985 67899999999999999999999999 999999999999999999999999999973
Q ss_pred -----------cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 168 -----------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 168 -----------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
.+|+.|||||++....|+..+|.||+|+++|||++|.+||...... .....+.
T Consensus 175 ~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----------------~~~~~I~ 238 (357)
T KOG0598|consen 175 DLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----------------KMYDKIL 238 (357)
T ss_pred cccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----------------HHHHHHh
Confidence 3378899999999999999999999999999999999999755211 1122222
Q ss_pred cCC--ccCHHHHHHHHHHHHHhhccCCCCCC
Q 048314 237 RGT--EVDKKNLENLVKVGLWCVQDEPALRP 265 (274)
Q Consensus 237 ~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp 265 (274)
..+ ..|.-.+.+..+++...|+.||++|-
T Consensus 239 ~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 239 KGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 222 23444678899999999999999995
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=295.34 Aligned_cols=235 Identities=19% Similarity=0.225 Sum_probs=187.2
Q ss_pred HhhhccccccCCCCCCCCcchhHH-------HHHHHHHh---cCCCCCCcHHHHHHHHhcCCCCccceEeEE-EEeCCc-
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSC-------MRALMATV---NSPYSPSRPLTLTSIVSRVSWTTDIEVSSV-AMRGSK- 87 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~- 87 (274)
...+|.....||.|.| |.||++ .++.|++- -+....+....|+.+|++|+|||||+++++ +.++..
T Consensus 17 ~l~~y~Il~~IG~GsF--g~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSF--GEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cHHHHHHHHHHcCCcc--hheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 3456778888999999 999999 33333321 111234556789999999999999999994 455555
Q ss_pred ceEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cccCCCCCCceEEcCCCcEEEeccc
Q 048314 88 PSTEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDEFWTAKISDFG 163 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~~~~~~kl~d~g 163 (274)
.+||||||.+|+|.+.++.. ..+.++++++|+++.|++.||..+|+. .+. ++||||||.||+++.++.+||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccch
Confidence 89999999999999999865 334599999999999999999999994 224 9999999999999999999999999
Q ss_pred cceecC-----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 164 LAKLLS-----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 164 ~~~~~~-----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
+++... ||.||+||.+...+|+.++||||+||++|||..-.+||... ++.. +...+.++..
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~-L~~KI~qgd~ 245 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLS-LCKKIEQGDY 245 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHH-HHHHHHcCCC
Confidence 998654 89999999999999999999999999999999999999744 1111 1111122211
Q ss_pred hhhhcCCccC-HHHHHHHHHHHHHhhccCCCCCCChhhHH
Q 048314 233 NKLVRGTEVD-KKNLENLVKVGLWCVQDEPALRPSMKCVV 271 (274)
Q Consensus 233 ~~~~~~~~~~-~~~~~~~~~li~~cl~~dp~~Rps~~evl 271 (274)
. +.| ...+.++..+|..|+..||+.||+...++
T Consensus 246 ~------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v 279 (375)
T KOG0591|consen 246 P------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYV 279 (375)
T ss_pred C------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHH
Confidence 1 234 67789999999999999999999854433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=297.75 Aligned_cols=235 Identities=20% Similarity=0.224 Sum_probs=185.0
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC--cceE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS--KPST 90 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 90 (274)
..++....++|+|.| |.||.+.. .++|..... ...+.+.+|+.+|++++|||||+++|...... ..++
T Consensus 16 ~~~~~~~~~lG~Gs~--G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSF--GSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccc--eEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 345666889999999 99999822 223322221 11344689999999999999999999854444 6899
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-CCcEEEeccccceec-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKISDFGLAKLL- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~d~g~~~~~- 168 (274)
.|||+++|||.+++.+... .++++.++.+..|+++||.|||++ +++|+||||+|||++. ++.+||+|||++...
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999998544 799999999999999999999999 9999999999999999 799999999977532
Q ss_pred -------------CCCCcCCCcccccCC-CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 -------------SDKGCMAPECYKRTP-ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 -------------~~~~~~ape~~~~~~-~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
+++.|||||++..+. ...++||||+||++.||+||..||... . ....+.........
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~-----~~~~~~~~ig~~~~--- 240 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F-----EEAEALLLIGREDS--- 240 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c-----chHHHHHHHhccCC---
Confidence 267799999998643 335999999999999999999999642 0 01111111111110
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
-| ++|...+.+..+++..|+..||++||||.++++.
T Consensus 241 --~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 241 --LP-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred --CC-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 11 4666788899999999999999999999999874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=300.98 Aligned_cols=236 Identities=16% Similarity=0.213 Sum_probs=186.0
Q ss_pred hhhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRG 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 85 (274)
.++|...+.||.|+| |.||++. ..++|..... ...+.+.+|+.++.++ +||||++++++|.+.
T Consensus 6 ~~~~~~~~~lG~G~f--g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAF--GKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCc--ceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 456777889999999 9999872 2334443322 1234577999999999 899999999998764
Q ss_pred -CcceEEEEeCCCCCHHHHHHhCC--------------------------------------------------------
Q 048314 86 -SKPSTEAALDLPWDLAYIIFCSA-------------------------------------------------------- 108 (274)
Q Consensus 86 -~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 108 (274)
+..+++|||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 45789999999999999997531
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-------------CC
Q 048314 109 ----ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-------------DK 171 (274)
Q Consensus 109 ----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-------------~~ 171 (274)
...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++... +.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 13478889999999999999999999 99999999999999999999999999986431 24
Q ss_pred CcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHH
Q 048314 172 GCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLV 250 (274)
Q Consensus 172 ~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (274)
.|+|||.+....++.++||||||+++|||++ |..||........ +. ....++.. ...+...++.+.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---~~----~~~~~~~~------~~~~~~~~~~l~ 307 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---FC----QRLKDGTR------MRAPENATPEIY 307 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---HH----HHHhcCCC------CCCCCCCCHHHH
Confidence 6999999988889999999999999999997 9999864321111 10 11111110 113345567899
Q ss_pred HHHHHhhccCCCCCCChhhHHhhC
Q 048314 251 KVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 251 ~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+++.+||+.||++|||+.||++.|
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l 331 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEIL 331 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=304.08 Aligned_cols=230 Identities=18% Similarity=0.172 Sum_probs=189.3
Q ss_pred hccccccCCCCCCCCcchhHH-------HHHHHHHhcCCCCCCc-HHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSPYSPSR-PLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~~~~~~-~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
.|..-..+|.|.- |.||.+ .+++++....++..++ .++|+.+|+..+|+|||+++..+...+.+++||||
T Consensus 274 ~y~~~~kigqgaS--G~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 274 KYTDFKKIGQGAT--GGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhcchhhhccccc--cceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4455666899998 999988 3333333333344444 46999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec------
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------ 168 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------ 168 (274)
|.+|+|.|.+.. ..+++.++..+++++++||+|||.+ +|+|||||.+|||+..++.+||+|||++...
T Consensus 352 m~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 352 MEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred cCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 999999999965 4599999999999999999999999 9999999999999999999999999998654
Q ss_pred -----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 169 -----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 169 -----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
+|+.|||||++....|+.++||||||++++||+.|.+||... .+-.... ....++. .+ -..+.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE-~PlrAly------LIa~ng~-P~----lk~~~ 493 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALY------LIATNGT-PK----LKNPE 493 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC-ChHHHHH------HHhhcCC-CC----cCCcc
Confidence 388999999999999999999999999999999999999643 1111111 1111111 00 03566
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 244 KNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+..+.+++.+||+.|+++|||+.|+|+
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 77889999999999999999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=297.50 Aligned_cols=244 Identities=18% Similarity=0.152 Sum_probs=191.8
Q ss_pred hhhccccccCCCCCCCCcchhHH-------HHHHHHHhcCCCCCCcH--HHHHHHHhcCC-CCccceEeEEEEeCC-cce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSPYSPSRP--LTLTSIVSRVS-WTTDIEVSSVAMRGS-KPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~~~~~~~--~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~ 89 (274)
.++|.....+|.|+| |.||++ .+|+|+..++-...++. ++|++.|++++ |||||++.+++.+.+ .++
T Consensus 9 m~RY~~i~klGDGTf--GsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTF--GSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcc--eeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 345666777999999 999999 56666666555555554 48999999999 999999999998887 899
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+|||||+ .+|++.++.+ +..|++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+++...
T Consensus 87 fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 9999997 5999999984 78899999999999999999999999 99999999999999988899999999998754
Q ss_pred ----------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH----------HHh
Q 048314 170 ----------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK----------CFI 228 (274)
Q Consensus 170 ----------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~ 228 (274)
|.-|+|||++.. +-|+.+.|+|++||+++|+.+-++.|... .+.+++.-.-.+.. ...
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~-sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA-SEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC-cHHHHHHHHHHHhCCCccccchhHHHH
Confidence 567999998764 57899999999999999999988888644 22221111000000 000
Q ss_pred hhhhh---hhhcCC----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 229 NRELN---KLVRGT----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 229 ~~~~~---~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
...+. ..+.+. ..+. ++.++.++|.+|+.+||++|||++|.+++
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00000 001111 1233 67899999999999999999999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=299.04 Aligned_cols=222 Identities=22% Similarity=0.222 Sum_probs=186.0
Q ss_pred cccCCCCCCCCcchhHH-----HHHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHH
Q 048314 27 SSLNDRNSPRSKSVWSC-----MRALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLA 101 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~-----~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 101 (274)
..-+|.|.- |.||.| .+++||...- -..+|+-|++|+|||||.+.|+|...+-+|||||||+.|-|+
T Consensus 129 LeWlGSGaQ--GAVF~Grl~netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQ--GAVFLGRLHNETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcc--cceeeeeccCceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 455899999 999999 4444443322 236899999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----------CC
Q 048314 102 YIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----------DK 171 (274)
Q Consensus 102 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----------~~ 171 (274)
.+|+. +..+.-...++|..+||.|+.|||.+ .|||||||..|||+..+-.+||+|||.++... |.
T Consensus 201 ~VLka--~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTV 275 (904)
T KOG4721|consen 201 EVLKA--GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTV 275 (904)
T ss_pred HHHhc--cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhH
Confidence 99985 56788899999999999999999999 99999999999999999999999999986543 67
Q ss_pred CcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHH
Q 048314 172 GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVK 251 (274)
Q Consensus 172 ~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (274)
.|||||++...+.+.|+|||||||+||||+||..||...+... .+| +.-.+.+. -+.|..+++.++-
T Consensus 276 aWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------IIw-----GVGsNsL~-LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 276 AWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------IIW-----GVGSNSLH-LPVPSTCPDGFKL 342 (904)
T ss_pred hhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-------eEE-----eccCCccc-ccCcccCchHHHH
Confidence 8999999999999999999999999999999999996431110 000 00001110 0467789999999
Q ss_pred HHHHhhccCCCCCCChhhHHhhC
Q 048314 252 VGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 252 li~~cl~~dp~~Rps~~evl~~L 274 (274)
|+++||+..|.+|||+.+++..|
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHH
Confidence 99999999999999999998764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=291.15 Aligned_cols=229 Identities=15% Similarity=0.147 Sum_probs=180.0
Q ss_pred cccCCCCCCCCcchhHH-----HHHHHHHhcCCCC----CCcHHHHHHHHhcCCCCccceEeEEEEe----CCcceEEEE
Q 048314 27 SSLNDRNSPRSKSVWSC-----MRALMATVNSPYS----PSRPLTLTSIVSRVSWTTDIEVSSVAMR----GSKPSTEAA 93 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~-----~~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e 93 (274)
...+++|++ +.||+| .++++........ .+.+.+|+.+|++++||||++++|++.+ ....++|||
T Consensus 25 ~~~i~~g~~--~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 25 SVLIKENDQ--NSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CeEEeeCCc--eEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 467899999 999999 2222221111112 2456699999999999999999999877 346799999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee------
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL------ 167 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~------ 167 (274)
|+++|+|.+++.. .+.+++.....++.|++.|+.|||+. .+++||||||+||+++.++.+|++|||+++.
T Consensus 103 y~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~ 178 (283)
T PHA02988 103 YCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178 (283)
T ss_pred eCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccccc
Confidence 9999999999975 45789999999999999999999973 1788999999999999999999999999864
Q ss_pred --cCCCCcCCCccccc--CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 168 --LSDKGCMAPECYKR--TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 168 --~~~~~~~ape~~~~--~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
.++..|+|||++.. ..++.++|||||||++|||++|..||.... .. .+.. ....... ....+.
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--~~--~~~~----~i~~~~~-----~~~~~~ 245 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--TK--EIYD----LIINKNN-----SLKLPL 245 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--HH--HHHH----HHHhcCC-----CCCCCC
Confidence 23567999999875 678999999999999999999999997431 11 1111 0100000 012344
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 244 KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.++..+.+++.+||+.||++|||+.|+++.|
T Consensus 246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred cCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 5678899999999999999999999999865
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=302.61 Aligned_cols=227 Identities=22% Similarity=0.233 Sum_probs=190.4
Q ss_pred hhccccccCCCCCCCCcchhHHHH-------HHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-------ALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-------~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
++|.....||+|+| |.||||.+ +++-+.+. ..+.+...+|++++++++|||||.+++||....++++|
T Consensus 2 e~yhv~e~iG~Gsf--g~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSF--GRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCcc--ceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 46777788999999 99999922 11111111 12233467999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
.|||.| +|..++.. ++.+++..+..++.|++.||.|||+. +|+|||+||.|||++..+++|++|||+++.++
T Consensus 80 te~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred ehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 999986 99999986 67899999999999999999999999 99999999999999999999999999997654
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh-cCC
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV-RGT 239 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (274)
++-|||||.+...+|+..+|+||+||++||+++|++||... .+...+ ..+. ++.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv---------~~I~~d~v 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQLV---------KSILKDPV 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHH---------HHHhcCCC
Confidence 78899999999999999999999999999999999999632 111111 1121 222
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..|...+..+.+++...|++||.+|.|..+++.
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 456677889999999999999999999998874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=324.84 Aligned_cols=229 Identities=24% Similarity=0.281 Sum_probs=190.0
Q ss_pred cccCCCCCCCCcchhHHH------------HHHHHH--hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 27 SSLNDRNSPRSKSVWSCM------------RALMAT--VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~------------~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
..+||+|.| |.||+|+ +++|.. ..+.+...+|++|..+|+.++|||||+++|+|.+...+++++
T Consensus 697 ~~~lG~G~F--G~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 697 LRVLGKGAF--GEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred eeeeccccc--cceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 578999999 9999991 222222 222255677999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 93 ALDLPWDLAYIIFCSA-----ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
|||.+|+|..||++.+ ...++...++.++.|+|.|..||++. +.+||||..+|||++....+||+|||+++.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHh
Confidence 9999999999999741 35589999999999999999999999 999999999999999999999999999984
Q ss_pred cC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 168 LS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 168 ~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
+. -.+|||||.+..+.++.|+|||||||++||+++ |..||... .+...+.. ....++
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~---~n~~v~~~----~~~ggR-- 922 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR---SNFEVLLD----VLEGGR-- 922 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc---chHHHHHH----HHhCCc--
Confidence 32 246999999999999999999999999999998 67888533 11111111 111110
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
-+.|..|++.+.++|.+||+.+|++||++..+++.+
T Consensus 923 -----L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~ 958 (1025)
T KOG1095|consen 923 -----LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQD 958 (1025)
T ss_pred -----cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhh
Confidence 147889999999999999999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=281.03 Aligned_cols=242 Identities=19% Similarity=0.163 Sum_probs=185.4
Q ss_pred hccccccCCCCCCCCcchhHH-------HHHHHHHhcCCCC---CCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSPYS---PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.|.....+|+|++ |.|||| .+|+++...+.++ .+-.++|+++|++++|||+|.++.+|......+||+
T Consensus 3 kYE~LgkvGEGSY--GvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 3 KYEKLGKVGEGSY--GVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred HHhhhhccccCcc--eEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 4556778999999 999999 4444555444322 233469999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
|||++ ++.+-|.. ...+++...++.++.|++.|+.|+|++ +++||||||+|||+..++.+||+|||+++...
T Consensus 81 E~~dh-TvL~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 81 EYCDH-TVLHELER-YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred eecch-HHHHHHHh-ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99986 55555655 356789999999999999999999999 99999999999999999999999999998766
Q ss_pred --------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH--------HHhhhh-
Q 048314 170 --------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK--------CFINRE- 231 (274)
Q Consensus 170 --------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~- 231 (274)
|..|+|||.+.+ ..|+..+|||++||++.||++|.+.|... +..+...+..-... .+....
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~-SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR-SDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc-chHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 445899999887 68999999999999999999999999644 22222222111111 111100
Q ss_pred -----hhhhhcCCc---cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 232 -----LNKLVRGTE---VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 232 -----~~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
++..-++.+ .-...+.-+.+++..||+.||.+|+|.+|++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 011111111 11122457889999999999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=304.91 Aligned_cols=229 Identities=21% Similarity=0.226 Sum_probs=187.1
Q ss_pred cccCCCCCCCCcchhHH---H-----H--HHHHHhc-----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 27 SSLNDRNSPRSKSVWSC---M-----R--ALMATVN-----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~---~-----~--~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
...+|+|.| |.||+| . . ++++... ......+|++|+++|++++|||||++||++.....+++|
T Consensus 162 ~kkLGeGaF--GeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 162 GKKLGEGAF--GEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cceeecccc--cEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 578999999 999999 1 1 1222211 123456688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
||+|.||+|.++|... ...++..++..++.+.+.||+|||+. +++||||-.+|||++.++.+||+|||+++...
T Consensus 240 mEl~~gGsL~~~L~k~-~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKN-KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred EEecCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 9999999999999973 33699999999999999999999999 99999999999999999999999999987653
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
...|+|||.+..+.|+.++|||||||++||+++ |..||..... ..+..++. .+ -.+.
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----~~v~~kI~---~~------~~r~ 382 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----YEVKAKIV---KN------GYRM 382 (474)
T ss_pred eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH----HHHHHHHH---hc------CccC
Confidence 246999999999999999999999999999988 7888864311 11111100 00 0111
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..|...+..+..++.+||..||++||||.++.+.|
T Consensus 383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 45667888999999999999999999999998753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=270.75 Aligned_cols=232 Identities=13% Similarity=0.114 Sum_probs=198.8
Q ss_pred HhhhccccccCCCCCCCCcchhHH-----------HHHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSC-----------MRALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~-----------~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
+.++|...+.+|+|.| |.||.+ .+++|..+........+.+|++|-+.|+||||+++|++|.+....
T Consensus 20 ~l~dfeigr~LgkgkF--G~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKF--GNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred chhhccccccccCCcc--ccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 4578999999999999 999998 233355666666778888999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
||++||.++|++...|.......+++.....+..|+|.||.|+|.. +++|||+||+|+|++..+.+|++|||.+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999999976667799999999999999999999999 9999999999999999999999999998654
Q ss_pred C---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 S---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ~---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
. +..|++||+..+..++..+|+|++|++.||++.|.+||...... ....++..-+
T Consensus 175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------etYkrI~k~~ 238 (281)
T KOG0580|consen 175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------ETYKRIRKVD 238 (281)
T ss_pred CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------HHHHHHHHcc
Confidence 3 66799999999999999999999999999999999999744211 1111111111
Q ss_pred -ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 -EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+|...+....++|.+|+..+|.+|.+..|+++
T Consensus 239 ~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 239 LKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 244566678899999999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.15 Aligned_cols=228 Identities=16% Similarity=0.177 Sum_probs=194.9
Q ss_pred cccCCCCCCCCcchhHH-------HHHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCC
Q 048314 27 SSLNDRNSPRSKSVWSC-------MRALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWD 99 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 99 (274)
.+.+|.|-+ |.||.| .++++....+....++|+.|+.+|+.++|||+|+|+|+|.....+|||+|||+.|+
T Consensus 272 khKLGGGQY--GeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 272 KHKLGGGQY--GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeccCCCcc--cceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 566999999 999999 44455555555678899999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----------
Q 048314 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---------- 169 (274)
Q Consensus 100 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---------- 169 (274)
|.+||.+.+...++--.++.|+.||..|+.||..+ ++|||||..+|||+..+-.+|++|||+++++.
T Consensus 350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGA 426 (1157)
T KOG4278|consen 350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGA 426 (1157)
T ss_pred HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCc
Confidence 99999987777788888999999999999999999 99999999999999999999999999999876
Q ss_pred --CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHH
Q 048314 170 --DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNL 246 (274)
Q Consensus 170 --~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (274)
...|+|||.+....++.|+|||+|||+|||+.| |-.||...+ +.+ +..++.++ .....|..|+
T Consensus 427 KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------lSq-VY~LLEkg------yRM~~PeGCP 492 (1157)
T KOG4278|consen 427 KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQ-VYGLLEKG------YRMDGPEGCP 492 (1157)
T ss_pred cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------HHH-HHHHHhcc------ccccCCCCCC
Confidence 235999999999999999999999999999976 778886431 111 11111111 1114788999
Q ss_pred HHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 247 ENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 247 ~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
+...+||+.||+++|.+||+++|+.+.
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHqa 519 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQA 519 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHHH
Confidence 999999999999999999999998654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=291.98 Aligned_cols=241 Identities=18% Similarity=0.155 Sum_probs=186.6
Q ss_pred hhhccccccCCCCCCCCcchhHH-------HHHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeC--Ccc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--SKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 88 (274)
...|.....||+|.| |.||++ ++|.||+.-+. ....-..+||.+|++|+||||++|.+...+. +.+
T Consensus 116 ~~~feki~kIGeGTy--g~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTY--GQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred hHHHHHHHHhcCcch--hheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 456777888999999 999999 34444422221 2233346999999999999999999999876 789
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
|||+|||++ +|..++.. ..-.|+..+++.++.|++.||.|+|++ +++|||||.+|||++++|.+||+|||++++.
T Consensus 194 YlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 999999986 89888875 556799999999999999999999999 9999999999999999999999999999865
Q ss_pred C------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh-----
Q 048314 169 S------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR----- 230 (274)
Q Consensus 169 ~------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 230 (274)
. |.-|+|||++.+. .|+..+|+||.||++.||+.|++.|+.. .+.....-++......
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~----tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR----TEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc----cHHHHHHHHHHHhCCCChhcc
Confidence 4 4459999999875 6999999999999999999999999753 1111111111111110
Q ss_pred ---hhh--hhhcCC--------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 231 ---ELN--KLVRGT--------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 231 ---~~~--~~~~~~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+. ..+.+. +.-...+....+|+..+|..||.+|.|+.++++
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000 111111 111122467789999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=284.72 Aligned_cols=234 Identities=16% Similarity=0.124 Sum_probs=186.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
.++|...+.+|+|+| |.||+|.. .++|..... .....+.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~ig~G~f--g~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRF--GELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCC--CeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 356777889999999 99998721 112222221 1224577999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++++|||.+...
T Consensus 82 ~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 82 MIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEEeCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999999976 345789999999999999999999999 9999999999999999999999999976532
Q ss_pred C------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 169 S------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 169 ~------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
. +..|+|||.+....++.++||||||+++||+++ |..||..... . ... ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~-~~~----~~~~~~----- 224 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---Q-DVI----KAVEDG----- 224 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---H-HHH----HHHHCC-----
Confidence 1 246999999988899999999999999999775 9999964311 0 011 111111
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ..+.+..++..+.+++..||+.+|++|||+.++++.|
T Consensus 225 ~-~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 225 F-RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred C-CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 0 1123445677899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=293.52 Aligned_cols=231 Identities=19% Similarity=0.184 Sum_probs=189.4
Q ss_pred HHhhhccccccCCCCCCCCcchhHH------HHHHHHHhcCC-------CCCCcHHHHHHHHhcCC-CCccceEeEEEEe
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSC------MRALMATVNSP-------YSPSRPLTLTSIVSRVS-WTTDIEVSSVAMR 84 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~~-------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 84 (274)
...+.|...+.+|.|.| |.|+.+ ...++|.++.. ...+...+|+.++++++ ||||++++.++..
T Consensus 14 ~~~g~y~~~~~lG~Gsf--gkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSF--GKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred cccCceeeeeeecCCCC--eeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 44567888999999999 999999 11222222221 12333458999999999 9999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC-CcEEEeccc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKISDFG 163 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~d~g 163 (274)
....++|||||.+|+|.+++.+ .+.+.+.....++.|++.|++|+|++ +|+||||||+|++++.+ +++||+|||
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999999986 67899999999999999999999999 99999999999999999 999999999
Q ss_pred cceec-C----------CCCcCCCcccccCC-Cc-cccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh
Q 048314 164 LAKLL-S----------DKGCMAPECYKRTP-IS-VKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR 230 (274)
Q Consensus 164 ~~~~~-~----------~~~~~ape~~~~~~-~~-~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
++... . ++.|+|||++.... |+ .++||||+|++||.|++|..||.... ......
T Consensus 167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-------~~~l~~------ 233 (370)
T KOG0583|consen 167 LSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-------VPNLYR------ 233 (370)
T ss_pred cccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------HHHHHH------
Confidence 99866 1 67899999999877 75 89999999999999999999997421 111111
Q ss_pred hhhhhhcCC-ccCHHH-HHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 231 ELNKLVRGT-EVDKKN-LENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 231 ~~~~~~~~~-~~~~~~-~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+.... .+|... +.++..++.+||..||.+|+|+.++++
T Consensus 234 ---ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 234 ---KIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---HHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 111121 344444 788999999999999999999999974
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=284.67 Aligned_cols=233 Identities=18% Similarity=0.202 Sum_probs=185.1
Q ss_pred ccccccCCCCCCCCcchhHHH------HHHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCM------RALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~------~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
|...+.+|+|+| |.||++. ..++|. .........+.+|+.++++++|+||+++++.+.+.+..++||
T Consensus 2 f~~~~~lg~G~~--g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGF--GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCC--EEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 556778999999 9999881 111111 111223345779999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
||+++|+|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999999988764445799999999999999999999999 9999999999999999999999999998653
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
++..|+|||++....++.++|||||||++|+|++|+.||.............. . ... .....+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~-----~~~--~~~~~~ 225 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR----R-----VKE--DQEEYS 225 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH----H-----hhc--ccccCC
Confidence 25679999999988999999999999999999999999975422111111100 0 000 011234
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCC-----hhhHHh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPS-----MKCVVM 272 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps-----~~evl~ 272 (274)
...+..+.+++.+||+.||++||| ++++++
T Consensus 226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 455678999999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=288.03 Aligned_cols=232 Identities=18% Similarity=0.162 Sum_probs=193.1
Q ss_pred HHHhhhccccccCCCCCCCCcchhHH----------HHHH-HHHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeC
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSC----------MRAL-MATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRG 85 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~----------~~~~-~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 85 (274)
...-+||.-...+|.|.| +.|+.+ .++. |+.+......+-...|-.+|.+| .||.|++|+--|.|.
T Consensus 69 kk~~~DF~Fg~~lGeGSY--StV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSY--STVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccc--eeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 334578888999999999 999998 2222 33333333445556899999999 699999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
..+|+|+||+++|+|.++|.. .+.|++...+.++.+|+.||.|||++ |||||||||+|||++.+++++|+|||.+
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred cceEEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 999999999999999999985 57899999999999999999999999 9999999999999999999999999998
Q ss_pred eecC------------------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHH
Q 048314 166 KLLS------------------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221 (274)
Q Consensus 166 ~~~~------------------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~ 221 (274)
+.+. |-.|.+||++.....++.+|+|+|||++|+|+.|.+||... .+..+..
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~----NeyliFq 297 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA----NEYLIFQ 297 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc----cHHHHHH
Confidence 7654 34599999999999999999999999999999999999643 1111111
Q ss_pred HHHHHHhhhhhhhhhcC-CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 222 WVYKCFINRELNKLVRG-TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 222 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
++++- -++|...++...+|+.+.|..||.+|+|+.||-+
T Consensus 298 ------------kI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 298 ------------KIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ------------HHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11111 1356666688999999999999999999998854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=310.18 Aligned_cols=229 Identities=21% Similarity=0.219 Sum_probs=194.0
Q ss_pred ccccccCCCCCCCCcchhHH---------HHHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSC---------MRALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~---------~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
...+.+||.|.| |.|++| .-+++|.++.. ..+.+|+.|+.||.++.||||++|.|+.......++|
T Consensus 631 i~Ie~VIGaGEF--GEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEF--GEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccc--cceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 344899999999 999999 11223333333 4577899999999999999999999999999989999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
.|||.+|+|+.||.. +++.+++.+++.|+++|+.|+.||.+. +++||||..+|||++.+..+|++|||+++.+.
T Consensus 709 TEyMENGsLDsFLR~-~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhhCCcHHHHHhh-cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999999998 556799999999999999999999999 99999999999999999999999999998764
Q ss_pred ------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 170 ------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 170 ------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
..+|+|||.+...+++..+||||||+++||+++ |..||-.- + ....+..+-
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm-S---------------NQdVIkaIe 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-S---------------NQDVIKAIE 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc-c---------------hHHHHHHHH
Confidence 136999999999999999999999999999775 88888522 0 011111222
Q ss_pred cCC--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 237 RGT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 237 ~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
++- +.|.+|+..|..||..||++|-.+||++.||+..|
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 222 57889999999999999999999999999998764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=298.13 Aligned_cols=236 Identities=17% Similarity=0.187 Sum_probs=185.7
Q ss_pred hhhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRG 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 85 (274)
.++|...+.||+|+| |.||+|. ..++|..... ...+.+.+|+.++..+ +||||++++++|.+.
T Consensus 34 ~~~~~~~~~LG~G~f--G~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAF--GKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCcc--ceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 347788899999999 9999872 1122222221 2234577999999999 799999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCC---------------------------------------------------------
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSA--------------------------------------------------------- 108 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 108 (274)
+..++|||||++|+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999997532
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 109 ----------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 109 ----------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 12478999999999999999999999 99999999999999999999999999986432
Q ss_pred ----------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 170 ----------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 170 ----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+..|+|||.+....++.++|+||||+++|||++ |..||...... ..... ...++. .
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~----~~~~~~-----~- 335 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYK----MIKEGY-----R- 335 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHH----HHHhCc-----c-
Confidence 235999999998899999999999999999998 88888543111 11111 111110 0
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+...+.++.+++.+||+.||++|||+.||+++|
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 012233456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=287.72 Aligned_cols=249 Identities=18% Similarity=0.183 Sum_probs=196.8
Q ss_pred hhhhhHHHHhhhccccccCCCCCCCCcchhHH------HHHHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEE
Q 048314 12 IARSSLCTKLRNFCRSSLNDRNSPRSKSVWSC------MRALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVA 82 (274)
Q Consensus 12 ~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 82 (274)
.+..+......+|.-...||.|.- +.||.+ .++++|.++ ...+.+...+|+.+|+.++||||++.+..|
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~s--a~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGAS--AVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred cccccCCCCccceeEEEEEeccce--eEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 344445566678888899999999 999998 222233222 112346678999999999999999999999
Q ss_pred EeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 83 MRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 83 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
..+..+++||.||.+||+.+.++..-..++++..+..++++++.||.|||.+ |.||||+|+.|||++.+|.+||+||
T Consensus 94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCc
Confidence 9999999999999999999999987667799999999999999999999999 9999999999999999999999999
Q ss_pred cccee---------------cCCCCcCCCccccc--CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH
Q 048314 163 GLAKL---------------LSDKGCMAPECYKR--TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225 (274)
Q Consensus 163 g~~~~---------------~~~~~~~ape~~~~--~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (274)
|.+.. .+++.|||||++.. ..|+.|+||||||++..|+++|..||... ++... .+..
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~--pPmkv----Ll~t 244 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY--PPMKV----LLLT 244 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC--ChHHH----HHHH
Confidence 87642 34788999999544 36899999999999999999999999743 22111 1111
Q ss_pred HHhhhhhh--hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 226 CFINRELN--KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 226 ~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+.+.... ....+..........+.+++..||++||.+|||++++++
T Consensus 245 -Lqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 245 -LQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -hcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111110 011111344455678999999999999999999999985
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=278.89 Aligned_cols=233 Identities=15% Similarity=0.174 Sum_probs=185.8
Q ss_pred hhccccccCCCCCCCCcchhHHHH-----HHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
.+|...+.+|.|+| |.||++.. .++|... .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~--~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQF--GVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcC--ceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 45666788999999 99998722 1122222 2223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++|+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 82 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 82 ENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999999975 234689999999999999999999999 99999999999999999999999999886432
Q ss_pred ------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 ------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 ------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
...|+|||.+....++.++|+||||+++|+|++ |+.||..... ...... ...+. ....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~~----i~~~~------~~~~~ 223 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEM----ISRGF------RLYRP 223 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH----HHCCC------CCCCC
Confidence 235999999988888999999999999999999 8889864311 111110 01100 01123
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+..+.+++.+||+.||++|||++++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 33456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=281.29 Aligned_cols=234 Identities=16% Similarity=0.173 Sum_probs=189.0
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
++|...+.+|.|++ |.||+|. ..++|... +....+.+.+|++++++++||||+++++++...+..+++|||
T Consensus 6 ~~~~~~~~ig~g~~--~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQY--GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCccc--ceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 45777888999999 9999872 12222222 222335678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+....
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999999865556699999999999999999999999 99999999999999999999999999886543
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||.+....++.++||||||+++|||++ |..||..... . ... ..... .. ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~--~~~----~~~~~-----~~-~~~~ 226 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--S--QVY----ELLEK-----GY-RMER 226 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--H--HHH----HHHHC-----CC-CCCC
Confidence 236999999988889999999999999999998 8888864311 1 110 11111 01 1124
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+.++.+++.+||+.||++|||+.+++++|
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 259 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAF 259 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 445668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=290.58 Aligned_cols=239 Identities=15% Similarity=0.102 Sum_probs=196.8
Q ss_pred hhhhHHHHhhhccccccCCCCCCCCcchhHH----------HHHHHH-HhcCCCCCCcHHHHHHHHhcCCCCccceEeEE
Q 048314 13 ARSSLCTKLRNFCRSSLNDRNSPRSKSVWSC----------MRALMA-TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSV 81 (274)
Q Consensus 13 ~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~----------~~~~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 81 (274)
...+.....++|.....||+|+| |.||.+ ++..+| ..-.....+..+.|..+|....+|+||+|+-.
T Consensus 132 R~~R~r~~~~DFe~Lk~IgkGAf--GeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 132 RLRRTRLSLDDFELLKVIGKGAF--GEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred HhccccCCcccchhheeeccccc--eeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 33444455689999999999999 999988 333322 23333566777899999999999999999999
Q ss_pred EEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEec
Q 048314 82 AMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISD 161 (274)
Q Consensus 82 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 161 (274)
|.+...+||||||.+||++..+|.. .+.|++.....++.+++.|+..+|+. |+|||||||+|+|++..|++||+|
T Consensus 210 FQD~~~LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 210 FQDKEYLYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred ecCCCeeEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence 9999999999999999999999985 67899999999999999999999999 999999999999999999999999
Q ss_pred cccceecC----------------------------------------------------------CCCcCCCcccccCC
Q 048314 162 FGLAKLLS----------------------------------------------------------DKGCMAPECYKRTP 183 (274)
Q Consensus 162 ~g~~~~~~----------------------------------------------------------~~~~~ape~~~~~~ 183 (274)
||++.... ||.|+|||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 99985311 56699999999999
Q ss_pred CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCC
Q 048314 184 ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPAL 263 (274)
Q Consensus 184 ~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~ 263 (274)
|+..+|.||+||++|||+.|.+||...........+.+|..... .| .....+.+.++||.+|+. ||++
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---------fP--~~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---------FP--EEVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---------CC--CcCcccHHHHHHHHHHhc-CHHH
Confidence 99999999999999999999999987644444455555543221 11 222334788999999999 9999
Q ss_pred CCC---hhhH
Q 048314 264 RPS---MKCV 270 (274)
Q Consensus 264 Rps---~~ev 270 (274)
|-- +.||
T Consensus 433 RLG~~G~~EI 442 (550)
T KOG0605|consen 433 RLGSKGAEEI 442 (550)
T ss_pred hcCcccHHHH
Confidence 964 5554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=286.77 Aligned_cols=242 Identities=19% Similarity=0.185 Sum_probs=184.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH----------------------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR----------------------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTD 75 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~----------------------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni 75 (274)
.++|...+.+|+|+| |.||+|.. .++|..... ....++.+|+.++.+++||||
T Consensus 4 ~~~~~~~~~lg~G~f--g~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQF--GEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCC--eEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 356677788999999 99998731 111222211 123457899999999999999
Q ss_pred ceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 048314 76 IEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSA-----------------ERNPYWNQRVRIALDVAKGILYLHDECEPP 138 (274)
Q Consensus 76 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ 138 (274)
+++++++.+.+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 999999999999999999999999999996531 12478899999999999999999999 9
Q ss_pred cccCCCCCCceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh--c
Q 048314 139 ILHCDIKPQNILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC--C 203 (274)
Q Consensus 139 i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~--g 203 (274)
++|+||||+||+++.++.+||+|||++.... +..|+|||++....++.++|+||||+++|+|++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999986432 346999999988889999999999999999987 4
Q ss_pred CCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 204 WENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 204 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..||.... . . ............... .. .. ..+..++..+.+++.+||+.||++|||+.+|...|
T Consensus 239 ~~p~~~~~--~-~-~~~~~~~~~~~~~~~-~~-~~-~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l 302 (304)
T cd05096 239 EQPYGELT--D-E-QVIENAGEFFRDQGR-QV-YL-FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302 (304)
T ss_pred CCCCCcCC--H-H-HHHHHHHHHhhhccc-cc-cc-cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 56665321 1 1 111111111111100 00 00 12334567899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=297.09 Aligned_cols=236 Identities=19% Similarity=0.196 Sum_probs=185.7
Q ss_pred hhhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRG 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 85 (274)
.++|...+.+|+|+| |.||++. ..++|..... ...+.+.+|+.+++.+ +|+|||+++++|.+.
T Consensus 37 ~~~~~~~~~LG~G~f--g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAF--GKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCc--ccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 357888999999999 9999762 1223333222 1124567899999999 799999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCC---------------------------------------------------------
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSA--------------------------------------------------------- 108 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 108 (274)
+..++|||||++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999986421
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--------
Q 048314 109 -----------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-------- 169 (274)
Q Consensus 109 -----------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-------- 169 (274)
...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 12478899999999999999999999 99999999999999999999999999986432
Q ss_pred -----CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 170 -----DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 170 -----~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
+..|+|||.+....++.++||||||+++|+|++ |+.||....... ... .....+ ... ..+.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~----~~~~~~-----~~~-~~~~ 338 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFY----KMVKRG-----YQM-SRPD 338 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHH----HHHHcc-----cCc-cCCC
Confidence 235999999988889999999999999999997 999996432111 010 000000 000 1222
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 244 KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+.++.+++.+||+.||++|||+.+|+++|
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 3357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=270.08 Aligned_cols=221 Identities=19% Similarity=0.179 Sum_probs=188.7
Q ss_pred hhhccccccCCCCCCCCcchhHH----------HHHH-HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC----------MRAL-MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~----------~~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|.....+|.|+| |+|..+ +++. +..+..-...+...+|..+|+.+.||.++++++.|.+.+..+
T Consensus 43 l~dfe~~~tlGtGSF--GrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSF--GRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred hhhhhheeeeccCcc--ceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 357788889999999 999876 3333 222333245566789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
|||||.+||.|..+++. .+.++++..+.++.|++.||.|||+. +|++|||||+|||++++|.+|++|||+++...
T Consensus 121 mvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999999985 57899999999999999999999999 99999999999999999999999999997644
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-c
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-E 240 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (274)
|+.|+|||.++..+++..+|.|+|||++|||+.|.+||..... . ....+++... .
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~------------~iY~KI~~~~v~ 259 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----I------------QIYEKILEGKVK 259 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----H------------HHHHHHHhCccc
Confidence 8999999999999999999999999999999999999975421 0 1122333333 4
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCC
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALR 264 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~R 264 (274)
+|...+.++.+|+...|+.|-.+|
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhh
Confidence 677777889999999999998888
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=286.84 Aligned_cols=229 Identities=20% Similarity=0.259 Sum_probs=179.1
Q ss_pred cccCCCCCCCCcchhHHHHH----------HHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 27 SSLNDRNSPRSKSVWSCMRA----------LMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~~----------~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
...||.|.| |.||+|... +++..... ...+.+.+|++.+++++||||++++|+|.+.+..++|+|
T Consensus 4 ~~~ig~G~f--g~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 4 IKQIGEGSF--GKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEESS--EEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred eeEEccCCC--cEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 467999999 999997332 23333222 124678899999999999999999999998888999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++|+|.+++.......+++..+..++.|++.||.|||+. +++|++|+++||+++.++.+||+|||++....
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999999985467899999999999999999999999 99999999999999999999999999987762
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
...|+|||.+....++.++||||||+++||+++ |..||... . ...+.. . ..+... .
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~-~~~~~~---~-~~~~~~------~ 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---D-NEEIIE---K-LKQGQR------L 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---C-HHHHHH---H-HHTTEE------T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---c-cccccc---c-cccccc------c
Confidence 346999999988889999999999999999999 67887533 1 111111 1 111111 1
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+..++..+.+++.+||+.||++|||+.++++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 23445678899999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=287.79 Aligned_cols=223 Identities=16% Similarity=0.151 Sum_probs=180.6
Q ss_pred ccCCCCCCCCcchhHHHH------HHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCC
Q 048314 28 SLNDRNSPRSKSVWSCMR------ALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
+++|+|+| |.||++.. .++|. .........+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~--g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTF--GKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCC--eEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 36899999 99998711 11111 1112233456789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-------- 168 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-------- 168 (274)
+|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 79 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 79 GGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 9999999975 45789999999999999999999999 9999999999999999999999999987642
Q ss_pred ---CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHH
Q 048314 169 ---SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKN 245 (274)
Q Consensus 169 ---~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (274)
+++.|+|||.+....++.++|+||+||++|||++|..||.... .. .+.. .... .....+...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~-~~~~----~~~~-------~~~~~p~~~ 218 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HE-KLFE----LILM-------EEIRFPRTL 218 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HH-HHHH----HHHc-------CCCCCCCCC
Confidence 3678999999998889999999999999999999999996431 11 1110 0000 111244556
Q ss_pred HHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 246 LENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 246 ~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
+.++.+++.+||+.||++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 67899999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=280.61 Aligned_cols=234 Identities=18% Similarity=0.201 Sum_probs=187.7
Q ss_pred hhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
++|.....+|.|++ |.||+|.. .++|..... .....+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAF--GKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccC--CcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 56777889999999 99998721 112222211 112457789999999999999999999999889
Q ss_pred ceEEEEeCCCCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC
Q 048314 88 PSTEAALDLPWDLAYIIFCSAE--------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 153 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~ 153 (274)
.+++|||+++|+|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 9999999999999999976321 4588999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHH
Q 048314 154 FWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIIL 219 (274)
Q Consensus 154 ~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~ 219 (274)
++.++|+|||++.... +..|+|||.+....++.++|+||||+++|||++ |..||..... . .+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~--~~ 235 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--Q--EV 235 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--H--HH
Confidence 9999999999986432 345999999988889999999999999999997 9999864311 1 11
Q ss_pred HHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 220 TNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. .+.++.. ...+..++.++.+++.+||+.||.+|||+.||+++|
T Consensus 236 ~~----~i~~~~~------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 236 IE----MIRSRQL------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred HH----HHHcCCc------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11 1111111 124456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=287.27 Aligned_cols=243 Identities=17% Similarity=0.181 Sum_probs=186.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|...+.+|.|+| |.||++.. .++|..... ...+++.+|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNG--GVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCC--EEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 367888899999999 99998721 122222211 1234578999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 82 MEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred eecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999999975 35689999999999999999999985 16999999999999999999999999988643
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh-------------
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN------------- 229 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 229 (274)
++..|+|||.+.+..++.++|+|||||++|+|++|+.||....... +..........
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhcccccccccCCccccCccc
Confidence 3668999999998889999999999999999999999996431110 10000000000
Q ss_pred ---------------------hhhhhhhc---CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 230 ---------------------RELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 230 ---------------------~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.....+.. +.......+.++.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 101122346789999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=277.22 Aligned_cols=235 Identities=16% Similarity=0.219 Sum_probs=188.4
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----HHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
.++|.....+|.|++ |.||++.. .++|... .....+.+.+|+.++++++|+||+++++.+.+.+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~--g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQF--GEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCC--ceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 356777888999999 99999832 1112111 222345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
+++++|.+++.......+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999875556789999999999999999999999 99999999999999999999999999987543
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||.+....++.++|+||||+++|+|++ |..||.... .. ..... .... .. .+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~-~~~~~----~~~~-----~~-~~~ 225 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NS-DVMSA----LQRG-----YR-MPR 225 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC---HH-HHHHH----HHcC-----CC-CCC
Confidence 235999999988888999999999999999998 899985331 11 11111 0110 00 112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+.++.+++.+||+.+|++|||++++.+.|
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 258 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 234557889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=287.11 Aligned_cols=230 Identities=16% Similarity=0.102 Sum_probs=185.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|.....+|.|+| |.||+|.. .++|. .......+.+.+|+.++++++||||+++++++.+++..+
T Consensus 17 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSF--GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred chheEEEEEEEecCC--eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 367788889999999 99998811 11111 112223456789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
+||||+++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 95 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999999985 45789999999999999999999999 9999999999999999999999999998754
Q ss_pred -------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 169 -------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 169 -------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+++.|+|||.+....++.++|+|||||++|+|++|..||.... . . ... .....+. ...
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~-~-~~~----~~i~~~~-------~~~ 234 (329)
T PTZ00263 170 DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--P-F-RIY----EKILAGR-------LKF 234 (329)
T ss_pred CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--H-H-HHH----HHHhcCC-------cCC
Confidence 3567999999998889999999999999999999999996431 1 0 000 0011110 023
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCC-----hhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPS-----MKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps-----~~evl~ 272 (274)
+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 235 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 3344567899999999999999997 677764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=275.73 Aligned_cols=235 Identities=20% Similarity=0.239 Sum_probs=189.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----HHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
+++|...+.+|.|++ |.||+|.. .++|... .....+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~--~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQF--GEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCC--ccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456777899999999 99998731 1122222 122345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
+++++|.+++.......+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999999864445699999999999999999999999 99999999999999999999999999987543
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
...|+|||.+....++.++|+||||+++++|++ |+.||.... .. .+.. ..... . ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~-~~~~----~~~~~-----~-~~~~ 225 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NA-EVLQ----QVDQG-----Y-RMPC 225 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HH-HHHH----HHHcC-----C-CCCC
Confidence 125999999988889999999999999999999 898886431 11 1111 11000 0 0113
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l 258 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 344567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=297.26 Aligned_cols=231 Identities=21% Similarity=0.223 Sum_probs=185.8
Q ss_pred cccCCCCCCCCcchhHH----HHHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCC
Q 048314 27 SSLNDRNSPRSKSVWSC----MRALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWD 99 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~----~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 99 (274)
..-||.|.| |+||+| .+|+|....+. ...+.|.+|+.++++-+|.||+-++|||..++. .+|+.+|.|.|
T Consensus 397 ~~rIGsGsF--GtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsS 473 (678)
T KOG0193|consen 397 GERIGSGSF--GTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSS 473 (678)
T ss_pred cceeccccc--cceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCch
Confidence 455999999 999999 44443322221 345678899999999999999999999998887 99999999999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----------
Q 048314 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---------- 169 (274)
Q Consensus 100 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---------- 169 (274)
|+.+++. .+..|...+..+|+.|+++|+.|||.+ +|||||||..||++.+++++||+|||++....
T Consensus 474 LY~hlHv-~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~q 549 (678)
T KOG0193|consen 474 LYTHLHV-QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQ 549 (678)
T ss_pred hhhhccc-hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCC
Confidence 9999987 557799999999999999999999999 99999999999999999999999999986432
Q ss_pred ---CCCcCCCccccc---CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 170 ---DKGCMAPECYKR---TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 170 ---~~~~~ape~~~~---~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
...|||||++.. .+|+..+||||||+++|||++|..||... ..+.+.. + ...+. -..|......
T Consensus 550 p~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~--~~dqIif---m---VGrG~--l~pd~s~~~s 619 (678)
T KOG0193|consen 550 PHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ--NRDQIIF---M---VGRGY--LMPDLSKIRS 619 (678)
T ss_pred CccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC--ChhheEE---E---ecccc--cCccchhhhc
Confidence 345999999874 47899999999999999999999999722 1111110 0 00000 0001112445
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 244 KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.++.++++|+..||..++++||++.+|+.+|
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l 650 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKL 650 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHH
Confidence 6778999999999999999999999998854
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=286.02 Aligned_cols=232 Identities=17% Similarity=0.197 Sum_probs=184.6
Q ss_pred hhccccccCCCCCCCCcchhHHHH----------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR----------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
.+|...+.+|+|+| |.||+|.. .++|..... ...+++.+|+.+++.++||||++++|+|... ..
T Consensus 7 ~~f~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAF--GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCC--ceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 57888999999999 99999821 122222211 2235677899999999999999999999765 57
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++++||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~v~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 84 QLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeeecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 899999999999999986 345689999999999999999999999 9999999999999999999999999998754
Q ss_pred C-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 S-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
. +..|++||.+....++.++||||||+++||+++ |..||.... ... +.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--~~~--~~~----~~~~~---- 227 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASE--ISS----ILEKG---- 227 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHH--HHH----HHhCC----
Confidence 3 235999999988889999999999999999987 999986431 111 111 00110
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. ...+..++..+.+++.+||..||++|||+.+++..|
T Consensus 228 -~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l 265 (316)
T cd05108 228 -ER-LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 265 (316)
T ss_pred -CC-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00 012334556789999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=284.44 Aligned_cols=228 Identities=16% Similarity=0.077 Sum_probs=184.2
Q ss_pred hccccccCCCCCCCCcchhHHHHH------HHHHh-----cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMRA------LMATV-----NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~~------~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|...+.+|.|+| |.||++... ++|.. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 2 ~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 2 DLERIKTVGTGTF--GRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CceeeeeeecCCC--eEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 5777889999999 999998211 11111 1112334577899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|||+++|+|.+++.. .+.+++.....++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 80 MEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999999975 45789999999999999999999999 9999999999999999999999999998643
Q ss_pred -----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 169 -----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 169 -----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
+++.|+|||.+....++.++|||||||++|+|++|..||..... . ... ...... ....+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~-~~~----~~i~~~-------~~~~~~ 219 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---F-GIY----EKILAG-------KLEFPR 219 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H-HHH----HHHHhC-------CcCCCc
Confidence 36679999999888889999999999999999999999964311 0 000 000111 112344
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC-----hhhHHh
Q 048314 244 KNLENLVKVGLWCVQDEPALRPS-----MKCVVM 272 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps-----~~evl~ 272 (274)
..+..+.+++.+||+.||.+||+ +.++++
T Consensus 220 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 220 HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 45678899999999999999995 888775
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=283.34 Aligned_cols=221 Identities=16% Similarity=0.111 Sum_probs=178.2
Q ss_pred CCCCCCCCcchhHHHH------HHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCC
Q 048314 30 NDRNSPRSKSVWSCMR------ALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPW 98 (274)
Q Consensus 30 ~g~g~~~~g~vy~~~~------~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 98 (274)
+|+|+| |.||++.. .++|. .........+.+|+.++.+++||||+++++++.+.+..++||||+++|
T Consensus 1 lg~G~~--g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSF--GKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCC--eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 689999 99998821 11111 112233455778999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----------
Q 048314 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---------- 168 (274)
Q Consensus 99 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---------- 168 (274)
+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 79 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 79 ELFHHLQR--EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 99999975 45799999999999999999999999 9999999999999999999999999988642
Q ss_pred -CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHH
Q 048314 169 -SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLE 247 (274)
Q Consensus 169 -~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (274)
+++.|+|||.+.+..++.++|||||||++|+|++|..||..... . ...... .. .+...+...+.
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---~----~~~~~~-~~-------~~~~~~~~~~~ 218 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---N----EMYRKI-LQ-------EPLRFPDGFDR 218 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---H----HHHHHH-Hc-------CCCCCCCcCCH
Confidence 36789999999988899999999999999999999999964311 1 000000 00 11134455667
Q ss_pred HHHHHHHHhhccCCCCCCC---hhhHHh
Q 048314 248 NLVKVGLWCVQDEPALRPS---MKCVVM 272 (274)
Q Consensus 248 ~~~~li~~cl~~dp~~Rps---~~evl~ 272 (274)
.+.+++.+||+.||++||+ +.|+++
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 8999999999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=274.90 Aligned_cols=233 Identities=16% Similarity=0.170 Sum_probs=186.5
Q ss_pred hhccccccCCCCCCCCcchhHHHH-----HHHHHhcC-CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNS-PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
.+|...+.+|.|++ |.||++.. .++|.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~--~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQF--GVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCC--ceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 35667788999999 99998721 11222222 123456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++++|.+++... ...+++..++.++.|++.||.|||+. +++|+|+||+||+++.++.++++|||.++...
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 82 ANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999999763 34789999999999999999999999 99999999999999999999999999886432
Q ss_pred ------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 ------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 ------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|+|||.+....++.++|+||||+++|++++ |..||..... .. ... . ...... ...+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~-~~~----~-----~~~~~~-~~~~ 223 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SE-VVE----S-----VSAGYR-LYRP 223 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HH-HHH----H-----HHcCCc-CCCC
Confidence 125999999988889999999999999999998 7888864311 10 000 0 000001 1233
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 44677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.57 Aligned_cols=228 Identities=16% Similarity=0.159 Sum_probs=185.2
Q ss_pred hhccccccCCCCCCCCcchhHH-------HHHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
.+|.....+|+|.+ |+|-++ .++++.+.+++ ++.-...+||++|+.|+||||+.++.+|...+...+
T Consensus 53 HRyE~~etLGkGTY--GKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTY--GKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcc--cceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 45556677999999 988777 23333322222 222334699999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
||||..+|.|+||+.+ .+.|++.+...+++||++|+.|+|.+ +++|||||.+|||++++.++||+|||++...
T Consensus 131 vMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999986 56899999999999999999999999 9999999999999999999999999998643
Q ss_pred --------CCCCcCCCcccccCCCc-cccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 --------SDKGCMAPECYKRTPIS-VKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 --------~~~~~~ape~~~~~~~~-~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+++-|.+||++.+.+|. +.+|.||+|++||.|+.|..||+..+. ..+. ..+..+.+.+
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lv----rQIs~GaYrE----- 272 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLV----RQISRGAYRE----- 272 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHH----HHhhcccccC-----
Confidence 36789999999999885 789999999999999999999975521 1111 1122222221
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+....-||+|||-.||++|.|+.+|..
T Consensus 273 ---P~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 273 ---PETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ---CCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 223345678999999999999999999875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=275.74 Aligned_cols=234 Identities=19% Similarity=0.175 Sum_probs=188.2
Q ss_pred hhhccccccCCCCCCCCcchhHHHHH---------HHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMRA---------LMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~~---------~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
.++|.....+|.|+| |.||+|... ++|..... ....+|.+|+.++++++||||+++++++.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~--g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEF--GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCcc--ceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 367888899999999 999988321 12222221 1234577899999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
+++|||+++++|.+++.. ..+.+++..+..++.|++.|+.|||+. +++|+|++|+||+++.++.++++|||++...
T Consensus 81 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 81 MIITEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEEcCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999999976 345789999999999999999999999 9999999999999999999999999998764
Q ss_pred C-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 S-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
. +..|+|||.+....++.++|+||||+++|++++ |..||.... ...+. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~----~~~~~----~~~~~~---- 224 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS----NQDVI----KAVEDG---- 224 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC----HHHHH----HHHHcC----
Confidence 3 245999999988889999999999999999987 999985321 01111 111110
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ..+.+...+..+.+++.+||+.+|++|||+.||++.|
T Consensus 225 ~--~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 225 Y--RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred C--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0 1123345567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=271.19 Aligned_cols=224 Identities=16% Similarity=0.226 Sum_probs=176.4
Q ss_pred cCCCCCCCCcchhHHHH-------------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 29 LNDRNSPRSKSVWSCMR-------------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~-------------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
.+|.|+| |.||+|.. .++|..... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~lg~G~~--~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTF--TKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccc--hhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 5899999 99999832 233333221 223567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc--------EEEeccccc
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT--------AKISDFGLA 165 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~--------~kl~d~g~~ 165 (274)
|+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++. ++++|||.+
T Consensus 80 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 80 YVKFGSLDTYLKK-NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred cCCCCcHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999986 334689999999999999999999999 9999999999999977654 699999987
Q ss_pred eec-------CCCCcCCCcccccC-CCccccceeehhHhHHHHhhcC-CCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 166 KLL-------SDKGCMAPECYKRT-PISVKADVYGYGIVLLETICCW-ENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 166 ~~~-------~~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
... .+..|+|||.+... .++.++|+||||+++|+|++|. .|+... ..... .. . ..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-~~~~~---~~----~-~~------- 219 (258)
T cd05078 156 ITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-DSQKK---LQ----F-YE------- 219 (258)
T ss_pred cccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-cHHHH---HH----H-HH-------
Confidence 543 25679999998864 5788999999999999999995 555322 11100 00 0 00
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+.....++.+++.+||+.||++|||++++++.|
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 220 DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 01123333446789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=286.31 Aligned_cols=231 Identities=15% Similarity=0.087 Sum_probs=186.7
Q ss_pred HhhhccccccCCCCCCCCcchhHHH-------HHHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM-------RALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
..++|.....+|.|+| |.||++. ..++|. .......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~ig~G~~--g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSF--GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred ChhhcEEEEEEeecCC--eEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 4567888899999999 9999882 111111 1112234457789999999999999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999999975 45799999999999999999999999 999999999999999999999999999875
Q ss_pred c--------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 168 L--------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 168 ~--------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
. +++.|+|||++....++.++|+|||||++|||++|..||..... . ... .....+. .
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~-~~~----~~i~~~~-------~ 245 (340)
T PTZ00426 181 VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---L-LIY----QKILEGI-------I 245 (340)
T ss_pred cCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---H-HHH----HHHhcCC-------C
Confidence 3 35679999999888889999999999999999999999964311 1 000 0011110 1
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
..|...+..+.+++.+||+.||++|+ |+.++++
T Consensus 246 ~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 23444556789999999999999995 8998875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=279.75 Aligned_cols=244 Identities=16% Similarity=0.109 Sum_probs=182.7
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
++|...+.+|.|+| |.||++.. .++|.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAY--GVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCC--EEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 35777888999999 99998821 12222221 12345577999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|||++++++..+.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 79 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 79 FEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred EecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99999877765543 245699999999999999999999999 9999999999999999999999999998643
Q ss_pred ---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH-------HHH-Hhhhh
Q 048314 169 ---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV-------YKC-FINRE 231 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~-~~~~~ 231 (274)
++..|+|||.+.+..++.++|+|||||++|+|++|+.||................ ... ..+..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 2567999999988889999999999999999999999997532111100000000 000 00000
Q ss_pred hhhhhcCC---------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 232 LNKLVRGT---------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 232 ~~~~~~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
......+. ......+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 011124567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=276.77 Aligned_cols=196 Identities=22% Similarity=0.281 Sum_probs=158.4
Q ss_pred cHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 048314 59 RPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP 138 (274)
Q Consensus 59 ~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ 138 (274)
.+.+|+.++++++||||++++++|.+.+..++||||+++|+|.+++.. ..+.+++..+..++.|++.||.|||+. +
T Consensus 62 ~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ 137 (274)
T cd05076 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDK---N 137 (274)
T ss_pred HHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC---C
Confidence 467889999999999999999999999999999999999999999975 345789999999999999999999999 9
Q ss_pred cccCCCCCCceEEcCCC-------cEEEeccccceec-------CCCCcCCCccccc-CCCccccceeehhHhHHHHh-h
Q 048314 139 ILHCDIKPQNILMDEFW-------TAKISDFGLAKLL-------SDKGCMAPECYKR-TPISVKADVYGYGIVLLETI-C 202 (274)
Q Consensus 139 i~h~dl~~~nil~~~~~-------~~kl~d~g~~~~~-------~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~-~ 202 (274)
++||||||+||+++..+ .++++|||.+... .+..|+|||.+.. ..++.++|+||||+++||++ +
T Consensus 138 iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~ 217 (274)
T cd05076 138 LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD 217 (274)
T ss_pred ccCCCCCcccEEEeccCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999997543 4799999987532 2567999998865 46789999999999999984 6
Q ss_pred cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 203 CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 203 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
|..||.... +.. .... ... ....+......+.+++.+||+.+|++|||+.+|++.|
T Consensus 218 g~~p~~~~~-~~~---~~~~----~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 218 GEVPLKERT-PSE---KERF----YEK--------KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCCCccccC-hHH---HHHH----HHh--------ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 888886431 111 0000 000 0012222335789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=276.34 Aligned_cols=235 Identities=17% Similarity=0.204 Sum_probs=188.5
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
.++|.....+|.|++ |.||+|.. .++|...... ..+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~--~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAF--GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCC--ceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 456777889999999 99999832 1122222221 2356789999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC
Q 048314 87 KPSTEAALDLPWDLAYIIFCSA------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 154 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 154 (274)
..++||||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence 9999999999999999997532 23488999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHH
Q 048314 155 WTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILT 220 (274)
Q Consensus 155 ~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~ 220 (274)
+.++|+|||.+.... +..|+|||.+....++.++||||||+++|+|++ |..||..... . ...
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~-~~~ 234 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---E-EVI 234 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---H-HHH
Confidence 999999999886431 245999999998889999999999999999998 9999864311 1 111
Q ss_pred HHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 221 NWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ....+. ....+...+..+.+++.+||+.||++|||+.|++++|
T Consensus 235 ~----~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 235 E----CITQGR------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred H----HHHcCC------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 1 111111 1123345567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=285.18 Aligned_cols=233 Identities=18% Similarity=0.157 Sum_probs=192.4
Q ss_pred hhccccccCCCCCCCCcchhHHH-------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc-ceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM-------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK-PST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~-------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~l 90 (274)
.+|.....+|+|.| |.++.+. .++|++.-.. ..++...+|+.++++++|||||.+.+.|.+++. .+|
T Consensus 4 ~~Ye~~~~iG~Gaf--G~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAF--GSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCcccc--chhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 45556788999999 7766662 2222221111 123345799999999999999999999999888 999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
||+||.||++.+.+...++..++++.+..++.|++.|+.|||++ .|+|||||+.||++..+..++|+|||+++...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999999986667799999999999999999999998 99999999999999999999999999997654
Q ss_pred ----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 ----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 ----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
|+.|++||++.+.+|..|+|||||||++|||.+=+++|...+... . ..........
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-------L-----i~ki~~~~~~-- 224 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-------L-----ILKINRGLYS-- 224 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-------H-----HHHHhhccCC--
Confidence 788999999999999999999999999999999999997542211 1 1111111122
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
+.|...+.++..++..||..+|+.|||+.+++.+
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 4788889999999999999999999999999864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=279.33 Aligned_cols=235 Identities=17% Similarity=0.227 Sum_probs=186.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
.++|...+.+|.|++ |.||.|.. .+++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~--g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 4 RRDIVLKRELGEGAF--GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred hHHeEEeeeecccCC--CeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 356777889999999 99998731 111122111 112457799999999999999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC
Q 048314 88 PSTEAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 153 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~ 153 (274)
.++||||+++++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 999999999999999997532 23489999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHH
Q 048314 154 FWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIIL 219 (274)
Q Consensus 154 ~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~ 219 (274)
++.++++|||++.... +..|+|||.+....++.++|+||||+++|+|++ |..||..... . ..
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~---~~ 234 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-T---EV 234 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-H---HH
Confidence 9999999999985432 345999999988888999999999999999998 9999854311 0 01
Q ss_pred HHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 220 TNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. .....+... ..+...+..+.+++.+||+.||++|||+.+|+++|
T Consensus 235 ~----~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 235 I----ECITQGRVL------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred H----HHHhCCCCC------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 1 111111111 12334567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=291.73 Aligned_cols=236 Identities=16% Similarity=0.192 Sum_probs=186.0
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC---CCCCcHHHHHHHHhcCC-CCccceEeEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP---YSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRG 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 85 (274)
.+.|....+||.|+| |.||+|.. .++|.+... ...+.+.+|+++++++. ||||++++++|.+.
T Consensus 36 ~~~~~~~~~LG~G~f--G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAF--GKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCC--ceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 456677889999999 99998731 122222221 22345789999999996 99999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCC---------------------------------------------------------
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSA--------------------------------------------------------- 108 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 108 (274)
+..++|||||++|+|.+++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999999987531
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE
Q 048314 109 -------------------------------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 151 (274)
Q Consensus 109 -------------------------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~ 151 (274)
...+++..++.++.|++.||.|||+. +++|+||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 12478889999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhH
Q 048314 152 DEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEI 217 (274)
Q Consensus 152 ~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~ 217 (274)
+.++.+|++|||++.... +..|+|||.+....++.++||||||+++|+|++ |..||.......
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--- 347 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--- 347 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---
Confidence 999999999999986432 246999999988889999999999999999997 888886331110
Q ss_pred HHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 218 ILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+ ......+ .. ...+...+..+.+++.+||+.||++|||+.+|.+.|
T Consensus 348 ~~----~~~~~~~-----~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 348 TF----YNKIKSG-----YR-MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred HH----HHHHhcC-----CC-CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 00 0111111 00 123445667899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=282.91 Aligned_cols=222 Identities=17% Similarity=0.149 Sum_probs=179.6
Q ss_pred cCCCCCCCCcchhHHH------HHHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCC
Q 048314 29 LNDRNSPRSKSVWSCM------RALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLP 97 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~------~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 97 (274)
.+|+|+| |.||++. ..++|. .........+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 2 ~lG~G~~--g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 2 LLGKGTF--GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred eeeeCCC--EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 5899999 9999871 111111 11222345677899999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---------
Q 048314 98 WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--------- 168 (274)
Q Consensus 98 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--------- 168 (274)
|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 80 g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 80 GELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 999999875 45799999999999999999999999 9999999999999999999999999987642
Q ss_pred --CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHH
Q 048314 169 --SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNL 246 (274)
Q Consensus 169 --~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (274)
+++.|+|||.+....++.++|||||||++|+|++|..||..... . .... .... .....+...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~-~~~~----~~~~-------~~~~~p~~~~ 219 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E-KLFE----LILM-------EDIKFPRTLS 219 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---H-HHHH----Hhcc-------CCccCCCCCC
Confidence 35789999999888899999999999999999999999964311 1 0000 0000 1112444556
Q ss_pred HHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 247 ENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 247 ~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
.++.+++.+||+.||++|| ++.|+++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 7889999999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=272.92 Aligned_cols=233 Identities=15% Similarity=0.153 Sum_probs=185.2
Q ss_pred hhccccccCCCCCCCCcchhHHHH-----HHHHHhcC-CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNS-PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
++|.....+|.|++ |.||.+.. .++|.... ....+.+.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus 4 ~~~~~~~~lg~G~~--~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQF--GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCccc--ceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 45666778999999 99998821 11222222 223456889999999999999999999999888899999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
.+|+|.+++... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+|++|||.++...
T Consensus 82 ~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 82 SNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999999763 34689999999999999999999999 99999999999999999999999999886432
Q ss_pred ------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 ------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 ------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|++||.+....++.++|+||||+++|+|++ |..||..... . .... ...+... ...+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~-~~~~----~~~~~~~------~~~~ 223 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---S-ETVE----KVSQGLR------LYRP 223 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---H-HHHH----HHhcCCC------CCCC
Confidence 235999999988888999999999999999998 8999853311 0 0100 0111100 0122
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+..+.+++.+||+.||++|||+.+|++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 33467899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=272.30 Aligned_cols=226 Identities=18% Similarity=0.179 Sum_probs=180.6
Q ss_pred cCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCC
Q 048314 29 LNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWD 99 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 99 (274)
.+|.|+| |.||++.. .++|..... .....+.+|++++++++||||+++++++.+....++||||+++++
T Consensus 2 ~lg~g~~--g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNF--GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccC--ccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 5899999 99998722 122222211 123457899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----------
Q 048314 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---------- 169 (274)
Q Consensus 100 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---------- 169 (274)
|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 80 L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 80 FLTFLRT-EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9999975 345689999999999999999999999 99999999999999999999999999976432
Q ss_pred ---CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHH
Q 048314 170 ---DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKN 245 (274)
Q Consensus 170 ---~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (274)
...|+|||.+....++.++|+||||+++|++++ |..||..... . ... .... .. .+...+...
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~-~~~----~~~~-----~~-~~~~~~~~~ 221 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---Q-QTR----EAIE-----QG-VRLPCPELC 221 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---H-HHH----HHHH-----cC-CCCCCcccC
Confidence 134999999988889999999999999999997 8888853211 0 000 0000 00 111234455
Q ss_pred HHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 246 LENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 246 ~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+..+.+++.+||+.||++|||+.+|+++|
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 67899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=283.53 Aligned_cols=223 Identities=17% Similarity=0.156 Sum_probs=179.3
Q ss_pred ccCCCCCCCCcchhHHHH------HHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCC
Q 048314 28 SLNDRNSPRSKSVWSCMR------ALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
+.+|+|+| |.||++.. .++|. .........+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTF--GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCC--EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 36899999 99998711 11111 1122233456789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-------- 168 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-------- 168 (274)
+|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 79 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 79 GGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 9999999875 45789999999999999999999999 9999999999999999999999999987542
Q ss_pred ---CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHH
Q 048314 169 ---SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKN 245 (274)
Q Consensus 169 ---~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (274)
+++.|+|||.+....++.++|+|||||++|+|++|..||..... .. ... .... .....+...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~-~~~----~~~~-------~~~~~p~~~ 218 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ER-LFE----LILM-------EEIRFPRTL 218 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HH-HHH----HHhc-------CCCCCCCCC
Confidence 35689999999888899999999999999999999999964311 10 000 0000 011234455
Q ss_pred HHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 246 LENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 246 ~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
+..+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 67889999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=282.11 Aligned_cols=234 Identities=15% Similarity=0.126 Sum_probs=185.5
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|.....+|.|+| |.||++.. .++|. .......+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 2 ~y~~~~~ig~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 2 DFQILTQVGQGGY--GQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CcEEEEEEeecCC--eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 5777888999999 99998821 11111 11112334577899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|||+++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 80 ~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~ 154 (333)
T cd05600 80 MEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY 154 (333)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence 999999999999975 45789999999999999999999999 9999999999999999999999999998643
Q ss_pred -----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc-CC--c
Q 048314 169 -----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR-GT--E 240 (274)
Q Consensus 169 -----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~ 240 (274)
+++.|+|||++....++.++|||||||++|||++|..||...........+..+ ..... +. .
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------~~~~~~~~~~~ 224 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW----------KETLQRPVYDD 224 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc----------cccccCCCCCc
Confidence 367899999999888999999999999999999999999643111100001000 00000 10 0
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.....+.++.+++.+||..+|.+|||+.++++.
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 112346788999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=277.19 Aligned_cols=246 Identities=17% Similarity=0.166 Sum_probs=183.0
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|...+.+|.|+| |.||+|. ..++|.+.. ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTY--ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCC--EEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 356777889999999 9999981 112222221 12344577999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|||++ |+|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 82 ~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 82 FEYLD-SDLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred EeCCC-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 99997 499999875 344689999999999999999999999 99999999999999999999999999986432
Q ss_pred ---------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH-------HHHH-hhhh
Q 048314 170 ---------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV-------YKCF-INRE 231 (274)
Q Consensus 170 ---------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~-~~~~ 231 (274)
+..|+|||.+.+ ..++.++|+||+||++|+|++|+.||................ ++.. ....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 456999998865 468899999999999999999999996542111100000000 0000 0000
Q ss_pred hhhhhcCC-------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 232 LNKLVRGT-------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 232 ~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
......+. ........++.+++.+||+.||.+|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00111110 0011234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=278.77 Aligned_cols=234 Identities=18% Similarity=0.196 Sum_probs=184.3
Q ss_pred hhccccccCCCCCCCCcchhHHHH--------HHHHHhcC---CCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcce
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR--------ALMATVNS---PYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~--------~~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 89 (274)
++|....++|.|+| |.||+|.. +.++.... ....+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus 2 ~~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNF--GQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCc--ceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 46777889999999 99998821 11111211 11234578899999999 6999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC
Q 048314 90 TEAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~ 155 (274)
+++||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence 9999999999999997532 13489999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHH
Q 048314 156 TAKISDFGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVY 224 (274)
Q Consensus 156 ~~kl~d~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 224 (274)
.+||+|||++.... ...|+|||.+....++.++||||||+++|||++ |..||..... . .+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~-~~~---- 228 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---A-ELY---- 228 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---H-HHH----
Confidence 99999999875321 235999999988889999999999999999997 9999864311 0 010
Q ss_pred HHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 225 KCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..... . .. ...+...+..+.+++.+||+.||.+|||++++++.|
T Consensus 229 ~~~~~----~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 229 EKLPQ----G-YR-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred HHHhc----C-CC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00000 0 00 113344567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=274.02 Aligned_cols=236 Identities=22% Similarity=0.250 Sum_probs=190.3
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH-----HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
...+|...+.+|.|++ |.||++.. .++|..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~~~~y~~~~~ig~g~~--~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYF--GEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCC--ccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 4567788889999999 99998722 112222221 23456789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++++|.+++.......+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++++|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999999875556799999999999999999999999 99999999999999999999999999986543
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+..|++||.+....++.++|+||||+++++|++ |..||.... .. ..... .... .. ..
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~-~~~~~----~~~~-----~~-~~ 224 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NH-EVYDQ----ITAG-----YR-MP 224 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HH-HHHHH----HHhC-----Cc-CC
Confidence 245999999988888999999999999999998 888885431 11 11110 0100 00 12
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+...+..+.+++.+||+.||++|||++++++.|
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 3445667899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=286.80 Aligned_cols=230 Identities=21% Similarity=0.212 Sum_probs=188.5
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
..|....+||+|.| |.||+|.. +++|.++ ...+.++..+|+.+|++++++||.+.||.+..+..++++|
T Consensus 13 ~~~~~~~~IgrGsf--G~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSF--GEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhcccccc--ceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 45666789999999 99999922 2222222 2244566779999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee-----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL----- 167 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~----- 167 (274)
|||.+|++.+.+.. ...+.+..+.-++++++.|+.|||.+ +.+|||||+.||++..++.+|++|||++..
T Consensus 91 ey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999999975 44558888888999999999999999 999999999999999999999999999854
Q ss_pred ------cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 168 ------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 168 ------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
.+|+.|||||+++...|+.++||||||++.+||++|.+|+.... +..... ..... .|...
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h-Pmrvlf--------lIpk~-----~PP~L 231 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH-PMRVLF--------LIPKS-----APPRL 231 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC-cceEEE--------eccCC-----CCCcc
Confidence 34889999999998899999999999999999999999996431 100000 00000 11123
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+..+++++..||++||+.||||.++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3467788999999999999999999999986
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=271.58 Aligned_cols=235 Identities=18% Similarity=0.166 Sum_probs=187.4
Q ss_pred hhhccccccCCCCCCCCcchhHHH----HHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEE-eCCcceEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM----RALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAM-RGSKPSTEAALD 95 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~----~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 95 (274)
.++|.....+|.|++ |.||++. ..++|........+.+.+|+.++++++|+|++++++++. +++..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~--~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEF--GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCC--CeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 356777889999999 9999872 222222333233456789999999999999999999865 456789999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++++|.+++.......+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++++|||.+....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 159 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCCCC
Confidence 999999999875555689999999999999999999999 99999999999999999999999999987543
Q ss_pred --CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHH
Q 048314 170 --DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNL 246 (274)
Q Consensus 170 --~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (274)
+..|+|||.+....++.++|+||||+++|+|++ |+.||..... ..+.. ....+ .....+...+
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~----~~~~~------~~~~~~~~~~ 225 (256)
T cd05082 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVP----RVEKG------YKMDAPDGCP 225 (256)
T ss_pred ccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHH----HHhcC------CCCCCCCCCC
Confidence 336999999988888999999999999999997 8888853311 01111 01110 0112334556
Q ss_pred HHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 247 ENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 247 ~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+.+++.+||+.||++|||+.++++.|
T Consensus 226 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l 253 (256)
T cd05082 226 PVVYDVMKQCWHLDAATRPSFLQLREQL 253 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 7899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=272.48 Aligned_cols=235 Identities=21% Similarity=0.235 Sum_probs=189.3
Q ss_pred hhhccccccCCCCCCCCcchhHHH----HHHHHHhcCC-CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM----RALMATVNSP-YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~----~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
.++|...+.+|.|++ |.||++. .+++|..... ...+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~--g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEF--GDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCC--ceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457778899999999 9999872 1122222222 22456789999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++++|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~ 159 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG 159 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccccC
Confidence 999999999875445799999999999999999999999 99999999999999999999999999887543
Q ss_pred --CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHH
Q 048314 170 --DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNL 246 (274)
Q Consensus 170 --~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (274)
...|+|||.+....++.++|+||||++++++++ |..||.... .. .+.. ..... . ....+...+
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~-~~~~----~~~~~-----~-~~~~~~~~~ 225 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LK-DVVP----HVEKG-----Y-RMEAPEGCP 225 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HH-HHHH----HHhcC-----C-CCCCccCCC
Confidence 345999999988888999999999999999997 999986431 11 1111 00110 0 012333456
Q ss_pred HHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 247 ENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 247 ~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+.+++.+||..+|++|||+.+++++|
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 7899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.52 Aligned_cols=236 Identities=20% Similarity=0.277 Sum_probs=185.5
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
.+++|...+.+|.|++ |.||++.. .++|..... ....++.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~ig~G~~--g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSF--GMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccC--CeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4677888999999999 99997621 111222111 1123477899999999999999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcE
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSA--------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 157 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~ 157 (274)
...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 99999999999999999997532 12368889999999999999999999 99999999999999999999
Q ss_pred EEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHH
Q 048314 158 KISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWV 223 (274)
Q Consensus 158 kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 223 (274)
+++|||++.... +..|+|||.+....++.++|+||||+++|||++ |..||.... ... ...
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~---~~~-~~~-- 232 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---NEQ-VLR-- 232 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHH-HHH--
Confidence 999999875321 346999999988889999999999999999998 678885331 111 111
Q ss_pred HHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 224 YKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
....... ...+...+..+.+++.+||+.||++|||+.|++++|
T Consensus 233 --~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 233 --FVMEGGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred --HHHcCCc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 1111110 123344567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=270.88 Aligned_cols=233 Identities=20% Similarity=0.237 Sum_probs=185.8
Q ss_pred hhccccccCCCCCCCCcchhHHH-----HHHHHHhcC-CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM-----RALMATVNS-PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~-----~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
++|...+.+|.|++ |.||++. ..++|.... ....+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 6 ~~~~~~~~ig~g~~--~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 6 ESLQLIKKLGNGQF--GEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred HHhhhhheeccccC--ceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 46777888999999 9999882 122222222 233456889999999999999999999875 45689999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++++|.+++.......+++..+..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||.+....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999864455689999999999999999999999 99999999999999999999999999986532
Q ss_pred ------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 ------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 ------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|+|||.+....++.++|+||||+++|++++ |..||.... ....... .... ...+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~----~~~~~~~----~~~~------~~~~~~ 225 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN----NREVLEQ----VERG------YRMPCP 225 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC----HHHHHHH----HHcC------CCCCCC
Confidence 235999999888888999999999999999999 888885431 1111111 0000 011234
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+..+.+++.+||..||++|||++++.+.|
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 45667899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=275.19 Aligned_cols=234 Identities=21% Similarity=0.228 Sum_probs=185.4
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|...+.+|+|+| |.||++.. .++|.+ ........+.+|+.++++++||||+++++.+.+++..++|
T Consensus 1 ~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGF--GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCC--eEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 3666788999999 99998721 111211 1112234567899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|||+.+|+|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999999998764445799999999999999999999999 99999999999999999999999999987532
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||.+....++.++|+||+|+++|++++|..||............ ... +.. .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~----~~~-----~~~--~~~~~ 224 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV----ERR-----VKE--DQEEY 224 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH----HHH-----hhh--ccccc
Confidence 46799999998888999999999999999999999999743211110000 000 000 01123
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
+...+..+.+++..||+.||++|| +++++++
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 445667889999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=273.15 Aligned_cols=228 Identities=22% Similarity=0.240 Sum_probs=177.2
Q ss_pred CCCCCCCCcchhHHHH-------H---H-HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCC
Q 048314 30 NDRNSPRSKSVWSCMR-------A---L-MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPW 98 (274)
Q Consensus 30 ~g~g~~~~g~vy~~~~-------~---~-~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 98 (274)
+|.|+| |.||++.. + + +...........+..|++++++++||||+++++++.++...++||||++++
T Consensus 1 lg~G~~--g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGF--GEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCc--eEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 689999 99998711 1 1 111111122334567999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----------
Q 048314 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---------- 168 (274)
Q Consensus 99 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---------- 168 (274)
+|.+++.......+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA 155 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence 999998765555699999999999999999999999 9999999999999999999999999987643
Q ss_pred CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHH
Q 048314 169 SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLEN 248 (274)
Q Consensus 169 ~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (274)
++..|+|||++....++.++|+||+||++|+|++|..||............. ......... ......+.+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~--~~~~~~~~~ 225 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK--------RRTLEDEVK--FEHQNFTEE 225 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH--------HHhhccccc--cccccCCHH
Confidence 2568999999988889999999999999999999999996432211111110 000000000 011234567
Q ss_pred HHHHHHHhhccCCCCCCChhhHHh
Q 048314 249 LVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 249 ~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+.+++..||+.||++|||++|+++
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchh
Confidence 899999999999999999976553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=277.00 Aligned_cols=235 Identities=18% Similarity=0.226 Sum_probs=185.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
.++|...+.+|.|+| |.||++.. .+++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~G~~--~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAF--GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred hHHeeeccccCCcCC--eeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 467888899999999 99998731 111222211 123457899999999999999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc
Q 048314 88 PSTEAALDLPWDLAYIIFCSA-----------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 156 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~ 156 (274)
.++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999999997532 13489999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHH
Q 048314 157 AKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNW 222 (274)
Q Consensus 157 ~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 222 (274)
++++|||.+.... +..|+|||.+....++.++|+||||+++++|++ |..||.... ... ..
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~---~~~-~~-- 232 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNE-VI-- 232 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHH-HH--
Confidence 9999999986432 336999999988888999999999999999998 888885431 110 00
Q ss_pred HHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 223 VYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+... ..+...+.++.+++.+||+.||.+|||+.++++.|
T Consensus 233 --~~i~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l 276 (288)
T cd05093 233 --ECITQGRVL------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276 (288)
T ss_pred --HHHHcCCcC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 111111110 12233456799999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=282.29 Aligned_cols=246 Identities=17% Similarity=0.182 Sum_probs=184.7
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|...+.+|.|+| |.||++.. .+++..... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~g~~--g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNG--GVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCC--EEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 467888999999999 99998721 122222111 1234578999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|||+++|+|.+++.. .+.+++.....++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||++...
T Consensus 82 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 82 MEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999975 45689999999999999999999974 17999999999999999999999999988643
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHH--------------------H
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN--------------------W 222 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~--------------------~ 222 (274)
++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.. .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence 35679999999888889999999999999999999999964311100000000 0
Q ss_pred HHHH-------Hhhhhhhh-hhcCC--cc-CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 223 VYKC-------FINRELNK-LVRGT--EV-DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 223 ~~~~-------~~~~~~~~-~~~~~--~~-~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.... ........ +.... .. ....+.++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000 00000000 00000 01 1123467899999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=270.87 Aligned_cols=224 Identities=17% Similarity=0.230 Sum_probs=173.3
Q ss_pred cCCCCCCCCcchhHHHH------------------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 29 LNDRNSPRSKSVWSCMR------------------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~------------------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
.+|+|++ |.||+|.. +++|..... .....+.+|+.+++.++||||+++++++.++...
T Consensus 2 ~lg~G~~--~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 2 HLGRGTR--TQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred ccccCCc--ceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 5899999 99999942 111211111 1223567889999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc-------EEEec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT-------AKISD 161 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~-------~kl~d 161 (274)
+++|||+++|+|..++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++. ++++|
T Consensus 80 ~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999999875 345689999999999999999999999 9999999999999976553 89999
Q ss_pred cccceecC-------CCCcCCCcccc-cCCCccccceeehhHhHHHHh-hcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 162 FGLAKLLS-------DKGCMAPECYK-RTPISVKADVYGYGIVLLETI-CCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 162 ~g~~~~~~-------~~~~~ape~~~-~~~~~~~~Di~s~G~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
||.+.... +..|+|||.+. ...++.++||||||+++|+|+ .|..|+...... . ... ......
T Consensus 156 ~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~---~~~-----~~~~~~ 226 (262)
T cd05077 156 PGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-E---KER-----FYEGQC 226 (262)
T ss_pred CCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-H---HHH-----HHhcCc
Confidence 99886432 45699999886 456889999999999999997 577777532110 0 000 000000
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
........++.+++.+||+.||++||++.+|++.|
T Consensus 227 -------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 -------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11112246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=285.07 Aligned_cols=231 Identities=18% Similarity=0.147 Sum_probs=191.3
Q ss_pred cccccCCCCCCCCcchhHH------HHHHHHHhc--CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCC
Q 048314 25 CRSSLNDRNSPRSKSVWSC------MRALMATVN--SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 25 ~~~~~~g~g~~~~g~vy~~------~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
....-+|.|.| |+||++ ..++-|.+. +.+..++++-||.||+.+.||+||+|++.|+..+.+++..|||+
T Consensus 35 eIiGELGDGAF--GKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 35 EIIGELGDGAF--GKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHhhhcCccc--hhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 33566899999 999999 333333333 33667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce----------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK---------- 166 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~---------- 166 (274)
||.++..+.. -+..|.+.++..++.|++.||.|||+. .|||||||..|||+..+|.++|+|||++.
T Consensus 113 GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 113 GGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred CchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 9999999987 457899999999999999999999999 99999999999999999999999999984
Q ss_pred -ecCCCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 167 -LLSDKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 167 -~~~~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+++++.|||||++. ..+|++++||||||++|.||..+.+|.... +-...+... .+...+.+ .
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-------npMRVllKi-aKSePPTL----l 256 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-------NPMRVLLKI-AKSEPPTL----L 256 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-------chHHHHHHH-hhcCCCcc----c
Confidence 45689999999764 468999999999999999999999987422 111111111 11111111 3
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.|..++..+.+++.+||.+||..||+++++++.
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 677899999999999999999999999999863
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=274.44 Aligned_cols=234 Identities=18% Similarity=0.185 Sum_probs=184.6
Q ss_pred hhccccccCCCCCCCCcchhHHHH----------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR----------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
.+|+....+|+|+| |.||+|.. .++|..... .....+.+|+.++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~--g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAF--GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCC--cceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 46777788999999 99999731 112222211 1124577899999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC
Q 048314 89 STEAALDLPWDLAYIIFCSA---------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 153 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~ 153 (274)
+++|||+++++|.+++.... ...+++.....++.|++.||.|||+. +++|+||||+||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 99999999999999996321 23478999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHH
Q 048314 154 FWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIIL 219 (274)
Q Consensus 154 ~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~ 219 (274)
++.++++|||++.... +..|+|||.+....++.++|+||||+++|||++ |..||.... . ...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~-~~~ 235 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---N-QEV 235 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---H-HHH
Confidence 9999999999986432 235999999988888999999999999999998 888885431 0 011
Q ss_pred HHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 220 TNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. ....... ...+...+..+.+++.+||+.||++||++.+|+++|
T Consensus 236 ~~----~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 236 IE----MVRKRQL------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HH----HHHcCCc------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 11 0011100 013344567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=275.64 Aligned_cols=243 Identities=16% Similarity=0.152 Sum_probs=178.8
Q ss_pred hccccccCCCCCCCCcchhHHHH-------HHHHHhcCC----CCCCcHHHHHHHHhcC---CCCccceEeEEEE-----
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR-------ALMATVNSP----YSPSRPLTLTSIVSRV---SWTTDIEVSSVAM----- 83 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~-------~~~~~~~~~----~~~~~~~~e~~~l~~l---~h~niv~l~~~~~----- 83 (274)
+|...+.+|+|+| |.||++.. .++|..... .....+.+|+.+++++ +||||++++++|.
T Consensus 2 ~Y~~~~~lg~G~~--g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 2 QYECVAEIGEGAY--GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CcceeeEeccCCC--eEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 4666788999999 99998821 122222211 1223456787777765 6999999999985
Q ss_pred eCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccc
Q 048314 84 RGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG 163 (274)
Q Consensus 84 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g 163 (274)
.....++||||++ ++|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 2456899999996 6999999875556799999999999999999999999 99999999999999999999999999
Q ss_pred cceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh-
Q 048314 164 LAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL- 232 (274)
Q Consensus 164 ~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (274)
++.... +..|+|||.+....++.++|||||||++|||++|.+||...........+..... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~-~~~~~~~~ 234 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LPGEEDWP 234 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC-CCChhhch
Confidence 986532 5679999999888899999999999999999999999974421111111110000 0000000
Q ss_pred ------hhhhcCC------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 ------NKLVRGT------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 ------~~~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000 011234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=278.36 Aligned_cols=235 Identities=18% Similarity=0.176 Sum_probs=184.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHHH--------HHHHhcC---CCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMRA--------LMATVNS---PYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~~--------~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 88 (274)
.++|...+.+|.|+| |.||++... +++.... ....+.+.+|+.++.++ +||||+++++++.+++..
T Consensus 6 ~~~~~~~~~lg~G~~--g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNF--GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCC--ceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 467888899999999 999999321 1111111 11223567899999999 899999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC
Q 048314 89 STEAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 154 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 154 (274)
++||||+++|+|.+++.... ...+++..++.++.|++.|++|||+. +++||||||+||+++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence 99999999999999997532 13589999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHH
Q 048314 155 WTAKISDFGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWV 223 (274)
Q Consensus 155 ~~~kl~d~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 223 (274)
+.++|+|||++.... +..|+|||.+....++.++||||||+++|+|++ |..||...... ....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~-- 234 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYE-- 234 (303)
T ss_pred CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH----HHHH--
Confidence 999999999985321 345999999888888999999999999999998 99998633111 0000
Q ss_pred HHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 224 YKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
... ... ....+...+..+.+++.+||+.+|++|||+.+++++|
T Consensus 235 --~~~-----~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 235 --KLP-----QGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred --HHh-----cCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 000 000 0012333456789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=296.11 Aligned_cols=230 Identities=16% Similarity=0.146 Sum_probs=183.5
Q ss_pred ccccccCCCCCCCCcchhHHHH-------HHHHHhc-CC-CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR-------ALMATVN-SP-YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~-------~~~~~~~-~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
|...+.+|+|++ |.||++.. +++|... .. .....+.+|+.+|+.++|||||++++++.+.+..++||||
T Consensus 69 y~~~~~lg~G~~--g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 69 YVLTTLVGRNPT--TAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred EEEEEEEEeCCC--cEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 666888999999 99998721 1111111 11 1123456899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 95 DLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 95 ~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
+++|+|.+++.+. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988653 234689999999999999999999999 9999999999999999999999999998643
Q ss_pred ---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+++.|+|||.+....++.++|||||||++|+|++|..||.... ... +.. . ...+. ..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~-~~~---~-~~~~~------~~ 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QRE-IMQ---Q-VLYGK------YD 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHH-HHH---H-HHhCC------CC
Confidence 3567999999988889999999999999999999999996431 110 000 0 00010 01
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+...+..+.+++.+||+.||++|||+++++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 234455678999999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=261.08 Aligned_cols=240 Identities=18% Similarity=0.155 Sum_probs=185.7
Q ss_pred hccccccCCCCCCCCcchhHH-------HHHHHHHhcCC--CC-CCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSP--YS-PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~--~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.|.....+|+|.| |.||++ .+++||+.... +. ....++||+.|+.++|+||+.++++|-..+...||+
T Consensus 3 rY~~~~~lGEG~~--gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 3 RYEKLEKLGEGTY--GVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred hhhhhhhhcCcce--EEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4555778999999 999999 33333322211 12 233579999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
|||+ -+|+..++. +...++...++.++.+++.|++|||++ .|+|||+||.|+|++.++.+|++|||+++..+
T Consensus 81 Efm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred Eecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9997 489999987 566799999999999999999999999 99999999999999999999999999999876
Q ss_pred --------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh---------h
Q 048314 170 --------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR---------E 231 (274)
Q Consensus 170 --------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 231 (274)
+.-|+|||.+.+. .|+..+|+||.||++.||+.|.+.|... +..++ ...+...+... .
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-sDidQ---L~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-SDIDQ---LSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-chHHH---HHHHHHHcCCCCcccCccccc
Confidence 3458999988765 5899999999999999999988777543 22222 11111211111 0
Q ss_pred hhhhhc----CC----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 232 LNKLVR----GT----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 232 ~~~~~~----~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
+.++++ |. ..-..++.+..+++..||..||.+|+|+.|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111 10 1122345667999999999999999999999874
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=270.49 Aligned_cols=233 Identities=20% Similarity=0.242 Sum_probs=184.6
Q ss_pred hhccccccCCCCCCCCcchhHHH-----HHHHHHhcC-CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM-----RALMATVNS-PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~-----~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
++|...+.+|.|++ |.||++. ..++|.... ....+.+.+|+.++++++||||+++++.+. .+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~--~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCC--CcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 45777889999999 9999882 122222222 233456889999999999999999999874 45689999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++|+|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999864445689999999999999999999999 99999999999999999999999999986432
Q ss_pred ------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 ------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 ------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|++||......++.++|+||||+++|++++ |..||..... .. .. ...... . +...+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~-~~----~~~~~~-----~-~~~~~ 225 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---RE-VL----DQVERG-----Y-RMPCP 225 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HH-HH----HHHhcC-----C-CCCCc
Confidence 235999999988889999999999999999999 7778853311 10 00 000000 0 01233
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+..+.+++.+||+.||++|||++++++.|
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l 257 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFL 257 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 45667899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=273.10 Aligned_cols=232 Identities=16% Similarity=0.163 Sum_probs=181.5
Q ss_pred hhccccccCCCCCCCCcchhHHHH----------HHHHHhcCCCC---CCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR----------ALMATVNSPYS---PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
++|...+.+|.|+| |.||+|.. .++|....... ..++..|+.+++++.||||+++++++. ....
T Consensus 7 ~~~~~~~~lg~G~~--~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVF--GTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred hhceeccccCccCC--cceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 46777889999999 99998831 12222222211 234567888899999999999999875 4557
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++++||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+|++|||.++..
T Consensus 84 ~~i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 899999999999999976 345789999999999999999999999 9999999999999999999999999998643
Q ss_pred C-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 S-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
. +..|++||.+....++.++|+||||+++||+++ |..||..... ..... ...++..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~----~~~~~~~-- 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVPD----LLEKGER-- 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH----HHHCCCc--
Confidence 2 346999999988889999999999999999998 9999864311 11111 1111110
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ..+..++..+.+++.+||..||++|||+.|+++.|
T Consensus 230 ~----~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l 265 (279)
T cd05111 230 L----AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265 (279)
T ss_pred C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0 12223456789999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=270.58 Aligned_cols=224 Identities=18% Similarity=0.202 Sum_probs=177.6
Q ss_pred cCCCCCCCCcchhHHHH--------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCC
Q 048314 29 LNDRNSPRSKSVWSCMR--------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~--------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
.+|+|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++. ....++||||++
T Consensus 2 ~lg~G~~--g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNF--GTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCC--cceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 4899999 99998721 112222211 12345778999999999999999999875 456799999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------- 169 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------- 169 (274)
+|+|.+++.. ...+++.....++.|++.||.|||+. +++|+||||.||+++.++.++++|||.+....
T Consensus 79 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 79 LGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999999975 35689999999999999999999999 99999999999999999999999999986432
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||.+....++.++|+||||+++|||++ |..||..... ..+.. ...++. ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~----~i~~~~------~~~~ 219 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQ----MIESGE------RMEC 219 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH----HHHCCC------CCCC
Confidence 246999999988888999999999999999997 9999964311 11111 111111 0123
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+.++.++|.+||+.||++|||+++|.+.|
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence 445678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.26 Aligned_cols=239 Identities=18% Similarity=0.192 Sum_probs=182.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
.++|.....+|.|+| |.||++.. .++|. .....+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~--g~V~~~~d~~~~~~vaiK~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAE--GFAFACIDNKTCEHVVIKA----GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCC--eEEEEEEECCCCCEEEEec----hhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357888999999999 99999821 11111 1234578999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee-------
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL------- 167 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~------- 167 (274)
+. ++|..++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 165 ~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 85 789998875 45689999999999999999999999 999999999999999999999999999853
Q ss_pred -----cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCCh----hhHHHHHHHHHHHh----------
Q 048314 168 -----LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKP----EEIILTNWVYKCFI---------- 228 (274)
Q Consensus 168 -----~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~---------- 228 (274)
.+++.|+|||++....++.++|||||||++|||++|..|+....... ....+.. +.....
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~-i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL-IIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH-HHHHhcCChhhcCcch
Confidence 23678999999988889999999999999999999998875321110 0000000 000000
Q ss_pred hhhhhh---------hhcCCcc-----CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 229 NRELNK---------LVRGTEV-----DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 229 ~~~~~~---------~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...... ...+... ....+.++.+++.+||+.||++|||+.|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 0001001 1123567899999999999999999999986
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=269.06 Aligned_cols=233 Identities=22% Similarity=0.268 Sum_probs=185.5
Q ss_pred hhccccccCCCCCCCCcchhHHHHH----HHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMRA----LMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLP 97 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~~----~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 97 (274)
++|...+.+|.|+| |.||+|... ++|........+.+.+|+.++++++|||++++++++... ..+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~--g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEF--GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCC--CceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 56777899999999 999998321 122222222345678999999999999999999998655 47999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--------
Q 048314 98 WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-------- 169 (274)
Q Consensus 98 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-------- 169 (274)
++|.+++.......+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++|+|||.+....
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL 159 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCC
Confidence 9999999875555689999999999999999999999 99999999999999999999999999886532
Q ss_pred CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHH
Q 048314 170 DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLEN 248 (274)
Q Consensus 170 ~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (274)
...|+|||.+....++.++|+||||+++|+|++ |..||..... . ... .....+ ... ..+...+..
T Consensus 160 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~--~~~----~~~~~~-----~~~-~~~~~~~~~ 225 (254)
T cd05083 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--K--EVK----ECVEKG-----YRM-EPPEGCPAD 225 (254)
T ss_pred CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--H--HHH----HHHhCC-----CCC-CCCCcCCHH
Confidence 346999999988889999999999999999997 8888864311 0 010 111110 011 123345678
Q ss_pred HHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 249 LVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 249 ~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+.+++.+||+.+|++|||++++++.|
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~~l 251 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLREKL 251 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 89999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=282.04 Aligned_cols=223 Identities=17% Similarity=0.159 Sum_probs=178.7
Q ss_pred ccCCCCCCCCcchhHHH-------HH---HHH-HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCC
Q 048314 28 SLNDRNSPRSKSVWSCM-------RA---LMA-TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~-------~~---~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
+.+|+|+| |.||++. ++ +.+ ..........+.+|++++..++||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~--g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTF--GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCC--EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 36899999 9999771 11 111 11122234456789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
+|+|.+++.. ...+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||++...
T Consensus 79 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 79 GGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 9999999875 4579999999999999999999997 7 9999999999999999999999999987542
Q ss_pred ----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 169 ----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 169 ----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
+++.|+|||++....++.++|||||||++|+|++|..||..... . .... .... .....+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~-~~~~----~i~~-------~~~~~p~~ 218 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E-KLFE----LILM-------EEIRFPRT 218 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---H-HHHH----HHhc-------CCCCCCCC
Confidence 36789999999888899999999999999999999999964311 1 0000 0000 01123444
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 245 NLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
.+.++.+++.+||+.||++|+ ++.++++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 567889999999999999996 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=278.15 Aligned_cols=222 Identities=16% Similarity=0.159 Sum_probs=178.6
Q ss_pred ccCCCCCCCCcchhHHHH---------HHHHHh------cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 28 SLNDRNSPRSKSVWSCMR---------ALMATV------NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~---------~~~~~~------~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+.+|.|+| |.||++.. .++|.+ ........+.+|+.+|++++||||+++++++.+++..++||
T Consensus 2 ~~lg~G~~--g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGY--GKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred ceeeecCC--eEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 46899999 99997621 111111 11122344678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
||+++|+|.+++.. .+.+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 80 EYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred eCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999999975 45688999999999999999999999 9999999999999999999999999987632
Q ss_pred -------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-c
Q 048314 169 -------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-E 240 (274)
Q Consensus 169 -------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (274)
+++.|+|||++....++.++||||||+++|||++|+.||..... ... ...+.... .
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---~~~-------------~~~~~~~~~~ 218 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---KKT-------------IDKILKGKLN 218 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---HHH-------------HHHHHcCCCC
Confidence 35679999999888889999999999999999999999964311 000 01111111 2
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
.+...+..+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 3445567889999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=276.90 Aligned_cols=242 Identities=16% Similarity=0.150 Sum_probs=181.2
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|...+.+|.|+| |.||+|.. .++|.+... .....+.+|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSY--ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCC--EEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 467888899999999 99998821 122222211 2233567999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|||+. ++|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 82 ~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 82 FEYVH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred EECCC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 99996 688888875 345689999999999999999999999 99999999999999999999999999886432
Q ss_pred ---------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh---hhhh---
Q 048314 170 ---------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN---RELN--- 233 (274)
Q Consensus 170 ---------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~--- 233 (274)
+..|+|||.+.+ ..++.++|+||+||++|+|++|..||........ .+.... ..... ....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIF-LVLGTPNEDTWPGVH 233 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHH-HHhCCCChhhccchh
Confidence 466999998865 4578899999999999999999999974311111 111100 00000 0000
Q ss_pred --hhhc--------CCcc-----CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 --KLVR--------GTEV-----DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 --~~~~--------~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+ +... ....+..+.+++..||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 0000 0012356789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=272.74 Aligned_cols=226 Identities=19% Similarity=0.198 Sum_probs=179.0
Q ss_pred CCCCCCCCcchhHHH-------HHHHHH----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCC
Q 048314 30 NDRNSPRSKSVWSCM-------RALMAT----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPW 98 (274)
Q Consensus 30 ~g~g~~~~g~vy~~~-------~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 98 (274)
+|.|+| |.||++. +++|.. .......+.+..|+.++++++|+||+++.+++...+..++||||+++|
T Consensus 1 lg~G~~--g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGF--GEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCc--eeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 689999 9999871 111111 111122345678999999999999999999999999999999999999
Q ss_pred CHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--------
Q 048314 99 DLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-------- 168 (274)
Q Consensus 99 sL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-------- 168 (274)
+|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+...
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 999888542 235699999999999999999999999 9999999999999999999999999998642
Q ss_pred ---CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh-cCCccCHH
Q 048314 169 ---SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV-RGTEVDKK 244 (274)
Q Consensus 169 ---~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 244 (274)
+++.|+|||.+....++.++|+||||+++|+|++|+.||.............. ... .+...+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~------------~~~~~~~~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------RILNDSVTYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH------------hhcccCCCCccc
Confidence 25679999999988999999999999999999999999975422211111100 111 11124445
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 245 NLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
.+..+.+++.+||+.||++|| |++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 677899999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=282.06 Aligned_cols=220 Identities=18% Similarity=0.114 Sum_probs=175.3
Q ss_pred ccCCCCCCCCcchhHHHHH---------HHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 28 SLNDRNSPRSKSVWSCMRA---------LMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~~---------~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
+.+|.|+| |.||++... ++|.+. .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~lg~G~~--g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSF--GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCC--EEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 46899999 999965211 111111 112234466899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec------
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------ 168 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------ 168 (274)
+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 80 LRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 999999999975 45699999999999999999999999 9999999999999999999999999987643
Q ss_pred -----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 169 -----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 169 -----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
++..|+|||.+....++.++|+||||+++|+|++|+.||.... .. ..... .... ....+.
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~-~~~~~----i~~~-------~~~~p~ 219 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RK-ETMTM----ILKA-------KLGMPQ 219 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HH-HHHHH----HHcC-------CCCCCC
Confidence 2557999999988888999999999999999999999996431 11 11000 0000 012344
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChhh
Q 048314 244 KNLENLVKVGLWCVQDEPALRPSMKC 269 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps~~e 269 (274)
..+..+.+++.+||+.||++|||+.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 45678899999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=272.36 Aligned_cols=231 Identities=17% Similarity=0.196 Sum_probs=178.8
Q ss_pred cccccCCCCCCCCcchhHHHH--------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeC------C
Q 048314 25 CRSSLNDRNSPRSKSVWSCMR--------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG------S 86 (274)
Q Consensus 25 ~~~~~~g~g~~~~g~vy~~~~--------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 86 (274)
.....+|.|+| |.||+|.. .++|.... ....+.+.+|+.++++++||||+++++.+... .
T Consensus 2 ~i~~~ig~G~~--g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEF--GSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccC--ceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 34578999999 99999821 12222111 12245577899999999999999999987532 2
Q ss_pred cceEEEEeCCCCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 87 KPSTEAALDLPWDLAYIIFCS----AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
..+++|||+++|+|.+++... ....+++.....++.|++.||.|||+. +++||||||+||+++.++.++++||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 568999999999999998532 223489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHh
Q 048314 163 GLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFI 228 (274)
Q Consensus 163 g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (274)
|++.... +..|++||.+....++.++|+||||+++|+|++ |..||.... .. .. .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~-~~----~~~~~ 228 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NS-EI----YDYLR 228 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HH-HH----HHHHH
Confidence 9987532 346899999988889999999999999999999 788885421 11 11 01111
Q ss_pred hhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 229 NRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
++.. ...+...+..+.+++.+||+.||++|||+.+|++.|
T Consensus 229 ~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 229 QGNR------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred cCCC------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1110 012334567799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=274.07 Aligned_cols=234 Identities=17% Similarity=0.185 Sum_probs=184.6
Q ss_pred hhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
+++.-...+|.|+| |.||++.. .+++..... ...+.+.+|++++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAF--GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccC--CeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 45666788999999 99998721 111111111 1234578999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC
Q 048314 89 STEAALDLPWDLAYIIFCSAE-------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~ 155 (274)
+++|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 999999999999999976321 3489999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHH
Q 048314 156 TAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTN 221 (274)
Q Consensus 156 ~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~ 221 (274)
.++|+|||++.... ++.|+|||.+....++.++|+||||+++|+|++ |..||..... .. ..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~-~~- 234 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TE-AI- 234 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HH-HH-
Confidence 99999999986431 346999999988889999999999999999998 8888853311 10 00
Q ss_pred HHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 222 WVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+. +...+...+..+.+++.+||+.||++|||+++|++.|
T Consensus 235 ---~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 235 ---ECITQGR------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred ---HHHHcCc------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 0000100 1123334567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=268.25 Aligned_cols=232 Identities=21% Similarity=0.260 Sum_probs=186.7
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|.....+|.|++ |.||++.. .+++... .....+.+.+|+.++++++||||+++++.+.+.+..++||
T Consensus 1 ~~~~~~~l~~g~~--~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSF--GVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCC--eEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 4566788999999 99999822 1111111 1123456778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++++|.+++.......+++..++.++.|++.||.|||+. +++|+|++|+||+++.++.++++|||.+....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999999875456799999999999999999999999 99999999999999999999999999876532
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||++....++.++|+||||+++++|++|+.||.... .. .... ....+.. ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~-~~~~----~~~~~~~------~~~ 221 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QG-ALIL----KIIRGVF------PPV 221 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HH-HHHH----HHHcCCC------CCC
Confidence 456999999998888999999999999999999999996442 11 1100 0011100 113
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
+...+..+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 33556789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=270.02 Aligned_cols=224 Identities=17% Similarity=0.173 Sum_probs=177.8
Q ss_pred CCCCCCCCcchhHHHH--------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCC
Q 048314 30 NDRNSPRSKSVWSCMR--------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPW 98 (274)
Q Consensus 30 ~g~g~~~~g~vy~~~~--------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 98 (274)
+|.|+| |.||+|.. +++|..... ...+.+.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 3 ig~G~~--g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSGNF--GCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred cCCCCc--ccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 899999 99998721 122222221 12345779999999999999999999875 45689999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---------
Q 048314 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--------- 169 (274)
Q Consensus 99 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--------- 169 (274)
+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++++|||++....
T Consensus 80 ~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 80 PLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99999975 345789999999999999999999999 99999999999999999999999999886432
Q ss_pred -----CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 170 -----DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 170 -----~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
+..|+|||.+....++.++|+||||+++|++++ |..||..... . ... .....+. ....+.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~--~~~----~~~~~~~------~~~~~~ 221 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--P--EVM----SFIEQGK------RLDCPA 221 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--H--HHH----HHHHCCC------CCCCCC
Confidence 246999999988888999999999999999996 9999864311 0 000 1111110 112444
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 244 KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.++.++.+++.+||..||++||++.+|.+.|
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l 252 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERM 252 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 5678899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=274.78 Aligned_cols=233 Identities=21% Similarity=0.222 Sum_probs=184.0
Q ss_pred hccccccCCCCCCCCcchhHHHHH-----------HHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMRA-----------LMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~~-----------~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
+|...+.+|.|+| |.||+|... +++...... ..+++.+|+.++++++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~--g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEF--GKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCC--cceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 3556788999999 999998321 122222111 123577899999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCC
Q 048314 89 STEAALDLPWDLAYIIFCSA----------------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKP 146 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~ 146 (274)
++++||+.+|+|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 99999999999999986421 13488999999999999999999999 999999999
Q ss_pred CceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCC
Q 048314 147 QNILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDAS 212 (274)
Q Consensus 147 ~nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~ 212 (274)
+||++++++.++|+|||.+.... +..|+|||.+....++.++||||||+++++|++ |..||....
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~- 234 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA- 234 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-
Confidence 99999999999999999986431 346999999888888999999999999999998 888885331
Q ss_pred ChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 213 KPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. .+.. .... ... ...+...+..+.+++.+||+.||++|||++++++.|
T Consensus 235 -~~--~~~~----~~~~-----~~~-~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 235 -PE--RLFN----LLKT-----GYR-MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred -HH--HHHH----HHhC-----CCC-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 11 1111 1110 001 123445567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=274.50 Aligned_cols=237 Identities=19% Similarity=0.206 Sum_probs=186.7
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHHH-----------HHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEE
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMRA-----------LMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAM 83 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~~-----------~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 83 (274)
...++|.....+|+|++ |.||++... ++|..... ....++.+|+.++.++ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~--g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAF--GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEeccccc--ccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34567888889999999 999988321 11222111 1123467899999999 7999999999999
Q ss_pred eCCcceEEEEeCCCCCHHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCce
Q 048314 84 RGSKPSTEAALDLPWDLAYIIFCS--------------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 149 (274)
Q Consensus 84 ~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 149 (274)
+++..+++|||+++|+|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 999999999999999999999752 234689999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChh
Q 048314 150 LMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPE 215 (274)
Q Consensus 150 l~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~ 215 (274)
+++.++.++|+|||.+.... +..|+|||.+....++.++|||||||++|++++ |..||..... .
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~ 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--E 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--H
Confidence 99999999999999986432 245999999888889999999999999999997 8888853311 0
Q ss_pred hHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 216 EIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. .. ....... ....+...+..+.+++.+||..||++|||+.|+++.|
T Consensus 242 ~--~~----~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 242 E--LF----KLLKEGY------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred H--HH----HHHHcCC------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 0 00 1111100 0023445567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=284.52 Aligned_cols=230 Identities=17% Similarity=0.152 Sum_probs=191.4
Q ss_pred hhccccccCCCCCCCCcchhHH------HHHHHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC------MRALMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
+-|.-..-+|.|+- |.|-.+ ..+++|++... .......+|+.+|+-+.|||++++|+++.++.++|+
T Consensus 12 GpwkLgkTLG~Gst--g~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGST--GCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cceeccccccCCCC--ceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 44555777999999 888877 34444433332 335556799999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
|.||+++|-|.+++.. ++++++.+..+++.||+.|+.|+|.. +|+|||+||+|+|++.+..+||+|||.+...
T Consensus 90 vlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999999986 67899999999999999999999999 9999999999999999999999999998653
Q ss_pred --------CCCCcCCCcccccCCCc-cccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 --------SDKGCMAPECYKRTPIS-VKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 --------~~~~~~ape~~~~~~~~-~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+.++|.|||++.+.+|. .++||||+||+||.|++|+.||+.+ ++...+.. ++.+..
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-------Nir~LLlK-V~~G~f------- 229 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-------NIRVLLLK-VQRGVF------- 229 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-------cHHHHHHH-HHcCcc-------
Confidence 36889999999999885 7999999999999999999999733 12221111 111111
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
+.|...+.+..+|+++|+..||+.|.|++||++.
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 4666777899999999999999999999999863
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=270.99 Aligned_cols=234 Identities=19% Similarity=0.199 Sum_probs=187.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
.++|...+.+|+|++ |.||+|.. .++|..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~--g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEF--GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCC--ccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 357788899999999 99998832 122222211 1234577899999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||||+++++|.+++.. ..+.+++..+..++.|++.|+.|||+. +++|+|+||+||+++.++.++++|||++...
T Consensus 82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 82 MIITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999999976 346799999999999999999999999 9999999999999999999999999998644
Q ss_pred C--------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 169 S--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 169 ~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
. ...|+|||.+....++.++|+||||+++||+++ |..||..... ..... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~~~----~i~~~--- 226 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMK----AINDG--- 226 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHH----HHhcC---
Confidence 2 125999999988888999999999999999987 9999854311 11111 11110
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+.+...+..+.+++.+||+.+|++||++.+|++.|
T Consensus 227 ---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 227 ---FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 01122334567889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.16 Aligned_cols=227 Identities=21% Similarity=0.264 Sum_probs=183.9
Q ss_pred cccCCCCCCCCcchhHH------------HHHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc--ceEEE
Q 048314 27 SSLNDRNSPRSKSVWSC------------MRALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK--PSTEA 92 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~------------~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 92 (274)
..++|+|.| .+||+| .+.+-...++....++|..|+.+|+.|+|||||++|.+|.+... ..+|+
T Consensus 45 ~evLGrGaf--KtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 45 DEVLGRGAF--KTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred hhhcccccc--eeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 678999999 999999 11112233344555789999999999999999999999987554 77899
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-CCcEEEecccccee----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKISDFGLAKL---- 167 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~d~g~~~~---- 167 (274)
|++..|+|..|+.+ .+..+.+.++.|++||+.||.|||++ .|+|||||||++||++.+ .|.+||+|+|++..
T Consensus 123 EL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999986 56789999999999999999999998 789999999999999975 48899999999864
Q ss_pred -----cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 168 -----LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 168 -----~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
++||.+||||+.. ..|+..+||||||+.++||+|+.-||.....+. . +.+.+..+..+. .+.
T Consensus 200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-Q------IYKKV~SGiKP~-----sl~ 266 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-Q------IYKKVTSGIKPA-----ALS 266 (632)
T ss_pred ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-H------HHHHHHcCCCHH-----Hhh
Confidence 5699999999887 789999999999999999999999997552221 1 112222221111 122
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.-..++++++|.+|+.. .++|||+.|+|+
T Consensus 267 kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 KVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 22246789999999999 999999999986
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=266.16 Aligned_cols=228 Identities=18% Similarity=0.229 Sum_probs=181.8
Q ss_pred ccCCCCCCCCcchhHHHH------------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 28 SLNDRNSPRSKSVWSCMR------------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+.+|.|++ |.||+|.. .++|..... .....+.+|+.++++++||||+++++++...+..+++|
T Consensus 1 ~~lg~g~~--g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAF--GEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred Cccccccc--eeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999 99998832 233333322 23456789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC-----cEEEecc
Q 048314 93 ALDLPWDLAYIIFCSA-----ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-----TAKISDF 162 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-----~~kl~d~ 162 (274)
||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+|++|+||+++.+. .++++||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999997532 23488999999999999999999999 999999999999998877 8999999
Q ss_pred ccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHh
Q 048314 163 GLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFI 228 (274)
Q Consensus 163 g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (274)
|++.... +..|+|||.+....++.++|+||||+++|+|++ |..||.... ....... ..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~----~~~~~~~----~~ 227 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN----NQEVLQH----VT 227 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC----HHHHHHH----Hh
Confidence 9875432 356999999998889999999999999999998 999985331 1111110 00
Q ss_pred hhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 229 NRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. . ....+...+..+.+++.+||..+|.+|||+.++++.|
T Consensus 228 ~~---~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 228 AG---G---RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred cC---C---ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 00 0 0123345567899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=285.41 Aligned_cols=232 Identities=16% Similarity=0.125 Sum_probs=179.5
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhc-----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVN-----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|.....||+|+| |.||++.. .++|.+. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 2 ~f~~~~~LG~G~~--g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAF--GEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCC--EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 4666788999999 99998811 1112111 112234577899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee----
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL---- 167 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~---- 167 (274)
|||+++|+|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 80 MDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999999975 45689999999999999999999999 999999999999999999999999998531
Q ss_pred ------------------------------------------------------cCCCCcCCCcccccCCCccccceeeh
Q 048314 168 ------------------------------------------------------LSDKGCMAPECYKRTPISVKADVYGY 193 (274)
Q Consensus 168 ------------------------------------------------------~~~~~~~ape~~~~~~~~~~~Di~s~ 193 (274)
.++..|+|||.+....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 24678999999988889999999999
Q ss_pred hHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHH--hhccCCCCCCChhhHH
Q 048314 194 GIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLW--CVQDEPALRPSMKCVV 271 (274)
Q Consensus 194 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dp~~Rps~~evl 271 (274)
||++|||++|..||..............+ ..... .+.....+.++.+++.+ |+..+|..|||+.+++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~----------~~~~~-~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINW----------ENTLH-IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcc----------ccccC-CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999999643211110000000 00000 01112345678888887 5556667799999997
Q ss_pred h
Q 048314 272 M 272 (274)
Q Consensus 272 ~ 272 (274)
+
T Consensus 304 ~ 304 (381)
T cd05626 304 A 304 (381)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=267.99 Aligned_cols=233 Identities=19% Similarity=0.243 Sum_probs=184.2
Q ss_pred hhccccccCCCCCCCCcchhHHH-----HHHHHHhcC-CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM-----RALMATVNS-PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~-----~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
++|.....+|.|++ |.||++. ..++|.... ....+.+.+|+.++++++|||++++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~--~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCF--GEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCC--CeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 45667788999999 9999882 112222222 123356789999999999999999999875 45689999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++++|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999865445689999999999999999999999 99999999999999999999999999986532
Q ss_pred ------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 ------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 ------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|+|||.......+.++|+||||+++|+|++ |..||.... .. ..... .... . ....+
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~-~~~~~----~~~~-----~-~~~~~ 225 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV---NR-EVLEQ----VERG-----Y-RMPCP 225 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC---HH-HHHHH----HHcC-----C-CCCCC
Confidence 235999999988888999999999999999999 888886331 11 11110 0000 0 01233
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+..+.+++.+||+.||++|||+++|++.|
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 45567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=268.21 Aligned_cols=234 Identities=18% Similarity=0.247 Sum_probs=186.4
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----HHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
.++|...+.+|.|+| |.||++.. .++|... .....+++.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~G~~--g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQF--GEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCcc--ceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 456777889999999 99999832 1122222 2233456889999999999999999999864 5568999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999999865556799999999999999999999999 99999999999999999999999999986533
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||.+....++.++|+||||+++|++++ |+.||.....+ ..... .... . ..+.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~----~~~~-----~-~~~~ 224 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----EVIQN----LERG-----Y-RMPR 224 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----HHHHH----HHcC-----C-CCCC
Confidence 246999999988888999999999999999998 99999643111 01000 0000 0 0123
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+.++.+++.+||+.||++|||++++++.|
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 334567899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=277.91 Aligned_cols=236 Identities=17% Similarity=0.203 Sum_probs=184.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCCCC---CCcHHHHHHHHhcC-CCCccceEeEEEEe-
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSPYS---PSRPLTLTSIVSRV-SWTTDIEVSSVAMR- 84 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~l~~~~~~- 84 (274)
.++|...+.+|.|+| |.||++.. .++|.+..... .+.+.+|+.++.++ +|+||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~f--g~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAF--GKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcC--ceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 356888899999999 99998831 22333332211 23456899999999 79999999998865
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCC--------------------------------------------------------
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSA-------------------------------------------------------- 108 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 108 (274)
....+++|||+++++|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 456789999999999999986422
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-------------CCC
Q 048314 109 ---ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-------------DKG 172 (274)
Q Consensus 109 ---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-------------~~~ 172 (274)
...++|..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.... +..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12689999999999999999999999 99999999999999999999999999986532 346
Q ss_pred cCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHH
Q 048314 173 CMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVK 251 (274)
Q Consensus 173 ~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (274)
|+|||.+.+..++.++|||||||++|||++ |..||....... .+. ...... .. ...+...+.++.+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~-----~~-~~~~~~~~~~~~~ 307 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFC----RRLKEG-----TR-MRAPEYATPEIYS 307 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHH----HHHhcc-----CC-CCCCccCCHHHHH
Confidence 999999999999999999999999999997 999986431111 011 111111 01 0123345678999
Q ss_pred HHHHhhccCCCCCCChhhHHhhC
Q 048314 252 VGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 252 li~~cl~~dp~~Rps~~evl~~L 274 (274)
++.+||+.+|++|||+.||++.|
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l 330 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEIL 330 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=275.94 Aligned_cols=237 Identities=18% Similarity=0.207 Sum_probs=187.0
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEEe
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMR 84 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 84 (274)
..++|...+.+|.|+| |.||++.. .++|..... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~~~~~~~ig~G~~--g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAF--GKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cHHHeEEcceeeccCC--eeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 3467888999999999 99997621 111111111 1123577899999999 79999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
.+..+++|||+++|+|.+++.......+++.++..++.|++.||.|||+. +++|+||||+||+++.+..++++|||.
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999999864444589999999999999999999999 999999999999999999999999999
Q ss_pred ceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhh
Q 048314 165 AKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINR 230 (274)
Q Consensus 165 ~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
+.... +..|+|||.+....++.++||||||+++|+|++ |..||........ +.. ....+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~~----~~~~~ 260 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FYK----LIKEG 260 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HHH----HHHcC
Confidence 86432 245999999988889999999999999999998 9999864321111 111 00000
Q ss_pred hhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 231 ELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. ...+...+..+.+++.+||+.+|++|||+.||++.|
T Consensus 261 -----~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 261 -----YR-MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred -----Cc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 00 012233456899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=271.11 Aligned_cols=237 Identities=15% Similarity=0.122 Sum_probs=184.5
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhc-CCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeC----
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN-SPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRG---- 85 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~---- 85 (274)
..+.+.|.....+|.|++ |.||+|.. .++|... .......+.+|+.+++++ +||||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~--g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 2 RDPAGIFELVELVGNGTY--GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred CChhhhhhHHHheeecCC--eEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 346778888899999999 99998821 2222222 223344577999999998 699999999998753
Q ss_pred --CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccc
Q 048314 86 --SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG 163 (274)
Q Consensus 86 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g 163 (274)
...+++|||+++++|.+++.......+++..+..++.|++.|++|||+. +++|+|++|+||+++.++.++|+|||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 4578999999999999999875556799999999999999999999999 99999999999999999999999999
Q ss_pred cceecC-----------CCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH
Q 048314 164 LAKLLS-----------DKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF 227 (274)
Q Consensus 164 ~~~~~~-----------~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (274)
++.... +..|+|||++. ...++.++|+||||+++|+|++|..||..... .... . ..
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-~~~~-----~--~~ 228 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-MRAL-----F--LI 228 (272)
T ss_pred CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-HHHH-----H--HH
Confidence 986432 45699999886 33578899999999999999999999953311 0000 0 00
Q ss_pred hhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 INRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
. ........+...+..+.+++.+||+.||.+|||+.++++
T Consensus 229 ~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 P-----RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred h-----cCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 000111122344567899999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=270.14 Aligned_cols=228 Identities=19% Similarity=0.203 Sum_probs=178.7
Q ss_pred ccCCCCCCCCcchhHHHH--------HHHHHhcC---CCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR--------ALMATVNS---PYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~--------~~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+++|.|++ |.||+|.. ++++.... ....+.+.+|+.++.++ +||||+++++++...+..+++|||+
T Consensus 1 ~~lg~g~~--g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNF--GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCC--ceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 36899999 99999831 11122221 12234577899999999 7999999999999999999999999
Q ss_pred CCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEec
Q 048314 96 LPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISD 161 (274)
Q Consensus 96 ~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 161 (274)
++|+|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 9999999997532 12488999999999999999999999 999999999999999999999999
Q ss_pred cccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhh
Q 048314 162 FGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINR 230 (274)
Q Consensus 162 ~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
||++.... +..|+|||.+....++.++|+||||++++||++ |..||..... . .... . ....
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~-~~~~---~-~~~~ 227 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---A-ELYE---K-LPQG 227 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---H-HHHH---H-HhCC
Confidence 99974221 345999999988888999999999999999997 9999853211 0 0000 0 0000
Q ss_pred hhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 231 ELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ..+.+...+..+.+++.+||+.||.+|||+.+++.+|
T Consensus 228 -----~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 228 -----Y-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred -----C-CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 0 0112334556789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=272.72 Aligned_cols=234 Identities=18% Similarity=0.176 Sum_probs=183.8
Q ss_pred hhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCCCC---CCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSPYS---PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
.+|...+.+|.|+| |.||+|.. .++|....... .+.+..|+.++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~G~~--g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 5 STVRFMEELGEDRF--GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHhCCCCC--CeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 34556677999999 99999832 11222222111 2346789999999999999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC
Q 048314 88 PSTEAALDLPWDLAYIIFCS--------------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 153 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~ 153 (274)
.++++||+++++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++.+
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence 99999999999999998632 123488999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHH
Q 048314 154 FWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIIL 219 (274)
Q Consensus 154 ~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~ 219 (274)
++.+|++|||+++... ++.|+|||.+....++.++|+||||+++|||++ |..||..... ...
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~ 235 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDV 235 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 9999999999876432 346999999988889999999999999999998 7778753311 011
Q ss_pred HHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 220 TNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ....+... ...+..++..+.+++..||+.+|++|||+++|+..|
T Consensus 236 ~----~~i~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 236 I----EMIRNRQV------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred H----HHHHcCCc------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 1 11111110 123456678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=278.02 Aligned_cols=231 Identities=14% Similarity=0.173 Sum_probs=179.6
Q ss_pred ccCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.+|.|+| |.||++.. .++|.+ ......+.+..|..++.++ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~--g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSY--AKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCC--eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 36899999 99998811 111111 1112334467899999988 6999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee--------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL-------- 167 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~-------- 167 (274)
++|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 79 ~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 79 SGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 99999999875 45799999999999999999999999 999999999999999999999999998763
Q ss_pred ---cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChh-hHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 168 ---LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPE-EIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 168 ---~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
.++..|+|||++....++.++|+|||||++|+|++|+.||........ ......+........ ....|.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~p~ 226 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-------QIRIPR 226 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-------CCCCCC
Confidence 236679999999988899999999999999999999999964322110 011111111111111 112344
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC------hhhHHh
Q 048314 244 KNLENLVKVGLWCVQDEPALRPS------MKCVVM 272 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps------~~evl~ 272 (274)
..+..+.+++.+||+.||.+||| +.++++
T Consensus 227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 55678899999999999999998 567754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.95 Aligned_cols=226 Identities=16% Similarity=0.180 Sum_probs=175.9
Q ss_pred ccCCCCCCCCcchhHHH------HHHHHHh-----cCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCM------RALMATV-----NSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~------~~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.+|+|+| |.||++. ..++|.+ ......+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSY--AKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCC--eEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 36899999 9999881 1111111 1112234466888888876 7999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 79 ~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 79 NGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 99999999875 45799999999999999999999999 9999999999999999999999999987642
Q ss_pred ----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChh-hHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 169 ----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPE-EIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 169 ----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
++..|+|||++.+..++.++|+||||+++|+|++|..||........ ......+........ ....|.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------~~~~p~ 226 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------QIRIPR 226 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-------CCCCCC
Confidence 36679999999988899999999999999999999999963221111 011111111111111 112455
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCh
Q 048314 244 KNLENLVKVGLWCVQDEPALRPSM 267 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps~ 267 (274)
..+..+.+++.+||+.||++|||+
T Consensus 227 ~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 566788999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=285.21 Aligned_cols=224 Identities=18% Similarity=0.228 Sum_probs=189.8
Q ss_pred cccCCCCCCCCcchhHHHH----------HHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 27 SSLNDRNSPRSKSVWSCMR----------ALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~----------~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
..+||.|-| |.||+|.. +++|..+ ...+.+.|+.|..+|++++|||||+++|+|.+.+ .++|||
T Consensus 394 ~r~iG~GqF--GdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~WivmE 470 (974)
T KOG4257|consen 394 KRLIGEGQF--GDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIVME 470 (974)
T ss_pred HHhhcCCcc--cceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEEEe
Confidence 678999999 99999921 1233222 2255788999999999999999999999999776 899999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
+++-|.|..||+. +...|+..+...++.|++.||+|||+. ..+||||..+|||+.....+||+|||+++...
T Consensus 471 L~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 471 LAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred cccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 9999999999998 556799999999999999999999999 99999999999999999999999999998776
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHh-hcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETI-CCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT- 239 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (274)
...|||||.+....++..+|||=|||.+||++ .|..||+.... +..+..+-.+.
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sDVI~~iEnGeR 610 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SDVIGHIENGER 610 (974)
T ss_pred hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cceEEEecCCCC
Confidence 23599999999999999999999999999986 59999975411 11122222222
Q ss_pred -ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 240 -EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 240 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
+.|+.|++.+..|+.+||.+||.+||++.|+...
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ 645 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAI 645 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHH
Confidence 5788999999999999999999999999998654
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=275.98 Aligned_cols=223 Identities=16% Similarity=0.126 Sum_probs=177.6
Q ss_pred ccCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.+|.|+| |.||+|.. .++|.+ ......+.+..|.+++..+ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~--g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSF--GKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCC--eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 36899999 99998811 111111 1122334567889988865 6999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 79 NGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 99999999875 45789999999999999999999999 9999999999999999999999999987642
Q ss_pred ----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 169 ----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 169 ----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
++..|+|||++....++.++|+||||+++|+|++|+.||.... ... +.. . .... ....+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~-~~~---~-i~~~-------~~~~p~~ 218 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDD-LFE---S-ILHD-------DVLYPVW 218 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHH-HHH---H-HHcC-------CCCCCCC
Confidence 2567999999988889999999999999999999999996431 111 110 0 0000 0123334
Q ss_pred HHHHHHHHHHHhhccCCCCCC-------ChhhHHh
Q 048314 245 NLENLVKVGLWCVQDEPALRP-------SMKCVVM 272 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rp-------s~~evl~ 272 (274)
.+.++.+++..||+.||++|| ++.++++
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 457889999999999999999 7788765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=265.67 Aligned_cols=224 Identities=18% Similarity=0.275 Sum_probs=176.3
Q ss_pred ccCCCCCCCCcchhHHHH----------------HHHHHhcCCCC-CCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 28 SLNDRNSPRSKSVWSCMR----------------ALMATVNSPYS-PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~----------------~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
+.+|.|+| |.||+|.. .+.+....... ...+.+|+.++++++||||+++++++.. +..++
T Consensus 1 ~~lg~G~~--~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTF--TNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred Cccccccc--ceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 36899999 99998822 12222222212 4567899999999999999999999988 77899
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC-------cEEEeccc
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-------TAKISDFG 163 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-------~~kl~d~g 163 (274)
||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++++|||
T Consensus 78 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 78 VEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999999862 33789999999999999999999999 999999999999999887 79999999
Q ss_pred cceecC-------CCCcCCCcccccC--CCccccceeehhHhHHHHhhc-CCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 164 LAKLLS-------DKGCMAPECYKRT--PISVKADVYGYGIVLLETICC-WENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 164 ~~~~~~-------~~~~~ape~~~~~--~~~~~~Di~s~G~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
.+.... ...|+|||.+... .++.++|+||||+++|++++| ..|+.... ..... .. ..
T Consensus 154 ~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~---~~----~~----- 220 (259)
T cd05037 154 IPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKE---RF----YQ----- 220 (259)
T ss_pred cccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHH---HH----Hh-----
Confidence 987632 4579999998776 688999999999999999994 66665331 11100 00 00
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+......+.+++.+||+.+|.+|||+.+|++.|
T Consensus 221 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 ---DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ---cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11111112227889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=266.18 Aligned_cols=226 Identities=22% Similarity=0.211 Sum_probs=179.9
Q ss_pred cCCCCCCCCcchhHHHH-----HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCH
Q 048314 29 LNDRNSPRSKSVWSCMR-----ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDL 100 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~-----~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 100 (274)
++|.|++ |.||+|.. .++|..... .....+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 2 ~ig~g~~--g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNF--GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCC--ceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 6899999 99998832 112222211 1123477899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----------
Q 048314 101 AYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----------- 169 (274)
Q Consensus 101 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----------- 169 (274)
.+++.. ....+++..+..++.|++.||.|+|+. +++|+|++|+||+++.++.++++|||++....
T Consensus 80 ~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 80 LSFLRK-KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 999976 345689999999999999999999999 99999999999999999999999999886432
Q ss_pred -CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHH
Q 048314 170 -DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLE 247 (274)
Q Consensus 170 -~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (274)
...|+|||++....++.++|+||||+++|++++ |..||..... . ... ..... ... ...+...+.
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-~---~~~----~~~~~-----~~~-~~~~~~~~~ 221 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-Q---QAR----EQVEK-----GYR-MSCPQKCPD 221 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-H---HHH----HHHHc-----CCC-CCCCCCCCH
Confidence 235999999988888999999999999999998 8989864311 0 000 00000 001 123334567
Q ss_pred HHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 248 NLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 248 ~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+.+++.+||+.+|++|||+.|+++.|
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.07 Aligned_cols=241 Identities=16% Similarity=0.195 Sum_probs=176.3
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeC-----Ccc
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG-----SKP 88 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 88 (274)
|...+.+|.|+| |.||+|.. .++|.+. ......++.+|+.++++++||||+++++++... ...
T Consensus 2 y~i~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 2 YKIQEVIGKGSY--GVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred eEEEEEEeecCC--eEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 556778999999 99998821 1122111 112334578999999999999999999988643 247
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++|||||. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 80 ~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 80 YVVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 99999995 689999875 45699999999999999999999999 9999999999999999999999999998642
Q ss_pred --------------CCCCcCCCccccc--CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH-------HH
Q 048314 169 --------------SDKGCMAPECYKR--TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV-------YK 225 (274)
Q Consensus 169 --------------~~~~~~ape~~~~--~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------~~ 225 (274)
++..|+|||.+.. ..++.++|||||||++|+|++|+.||...........+.... ..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 2567999998865 578899999999999999999999996432110000000000 00
Q ss_pred HHhhhhh----hhhhcCCccC-----HHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 226 CFINREL----NKLVRGTEVD-----KKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 226 ~~~~~~~----~~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+... ..+......+ ...+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 0000000010 123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=272.30 Aligned_cols=242 Identities=17% Similarity=0.187 Sum_probs=185.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHHH----------------------HHHHhcCC---CCCCcHHHHHHHHhcCCCCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMRA----------------------LMATVNSP---YSPSRPLTLTSIVSRVSWTTD 75 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~~----------------------~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni 75 (274)
.++|.....+|+|+| |.||++... ++|..... ...+.+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~--g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQF--GEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCC--ccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 456777899999999 999986211 11211111 123456789999999999999
Q ss_pred ceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCC
Q 048314 76 IEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSA---------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKP 146 (274)
Q Consensus 76 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~ 146 (274)
+++++++..++..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence 999999999999999999999999999997632 12589999999999999999999999 999999999
Q ss_pred CceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh--cCCCccccC
Q 048314 147 QNILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC--CWENMEIDA 211 (274)
Q Consensus 147 ~nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~--g~~p~~~~~ 211 (274)
+||+++.++.++++|||.+.... +..|+|||.+....++.++||||||+++|+|++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999999986432 346999999988889999999999999999988 667774321
Q ss_pred CChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 212 SKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
... ................. ...+...+.++.+++.+||+.||++|||+.||++.|
T Consensus 239 ---~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 239 ---DQQ-VIENAGHFFRDDGRQIY---LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred ---hHH-HHHHHHhcccccccccc---CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 111 11111111000000000 012334557899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=271.56 Aligned_cols=241 Identities=19% Similarity=0.203 Sum_probs=181.6
Q ss_pred ccccccCCCCCCCCcchhHHH----------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeC--Ccc
Q 048314 24 FCRSSLNDRNSPRSKSVWSCM----------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--SKP 88 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~----------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 88 (274)
+.....+|.|+| |.||.+. ..++|..... ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus 6 ~~~~~~lg~g~~--g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHF--GKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCC--cEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 366788999999 9996531 1112222211 1234577999999999999999999998653 357
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
+++|||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 899999999999999975 3599999999999999999999999 9999999999999999999999999998653
Q ss_pred C--------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 S--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
. ...|++||.+....++.++|+||||+++++|++|..|+......... ...............+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE--MIGPKQGQMTVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh--hhcccccccchhhhhh
Confidence 2 23489999998888899999999999999999999998643211110 0000000000001111
Q ss_pred hhcCC---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGT---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+.. +.+...+..+.+++..||+.||++|||++++++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 11111 23445668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=267.00 Aligned_cols=237 Identities=17% Similarity=0.200 Sum_probs=187.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcC-----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS-----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.+|.|.| |.||+|.. .++|.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~i~~~l~~g~~--~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQF--SEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCC--eeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 46778899999999 99998821 11221111 1122356789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 91 EAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||+++|+|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 99999999999998643 234589999999999999999999999 9999999999999999999999999987653
Q ss_pred C-----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 S-----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 ~-----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
. +..|+|||.+....++.++|+||||+++|+|++|..||......... ... . ......
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~--~~~----~-----~~~~~~ 225 (267)
T cd08228 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS--LCQ----K-----IEQCDY 225 (267)
T ss_pred cchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH--HHH----H-----HhcCCC
Confidence 2 45699999998888889999999999999999999998643221111 100 0 111111
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+...+..+.+++.+||+.+|++|||+.+|++.|
T Consensus 226 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 226 PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 1122335567899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=253.50 Aligned_cols=233 Identities=15% Similarity=0.147 Sum_probs=183.6
Q ss_pred hhccccccCCCCCCCCcchhHH------HHHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC------MRALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+.|+.-..||+|.| +.||.+ ..-+.+.++.+ .+.++..+|+.+-+.|+||||+++.....+.+..+||
T Consensus 11 d~y~l~e~igkG~F--SvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 11 DNYDVKEELGKGAF--SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred hhhhHHHHHccCch--HHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 45555677999999 999998 22223322221 3556667999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC---CCcEEEeccccceec
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKISDFGLAKLL 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~d~g~~~~~ 168 (274)
+|+|.|++|..-+..+ .-+++...-..+.||+.||.|+|++ +|+|||+||.|+++.. .--+||+|||++...
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999997666542 3467888888999999999999999 9999999999999864 345899999998654
Q ss_pred ----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 169 ----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 169 ----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
++|+|||||++...+|+..+|||+.|++||-++.|.+||...... .+. ..+..+. +--+
T Consensus 164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~----rly----e~I~~g~---yd~~ 232 (355)
T KOG0033|consen 164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLY----EQIKAGA---YDYP 232 (355)
T ss_pred CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH----HHH----HHHhccc---cCCC
Confidence 388999999999999999999999999999999999999753111 111 1111111 1011
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+.....+++.++|+++||..||.+|.|+.|.++
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1234456788999999999999999999999875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=284.92 Aligned_cols=232 Identities=16% Similarity=0.104 Sum_probs=179.9
Q ss_pred hccccccCCCCCCCCcchhHHH-------HHHHH----HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM-------RALMA----TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~-------~~~~~----~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|...+.+|.|+| |.||++. +++|. ........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 2 ~y~~~~~lG~G~~--g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 2 DFHTVKVIGKGAF--GEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CceEeEEEeecCC--EEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 5777888999999 9999871 11111 111112334567899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee----
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL---- 167 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~---- 167 (274)
|||+++|+|.+++.. .+.+++.....++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 80 MEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999975 45789999999999999999999999 999999999999999999999999998741
Q ss_pred ------------------------------------------------------cCCCCcCCCcccccCCCccccceeeh
Q 048314 168 ------------------------------------------------------LSDKGCMAPECYKRTPISVKADVYGY 193 (274)
Q Consensus 168 ------------------------------------------------------~~~~~~~ape~~~~~~~~~~~Di~s~ 193 (274)
.+++.|+|||++....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 24667999999988889999999999
Q ss_pred hHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCC---CChhhH
Q 048314 194 GIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALR---PSMKCV 270 (274)
Q Consensus 194 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R---ps~~ev 270 (274)
||++|||++|..||..... ...+. . .... ...+..+ .....+..+.+++.+||. +|.+| ||+.|+
T Consensus 235 Gvil~elltG~~Pf~~~~~---~~~~~----~-i~~~-~~~~~~p--~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS---HETYR----K-IINW-RETLYFP--DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred chhhhhhhcCCCCCCCCCH---HHHHH----H-HHcc-CCccCCC--CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999999964311 10000 0 0000 0000000 111345678999999997 67765 599998
Q ss_pred Hhh
Q 048314 271 VMM 273 (274)
Q Consensus 271 l~~ 273 (274)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.97 Aligned_cols=235 Identities=21% Similarity=0.274 Sum_probs=185.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHHH-----------HHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMRA-----------LMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~~-----------~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
.++|.....+|.|+| |.||+|... ++|...... ....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSF--GMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCC--ceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 457777889999999 999987321 122222111 1234678999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEE
Q 048314 87 KPSTEAALDLPWDLAYIIFCSA--------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~k 158 (274)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 9999999999999999997532 12378999999999999999999999 999999999999999999999
Q ss_pred EeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHH
Q 048314 159 ISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVY 224 (274)
Q Consensus 159 l~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 224 (274)
|+|||.++... +..|+|||.+....++.++|+||||+++||+++ |..||.... . ......
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~---~~~~~~-- 233 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-N---EEVLKF-- 233 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-H---HHHHHH--
Confidence 99999875321 346999999988888999999999999999998 888885321 1 111111
Q ss_pred HHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 225 KCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..... ....+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 234 --~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 234 --VIDGG------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred --HhcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 11110 0123444578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=276.50 Aligned_cols=223 Identities=17% Similarity=0.132 Sum_probs=178.6
Q ss_pred ccCCCCCCCCcchhHHHH------HHHHH-----hcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR------ALMAT-----VNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------~~~~~-----~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.+|.|+| |.||++.. .++|. .......+.+..|..++..+ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSF--GKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCC--eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 36899999 99998811 11111 11222344567888999887 6999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
++|+|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 79 NGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 99999999875 45799999999999999999999999 9999999999999999999999999987542
Q ss_pred ----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 169 ----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 169 ----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
++..|+|||++.+..++.++|+|||||++|+|++|..||.... .. ... ...... ....+..
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~-~~~----~~i~~~-------~~~~~~~ 218 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---ED-ELF----QSILED-------EVRYPRW 218 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HH-HHH----HHHHcC-------CCCCCCc
Confidence 3567999999998899999999999999999999999996431 11 110 000000 1123444
Q ss_pred HHHHHHHHHHHhhccCCCCCCCh-----hhHHh
Q 048314 245 NLENLVKVGLWCVQDEPALRPSM-----KCVVM 272 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~-----~evl~ 272 (274)
.+..+.+++.+||+.||++|||+ .++++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 56788999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=268.48 Aligned_cols=232 Identities=17% Similarity=0.214 Sum_probs=181.4
Q ss_pred ccccccCCCCCCCCcchhHHHH---------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc---
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK--- 87 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 87 (274)
|...+.+|.|+| |.||+|.. .++|..... ...+.+.+|+..++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~--g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEF--GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCC--ceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 344678999999 99998731 112222211 112457789999999999999999999876554
Q ss_pred ---ceEEEEeCCCCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEe
Q 048314 88 ---PSTEAALDLPWDLAYIIFCS----AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKIS 160 (274)
Q Consensus 88 ---~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~ 160 (274)
.++++||+++|+|..++... ....+++.....++.|++.||.|||+. +++|+|+||+||+++.++.+|++
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence 79999999999999998643 223589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHH
Q 048314 161 DFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKC 226 (274)
Q Consensus 161 d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 226 (274)
|||+++... +..|++||.+....++.++|+||||+++|||++ |..||..... ..+...
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~---- 227 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDY---- 227 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH----
Confidence 999987532 246899999988889999999999999999999 8888853311 111111
Q ss_pred HhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 227 FINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+. ....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 228 ~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 228 LRHGN------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred HHcCC------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11110 1123445677899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=295.80 Aligned_cols=228 Identities=18% Similarity=0.156 Sum_probs=184.5
Q ss_pred hccccccCCCCCCCCcchhHH-------HHHHHHHhcC-CCCCCcHHHHHHHHhcCC-CCccceEeEE-EEe---C---C
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC-------MRALMATVNS-PYSPSRPLTLTSIVSRVS-WTTDIEVSSV-AMR---G---S 86 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~---~---~ 86 (274)
.....++|-+||| +.||.+ ..+.|+.+.. ....+...+||.+|+.|+ |+|||.+++. ... . -
T Consensus 38 ~v~V~~vLAEGGF--a~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGF--AQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCc--EEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 4445788999999 999988 1222333322 233445579999999998 9999999993 221 1 2
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
+.+|.||||.+|+|-|+|..+-...|++.++++|+.|+++|+++||.. .++|||||||.+|+|+..++..||||||.+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 568999999999999999976556699999999999999999999986 6779999999999999999999999999885
Q ss_pred ecC--------------------CCCcCCCccc---ccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH
Q 048314 167 LLS--------------------DKGCMAPECY---KRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV 223 (274)
Q Consensus 167 ~~~--------------------~~~~~ape~~---~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 223 (274)
... |+.|++||++ .+.+.+.|+|||+|||+||-|..+..||...+.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 322 7789999987 355789999999999999999999999974311
Q ss_pred HHHHhhhhhhhhhcCC---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 224 YKCFINRELNKLVRGT---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 224 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..++... +.....+..|.+||+.||+.||++||++-||++.
T Consensus 264 ---------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 264 ---------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ---------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 1122222 2334788999999999999999999999999875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=284.49 Aligned_cols=232 Identities=16% Similarity=0.120 Sum_probs=182.2
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhc-----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVN-----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.||.|+| |.||++. ..++|.+. .......+.+|+.++..++||||+++++++.+.+..++
T Consensus 1 ~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAF--GEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCC--EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 36778899999999 9999871 11122111 11233446789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee---
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL--- 167 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~--- 167 (274)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 79 v~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 79 IMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred EECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999999975 45699999999999999999999999 999999999999999999999999998753
Q ss_pred ----------------------------------------------cCCCCcCCCcccccCCCccccceeehhHhHHHHh
Q 048314 168 ----------------------------------------------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETI 201 (274)
Q Consensus 168 ----------------------------------------------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~ 201 (274)
.+++.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 2467899999998888999999999999999999
Q ss_pred hcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCC---hhhHHh
Q 048314 202 CCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPS---MKCVVM 272 (274)
Q Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~evl~ 272 (274)
+|..||..... .. ... . ..+.. ..... ..+...++.+.+++.+|+. +|.+|++ +.|+++
T Consensus 234 ~G~~Pf~~~~~--~~-~~~----~-i~~~~-~~~~~--~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNP--QE-TYR----K-IINWK-ETLQF--PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCH--HH-HHH----H-HHcCC-CccCC--CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999964311 10 000 0 00000 00000 1111345678899999996 9999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=255.03 Aligned_cols=243 Identities=19% Similarity=0.144 Sum_probs=191.8
Q ss_pred HHHhhhccccccCCCCCCCCcchhHH-------HHHHHHHhcCC-CCCCcHHHHHHHHhcCCCCccceEeEEEEeC----
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSP-YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG---- 85 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 85 (274)
....++|.....+|.||| +-||.+ ..+.|++.-.. ++.+..++|++..++++|||++++++.+..+
T Consensus 17 ~In~~Ryri~~~LgeGGf--sfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGF--SFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEcCceEEEeeeecCCCc--eeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 334567888899999999 999988 45666655544 6677778999999999999999999887532
Q ss_pred -CcceEEEEeCCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 86 -SKPSTEAALDLPWDLAYIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 86 -~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
...||+++|...|||.+.+.... +..+++.+.+.++.+++.||.+||+. .+++.||||||.||++.+.+.+++.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 34899999999999999998763 33589999999999999999999998 345999999999999999999999999
Q ss_pred ccceecC--------------------CCCcCCCccccc---CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHH
Q 048314 163 GLAKLLS--------------------DKGCMAPECYKR---TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219 (274)
Q Consensus 163 g~~~~~~--------------------~~~~~ape~~~~---~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~ 219 (274)
|.+.... +..|+|||.+.- ...+.++|||||||++|+|+.|..||......- ..+
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G--gSl 251 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG--GSL 251 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC--CeE
Confidence 9987543 567999998854 456899999999999999999999996431100 000
Q ss_pred HHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 220 TNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. -...+ .++.-| .....++.+.+++.+|++.||.+||++.+++..+
T Consensus 252 a----LAv~n---~q~s~P--~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~ 297 (302)
T KOG2345|consen 252 A----LAVQN---AQISIP--NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKL 297 (302)
T ss_pred E----Eeeec---cccccC--CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 0 00000 112222 2223778999999999999999999999998764
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=276.07 Aligned_cols=218 Identities=17% Similarity=0.164 Sum_probs=174.4
Q ss_pred ccCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.+|.|+| |.||++.. .++|.+ ......+.+..|..++..+ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSF--GKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCC--eEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 36899999 99998811 111111 1122344567888888876 5999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
++|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 79 ~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 79 NGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 99999999975 45799999999999999999999999 9999999999999999999999999987642
Q ss_pred ----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 169 ----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 169 ----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
+++.|+|||.+....++.++|+|||||++|+|++|+.||..... ..+.. ..... ....+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~----~i~~~-------~~~~~~~ 218 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----DDLFE----AILND-------EVVYPTW 218 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHHHH----HHhcC-------CCCCCCC
Confidence 36789999999888899999999999999999999999964311 11111 01110 1123334
Q ss_pred HHHHHHHHHHHhhccCCCCCCCh
Q 048314 245 NLENLVKVGLWCVQDEPALRPSM 267 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~ 267 (274)
.+.++.+++.+||+.||++||++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCC
Confidence 56788999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=273.36 Aligned_cols=237 Identities=18% Similarity=0.185 Sum_probs=187.1
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH-------------HHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEE
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR-------------ALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSV 81 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~-------------~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~ 81 (274)
....+|.....+|.|+| |.||++.. .++|..... ...+++.+|+.+++.+ +||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCF--GQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCC--ceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 34567888899999999 99997731 122222211 2234577999999999 79999999999
Q ss_pred EEeCCcceEEEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCC
Q 048314 82 AMRGSKPSTEAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQ 147 (274)
Q Consensus 82 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ 147 (274)
+...+..+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence 999999999999999999999998632 23578999999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCC
Q 048314 148 NILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASK 213 (274)
Q Consensus 148 nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~ 213 (274)
||+++.++.++|+|||.+.... +..|+|||.+....++.++||||||+++|++++ |..||... +
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~ 244 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--P 244 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--C
Confidence 9999999999999999986542 245999999988889999999999999999998 77777532 1
Q ss_pred hhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 214 PEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
... +. ....... ....+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 245 ~~~--~~----~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 245 VEE--LF----KLLKEGH------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHH--HH----HHHHcCC------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 111 10 1111110 0113345667899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=270.74 Aligned_cols=236 Identities=19% Similarity=0.202 Sum_probs=185.8
Q ss_pred HhhhccccccCCCCCCCCcchhHHHHH-----------HHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMRA-----------LMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~~-----------~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
.+++|...+.+|.|++ |.||++... ++|..... .....|.+|+.++++++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~--g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAF--GEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCC--CcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3577888999999999 999988321 11211111 1123578899999999999999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC---cE
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAE-----RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TA 157 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~---~~ 157 (274)
+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence 999999999999999999976421 2589999999999999999999999 999999999999998654 68
Q ss_pred EEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHH
Q 048314 158 KISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWV 223 (274)
Q Consensus 158 kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 223 (274)
+++|||.++... ...|+|||.+....++.++|||||||++|+|++ |..||..... .. +..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~-~~~-- 232 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QE-VME-- 232 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HH-HHH--
Confidence 999999986532 235999999988889999999999999999996 8899864311 11 111
Q ss_pred HHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 224 YKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..... .....+...+..+.+++.+||+.||++|||+.+|++.|
T Consensus 233 --~~~~~------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 233 --FVTGG------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred --HHHcC------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 00000 01123344567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=271.12 Aligned_cols=242 Identities=18% Similarity=0.198 Sum_probs=183.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHHH--------------------HHHHhcCC---CCCCcHHHHHHHHhcCCCCccce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMRA--------------------LMATVNSP---YSPSRPLTLTSIVSRVSWTTDIE 77 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~~--------------------~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~ 77 (274)
.++|...+.+|+|+| |.||.+... ++|..... ...+.+.+|++++++++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~--g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQF--GEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCC--ceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 356777888999999 999987321 11212111 11235778999999999999999
Q ss_pred EeEEEEeCCcceEEEEeCCCCCHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCC
Q 048314 78 VSSVAMRGSKPSTEAALDLPWDLAYIIFCSA----------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQ 147 (274)
Q Consensus 78 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ 147 (274)
+++++...+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 9999999999999999999999999996521 12378999999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh--cCCCccccCC
Q 048314 148 NILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC--CWENMEIDAS 212 (274)
Q Consensus 148 nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~--g~~p~~~~~~ 212 (274)
||+++.++.+|++|||++.... +..|+|||.+....++.++|+||||+++++|++ |..||....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~- 237 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS- 237 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-
Confidence 9999999999999999986432 346999999988889999999999999999988 556665321
Q ss_pred ChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 213 KPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
........ ............. ..+...+..+.+++.+||+.||++|||+++|++.|
T Consensus 238 --~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 238 --DEQVIENT-GEFFRNQGRQIYL---SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred --hHHHHHHH-HHhhhhccccccC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 11111110 0000000000000 12223457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=274.74 Aligned_cols=236 Identities=19% Similarity=0.200 Sum_probs=186.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH-------------HHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR-------------ALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVA 82 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~-------------~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 82 (274)
...+|...+.+|.|++ |.||++.. .++|..... .....+.+|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~--g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCF--GQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCc--ccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 3467788899999999 99998731 122222221 1123567899999999 599999999999
Q ss_pred EeCCcceEEEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 048314 83 MRGSKPSTEAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQN 148 (274)
Q Consensus 83 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~n 148 (274)
.+.+..+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 99999999999999999999997632 23589999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCCh
Q 048314 149 ILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKP 214 (274)
Q Consensus 149 il~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~ 214 (274)
|+++.++.++|+|||.++... +..|+|||.+....++.++|+||||+++|+|++ |..||.... .
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~--~ 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP--V 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC--H
Confidence 999999999999999986432 135999999988889999999999999999998 888885331 1
Q ss_pred hhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 215 EEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. +.. ...... ....+...+.++.+++.+||+.||++|||+.++++.|
T Consensus 243 ~~--~~~----~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 243 EE--LFK----LLREGH------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred HH--HHH----HHHcCC------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11 111 111110 0123445567889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.01 Aligned_cols=233 Identities=20% Similarity=0.206 Sum_probs=185.9
Q ss_pred hhccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
++|.....+|.|+| |.||+|.. .+++..... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus 4 ~~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEF--GEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCC--CceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 56777899999999 99998731 112222211 12345788999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+....
T Consensus 82 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 82 IVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999999986 345689999999999999999999999 99999999999999999999999999886532
Q ss_pred --------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 170 --------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 170 --------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
+..|++||.+....++.++|+||||+++|++++ |..||..... .. ... ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~--~~~----~~~~~---- 225 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QD--VIK----AIEEG---- 225 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HH--HHH----HHhCC----
Confidence 235899999988889999999999999999886 9999864311 10 111 11111
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ..+.+...+..+.+++.+||+.+|.+|||+.++++.|
T Consensus 226 -~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 263 (267)
T cd05066 226 -Y-RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263 (267)
T ss_pred -C-cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHH
Confidence 0 0122334567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=269.32 Aligned_cols=233 Identities=21% Similarity=0.222 Sum_probs=183.6
Q ss_pred ccccccCCCCCCCCcchhHHH------HHHHHHhcC-----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCM------RALMATVNS-----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
|...+++|+|+| |.||++. ..++|.+.. ....+.+.+|+.++++++|+||+++++.+.+.+..++||
T Consensus 2 f~~~~~ig~G~~--g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGF--GEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceeeEEeecCCC--eEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 556788999999 9999871 111221111 112234678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
||+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||++...
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999999764455699999999999999999999999 9999999999999999999999999988643
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
++..|+|||.+....++.++|+||||+++|+|++|..||................ .. .. ...+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~----~~--~~-----~~~~ 225 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----KE--VQ-----EEYS 225 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh----hh--hh-----hhcC
Confidence 2567999999988889999999999999999999999997532211111111100 00 00 0123
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCC-----hhhHHh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPS-----MKCVVM 272 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps-----~~evl~ 272 (274)
...+..+.+++..||+.||++||| +.|+++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 344567899999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=267.18 Aligned_cols=237 Identities=17% Similarity=0.213 Sum_probs=186.5
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhc-----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN-----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.+|.|++ |.||++.. .++|... .....+++.+|+.+++.++||||+++++++.+++..++
T Consensus 2 ~~y~~~~~ig~g~~--g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQF--SEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCC--eEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 45677888999999 99998831 1122111 11223467789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 91 EAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
+|||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 99999999999998742 234689999999999999999999999 9999999999999999999999999987543
Q ss_pred -----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 -----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 -----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
++..|+|||.+....++.++|+||||+++|+|++|..||........ ... . .......
T Consensus 157 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~----~-----~~~~~~~ 225 (267)
T cd08229 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLC----K-----KIEQCDY 225 (267)
T ss_pred ccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HHh----h-----hhhcCCC
Confidence 24569999999888889999999999999999999999864321110 000 0 1111111
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+...+..+.+++.+||+.||++|||+.+|++.|
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 226 PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 1122334667899999999999999999999887754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=270.47 Aligned_cols=233 Identities=15% Similarity=0.162 Sum_probs=183.7
Q ss_pred hhhccccccCCCCCCCCcchhHHHH----------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR----------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
.++|...+.+|.|+| |.||+|.. .++|..... ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~--g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAF--GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred hhheeeeeecCCCCC--ceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 356777889999999 99999821 112222211 123456789999999999999999999875 45
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++++||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||++.+++.++|+|||+++.
T Consensus 83 ~~l~~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred cEEEEEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 7899999999999999976 345699999999999999999999999 999999999999999999999999999865
Q ss_pred cC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 168 LS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 168 ~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
.. +..|++||.+....++.++||||||+++||+++ |..||.... ...+..+. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~~~----~~~--- 227 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP----AREIPDLL----EKG--- 227 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHH----HCC---
Confidence 42 246999999988889999999999999999998 888886431 11111111 110
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+.+...+..+.+++..||+.||++|||+.++++.|
T Consensus 228 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l 265 (279)
T cd05109 228 ---ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEF 265 (279)
T ss_pred ---CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 01122334567889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=265.68 Aligned_cols=234 Identities=16% Similarity=0.255 Sum_probs=185.7
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----HHHHHhcC-CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNS-PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
..+|...+.+|.|+| |.||++.. .++|.... ....+.+.+|+.++++++|+||+++++.+.+ ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~--~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQF--GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccc--eEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 346777889999999 99998821 11222222 1234568899999999999999999999887 778999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999864455689999999999999999999999 99999999999999999999999999876532
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
...|+|||.+....++.++|+||||+++|++++ |..||...... .+.. ...... ..+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~----~~~~~~------~~~~ 224 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIR----ALERGY------RMPR 224 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHH----HHhCCC------CCCC
Confidence 235999999988888999999999999999998 88888643110 0111 001100 0012
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+.++.+++.+||+.||++|||+.++.+.|
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 334567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=269.92 Aligned_cols=241 Identities=18% Similarity=0.216 Sum_probs=184.0
Q ss_pred hhccccccCCCCCCCCcchhHHHHH----------------------HHHHhcCC---CCCCcHHHHHHHHhcCCCCccc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMRA----------------------LMATVNSP---YSPSRPLTLTSIVSRVSWTTDI 76 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~~----------------------~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv 76 (274)
++|...+.+|+|+| |.||++... ++|..... ...+.+.+|+.++++++|+||+
T Consensus 5 ~~~~~~~~lg~G~~--g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQF--GEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCC--CeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 56777889999999 999986211 11111111 1224577999999999999999
Q ss_pred eEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCC
Q 048314 77 EVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAE---------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQ 147 (274)
Q Consensus 77 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ 147 (274)
++++++.+.+..+++|||+++|+|.+++..... ..+++.....++.|++.||+|||+. +++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 999999999999999999999999999976321 2378889999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh--cCCCccccCC
Q 048314 148 NILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC--CWENMEIDAS 212 (274)
Q Consensus 148 nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~--g~~p~~~~~~ 212 (274)
||+++.++.++++|||.+.... ...|++||....+.++.++|+||||+++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999986431 246899998888889999999999999999998 6677753211
Q ss_pred ChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 213 KPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. .... ......... ..... +.+..++..+.+++.+||+.||++|||+.+|++.|
T Consensus 240 --~~-~~~~-~~~~~~~~~-~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 240 --EQ-VIEN-TGEFFRDQG-RQVYL--PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred --HH-HHHH-HHHHHhhcc-ccccC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 11 1110 001111100 00011 12334567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=266.00 Aligned_cols=235 Identities=21% Similarity=0.271 Sum_probs=188.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----HHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
.++|.....+|.|++ |.||++.. .++|... .....+++.+|+.++++++|+||+++++++.+....+++|||
T Consensus 5 ~~~~~i~~~ig~g~~--~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQF--GEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcc--eEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 467888889999999 99998721 1222222 223345688999999999999999999999988899999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
+++++|.+++.......+++..+..++.|++.|+.|||+. +++|+|++|+||+++.++.++++|||.+....
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999999875445799999999999999999999999 99999999999999999999999999986543
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||.+.+..++.++|+||||++++++++ |+.||.... ....+.. .... . ....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~-----~~~~-----~-~~~~ 225 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQ-----VERG-----Y-RMPR 225 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH-----HHcC-----C-CCCC
Confidence 246999999988888999999999999999998 899985331 1111110 0000 0 0112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+..+.+++.+||+.||++|||++++++.|
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l 258 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 333467899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=280.10 Aligned_cols=237 Identities=15% Similarity=0.078 Sum_probs=184.0
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHH------HHHHHHh-----cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCM------RALMATV-----NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
+....++|...+.+|.|+| |.||++. ..++|.+ ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAF--GEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred CCCCHHHcEEEEEEeeCCC--EEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3445678888999999999 9999771 1111111 1112334467899999999999999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
+..++||||+++|+|.+++.+ ..++......++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 999999999999999999975 3588899999999999999999999 9999999999999999999999999997
Q ss_pred eec------------CCCCcCCCcccccC----CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh
Q 048314 166 KLL------------SDKGCMAPECYKRT----PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN 229 (274)
Q Consensus 166 ~~~------------~~~~~~ape~~~~~----~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (274)
... +++.|+|||++... .++.++|+|||||++|||++|..||...... ... .....
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~-----~~i~~ 261 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTY-----SKIMD 261 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHH-----HHHHc
Confidence 543 35679999988653 3788999999999999999999999744210 000 00000
Q ss_pred hhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCC--CCChhhHHh
Q 048314 230 RELNKLVRGTEVDKKNLENLVKVGLWCVQDEPAL--RPSMKCVVM 272 (274)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~evl~ 272 (274)
.. ..... +.....+..+.+++..||+.+|.+ |||+.|+++
T Consensus 262 ~~-~~~~~--~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 262 HK-NSLTF--PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CC-CcCCC--CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 00 00000 111134678899999999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=264.19 Aligned_cols=227 Identities=21% Similarity=0.198 Sum_probs=181.1
Q ss_pred cCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCC
Q 048314 29 LNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
.+|.|++ |.||++.. .++|..... ...+++.+|+.++++++||||+++++.+.+ ...++++||++
T Consensus 2 ~ig~g~~--~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 2 KLGDGSF--GVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred cCCccCc--ccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 5899999 99998831 122322222 123467789999999999999999999988 88999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------- 169 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------- 169 (274)
+++|.+++.+.....+++...+.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 99999999874335789999999999999999999999 99999999999999999999999999886543
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||.+....++.++|+||||+++|+|++ |..||..... .. ... .. .. .. .....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~--~~~---~~-~~-~~----~~~~~ 222 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--SQ--ILK---KI-DK-EG----ERLER 222 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HH--HHH---HH-Hh-cC----CcCCC
Confidence 246999999988889999999999999999998 9999853311 10 100 00 00 00 01112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence 334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=274.09 Aligned_cols=235 Identities=19% Similarity=0.194 Sum_probs=185.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-------------HHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-------------ALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAM 83 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-------------~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 83 (274)
.++|...+.+|+|+| |.||++.. .++|..... ...+++.+|+.+++++ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~--g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCF--GQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCC--eeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 467888899999999 99997731 112222211 1223567899999999 6999999999999
Q ss_pred eCCcceEEEEeCCCCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCce
Q 048314 84 RGSKPSTEAALDLPWDLAYIIFCSAE--------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 149 (274)
Q Consensus 84 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 149 (274)
+.+..++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+. +++|+||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 99999999999999999999986321 3489999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChh
Q 048314 150 LMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPE 215 (274)
Q Consensus 150 l~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~ 215 (274)
+++.++.++|+|||.+.... +..|+|||.+....++.++|+||||+++|+|++ |..||... +..
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~--~~~ 249 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVE 249 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--CHH
Confidence 99999999999999986432 246999999988888999999999999999998 78888532 111
Q ss_pred hHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 216 EIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. +. ...... ...+.+...+..+.+++.+||+.+|++|||+.+|++.|
T Consensus 250 ~--~~----~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 250 E--LF----KLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred H--HH----HHHHcC------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 1 00 001111 01123445567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=265.26 Aligned_cols=232 Identities=16% Similarity=0.175 Sum_probs=185.4
Q ss_pred hccccccCCCCCCCCcchhHHH------HHHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM------RALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
+|...+.+|.|++ |.||++. ..++|... .....+.+.+|+.++++++||||+++++.+.+.+..+++||
T Consensus 1 ~y~~~~~lg~g~~--g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSF--GRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCC--eEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 3556788999999 9999871 11222221 11234556789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++|+|.+++.......+++...+.++.|++.||.|||+. +++|+||+|.||+++.++.++++|||.+....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999999765556689999999999999999999999 99999999999999999999999999986543
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|+|||++....++.++|+||||+++|+|++|..||.... ..... .. ...+.. ...+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~----~~-~~~~~~------~~~~ 221 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLI----LK-VCQGSY------KPLP 221 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHH----HH-HhcCCC------CCCC
Confidence 446999999988888999999999999999999999996431 10000 00 001110 1233
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
...+..+.+++.+||+.||++|||+.+++..
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 4456778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=265.05 Aligned_cols=233 Identities=17% Similarity=0.237 Sum_probs=184.8
Q ss_pred hhccccccCCCCCCCCcchhHHHHH-----HHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMRA-----LMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~~-----~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
.+|.....+|.|++ |.||++... ++|... .....+.+.+|++++++++|||++++++++......+++|||+
T Consensus 4 ~~~~~~~~ig~g~~--g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQF--GLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCccc--ceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 35566788999999 999987221 122222 1223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++++|.+++.. ....+++..++.++.|++.|+.|||+. +++|+|++|+||+++.++.++++|||.+....
T Consensus 82 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 82 EHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999999976 345689999999999999999999999 99999999999999999999999999876432
Q ss_pred ------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 ------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 ------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|+|||.+....++.++|+||||+++|++++ |..||.... .. .+.. . .... ... ..+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~-~~~~---~-~~~~--~~~----~~~ 223 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS---NS-EVVE---T-INAG--FRL----YKP 223 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---HH-HHHH---H-HhCC--CCC----CCC
Confidence 246999999988888999999999999999998 899986331 11 1111 0 0000 011 122
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 23457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=275.65 Aligned_cols=232 Identities=15% Similarity=0.109 Sum_probs=180.9
Q ss_pred hccccccCCCCCCCCcchhHHHHH---------HHHHh------cCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCC
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMRA---------LMATV------NSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGS 86 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~~---------~~~~~------~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 86 (274)
+|...+.||.|+| |.||.+..+ ++|.. ......+.+..|+.++.+++ ||||+++++++.+.+
T Consensus 1 ~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAY--GKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCC--EEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 3566788999999 999975221 11111 11122345678999999995 899999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999999975 45689999999999999999999999 99999999999999999999999999886
Q ss_pred ec------------CCCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 167 LL------------SDKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 167 ~~------------~~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
.. ++..|+|||.+... .++.++|||||||++|||++|..||...........+.. ...
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----~~~----- 224 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----RIL----- 224 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH----HHh-----
Confidence 42 35679999998764 478899999999999999999999964422221111111 000
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
. .....+...+..+.+++.+||+.||++|| ++.++++
T Consensus 225 ~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 225 K--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred c--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0 01123445567889999999999999999 6677765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=281.13 Aligned_cols=231 Identities=18% Similarity=0.191 Sum_probs=177.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
..+|.....||.|+| |.||++.. .++|..... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 73 ~~~~~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAG--GTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCC--eEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 355666788999999 99999821 122222211 1124577999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|||+.+|+|.+.. ..++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 151 ~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 151 LEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999999986532 356788889999999999999999 9999999999999999999999999998643
Q ss_pred --------CCCCcCCCcccccC-----CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 169 --------SDKGCMAPECYKRT-----PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 169 --------~~~~~~ape~~~~~-----~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
++..|+|||.+... ..+.++|||||||++|||++|+.||......... .+.. .. . .
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~---~~----~---~ 290 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA-SLMC---AI----C---M 290 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHH---HH----h---c
Confidence 25679999987432 2346899999999999999999999733111111 0000 00 0 0
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
......+...+.++.+++.+||+.||++|||+.|+++.
T Consensus 291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112344566789999999999999999999999863
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=266.79 Aligned_cols=233 Identities=20% Similarity=0.175 Sum_probs=186.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
+++.....+|.|+| |.||+|.. .++|..... ...+.|..|+.++++++||||+++++++.++...+
T Consensus 4 ~~~~~~~~lg~g~~--g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEF--GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCC--CeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 45667889999999 99998731 222222221 12346789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+||||+++++|.+++.. ..+.+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 82 IITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEecCCCCcHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999999976 345689999999999999999999999 99999999999999999999999999876432
Q ss_pred ----------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 170 ----------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 170 ----------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
+..|++||.+....++.++|+||||+++||+++ |..||..... ....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~~~i----~---- 225 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVINAI----E---- 225 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHHHHH----H----
Confidence 125999999988889999999999999999886 9999853311 1111111 0
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. .+.+.+...+..+.+++.+||+.+|.+||++.+|+.+|
T Consensus 226 -~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 265 (269)
T cd05065 226 -QD-YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265 (269)
T ss_pred -cC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00 01123345567889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=277.35 Aligned_cols=233 Identities=18% Similarity=0.113 Sum_probs=181.7
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|.....+|.|+| |.||++. ..++|. .......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 ~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHF--GEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccC--EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 35777889999999 9999871 111111 1112234456789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
||||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 79 VMEYQPGGDLLSLLNR-YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred EECCCCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999999986 335799999999999999999999999 9999999999999999999999999998643
Q ss_pred ----------CCCCcCCCcccc------cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 169 ----------SDKGCMAPECYK------RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 169 ----------~~~~~~ape~~~------~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
+++.|+|||++. ...++.++|||||||++|+|++|..||...... .... .. .+.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~----~i-~~~-- 224 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---KTYN----NI-MNF-- 224 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH---HHHH----HH-HcC--
Confidence 256799999886 445788999999999999999999999643111 1010 00 000
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.....- +.+...+..+.+++..||+ ||.+|||+.++++
T Consensus 225 ~~~~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 225 QRFLKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCccCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000000 1112345778999999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=282.19 Aligned_cols=231 Identities=18% Similarity=0.103 Sum_probs=180.2
Q ss_pred hccccccCCCCCCCCcchhHHH------HHHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM------RALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~------~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|...+.||.|+| |.||++. ..++|. .......+.+.+|+.+|++++||||+++++.+.+++..++|
T Consensus 2 ~y~~~~~lG~G~~--g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAF--GEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCC--eEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 5677888999999 9999881 111111 11112345567899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce-----
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK----- 166 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~----- 166 (274)
|||+++|+|.+++.. .+.+++.....++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.
T Consensus 80 ~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 80 MDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999999975 45689999999999999999999999 99999999999999999999999999863
Q ss_pred -------------------------------------------------ecCCCCcCCCcccccCCCccccceeehhHhH
Q 048314 167 -------------------------------------------------LLSDKGCMAPECYKRTPISVKADVYGYGIVL 197 (274)
Q Consensus 167 -------------------------------------------------~~~~~~~~ape~~~~~~~~~~~Di~s~G~~l 197 (274)
..+++.|+|||++....++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 1346789999999988899999999999999
Q ss_pred HHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCC---ChhhHHh
Q 048314 198 LETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRP---SMKCVVM 272 (274)
Q Consensus 198 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp---s~~evl~ 272 (274)
|||++|+.||............ ..... .... +.....+..+.+++.+|+ .+|++|+ |+.|+++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i--------~~~~~-~~~~--~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKV--------INWET-TLHI--PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHH--------hccCc-cccC--CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999999644211100000 00000 0000 111234567788888876 5999999 8999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=265.03 Aligned_cols=225 Identities=20% Similarity=0.226 Sum_probs=178.2
Q ss_pred ccCCCCCCCCcchhHHHH---------HHHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR---------ALMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~---------~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.||.|+| |.||+|.. .++|...... ..+.+.+|+.+++++.||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~--g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNF--GSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCc--eeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 36899999 99998831 1122222111 2345778999999999999999999875 45689999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++|+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 78 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 78 PLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999999986 33789999999999999999999999 99999999999999999999999999986432
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+..|+|||.+....++.++|+||||+++|++++ |..||..... ..+.... ... ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~----~~~------~~~~ 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAML----ESG------ERLP 218 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHH----HcC------CcCC
Confidence 135999999988889999999999999999997 9999864311 1111111 111 1112
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+...+..+.+++.+||+.||++|||+.+|++.|
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 3445567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=272.80 Aligned_cols=221 Identities=15% Similarity=0.109 Sum_probs=174.4
Q ss_pred cCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHHHHhc-CCCCccceEeEEEEeCCcceEEEEeCC
Q 048314 29 LNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTSIVSR-VSWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
.||.|+| |.||++.. .++|.+ ......+.+..|..++.. .+||||+++++++...+..++||||++
T Consensus 2 ~lG~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 2 VLGKGSF--GKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred eeeeCCC--eEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 6899999 99998821 111111 111233445667777765 479999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-------- 168 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-------- 168 (274)
+|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 80 gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 80 GGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 9999999975 45689999999999999999999999 9999999999999999999999999998642
Q ss_pred ---CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHH
Q 048314 169 ---SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKN 245 (274)
Q Consensus 169 ---~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (274)
+++.|+|||++.+..++.++|+|||||++|+|++|..||..... .. +. ..... .....+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~-~~----~~i~~-------~~~~~~~~~ 219 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DE-LF----DSILN-------DRPHFPRWI 219 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HH-HH----HHHHc-------CCCCCCCCC
Confidence 26789999999888899999999999999999999999964311 10 10 00000 011234445
Q ss_pred HHHHHHHHHHhhccCCCCCCChh-hHH
Q 048314 246 LENLVKVGLWCVQDEPALRPSMK-CVV 271 (274)
Q Consensus 246 ~~~~~~li~~cl~~dp~~Rps~~-evl 271 (274)
+..+.+++.+||+.||++||++. +++
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 67789999999999999999975 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=265.49 Aligned_cols=227 Identities=22% Similarity=0.295 Sum_probs=174.8
Q ss_pred ccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEe-CCcceEEEEe
Q 048314 28 SLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR-GSKPSTEAAL 94 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 94 (274)
+.+|+|+| |.||+|.. .++|..... ...+.+.+|+.+++.++||||+++++++.. ++..++++||
T Consensus 1 ~~lg~g~~--g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHF--GCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCC--ceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 36899999 99998731 122222111 123467789999999999999999998764 5568999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||++....
T Consensus 79 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 79 MKHGDLRNFIRS-ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999999976 334578888899999999999999999 99999999999999999999999999886321
Q ss_pred ----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcC-CCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 170 ----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCW-ENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 170 ----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+..|+|||.+....++.++||||||+++|||++|. +||... . ...+.... ..+ ..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~---~~~~~~~~----~~~------~~ 220 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-D---SFDITVYL----LQG------RR 220 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-C---HHHHHHHH----hcC------CC
Confidence 34699999998888999999999999999999964 455322 1 11111110 000 01
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+...+..+.+++..||+.+|++|||+.+|++.|
T Consensus 221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 112333456899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=274.60 Aligned_cols=226 Identities=19% Similarity=0.153 Sum_probs=175.6
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHHHH---hcCCCCccceEeEEEEeCCcce
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTSIV---SRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~ 89 (274)
|...+.+|.|++ |.||++.. .++|.. ......+.+.+|++++ ++++||||+++++++.+.+..+
T Consensus 1 y~i~~~lg~G~~--g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHF--GKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCC--EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 344678999999 99998821 111111 1112234455665554 5678999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
+||||+++|+|..++.. ..+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 79 lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999999988853 5699999999999999999999999 9999999999999999999999999987532
Q ss_pred ----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 169 ----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 169 ----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+++.|+|||.+....++.++|+|||||++|+|++|..||.... ..... ...... .
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~-----~~i~~~-------~ 217 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVF-----DSIVND-------E 217 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHH-----HHHHhC-------C
Confidence 3668999999988889999999999999999999999996431 11100 000110 1
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
...+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 218 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 123444567889999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=271.17 Aligned_cols=246 Identities=18% Similarity=0.188 Sum_probs=181.9
Q ss_pred hhccccccCCCCCCCCcchhHHHH----------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEe--CCc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR----------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--GSK 87 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 87 (274)
++|...+.+|.|+| |.||++.. .++|..... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNF--GSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCC--ceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 45677888999999 99998631 112222111 123457799999999999999999998754 346
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++|+||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred eEEEEEecCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 8999999999999999975 334689999999999999999999999 999999999999999999999999999875
Q ss_pred cC--------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 168 LS--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 168 ~~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
.. ...|+|||.+....++.++|+||||++++||++|..++.......... .............+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM-MGNDKQGQMIVYHLI 236 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh-cccccccccchHHHH
Confidence 32 123899999988888999999999999999999877654221100000 000000000000000
Q ss_pred hhhcCC---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVRGT---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+.+... ..+...+..+.+++.+||..+|++|||+.||++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 111111 23344567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=265.45 Aligned_cols=231 Identities=17% Similarity=0.167 Sum_probs=173.5
Q ss_pred cCCCCCCCCcchhHHHH--------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCC
Q 048314 29 LNDRNSPRSKSVWSCMR--------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLP 97 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~--------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 97 (274)
.+|+|+| |.||+|.. .+++..... .....+.+|+.+++.++||||+++++.+.+....++||||+++
T Consensus 2 ~lg~G~f--g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWF--GKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCC--ceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 4899999 99998821 112222211 1123467899999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 98 WDLAYIIFCSAE---RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 98 gsL~~~l~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
|+|.+++..... ...++.....++.|++.||+|||+. +++||||||+||+++.++.+|++|||++....
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999986432 2357888899999999999999999 99999999999999999999999999975421
Q ss_pred --------CCCcCCCccccc-------CCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 170 --------DKGCMAPECYKR-------TPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 170 --------~~~~~ape~~~~-------~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
+..|+|||++.. ..++.++|+||||+++|||++ |..||... .....+.. ... ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~---~~~~~~~~----~~~-~~~~ 228 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL---SDEQVLKQ----VVR-EQDI 228 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC---CHHHHHHH----Hhh-ccCc
Confidence 345999998743 346789999999999999998 67777533 11111111 001 1111
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+ ..+...+..+.+++..|| .||++|||+++|++.|
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11111 233355677888999999 5999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=281.89 Aligned_cols=231 Identities=16% Similarity=0.098 Sum_probs=178.2
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhc-----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVN-----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|...+.||+|+| |.||++.. .++|.+. .....+.+.+|+.++++++||||+++++.+.+.+..++|
T Consensus 2 ~f~~~~~LG~G~~--g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAF--GEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCC--EEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 4667788999999 99999821 1111111 112234567899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee----
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL---- 167 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~---- 167 (274)
||||++|+|.+++.. .+.+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 80 MDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999999975 35689999999999999999999999 999999999999999999999999998531
Q ss_pred ------------------------------------------------------cCCCCcCCCcccccCCCccccceeeh
Q 048314 168 ------------------------------------------------------LSDKGCMAPECYKRTPISVKADVYGY 193 (274)
Q Consensus 168 ------------------------------------------------------~~~~~~~ape~~~~~~~~~~~Di~s~ 193 (274)
.+++.|+|||++....++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 24567999999988889999999999
Q ss_pred hHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCC---hhhH
Q 048314 194 GIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPS---MKCV 270 (274)
Q Consensus 194 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~ev 270 (274)
||++|||++|..||............ .... ... ..+.....++++.+++.+|+ .||++|++ +.++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i--------~~~~-~~~--~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKV--------INWQ-TSL--HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHH--------HccC-CCc--CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999999643111000000 0000 000 00111234567788888876 59999997 8887
Q ss_pred Hh
Q 048314 271 VM 272 (274)
Q Consensus 271 l~ 272 (274)
++
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 64
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=266.96 Aligned_cols=229 Identities=18% Similarity=0.125 Sum_probs=188.1
Q ss_pred hhccccccCCCCCCCCcchhHH----------HHHH-HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC----------MRAL-MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~----------~~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
+.|...+.+|.|.. |.||.+ ++++ +....+.....+...|-+||+.++||.++.||..+..+...|+
T Consensus 77 ~~f~llk~LG~Gdi--G~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDI--GTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred HHHHHHHHcCCCCc--eeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 45666778999999 999988 2222 3333333455566789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
+||||+||+|...++...++.+++..++.++.+++.||.|||-. ||++|||||+|||+.++|++.|+||.++....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999999988888899999999999999999999999 99999999999999999999999998763110
Q ss_pred ------------------------------------------------------------------CCCcCCCcccccCC
Q 048314 170 ------------------------------------------------------------------DKGCMAPECYKRTP 183 (274)
Q Consensus 170 ------------------------------------------------------------------~~~~~ape~~~~~~ 183 (274)
|..|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 33499999999999
Q ss_pred CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-cc--CHHHHHHHHHHHHHhhccC
Q 048314 184 ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-EV--DKKNLENLVKVGLWCVQDE 260 (274)
Q Consensus 184 ~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~li~~cl~~d 260 (274)
.+..+|.|+|||++|||+.|..||........ ..+++... .+ ....+..++|||++.|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 99999999999999999999999975532221 12222211 11 2255678999999999999
Q ss_pred CCCCCC----hhhHH
Q 048314 261 PALRPS----MKCVV 271 (274)
Q Consensus 261 p~~Rps----~~evl 271 (274)
|.+|.- ++||-
T Consensus 376 P~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIK 390 (459)
T ss_pred hhhhhccccchHHhh
Confidence 999986 66653
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=262.37 Aligned_cols=236 Identities=17% Similarity=0.205 Sum_probs=187.8
Q ss_pred hhccccccCCCCCCCCcchhHHHHH------HHHHh-----cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMRA------LMATV-----NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~~------~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.+|.|++ |.||+|... ++|.. ......+.+.+|++++++++|+|++++++.+.+.+..++
T Consensus 2 ~~y~~~~~lg~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQF--SVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCc--eEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 56777889999999 999988221 12211 111234567899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 91 EAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
+|||+++|+|.+++... ....+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.++++|||.+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 99999999999999753 234589999999999999999999999 9999999999999999999999999987643
Q ss_pred C-----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 S-----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 ~-----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
. +..|+|||.+....++.++|+||||+++|+|++|..||....... .... .....+ ..
T Consensus 157 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~-----~~ 225 (267)
T cd08224 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLC-KKIEKC-----DY 225 (267)
T ss_pred cCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-----HHHH-hhhhcC-----CC
Confidence 2 446999999988888999999999999999999999986442111 0000 000000 01
Q ss_pred CCccCH-HHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 238 GTEVDK-KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 238 ~~~~~~-~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+ +.+. ..+..+.+++.+||+.+|++|||+.+|+++|
T Consensus 226 ~-~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 226 P-PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred C-CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 1 1222 5567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=264.70 Aligned_cols=231 Identities=17% Similarity=0.165 Sum_probs=173.4
Q ss_pred cCCCCCCCCcchhHHHH--------HHHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCC
Q 048314 29 LNDRNSPRSKSVWSCMR--------ALMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLP 97 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~--------~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 97 (274)
.+|.|+| |.||+|.. .+++...... ....+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G~~--g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWF--GKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCC--ceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 5899999 99998831 1122222211 123567899999999999999999999998899999999999
Q ss_pred CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 98 WDLAYIIFCSAE---RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 98 gsL~~~l~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
|+|.+++..... ..+++..+..++.|++.|+.|||+. +++|+|+||+||+++.++.++++|||.+....
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999975321 2467888889999999999999999 99999999999999999999999999885321
Q ss_pred --------CCCcCCCcccccC-------CCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 170 --------DKGCMAPECYKRT-------PISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 170 --------~~~~~ape~~~~~-------~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
+..|+|||++... .++.++|+||||+++|||++ |..||..... ... ... .......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~--~~~----~~~~~~~ 228 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQV--LTY----TVREQQL 228 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--HHH--HHH----HhhcccC
Confidence 3459999987532 35789999999999999996 9999964311 110 000 0001111
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...++ ......+..+.+++..|| .+|++|||++||+..|
T Consensus 229 ~~~~~-~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 229 KLPKP-RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred CCCCC-ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 11111 122234567889999999 6899999999998765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=279.90 Aligned_cols=232 Identities=17% Similarity=0.161 Sum_probs=183.8
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|...+.+|.|+| |.||++.. .++|. .........+.+|+.++..++||||+++++++.+.+..++|
T Consensus 2 ~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 2 DFEVIKVIGRGAF--GEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CceEEEEEEeCCc--EEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 5777889999999 99998821 11111 11223345577899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 80 MEYMPGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999986 36799999999999999999999999 9999999999999999999999999987532
Q ss_pred -------------------------------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccC
Q 048314 169 -------------------------------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDA 211 (274)
Q Consensus 169 -------------------------------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~ 211 (274)
+++.|+|||++....++.++|||||||++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2566999999998899999999999999999999999997542
Q ss_pred CChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCC-hhhHHhh
Q 048314 212 SKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPS-MKCVVMM 273 (274)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~evl~~ 273 (274)
... .. ...... ...... +.....+..+.+++.+|+. ||.+||+ ++++++.
T Consensus 235 ~~~---~~-----~~i~~~-~~~~~~--p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE---TY-----NKIINW-KESLRF--PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH---HH-----HHHhcc-CCcccC--CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 110 00 000000 000000 1111246789999999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=273.17 Aligned_cols=219 Identities=17% Similarity=0.145 Sum_probs=171.9
Q ss_pred ccCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHH-HHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTS-IVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
++||.|+| |.||++.. .++|.+ ........+..|.. +++.++||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSF--GKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCC--eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 36899999 99998821 111111 11122234455555 467899999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
.+|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 79 ~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 79 NGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 99999999975 45789999999999999999999999 9999999999999999999999999987532
Q ss_pred ----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 169 ----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 169 ----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
+++.|+|||++....++.++|||||||++|+|++|..||..... .. + . ...... +...+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~-~---~-~~i~~~-------~~~~~~~ 218 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AE-M---Y-DNILNK-------PLRLKPN 218 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HH-H---H-HHHHcC-------CCCCCCC
Confidence 35679999999988899999999999999999999999964311 00 0 0 000010 1112334
Q ss_pred HHHHHHHHHHHhhccCCCCCCChh
Q 048314 245 NLENLVKVGLWCVQDEPALRPSMK 268 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~~ 268 (274)
.+..+.+++.+||+.||.+||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 467889999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=305.83 Aligned_cols=242 Identities=18% Similarity=0.370 Sum_probs=188.0
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
...|...+++|+|+| |.||+|.. .++|.... .......|++++++++|||||+++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~--g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKK--GASYKGKSIKNGMQFVVKEIND--VNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCC--eeEEEEEECCCCcEEEEEEccC--CccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 345777889999999 99999931 12222222 222335679999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee-------
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL------- 167 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~------- 167 (274)
+++|+|.+++.. ++|..+..++.|++.|++|||..+.++++|||+||+||+++.+...++. ++....
T Consensus 765 ~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~ 838 (968)
T PLN00113 765 IEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKC 838 (968)
T ss_pred CCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCc
Confidence 999999999963 8999999999999999999996555699999999999999988877765 444322
Q ss_pred cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-----ccC
Q 048314 168 LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-----EVD 242 (274)
Q Consensus 168 ~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 242 (274)
..+..|+|||++....++.++|||||||++|||++|+.||...... ...+..|............++++. ..+
T Consensus 839 ~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred cccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 2257899999999888999999999999999999999999643211 122334443333222333333332 344
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....++.+++.+||+.||++||||+||+++|
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 56677889999999999999999999999875
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=272.88 Aligned_cols=223 Identities=18% Similarity=0.167 Sum_probs=177.6
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHHHHhcCCC-CccceEeEEEEeCCcceE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTSIVSRVSW-TTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~l 90 (274)
+|...+.+|.|+| |.||+|.. .++|.+ ......+.+..|+.++..++| ++|+++++++.+.+..++
T Consensus 1 ~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSF--GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccC--eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 4666788999999 99998811 111111 122334567789999999976 458889999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
||||+++|+|.+++.. ...+++...+.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 79 v~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 79 VMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999999975 45689999999999999999999999 9999999999999999999999999987632
Q ss_pred ---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+++.|+|||++....++.++|+||+||++|+|++|+.||.... .. .+... .... ..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~-~~~~~----i~~~-------~~ 218 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---ED-ELFQS----IMEH-------NV 218 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HH-HHHHH----HHcC-------CC
Confidence 3678999999998889999999999999999999999996431 11 11100 0000 01
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCCh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSM 267 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~ 267 (274)
..+...+..+.+++.+||+.||.+||+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 2344456788999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=272.32 Aligned_cols=222 Identities=14% Similarity=0.108 Sum_probs=175.4
Q ss_pred ccCCCCCCCCcchhHHHH------HHHHHhc-----CCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR------ALMATVN-----SPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------~~~~~~~-----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.+|.|+| |.||++.. .++|... .....+....|..++... +||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~~--g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSF--GKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCC--eEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 36899999 99998811 1111111 112334566788888754 7999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 79 ~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 79 NGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 99999999975 45789999999999999999999999 9999999999999999999999999987632
Q ss_pred ----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 169 ----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 169 ----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
++..|+|||++....++.++|+||+||++|+|++|..||.... .. .+. ..... .....+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~-~~~----~~~~~-------~~~~~~~~ 218 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---ED-ELF----ESIRV-------DTPHYPRW 218 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HH-HHH----HHHHh-------CCCCCCCC
Confidence 3678999999998889999999999999999999999996431 11 111 00000 01123334
Q ss_pred HHHHHHHHHHHhhccCCCCCCChh-hHH
Q 048314 245 NLENLVKVGLWCVQDEPALRPSMK-CVV 271 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~~-evl 271 (274)
.+.++.+++.+||+.||++||++. +++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 567789999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.01 Aligned_cols=243 Identities=19% Similarity=0.212 Sum_probs=180.8
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
....+|...+.+|.|+| |.||+|.. +++|. ........|+.++++++||||+++++++.+.+..++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~valK~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSE--GRVFVATKPGQPDPVVLKI----GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCC--eEEEEEEECCCCceEEEEe----CCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34457888999999999 99999822 11111 22344568999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
|++. ++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+...
T Consensus 137 e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 137 PHYS-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EccC-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 9985 689999876 446799999999999999999999999 9999999999999999999999999998642
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCcc-ccCCChhhH--HHHHHHHHHHhh-----hhh--
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENME-IDASKPEEI--ILTNWVYKCFIN-----REL-- 232 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~-~~~~~~~~~--~~~~~~~~~~~~-----~~~-- 232 (274)
++..|+|||++....++.++|+|||||++|||+++..|+. ......... .....+...... ...
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 3567999999998889999999999999999998655543 221111110 000011110000 000
Q ss_pred -------hhhhcCC-----c-------cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 -------NKLVRGT-----E-------VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 -------~~~~~~~-----~-------~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...++.. . .....+..+.++|.+||+.||++|||+.||++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 0000000 0 00122345677999999999999999999986
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=269.80 Aligned_cols=236 Identities=19% Similarity=0.266 Sum_probs=183.8
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
..++|...+.+|.|+| |.||+|.. .++|...... ....+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~--g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSF--GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCC--cEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3567888899999999 99998721 1122222111 123467899999999999999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcE
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSA--------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 157 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~ 157 (274)
+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 99999999999999999997532 12357788899999999999999999 99999999999999999999
Q ss_pred EEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHH
Q 048314 158 KISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWV 223 (274)
Q Consensus 158 kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 223 (274)
+++|||+++... +..|+|||.+....++.++|+||||+++|||++ |..||.... .. ....
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~---~~-~~~~-- 232 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---NE-QVLK-- 232 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC---HH-HHHH--
Confidence 999999876421 245999999988889999999999999999998 677885321 11 0111
Q ss_pred HHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 224 YKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
....+.. ...+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 233 --~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l 275 (288)
T cd05061 233 --FVMDGGY------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275 (288)
T ss_pred --HHHcCCC------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 0000000 012334467899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=268.16 Aligned_cols=236 Identities=19% Similarity=0.194 Sum_probs=185.5
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
..++|...+.+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++.++
T Consensus 3 ~~~~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAF--GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceeccccccccc--ccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3568888999999999 99998621 111222211 1134577899999999999999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSA--------------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIK 145 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~ 145 (274)
+..+++|||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 99999999999999999997421 12478999999999999999999999 99999999
Q ss_pred CCceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccC
Q 048314 146 PQNILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDA 211 (274)
Q Consensus 146 ~~nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~ 211 (274)
|+||+++.++.++++|||.+.... +..|+|||.+....++.++|+||||+++|+|++ |..||....
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999886422 235999999888889999999999999999997 777875321
Q ss_pred CChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 212 SKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+ .. ....++... ..+...+.++.+++.+||+.||++|||+.|+++.|
T Consensus 238 --~~~--~~----~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l 286 (288)
T cd05050 238 --HEE--VI----YYVRDGNVL------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286 (288)
T ss_pred --HHH--HH----HHHhcCCCC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 111 00 111111110 12334567899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=271.71 Aligned_cols=221 Identities=17% Similarity=0.113 Sum_probs=175.2
Q ss_pred cCCCCCCCCcchhHHHH------HHHHHhc-----CCCCCCcHHHHHHHHhc-CCCCccceEeEEEEeCCcceEEEEeCC
Q 048314 29 LNDRNSPRSKSVWSCMR------ALMATVN-----SPYSPSRPLTLTSIVSR-VSWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~------~~~~~~~-----~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
.+|.|+| |.||+|.. .++|.+. .....+.+..|..++.. ++||||+++++++.+.+..++||||++
T Consensus 2 ~lG~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 2 MLGKGSF--GKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred eeeeCCC--EEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 5899999 99998821 1111111 11233446678888876 489999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-------- 168 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-------- 168 (274)
+|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 80 ~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 80 GGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 9999999975 35689999999999999999999999 9999999999999999999999999987642
Q ss_pred ---CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHH
Q 048314 169 ---SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKN 245 (274)
Q Consensus 169 ---~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (274)
++..|+|||++.+..++.++|+|||||++|+|++|..||.... .. .+... ... . ....+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~-~~~~~----i~~---~----~~~~~~~~ 219 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EE-ELFQS----IRM---D----NPCYPRWL 219 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HH-HHHHH----HHh---C----CCCCCccC
Confidence 2567999999988889999999999999999999999996431 11 11110 000 0 01123345
Q ss_pred HHHHHHHHHHhhccCCCCCCChh-hHH
Q 048314 246 LENLVKVGLWCVQDEPALRPSMK-CVV 271 (274)
Q Consensus 246 ~~~~~~li~~cl~~dp~~Rps~~-evl 271 (274)
+..+.+++.+||+.||++||++. ++.
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 56789999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=262.42 Aligned_cols=232 Identities=16% Similarity=0.124 Sum_probs=185.7
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-------CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-------YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
++|...+.+|.|++ |.||.+.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~~~lg~g~~--~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAF--GRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETL 79 (263)
T ss_pred CcccccceecCCCc--eEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeE
Confidence 46888899999999 99998821 122221111 1123567899999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999999975 45689999999999999999999999 9999999999999999999999999988643
Q ss_pred C--------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 S--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
. +..|+|||.+....++.++|+||||+++|++++|+.||.... ....... . .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~----~-~~----~ 222 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE---AMAAIFK----I-AT----Q 222 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc---hHHHHHH----H-hc----c
Confidence 2 346999999998888999999999999999999999986331 1100000 0 00 0
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
-.....+...+..+.+++.+||..+|++|||+.++++.
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 -PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00112444566789999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=267.61 Aligned_cols=236 Identities=21% Similarity=0.218 Sum_probs=185.8
Q ss_pred HhhhccccccCCCCCCCCcchhHHHHHH----------HHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEe-C
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMRAL----------MATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR-G 85 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~~~----------~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~ 85 (274)
..++|....++|.|+| |.||+|.... +|..... ...+.+.+|+.++++++||||+++++++.+ +
T Consensus 4 ~~~~~~~~~~i~~g~~--g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTF--GRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCC--ceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3567888899999999 9999983221 2212111 123446789999999999999999999876 5
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEE
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAE------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl 159 (274)
...++++||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+|+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence 678999999999999999976322 4589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHH
Q 048314 160 SDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYK 225 (274)
Q Consensus 160 ~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 225 (274)
+|||+++... +..|+|||.+....++.++||||||+++||+++ |+.||.... . ..+..+.
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~--~~~~~~~-- 232 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--P--FEMAAYL-- 232 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--H--HHHHHHH--
Confidence 9999987431 235999999988889999999999999999998 999986431 1 1111111
Q ss_pred HHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 226 CFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+ ... ..+...+.++.+++.+||+.||++|||+.++++.|
T Consensus 233 --~~~-----~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 233 --KDG-----YRL-AQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred --HcC-----CCC-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 111 000 12233457899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=281.26 Aligned_cols=245 Identities=17% Similarity=0.145 Sum_probs=181.6
Q ss_pred hhccccccCCCCCCCCcchhHHHHHH--HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMRAL--MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWD 99 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~~~--~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 99 (274)
.+|...+.+|.|+| |.||++.... .....+......+.+|+++|++++|+|||++++++...+..++|||++. ++
T Consensus 169 ~gy~i~~~Lg~G~~--G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~ 245 (461)
T PHA03211 169 LGFAIHRALTPGSE--GCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD 245 (461)
T ss_pred CCeEEEEEEccCCC--eEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence 35777889999999 9999982211 0000011233457899999999999999999999999999999999985 79
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-----------
Q 048314 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL----------- 168 (274)
Q Consensus 100 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~----------- 168 (274)
|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++..
T Consensus 246 L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 246 LYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 9999875 345799999999999999999999999 9999999999999999999999999998642
Q ss_pred --CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCCh----hhHHHHHHHHHHHhh-------------
Q 048314 169 --SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKP----EEIILTNWVYKCFIN------------- 229 (274)
Q Consensus 169 --~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~------------- 229 (274)
++..|+|||++.+..++.++|||||||++|||++|..++....... ....+...+......
T Consensus 322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~ 401 (461)
T PHA03211 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV 401 (461)
T ss_pred cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence 3678999999988889999999999999999999876654321111 111111111110000
Q ss_pred hhhhhh----hcCC-ccC-----HHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 230 RELNKL----VRGT-EVD-----KKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 230 ~~~~~~----~~~~-~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
...... ..+. ..+ ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 402 SQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 0000 000 0223468899999999999999999999874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.52 Aligned_cols=228 Identities=20% Similarity=0.269 Sum_probs=185.3
Q ss_pred ccCCCCCCCCcchhHH-----HHHHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCC
Q 048314 28 SLNDRNSPRSKSVWSC-----MRALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWD 99 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~-----~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 99 (274)
+.||+|.| |.|-.| .++++|..+ .+..+.+|.+|+++|.+++|||||+++|+|..++..++++|||.+|+
T Consensus 544 ekiGeGqF--GEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 544 EKIGEGQF--GEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhcCccc--ceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 45888888 888877 223333332 22446789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----------
Q 048314 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---------- 169 (274)
Q Consensus 100 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---------- 169 (274)
|.+|+..+....+.-...+.++.||+.|++||.+. +++|||+.++|||++.++++||+|||.++-..
T Consensus 622 LnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr 698 (807)
T KOG1094|consen 622 LNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR 698 (807)
T ss_pred HHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence 99999986444456677788999999999999999 99999999999999999999999999997432
Q ss_pred ---CCCcCCCcccccCCCccccceeehhHhHHHHh--hcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-----
Q 048314 170 ---DKGCMAPECYKRTPISVKADVYGYGIVLLETI--CCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT----- 239 (274)
Q Consensus 170 ---~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 239 (274)
..+|||+|.+..++++.++|+|+||+++||++ +...||... ..+.. -++....++..
T Consensus 699 ~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l---t~e~v----------ven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 699 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL---TDEQV----------VENAGEFFRDQGRQVV 765 (807)
T ss_pred eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh---hHHHH----------HHhhhhhcCCCCccee
Confidence 24699999999999999999999999999975 578888532 11110 11122222222
Q ss_pred -ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 240 -EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 240 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..|..++..+.++|.+||..|.++|||++++...
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 3677888999999999999999999999998654
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=280.40 Aligned_cols=237 Identities=17% Similarity=0.183 Sum_probs=185.3
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC---CCCCcHHHHHHHHhcCC-CCccceEeEEEEe
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP---YSPSRPLTLTSIVSRVS-WTTDIEVSSVAMR 84 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 84 (274)
..+++.....+|+|+| |.||+|.. .++|.+... ...+.+.+|+++|.++. |||||++++.|.+
T Consensus 35 ~~~~~~~~~~lG~G~f--G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAF--GRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred cHHHeehhhhccCCCc--eeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3456777789999999 99998831 122222221 11235779999999998 9999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCC-------------------------------------------------------
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAE------------------------------------------------------- 109 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 109 (274)
.+..++||||+++|+|.+++.....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999975321
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 048314 110 -----------------------------------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQN 148 (274)
Q Consensus 110 -----------------------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~n 148 (274)
..+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 2367888899999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCCh
Q 048314 149 ILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKP 214 (274)
Q Consensus 149 il~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~ 214 (274)
|+++.++.++++|||+++... +..|+|||.+....++.++|+||||+++|||++ |..||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 999999999999999986431 346999999988888999999999999999998 888885431111
Q ss_pred hhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 215 EEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+. .....+. . ...+...+..+.+++.+||+.+|.+|||+++|++.|
T Consensus 350 ---~~~----~~~~~~~-----~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 350 ---QFY----NAIKRGY-----R-MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred ---HHH----HHHHcCC-----C-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 010 1111110 0 013334567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=272.13 Aligned_cols=243 Identities=13% Similarity=0.046 Sum_probs=175.9
Q ss_pred cccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCC
Q 048314 27 SSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
..+||+|.++.+.||++.. .++|.+... ...+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3678999544488998821 122222211 112334579999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-------- 168 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-------- 168 (274)
+|+|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.++.++++||+.....
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999999764455699999999999999999999999 9999999999999999999999998753221
Q ss_pred ----------CCCCcCCCccccc--CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH-HHh-----hh
Q 048314 169 ----------SDKGCMAPECYKR--TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK-CFI-----NR 230 (274)
Q Consensus 169 ----------~~~~~~ape~~~~--~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~-----~~ 230 (274)
.+..|+|||++.. ..++.++|||||||++|+|++|..||.................. ... ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1345899999875 35889999999999999999999999643111100000000000 000 00
Q ss_pred hh-------------hhh-----hcC-------CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 231 EL-------------NKL-----VRG-------TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 231 ~~-------------~~~-----~~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. ... ..+ .+........+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 000 000 0112234568999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=279.43 Aligned_cols=233 Identities=15% Similarity=0.139 Sum_probs=177.7
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhc-----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN-----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.+|.|+| |.||++.. .++|.+. .......+.+|+.++.+++|+||+++++.+.+....++
T Consensus 1 ~~y~~~~~LG~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAF--GEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCC--EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 36777889999999 99998711 1112111 11223456789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee---
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL--- 167 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~--- 167 (274)
||||+++|+|.+++.. .+.+++.....++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++.
T Consensus 79 v~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 79 IMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999999975 45799999999999999999999999 999999999999999999999999998752
Q ss_pred -------------------------------------------cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcC
Q 048314 168 -------------------------------------------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCW 204 (274)
Q Consensus 168 -------------------------------------------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~ 204 (274)
.+++.|+|||++.+..++.++|+|||||++|||++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 2466799999999888999999999999999999999
Q ss_pred CCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhc--cCCCCCCChhhHHh
Q 048314 205 ENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQ--DEPALRPSMKCVVM 272 (274)
Q Consensus 205 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~dp~~Rps~~evl~ 272 (274)
.||..... .. .. ....... .....+ .....++.+.+++.+++. .++..||+++||++
T Consensus 234 ~Pf~~~~~--~~-~~-----~~i~~~~-~~~~~p--~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 234 PPFCSETP--QE-TY-----KKVMNWK-ETLIFP--PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCCCCH--HH-HH-----HHHHcCc-CcccCC--CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 99964311 10 00 0000000 001111 111234567788877553 23445689999976
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=272.80 Aligned_cols=223 Identities=18% Similarity=0.165 Sum_probs=177.2
Q ss_pred hccccccCCCCCCCCcchhHHH------HHHHHHhc-----CCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM------RALMATVN-----SPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~-----~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 90 (274)
+|.....+|+|+| |.||+|. ..++|.+. .....+.+..|..++..+. |++|+++++++.+.+..++
T Consensus 1 df~~~~~lg~G~~--g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSF--GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCC--eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 4667788999999 9999881 11112111 1122334567888888774 8999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 79 v~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 79 VMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999999975 45689999999999999999999999 9999999999999999999999999988642
Q ss_pred ---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+++.|+|||++....++.++|+|||||++|||++|..||.... .. .+.. ..... ..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~-~~~~----~i~~~-------~~ 218 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---ED-ELFQ----SIMEH-------NV 218 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HH-HHHH----HHHhC-------CC
Confidence 2667999999999899999999999999999999999996431 11 1111 00110 11
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCCh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSM 267 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~ 267 (274)
..|...+.++.+++.+||+.||++|++.
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 2344556788999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=270.42 Aligned_cols=233 Identities=18% Similarity=0.208 Sum_probs=182.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH----------HHHHHhcCCCC---CCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR----------ALMATVNSPYS---PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
.++|...+.+|.|++ |.||+|.. .++|....... ...+.+|+.++++++||||++++|+|... .
T Consensus 6 ~~~~~~~~~lg~G~~--g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAF--GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCC--ccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 356777889999999 99999821 12222222111 22567899999999999999999998754 4
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++++||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 83 ~~~v~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ceeeehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 6799999999999999976 344689999999999999999999999 999999999999999999999999999864
Q ss_pred cC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 168 LS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 168 ~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
.. +..|++||.+....++.++||||||+++||+++ |..||.... . .....+. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~--~~~~~~~----~~~~-- 228 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--T--REIPDLL----EKGE-- 228 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--H--HHHHHHH----HCCC--
Confidence 32 246999999988889999999999999999987 888885331 1 1111111 1110
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
....+..++..+.+++..||..+|++|||++++++.|
T Consensus 229 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l 265 (303)
T cd05110 229 ----RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEF 265 (303)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0012233456789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=270.60 Aligned_cols=245 Identities=17% Similarity=0.171 Sum_probs=184.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
++|...+.+|.|+| |.||++.. .+++..... ...+++.+|++++++++||||+++++.+.+++..++||
T Consensus 1 ~~~~~~~~lg~G~~--g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNG--GVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCC--eEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36778889999999 99998721 112222111 11244678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ . +++|+|++|+||+++.++.++++|||.+...
T Consensus 79 ey~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 79 EHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred eccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 99999999999975 3678999999999999999999997 5 8999999999999999999999999987643
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH---------------
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF--------------- 227 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 227 (274)
++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 25679999998887889999999999999999999999864321110000000000000
Q ss_pred -----hhhhhhhhhc---CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 228 -----INRELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 228 -----~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.......... +.......+.++.+++.+||..||++|||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 000111245679999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=276.40 Aligned_cols=238 Identities=14% Similarity=0.078 Sum_probs=182.3
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHH------HHHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCM------RALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
+....++|...+.+|.|+| |.||++. ..++|. .......+.+.+|+.+++.++||||+++++++.++
T Consensus 38 ~~~~~~~y~~~~~lG~G~f--g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAF--GEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred cCCCHHHCeEEEEEEecCC--eEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 4445578888899999999 9999771 111111 11112334467899999999999999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
+..++||||+++|+|.+++.. ..+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999999999965 3589999999999999999999999 9999999999999999999999999998
Q ss_pred eec------------CCCCcCCCcccccC----CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh
Q 048314 166 KLL------------SDKGCMAPECYKRT----PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN 229 (274)
Q Consensus 166 ~~~------------~~~~~~ape~~~~~----~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (274)
... +++.|+|||++... .++.++|+||+||++|+|++|..||..... ..... .....
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---~~~~~----~i~~~ 262 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---VGTYS----KIMDH 262 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---HHHHH----HHHhC
Confidence 643 36679999998654 377899999999999999999999964311 11010 00000
Q ss_pred hhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCC--CCChhhHHhh
Q 048314 230 RELNKLVRGTEVDKKNLENLVKVGLWCVQDEPAL--RPSMKCVVMM 273 (274)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~evl~~ 273 (274)
.. .... +.+...+..+.+++..||..++.+ |||+.|+++.
T Consensus 263 ~~--~~~~--p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KN--SLNF--PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred Cc--ccCC--CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 0000 112234677889999999865543 8999998863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=266.01 Aligned_cols=233 Identities=18% Similarity=0.199 Sum_probs=181.8
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhc-----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVN-----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
|...+.+|.|+| |.||++.. .++|... .......+.+|+.++++++|+||+.+++.+.+++..+++|
T Consensus 2 ~~~~~~lg~G~~--g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGF--GEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCC--eEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 455678999999 99998711 1112111 1122344678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
||+++++|.+++.......+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999999999764445799999999999999999999999 9999999999999999999999999988543
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
++..|+|||.+....++.++|+||||+++|++++|..||..... ....... .. ..... ....+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~---~~~~~~~-~~-----~~~~~--~~~~~ 225 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE---KVKREEV-DR-----RVLET--EEVYS 225 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH-HH-----hhhcc--ccccC
Confidence 25679999999888899999999999999999999999964311 1000000 00 00000 00133
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCC-----hhhHHh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPS-----MKCVVM 272 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps-----~~evl~ 272 (274)
...+..+.+++..||+.||++||| ++++++
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 345567899999999999999999 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=264.39 Aligned_cols=235 Identities=18% Similarity=0.177 Sum_probs=185.2
Q ss_pred hhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCCCC---CCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSPYS---PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
.+|.....+|.|+| |.||++.. .++|....... .+++.+|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEF--GEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred Hhceeeeeecccce--eEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 57778889999999 99998842 11222222211 2457899999999999999999999999899
Q ss_pred ceEEEEeCCCCCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEe
Q 048314 88 PSTEAALDLPWDLAYIIFCSAE-------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKIS 160 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~ 160 (274)
.++||||+++|+|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 9999999999999999986431 1589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecC------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHH
Q 048314 161 DFGLAKLLS------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCF 227 (274)
Q Consensus 161 d~g~~~~~~------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (274)
|||++.... +..|++||.+.....+.++|+||||++++++++ |..||.... ... .. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~---~~~-~~----~~~ 231 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---DEE-VL----NRL 231 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc---hHH-HH----HHH
Confidence 999875432 234999999888888899999999999999998 777885321 111 10 001
Q ss_pred hhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 228 INRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...... ...+...+..+.+++.+||+.||++|||+.|++..|
T Consensus 232 ~~~~~~-----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 232 QAGKLE-----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred HcCCcC-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 111110 012334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.21 Aligned_cols=225 Identities=16% Similarity=0.179 Sum_probs=176.0
Q ss_pred ccCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.+|+|+| |.||++.. .++|.+ ......+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSY--AKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCC--eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 36899999 99998811 111111 1112334567899999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
++|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 79 ~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 79 NGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 99999999875 45799999999999999999999999 9999999999999999999999999988642
Q ss_pred ----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 169 ----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 169 ----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
+++.|+|||++....++.++|+||||+++|+|++|..||........ ............. .+...|..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~-------~~~~~p~~ 225 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILE-------KPIRIPRF 225 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHh-------CCCCCCCC
Confidence 36679999999988999999999999999999999999964322111 0111111111111 11124445
Q ss_pred HHHHHHHHHHHhhccCCCCCCCh
Q 048314 245 NLENLVKVGLWCVQDEPALRPSM 267 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~ 267 (274)
.+..+.+++.+||+.||++||++
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCC
Confidence 56778999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=265.15 Aligned_cols=240 Identities=16% Similarity=0.142 Sum_probs=186.8
Q ss_pred hHHHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 16 SLCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 16 ~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
|+.-+++++.....+|+|+| |.||+|.. .+++..... ...+.+.+|+.++++++|+||+++++++.+++.
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~--g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTY--GIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred CcccccccCCceEEEecCCc--eEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 34556788888899999999 99999931 112211111 223457799999999999999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-CCcEEEecccc
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNP--YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKISDFGL 164 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~d~g~ 164 (274)
.++++||+++++|.+++... ...+ ++..+..++.|++.||.|||+. +++|+|++|+||+++. ++.++|+|||.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEEEecCCCCCHHHHHHHh-cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 99999999999999999862 2345 8888999999999999999999 9999999999999976 67899999998
Q ss_pred ceec-----------CCCCcCCCcccccCC--CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhh
Q 048314 165 AKLL-----------SDKGCMAPECYKRTP--ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRE 231 (274)
Q Consensus 165 ~~~~-----------~~~~~~ape~~~~~~--~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (274)
+... ++..|+|||.+.... ++.++|+||||+++|+|++|..||.......... + . ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~--~---~~- 225 (268)
T cd06624 156 SKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----F--K---VG- 225 (268)
T ss_pred heecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----h--h---hh-
Confidence 7543 256799999986543 7889999999999999999999986432111100 0 0 00
Q ss_pred hhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 232 LNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.. -.....+......+.+++.+||+.+|++|||+.|+++.
T Consensus 226 ~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 226 MF--KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hh--ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00 00112444566789999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=260.69 Aligned_cols=233 Identities=20% Similarity=0.199 Sum_probs=184.5
Q ss_pred hccccccCCCCCCCCcchhHH------HHHHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC------MRALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|...+++|.|.+ |.||.+ ...++|... +....+++.+|+.++++++|+||+++++++.+.+..+++|
T Consensus 1 ~y~~~~~ig~g~~--g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAF--GEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCC--ceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 3566788999999 766555 111122111 1123345779999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
||+++++|.+++.......+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.+|++|||.+...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999999875456689999999999999999999999 9999999999999999999999999987653
Q ss_pred -------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 169 -------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 169 -------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+++.|+|||.+.+..++.++|+||||+++++|++|..||...... ...... ..+.. ...
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~~~-~~~~~------~~~ 221 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------NLVVKI-VQGNY------TPV 221 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHH-HcCCC------CCC
Confidence 256799999998878889999999999999999999999643110 000000 01100 112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+..+.+++.+||+.||++|||+.++++.+
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 334567799999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=268.62 Aligned_cols=244 Identities=15% Similarity=0.163 Sum_probs=181.4
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.+|...+.+|.|+| |.||+|.. .++|.+. .......+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTY--ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCC--EEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 46777889999999 99998821 1222222 1122345779999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++ +|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 84 e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 84 EYLDK-DLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred eCCCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 99975 89888875 345689999999999999999999999 99999999999999999999999999986432
Q ss_pred --------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH-------HHHHHhh-hhh
Q 048314 170 --------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW-------VYKCFIN-REL 232 (274)
Q Consensus 170 --------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~-~~~ 232 (274)
+..|+|||.+.. ..++.++|+||||+++|+|++|+.||............... .++.... ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 456999998865 45789999999999999999999999644221110000000 0000000 000
Q ss_pred hhhhcCC-------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 NKLVRGT-------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 ~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...-.+. ......+.++.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000 011123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=264.80 Aligned_cols=236 Identities=17% Similarity=0.100 Sum_probs=183.5
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.++|.....+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~g~~--g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTY--GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCC--eEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 356888899999999 99999831 222222221 22344668999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++++|.+++.. ...+++..+..++.|++.|+.|||+. +++|+|++|.||+++.++.++++|||.+....
T Consensus 86 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 86 EYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999999999975 45789999999999999999999999 99999999999999999999999999886432
Q ss_pred --------CCCcCCCcccc---cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 170 --------DKGCMAPECYK---RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 170 --------~~~~~ape~~~---~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+..|+|||.+. ...++.++|+||||+++|+|++|..||..... ... ... .... ....+
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~-~~~--~~~-----~~~~---~~~~~ 229 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP-MRA--LFL-----MSKS---NFQPP 229 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hhh--hee-----eecC---CCCCC
Confidence 35699999874 34467899999999999999999999853210 000 000 0000 00000
Q ss_pred C-ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 239 T-EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 239 ~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ......+..+.+++.+||+.||++|||++++++.|
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 11123457899999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=264.31 Aligned_cols=233 Identities=15% Similarity=0.170 Sum_probs=183.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
.++|.....+|.|++ |.||+|.. +++|..... ...+.+.+|+.++++++||||+++++++.+ +..
T Consensus 5 ~~~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQF--GDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccc--eeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 345677889999999 99998831 122222221 123467899999999999999999998875 557
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 82 WIVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEEcCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 899999999999999976 334689999999999999999999999 9999999999999999999999999998653
Q ss_pred C------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 169 S------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 169 ~------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
. ...|+|||.+....++.++|+||||++++++++ |..||...... ..... ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~----~~~~~---- 225 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGR----IENGE---- 225 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHH----HHcCC----
Confidence 2 236999999888888999999999999999886 99999644111 11010 01100
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
....+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 226 --~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l 262 (270)
T cd05056 226 --RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262 (270)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1123345567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=260.04 Aligned_cols=228 Identities=20% Similarity=0.204 Sum_probs=184.0
Q ss_pred ccCCCCCCCCcchhHHHHH---------HHHHhcCCCC---CCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMRA---------LMATVNSPYS---PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~~---------~~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.+|.|+| |.||++... ++|....... .+.+.+|+++++.++|+||+++++++.+....+++|||+
T Consensus 1 ~~ig~g~~--g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAF--GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCc--eEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 36899999 999998332 1222222211 356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 96 LPWDLAYIIFCSA-------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~-------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 9999999998631 36799999999999999999999999 9999999999999999999999999998754
Q ss_pred C-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 S-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
. +..|+|||.+....++.++|+||+|+++++|++ |..||.... ...+. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~----~~~~~~---- 223 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----NEEVL----EYLRKG---- 223 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC----HHHHH----HHHHcC----
Confidence 3 346999999988888999999999999999998 588886441 11111 111110
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+...+.++.+++.+||+.||++|||+.|+++.|
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01124445578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=262.46 Aligned_cols=231 Identities=16% Similarity=0.140 Sum_probs=173.3
Q ss_pred cCCCCCCCCcchhHHHH--------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCC
Q 048314 29 LNDRNSPRSKSVWSCMR--------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLP 97 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~--------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 97 (274)
.+|+|+| |.||+|.. .+++..... ...+.+.+|+.+++.++||||+++++.|.+....++||||+++
T Consensus 2 ~lg~G~~--g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWF--GKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcC--ceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5899999 99998721 111111111 2235678999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 98 WDLAYIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 98 gsL~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
|+|.+++.+.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++++|||++...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999998632 23467788889999999999999999 9999999999999999999999999987531
Q ss_pred ------CCCCcCCCccccc-------CCCccccceeehhHhHHHHhhc-CCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 ------SDKGCMAPECYKR-------TPISVKADVYGYGIVLLETICC-WENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ------~~~~~~ape~~~~-------~~~~~~~Di~s~G~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
.+..|+|||++.. ..++.++|+||||+++|||+++ ..||... .. ...+. .. ..+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~--~~~~~----~~-~~~~~~~ 228 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-SD--REVLN----HV-IKDQQVK 228 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-CH--HHHHH----HH-Hhhcccc
Confidence 1357999998743 2357889999999999999874 6677432 11 11111 11 1111112
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..++. .+....+.+.+++..|| .+|++|||+++|++.|
T Consensus 229 ~~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 229 LFKPQ-LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cCCCc-cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 22222 22235567888999999 6799999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=271.73 Aligned_cols=219 Identities=17% Similarity=0.152 Sum_probs=172.4
Q ss_pred ccCCCCCCCCcchhHHHH------HHHHH-----hcCCCCCCcHHHHHH-HHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR------ALMAT-----VNSPYSPSRPLTLTS-IVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------~~~~~-----~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
++||.|+| |.||++.. .++|. .........+.+|.. +++.++||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~~--g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSF--GKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCC--EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 36899999 99998821 11111 111122334455554 678899999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 79 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 79 NGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 99999998875 45689999999999999999999999 9999999999999999999999999987642
Q ss_pred ----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 169 ----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 169 ----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
+++.|+|||.+....++.++|+|||||++|+|++|..||..... ..+. ..... .+...+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~----~~i~~-------~~~~~~~~ 218 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV----SQMY----DNILH-------KPLQLPGG 218 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH----HHHH----HHHhc-------CCCCCCCC
Confidence 25679999999888899999999999999999999999964311 0010 00000 11134445
Q ss_pred HHHHHHHHHHHhhccCCCCCCChh
Q 048314 245 NLENLVKVGLWCVQDEPALRPSMK 268 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~~ 268 (274)
....+.+++.+||+.||.+||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 567899999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=265.63 Aligned_cols=232 Identities=18% Similarity=0.190 Sum_probs=184.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH----------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR----------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
++|.....+|.|+| |.||+|.. .++|..... .....+.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~--g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAF--GTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCC--ccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 56677788999999 99998731 111212111 122456789999999999999999999987 789
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.++..
T Consensus 84 ~~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 84 QLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEEecCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999999986 344699999999999999999999999 9999999999999999999999999998653
Q ss_pred C-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 S-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
. +..|++||.+....++.++|+||||+++||+++ |..||..... . .+.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~--~~~~----~~~~~---- 227 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--V--EIPD----LLEKG---- 227 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--H--HHHH----HHhCC----
Confidence 2 235999999988888999999999999999998 9999864311 1 1111 11110
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+..++..+.+++.+||..||.+|||+.++++.|
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l 265 (279)
T cd05057 228 --ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265 (279)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 01123334557789999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=260.00 Aligned_cols=242 Identities=18% Similarity=0.161 Sum_probs=184.7
Q ss_pred HHhhhccccccCCCCCCCCcchhHH-------HHHHHHHhcCCCCCCcH----HHHHHHHhcCCCCccceEeEEEE--eC
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSPYSPSRP----LTLTSIVSRVSWTTDIEVSSVAM--RG 85 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~~~~~~~----~~e~~~l~~l~h~niv~l~~~~~--~~ 85 (274)
....+|...+.|++|+| |.||+| .+|.|+ ++-....+.| ++||.+|.+++|||||.+-.+.. +-
T Consensus 73 rsv~efe~lnrI~EGty--GiVYRakdk~t~eIVALKr-~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTY--GVVYRAKDKKTDEIVALKR-LKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred ccHHHHHHHhhcccCcc--eeEEEeccCCcceeEEeee-cccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 34467777888999999 999999 233333 2222233334 69999999999999999988764 45
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
+..|||||||.+ +|...+.. -.+++...+++.+..|++.|+.|||++ .|+|||||++|+|+...|.+|++|||++
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchh
Confidence 679999999975 89999987 346899999999999999999999999 9999999999999999999999999999
Q ss_pred eecCC-----------CCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh----
Q 048314 166 KLLSD-----------KGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN---- 229 (274)
Q Consensus 166 ~~~~~-----------~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 229 (274)
+..+. .-|+|||.+.+. .|+...|+||+||++.|++.+++.|... ++..+. +-+...+..
T Consensus 225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~-sE~dQl---~~If~llGtPte~ 300 (419)
T KOG0663|consen 225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK-SEIDQL---DKIFKLLGTPSEA 300 (419)
T ss_pred hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC-chHHHH---HHHHHHhCCCccc
Confidence 87763 359999999876 5899999999999999999999999654 222221 111111100
Q ss_pred -------hhhh-hhhcCC--------ccCHH-HHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 230 -------RELN-KLVRGT--------EVDKK-NLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 230 -------~~~~-~~~~~~--------~~~~~-~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
-..- .+-.+. .++.. .++.-.+|+..+|..||.+|.|+.|.|+
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000 000000 01111 3467789999999999999999999875
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=277.03 Aligned_cols=244 Identities=19% Similarity=0.167 Sum_probs=184.2
Q ss_pred hhhccccccCCCCCCCCcchhHHHHH----HHH-HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMRA----LMA-TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~~----~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
...|...+.+|.|+| |.||++... ..+ .++.....+...+|+++|++++||||+++++++......+++||++
T Consensus 91 ~~~y~i~~~Lg~G~~--g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 91 RMQYNILSSLTPGSE--GEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred cCceEEEEeecCCCC--eEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 346888899999999 999987211 111 1111122345678999999999999999999999999999999998
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
. ++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 169 ~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 169 K-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred C-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 6 689998853 56799999999999999999999999 9999999999999999999999999987532
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh------------
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR------------ 230 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------ 230 (274)
++..|+|||++....++.++|||||||++|||++|+.||...........+...... ....
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~-~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC-MQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH-hccCccccCCccchhH
Confidence 366799999999888999999999999999999999999754332211111111110 0000
Q ss_pred --h---hhhhhcCC-ccC-----HHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 231 --E---LNKLVRGT-EVD-----KKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 231 --~---~~~~~~~~-~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
. .....++. ..+ .....++.+++.+||..||++|||+.|++..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000000 000 1234578899999999999999999999863
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=273.29 Aligned_cols=234 Identities=19% Similarity=0.192 Sum_probs=184.7
Q ss_pred hhccccccCCCCCCCCcchhHHHH-------------HHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEEe
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-------------ALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMR 84 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-------------~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 84 (274)
.+|...+.+|.|+| |.||++.. .++|..... ...+.+.+|+++++++ +||||++++++|.+
T Consensus 12 ~~~~i~~~ig~G~~--g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCF--GQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred hHeeecceeccccC--CcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 45777889999999 99997731 112222211 1234577999999999 79999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceE
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNIL 150 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil 150 (274)
.+..++++||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 999999999999999999997532 23488999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhh
Q 048314 151 MDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEE 216 (274)
Q Consensus 151 ~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~ 216 (274)
++.++.++|+|||+++... +..|+|||.+....++.++|+||||+++|||++ |..||.... ..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~ 243 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---VE 243 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---HH
Confidence 9999999999999986432 235999999988889999999999999999998 788885331 11
Q ss_pred HHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 217 IILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. .. ....... ....+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 244 ~-~~----~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 244 E-LF----KLLKEGH------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred H-HH----HHHHcCC------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 1 10 0011100 0123345567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=260.72 Aligned_cols=229 Identities=20% Similarity=0.192 Sum_probs=182.3
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhcCC-CC----------CCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-YS----------PSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-~~----------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
|...+.+|.|++ |.||+|.. .+++..... .. .+.+.+|+.++++++||||+++++++.+.+
T Consensus 2 ~~~~~~ig~g~~--~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 2 WIKGALIGSGSF--GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79 (267)
T ss_pred ccccceeecCCC--eEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence 344678999999 99999832 112211111 11 134668999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++++||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred ccEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999975 35689999999999999999999999 99999999999999999999999999875
Q ss_pred ecC-----------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh
Q 048314 167 LLS-----------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN 229 (274)
Q Consensus 167 ~~~-----------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (274)
... +..|+|||.+....++.++|+||||+++|+|++|..||..... ..... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~---- 223 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIF----K---- 223 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHH----H----
Confidence 432 3469999999888889999999999999999999999964311 00000 0
Q ss_pred hhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 230 RELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
...... ...+...+..+.+++.+||+.||.+||++.|+++.
T Consensus 224 --~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 224 --IGENAS-PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --HhccCC-CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 001111 12444566889999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=288.23 Aligned_cols=238 Identities=18% Similarity=0.203 Sum_probs=186.1
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
.....++|...+.||.|+| |.||++.. .++|.+... .....+.+|+.++..++|+||++++..+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~f--G~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGAT--GTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccCCCEEEEEEEecCCC--EEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 3445578888999999999 99998821 122222211 12344678999999999999999988764322
Q ss_pred --------cceEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc
Q 048314 87 --------KPSTEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 156 (274)
Q Consensus 87 --------~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~ 156 (274)
..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence 368999999999999999753 234689999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceec-------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH
Q 048314 157 AKISDFGLAKLL-------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV 223 (274)
Q Consensus 157 ~kl~d~g~~~~~-------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 223 (274)
+||+|||+++.. +++.|+|||++....++.++||||||+++|||++|+.||.... .. ...
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~----~~~ 254 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---ME----EVM 254 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HH----HHH
Confidence 999999997642 2567999999998889999999999999999999999996431 10 000
Q ss_pred HHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 224 YKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.. ...+ ... ..+...+..+.+++..||+.||.+|||+.++++.
T Consensus 255 ~~-~~~~----~~~--~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 HK-TLAG----RYD--PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HH-HhcC----CCC--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 0111 011 2444566789999999999999999999999763
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=261.94 Aligned_cols=234 Identities=20% Similarity=0.164 Sum_probs=186.9
Q ss_pred hhccccccCCCCCCCCcchhHHHHH------HHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMRA------LMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~~------~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
++|.....+|.|.+ |.||+|... +++........+.+.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~--~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSY--GSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCC--eEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 56777888999999 999988321 1222222122456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++++|.+++.. ....+++.....++.|++.|+.|||+. +++|+|++|.||+++.++.++++|||++....
T Consensus 81 ~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 81 GAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 99999999975 346789999999999999999999999 99999999999999999999999999876432
Q ss_pred -----CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 170 -----DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 170 -----~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
+..|++||.+.+..++.++|+||||+++|+|++|+.||...... .. .. .... ........+..
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-~~--~~-----~~~~----~~~~~~~~~~~ 224 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-RA--IF-----MIPN----KPPPTLSDPEK 224 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-hh--hh-----hhcc----CCCCCCCchhh
Confidence 45699999998888899999999999999999999999643111 00 00 0000 00000122334
Q ss_pred HHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 245 NLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.+..+.+++.+||+.||++|||+.||++.
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 55789999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=277.62 Aligned_cols=242 Identities=17% Similarity=0.194 Sum_probs=179.3
Q ss_pred hccccccCCCCCCCCcchhHHH------HHHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC-----c
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM------RALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS-----K 87 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 87 (274)
+|+..+.+|.|+| |.||++. ..++|.... ....+++.+|+.+++.++||||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAF--GVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCC--EEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 4777889999999 9999882 112222211 122345779999999999999999999998766 7
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 79 ~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 899999986 588888864 45799999999999999999999999 999999999999999999999999999864
Q ss_pred cC------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH-------HHH
Q 048314 168 LS------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY-------KCF 227 (274)
Q Consensus 168 ~~------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~~ 227 (274)
.. +..|+|||.+.+. .++.++||||+||++|||++|+.||...........+..... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 32 4569999988764 478999999999999999999999964421110000000000 000
Q ss_pred hhhhhhhhh----cCC------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 INRELNKLV----RGT------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 ~~~~~~~~~----~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.......+. .+. ......++++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000000000 000 112233567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=266.00 Aligned_cols=232 Identities=16% Similarity=0.114 Sum_probs=180.6
Q ss_pred ccccccCCCCCCCCcchhHHHHH------HHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMRA------LMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~~------~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
|.....+|.|++ |.||+|... +++..... ...+.+.+|+++++.++||||+++++.+...+..++|+||+
T Consensus 7 ~~i~~~lg~g~~--g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAF--GKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCC--eEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 344567999999 999998211 11211111 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
++++|..++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++...
T Consensus 85 ~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 85 AGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred CCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 99999998865 345799999999999999999999999 9999999999999999999999999987543
Q ss_pred ----CCCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ----SDKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ----~~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
.+..|+|||++. ...++.++|+|||||++|+|++|..||.... ....... . ....... .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~~~----~-~~~~~~~----~ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN---PMRVLLK----I-AKSEPPT----L 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC---HHHHHHH----H-hhcCCCC----C
Confidence 245799999874 3456789999999999999999999986431 1111111 0 0000000 1
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1233456789999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=258.59 Aligned_cols=227 Identities=19% Similarity=0.204 Sum_probs=180.6
Q ss_pred ccCCCCCCCCcchhHHHH-----HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCC
Q 048314 28 SLNDRNSPRSKSVWSCMR-----ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWD 99 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~-----~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 99 (274)
+.+|.|++ |.||++.. .++|..... ...+.+.+|++++++++|+||+++++++.+....++||||+.+++
T Consensus 1 ~~lg~g~~--g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNF--GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCC--ceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 36899999 99998732 112222211 123467899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----------
Q 048314 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---------- 169 (274)
Q Consensus 100 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---------- 169 (274)
|.+++.. ....+++..+..++.+++.||.|||++ +++|+|++|+||+++.++.++++|||.+....
T Consensus 79 l~~~l~~-~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 79 LLTFLRK-KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9999976 345689999999999999999999999 99999999999999999999999999886432
Q ss_pred ---CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHH
Q 048314 170 ---DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKN 245 (274)
Q Consensus 170 ---~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (274)
+..|+|||.+....++.++|+||||+++|+|++ |..||...... .... . .... .....+...
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~~~~----~-----~~~~-~~~~~~~~~ 220 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----QTRE----R-----IESG-YRMPAPQLC 220 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----HHHH----H-----HhcC-CCCCCCccC
Confidence 234999999988889999999999999999998 78888543110 0000 0 0000 011234455
Q ss_pred HHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 246 LENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 246 ~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+..+.+++.+||+.+|.+|||+.||++.|
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 67899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=252.37 Aligned_cols=233 Identities=21% Similarity=0.226 Sum_probs=184.2
Q ss_pred hhccccccCCCCCCCCcchhHHHH-------HHHHHhc-----CCCCC----CcHHHHHHHHhcCC-CCccceEeEEEEe
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-------ALMATVN-----SPYSP----SRPLTLTSIVSRVS-WTTDIEVSSVAMR 84 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-------~~~~~~~-----~~~~~----~~~~~e~~~l~~l~-h~niv~l~~~~~~ 84 (274)
+.|.+...+|+|.. +.|-.+.. +++++.. +.+.. +..++|+.+|+++. ||+|+++.+++.+
T Consensus 17 ~~y~pkeilgrgvs--s~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVS--SVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred hhcChHHHhcccch--hhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 45666888999988 77777721 1111111 11111 22357999999987 9999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
+...++|+|.|+.|.|.|+|.. .-.++++....+++|+..|+.|||.+ +|+||||||+|||++++.+++|+|||+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999975 56799999999999999999999999 999999999999999999999999999
Q ss_pred ceecC----------CCCcCCCccccc------CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh
Q 048314 165 AKLLS----------DKGCMAPECYKR------TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI 228 (274)
Q Consensus 165 ~~~~~----------~~~~~ape~~~~------~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (274)
+..+. |++|+|||.+.. ..|+..+|+|++|+++|.++.|.+||..- ... .+...+.
T Consensus 170 a~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----kQm----lMLR~Im 241 (411)
T KOG0599|consen 170 ACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----KQM----LMLRMIM 241 (411)
T ss_pred eeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----HHH----HHHHHHH
Confidence 97654 899999998853 35788999999999999999999999521 111 1112222
Q ss_pred hhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 229 NRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+.. --..+...+.+...++||.+||+.||.+|.|++|++.
T Consensus 242 eGky---qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 242 EGKY---QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hccc---ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2221 1111344566778999999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=265.56 Aligned_cols=245 Identities=20% Similarity=0.224 Sum_probs=186.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH----------HHHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEe--CC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR----------ALMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMR--GS 86 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~ 86 (274)
++|...+.+|.|+| |.||++.. .++|...... ..+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~--~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHF--GKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCC--eeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 45666788999999 99998842 1122222221 24567899999999999999999999877 55
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..+++|||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+.
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred ceEEEEecCCCCCHHHHHHh-CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 78999999999999999986 334699999999999999999999999 99999999999999999999999999987
Q ss_pred ecC--------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 167 LLS--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 167 ~~~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
... ...|++||.+....++.++|+||||+++++|++|..|+............... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ--GQMIVTRL 235 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc--ccccHHHH
Confidence 644 22489999998888899999999999999999999998643111100000000 00000000
Q ss_pred hhhhcC---CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 233 NKLVRG---TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 233 ~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+.. ...+..++.++.+++.+||+.||++|||+.||+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 011100 122345567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=282.81 Aligned_cols=227 Identities=18% Similarity=0.178 Sum_probs=187.7
Q ss_pred ccCCCCCCCCcchhHH------HHHHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCC
Q 048314 28 SLNDRNSPRSKSVWSC------MRALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWD 99 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~------~~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 99 (274)
-++|+|.+ |.||.| .+.++|.+..+ ...+-...||..-++++|.|||+.+|.|.+++.+-+.||.++|||
T Consensus 581 vVLGKGTY--G~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTY--GTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCce--eEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 36999999 999999 22334444433 334556799999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc-CCCcEEEeccccceec--------
Q 048314 100 LAYIIFCSAERNP--YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKISDFGLAKLL-------- 168 (274)
Q Consensus 100 L~~~l~~~~~~~l--~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-~~~~~kl~d~g~~~~~-------- 168 (274)
|.+.|.. .=+++ ++.+.-.+..||++||.|||++ .|+|||||-+|+|+. -.|.+||+|||.++..
T Consensus 659 LSsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 659 LSSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred HHHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 9999986 45666 8999999999999999999999 999999999999996 4688999999998753
Q ss_pred ---CCCCcCCCcccccC--CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 169 ---SDKGCMAPECYKRT--PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 169 ---~~~~~~ape~~~~~--~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
+|..|||||++-.+ .|+..+|||||||++.||.||++||...+.+.....-. + +.+ .-.++|.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV---------G-myK--vHP~iPe 802 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV---------G-MYK--VHPPIPE 802 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh---------c-cee--cCCCCcH
Confidence 25679999999776 48899999999999999999999997654433221100 0 111 1115888
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 244 KNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+.+++.+.+|.+|+.+||.+|||+.++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 99999999999999999999999999975
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=265.28 Aligned_cols=242 Identities=16% Similarity=0.116 Sum_probs=176.5
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcC---CCCccceEeEEEEe-----C
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRV---SWTTDIEVSSVAMR-----G 85 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~ 85 (274)
|.....+|.|++ |.||++.. .++|.+... .....+.+|+.+++++ +||||+++++++.+ .
T Consensus 2 y~~~~~lg~g~~--g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 2 YEPVAEIGVGAY--GTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred ceEeeEEeecCC--eEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 556678999999 99999821 122222211 1223455777777665 69999999998864 2
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
...+++|||++ ++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 45799999997 5899999865555699999999999999999999999 9999999999999999999999999998
Q ss_pred eecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh-
Q 048314 166 KLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK- 234 (274)
Q Consensus 166 ~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (274)
.... +..|+|||++.+..++.++||||+||++|+|++|.+||................. .........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPPEDDWPRD 234 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC-CCChhhCccc
Confidence 6532 4569999999888899999999999999999999999864321111111110000 000000000
Q ss_pred ------hhcCC------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 235 ------LVRGT------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 235 ------~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 011234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=264.85 Aligned_cols=234 Identities=18% Similarity=0.199 Sum_probs=180.0
Q ss_pred hccccccCCCCCCCCcchhHHH------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
+|....++|.|++ |.||+|. ..++|..... ...+.+.+|++++++++||||+++++.+...+..++|||
T Consensus 2 ~~~~~~~lg~g~~--~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNG--GTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCC--eEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 5666788999999 9999982 1112222111 122457799999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++++|..+. .+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~ 150 (279)
T cd06619 80 FMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA 150 (279)
T ss_pred cCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc
Confidence 99999997552 478999999999999999999999 99999999999999999999999999986432
Q ss_pred -----CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 170 -----DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 170 -----~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
+..|+|||.+....++.++|+||||+++|+|++|..||............... .....+. ..+......
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~ 224 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDE-----DPPVLPVGQ 224 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhcc-----CCCCCCCCc
Confidence 56799999998888999999999999999999999999643211110000000 0000000 011111223
Q ss_pred HHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 245 NLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.+.++.+++.+||+.||++||+++|+++.
T Consensus 225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 225 FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 45678999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=263.83 Aligned_cols=242 Identities=18% Similarity=0.144 Sum_probs=181.6
Q ss_pred hhhccccccCCCCCCCCcchhHH-------HHHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC-----cc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS-----KP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 88 (274)
+-.|...+++|.|.| |.||+| .+|+||... +.+---+|+.+|+++.|||||+|.-+|.... ..
T Consensus 23 ~i~~~~~~liG~GsF--g~Vyq~~~~e~~~~vAIKKv~~---d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSF--GVVYQAKLRETEEEVAIKKVLQ---DKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEEeeEEEeeccc--ceEEEEEEcCCCceeEEEEecC---CCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 345677899999999 999999 223333322 2332238999999999999999998886422 45
Q ss_pred eEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC-CcEEEeccccc
Q 048314 89 STEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKISDFGLA 165 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~d~g~~ 165 (274)
.+|||||+. +|.+++... .+..++...++-+.-|+..||+|||+. +|+||||||.|+|++.+ +.+||+|||.+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 799999985 999999853 346688888899999999999999998 99999999999999865 89999999999
Q ss_pred eecC----------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 166 KLLS----------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 166 ~~~~----------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
+... +..|+|||.+.+. .|+.+.||||.||++.||+-|++.|....+...-......+ .....+.+..
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l-G~Pt~e~I~~ 252 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL-GTPTREDIKS 252 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh-CCCCHHHHhh
Confidence 8765 4569999998875 69999999999999999999999997642222111111111 0001111110
Q ss_pred -----------hhcCC---c-cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 235 -----------LVRGT---E-VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 235 -----------~~~~~---~-~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
-+.+. . .....+++..+++.++|..+|.+|.|+.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 01111 1 33455678999999999999999999999875
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=272.07 Aligned_cols=219 Identities=17% Similarity=0.133 Sum_probs=171.4
Q ss_pred ccCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHH-HHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTS-IVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.+|.|+| |.||++.. .++|.. ........+..|.. +++.++||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSF--GKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCC--eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 36899999 99998721 111111 11122234455555 467799999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 79 NGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 99999999875 45799999999999999999999999 9999999999999999999999999987642
Q ss_pred ----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 169 ----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 169 ----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
++..|+|||++....++.++|||||||++|+|++|..||..... .. +. ...... ....+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~-~~----~~~~~~-------~~~~~~~ 218 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV---AE-MY----DNILHK-------PLVLRPG 218 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH---HH-HH----HHHHcC-------CccCCCC
Confidence 25679999999988899999999999999999999999964311 00 00 000010 0112223
Q ss_pred HHHHHHHHHHHhhccCCCCCCChh
Q 048314 245 NLENLVKVGLWCVQDEPALRPSMK 268 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~~ 268 (274)
.+..+.+++.+||+.||.+||++.
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCC
Confidence 556788999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=264.40 Aligned_cols=240 Identities=19% Similarity=0.158 Sum_probs=186.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|...+.+|+|++ |.||++.. .++|.... ....+.+.+|+++++.++||||+++++.+...+.+++|
T Consensus 4 ~~~~~~~~~ig~g~~--g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNG--GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCC--eEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 356777888999999 99998721 12222111 12235677999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
|||+++++|.+++.. .+.+++.....++.+++.||.|||+ . +++|+|++|+||+++.++.++++|||++...
T Consensus 82 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999999875 4568999999999999999999996 5 8999999999999999999999999987542
Q ss_pred -------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChh----hHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 -------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPE----EIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 -------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
++..|+|||.+....++.++|+|||||++|++++|..||........ ...+..+...... .. .
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----~ 230 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EP-----P 230 (284)
T ss_pred hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-cc-----C
Confidence 35679999999888889999999999999999999999975422211 1111111111100 00 0
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
+.......+..+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111112355779999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=269.39 Aligned_cols=177 Identities=20% Similarity=0.214 Sum_probs=144.2
Q ss_pred cccCCCCCCCCcchhHHHH--------HHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEe--CCcceEEEEeCC
Q 048314 27 SSLNDRNSPRSKSVWSCMR--------ALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--GSKPSTEAALDL 96 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~--------~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 96 (274)
...+|+|+| |.||+|.. .++|..........+.+|+.++++++||||+++++++.+ +...+++|||+.
T Consensus 6 ~~~lG~G~~--g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTY--GHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCC--eEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999 99999831 112222222233457799999999999999999999864 456789999986
Q ss_pred CCCHHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE----cCCCcEEEeccccc
Q 048314 97 PWDLAYIIFCS-------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKISDFGLA 165 (274)
Q Consensus 97 ~gsL~~~l~~~-------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~----~~~~~~kl~d~g~~ 165 (274)
++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5888887632 123589999999999999999999999 99999999999999 45678999999998
Q ss_pred eecC--------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccc
Q 048314 166 KLLS--------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEI 209 (274)
Q Consensus 166 ~~~~--------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~ 209 (274)
.... ++.|+|||++.+. .++.++|+||+||++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 6432 5569999988764 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=272.90 Aligned_cols=244 Identities=18% Similarity=0.144 Sum_probs=179.7
Q ss_pred HhhhccccccCCCCCCCCcchhHHH------HHHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC---
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM------RALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS--- 86 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 86 (274)
..++|.....||.|+| |.||++. ..++|.+. .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 19 VLKRYQQLKPIGSGAQ--GIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhceEEEEEeecCCC--EEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 4578888999999999 9999982 12222221 1123455678999999999999999999986433
Q ss_pred ---cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccc
Q 048314 87 ---KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG 163 (274)
Q Consensus 87 ---~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g 163 (274)
..++||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999975 67776643 488999999999999999999999 99999999999999999999999999
Q ss_pred cceec----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHH-----------HHH
Q 048314 164 LAKLL----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL-----------TNW 222 (274)
Q Consensus 164 ~~~~~----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~-----------~~~ 222 (274)
++... ++..|+|||.+.+..++.++||||||+++|+|++|..||............ ...
T Consensus 169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 169 LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred CccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 98643 256799999999888999999999999999999999999744211100000 000
Q ss_pred HHHHH----hhhh------hh----hhhcCC--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 223 VYKCF----INRE------LN----KLVRGT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 223 ~~~~~----~~~~------~~----~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..... .... .. .+..+. ..+......+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0000 00 000000 1112234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=274.06 Aligned_cols=241 Identities=14% Similarity=0.060 Sum_probs=184.5
Q ss_pred hhhHHHHhhhccccccCCCCCCCCcchhHHHH------HHHH-----HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEE
Q 048314 14 RSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMA-----TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVA 82 (274)
Q Consensus 14 ~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 82 (274)
..++....++|...+.+|+|+| |.||++.. .++| ........+.+.+|+.+++.++||||+++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~f--g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAF--GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCC--eEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4456666789999999999999 99998811 1111 111112234467899999999999999999999
Q ss_pred EeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 83 MRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 83 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
.+++..++||||+++|+|.+++.. ..++...+..++.|++.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999999999975 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccceec------------CCCCcCCCcccccC----CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH
Q 048314 163 GLAKLL------------SDKGCMAPECYKRT----PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226 (274)
Q Consensus 163 g~~~~~------------~~~~~~ape~~~~~----~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (274)
|++... +++.|+|||++... .++.++|+|||||++|||++|..||..... ..... ..
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~----~i 259 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYS----KI 259 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---HHHHH----HH
Confidence 998643 36679999998653 378899999999999999999999964311 10000 00
Q ss_pred HhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCC--CCChhhHHhh
Q 048314 227 FINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPAL--RPSMKCVVMM 273 (274)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~evl~~ 273 (274)
........ .+.+...+..+.+++..||..++.+ ||+++|+++.
T Consensus 260 ~~~~~~~~----~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 260 MNHKNSLT----FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HcCCCccc----CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00000000 0112245678899999999844443 7899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=266.91 Aligned_cols=232 Identities=16% Similarity=0.151 Sum_probs=184.4
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcC--CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS--PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
..+|...+.+|.|++ |.||+|.. .+++.... ....+.+.+|+.+++++.|+||+++++.+......++||
T Consensus 19 ~~~y~~~~~lg~g~~--~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGAS--GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCC--eEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 356777888999999 99999831 11122221 123355778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
||+++++|.+++.+ ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+...
T Consensus 97 e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 97 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 99999999999964 4589999999999999999999999 9999999999999999999999999987532
Q ss_pred -------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 169 -------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 169 -------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+++.|+|||.+....++.++|+||||+++|+|++|..||..... .. ... ...... ......
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--~~-~~~----~~~~~~-----~~~~~~ 238 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LR-ALY----LIATNG-----TPELQN 238 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--HH-hHH----HHhcCC-----CCCCCC
Confidence 24579999999888889999999999999999999999964311 00 000 000000 001112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+...+..+.+++.+||..||++|||+.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 3345577899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=262.72 Aligned_cols=244 Identities=18% Similarity=0.181 Sum_probs=180.1
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|...+.+|.|++ |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~y~~~~~l~~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTY--GVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCc--eEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 3566778999999 99999821 112221111 12345678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 93 ALDLPWDLAYIIFCSAE-RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
||++ ++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9997 689999875332 5689999999999999999999999 99999999999999999999999999886432
Q ss_pred ---------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH-------HHHHhh-hh
Q 048314 170 ---------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV-------YKCFIN-RE 231 (274)
Q Consensus 170 ---------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~-~~ 231 (274)
+..|+|||.+... .++.++|+||||+++++|++|+.||................ +..... ..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 4579999987654 56889999999999999999999996432111110000000 000000 00
Q ss_pred hhhhhcC----C--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 232 LNKLVRG----T--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 232 ~~~~~~~----~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....... . ......+.++.+++.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0 011224567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=270.71 Aligned_cols=233 Identities=19% Similarity=0.205 Sum_probs=182.7
Q ss_pred HHHhhhccccccCCCCCCCCcchhHH------HHHHHHHhc---CCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCc
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSC------MRALMATVN---SPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSK 87 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 87 (274)
....+.|.....||.||. +.||++ ..++++... +....+.|.+|+..|.+|+ |.+||+|++|-..++.
T Consensus 357 ~Vkg~~Yeilk~iG~GGS--SkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGS--SKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCc--ceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 344556777888999999 999998 344444322 2245667899999999998 9999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
+|||||| ...+|..+|.........| .++.+..|++.|+.++|++ ||||.||||.|+|+- .|.+||+|||++..
T Consensus 435 lYmvmE~-Gd~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 435 LYMVMEC-GDIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred EEEEeec-ccccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 9999995 6789999998743333345 8899999999999999999 999999999999984 46899999999975
Q ss_pred cC-------------CCCcCCCcccccC-----------CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH
Q 048314 168 LS-------------DKGCMAPECYKRT-----------PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV 223 (274)
Q Consensus 168 ~~-------------~~~~~ape~~~~~-----------~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 223 (274)
+. |..||+||.+... ..+.++||||+||+||+|+.|+.||... .+
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------~n-- 577 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------IN-- 577 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------HH--
Confidence 43 7889999987432 2467899999999999999999999632 00
Q ss_pred HHHHhhhhhhhhhcCC---ccCHHHHH-HHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 224 YKCFINRELNKLVRGT---EVDKKNLE-NLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 224 ~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.-..+..+.++. ++|.-... ++.+++..||.+||.+|||+.|||+.
T Consensus 578 ----~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 ----QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 011233444442 33332222 29999999999999999999999863
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=265.00 Aligned_cols=240 Identities=16% Similarity=0.218 Sum_probs=181.6
Q ss_pred hhccccccCCCCCCCCcchhHHH----------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeC--C
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM----------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--S 86 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~----------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 86 (274)
+.|...+.+|+|+| |.||.+. ..++|..... ...+.+.+|+.++++++||||+++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHF--GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCc--eeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 45677788999999 9998652 1112222211 2234577899999999999999999998775 5
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred ceEEEEEccCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 68999999999999999975 334689999999999999999999999 99999999999999999999999999886
Q ss_pred ecC--------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCCh--------hhHHHHHHHH
Q 048314 167 LLS--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKP--------EEIILTNWVY 224 (274)
Q Consensus 167 ~~~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~--------~~~~~~~~~~ 224 (274)
... +..|+|||.+....++.++|+||||+++|+++++..|........ .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV- 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-
Confidence 432 235899999888888999999999999999999876653210000 000000000
Q ss_pred HHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 225 KCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...... .....+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 237 ~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 237 RVLEEG------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred HHHHcC------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 000000 00122344667899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=282.32 Aligned_cols=245 Identities=16% Similarity=0.128 Sum_probs=177.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeC--------
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG-------- 85 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 85 (274)
..++|...+.+|.|+| |.||+|.. .++|.+. .......+|+.+|++++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~f--g~Vy~~~~~~~~~~vAiK~i~--~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSF--GVVYEAICIDTSEKVAIKKVL--QDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCC--EEEEEEEECCCCCEEEEEEEe--cCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3457888999999999 99999822 1122111 1233455899999999999999999886432
Q ss_pred CcceEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC-cEEEecc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKISDF 162 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~d~ 162 (274)
...++||||+++ +|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.+. .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999984 787777532 345699999999999999999999999 999999999999998654 6999999
Q ss_pred ccceec----------CCCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH----HHH
Q 048314 163 GLAKLL----------SDKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY----KCF 227 (274)
Q Consensus 163 g~~~~~----------~~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~----~~~ 227 (274)
|+++.. +++.|+|||++.+. .++.++|||||||++|||++|.+||................. ...
T Consensus 216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 998643 25679999988654 689999999999999999999999964421111111100000 000
Q ss_pred --hhhhhhhhhcCC--------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 --INRELNKLVRGT--------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 --~~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+.....+..+. .++...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000000000 123344578999999999999999999999975
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=270.21 Aligned_cols=219 Identities=18% Similarity=0.151 Sum_probs=171.4
Q ss_pred cCCCCCCCCcchhHHHH------HHHHHhc-----CCCCCCcHHHHHH-HHhcCCCCccceEeEEEEeCCcceEEEEeCC
Q 048314 29 LNDRNSPRSKSVWSCMR------ALMATVN-----SPYSPSRPLTLTS-IVSRVSWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~------~~~~~~~-----~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
.+|.|+| |.||++.. .++|.+. .......+..|.. +++.++||||+++++++.+.+..++||||++
T Consensus 2 ~lg~G~f--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 2 VIGKGSF--GKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred eeeeCCC--eEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 6899999 99998811 1111111 1112223444444 5678999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-------- 168 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-------- 168 (274)
+|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 80 ~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 80 GGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 9999999975 45688899999999999999999999 9999999999999999999999999987632
Q ss_pred ---CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHH
Q 048314 169 ---SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKN 245 (274)
Q Consensus 169 ---~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (274)
+++.|+|||++....++.++||||+||++|+|++|..||.... ... ... ..... +...+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~-~~~----~i~~~-------~~~~~~~~ 219 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAE-MYD----NILNK-------PLQLKPNI 219 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHH-HHH----HHHhC-------CcCCCCCC
Confidence 3678999999998889999999999999999999999996431 111 100 00010 11233345
Q ss_pred HHHHHHHHHHhhccCCCCCCChhh
Q 048314 246 LENLVKVGLWCVQDEPALRPSMKC 269 (274)
Q Consensus 246 ~~~~~~li~~cl~~dp~~Rps~~e 269 (274)
+..+.+++.+||+.||.+||++.+
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCC
Confidence 678899999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=265.19 Aligned_cols=243 Identities=15% Similarity=0.124 Sum_probs=188.6
Q ss_pred hhhhhHHHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcC-CCCCCcHHHHHHHHhcC-CCCccceEeEEEE
Q 048314 12 IARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS-PYSPSRPLTLTSIVSRV-SWTTDIEVSSVAM 83 (274)
Q Consensus 12 ~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 83 (274)
.+..++....+.|.....+|.|+| |.||++.. .++|.... ......+..|+.+++++ +|+||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~--~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTY--GQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCC--eEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 356666677889999999999999 99998722 11222221 12334567899999998 6999999999985
Q ss_pred e------CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcE
Q 048314 84 R------GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 157 (274)
Q Consensus 84 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~ 157 (274)
. ....+++|||+++|+|.+++.......+++..+..++.|++.|+.|||+. +++|+|++|+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 3 45689999999999999999875556689999999999999999999999 99999999999999999999
Q ss_pred EEeccccceec-----------CCCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHH
Q 048314 158 KISDFGLAKLL-----------SDKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221 (274)
Q Consensus 158 kl~d~g~~~~~-----------~~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~ 221 (274)
+|+|||++... ++..|+|||.+. ...++.++|+||||+++|+|++|..||.... +.... .
T Consensus 161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-~~~~~--~- 236 (282)
T cd06636 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-PMRAL--F- 236 (282)
T ss_pred EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC-HHhhh--h-
Confidence 99999987532 245699999875 3457789999999999999999999996431 11100 0
Q ss_pred HHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 222 WVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.......+.......+..+.+++.+||+.||.+|||+.|+++
T Consensus 237 ---------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ---------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000101111122245678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=266.43 Aligned_cols=246 Identities=15% Similarity=0.095 Sum_probs=189.7
Q ss_pred hhhhhhhHHHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-CCCCcHHHHHHHHhcC-CCCccceEeEE
Q 048314 10 AWIARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-YSPSRPLTLTSIVSRV-SWTTDIEVSSV 81 (274)
Q Consensus 10 ~~~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~ 81 (274)
+.++..++....++|.....+|.|++ |.||++.. .++|..... ...+.+.+|+.++.++ +|||+++++++
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~l~~g~~--~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~ 87 (291)
T cd06639 10 SMLGLESLGDPTDTWEIIETIGKGTY--GKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87 (291)
T ss_pred hhhhcccCCCCCCCeEEEEEeecCCC--eEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 35677888888999999999999999 99998722 112222211 1234566899999998 79999999999
Q ss_pred EEeC-----CcceEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC
Q 048314 82 AMRG-----SKPSTEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 154 (274)
Q Consensus 82 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 154 (274)
+... +..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.+
T Consensus 88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~ 164 (291)
T cd06639 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE 164 (291)
T ss_pred EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence 8753 3589999999999999998642 235689999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecC-----------CCCcCCCcccccC-----CCccccceeehhHhHHHHhhcCCCccccCCChhhHH
Q 048314 155 WTAKISDFGLAKLLS-----------DKGCMAPECYKRT-----PISVKADVYGYGIVLLETICCWENMEIDASKPEEII 218 (274)
Q Consensus 155 ~~~kl~d~g~~~~~~-----------~~~~~ape~~~~~-----~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~ 218 (274)
+.++++|||++.... +..|+|||.+... .++.++|+||||+++|+|++|+.||..... ...
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~ 241 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKT 241 (291)
T ss_pred CCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHH
Confidence 999999999876432 4569999987643 257899999999999999999999964311 111
Q ss_pred HHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 219 LTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+... ........ ..+......+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~-----~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 LFKI-----PRNPPPTL----LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHH-----hcCCCCCC----CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1100 00101111 123344567999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=277.89 Aligned_cols=182 Identities=18% Similarity=0.177 Sum_probs=156.9
Q ss_pred hccccccCCCCCCCCcchhHH------HHHHHHHhcCC-CCCCcHHHHHHHHhcCC-C-----CccceEeEEEEeCCcce
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC------MRALMATVNSP-YSPSRPLTLTSIVSRVS-W-----TTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~~-~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 89 (274)
.|....+||+|.| |.|.+| ..+++|++++. .-..+...|+++|..++ | -|+|+++++|...++.|
T Consensus 187 rY~V~e~LGkGtF--GQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSF--GQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEeccccc--ceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 4566889999999 999999 22334444433 33444568999999997 4 46999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC--CCcEEEecccccee
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE--FWTAKISDFGLAKL 167 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~--~~~~kl~d~g~~~~ 167 (274)
||+|.+. -||+++++.++..+++.+.++.++.||+.||.+||+. +|||+||||+|||+.+ ...+|++|||.+..
T Consensus 265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999875 6999999999999999999999999999999999999 9999999999999964 34789999999976
Q ss_pred cC--------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCcccc
Q 048314 168 LS--------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEID 210 (274)
Q Consensus 168 ~~--------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~ 210 (274)
.. +..|+|||++.+.+|+.+.|||||||++.||.+|.+.|...
T Consensus 341 ~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 341 ESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 55 56799999999999999999999999999999998888654
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=258.86 Aligned_cols=231 Identities=20% Similarity=0.214 Sum_probs=184.5
Q ss_pred ccccccCCCCCCCCcchhHH------HHHHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSC------MRALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
|...+.+|.|+| |.+|.+ ...+++... .....+++.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 2 y~~~~~lg~g~~--g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 2 YVKVKKIGEGSF--GKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred ceEEEEeccCCc--eEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 566788999999 888876 111112111 11223467899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++++|.+++.......+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999999764445689999999999999999999999 99999999999999999999999999886542
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|+|||.+.....+.++|+||||++++++++|..||..... . ...... ..+.. ...+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~----~~~~~~-~~~~~------~~~~ 222 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---K----NLVLKI-IRGSY------PPVS 222 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---H----HHHHHH-hcCCC------CCCc
Confidence 4569999999888889999999999999999999999864311 0 000010 01100 1234
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
...+.++.+++.+||+.+|++||++.+|++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 4556789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=264.10 Aligned_cols=245 Identities=15% Similarity=0.094 Sum_probs=188.3
Q ss_pred hhhhhHHHHhhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC-CCCCcHHHHHHHHhcC-CCCccceEeEEEE
Q 048314 12 IARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP-YSPSRPLTLTSIVSRV-SWTTDIEVSSVAM 83 (274)
Q Consensus 12 ~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 83 (274)
+.++.+....++|.....+|.|++ |.||++. ..++|..... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~--~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTY--GKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCC--cEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 456777888999999999999999 9999871 1222222221 2234567899999999 6999999999884
Q ss_pred -----eCCcceEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc
Q 048314 84 -----RGSKPSTEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 156 (274)
Q Consensus 84 -----~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~ 156 (274)
+++.+++||||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence 345689999999999999988642 235689999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecC-----------CCCcCCCccccc-----CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHH
Q 048314 157 AKISDFGLAKLLS-----------DKGCMAPECYKR-----TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILT 220 (274)
Q Consensus 157 ~kl~d~g~~~~~~-----------~~~~~ape~~~~-----~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~ 220 (274)
++++|||++.... +..|+|||.+.. ..++.++|+||+|+++|+|++|..||..... .. .+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-~~--~~~ 239 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-MR--ALF 239 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-hH--HHh
Confidence 9999999986432 456999998753 3478899999999999999999999864311 00 000
Q ss_pred HHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 221 NWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
. ......... ..+...+..+.+++.+||+.||++|||+.||++.
T Consensus 240 ----~-~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 ----K-IPRNPPPTL----HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----h-ccccCCCcc----cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000000000 1222345679999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=280.43 Aligned_cols=225 Identities=19% Similarity=0.159 Sum_probs=187.6
Q ss_pred HHhhhccccccCCCCCCCCcchhHH----------HHHHHH-HhcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCC
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSC----------MRALMA-TVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGS 86 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~----------~~~~~~-~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 86 (274)
...++|.-.+++|+|+| |+|+.+ .++.+| .+-...+.+..+.|-+|+.-.. ||.+++++..|.+..
T Consensus 365 ~~l~~F~~l~vLGkGsF--GkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSF--GKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred ccccceEEEEEeccCcC--ceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 34578888999999999 999988 334444 2333356677788999888776 999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
+.|.||||+.||++..++ ..+.+++.....++..++.||.|||++ +||+||||.+|||++.+|++||+|||+++
T Consensus 443 ~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred eEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 999999999999944333 346799999999999999999999999 99999999999999999999999999997
Q ss_pred ec-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 167 LL-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 167 ~~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
.. +|+.|+|||++....|+..+|.|||||++|||+.|..||..++. +. +. ..+
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---ee-~F------------dsI 580 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---EE-VF------------DSI 580 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---HH-HH------------HHH
Confidence 43 37899999999999999999999999999999999999975421 11 11 111
Q ss_pred h-cCCccCHHHHHHHHHHHHHhhccCCCCCCCh
Q 048314 236 V-RGTEVDKKNLENLVKVGLWCVQDEPALRPSM 267 (274)
Q Consensus 236 ~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 267 (274)
+ |...+|.-.+.+..++++++|..||++|--+
T Consensus 581 ~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 2224677888899999999999999999755
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=261.50 Aligned_cols=234 Identities=19% Similarity=0.136 Sum_probs=195.4
Q ss_pred hhccccccCCCCCCCCcchhHH------HHHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC------MRALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
..|.....+|+|++ |.|||+ .+.++|.+....+.++.+.|+.+|+++..|++|++||.++.+..+++|||||
T Consensus 33 EVFDi~~KLGEGSY--GSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSY--GSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcc--hHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 45666778999999 999999 2333444444456778889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee--------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL-------- 167 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~-------- 167 (274)
.-||+.|.+.. +..+|++.++..++.+.+.||.|||.. .-+|||||..|||+..+|..||+|||++..
T Consensus 111 GAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 111 GAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred CCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 99999999987 567899999999999999999999998 899999999999999999999999999854
Q ss_pred ---cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 168 ---LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 168 ---~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
++++.|||||++..-.|..++||||+|++..||..|++||... .+-..+. ........-+ .-|..
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI-HPMRAIF--------MIPT~PPPTF---~KPE~ 254 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI-HPMRAIF--------MIPTKPPPTF---KKPEE 254 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc-cccceeE--------eccCCCCCCC---CChHh
Confidence 4489999999999989999999999999999999999999633 1100000 0000000001 35778
Q ss_pred HHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 245 NLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
++.++.++++.||.++|++|.|+-++++.
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 89999999999999999999999998863
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=263.85 Aligned_cols=233 Identities=18% Similarity=0.136 Sum_probs=181.5
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
+.|...+.+|.|++ |.||+|.. .+++..... ...+.+.+|+.++++++||||+++++.+..++..++|||
T Consensus 12 ~~y~i~~~lg~g~~--g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAF--GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCC--eEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 45666788999999 99998821 111211111 223457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL----- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~----- 168 (274)
|+++++|..++.+ ....+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++|+|||.+...
T Consensus 90 ~~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 90 FCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred cCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999999998865 345699999999999999999999999 9999999999999999999999999987542
Q ss_pred ------CCCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 ------SDKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 ------~~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
.+..|+|||.+. ...++.++|+||||+++|+|++|..||..... .. .... .......
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~-~~~~-----~~~~~~~---- 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MR-VLLK-----IAKSEPP---- 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HH-HHHH-----HhcCCCc----
Confidence 245799999885 34467899999999999999999999864311 00 0000 0000000
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+...+.++.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00123345567899999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=268.47 Aligned_cols=223 Identities=18% Similarity=0.163 Sum_probs=177.0
Q ss_pred hccccccCCCCCCCCcchhHHH------HHHHHHh-----cCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM------RALMATV-----NSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~-----~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 90 (274)
+|...+.+|.|+| |.||++. ..++|.. ......+.+..|..++..+. |++|+++++++.+.+..++
T Consensus 1 ~f~~~~~lg~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSF--GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred CceEEEEEEecCC--eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 4667789999999 9999871 1111211 11123345678899998886 5778889999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 79 v~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 79 VMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999999975 45699999999999999999999999 9999999999999999999999999987642
Q ss_pred ---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
++..|+|||++....++.++|+||+|+++|+|++|..||.... .. .+.. ..... ..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~-~~~~----~i~~~-------~~ 218 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---ED-ELFQ----SIMEH-------NV 218 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HH-HHHH----HHHhC-------CC
Confidence 3667999999988889999999999999999999999996431 11 1111 00010 11
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCCh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSM 267 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~ 267 (274)
..+...+..+.+++.+||+.||.+|++.
T Consensus 219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 2344456788999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=263.61 Aligned_cols=229 Identities=21% Similarity=0.228 Sum_probs=196.2
Q ss_pred HhhhccccccCCCCCCCCcchhHH-------HHHH----HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSC-------MRAL----MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~-------~~~~----~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
..+.|..-+++|+|+| |.||.| +.+. ||.++.+......++|-.+|++++.+.||.+--.+.+.+.+
T Consensus 183 t~n~F~~~RvlGkGGF--GEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGF--GEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred cccceeeeEEEecccc--cceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 3478999999999999 888877 3333 55566656667778999999999999999998889999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
|+|+..|.||+|.-+|.+..+..+++...+.++.+|+-||.+||.. +|++||+||+|||+|++|+++|+|+|++..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999999999999987777899999999999999999999999 9999999999999999999999999999654
Q ss_pred ----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh--
Q 048314 169 ----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV-- 236 (274)
Q Consensus 169 ----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (274)
+|.+|||||++..+.|+...|.||+||++|||+.|+.||...... ...+.+...+
T Consensus 338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-------------vk~eEvdrr~~~ 404 (591)
T KOG0986|consen 338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-------------VKREEVDRRTLE 404 (591)
T ss_pred CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-------------hhHHHHHHHHhc
Confidence 388999999999999999999999999999999999999754221 1222222222
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCC
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPS 266 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 266 (274)
++.+.+...+++.+++.+..|++||++|--
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 233677888899999999999999999863
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=270.96 Aligned_cols=236 Identities=17% Similarity=0.191 Sum_probs=181.2
Q ss_pred hhhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRG 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 85 (274)
.++|...+.||.|+| |.||+|. ..++|.+... ...+.+.+|+.++.++ +||||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~f--g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAF--GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCcc--ceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 356788899999999 9999873 1122322221 1123467899999999 689999999988654
Q ss_pred -CcceEEEEeCCCCCHHHHHHhCC--------------------------------------------------------
Q 048314 86 -SKPSTEAALDLPWDLAYIIFCSA-------------------------------------------------------- 108 (274)
Q Consensus 86 -~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 108 (274)
...+++||||++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45789999999999999997531
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----------
Q 048314 109 ---------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---------- 169 (274)
Q Consensus 109 ---------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---------- 169 (274)
...+++..+..++.|++.||.|||+. +++||||||.||+++.++.++++|||++....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12368888999999999999999999 99999999999999999999999999886431
Q ss_pred ---CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHH
Q 048314 170 ---DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKN 245 (274)
Q Consensus 170 ---~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (274)
+..|+|||.+....++.++|+||||+++|+|++ |..||........ .. ....++.. ...+...
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~~~------~~~~~~~ 307 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FC----RRLKEGTR------MRAPDYT 307 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH---HH----HHHhccCC------CCCCCCC
Confidence 245999999988889999999999999999997 8888864311110 00 11111100 0122234
Q ss_pred HHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 246 LENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 246 ~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+..+.+++..||+.||++|||+.||++.|
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 46789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=275.44 Aligned_cols=231 Identities=16% Similarity=0.134 Sum_probs=178.6
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|...+.+|.|+| |.||++.. .++|.+ ......+.+.+|+.++.+++||||+++++.+.+.+..++|
T Consensus 2 ~f~~~~~lG~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 2 DFESLKVIGRGAF--GEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CceEEEEEeeCCC--EEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 5777889999999 99998711 111211 1222344567899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee----
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL---- 167 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~---- 167 (274)
|||+++|+|.+++.. .+.+++.....++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 80 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 80 MEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999999975 45789999999999999999999999 999999999999999999999999998642
Q ss_pred ------------------------------------------cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCC
Q 048314 168 ------------------------------------------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWE 205 (274)
Q Consensus 168 ------------------------------------------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~ 205 (274)
.+++.|+|||++....++.++|+|||||++|||++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 24667999999998889999999999999999999999
Q ss_pred CccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCC---hhhHHh
Q 048314 206 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPS---MKCVVM 272 (274)
Q Consensus 206 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~evl~ 272 (274)
||....... ... . ..+.. .....+ .....+..+.+++.+|+ .||.+|++ +.|+++
T Consensus 235 Pf~~~~~~~---~~~----~-i~~~~-~~~~~p--~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETPQE---TYR----K-VMNWK-ETLVFP--PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCHHH---HHH----H-HHcCC-CceecC--CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 996431110 000 0 00000 000001 11123567888888877 49999985 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=278.97 Aligned_cols=222 Identities=20% Similarity=0.195 Sum_probs=187.2
Q ss_pred ccCCCCCCCCcchhHH---------HHHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSC---------MRALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~---------~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
.++|.|.| |.|+.| +-+++|-+++. ...++|++|+.+|.+|+|||+|+|||+..+ ....||+|++
T Consensus 116 e~LG~GsF--gvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 116 ELLGEGSF--GVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHhcCcce--eeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 45999999 999999 22223333322 256789999999999999999999999998 5578999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
+.|||.+.|.......|....+.+++.||+.|+.||.++ ++|||||-.+|+++.....+||+|||+.+-++
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 999999999875556799999999999999999999999 99999999999999999999999999998765
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT- 239 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (274)
-..|.|||.+....++.++|+|+|||++|||++ |..||-... ...+.+.+|..
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----------------g~qIL~~iD~~e 332 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----------------GIQILKNIDAGE 332 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----------------HHHHHHhccccc
Confidence 235899999999999999999999999999997 678885431 11122223322
Q ss_pred --ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 --EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 --~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+.|..|++++.+++..||..+|++|||+..|.+
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 478899999999999999999999999998864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=258.99 Aligned_cols=230 Identities=14% Similarity=0.147 Sum_probs=182.1
Q ss_pred ccccccCCCCCCCCcchhHHHH-----HHHHHhcCC-C-------CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSP-Y-------SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~-~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
|...+.+|.|+| |.||+|.. .++|.+... . ....+.+|+.++++++|+||+++++++.+.+..++
T Consensus 2 ~~~~~~ig~g~~--~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 2 WTKGEVLGKGAY--GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred ccccceEeccCC--eEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 455678999999 99998732 122222211 0 11346789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+...
T Consensus 80 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 80 FMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999975 35689999999999999999999999 9999999999999999999999999987542
Q ss_pred ---------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 169 ---------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 169 ---------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
++..|+|||.+....++.++|+||||++++++++|..||..... ..... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~-------~~~~~~ 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR---LAAMF-------YIGAHR 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh---HHHHH-------Hhhhcc
Confidence 24569999999888889999999999999999999999964311 00000 000000
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
... ...+...+..+.+++.+||+.+|++|||+.++++
T Consensus 225 ~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLM--PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC--CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 1234456678899999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=256.75 Aligned_cols=231 Identities=20% Similarity=0.244 Sum_probs=182.1
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEe-CCcceEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR-GSKPSTEA 92 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 92 (274)
|...+.+|.|++ |.||.+.. .++|.+.. ....+.+.+|++++++++|+|++++++.+.. .+..+++|
T Consensus 2 y~~~~~lg~g~~--~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 2 YCFVRVVGKGSY--GEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred ceEEEEecCCCC--eEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 555678999999 99997721 11222211 1223456789999999999999999998764 44679999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++++|.+++.......+++.+++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999999875556699999999999999999999999 99999999999999999999999999886432
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
++.|+|||.+....++.++|+||||++++++++|+.||.... .. ..... ...+.. ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~----~~~~~-~~~~~~------~~~ 222 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MN----SLVYR-IIEGKL------PPM 222 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HH----HHHHH-HHhcCC------CCC
Confidence 457999999988888999999999999999999999986331 11 00001 011111 013
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
+...+..+.+++.+||+.||++|||+.++++.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 34556789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=271.30 Aligned_cols=245 Identities=18% Similarity=0.133 Sum_probs=180.4
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeC---
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--- 85 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--- 85 (274)
...++|...+.+|.|+| |.||++.. .++|.+.. ......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQ--GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred chhcceeEEEEeecCCC--eEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 34578999999999999 99998821 11222221 12234567899999999999999999987543
Q ss_pred ---CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 86 ---SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 86 ---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
...++||||+++ +|.+++.. .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence 357999999974 78887753 488999999999999999999999 9999999999999999999999999
Q ss_pred ccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHH-----------
Q 048314 163 GLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN----------- 221 (274)
Q Consensus 163 g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~----------- 221 (274)
|+++... +..|+|||.+.+..++.++|||||||++|+|++|+.||..............
T Consensus 171 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 171 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9986432 5679999999988899999999999999999999999964321110000000
Q ss_pred ----HHHHHHhhhh------hhhhhcCC------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 222 ----WVYKCFINRE------LNKLVRGT------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 222 ----~~~~~~~~~~------~~~~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.......+.. ........ ..+......+.+++.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 00000000 1111234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=263.53 Aligned_cols=231 Identities=19% Similarity=0.210 Sum_probs=179.7
Q ss_pred HHHhhhccccccCCCCCCCCcchhHH----------HHHH-HHHhcCC-----------CCCCcHHHHHHHHhcCCCCcc
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSC----------MRAL-MATVNSP-----------YSPSRPLTLTSIVSRVSWTTD 75 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~----------~~~~-~~~~~~~-----------~~~~~~~~e~~~l~~l~h~ni 75 (274)
.+..|.|....-+|.|.+ |.|-.+ ++++ ++..... ...++..+||.+|++++||||
T Consensus 93 ~k~lNqy~l~~eiG~G~y--GkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQY--GKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ceehhheehhhhhcCCcc--ceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 445577888889999999 888777 2222 2211111 112356789999999999999
Q ss_pred ceEeEEEEe--CCcceEEEEeCCCCCHHHHHHhCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc
Q 048314 76 IEVSSVAMR--GSKPSTEAALDLPWDLAYIIFCSAERN-PYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD 152 (274)
Q Consensus 76 v~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~ 152 (274)
|+|+.+-.+ .+..|||+|||..|.+...- .... +++.+.++++++++.||.|||.+ +|+||||||+|+|++
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS 244 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence 999999866 46789999999998876543 2344 99999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceec----------------CCCCcCCCcccccCC----CccccceeehhHhHHHHhhcCCCccccCC
Q 048314 153 EFWTAKISDFGLAKLL----------------SDKGCMAPECYKRTP----ISVKADVYGYGIVLLETICCWENMEIDAS 212 (274)
Q Consensus 153 ~~~~~kl~d~g~~~~~----------------~~~~~~ape~~~~~~----~~~~~Di~s~G~~l~el~~g~~p~~~~~~ 212 (274)
.++++||+|||.+... +|+.++|||++..+. .+.+.||||+||+||-++.|+.||...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-- 322 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-- 322 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--
Confidence 9999999999998754 388999999987732 357899999999999999999999643
Q ss_pred ChhhHHHHHHHHHHHhhhhhhhhhcCC-ccCH--HHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 213 KPEEIILTNWVYKCFINRELNKLVRGT-EVDK--KNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
... .. ..+++... .+|. +..+.+.+||.++|.+||++|.++.+|..
T Consensus 323 --~~~-------~l-----~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 323 --FEL-------EL-----FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred --hHH-------HH-----HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 111 11 11111111 2222 45788999999999999999999998754
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=257.04 Aligned_cols=235 Identities=17% Similarity=0.114 Sum_probs=185.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcC--CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS--PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
++|.....+|.|++ |.||++.. .+++.... ....+.+.+|+.++++++||||+++++.+.+.+..+++||
T Consensus 3 ~~~~~~~~l~~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTY--GDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCc--eEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 46777788999999 99999832 11222211 1234567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 81 ~~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 81 YCGGGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999999976 335799999999999999999999999 99999999999999999999999999875432
Q ss_pred -------CCCcCCCcccccC---CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 -------DKGCMAPECYKRT---PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 -------~~~~~ape~~~~~---~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+..|++||.+... .++.++|+||||+++|+|++|..||.... +... ... ......... ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~-~~~~--~~~-----~~~~~~~~~--~~ 226 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH-PMRA--LFL-----ISKSNFPPP--KL 226 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHH--HHH-----HHhccCCCc--cc
Confidence 4469999998766 78899999999999999999999996431 1110 000 000000000 00
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+...+.++.+++.+||..||.+|||+.+|++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 123345678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=264.72 Aligned_cols=241 Identities=15% Similarity=0.174 Sum_probs=182.0
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|...+.+|.|++ |.||+|.. .++|.+. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lg~g~~--g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTY--ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcC--EEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 356777888999999 99999821 1122222 112234567999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|||++ ++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||++....
T Consensus 83 ~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 83 FEYLD-KDLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred Eeccc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 99997 599999876 345689999999999999999999999 99999999999999999999999999886432
Q ss_pred ---------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH---hhhhhhhhh
Q 048314 170 ---------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF---INRELNKLV 236 (274)
Q Consensus 170 ---------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 236 (274)
+..|+|||.+... .++.++||||||+++|+|++|+.||....... . ........ .........
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-Q---LHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-H---HHHHHHHcCCCChhhchhhh
Confidence 4569999987653 57889999999999999999999997442111 1 00000000 000000000
Q ss_pred c---------CC-------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 R---------GT-------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 ~---------~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
. +. ......+..+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 00 011123557899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=256.99 Aligned_cols=231 Identities=20% Similarity=0.240 Sum_probs=183.2
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|...+.+|.|++ |.||++.. .++|..... ...+.+.+|+.++++++|||++++++.+...+..++||
T Consensus 1 ~y~~~~~lg~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAF--GIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCc--eEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 3566788999999 99998721 112222211 22345778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC-CcEEEeccccceecC--
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKISDFGLAKLLS-- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~d~g~~~~~~-- 169 (274)
||+++++|.+++.......+++..+..++.+++.|+.|||++ +++|+|++|+||+++.+ ..++++|||.+....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999999874455689999999999999999999999 99999999999999754 468999999987543
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||.+....++.++|+||||+++++|++|..||....... ... .. .... ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----~~~---~~-~~~~------~~~~ 221 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----LVL---KI-MSGT------FAPI 221 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH----HHH---HH-HhcC------CCCC
Confidence 457999999988888999999999999999999999996432111 000 00 0000 0123
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+...+..+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 3345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=256.84 Aligned_cols=242 Identities=19% Similarity=0.177 Sum_probs=183.0
Q ss_pred hhccccccCCCCCCCCcchhHH-------HHHHHHHhcCCC---CCCcHHHHHHHHhcCCCCc-cceEeEEEEeCC----
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSPY---SPSRPLTLTSIVSRVSWTT-DIEVSSVAMRGS---- 86 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~---- 86 (274)
..|.....+|+|.+ |.||+| .++.|+.-...+ .+....+|+.+|++++|+| ||++++++.+.+
T Consensus 11 ~~~~~~eklGeGty--g~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTY--GVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHhCCCCc--eEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 34555556999999 999999 233333222211 3455689999999999999 999999998876
Q ss_pred --cceEEEEeCCCCCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 87 --KPSTEAALDLPWDLAYIIFCSAE--RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 87 --~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
..++|+||+. -+|..++..... ..++...++.+..|++.||+|||++ +|+||||||.|++++.++.+||+||
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence 7899999986 599999997543 4688899999999999999999999 9999999999999999999999999
Q ss_pred ccceecC-----------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh
Q 048314 163 GLAKLLS-----------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR 230 (274)
Q Consensus 163 g~~~~~~-----------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
|+++... |..|.|||.+.+. .|+...||||+||++.||++++..|..... ......+.......
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----IDQLFRIFRLLGTP 240 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHHHcCCC
Confidence 9997544 3459999999876 689999999999999999999999875422 11111111111110
Q ss_pred h---h-------------hhhhcCCccCHHH---HHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 231 E---L-------------NKLVRGTEVDKKN---LENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 231 ~---~-------------~~~~~~~~~~~~~---~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
. . ...-.+....... ..+..+++.+||+.+|.+|.|++.++++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 0 0000011111111 1478999999999999999999998764
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=265.87 Aligned_cols=177 Identities=20% Similarity=0.215 Sum_probs=143.5
Q ss_pred cccCCCCCCCCcchhHHHH--------HHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEe--CCcceEEEEeCC
Q 048314 27 SSLNDRNSPRSKSVWSCMR--------ALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--GSKPSTEAALDL 96 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~--------~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 96 (274)
.+.+|.|+| |.||++.. .++|..........+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~--g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTY--GHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCC--eeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 467999999 99999831 112222222233457799999999999999999999854 556799999987
Q ss_pred CCCHHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE----cCCCcEEEeccccc
Q 048314 97 PWDLAYIIFCS-------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKISDFGLA 165 (274)
Q Consensus 97 ~gsL~~~l~~~-------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~----~~~~~~kl~d~g~~ 165 (274)
++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4788887532 123489999999999999999999999 99999999999999 45678999999998
Q ss_pred eecC--------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccc
Q 048314 166 KLLS--------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEI 209 (274)
Q Consensus 166 ~~~~--------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~ 209 (274)
+... +..|+|||.+... .++.++||||||+++|||++|..||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 6532 4569999988764 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=263.06 Aligned_cols=234 Identities=18% Similarity=0.144 Sum_probs=183.4
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.++|...+.+|.|++ |.||++.. .++|..... ...+.+.+|++++++++||||+++++.+.++...++||
T Consensus 4 ~~~~~i~~~l~~g~~--~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAF--GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCC--ceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 456777788999999 99999822 112221111 22345778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+|++|+||+++.++.++++|||.+...
T Consensus 82 e~~~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 82 EFCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred eccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999999976 345799999999999999999999999 9999999999999999999999999987532
Q ss_pred -------CCCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 169 -------SDKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 169 -------~~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
++..|++||.+. ...++.++|+||||+++|+|++|..||..... ...... ........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~~~-----~~~~~~~~-- 227 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVLLK-----ILKSEPPT-- 227 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHHHH-----HhcCCCCC--
Confidence 255799999875 33567899999999999999999999964311 110100 01100000
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+...+..+.+++..||+.||.+|||+.++++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 228 --LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred --cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 0123345678899999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=260.29 Aligned_cols=238 Identities=16% Similarity=0.115 Sum_probs=183.9
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcC-CCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCC----
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS-PYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGS---- 86 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~---- 86 (274)
..+++|.....+|.|++ |.||++.. .+++.... ....+.+.+|+.+++++ .|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~--~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVIGEGTY--GKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CchhheeheeeecCCCC--eEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 45788999999999999 99999822 11111111 12235678999999999 6999999999997644
Q ss_pred --cceEEEEeCCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 87 --KPSTEAALDLPWDLAYIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 87 --~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999999987533 45799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecC-----------CCCcCCCccccc-----CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH
Q 048314 163 GLAKLLS-----------DKGCMAPECYKR-----TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226 (274)
Q Consensus 163 g~~~~~~-----------~~~~~ape~~~~-----~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (274)
|.+.... +..|+|||.+.. ..++.++|+||||++++++++|..||..... ...+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~- 229 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---MRALF----K- 229 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---HHHHH----H-
Confidence 9876432 456999998753 2467889999999999999999999963211 00010 0
Q ss_pred HhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 227 FINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
...... .....+...+..+.+++.+||..||++|||+.++++.
T Consensus 230 ~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 230 IPRNPP----PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hhccCC----CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000000 0112233456789999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=259.65 Aligned_cols=235 Identities=16% Similarity=0.121 Sum_probs=182.0
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.++|...+.+|.|++ |.||++.. .++|..... .....+.+|+.+++.++||||+++++.+.+.+..+++|
T Consensus 8 ~~~~~~~~~lg~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTY--GDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCC--eEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 357777888999999 99998821 112222211 22334678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
||+++++|.+++.. .+.+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||.+...
T Consensus 86 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 86 EFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred eccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999999975 45799999999999999999999999 9999999999999999999999999987543
Q ss_pred -------CCCCcCCCcccc---cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 169 -------SDKGCMAPECYK---RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 169 -------~~~~~~ape~~~---~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
++..|+|||.+. ...++.++|+|||||++|+|++|..||..... .. .+.. ....... .+
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~-~~--~~~~-----~~~~~~~---~~ 229 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-MR--ALFL-----MTKSNFQ---PP 229 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc-hh--hHHh-----hhccCCC---CC
Confidence 256799999874 44578899999999999999999999853311 10 0000 0000000 00
Q ss_pred C-ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 239 T-EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 239 ~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
. ......+..+.+++.+||+.||++|||+++|++.
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 0111234678999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=263.46 Aligned_cols=231 Identities=15% Similarity=0.164 Sum_probs=184.5
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcC--CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNS--PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
.+|.....+|.|++ |.||+|. ..++|.... ....+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 19 ~~y~~~~~lg~g~~--g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGAS--GTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCC--eEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 35788889999999 9999872 111222221 1234567789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL----- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~----- 168 (274)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 97 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 97 YLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred ecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999999864 4589999999999999999999999 9999999999999999999999999987542
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
.+..|+|||.+....++.++|+||||+++|++++|..||..... ... .. . ..... ......+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-~~~--~~----~-~~~~~----~~~~~~~ 238 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRA--LY----L-IATNG----TPELQNP 238 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHH--HH----H-HHhcC----CcccCCc
Confidence 24569999999888889999999999999999999999964311 110 00 0 00000 0011233
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+..+.+++.+||..||++|||+.+++.
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 445667899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=265.46 Aligned_cols=231 Identities=17% Similarity=0.152 Sum_probs=188.5
Q ss_pred hccccccCCCCCCCCcchhHH-------HHHH----HHHhcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC-------MRAL----MATVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~-------~~~~----~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 90 (274)
.|.-...+|.|.| |.||++ ..+. ++......+.+...+|+.+|+++. |||||++.+.+.+....++
T Consensus 36 ~Y~l~~~lG~G~F--g~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 36 KYELGRELGRGQF--GVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cEEehhhhCCCCc--eEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4555688999999 999998 1111 222222234467789999999999 9999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC----CcEEEeccccce
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF----WTAKISDFGLAK 166 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~----~~~kl~d~g~~~ 166 (274)
|||+|.||.|.+.+... .+++.....++.|++.++.|||+. +++|||+||+|+|+... +.++++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999874 399999999999999999999999 99999999999998643 479999999997
Q ss_pred ecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 167 LLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 167 ~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
... ++.|+|||++...+|+..+||||+|+++|.|++|.+||....... ... .+..+ ++-
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~---~~~-----~i~~~---~~~ 256 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE---IFL-----AILRG---DFD 256 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH---HHH-----HHHcC---CCC
Confidence 644 788999999999999999999999999999999999997552111 111 11111 111
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+.....+..+.++++.|+..||.+|+|++++++
T Consensus 257 f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 257 FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 122344566889999999999999999999999986
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=261.65 Aligned_cols=240 Identities=16% Similarity=0.159 Sum_probs=179.2
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
|...+.+|.|++ |.||++.. .++|... .......+.+|+.++++++||||+++++++.+.+..++++|
T Consensus 2 y~~~~~l~~g~~--~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 2 YEKLEKIGEGTY--GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred ceeEEEecccCC--eEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 556678999999 99998821 1112111 11233567789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+. ++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 80 YCD-QDLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred cCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 997 588888865 345699999999999999999999999 99999999999999999999999999886432
Q ss_pred -------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh------hhhhh
Q 048314 170 -------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR------ELNKL 235 (274)
Q Consensus 170 -------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 235 (274)
+..|+|||.+.+. .++.++|+||||+++|+|++|..|+......... +.. ........ .....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKR-IFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHH-HHHHhCCCChHHhHHhhhc
Confidence 4569999988664 4688999999999999999999887543221111 110 00000000 00000
Q ss_pred hc----CC--------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 236 VR----GT--------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 236 ~~----~~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.+ +. ......+..+.+++.+||+.||.+|||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 00 0112345788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=259.68 Aligned_cols=245 Identities=18% Similarity=0.178 Sum_probs=181.3
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|...+.+|.|++ |.||++.. .+++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTY--GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCc--eEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 4667788999999 99999821 11222211 122346789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+. ++|.+++.......+++..+..++.|++.||+|||+. +++|+|++|+||+++.++.++++|||++....
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 9996 6899999765556799999999999999999999999 99999999999999999999999999876432
Q ss_pred --------CCCcCCCcccccCC-CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH-------HHHHhh----
Q 048314 170 --------DKGCMAPECYKRTP-ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV-------YKCFIN---- 229 (274)
Q Consensus 170 --------~~~~~ape~~~~~~-~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~---- 229 (274)
+..|+|||.+.+.. ++.++|+||||+++|+|++|+.||................ +.....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 34699999886644 5788999999999999999999996432111100000000 000000
Q ss_pred -hhhhhhhcCC--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 230 -RELNKLVRGT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 230 -~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.......... ......+..+.+++.+||+.||++|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 0111234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=262.32 Aligned_cols=229 Identities=18% Similarity=0.168 Sum_probs=182.2
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
.|+....+|.|++ |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 5 ~y~~~~~l~~g~~--~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSF--GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCC--eeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4555677999999 99999821 122222211 122356799999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999999864 5689999999999999999999999 99999999999999999999999999886532
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|+|||.+....++.++|+||||+++++|++|..|+..... .. ... ..... . ....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~--~~~----~~~~~-----~-~~~~~ 222 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP--MR--VLF----LIPKN-----S-PPTLE 222 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch--hh--HHh----hhhcC-----C-CCCCC
Confidence 4569999999888889999999999999999999999853311 00 000 00000 0 11123
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
...+..+.+++.+||+.+|++|||+.++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 3456778999999999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=262.34 Aligned_cols=231 Identities=18% Similarity=0.153 Sum_probs=179.6
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhc-----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN-----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.+|.|+| |.||++.. .+++... .....+.+.+|+.+++.++||||+++++.+.+++..++
T Consensus 1 ~~y~~~~~l~~g~~--~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAY--GAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCC--eeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 36777889999999 99997711 1111111 11223456789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee---
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL--- 167 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~--- 167 (274)
||||+++++|.+++.. .+.+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.++.
T Consensus 79 v~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 79 VMEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999999975 35689999999999999999999999 999999999999999999999999998753
Q ss_pred -----------------------cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH
Q 048314 168 -----------------------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224 (274)
Q Consensus 168 -----------------------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 224 (274)
..+..|+|||.+....++.++|+||||+++|++++|..||.... ... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--~~~-----~~- 225 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--PEE-----LF- 225 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHH-----HH-
Confidence 12446999999988888999999999999999999999996331 110 00
Q ss_pred HHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHH
Q 048314 225 KCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVV 271 (274)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl 271 (274)
...... ....+. .+...+..+.+++.+||+.||++|||..++.
T Consensus 226 ~~~~~~---~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~ 268 (305)
T cd05609 226 GQVISD---DIEWPE-GDEALPADAQDLISRLLRQNPLERLGTGGAF 268 (305)
T ss_pred HHHHhc---ccCCCC-ccccCCHHHHHHHHHHhccChhhccCccCHH
Confidence 000111 111111 1124567789999999999999999854443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=258.76 Aligned_cols=228 Identities=19% Similarity=0.152 Sum_probs=182.6
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
+|...+.+|.|++ |.||++.. .+++..... .....+.+|+.++++++|+||+++++.+.++...++|+|
T Consensus 2 ~y~~~~~lg~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSF--GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCC--eEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 4666788999999 99998821 122222211 223456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+|++|+||+++.++.++++|||++....
T Consensus 80 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 80 YCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999999975 3789999999999999999999999 99999999999999999999999999886543
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|++||.+....++.++|+||||+++|+|++|..||.... + .. .. ...... . +...+
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-~-~~--~~----~~~~~~-----~-~~~~~ 219 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-P-MR--VL----FLIPKN-----N-PPSLE 219 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-h-HH--HH----HHhhhc-----C-CCCCc
Confidence 345999999988889999999999999999999999996431 1 00 00 000011 1 11112
Q ss_pred HH-HHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 243 KK-NLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 243 ~~-~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. .+..+.+++.+||..||++|||++++++
T Consensus 220 ~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 22 5677999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=271.54 Aligned_cols=244 Identities=18% Similarity=0.147 Sum_probs=179.9
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeC---
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--- 85 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--- 85 (274)
...++|...+.+|.|+| |.||++.. .++|.+... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQ--GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCC--EEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 34678888999999999 99998721 112222211 1234566899999999999999999988643
Q ss_pred ---CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 86 ---SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 86 ---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
...++||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999974 67777753 589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH-------HH
Q 048314 163 GLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV-------YK 225 (274)
Q Consensus 163 g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------~~ 225 (274)
|+++... +..|+|||.+.+..++.++|+|||||++|+|++|+.||................ ..
T Consensus 164 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9986532 567999999988889999999999999999999999996432111000000000 00
Q ss_pred HHhhhhhhhhhcC---------------C------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 226 CFINRELNKLVRG---------------T------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 226 ~~~~~~~~~~~~~---------------~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
... ......+.. . ..+......+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhc-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 000000000 0 1112234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=259.18 Aligned_cols=244 Identities=17% Similarity=0.146 Sum_probs=181.2
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhc-C---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVN-S---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|.....+|.|++ |.||++.. .++|... . ....+.+.+|+.++++++|||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~--~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 2 KYEKLSKIGEGSY--GVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred ceeeeeeecccCC--eEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 5667788999999 99999821 1122111 1 122345679999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++++|..++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 80 EYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred eccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999988888764 44699999999999999999999999 99999999999999999999999999987543
Q ss_pred --------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh-------hh-h
Q 048314 170 --------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN-------RE-L 232 (274)
Q Consensus 170 --------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~-~ 232 (274)
+..|+|||.+.. ..++.++|+||||+++|+|++|..||...................... .. .
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 346899998865 457889999999999999999999996432111111111000000000 00 0
Q ss_pred hhhhcCCc---c-----CHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 233 NKLVRGTE---V-----DKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 233 ~~~~~~~~---~-----~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.....+.. . ....+..+.+++.+||+.||++|||+.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000 0 01235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=258.40 Aligned_cols=229 Identities=18% Similarity=0.158 Sum_probs=183.9
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
.|...+.+|.|++ |.||+|.. .++|..... .....+.+|+.+++++.||||+++++.+.+++..++|||
T Consensus 5 ~y~~~~~lg~g~~--~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSF--GEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCC--eEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 4556677999999 99999821 122222211 123457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++|+|.+++.. ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 83 ~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 83 YLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999999864 4689999999999999999999999 99999999999999999999999999985433
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|+|||.+....++.++|+||||+++|+|++|..||.... +.. .. ..... ..+...+
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~---~~----~~~~~------~~~~~~~ 222 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMR---VL----FLIPK------NNPPTLT 222 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHh---Hh----hhhhc------CCCCCCc
Confidence 345899999988888999999999999999999999986431 100 00 00000 0112345
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
...+..+.+++.+||+.+|++|||+.+++..
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 5667889999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=254.33 Aligned_cols=230 Identities=20% Similarity=0.225 Sum_probs=183.1
Q ss_pred ccccCCCCCCCCcchhHHHHH----------HHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 26 RSSLNDRNSPRSKSVWSCMRA----------LMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 26 ~~~~~g~g~~~~g~vy~~~~~----------~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
....+|.|+| |.||++... ++|...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 3 ~~~~lg~g~~--g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 3 LGKKLGEGAF--GEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred ccceeccCCC--cceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567999999 999988221 122222221 2446779999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++++|.+++.......+++..+..++.|++.||.+||+. +++|+|++|+||+++.++.++++|||.+....
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999863333399999999999999999999999 99999999999999999999999999986543
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+..|++||.+....++.++|+||+|+++++|++ |..||.... ...+.. ...... ..
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~----~~~~~~----~~~~~~------~~ 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS----NEEVLE----YLKKGY------RL 223 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHH----HHhcCC------CC
Confidence 256999999987888999999999999999998 778775321 111111 011110 01
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 23334667899999999999999999999999876
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=289.60 Aligned_cols=232 Identities=19% Similarity=0.222 Sum_probs=180.9
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.+|+|+| |.||+|. ..++|.+... ...+++.+|++++++++||||+++++++.+++..++
T Consensus 2 grYeIi~~LGkGgf--G~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGM--GEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCC--EEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 46777889999999 9999982 1122222211 113457899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEec
Q 048314 91 EAALDLPWDLAYIIFCSA---------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISD 161 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 161 (274)
+|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEe
Confidence 999999999999987421 13367788899999999999999999 999999999999999999999999
Q ss_pred cccceec-----------------------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCC
Q 048314 162 FGLAKLL-----------------------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDAS 212 (274)
Q Consensus 162 ~g~~~~~-----------------------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~ 212 (274)
||++... +++.|+|||.+.+..++.++|||||||++|||++|..||.....
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 9998644 36679999999988899999999999999999999999964311
Q ss_pred ChhhHHHHHHHHHHHhhhhhhhhhcCC--ccCHHHHHHHHHHHHHhhccCCCCCCC-hhhHHh
Q 048314 213 KPEEIILTNWVYKCFINRELNKLVRGT--EVDKKNLENLVKVGLWCVQDEPALRPS-MKCVVM 272 (274)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps-~~evl~ 272 (274)
. ... ... ....+. ......+..+.+++.+||+.||++||+ +.++++
T Consensus 237 ~--ki~---------~~~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 237 R--KIS---------YRD---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred h--hhh---------hhh---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 000 000 000111 011234567889999999999999976 444443
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=259.63 Aligned_cols=241 Identities=23% Similarity=0.213 Sum_probs=184.0
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEe--CCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--GSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 91 (274)
+|.....+|.|.+ |.||++.. .+++..... ....++.+|++++++++||||+++++++.+ .+.+++|
T Consensus 2 ~~~~~~~lg~g~~--~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAG--GSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCc--eEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 5667788999999 99998822 122222211 123457899999999999999999999865 4478999
Q ss_pred EEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 92 AALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
|||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++++|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999987642 345689999999999999999999999 99999999999999999999999999875422
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCCh-hhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKP-EEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+..|++||.+....++.++|+||+|+++|+|++|..||.....+. ....+..+.. ........+..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 232 (287)
T cd06621 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNPELKDEP 232 (287)
T ss_pred ccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCchhhccCC
Confidence 456999999988889999999999999999999999997542211 1111111111 10111111111
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111235678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=292.99 Aligned_cols=238 Identities=16% Similarity=0.108 Sum_probs=180.5
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEe--CC
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--GS 86 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~ 86 (274)
...++|.....||.|+| |.||++.. .+++.+.. ......+..|+.++++++|||||++++++.+ ..
T Consensus 10 ~~l~~YeIl~kLG~GgF--GtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRF--GEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred cccCCEEEEEEEecCCC--eEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 34568888999999999 99998811 11121111 1223457799999999999999999998865 45
Q ss_pred cceEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCcccCCCCCCceEEcC-------
Q 048314 87 KPSTEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECE----PPILHCDIKPQNILMDE------- 153 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~----~~i~h~dl~~~nil~~~------- 153 (274)
.++|||||+++|+|.++|... ....+++..++.++.||+.||.|||+... .+|+|+||||+|||+..
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999999753 23569999999999999999999998511 25999999999999954
Q ss_pred ----------CCcEEEeccccceec----------CCCCcCCCccccc--CCCccccceeehhHhHHHHhhcCCCccccC
Q 048314 154 ----------FWTAKISDFGLAKLL----------SDKGCMAPECYKR--TPISVKADVYGYGIVLLETICCWENMEIDA 211 (274)
Q Consensus 154 ----------~~~~kl~d~g~~~~~----------~~~~~~ape~~~~--~~~~~~~Di~s~G~~l~el~~g~~p~~~~~ 211 (274)
...+||+|||++... +++.|+|||++.. ..++.++|||||||++|+|++|..||....
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 235899999998643 3678999999864 357899999999999999999999996431
Q ss_pred CChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 212 SKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
... .+ + ..+... +.......+..+.+||..||+.+|.+|||+.|++.
T Consensus 248 ~~~---ql---i-~~lk~~-------p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFS---QL---I-SELKRG-------PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHH---HH---H-HHHhcC-------CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 110 01 0 101100 11111234578999999999999999999999874
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=272.18 Aligned_cols=242 Identities=19% Similarity=0.149 Sum_probs=193.9
Q ss_pred cchhhhhhhHHHHhhhccccccCCCCCCCCcchhHH-------HHHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccc
Q 048314 8 TSAWIARSSLCTKLRNFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSP----YSPSRPLTLTSIVSRVSWTTDI 76 (274)
Q Consensus 8 ~~~~~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv 76 (274)
|+.+|..++= -..|+..+-||-|+| |.||-+ +++++|..-+. +...+.+.|++.|.+++|||+|
T Consensus 15 iA~LF~k~DP---Eklf~dLrEIGHGSF--GAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPnti 89 (948)
T KOG0577|consen 15 IADLFFKDDP---EKLFSDLREIGHGSF--GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTI 89 (948)
T ss_pred HHHHHccCCH---HHHHHHHHHhcCCcc--ceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcc
Confidence 4555555543 234555667999999 999988 45555533222 2345568999999999999999
Q ss_pred eEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc
Q 048314 77 EVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 156 (274)
Q Consensus 77 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~ 156 (274)
.+-|+|......+||||||- ||-.|.+.- ...++.+-.+..++.+.+.||+|||+. +.||||||..|||+.+.+.
T Consensus 90 eYkgCyLre~TaWLVMEYCl-GSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~ 164 (948)
T KOG0577|consen 90 EYKGCYLREHTAWLVMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGL 164 (948)
T ss_pred cccceeeccchHHHHHHHHh-ccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCe
Confidence 99999999999999999996 578888875 456899999999999999999999999 9999999999999999999
Q ss_pred EEEeccccce-------ecCCCCcCCCccccc---CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH
Q 048314 157 AKISDFGLAK-------LLSDKGCMAPECYKR---TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226 (274)
Q Consensus 157 ~kl~d~g~~~-------~~~~~~~~ape~~~~---~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (274)
+||+|||.+. +.+||.|||||++.- +.|+.++||||+|+++.|+..+++|+..- +-...+...
T Consensus 165 VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-------NAMSALYHI 237 (948)
T KOG0577|consen 165 VKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-------NAMSALYHI 237 (948)
T ss_pred eeeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-------hHHHHHHHH
Confidence 9999999885 456999999998863 57999999999999999999999998532 111111111
Q ss_pred HhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 227 FINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+. .|.....+++..+..++..||++-|.+|||.++++.
T Consensus 238 AQNe------sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 238 AQNE------SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HhcC------CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1111 122356688999999999999999999999999875
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=280.78 Aligned_cols=247 Identities=15% Similarity=0.153 Sum_probs=177.2
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcC-CCCCCcHHHHHHHHhcCCCC------ccceEeEEEE
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS-PYSPSRPLTLTSIVSRVSWT------TDIEVSSVAM 83 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~-~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~ 83 (274)
+...+++|...+.||.|+| |.||++.. .++|.++. ....+.+..|+.++..++|. +++++++++.
T Consensus 124 ~~~~~~~y~i~~~lG~G~f--g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTF--GKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cccCCCcEEEEEEEEeccC--EEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3445678888999999999 99999821 12222221 12233456688888777654 5888998886
Q ss_pred eC-CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCC------
Q 048314 84 RG-SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFW------ 155 (274)
Q Consensus 84 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~------ 155 (274)
.. ++.++|||++ +++|.+++.. .+.+++..+..++.|++.||.|||+ . +|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccc
Confidence 54 5789999987 6789998875 4579999999999999999999997 6 999999999999998654
Q ss_pred ----------cEEEecccccee--------cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhH
Q 048314 156 ----------TAKISDFGLAKL--------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEI 217 (274)
Q Consensus 156 ----------~~kl~d~g~~~~--------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~ 217 (274)
.+||+|||.+.. .++..|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~ 354 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN-LEHL 354 (467)
T ss_pred cccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Confidence 489999997643 346789999999988999999999999999999999999975421 1111
Q ss_pred HHHH---------HHHHH--------Hhh----------hhhhhhhcCC-ccCHHHHHHHHHHHHHhhccCCCCCCChhh
Q 048314 218 ILTN---------WVYKC--------FIN----------RELNKLVRGT-EVDKKNLENLVKVGLWCVQDEPALRPSMKC 269 (274)
Q Consensus 218 ~~~~---------~~~~~--------~~~----------~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 269 (274)
.... |.... +.. .....+.... .........+.+||.+||++||++|||++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 1100 00000 000 0000000000 001112356889999999999999999999
Q ss_pred HHh
Q 048314 270 VVM 272 (274)
Q Consensus 270 vl~ 272 (274)
+++
T Consensus 435 ~L~ 437 (467)
T PTZ00284 435 MTT 437 (467)
T ss_pred Hhc
Confidence 986
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=255.84 Aligned_cols=232 Identities=18% Similarity=0.170 Sum_probs=183.3
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|...+.+|.|++ |.||+|.. .+++.... ....+.+.+|+.++++++|+||+++++.+.+.+..++++
T Consensus 1 ~~~~~~~l~~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSF--GKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCc--ceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 3566788999999 99998821 12222111 123456779999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC-cEEEeccccceec---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKISDFGLAKLL--- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~d~g~~~~~--- 168 (274)
||+++++|.+++.......+++..+..++.|++.||.|||+. +++|+|++|+||+++.++ .++++|||.+...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999999874445689999999999999999999999 999999999999998875 5699999987543
Q ss_pred --------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 169 --------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 169 --------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+++.|+|||.+....++.++|+||||++++++++|..||..... ....... ...... .
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~-----~~~~~~--~ 221 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKI-----CQGYFA--P 221 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHH-----hcccCC--C
Confidence 24569999998888889999999999999999999999864311 1111111 011111 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.+...+..+.+++.+||..+|++|||+.|++..
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 233445689999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=257.20 Aligned_cols=244 Identities=16% Similarity=0.147 Sum_probs=182.7
Q ss_pred hccccccCCCCCCCCcchhHHH------HHHHHHh----cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM------RALMATV----NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|...+.+|.|++ |.||++. ..++|.. ......+.+.+|++++++++|+||+++++++.+++..+++|
T Consensus 2 ~y~~~~~i~~g~~--~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAY--GVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCC--eeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 5677788999999 9999971 1122222 22233466889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||++++.+..+... ...+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++|+|||.+....
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 80 EYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99998777666543 45689999999999999999999999 99999999999999999999999999876533
Q ss_pred ---------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH-------Hh-hhh
Q 048314 170 ---------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC-------FI-NRE 231 (274)
Q Consensus 170 ---------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~-~~~ 231 (274)
+..|+|||++... .++.++|+||||+++|+|++|..||...........+....... .. +..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 3459999999887 78899999999999999999999986432111000000000000 00 000
Q ss_pred -----hhhhhcCC----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 232 -----LNKLVRGT----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 232 -----~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..+...+. ..+...+..+.+++.+||+.||++|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000 1222346889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=255.49 Aligned_cols=230 Identities=18% Similarity=0.156 Sum_probs=178.7
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-------CCCCcHHHHHHHHhcCCCCccceEeEEEEe--CC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-------YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--GS 86 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~ 86 (274)
.+|...+.+|.|++ |.||++.. .+++..... ...+.+.+|+.++++++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~--g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (266)
T cd06651 2 INWRRGKLLGQGAF--GRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEK 79 (266)
T ss_pred CCccccceecCCCC--EEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCC
Confidence 46888899999999 99999821 111211111 112346789999999999999999998875 35
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++++||+++++|.+++.. ...+++...+.++.|++.||.|||+. +++|+|++|+||+++.++.++|+|||++.
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 67899999999999999975 34689999999999999999999999 99999999999999999999999999875
Q ss_pred ec--------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 167 LL--------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 167 ~~--------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
.. ++..|+|||.+....++.++|+||||+++|++++|+.||..... . ... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-~--~~~----~~~------ 221 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-M--AAI----FKI------ 221 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-H--HHH----HHH------
Confidence 32 24469999999888889999999999999999999999963311 0 000 000
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.........+....+.+.+++ .||..+|++|||++||++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 ATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000011123445566778887 688899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=276.65 Aligned_cols=247 Identities=15% Similarity=0.164 Sum_probs=176.2
Q ss_pred hhhccccccCCCCCCCCcchhHHH-------------------------HHHHHHh-cCCCCCCcHHHHHHHHhcCCCCc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-------------------------RALMATV-NSPYSPSRPLTLTSIVSRVSWTT 74 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-------------------------~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~n 74 (274)
.++|.....||+|+| |.||+|. +.+.+.. ........+.+|+.+|++++|||
T Consensus 147 ~~~Y~ii~~LG~G~f--G~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 147 LAHFRVIDDLPAGAF--GKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhccEEEeEecCCCC--cceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 467888899999999 9999651 0011111 11122344679999999999999
Q ss_pred cceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE
Q 048314 75 DIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSA---ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 151 (274)
Q Consensus 75 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~ 151 (274)
||++++++.+.+..++++|++. ++|.+++.... ...........++.|++.||.|||+. +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 57888776421 12234566778999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceec------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHH
Q 048314 152 DEFWTAKISDFGLAKLL------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219 (274)
Q Consensus 152 ~~~~~~kl~d~g~~~~~------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~ 219 (274)
+.++.+||+|||++... ++..|+|||++.+..++.++|||||||++|||++|..++...........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999998643 366799999999888999999999999999999987554322111111111
Q ss_pred HHHHHHHH-hhh-------hhhhhhcCC-------cc-----CHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 220 TNWVYKCF-INR-------ELNKLVRGT-------EV-----DKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 220 ~~~~~~~~-~~~-------~~~~~~~~~-------~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
........ ... ...+.+... .. .......+.+++.+||+.||.+|||+.|+++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11110000 000 000111000 00 01123467888999999999999999999863
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=258.64 Aligned_cols=242 Identities=16% Similarity=0.180 Sum_probs=181.0
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|.....+|.|++ |.||+|.. .++|.... ......+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~g~~--~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSY--ATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCC--eEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 356778889999999 99999821 11222211 12234567899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|||++ ++|.+++.. ....+++...+.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 ~e~~~-~~L~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 82 FEYLD-TDLKQYMDD-CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred EecCC-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 99998 499999876 345789999999999999999999999 99999999999999999999999999875432
Q ss_pred ---------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh---hhhhhh-
Q 048314 170 ---------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN---RELNKL- 235 (274)
Q Consensus 170 ---------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 235 (274)
+..|+|||.+.. ..++.++|+||+|+++|+|++|..||............ ....... ......
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK---IFRVLGTPTEETWPGVS 233 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH---HHHhcCCCChhhhhhhh
Confidence 456999998865 45788999999999999999999999644211111110 0000000 000000
Q ss_pred ------------hcCCc-----cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 ------------VRGTE-----VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ------------~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+.. ........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 00111267789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.64 Aligned_cols=233 Identities=17% Similarity=0.214 Sum_probs=183.9
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCCC--------CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPY--------SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
+|.....+|.|++ |.||++.. .++|...... ..+.+.+|++++++++|+||+++++++.+.+..
T Consensus 1 ~~~~~~~lg~g~~--~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAF--SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHF 78 (268)
T ss_pred CccccceecCcCc--eEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeE
Confidence 4667889999999 99998721 1111111111 124577899999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC-cEEEecccccee
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKISDFGLAKL 167 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~d~g~~~~ 167 (274)
++|+||+++++|.+++.+ ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 79 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999999975 45789999999999999999999999 999999999999998765 599999998754
Q ss_pred cC---------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 168 LS---------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 168 ~~---------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
.. +..|+|||.+....++.++|+||+|++++++++|..||.......... .... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~------~ 223 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA----LIFK------I 223 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH----HHHH------H
Confidence 32 346999999888888999999999999999999999996432211111 0000 0
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.........+...+..+.+++.+||..||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011112355566788999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=263.26 Aligned_cols=232 Identities=16% Similarity=0.117 Sum_probs=184.0
Q ss_pred hccccccCCCCCCCCcchhHHHHH------HHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMRA------LMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~~------~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|...+.+|.|++ |.||++... ++|..... ...+.+..|++++++++|+||+++++.+.+....++|
T Consensus 2 ~y~~~~~ig~g~~--g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 2 HFKKIKLLGKGDV--GRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred ceEEeeeecCCcc--EEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 5777888999999 999988221 12222111 1234567899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|||+.+++|.+++.......+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999999865556799999999999999999999999 9999999999999999999999999987532
Q ss_pred -------------------------------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccC
Q 048314 169 -------------------------------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDA 211 (274)
Q Consensus 169 -------------------------------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~ 211 (274)
++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 2446999999988888999999999999999999999996431
Q ss_pred CChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCC----hhhHHh
Q 048314 212 SKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPS----MKCVVM 272 (274)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps----~~evl~ 272 (274)
.. ..+.. ...... .. ......+..+.+++.+||+.||++||| +.|+++
T Consensus 237 ~~---~~~~~-----~~~~~~---~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD---ETFSN-----ILKKEV---TF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH---HHHHH-----HhcCCc---cC--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 11100 000000 00 111125678999999999999999999 888875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=260.71 Aligned_cols=243 Identities=17% Similarity=0.185 Sum_probs=181.0
Q ss_pred hccccccCCCCCCCCcchhHHHH-------HHHH---HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR-------ALMA---TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~-------~~~~---~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|...+.+|.|++ |.||+|.. +++. ........+.+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~y~~~~~lg~g~~--~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 2 KYENLGLVGEGSY--GMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred ceeEeeeeccCCC--eEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 5667788999999 99999821 1111 1111123455779999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++++|..+... ...+++..+..++.|++.||+|||+. +++|+|++|+||+++.++.++++|||++....
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 80 EFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred ecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999999887764 34589999999999999999999999 99999999999999999999999999876432
Q ss_pred --------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH-------Hhhhhh-
Q 048314 170 --------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC-------FINREL- 232 (274)
Q Consensus 170 --------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~- 232 (274)
+..|+|||.+.. ..++.++|+||||+++|+|++|..||...........+..+.... ......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 346899998865 346789999999999999999999886432111101111100000 000000
Q ss_pred hhhhcCC--------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 NKLVRGT--------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 ~~~~~~~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.....+. ......+..+.+++.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000 011234577999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=267.68 Aligned_cols=242 Identities=16% Similarity=0.165 Sum_probs=178.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeC----
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG---- 85 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 85 (274)
..++|.....+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 13 VPERYQNLTPVGSGAY--GSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhheecccCCC--eEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 3467888899999999 99999821 112222111 1234466899999999999999999987543
Q ss_pred --CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccc
Q 048314 86 --SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG 163 (274)
Q Consensus 86 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g 163 (274)
...++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 6899988853 5699999999999999999999999 99999999999999999999999999
Q ss_pred cceec--------CCCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH----------
Q 048314 164 LAKLL--------SDKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY---------- 224 (274)
Q Consensus 164 ~~~~~--------~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---------- 224 (274)
++... ++..|+|||.+.. ..++.++|||||||++|+|++|..||....... .+.....
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 164 LARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTPSPEVL 240 (343)
T ss_pred cceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCCHHHH
Confidence 98653 2567999999876 468899999999999999999999996431111 1111000
Q ss_pred HHHhhhhhhhhhcCC-ccC--------HHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 225 KCFINRELNKLVRGT-EVD--------KKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 225 ~~~~~~~~~~~~~~~-~~~--------~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
............... ..+ ....+.+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000 000 1123457899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=265.51 Aligned_cols=221 Identities=14% Similarity=0.146 Sum_probs=169.5
Q ss_pred CCCCCCCCcchhHHHH------HHHH-----HhcCCCCCCcHHHHHHHHhcC---CCCccceEeEEEEeCCcceEEEEeC
Q 048314 30 NDRNSPRSKSVWSCMR------ALMA-----TVNSPYSPSRPLTLTSIVSRV---SWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 30 ~g~g~~~~g~vy~~~~------~~~~-----~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+|.|+| |.||++.. .++| ..........+..|..++.+. .||||+++++++.+.+..++||||+
T Consensus 1 lG~G~~--g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTF--GQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCc--eEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 689999 99998711 1111 111111223345677777665 6999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 79 ~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 79 SGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 99999999875 46799999999999999999999999 9999999999999999999999999987642
Q ss_pred ----CCCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC-
Q 048314 169 ----SDKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD- 242 (274)
Q Consensus 169 ----~~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 242 (274)
++..|+|||.+... .++.++|||||||++|+|++|..||..... .... .....+. ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~-----~~i~~~~-------~~~~~ 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMY-----RNIAFGK-------VRFPK 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHH-----HHHHcCC-------CCCCC
Confidence 25679999988754 478999999999999999999999964311 1000 0000000 0111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCC----ChhhHHh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRP----SMKCVVM 272 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rp----s~~evl~ 272 (274)
...+..+.+++.+||+.||.+|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 12456788999999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=256.22 Aligned_cols=227 Identities=23% Similarity=0.219 Sum_probs=179.2
Q ss_pred CCCCCCCCcchhHHHH------HHHH-----HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCC
Q 048314 30 NDRNSPRSKSVWSCMR------ALMA-----TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPW 98 (274)
Q Consensus 30 ~g~g~~~~g~vy~~~~------~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 98 (274)
+|.|+| |.||++.. .++| ........+.+.+|++++++++||||+++++.+...+..++||||++++
T Consensus 1 lg~g~~--g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGF--GEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCc--eeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 588999 99998721 1111 1122233455678999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---------
Q 048314 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--------- 169 (274)
Q Consensus 99 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--------- 169 (274)
+|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA 155 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence 999999875445799999999999999999999999 99999999999999999999999999876432
Q ss_pred -CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHH
Q 048314 170 -DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLEN 248 (274)
Q Consensus 170 -~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (274)
+..|++||.+....++.++|+||||+++++|++|+.||...........+. .... ..+...+...+..
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~~~~ 224 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--------RRTL---EMAVEYPDKFSPE 224 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--------hccc---cccccCCccCCHH
Confidence 457999999988888999999999999999999999996442211111110 0000 0111244455778
Q ss_pred HHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 249 LVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 249 ~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
+.+++.+||+.||++|| ++.++++
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 99999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=262.05 Aligned_cols=232 Identities=14% Similarity=0.150 Sum_probs=184.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcC--CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS--PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.++|...+.+|.|++ |.||++.. .++|.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 18 ~~~y~~~~~lg~g~~--g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGAS--GTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCC--eEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 467788899999999 99998821 11222221 123345678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+...
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999999999964 4689999999999999999999999 9999999999999999999999999987643
Q ss_pred -------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 169 -------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 169 -------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
.++.|++||.+....++.++|+||||+++|++++|..||...... ... . . ...... .....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~-~~~-~-----~-~~~~~~----~~~~~ 237 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RAL-Y-----L-IATNGT----PELQN 237 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-hhe-e-----e-eccCCC----CCCCC
Confidence 245799999998888899999999999999999999999643111 000 0 0 000000 00012
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+...+..+.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 3345567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=262.68 Aligned_cols=235 Identities=13% Similarity=0.034 Sum_probs=178.1
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHH-----HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMA-----TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|...+.+|+|+| |.||++.. .++| ..........+.+|+.++..++|+||+++++.+.+.+..++|
T Consensus 2 ~y~~~~~lG~G~f--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 2 DFEILKVIGRGAF--GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CceEEEEEEeCCC--eEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 5677788999999 99998711 1111 111112234477899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee----
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL---- 167 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~---- 167 (274)
|||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 80 ~ey~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 80 MDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EeccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999976 345689999999999999999999999 999999999999999999999999998753
Q ss_pred --------cCCCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 168 --------LSDKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 168 --------~~~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
.+++.|+|||++. ...++.++|+|||||++|||++|+.||...... .. .... .+.. ..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~---~~----~~~i-~~~~-~~ 226 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ET----YGKI-MNHK-ER 226 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH---HH----HHHH-hCCC-cc
Confidence 2367899999886 345788999999999999999999999643110 00 0010 0000 00
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCC--CCChhhHHhh
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPAL--RPSMKCVVMM 273 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~evl~~ 273 (274)
.-.+ ......+..+.+++.+|+..++.+ |+++.|+++.
T Consensus 227 ~~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 112245678899999988664444 6899998753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=262.52 Aligned_cols=235 Identities=13% Similarity=0.024 Sum_probs=177.5
Q ss_pred hccccccCCCCCCCCcchhHHH------HHHHHHh-----cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM------RALMATV-----NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|...+.+|.|+| |.||++. ..++|.+ ......+.+.+|+.++..++|+||+++++++.+.+..++|
T Consensus 2 ~y~~~~~lG~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 2 DFEILKVIGRGAF--GEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CceEEEEEEecCC--eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 5667788999999 9999871 1111111 1112334577899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 80 MDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999999975 345689999999999999999999999 9999999999999999999999999987542
Q ss_pred ---------CCCCcCCCccccc-----CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 ---------SDKGCMAPECYKR-----TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ---------~~~~~~ape~~~~-----~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
+++.|+|||++.. ..++.++|+|||||++|+|++|+.||..... . ...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~---~----~~~~~i~~~~~--- 225 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---V----ETYGKIMNHKE--- 225 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH---H----HHHHHHHcCCC---
Confidence 3567999999863 3567899999999999999999999964311 0 00001100000
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCC--CCCChhhHHhh
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPA--LRPSMKCVVMM 273 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~--~Rps~~evl~~ 273 (274)
...-.......+..+.+++.+|+..+++ .||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 226 HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000011123467788999998865433 37899998763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=252.65 Aligned_cols=234 Identities=18% Similarity=0.194 Sum_probs=180.7
Q ss_pred hccccccCCCCCCCCcchhHHHH-------HHHHHhcC------------CCCCCcHHHHHHHHhc-CCCCccceEeEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR-------ALMATVNS------------PYSPSRPLTLTSIVSR-VSWTTDIEVSSVA 82 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~-------~~~~~~~~------------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~ 82 (274)
+|.....+|.|++ |.||+|.. .++|.... .....++.+|+.++.+ ++||||+++++++
T Consensus 1 ~y~~~~~ig~G~~--~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 78 (269)
T cd08528 1 EYAVLEHLGSGAF--GCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF 78 (269)
T ss_pred CchhhhhhcCCCC--ceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE
Confidence 3566778999999 99998821 11111110 0112335678888875 7899999999999
Q ss_pred EeCCcceEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEE
Q 048314 83 MRGSKPSTEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKI 159 (274)
Q Consensus 83 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl 159 (274)
.+++..+++|||+++++|.+++... ....+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.+++
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEE
Confidence 9999999999999999999998542 34568999999999999999999996 5 8999999999999999999999
Q ss_pred eccccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh
Q 048314 160 SDFGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN 229 (274)
Q Consensus 160 ~d~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (274)
+|||.+.... +..|++||.+....++.++|+||||+++|+|++|..||...... . .. ....+
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~-~~----~~~~~ 227 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---S-LA----TKIVE 227 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---H-HH----HHHhh
Confidence 9999986433 45699999998888899999999999999999999998633110 0 00 00111
Q ss_pred hhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 230 RELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
... .+ ......+..+.+++.+||+.||++|||+.|+.++|
T Consensus 228 ~~~----~~-~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 228 AVY----EP-LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred ccC----Cc-CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 111 11 01113457899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=257.51 Aligned_cols=243 Identities=16% Similarity=0.165 Sum_probs=180.6
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++++|...+.+|.|++ |.||+|.. .++|..... .....+.+|+.++++++|+||+++++++.+++..++
T Consensus 3 ~~~~y~~~~~ig~g~~--~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSY--ATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCC--EEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 4577888899999999 99998821 222222211 222356799999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
|+||+. ++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++...
T Consensus 81 v~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 81 VFEYMH-TDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred EEeccc-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 999996 688887765 335688999999999999999999999 99999999999999999999999999876422
Q ss_pred ----------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh---hh-----
Q 048314 170 ----------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI---NR----- 230 (274)
Q Consensus 170 ----------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~----- 230 (274)
+..|+|||.+... .++.++|+||||+++|+|++|..||....... +. +.. .+.... +.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~-~~~-~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQ-LEK-IWTVLGVPTEDTWPGV 232 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HH-HHH-HHHHcCCCChhhhhhh
Confidence 4569999988653 57889999999999999999999997442211 10 100 000000 00
Q ss_pred -hhh----hhhc---CCc-----cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 231 -ELN----KLVR---GTE-----VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 231 -~~~----~~~~---~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
... .... +.. ........+.+++.+|+..||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 0000 000 00112467889999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=254.87 Aligned_cols=231 Identities=18% Similarity=0.188 Sum_probs=182.2
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEe--CCcceEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--GSKPSTE 91 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 91 (274)
|...+.+|.|++ |.||++.. .+++.... ....+++.+|+.++++++||||+++++++.. ....+++
T Consensus 2 y~~~~~lg~g~~--~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 2 YEVLETIGKGSF--GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred ceeeeeeccCCC--eEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 556678999999 99998821 11222211 1123456789999999999999999998764 4567999
Q ss_pred EEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 92 AALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLH-----DECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh-----~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
|||+++++|.+++... ....+++..++.++.|++.||.||| +. +++|+||+|+||+++.++.++++|||.
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999999753 2456999999999999999999999 77 999999999999999999999999998
Q ss_pred ceecC-----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 165 AKLLS-----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 165 ~~~~~-----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
+.... +..|++||.+....++.++|+||||+++++|++|..||.... ...+.. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~----~~~~~~-- 226 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----QLQLAS----KIKEGK-- 226 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----HHHHHH----HHhcCC--
Confidence 76532 456999999988888999999999999999999999997442 111111 111111
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
....+...+..+.+++.+||+.+|++|||+.+|++.
T Consensus 227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112444566789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.40 Aligned_cols=232 Identities=18% Similarity=0.151 Sum_probs=182.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhc--CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN--SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
...|.....+|.|+| |.||++.. .++|... .....+.+.+|+.+++.++||||+++++.+..++..++++
T Consensus 20 ~~~~~~~~~ig~g~~--g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 20 RSLLENYIKIGEGST--GIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhhHHhhhhcCCCCc--eeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 345566778999999 99998821 1122222 1123445779999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 98 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 98 EFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred ecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 99999999998864 4689999999999999999999999 9999999999999999999999999987532
Q ss_pred -------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 169 -------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 169 -------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
++..|+|||.+....++.++|+||||+++++|++|..||.... +.. .+ . ......... ...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~--~~-~----~~~~~~~~~----~~~ 239 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS-PVQ--AM-K----RLRDSPPPK----LKN 239 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHH--HH-H----HHhccCCCC----ccc
Confidence 2567999999988888999999999999999999999996431 111 01 0 000000000 011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+...+..+.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 2234567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=257.38 Aligned_cols=228 Identities=16% Similarity=0.067 Sum_probs=183.3
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|.....+|.|++ |.||++.. .++|. .......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 2 ~y~~~~~ig~g~~--~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 2 DFEFIKTLGTGSF--GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred ceEEEEEeecCCC--eEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 5666788999999 99998711 11111 11112345577899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 80 MEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred EecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999999976 36799999999999999999999999 99999999999999999999999999987542
Q ss_pred ------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 170 ------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 170 ------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
++.|+|||.+.....+.++|+||||+++|+|++|..||.... .. ... .....+ ....+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~-~~~----~~~~~~-------~~~~~~ 219 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PI-QIY----EKILEG-------KVRFPS 219 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HH-HHH----HHHhcC-------CccCCc
Confidence 567999999988888899999999999999999999996442 10 000 000110 112344
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 244 KNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
..+..+.+++.+||+.||.+|| +++|+++
T Consensus 220 ~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 4567889999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=258.35 Aligned_cols=234 Identities=16% Similarity=0.181 Sum_probs=181.8
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
+|...+.+|.|++ |.||++.. .++|.+... ...+.+.+|+.++++++||||+++++.+...+..++|||
T Consensus 2 ~~~~~~~ig~g~~--g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNY--GSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCC--eEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4566778999999 99998821 112222211 113467799999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 94 LDLPWDLAYIIFCSA-ERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|+++++|.+++.... ...+++..+..++.|++.||.|||+ . +++|+||+|+||+++.++.++++|||.+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999987531 2368999999999999999999996 5 8999999999999999999999999988643
Q ss_pred ------CCCCcCCCcccccC------CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 169 ------SDKGCMAPECYKRT------PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 169 ------~~~~~~ape~~~~~------~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
++..|+|||.+... .++.++|+|||||++|+|++|..||....... ....... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~-~~~~------ 225 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQLSA-IVDG------ 225 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HHHHHHH-Hhhc------
Confidence 24579999988543 34789999999999999999999996431110 0000000 0000
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+...+...+.++.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 226 DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111244457788999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=254.48 Aligned_cols=243 Identities=16% Similarity=0.160 Sum_probs=186.5
Q ss_pred HhhhccccccCCCCCCCCcchhHH-------HHHHHHHh---cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEe-----
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSC-------MRALMATV---NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR----- 84 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----- 84 (274)
..+.|...+.+|+|.+ |.|.++ .+++||.. .+....++..+|++.|+.++|+||+.+.+.+..
T Consensus 20 i~~~y~~~~~iG~GAy--GvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAY--GVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred ccceecccccccCcce--eeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 3445555788999999 988876 45555543 333445677899999999999999999999865
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
-...|+|+|+| +-+|...++. ++.|+......+.-|++.||.|+|+. +++||||||.|+++..+..+|++|||+
T Consensus 98 f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 34679999999 4689999985 45599999999999999999999999 999999999999999999999999999
Q ss_pred ceecC-------------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHH--------H
Q 048314 165 AKLLS-------------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN--------W 222 (274)
Q Consensus 165 ~~~~~-------------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~--------~ 222 (274)
++... |.-|.|||++.. ..|+...||||.||++.||++|++.|...+.- ....+.- .
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-HQLQLILELLGTPSEE 250 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH-HHHHHHHHhcCCCCHH
Confidence 98773 445899998765 57999999999999999999999999653211 1111100 0
Q ss_pred HHHHHhhhhhhhhhcCC----------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 223 VYKCFINRELNKLVRGT----------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 223 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+.+....+++..- .+| ...+...+|+.+||..||.+|+|++|.++
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 01111222222222211 122 44577899999999999999999999886
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=252.82 Aligned_cols=229 Identities=20% Similarity=0.183 Sum_probs=181.7
Q ss_pred ccccccCCCCCCCCcchhHHHHH------HHHHhcCC-------CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMRA------LMATVNSP-------YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~~------~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
|.....+|.|++ |.||+|... ++|..... +..+.+.+|+.++++++|+||+++++++.+....++
T Consensus 2 ~~~~~~ig~g~~--~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 2 WRKGELLGSGSF--GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred ccccceeeecCC--ceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 455678999999 999998321 12221111 123457789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
++||+++++|.+++.. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.+||+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 80 FLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999999975 34689999999999999999999999 99999999999999999999999999876432
Q ss_pred ---------CCCcCCCcccccCC-CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 ---------DKGCMAPECYKRTP-ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~-~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+..|++||.+.... ++.++|+||||+++|++++|..||.... ..... .... ......
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~---~~~~~----~~~~------~~~~~~ 221 (258)
T cd06632 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE---GVAAV----FKIG------RSKELP 221 (258)
T ss_pred cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc---HHHHH----HHHH------hcccCC
Confidence 45699999887665 8899999999999999999999996431 11000 0000 000011
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+......+.+++.+||+.+|.+|||+.+++.
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 233445678899999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=256.45 Aligned_cols=232 Identities=20% Similarity=0.169 Sum_probs=180.8
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
..|...+.+|.|.+ |.||+|.. .++|..... ...+++.+|+.+++.++||||++++++|.+.+..++
T Consensus 15 ~~y~~~~~lg~g~~--g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSF--GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred hhhhhheeecCCCC--eEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 45777889999999 99998821 112222111 112356789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
|+||+. |++.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 93 v~e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 93 VMEYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EHHhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999997 688888765 335699999999999999999999999 99999999999999999999999999886543
Q ss_pred ------CCCcCCCcccc---cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 ------DKGCMAPECYK---RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 ------~~~~~ape~~~---~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+..|+|||.+. ...++.++||||||+++|+|++|..||...... .. .... ... ..+..
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~----~~---~~~~-~~~-----~~~~~ 234 (307)
T cd06607 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SA---LYHI-AQN-----DSPTL 234 (307)
T ss_pred CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH----HH---HHHH-hcC-----CCCCC
Confidence 56799999874 346788999999999999999999998643110 00 0000 000 00111
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.+...+..+.+++.+||+.||++|||+.+++..
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 233456789999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=254.27 Aligned_cols=231 Identities=19% Similarity=0.249 Sum_probs=176.7
Q ss_pred cccccCCCCCCCCcchhHHHH---------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC-----
Q 048314 25 CRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS----- 86 (274)
Q Consensus 25 ~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 86 (274)
...+.+|+|++ |.||+|.. .++|..... ...+++.+|++++++++||||+++++++....
T Consensus 2 ~~~~~ig~g~~--g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 2 TLGRMLGKGEF--GSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred cchhcccCCCC--CCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 44578999999 99998832 122222211 12345778999999999999999999886532
Q ss_pred -cceEEEEeCCCCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEec
Q 048314 87 -KPSTEAALDLPWDLAYIIFCSA----ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISD 161 (274)
Q Consensus 87 -~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 161 (274)
..++++||+.+|+|.+++.... ...+++.....++.|++.||+|||+. +++|+||||+||+++.++.++++|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 3478999999999999885321 12479999999999999999999999 999999999999999999999999
Q ss_pred cccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHH
Q 048314 162 FGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCF 227 (274)
Q Consensus 162 ~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (274)
||.+.... ...|++||.+....++.++|+||||+++|+|++ |..||.... ...+..+.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~----~~~~~~~~---- 228 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE----NSEIYNYL---- 228 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC----HHHHHHHH----
Confidence 99986542 246899999988888999999999999999998 788875331 11111111
Q ss_pred hhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 228 INRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.... ....+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 229 ~~~~------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 229 IKGN------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred HcCC------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0100 0012234557899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=287.78 Aligned_cols=234 Identities=18% Similarity=0.157 Sum_probs=192.0
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHH------HHHHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSC------MRALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
++..+-+++...+||.|.| |.||.+ ..+++|.+. .....+...+|++++..++|||+|+.+|+-.+.+
T Consensus 1230 lsnV~~rWqrg~~Ig~G~f--G~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTF--GKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred hccceeeeccccccCCcce--eeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH
Confidence 3455667888999999999 999988 333333222 2244555679999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..+|-||||.+|+|.+.+.. .+..++.....+..|++.|+.|||++ ||+|||+||.||+++.+|.+|++|||.+.
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeeccccee
Confidence 99999999999999999985 45578888888999999999999999 99999999999999999999999999986
Q ss_pred ec---------------CCCCcCCCcccccC---CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh
Q 048314 167 LL---------------SDKGCMAPECYKRT---PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI 228 (274)
Q Consensus 167 ~~---------------~~~~~~ape~~~~~---~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (274)
.+ +|+.|||||++.+. .....+||||+||+++||+||+.||...+.+. ..
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~------aI------ 1450 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW------AI------ 1450 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh------HH------
Confidence 53 37889999999764 35678999999999999999999996442211 00
Q ss_pred hhhhhhhhcC--CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 229 NRELNKLVRG--TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 229 ~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+.+..-+ ..+|...+.+-.+++..||+.||++|=++.|+++
T Consensus 1451 ---My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1451 ---MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ---HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1111111 1467778888999999999999999999999886
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=258.00 Aligned_cols=231 Identities=19% Similarity=0.168 Sum_probs=179.8
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.|...+.+|.|+| |.||++.. .+++..... .....+.+|++++++++|||++++++++.++...++|
T Consensus 26 ~f~~~~~lg~G~~--~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 26 LFTDLREIGHGSF--GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhheeccCCC--eEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 4777888999999 99998821 112222211 1123467899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|||+. |+|.+.+.. ....+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 104 ~e~~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 104 MEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred EeCCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 99997 588888765 345699999999999999999999999 99999999999999999999999999876443
Q ss_pred -----CCCcCCCcccc---cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 -----DKGCMAPECYK---RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 -----~~~~~ape~~~---~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||.+. ...++.++|+||||+++|+|++|..||..... ...... . .... .+...
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~----~-~~~~-----~~~~~ 245 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYH----I-AQNE-----SPTLQ 245 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHH----H-Hhcc-----CCCCC
Confidence 45799999874 34678899999999999999999999864311 000100 0 0000 01112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred CccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 33456679999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=260.34 Aligned_cols=227 Identities=16% Similarity=0.192 Sum_probs=185.4
Q ss_pred ccccccCCCCCCCCcchhHH------HHHHHHHhcC-C---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSC------MRALMATVNS-P---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~-~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
|.-+.-+|+|.| ..|-.+ .++++|.+.+ + -+...+.+|++.|+-++|||||+||.+......+|||+|
T Consensus 20 YDLekTlG~GHF--AVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 20 YDLEKTLGRGHF--AVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred ehhhhhhcCCce--ehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 444667999999 544333 3333333222 2 234556799999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE-cCCCcEEEeccccceecC---
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM-DEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~-~~~~~~kl~d~g~~~~~~--- 169 (274)
+=.+|+|.||+-. .+.++.+....+++.||+.|+.|+|+. .++||||||+|+++ ..-|-+||.|||++....
T Consensus 98 LGD~GDl~DyImK-He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK-HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHh-hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999987 567899999999999999999999999 99999999999976 466889999999986432
Q ss_pred -------CCCcCCCcccccCCCc-cccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-c
Q 048314 170 -------DKGCMAPECYKRTPIS-VKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-E 240 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~-~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (274)
...|-|||++.+..|+ +.+||||+||+||-|++|+.||+.... .+.+..++|=. .
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----------------SETLTmImDCKYt 237 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----------------SETLTMIMDCKYT 237 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------hhhhhhhhccccc
Confidence 4569999999998886 789999999999999999999974421 12222333333 5
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.|...+.++.+||..||..||.+|.|.+||..
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 78888999999999999999999999999864
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=251.14 Aligned_cols=234 Identities=18% Similarity=0.167 Sum_probs=180.0
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CC--------CCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YS--------PSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
|.....+|.|++ |.||+|.. .++|..... .. .+.+.+|+.++++++|||++++++++...
T Consensus 3 ~~~~~~lg~g~~--~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 3 WVKGELIGKGTY--GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred eeecceecccCc--eEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 344678999999 99999821 122221110 00 12456899999999999999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred CceEEEEecCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999976 35789999999999999999999999 9999999999999999999999999988
Q ss_pred eecC-------------CCCcCCCcccccCC--CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh
Q 048314 166 KLLS-------------DKGCMAPECYKRTP--ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR 230 (274)
Q Consensus 166 ~~~~-------------~~~~~ape~~~~~~--~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
.... +..|+|||.+.... ++.++|+||||++++++++|..||..... ..... .. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~----~~-~~~ 227 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMF----KL-GNK 227 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHHHH----Hh-hcc
Confidence 6432 34699999887654 78899999999999999999999853211 00000 00 000
Q ss_pred hhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 231 ELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.....+ +.......+..+.+++..||+.+|++|||+++|++.
T Consensus 228 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAPPI-PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCcC-CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000111 111222446789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=254.49 Aligned_cols=235 Identities=20% Similarity=0.215 Sum_probs=184.7
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
+|.....+|.|++ |.||++.. .++|..... ...+++.+|++++++++||||+++++.+...+..++++|
T Consensus 2 ~~~~~~~ig~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNS--GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCC--eEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 4556678999999 99999822 122222211 223457899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
|+++++|.+++... ...+++..+..++.|++.|+.|||+ . +++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 80 YMDGGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred ecCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999999863 2678999999999999999999999 8 9999999999999999999999999987543
Q ss_pred -----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 169 -----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 169 -----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
.+..|++||.+....++.++|+||||++++++++|..||......... ......... .. .....+.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~-~~------~~~~~~~ 226 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--IFELLQYIV-NE------PPPRLPS 226 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc--HHHHHHHHh-cC------CCCCCCh
Confidence 356799999998888999999999999999999999999644211111 111111100 00 0011222
Q ss_pred H-HHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 244 K-NLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 244 ~-~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
. .+..+.++|..||..||++|||+.+++.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 2 5677999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=260.42 Aligned_cols=231 Identities=17% Similarity=0.156 Sum_probs=181.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
+.+.....+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++|+||+++++.+...+..++|||
T Consensus 22 ~~~~~~~~lg~g~~--g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGST--GIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCC--eEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 34444567999999 99998721 112222111 223457799999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL----- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~----- 168 (274)
|+++++|.+++.. +.+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 100 ~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 100 FLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 9999999999854 4689999999999999999999999 9999999999999999999999999987532
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-cc
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-EV 241 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 241 (274)
++..|+|||.+....++.++|+||||+++||+++|..||..... ...+. . ......+. ..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~-----~-----~~~~~~~~~~~ 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMR-----R-----IRDNLPPRVKD 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH-----H-----HHhcCCCcccc
Confidence 24579999999888889999999999999999999999964311 00000 0 00111111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
....+..+.+++.+||..||++|||+.++++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 22345678899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=260.30 Aligned_cols=235 Identities=12% Similarity=0.037 Sum_probs=177.8
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.+|+|+| |.||++.. .++|.. ........+.+|+.++..++|+||+++++++.+.+..++
T Consensus 1 d~y~i~~~lG~G~f--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAF--GEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCC--eEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 35777889999999 99998811 111111 111223446789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
||||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 79 v~Ey~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 79 VMDYYVGGDLLTLLSK-FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEeCCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999999976 345789999999999999999999999 9999999999999999999999999987532
Q ss_pred ----------CCCCcCCCccccc-----CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 169 ----------SDKGCMAPECYKR-----TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 169 ----------~~~~~~ape~~~~-----~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
+++.|+|||++.. ..++.++|+||||+++|+|++|+.||..... ..... .. .....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~----~i-~~~~~- 225 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYG----KI-MNHEE- 225 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH---HHHHH----HH-HcCCC-
Confidence 3667999998865 4578899999999999999999999964311 00000 00 00000
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCC--CCChhhHHh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPAL--RPSMKCVVM 272 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~evl~ 272 (274)
. ..-.......++.+.+++.+|+..++.+ |++++++++
T Consensus 226 ~-~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 226 R-FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred c-ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0 0000011234578899999999876544 468888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=255.39 Aligned_cols=238 Identities=18% Similarity=0.169 Sum_probs=188.2
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHHHH------HHHHhcCC-CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCMRA------LMATVNSP-YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~~~------~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
...+++|.....+|.|++ |.||+|... ++|..... ...+.+.+|+.++++++|+|++++++.+...+..++
T Consensus 15 ~~~~~~~~~~~~l~~g~~--~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 15 GDPRELYKNLEKIGEGAS--GEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CCccccchHhHhccCCCC--eEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 345667777889999999 999998322 12222211 124567899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
++||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++++|||.+...
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999998732 4799999999999999999999999 9999999999999999999999999986532
Q ss_pred ---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
.+..|++||.+....++.++|+||||+++|+|++|..||..... ...... ...... ...
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~---~~~~~~-----~~~~~~----~~~ 236 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFL-----ITTKGI----PPL 236 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHHH-----HHhcCC----CCC
Confidence 24569999999888889999999999999999999999863311 110000 000000 111
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1222356789999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=251.51 Aligned_cols=237 Identities=20% Similarity=0.210 Sum_probs=184.5
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
++|...+.+|.|++ |.||+|.. .++|..... ...+.+.+|+.+++.++|+||+++++.+......++++
T Consensus 1 ~~y~~~~~lg~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGAT--AVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCC--eEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 35677788999999 99998831 112222211 23355779999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 93 ALDLPWDLAYIIFCSAE-RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|++++++|.+++..... ..+++.....++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999999986333 5689999999999999999999999 99999999999999999999999999875322
Q ss_pred -------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 170 -------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 170 -------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
+..|++||.+... .++.++|+||||+++++|++|..||...... ..+.... .. . ...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~----~~-~-~~~ 226 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTL----QN-D-PPS 226 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHh----cC-C-CCC
Confidence 4469999998776 6889999999999999999999999643111 1111100 00 0 000
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..........+..+.+++.+||+.||++|||+.+|++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1110111245678899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=250.92 Aligned_cols=231 Identities=18% Similarity=0.134 Sum_probs=179.6
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcC-C--C----CCCcHHHHHHHHhcCCCCccceEeEEEEeC--C
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS-P--Y----SPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--S 86 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~-~--~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 86 (274)
.+|...+.+|.|++ |.||.+.. .++|.... . . ..+.+.+|+.++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~l~~g~~--g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (265)
T cd06652 2 TNWRLGKLLGQGAF--GRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMER 79 (265)
T ss_pred CcceEeeEEecCCc--eEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCc
Confidence 46777899999999 99998821 11222211 1 1 123466899999999999999999988663 4
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
.++++|||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred eEEEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 67899999999999999975 34689999999999999999999999 99999999999999999999999999876
Q ss_pred ec--------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 167 LL--------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 167 ~~--------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
.. ++..|+|||.+....++.++|+||||+++|++++|+.||.... ...... .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~---~~~~~~----~~-----~ 222 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE---AMAAIF----KI-----A 222 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc---hHHHHH----HH-----h
Confidence 32 2446999999988888999999999999999999999996331 000000 00 0
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.... ....+......+.+++.+||. +|++|||++||++.
T Consensus 223 ~~~~-~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 TQPT-NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred cCCC-CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0000 112455566788899999995 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=253.36 Aligned_cols=243 Identities=17% Similarity=0.166 Sum_probs=180.2
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeC--Ccce
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--SKPS 89 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 89 (274)
++|...+.+|.|++ |.||+|.. .++|..... .....+.+|+.++++++||||+++++++... +..+
T Consensus 5 ~~y~~~~~lg~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTY--GVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCC--eEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 56777889999999 99999821 112222211 1122456899999999999999999998877 8899
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+|+||+. ++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 83 lv~e~~~-~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 83 MVMEYVE-HDLKSLMET-MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EEehhcC-cCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9999997 599999876 334699999999999999999999999 99999999999999999999999999887543
Q ss_pred -----------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH-------HHHHhh-
Q 048314 170 -----------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV-------YKCFIN- 229 (274)
Q Consensus 170 -----------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~- 229 (274)
+..|+|||.+... .++.++|+||+|+++++|++|..||...........+.... +.....
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 3459999988654 46889999999999999999999996432111111110000 000000
Q ss_pred -----hhh----hhhhcCCccCHH-HHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 230 -----REL----NKLVRGTEVDKK-NLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 230 -----~~~----~~~~~~~~~~~~-~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
... ...++. ..+.. .+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRK-KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhc-cccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 000000 12222 4677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=252.11 Aligned_cols=229 Identities=19% Similarity=0.175 Sum_probs=181.8
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
-|...+.+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 5 ~~~~~~~ig~G~~--~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSF--GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCC--eEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 4556677999999 99998821 112221111 122456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++++|.+++.. ..+++..+..++.|++.|+.+||+. +++|+|++|.||+++.++.++++|||++....
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999999864 4689999999999999999999999 99999999999999999999999999875432
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|++||.+.....+.++|+||||+++++|++|..||..... . .... . ..... ....+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~-~~~~---~-~~~~~------~~~~~ 222 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---M-KVLF---L-IPKNN------PPTLE 222 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---H-HHHH---H-HhcCC------CCCCC
Confidence 4568999999887888999999999999999999999863310 0 0000 0 00000 11233
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
...+..+.+++.+||+.+|++||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 4456778999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=250.85 Aligned_cols=234 Identities=20% Similarity=0.194 Sum_probs=187.3
Q ss_pred hhccccccCCCCCCCCcchhHHHHH------HHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMRA------LMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~~------~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
++|.....+|.|++ |.||++... +++..... ...+.+.+|+.++++++|+||+++++++...+..++|+
T Consensus 1 ~~~~~~~~i~~g~~--~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSS--GVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCC--eEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 35777889999999 999988221 12222221 12456789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
||+++++|.+++.. ...+++..++.++.|++.|+.|||+ . +++|+|++|+||+++.++.++|+|||.+....
T Consensus 79 e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 79 EYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred EecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 99999999999986 3679999999999999999999999 8 99999999999999999999999999887543
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+..|+|||.+....++.++|+||||+++|+|++|..||...... ....+..... .. ....
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~----~~------~~~~ 222 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAIC----DG------PPPS 222 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHh----cC------CCCC
Confidence 35699999998888899999999999999999999999654210 1111111110 00 0011
Q ss_pred cCHH-HHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 241 VDKK-NLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 241 ~~~~-~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.+.. .+..+.+++.+||+.+|++|||+.++++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 2333 56789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=252.73 Aligned_cols=228 Identities=18% Similarity=0.171 Sum_probs=179.2
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCC---CCccceEeEEEEeCCcceE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVS---WTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l 90 (274)
.|+....+|.|++ |.||+|.. .++|..... ...+++.+|+.++++++ |||++++++++.+.+..++
T Consensus 2 ~y~~~~~l~~g~~--g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAY--GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCC--ceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4566778999999 99999832 122222211 22345678999999987 9999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
||||+++++|.+++.. ..+++...+.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 80 IMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999999999865 3789999999999999999999999 99999999999999999999999999886543
Q ss_pred ----------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 170 ----------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 170 ----------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+..|+|||.+..+ .++.++|+||||+++|+|++|..||...... . ... ..... .+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~---~~~----~~~~~------~~ 219 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-R---AMM----LIPKS------KP 219 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-h---hhh----ccccC------CC
Confidence 3459999988654 4688999999999999999999999643110 0 000 00000 00
Q ss_pred CccCH-HHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 239 TEVDK-KNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 239 ~~~~~-~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+. ..+.++.+++.+||+.||++|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111 24568999999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=256.66 Aligned_cols=233 Identities=19% Similarity=0.235 Sum_probs=178.9
Q ss_pred ccccCCCCCCCCcchhHHHH------HHHHHhcCCCCC----CcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 26 RSSLNDRNSPRSKSVWSCMR------ALMATVNSPYSP----SRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 26 ~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
..+.+|.|+| |.||++.. .++|........ ....+|+.++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~lg~G~~--g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 3 LVKKLGSGGF--GTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEESS--EEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred EeEEEEeCCC--EEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 3578999999 99999911 122222222111 11235899999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
.+++|.+++.. ...+++..++.++.|++.||.+||+. +++|+||||+||+++.++.++|+|||.+...
T Consensus 81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred ccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 99999999983 45789999999999999999999999 9999999999999999999999999998642
Q ss_pred ----CCCCcCCCcccc-cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 169 ----SDKGCMAPECYK-RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 169 ----~~~~~~ape~~~-~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
.+..|+|||.+. ....+.++|+||+|+++++|++|..||..... ...... ............. ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-~~~~~~---~~~~~~~~~~~~~----~~~~ 227 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-DDQLEI---IEKILKRPLPSSS----QQSR 227 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-HHHHHH---HHHHHHTHHHHHT----TSHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc-hhhhhh---hhhcccccccccc----cccc
Confidence 155799999988 77889999999999999999999999974310 011111 1011000000000 0111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 244 KNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.....+.+++.+||+.||++|||+.++++.
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 113789999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=249.30 Aligned_cols=238 Identities=16% Similarity=0.086 Sum_probs=178.6
Q ss_pred hhhHHHHhhhccccccC--CCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEe
Q 048314 14 RSSLCTKLRNFCRSSLN--DRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMR 84 (274)
Q Consensus 14 ~~~l~~~~~~f~~~~~~--g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 84 (274)
..+.....++|...+.+ |.|+| |.||++.. .+++..... .... .|+.....+ +||||+++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~~k~~~~~-~~~~--~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKF--GKVSVLKHKPTQKLFVQKIIKAK-NFNA--IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCc--eEEEEEEEcCCCcEEEEEEEehh-hcch--hhHHHHHHhhcCCCEEEEEEEEec
Confidence 33444555666655555 99999 99998822 111111111 1111 133333222 69999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC-cEEEeccc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKISDFG 163 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~d~g 163 (274)
.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++++|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 9999999999999999999976 34899999999999999999999999 999999999999999988 99999999
Q ss_pred cceecC-------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 164 LAKLLS-------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 164 ~~~~~~-------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
.+.... +..|+|||.+....++.++|+||||+++++|++|..||..... .......+.... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~---------~ 224 (267)
T PHA03390 156 LCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLESLLKRQ---------Q 224 (267)
T ss_pred cceecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHHHHHHhh---------c
Confidence 886543 5679999999888899999999999999999999999973311 111111111110 0
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCC-hhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPS-MKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~evl~ 272 (274)
.....+...+..+.+++.+||+.||.+||+ ++|+++
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111233356678999999999999999996 699875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=254.35 Aligned_cols=244 Identities=18% Similarity=0.177 Sum_probs=179.8
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
|...+.+|.|++ |.||+|.. .++|..... ...+.+.+|+.++++++|||++++++++.+.+..+++||
T Consensus 1 y~~~~~l~~g~~--~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTY--GVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCC--eEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 345677999999 99999821 122222211 223467899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+. ++|.+++.......+++..++.++.|++.||.|||+. +++|+|++|+||+++.++.++++|||.+....
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 995 6999999864445799999999999999999999999 99999999999999999999999999986432
Q ss_pred -------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH-------HHHHhh-hh--
Q 048314 170 -------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV-------YKCFIN-RE-- 231 (274)
Q Consensus 170 -------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~-~~-- 231 (274)
+..|+|||.+... .++.++|+||||+++|+|++|..||................ +..... ..
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 4569999987654 56889999999999999999999996431111101100000 000000 00
Q ss_pred --hhhhhcCC--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 232 --LNKLVRGT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 232 --~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
........ ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 1112234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=256.12 Aligned_cols=239 Identities=17% Similarity=0.142 Sum_probs=178.9
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhcCCC-------CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPY-------SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
|...+.+|.|++ |.||+|.. .++|...... ....+..|++++++++|+||+++++++.+.+..++
T Consensus 2 y~~~~~lg~g~~--~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 2 YEKGKKLGEGTY--AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred ceeeeeeeeccc--cEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 556678999999 99999821 1222222111 12235689999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
||||+ +|+|.+++... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 v~e~~-~~~L~~~i~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 80 VFEFM-ETDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEccc-CCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 99999 89999999762 24799999999999999999999999 99999999999999999999999999987543
Q ss_pred ----------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh---h-----
Q 048314 170 ----------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN---R----- 230 (274)
Q Consensus 170 ----------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~----- 230 (274)
+..|+|||.+.. ..++.++|+||||+++++|++|.+||..... .. .+.... ..... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~--~~~~~~-~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-ID--QLGKIF-EALGTPTEENWPGV 230 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HH--HHHHHH-HHcCCCchhhhhhc
Confidence 245899998754 4578899999999999999999777754321 11 111110 00000 0
Q ss_pred -hhhhhhcC---C-----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 231 -ELNKLVRG---T-----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 231 -~~~~~~~~---~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
........ . ......+..+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000 0 1112345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=254.77 Aligned_cols=230 Identities=19% Similarity=0.160 Sum_probs=181.6
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcC--CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS--PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
+|..-+.+|.|++ |.||++.. .++|.... ....+.+.+|+.++++++||||+++++++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGST--GIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCC--eEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 5555678999999 99998821 11221211 12234467899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec------
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------ 168 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------ 168 (274)
+++++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||.+...
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 98 LEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 999999999975 4689999999999999999999999 9999999999999999999999999976532
Q ss_pred -----CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 169 -----SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 169 -----~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
++..|+|||.+....++.++|+||||+++++|++|..||..... .... ........... ..+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~~----~~~~~~~~~~~----~~~~ 239 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAM----KRIRDNLPPKL----KNLH 239 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHHH----HHHHhcCCCCC----cccc
Confidence 24579999999888889999999999999999999999864311 0000 00111100000 1122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 244 KNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+..+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 34578999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=246.88 Aligned_cols=233 Identities=19% Similarity=0.207 Sum_probs=183.8
Q ss_pred hccccccCCCCCCCCcchhHHHHH------HHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMRA------LMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~~------~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
+|...+.+|.|++ |.||++... +++..... ...+.+.+|+..+++++|+|++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~--~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGF--GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCc--eEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 3566788999999 999998321 12222221 1345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
+++++|.+++... ...+++..+..++.|++.||.+||+. +++|+|++|+||+++.++.++|+|||.+....
T Consensus 79 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 154 (253)
T cd05122 79 CSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR 154 (253)
T ss_pred CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccccc
Confidence 9999999999862 35799999999999999999999998 99999999999999999999999999886543
Q ss_pred -----CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 170 -----DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 170 -----~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
+..|++||.+.....+.++|+||||+++++|++|..||...... ... . . ......... ..+..
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~--~----~-~~~~~~~~~----~~~~~ 222 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-KAL--F----K-IATNGPPGL----RNPEK 222 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-HHH--H----H-HHhcCCCCc----Ccccc
Confidence 34699999998888899999999999999999999999643110 000 0 0 000000000 11112
Q ss_pred HHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 245 NLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.+..+.+++.+||+.||++|||++++++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 25779999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=251.12 Aligned_cols=239 Identities=19% Similarity=0.171 Sum_probs=180.2
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
|...+.+|.|++ |.||++.. .++|.... ....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 y~~~~~l~~g~~--~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 2 YKILGRIGEGAH--GIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred ceEEeecccCCC--cEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 556678999999 99998721 11222221 1224567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+ +++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 80 ~~-~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 80 YM-PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred cc-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99 9999999976 346799999999999999999999999 99999999999999999999999999876543
Q ss_pred --------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh----------
Q 048314 170 --------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR---------- 230 (274)
Q Consensus 170 --------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 230 (274)
+..|+|||.+... .++.++||||+|+++++|++|.+||..... . .............
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---I-EQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---H-HHHHHHHHHcCCCChHHHhhccC
Confidence 3469999988654 468899999999999999999777753311 1 1111111100000
Q ss_pred --hhhhhhcCC-------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 231 --ELNKLVRGT-------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 231 --~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.......+. .........+.+++.+||+.||++|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0111234789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=249.87 Aligned_cols=229 Identities=17% Similarity=0.166 Sum_probs=181.1
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
|.....+|.|++ |.||+|.. .+++..... ...+.+.+|+.++++++|+||+++++.+.+.+..++|+|
T Consensus 2 y~~~~~lg~G~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 2 WQRGNKIGGGTF--GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred ceeeeEeecCCC--cEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 566788999999 99999821 122222221 133456799999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++++|.+++.. ...+++..+..++.|++.|+.|||+. +++|+||+|.||+++.++.++++|||.+....
T Consensus 80 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 80 YCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred cCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999999975 34589999999999999999999999 99999999999999999999999999876532
Q ss_pred -----------CCCcCCCcccccCC---CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 170 -----------DKGCMAPECYKRTP---ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 170 -----------~~~~~ape~~~~~~---~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
+..|++||.+.... .+.++|+||||++++++++|..||..... ... ... .. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-~~~--~~~---~~-~~~----- 222 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-EFQ--IMF---HV-GAG----- 222 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-hHH--HHH---HH-hcC-----
Confidence 35799999987665 78999999999999999999999964321 110 000 00 000
Q ss_pred hcCCccCH--HHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 VRGTEVDK--KNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ~~~~~~~~--~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.....+. ..+..+.+++.+||+.||++|||+.+++.
T Consensus 223 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111222 23677889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=247.48 Aligned_cols=225 Identities=18% Similarity=0.095 Sum_probs=178.5
Q ss_pred CCCCCCCCcchhHHHHH------HHHHhc-----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCC
Q 048314 30 NDRNSPRSKSVWSCMRA------LMATVN-----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPW 98 (274)
Q Consensus 30 ~g~g~~~~g~vy~~~~~------~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 98 (274)
+|.|++ |.||++... ++|... .....+.+.+|+.++++++||||+++++.+.++...++++||++++
T Consensus 1 lg~g~~--~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGF--GRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCc--eEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 588889 899988221 111111 1122345779999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---------
Q 048314 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--------- 169 (274)
Q Consensus 99 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--------- 169 (274)
+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 ~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~ 153 (262)
T cd05572 79 ELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC 153 (262)
T ss_pred cHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccccc
Confidence 99999975 34689999999999999999999999 99999999999999999999999999987543
Q ss_pred -CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHH
Q 048314 170 -DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLEN 248 (274)
Q Consensus 170 -~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (274)
+..|++||.+....++.++|+||+|+++|++++|..||......... .. .. ..........+...+.+
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~---~~------~~~~~~~~~~~~~~~~~ 222 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME--IY---ND------ILKGNGKLEFPNYIDKA 222 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH--HH---HH------HhccCCCCCCCcccCHH
Confidence 45699999988888899999999999999999999999754221110 00 00 00000111234444778
Q ss_pred HHHHHHHhhccCCCCCCC-----hhhHHh
Q 048314 249 LVKVGLWCVQDEPALRPS-----MKCVVM 272 (274)
Q Consensus 249 ~~~li~~cl~~dp~~Rps-----~~evl~ 272 (274)
+.+++.+||+.||++||| ++|+++
T Consensus 223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 223 AKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 999999999999999999 888875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=255.43 Aligned_cols=245 Identities=16% Similarity=0.130 Sum_probs=177.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC----
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS---- 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 86 (274)
.++|...+.+|.|++ |.||++.. .++|..... .....+.+|++++++++||||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~--~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 11 VSKYEKLAKIGQGTF--GEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhheEEEEEeecCCC--EEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 457888899999999 99998821 112222211 11223568999999999999999999987654
Q ss_pred ----cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 87 ----KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 87 ----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
..++||||+. ++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+||
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 3499999996 588888875 344689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecC---------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH
Q 048314 163 GLAKLLS---------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226 (274)
Q Consensus 163 g~~~~~~---------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (274)
|.+.... +..|+|||.+... .++.++|+||||+++|+|++|..||..... .........+...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-~~~~~~~~~~~~~ 242 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-QHQLTLISQLCGS 242 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCC
Confidence 9886432 3459999987654 467899999999999999999999864421 1111111111000
Q ss_pred Hhhhhhh---------hhhcCC---------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 227 FINRELN---------KLVRGT---------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 227 ~~~~~~~---------~~~~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
....... ....+. ..+......+.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000 000000 0011123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=255.93 Aligned_cols=233 Identities=15% Similarity=0.153 Sum_probs=184.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhc--CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN--SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.++|...+.+|.|++ |.||++.. .++|... .....+.+.+|+.++++++||||+++++.+...+..++|+
T Consensus 18 ~~~~~~~~~lg~g~~--g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGAS--GTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCC--eEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 467778889999999 99999821 1122211 1122345778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+|++|+||+++.++.++|+|||++....
T Consensus 96 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred ecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999999974 4589999999999999999999999 99999999999999999999999999875332
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|++||.+....++.++|+||||+++|++++|..||....... . +. .....+ . .....
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-~--~~----~~~~~~-~----~~~~~ 237 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-A--LY----LIATNG-T----PELQN 237 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-h--ee----ehhcCC-C----CCCCC
Confidence 345999999988888999999999999999999999996431110 0 00 000000 0 00012
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
+...+..+.+++.+||..+|++||++.+++..
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33445678999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=252.16 Aligned_cols=242 Identities=17% Similarity=0.155 Sum_probs=179.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
++|.....+|.|.+ |.||+|.. .++|..... ...+.+.+|++++++++||||+++++++.+....++|
T Consensus 2 ~~y~~~~~l~~g~~--~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTY--GVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCC--EEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 46777888999999 99999821 112222111 2234578999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-CCcEEEeccccceecC-
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKISDFGLAKLLS- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~d~g~~~~~~- 169 (274)
|||++ ++|.+++.......+++.....++.|++.||.|||+. +++|+||+|+||+++. +..+|++|||++....
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 99996 5888888764444578899999999999999999999 9999999999999984 5678999999886432
Q ss_pred ----------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh--------
Q 048314 170 ----------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR-------- 230 (274)
Q Consensus 170 ----------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 230 (274)
+..|+|||.+... .++.++|+||||+++|+|++|..||....... .+.... ......
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~-~~~~~~~~~~~~~~ 231 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIF-RILGTPNEETWPGV 231 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH-HHhCCCChhhcccc
Confidence 3569999988653 57889999999999999999999996431111 111100 000000
Q ss_pred -hhhhhh------cCC---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 231 -ELNKLV------RGT---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 231 -~~~~~~------~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
...... ... ......+..+.+++.+||+.||++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 000 0112335678999999999999999999999863
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=253.18 Aligned_cols=244 Identities=17% Similarity=0.111 Sum_probs=177.4
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhc----CCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCc---
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVN----SPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSK--- 87 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~----~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~--- 87 (274)
++|...+.+|.|++ |.||+|. ..++|... .......+.+|+.+++++. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~--g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTY--GKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCC--eEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 35777889999999 9999982 11112111 1123356788999999996 6999999999877655
Q ss_pred --ceEEEEeCCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-CCcEEEec
Q 048314 88 --PSTEAALDLPWDLAYIIFCSA---ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKISD 161 (274)
Q Consensus 88 --~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~d 161 (274)
.+++|||+++ +|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++. ++.++++|
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence 7999999985 8999887532 23589999999999999999999999 9999999999999998 88999999
Q ss_pred cccceecC-----------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh
Q 048314 162 FGLAKLLS-----------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN 229 (274)
Q Consensus 162 ~g~~~~~~-----------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (274)
||.+.... ++.|+|||.+.. ..++.++|+||||+++|+|++|..||...........+...... ...
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~ 233 (295)
T cd07837 155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT-PTE 233 (295)
T ss_pred cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC-CCh
Confidence 99886432 456999998865 45789999999999999999999999643211111100000000 000
Q ss_pred hhhhhh------h-cCC-------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 230 RELNKL------V-RGT-------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 230 ~~~~~~------~-~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...... . .+. ......+..+.++|.+||+.||.+|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0 000 011234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=248.74 Aligned_cols=245 Identities=15% Similarity=0.146 Sum_probs=188.0
Q ss_pred hhhccccccCCCCCCCCcchhHH------HHHHHHHhc-CCCCCCcHHHHHHHHhcCCC--Cc----cceEeEEEEeCCc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC------MRALMATVN-SPYSPSRPLTLTSIVSRVSW--TT----DIEVSSVAMRGSK 87 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h--~n----iv~l~~~~~~~~~ 87 (274)
++.|...+++|+|.| |.|-++ ..+++|+++ ...-.+..+-|+++|.++.+ || +|++.+|+.-.++
T Consensus 88 ~~Ry~i~~~lGeGtF--GkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTF--GKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcc--cceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 567777899999999 999888 222233332 22355667789999999952 34 6888899999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC--------------
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-------------- 153 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-------------- 153 (274)
.|+|+|.+ |.|+.+||..++..+++..++..++.|+++++++||+. +++|.||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999976 56999999998888899999999999999999999999 9999999999999832
Q ss_pred ------CCcEEEeccccceec--------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHH
Q 048314 154 ------FWTAKISDFGLAKLL--------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219 (274)
Q Consensus 154 ------~~~~kl~d~g~~~~~--------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~ 219 (274)
+..++++|||.+... .|..|.|||++.+..++.++||||+||+|.|+.+|...|++++... ..-+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E-HLaM 320 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE-HLAM 320 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH-HHHH
Confidence 345799999998754 3788999999999999999999999999999999999999874221 1111
Q ss_pred HHHHH-----HHH---------hhhhhh----------h-hhcCC-------ccCHHHHHHHHHHHHHhhccCCCCCCCh
Q 048314 220 TNWVY-----KCF---------INRELN----------K-LVRGT-------EVDKKNLENLVKVGLWCVQDEPALRPSM 267 (274)
Q Consensus 220 ~~~~~-----~~~---------~~~~~~----------~-~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~ 267 (274)
...+. ... ..+.+. . ..++. .........+.+|++.||..||.+|+|+
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl 400 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL 400 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence 11000 000 000000 0 00000 2344566789999999999999999999
Q ss_pred hhHHh
Q 048314 268 KCVVM 272 (274)
Q Consensus 268 ~evl~ 272 (274)
.|++.
T Consensus 401 ~EAL~ 405 (415)
T KOG0671|consen 401 REALS 405 (415)
T ss_pred HHHhc
Confidence 99875
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=256.09 Aligned_cols=211 Identities=14% Similarity=0.100 Sum_probs=164.7
Q ss_pred CCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 048314 57 PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECE 136 (274)
Q Consensus 57 ~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~ 136 (274)
.+.+.+|+.++++++|+||+++++++.+.+..+++|||+++|+|.+++.......+++.....++.|++.||.|||+.
T Consensus 43 ~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~-- 120 (314)
T cd08216 43 LKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK-- 120 (314)
T ss_pred HHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 356789999999999999999999999999999999999999999999875556799999999999999999999999
Q ss_pred CCcccCCCCCCceEEcCCCcEEEeccccceecC------------------CCCcCCCcccccC--CCccccceeehhHh
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------------------DKGCMAPECYKRT--PISVKADVYGYGIV 196 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------------------~~~~~ape~~~~~--~~~~~~Di~s~G~~ 196 (274)
+++|+||+|+||+++.++.++++|||.+.... +..|+|||.+... .++.++|+||||++
T Consensus 121 -~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~i 199 (314)
T cd08216 121 -GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGIT 199 (314)
T ss_pred -CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHH
Confidence 99999999999999999999999999775321 3469999988653 57889999999999
Q ss_pred HHHHhhcCCCccccCCChhhHHHHHHHHHH----Hhh-------hhhhh----hhc-------CCccCHHHHHHHHHHHH
Q 048314 197 LLETICCWENMEIDASKPEEIILTNWVYKC----FIN-------RELNK----LVR-------GTEVDKKNLENLVKVGL 254 (274)
Q Consensus 197 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~-------~~~~~----~~~-------~~~~~~~~~~~~~~li~ 254 (274)
+++|++|..||....... .+....... ... ..... ..+ ...........+.+++.
T Consensus 200 l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 276 (314)
T cd08216 200 ACELANGHVPFKDMPATQ---MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVE 276 (314)
T ss_pred HHHHHhCCCCCCCCCHHH---HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHH
Confidence 999999999997432111 110000000 000 00000 000 00122334567899999
Q ss_pred HhhccCCCCCCChhhHHhh
Q 048314 255 WCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 255 ~cl~~dp~~Rps~~evl~~ 273 (274)
+||+.||++|||++++++.
T Consensus 277 ~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 277 LCLQRDPESRPSASQLLNH 295 (314)
T ss_pred HHhhcCCCcCcCHHHHhcC
Confidence 9999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=250.67 Aligned_cols=231 Identities=19% Similarity=0.131 Sum_probs=185.3
Q ss_pred hccccccCCCCCCCCcchhHHHHH------HHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMRA------LMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~~------~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
+|.....+|.|++ |.||++... ++|. .......+.+.+|++++++++||||+++++.+.++...++|
T Consensus 1 ~y~~~~~i~~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAF--GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCC--ceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 3566788999999 999998221 1111 11112345678999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
+||+.+++|.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 79 ~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 79 VDLLLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred EeCCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999999976 25789999999999999999999999 99999999999999999999999999886533
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|++||.+....++.++|+||||+++|+|++|..||........ ......... .....
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~-------~~~~~ 221 (258)
T cd05578 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-----DQIRAKQET-------ADVLY 221 (258)
T ss_pred ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-----HHHHHHhcc-------ccccC
Confidence 3469999999888889999999999999999999999975532211 111111000 11124
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCh--hhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSM--KCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~--~evl~ 272 (274)
+...+..+.+++.+||+.||.+||++ .|+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 44566889999999999999999999 88764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=249.11 Aligned_cols=236 Identities=14% Similarity=0.069 Sum_probs=172.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH---------HHHHHhcCCCCCCc---------------HHHHHHHHhcCCCCccce
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSPYSPSR---------------PLTLTSIVSRVSWTTDIE 77 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~~~~~~---------------~~~e~~~l~~l~h~niv~ 77 (274)
+.|...+.+|+|+| |.||+|.. ++++... ...+. ...+...+..+.|+|+++
T Consensus 12 ~~y~i~~~LG~G~f--G~Vy~~~~~~~~~~~~~~~~k~~~--~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 12 KEWKIDKLIGCGGF--GCVYETQCASDHCINNQAVAKIEN--LENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred CceEEeeEEecCCC--ceEEEEEEcCCcccccceEEEecc--ccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 56888899999999 99999821 1111110 11111 123344556778999999
Q ss_pred EeEEEEeCC----cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC
Q 048314 78 VSSVAMRGS----KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 153 (274)
Q Consensus 78 l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~ 153 (274)
+++.+.... ..++++|++. .++.+.+.. ....++..++.++.|++.||.|||+. +++||||||+||+++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 999876543 3477888764 467777764 23468888999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceec------------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChh
Q 048314 154 FWTAKISDFGLAKLL------------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPE 215 (274)
Q Consensus 154 ~~~~kl~d~g~~~~~------------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~ 215 (274)
++.++|+|||+++.. +++.|+|||...+..++.++|||||||+++||++|..||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999998642 36779999999888899999999999999999999999975422221
Q ss_pred hHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 216 EIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...... ..+ ...+..+......++..+.+++..||+.+|++||++.++++.|
T Consensus 242 ~~~~~~---~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAK---CDF----IKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhH---HHH----HHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111100 000 1111111111223457899999999999999999999998764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=249.36 Aligned_cols=226 Identities=20% Similarity=0.188 Sum_probs=172.8
Q ss_pred cCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHHh---cCCCCccceEeEEEEeCCcceEEEEe
Q 048314 29 LNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIVS---RVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
++|+|+| |.||++.. .++|..... .....+.+|..+++ ..+||||+++++.+.+.+..++||||
T Consensus 1 ~lg~G~~--g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGF--GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCC--eEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 4899999 99998721 112211111 11122344544333 44799999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec------
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------ 168 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------ 168 (274)
+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||++...
T Consensus 79 ~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (279)
T cd05633 79 MNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (279)
T ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCcc
Confidence 999999999975 45699999999999999999999999 9999999999999999999999999988543
Q ss_pred ---CCCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 169 ---SDKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 169 ---~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
++..|+|||.+.. ..++.++|+||||+++++|++|..||......... .+.... ...+...+..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~-----------~~~~~~~~~~ 221 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT-----------LTVNVELPDS 221 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh-----------hcCCcCCccc
Confidence 3668999998864 45789999999999999999999999654222111 111000 0011124455
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----ChhhHHhh
Q 048314 245 NLENLVKVGLWCVQDEPALRP-----SMKCVVMM 273 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rp-----s~~evl~~ 273 (274)
.+..+.+++.+||+.||++|| |+.|+++.
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 678899999999999999999 59998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=247.28 Aligned_cols=229 Identities=19% Similarity=0.248 Sum_probs=178.4
Q ss_pred ccccccCCCCCCCCcchhHHHH----------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR----------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
|...+.+|.|++ |.||++.. ..+...... .....+..|+.++++++||||+++++++.+....++
T Consensus 2 y~i~~~ig~g~~--g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 2 YILQQRLGKGSF--GTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred ceeeeeecCCCC--ceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 555678999999 99997711 111111111 112235578999999999999999999999899999
Q ss_pred EEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 91 EAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
|+||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+|++|+||+++. ..++++|||.+...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999999998742 335699999999999999999999999 9999999999999976 46999999987643
Q ss_pred C-----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 S-----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 ~-----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
. +..|++||.+....++.++|+||||+++++|++|..||.... . ... .... ... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~-~~~---~~~~-~~~------~ 221 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---F-LSV---VLRI-VEG------P 221 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---H-HHH---HHHH-HcC------C
Confidence 2 456999999887788899999999999999999999985321 1 000 0000 000 0
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+...+.++.+++.+||+.||++||++.|+++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11234566778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=247.12 Aligned_cols=231 Identities=23% Similarity=0.242 Sum_probs=184.0
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|.....+|.|++ |.||++.. .+++... ......++.+|+.++++++|+||+++++++.+....++|+
T Consensus 1 ~y~~~~~i~~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSY--GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCc--eeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 3566778999999 99998711 1111111 1122345678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 93 ALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 999999999998753 235689999999999999999999999 9999999999999999999999999988653
Q ss_pred -------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 169 -------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 169 -------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
.+..|++||.+....++.++|+||+|++++++++|..||..... ..+.. .... .. ....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~----~~~~----~~--~~~~ 221 (256)
T cd08530 156 NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QDLRY----KVQR----GK--YPPI 221 (256)
T ss_pred CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH----HHhc----CC--CCCC
Confidence 25679999999888889999999999999999999999964311 01100 0000 00 0124
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+...+.++.+++.+||+.+|++|||+.++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 4466788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=248.98 Aligned_cols=236 Identities=15% Similarity=0.114 Sum_probs=174.3
Q ss_pred cccccCCCCCCCCcchhHHHH------HHHHHhcC---CCCCCcHHHHHHHHhcCC-CCccceEeEEEEeC--CcceEEE
Q 048314 25 CRSSLNDRNSPRSKSVWSCMR------ALMATVNS---PYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRG--SKPSTEA 92 (274)
Q Consensus 25 ~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 92 (274)
...+.+|.|++ |.||+|.. .++|.... ........+|+.++.++. |+|++++++++.+. +..++||
T Consensus 2 ~~~~~lg~g~~--~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 2 KILGKIGEGTF--SEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred ceEeecccccc--ceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 34567999999 99999821 11111111 112223457999999986 99999999999887 8899999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++. +.++|+|||.+....
T Consensus 80 e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 80 ELMD-MNLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred ecCC-ccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9997 588888875 335789999999999999999999999 9999999999999999 999999999986542
Q ss_pred -------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH-----------hhh
Q 048314 170 -------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF-----------INR 230 (274)
Q Consensus 170 -------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~ 230 (274)
+..|+|||.+.. ..++.++|+|||||++|+|++|..||...... .......... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL----DQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH----HHHHHHHHHcCCCCHHHHHhhccc
Confidence 456999997654 45688999999999999999999999643211 1111111000 000
Q ss_pred hhhhhhcCC-------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 231 ELNKLVRGT-------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 231 ~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.......+. ......+..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000 011234688999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=249.64 Aligned_cols=234 Identities=18% Similarity=0.167 Sum_probs=176.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHH-HhcCCCCccceEeEEEEeCCcceEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSI-VSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
++|...+.+|.|+| |.||++.. .++|..... .....+..|+.+ ++.++||||+++++++.+++..+++
T Consensus 1 ~~~~~~~~ig~g~~--g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAY--GVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCC--eEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 46777888999999 99999821 112222211 112335566665 5667899999999999999999999
Q ss_pred EEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 92 AALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
|||++ |+|.+++... ....+++..++.++.|++.||.|||+++ +++|+||||+||+++.++.+||+|||.+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99996 6898888653 2346899999999999999999999852 8999999999999999999999999998643
Q ss_pred ---------CCCCcCCCccccc----CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 169 ---------SDKGCMAPECYKR----TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 169 ---------~~~~~~ape~~~~----~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
++..|+|||.+.. ..++.++|+||||+++|+|++|..||........ .+.. . ...
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~----~-~~~----- 223 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ--QLKQ----V-VEE----- 223 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH--HHHH----H-Hhc-----
Confidence 2456999998754 3467899999999999999999999963211111 1100 0 000
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+.......+.++.+++.+||..+|++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111112234678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=255.81 Aligned_cols=239 Identities=15% Similarity=0.088 Sum_probs=174.0
Q ss_pred cCCCC--CCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCC
Q 048314 29 LNDRN--SPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 29 ~~g~g--~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
.||.| ++ |.||.+.. .++|..... ...+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 5 ~ig~g~~~~--~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 5 EIGRGFCNL--TSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HhCCcccCc--eeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 35666 66 88988821 112222211 112456789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-------- 168 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-------- 168 (274)
+++|.+++.+.....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++++||+.....
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999999875555699999999999999999999999 9999999999999999999999998643211
Q ss_pred ----------CCCCcCCCcccccC--CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH-------------H
Q 048314 169 ----------SDKGCMAPECYKRT--PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW-------------V 223 (274)
Q Consensus 169 ----------~~~~~~ape~~~~~--~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~-------------~ 223 (274)
.+..|++||.+... .++.++|+||||+++|+|++|..||............... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 12359999998763 4788999999999999999999999643211110000000 0
Q ss_pred HHHHhh-----------hhhh-----hhhcC---CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 224 YKCFIN-----------RELN-----KLVRG---TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 224 ~~~~~~-----------~~~~-----~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.....+ .... ..... ...+...+..+.+++++||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000 0000 00000 0123456778999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=251.52 Aligned_cols=236 Identities=20% Similarity=0.202 Sum_probs=175.3
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcC---CCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS---PYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|.....+|.|+| |.||++.. .++|.... ......+.+|+.++.++. ||||+++++++..++..+++|
T Consensus 5 ~~~~~~~lg~G~~--g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAF--GTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCc--eEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4555677999999 99998711 11111111 122345678999999997 999999999999999999999
Q ss_pred EeCCCCCHHHHH---HhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 93 ALDLPWDLAYII---FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 93 e~~~~gsL~~~l---~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
||+. +++.++. .......+++.....++.|++.||+|||+. .+++||||||+||+++.++.++|+|||++...
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9986 4555543 222346799999999999999999999963 18999999999999999999999999987542
Q ss_pred ---------CCCCcCCCcccccC---CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 169 ---------SDKGCMAPECYKRT---PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~---~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
++..|+|||.+... .++.++|+||||+++|+|++|+.||.... .......... .......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~-~~~~~~~- 231 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVV-KGDPPIL- 231 (288)
T ss_pred cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhc-CCCCCcC-
Confidence 24579999998765 57899999999999999999999996431 0000000000 0000000
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+...+...+..+.+++.+||+.||++|||+.+|++
T Consensus 232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 232 -SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred -CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122345678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=258.44 Aligned_cols=243 Identities=18% Similarity=0.134 Sum_probs=180.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHH------HHHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeC----
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG---- 85 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 85 (274)
..+.|...+.+|.|++ |.||++. ..++|.... ....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQ--GIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCC--EEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 3477888999999999 9999882 112222211 12234566899999999999999999988643
Q ss_pred --CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccc
Q 048314 86 --SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG 163 (274)
Q Consensus 86 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g 163 (274)
...++||||+. ++|.+.+.. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999996 589888864 289999999999999999999999 99999999999999999999999999
Q ss_pred cceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHH-----------H
Q 048314 164 LAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN-----------W 222 (274)
Q Consensus 164 ~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~-----------~ 222 (274)
.+.... +..|+|||.+....++.++|+||||+++|+|++|+.||...+.......+.. .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 164 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred cceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 987543 4569999999888899999999999999999999999964421111000000 0
Q ss_pred ----HHHHHhhhh------hhhhhcCC-------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 223 ----VYKCFINRE------LNKLVRGT-------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 223 ----~~~~~~~~~------~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
......+.. ........ ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000000 00000000 012234667899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=243.88 Aligned_cols=231 Identities=20% Similarity=0.185 Sum_probs=185.2
Q ss_pred hccccccCCCCCCCCcchhHHHHH------HHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeC--CcceE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMRA------LMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--SKPST 90 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~~------~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 90 (274)
+|...+.+|.|++ |.||+|... +++..... ...+.+.+|+.++++++||||+++++.+.+. ...++
T Consensus 1 ~~~~~~~i~~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSF--GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCc--eEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 3666788999999 999998221 11211111 2245678999999999999999999999888 88999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
++||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++|+|||.+....
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 79 FLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999999863 3899999999999999999999999 99999999999999999999999999876543
Q ss_pred ------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 170 ------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 170 ------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
+..|++||.+.....+.++|+||||++++++++|..||....... ...... ...-.
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~------~~~~~ 221 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM------AALYKI------GSSGE 221 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHhc------cccCC
Confidence 346899999988888999999999999999999999997542100 000010 00001
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+...+..+.+++.+||+.||.+|||+.+++.
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11244555788999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=245.43 Aligned_cols=240 Identities=18% Similarity=0.132 Sum_probs=177.3
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcC---CCCccceEeEEEEeCCc---
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRV---SWTTDIEVSSVAMRGSK--- 87 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~--- 87 (274)
|...+.+|.|++ |.||+|.. .++|..... .....+.+|+.++.++ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~--~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAY--GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCc--eEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 345677999999 99999832 122222211 1123456787777665 59999999999988776
Q ss_pred --ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 88 --PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 88 --~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
.+++|||+. ++|.+++.......+++..++.++.|++.||.|||+. +++|+|++|+||+++.++.++++|||.+
T Consensus 79 ~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 5899998864445699999999999999999999999 9999999999999999999999999988
Q ss_pred eecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh---
Q 048314 166 KLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL--- 232 (274)
Q Consensus 166 ~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 232 (274)
.... +..|+|||.+....++.++|+||||+++|+|++|..||.... ....+.............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS---EADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC---hHHHHHHHHHHcCCCChHhcC
Confidence 6543 445999999988888999999999999999999998886431 111111111100000000
Q ss_pred ------hhhhcCC------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 ------NKLVRGT------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 ------~~~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....... .........+.+++.+||+.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 111234577889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=250.79 Aligned_cols=243 Identities=15% Similarity=0.089 Sum_probs=181.0
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC--
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS-- 86 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 86 (274)
...++|...+.+|.|.+ |.||+|.. .++|.... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~--g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTY--GQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCC--EEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 45678888999999999 99999822 11222221 122345678999999999999999999987654
Q ss_pred --------cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEE
Q 048314 87 --------KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158 (274)
Q Consensus 87 --------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~k 158 (274)
..++|+||+++ ++.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999975 78888765 345799999999999999999999999 999999999999999999999
Q ss_pred EeccccceecC------------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH
Q 048314 159 ISDFGLAKLLS------------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225 (274)
Q Consensus 159 l~d~g~~~~~~------------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (274)
|+|||.+.... +..|++||.+.. ..++.++|+||||+++++|++|+.||..... . ..+... ..
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~--~~~~~~-~~ 232 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-L--AQLELI-SR 232 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-H--HHHHHH-HH
Confidence 99999986532 345999998764 3568899999999999999999999964321 1 111111 01
Q ss_pred HHhh---hhhhhh--------hcCC--------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 226 CFIN---RELNKL--------VRGT--------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 226 ~~~~---~~~~~~--------~~~~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.... .....+ .++. ......+..+.+++.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 000000 0000 011123578899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=243.85 Aligned_cols=232 Identities=22% Similarity=0.224 Sum_probs=185.4
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|...+.+|.|++ |.||++.. .+++..... ...+.+.+|++++++++|||++++++.+.+.+..++++
T Consensus 1 ~y~~~~~l~~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSF--GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCC--eEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 3566778999999 99998722 112222211 23345678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 93 ALDLPWDLAYIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
||+++++|.+++.... ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 9999999999998643 36799999999999999999999999 99999999999999999999999999886543
Q ss_pred ----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 ----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 ----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
++.|+|||.+....++.++|+||+|+++++|++|..||..... .. ... . ..... ..
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~-~~~---~-----~~~~~--~~ 221 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LE-LAL---K-----ILKGQ--YP 221 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH---HH-HHH---H-----HhcCC--CC
Confidence 3469999998888889999999999999999999999864321 00 000 0 00000 11
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 2344556789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=251.52 Aligned_cols=247 Identities=17% Similarity=0.172 Sum_probs=180.2
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeC--Cc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--SK 87 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 87 (274)
..++|...+.+|.|.+ |.||+|.. .++|..... .....+.+|+.++++++|+||+++++++.+. +.
T Consensus 5 ~~~~y~~~~~ig~g~~--~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 5 SVTEFEKLNRIGEGTY--GIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccceeEeeeeeecCC--EEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 3467888999999999 99999821 122222211 1123456899999999999999999998754 56
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+. ++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 83 ~~lv~e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEEEecCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence 899999997 589999876 335699999999999999999999999 999999999999999999999999999875
Q ss_pred cC-----------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH-------HHHHHh
Q 048314 168 LS-----------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW-------VYKCFI 228 (274)
Q Consensus 168 ~~-----------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~ 228 (274)
.. +..|+|||.+.+ ..++.++|+||+|+++|+|++|..||............... .+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 43 345999998865 45789999999999999999999999643111110001000 000000
Q ss_pred hhhh-hhh-hcCCc------cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 229 NREL-NKL-VRGTE------VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 229 ~~~~-~~~-~~~~~------~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.... ... ..... .....+..+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 000 00000 001135678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=236.71 Aligned_cols=238 Identities=14% Similarity=0.112 Sum_probs=186.5
Q ss_pred Hhhhccc-cccCCCCCCCCcchhHH------HHHHHHHhcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEe----CCc
Q 048314 20 KLRNFCR-SSLNDRNSPRSKSVWSC------MRALMATVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMR----GSK 87 (274)
Q Consensus 20 ~~~~f~~-~~~~g~g~~~~g~vy~~------~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~----~~~ 87 (274)
.+++|+. ..++|.|-. |.|..| .+-+.|.+. +....++|++.--+.. |||||++++++.. ..-
T Consensus 59 itedY~is~qvLG~Gin--GkV~~C~~k~T~ekfALKvL~---Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGIN--GKVVQCVHKRTQEKFALKVLL---DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccC--CceEEEEeccchhhhHHHHHh---cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 3566665 467899988 999887 333444444 3345677887665554 9999999999854 345
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC---CCcEEEecccc
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKISDFGL 164 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~d~g~ 164 (274)
+.+|||.|.||.|.+.++++....+++.+.-.+..||+.|+.|||+. +|-||||||+|+|... +-.+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 78999999999999999987777899999999999999999999999 9999999999999864 56789999999
Q ss_pred ceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 165 AKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 165 ~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
++... |+.|.|||++....|+..+|+||+||++|-|++|.+||....... +..-+...+..+ .
T Consensus 211 AK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~g---q 283 (400)
T KOG0604|consen 211 AKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTG---Q 283 (400)
T ss_pred ccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhcc---C
Confidence 98644 678999999999999999999999999999999999997432211 111111111111 1
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+-.|.+-..+.++..+++|+.+|.-+|++|.|+.++++
T Consensus 284 y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 22233445577889999999999999999999999875
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=263.03 Aligned_cols=188 Identities=15% Similarity=0.164 Sum_probs=158.1
Q ss_pred hhccccccCCCCCCCCcchhHH------HHHHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeC------C
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC------MRALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG------S 86 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 86 (274)
..+.....+|.|+| |.||+| ...++|..+. ....+...+|+++|++++|||||+++++-.+. .
T Consensus 13 y~W~~~e~LG~Ga~--g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAF--GNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCcc--ceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 34556788999999 999999 2333443333 34566778999999999999999999986543 3
Q ss_pred cceEEEEeCCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC----CCcEEEec
Q 048314 87 KPSTEAALDLPWDLAYIIFCSA-ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE----FWTAKISD 161 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~----~~~~kl~d 161 (274)
.+.+|||||.+|||...|.+-. ..+|++.+.+.++.+++.||.|||++ +|+||||||.||++.. ....||+|
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence 6799999999999999998742 24699999999999999999999999 9999999999999742 23469999
Q ss_pred cccceecC----------CCCcCCCcccc-cCCCccccceeehhHhHHHHhhcCCCccccCCCh
Q 048314 162 FGLAKLLS----------DKGCMAPECYK-RTPISVKADVYGYGIVLLETICCWENMEIDASKP 214 (274)
Q Consensus 162 ~g~~~~~~----------~~~~~ape~~~-~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~ 214 (274)
||.++... |..|++||++. ...|+..+|.|||||++|+++||..||.+...+.
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk 231 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK 231 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence 99998544 78899999998 5889999999999999999999999998876554
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=249.08 Aligned_cols=241 Identities=15% Similarity=0.091 Sum_probs=178.1
Q ss_pred cccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeC--CcceEEE
Q 048314 25 CRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--SKPSTEA 92 (274)
Q Consensus 25 ~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 92 (274)
.....+|.|++ |.||+|.. .++|.... ......+.+|+.++++++|||++++++++.+. +..++|+
T Consensus 2 ~~~~~l~~g~~--~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 2 EKIAQIGEGTY--GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred eeeEEeccCCC--eEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 34567899999 99999821 11222221 12334577899999999999999999999887 8899999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++ +|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 80 e~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 80 EYMDH-DLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccccc-cHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 99974 89999876 335799999999999999999999999 99999999999999999999999999887543
Q ss_pred ---------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh-----
Q 048314 170 ---------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK----- 234 (274)
Q Consensus 170 ---------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 234 (274)
+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...... ........
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGS-PTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-Cchhhccccccch
Confidence 345999997764 45789999999999999999999999754221111111000000 00000000
Q ss_pred ---hhcCC---------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 235 ---LVRGT---------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 235 ---~~~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..... .....++..+.+++.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 0111136788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=248.23 Aligned_cols=243 Identities=17% Similarity=0.164 Sum_probs=180.6
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
+|.....+|.|++ |.||+|.. .++|.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~--~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTY--ATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCc--eEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4667788999999 99999832 12222111 1223456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 94 LDLPWDLAYIIFCSA-ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
|+++ +|.+++.... ...+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++++|||.+....
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9984 8999887532 24689999999999999999999999 99999999999999999999999999886432
Q ss_pred --------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh------hh
Q 048314 170 --------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL------NK 234 (274)
Q Consensus 170 --------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 234 (274)
+..|++||.+... .++.++|+||||+++|++++|..||................. ....... ..
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG-TPTESTWPGISQLPE 233 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCChhhHHHHhcCch
Confidence 4569999987654 468899999999999999999999964422111111110000 0000000 00
Q ss_pred hhcC---------CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 235 LVRG---------TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 235 ~~~~---------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.... .......+..+.+++.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0011233567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=242.68 Aligned_cols=229 Identities=18% Similarity=0.195 Sum_probs=183.3
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
+|.....+|.|.+ |.+|++.. .+++..... ...+.+.+|++++++++|||++++++++.+.+..++++
T Consensus 1 ~y~~~~~l~~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAF--GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCC--eEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 3566788999999 99998721 111111111 12345789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++++|.+++.. ...+++..+..++.|++.||.+||+. +++|+|++|+||+++.++.++|+|||.+....
T Consensus 79 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 79 EYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred ecCCCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999999986 36799999999999999999999999 99999999999999999999999999887543
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|++||.......+.++|+||+|+++++|++|..||.... ...... .. ... .....
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~---~~~~~~----~~-~~~------~~~~~ 219 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN---PMAALF----RI-VQD------DHPPL 219 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc---HHHHHH----HH-hcc------CCCCC
Confidence 456999999887778899999999999999999999986431 110000 00 000 01123
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 4455678999999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=255.75 Aligned_cols=245 Identities=17% Similarity=0.176 Sum_probs=179.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEe----CC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR----GS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~ 86 (274)
.++|.....+|.|++ |.||+|.. .++|.... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lg~g~~--g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAY--GVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCC--eEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 467888899999999 99998821 11121111 1234556789999999999999999998753 35
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred eEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 6899999995 689999875 35599999999999999999999999 99999999999999999999999999986
Q ss_pred ecC---------------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH-------H
Q 048314 167 LLS---------------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW-------V 223 (274)
Q Consensus 167 ~~~---------------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~-------~ 223 (274)
... +..|+|||.+.. ..++.++|+||||+++|+|++|+.||............... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 432 446899998765 45789999999999999999999999643211110000000 0
Q ss_pred HHHHhhhhhhhhh---cCC-cc-----CHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 224 YKCFINRELNKLV---RGT-EV-----DKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 224 ~~~~~~~~~~~~~---~~~-~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
............. ... .. ....+..+.+++.+||+.||++|||+++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000011100 000 11 12346789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=251.95 Aligned_cols=226 Identities=18% Similarity=0.141 Sum_probs=177.1
Q ss_pred cccCCCCCCCCcchhHHHH------HHHHHhc--CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCC
Q 048314 27 SSLNDRNSPRSKSVWSCMR------ALMATVN--SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPW 98 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~------~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 98 (274)
-..+|.|++ |.||++.. .++|... .....+.+.+|+.++++++|+||+++++.+...+..+++|||++++
T Consensus 25 ~~~lg~g~~--g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGST--GIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCC--eEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 356999999 99998711 1111111 1123345778999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---------
Q 048314 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--------- 169 (274)
Q Consensus 99 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--------- 169 (274)
+|.+++.. ..+++.....++.|++.|++|||+. +++|+|++|+||+++.++.++++|||.+....
T Consensus 103 ~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 103 ALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 99998854 4689999999999999999999999 99999999999999999999999999875432
Q ss_pred --CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHH
Q 048314 170 --DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLE 247 (274)
Q Consensus 170 --~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (274)
+..|++||.+....++.++|+||+|+++|+|++|..||..... .. ... ... ....... ......+.
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~-~~~----~~~-~~~~~~~---~~~~~~~~ 244 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LK-AMK----MIR-DNLPPKL---KNLHKVSP 244 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HH-HHH----HHH-hhCCccc---CCcccCCH
Confidence 4569999998887889999999999999999999999864311 10 000 000 0011000 11223456
Q ss_pred HHHHHHHHhhccCCCCCCChhhHHh
Q 048314 248 NLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 248 ~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+.+++.+||+.||.+|||+.++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 7889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=253.67 Aligned_cols=247 Identities=17% Similarity=0.178 Sum_probs=182.2
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHH-------HHHHHH---hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEe-C
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCM-------RALMAT---VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR-G 85 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~ 85 (274)
+-..+++|.....+|.|++ |.||++. +++|+. .......+.+..|+.++++++||||+++++++.. .
T Consensus 5 ~~~~~~~y~~~~~ig~g~~--g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAF--GLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred eeccccceEEEEeecccCC--eEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 3446788999999999999 9999882 122211 1112234567799999999999999999999865 5
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
...++++||+ +++|.+++.. ..+++.....++.|++.||.|||+. +++|+|++|+||+++.++.++++|||.+
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 6789999998 4689988864 4688999999999999999999999 9999999999999999999999999988
Q ss_pred eecC--------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH-------HHHhh
Q 048314 166 KLLS--------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY-------KCFIN 229 (274)
Q Consensus 166 ~~~~--------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~ 229 (274)
.... +..|++||.+.. ..++.++|+||||+++|+|++|..||...........+.+... .....
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 156 RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred cccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 6432 456999998765 4678999999999999999999999964321110001111000 00000
Q ss_pred hhhhhh---h-cCCccC-----HHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 230 RELNKL---V-RGTEVD-----KKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 230 ~~~~~~---~-~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+. . .....+ ...+..+.+++.+||+.+|++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0 000111 123578999999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=271.36 Aligned_cols=232 Identities=18% Similarity=0.203 Sum_probs=185.4
Q ss_pred cccccCCCCCCCCcchhHHHH-------------HHHHHhc---CCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCc
Q 048314 25 CRSSLNDRNSPRSKSVWSCMR-------------ALMATVN---SPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSK 87 (274)
Q Consensus 25 ~~~~~~g~g~~~~g~vy~~~~-------------~~~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 87 (274)
.....+|.|.| |.|++|.. +++|... ...+.+.+..|+++|..+- |+||+.++|+|..++.
T Consensus 299 ~~~~~lg~g~f--G~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAF--GQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccc--cceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 33458999999 99999810 1111111 1134566789999999986 9999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCC------------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC
Q 048314 88 PSTEAALDLPWDLAYIIFCSA------------E--RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 153 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~ 153 (274)
.++|+||+.+|+|.+|+...+ . ..++....+.++.||+.|++||++. +++||||-.+|||+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecC
Confidence 999999999999999998744 0 2389999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecC--------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHH
Q 048314 154 FWTAKISDFGLAKLLS--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEII 218 (274)
Q Consensus 154 ~~~~kl~d~g~~~~~~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~ 218 (274)
+..+|++|||+++... ...|||||.+....|+.++||||||++|||+++ |..||... ....+
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-~~~~~-- 530 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI-PPTEE-- 530 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-CcHHH--
Confidence 9999999999998432 124999999999999999999999999999987 67887532 10111
Q ss_pred HHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 219 LTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+.. .+.++. ..+.|..+..++.++|+.||+.+|++||++.++.+.|
T Consensus 531 l~~----~l~~G~------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 531 LLE----FLKEGN------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred HHH----HHhcCC------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 111 111111 1147788899999999999999999999999998753
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=248.68 Aligned_cols=241 Identities=15% Similarity=0.157 Sum_probs=179.7
Q ss_pred cccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 25 CRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 25 ~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
...+.+|.|++ |.||++.. .+++..... ...+.+.+|+.++++++|+||+++++++.+++..++++||
T Consensus 2 ~~~~~i~~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 2 QKLGKIGEGTY--GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred ccceeeecCCC--ceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 44577999999 99999832 112222111 1234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
+++ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 80 ~~~-~l~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 80 MDT-DLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred cCC-CHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 975 89988876 336799999999999999999999999 99999999999999999999999999876443
Q ss_pred ------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHH-HHHH-------HHHHHhh---hh
Q 048314 170 ------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEII-LTNW-------VYKCFIN---RE 231 (274)
Q Consensus 170 ------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~-~~~~-------~~~~~~~---~~ 231 (274)
+..|+|||.+... .++.++|+||+|+++|+|++|+.||..... ..... .... .+....+ ..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 3458999998766 688999999999999999999999854321 11100 0000 0000000 00
Q ss_pred hhhhhcC-----CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 232 LNKLVRG-----TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 232 ~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.....+. .......+..+.+++.+||+.||.+||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000 01223456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=251.43 Aligned_cols=233 Identities=17% Similarity=0.147 Sum_probs=180.2
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcC-----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS-----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.+.|...+.+|.|++ |.||+|.. .+++.... ....+++.+|++++++++|+|++++++++.+....+
T Consensus 14 ~~~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSF--GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCC--EEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 445777788999999 99998821 11222211 112234678999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+||||+. |++.+.+.. ....+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 92 lv~e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 92 LVMEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEEccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9999996 688888765 345689999999999999999999999 99999999999999999999999999886533
Q ss_pred -------CCCcCCCcccc---cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 -------DKGCMAPECYK---RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 -------~~~~~ape~~~---~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+..|+|||.+. ...++.++||||||+++|+|++|..||...... .... .. ... ..+.
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~----~~-~~~-----~~~~ 233 (308)
T cd06634 167 PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALY----HI-AQN-----ESPA 233 (308)
T ss_pred CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---HHHH----HH-hhc-----CCCC
Confidence 56799999874 345788999999999999999999998533110 0000 00 000 0111
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 1233456778999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=243.04 Aligned_cols=225 Identities=17% Similarity=0.137 Sum_probs=170.6
Q ss_pred ccCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHH-hcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIV-SRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.+|.|++ |.||++.. .++|..... .....+..|..++ ...+|+|++++++++.+++..++|+||+
T Consensus 2 ~~l~~g~~--~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAF--GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCC--eeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 35899999 99998822 112221111 1112234454444 4568999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------- 168 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------- 168 (274)
++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV 154 (260)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccccccCC
Confidence 99999999975 35689999999999999999999999 9999999999999999999999999987643
Q ss_pred CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHH
Q 048314 169 SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLEN 248 (274)
Q Consensus 169 ~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (274)
++..|++||.+.+..++.++|+||||+++|+|++|..||..... .... ....... ...+.......+..
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~-----~~~~~~~---~~~~~~~~~~~~~~ 223 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVF-----DNILSRR---INWPEEVKEFCSPE 223 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHH-----HHHHhcc---cCCCCcccccCCHH
Confidence 35679999999887789999999999999999999999964311 1100 1111111 00111223345678
Q ss_pred HHHHHHHhhccCCCCCCChhhH
Q 048314 249 LVKVGLWCVQDEPALRPSMKCV 270 (274)
Q Consensus 249 ~~~li~~cl~~dp~~Rps~~ev 270 (274)
+.+++.+||+.||++|||+.++
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~ 245 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGY 245 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcH
Confidence 9999999999999999977533
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=245.73 Aligned_cols=244 Identities=15% Similarity=0.149 Sum_probs=178.7
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhcCC-C--CCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceEEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-Y--SPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 93 (274)
|.....+|.|++ |.||+|.. .++|..... . ......+|+..+++++ |+||+++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~--g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTF--GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCc--eEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 344577999999 99999832 112211111 1 1223457999999999 9999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+ +|+|.+++.......+++..+..++.|++.+|.|||+. +++|+||+|.||+++.++.++|+|||.+....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 99 78999999874445789999999999999999999999 99999999999999999999999999986543
Q ss_pred ------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHH---------HHHHHHhhhhhh
Q 048314 170 ------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN---------WVYKCFINRELN 233 (274)
Q Consensus 170 ------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 233 (274)
+..|+|||.+.. ..++.++|+||||+++++|++|..||.............. |...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 446899998754 4578999999999999999999999864421111110000 000000000000
Q ss_pred hhhcCC------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 234 KLVRGT------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 234 ~~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..+... ......+..+.+++++||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 0011124679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=254.87 Aligned_cols=248 Identities=16% Similarity=0.152 Sum_probs=180.3
Q ss_pred hhhhhHHHHh----hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccce
Q 048314 12 IARSSLCTKL----RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIE 77 (274)
Q Consensus 12 ~~~~~l~~~~----~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~ 77 (274)
|++.++..+. ++|.....+|.|++ |.||+|.. .++|..... .....+.+|+.++++++||||++
T Consensus 1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~--g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 78 (342)
T cd07879 1 FYREEVNKTVWELPERYTSLKQVGSGAY--GSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIG 78 (342)
T ss_pred CchhhhhhhhhccccceEEEEEeeecCC--eEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccc
Confidence 3455555553 78888999999999 99998821 112222211 12234678999999999999999
Q ss_pred EeEEEEeCC------cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE
Q 048314 78 VSSVAMRGS------KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 151 (274)
Q Consensus 78 l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~ 151 (274)
+++++.... ..++|+||+. .+|.+++. ..+++..+..++.|++.||+|||+. +++||||+|+||++
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll 150 (342)
T cd07879 79 LLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAV 150 (342)
T ss_pred hhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEE
Confidence 999986543 4599999986 47777653 3689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecC--------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH
Q 048314 152 DEFWTAKISDFGLAKLLS--------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW 222 (274)
Q Consensus 152 ~~~~~~kl~d~g~~~~~~--------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~ 222 (274)
+.++.++++|||++.... +..|+|||.+.. ..++.++|+||||+++|||++|+.||..... ...+...
T Consensus 151 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~---~~~~~~~ 227 (342)
T cd07879 151 NEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQI 227 (342)
T ss_pred CCCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH
Confidence 999999999999986532 456999998876 4578899999999999999999999974311 1111110
Q ss_pred HH----------HHHhhhhhhhhhc-----CC-c---cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 223 VY----------KCFINRELNKLVR-----GT-E---VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 223 ~~----------~~~~~~~~~~~~~-----~~-~---~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. ............. +. . .....+..+.+++.+||+.||++|||+++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0000000000000 00 0 00123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=251.75 Aligned_cols=235 Identities=15% Similarity=0.113 Sum_probs=176.2
Q ss_pred cccCCCCCCCCcchhHHHH------HHHHHhcCCCC----------------CCcHHHHHHHHhcCCCCccceEeEEEEe
Q 048314 27 SSLNDRNSPRSKSVWSCMR------ALMATVNSPYS----------------PSRPLTLTSIVSRVSWTTDIEVSSVAMR 84 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~----------------~~~~~~e~~~l~~l~h~niv~l~~~~~~ 84 (274)
.+.+|.|++ |.||++.. .++|....... ...+.+|++++++++||||+++++++..
T Consensus 14 ~~~ig~G~~--g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 14 GAHLGEGTY--GKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhcccCCCc--eeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 577999999 99999821 11121111100 1146789999999999999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
.+..++||||+. |+|.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccc
Confidence 999999999997 699999975 45689999999999999999999999 999999999999999999999999998
Q ss_pred ceecC-------------------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHH
Q 048314 165 AKLLS-------------------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEII 218 (274)
Q Consensus 165 ~~~~~-------------------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~ 218 (274)
+.... +..|+|||.+.+. .++.++|+||||+++|+|++|..||.......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---- 241 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---- 241 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 86543 3469999988654 46889999999999999999999996442111
Q ss_pred HHHHHHHHHhhhh---hhh--------hhcC---C---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 219 LTNWVYKCFINRE---LNK--------LVRG---T---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 219 ~~~~~~~~~~~~~---~~~--------~~~~---~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
............. ... .... . ......+..+.+++..||+.||++|||++|++..
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1111111000000 000 0000 0 0112235678999999999999999999999863
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=246.65 Aligned_cols=231 Identities=16% Similarity=0.125 Sum_probs=178.4
Q ss_pred ccccccCCCCCCCCcchhHHHHH-------------HHH-H-hcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCc
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMRA-------------LMA-T-VNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSK 87 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~~-------------~~~-~-~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 87 (274)
|.....+|.|++ |.||++... .++ . .......+.+.+|+.++.+++ ||||+++++.+..+..
T Consensus 2 ~~~~~~ig~G~~--~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 2 FELLRVLGTGAY--GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred ceEEEEeccCCC--ceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 556778999999 999976211 111 1 111123456779999999994 9999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++|+|.+++.. ...+++.....++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999999975 35689999999999999999999999 999999999999999999999999998764
Q ss_pred c------------CCCCcCCCcccccCC--CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 168 L------------SDKGCMAPECYKRTP--ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 168 ~------------~~~~~~ape~~~~~~--~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
. ++..|++||.+.... .+.++|+||||+++++|++|..||...........+.. . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~------~~ 225 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR---R------IL 225 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH---H------HH
Confidence 2 245699999887654 67899999999999999999999964322111111110 0 00
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
. .....+...+..+.+++.+||+.||++|||+.++.+
T Consensus 226 ~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~ 262 (288)
T cd05583 226 K--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADE 262 (288)
T ss_pred c--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHH
Confidence 0 011233345567899999999999999999776644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=245.28 Aligned_cols=226 Identities=21% Similarity=0.191 Sum_probs=172.3
Q ss_pred cCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHH---HHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 29 LNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLT---SIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
++|.|+| |.||++.. .++|..... .....+..|. ..++...||||+++++.+.+.+..++||||
T Consensus 1 ~ig~g~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGF--GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCC--eEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 4799999 99997621 112211111 1112234443 344456799999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec------
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------ 168 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------ 168 (274)
+++|+|.+++.. ...+++..++.++.|++.|+.|||+. +++|+|++|+||+++.++.++|+|||.+...
T Consensus 79 ~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 153 (278)
T cd05606 79 MNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (278)
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc
Confidence 999999999875 45799999999999999999999999 9999999999999999999999999987643
Q ss_pred ---CCCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 169 ---SDKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 169 ---~~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
++..|+|||.+..+ .++.++|+||+|+++|+|++|..||.......... .. .... ......+..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~----~~~~-------~~~~~~~~~ 221 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-ID----RMTL-------TMAVELPDS 221 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HH----HHhh-------ccCCCCCCc
Confidence 35679999998754 57899999999999999999999996442211110 00 0000 001123444
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----ChhhHHhh
Q 048314 245 NLENLVKVGLWCVQDEPALRP-----SMKCVVMM 273 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rp-----s~~evl~~ 273 (274)
.+..+.+++.+||..||.+|| ++.++++.
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 567899999999999999999 99998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=253.87 Aligned_cols=245 Identities=17% Similarity=0.183 Sum_probs=179.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeC-----
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG----- 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 85 (274)
.+.|.....+|.|++ |.||++.. .++|... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~--~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAY--GIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCC--eEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 356788889999999 99998821 1122111 122344567899999999999999999988643
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
...++++||+. ++|.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 35799999996 689999875 45799999999999999999999999 9999999999999999999999999998
Q ss_pred eecC-----------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH-------HHH
Q 048314 166 KLLS-----------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV-------YKC 226 (274)
Q Consensus 166 ~~~~-----------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~ 226 (274)
.... +..|+|||.+.. ..++.++|+||||+++|+|++|..||................ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 6532 346999998765 457899999999999999999999996431110000000000 000
Q ss_pred HhhhhhhhhhcC-------C--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 227 FINRELNKLVRG-------T--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 227 ~~~~~~~~~~~~-------~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.........++. . ......+..+.+++.+||+.||++|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000011111100 0 1112346778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=251.53 Aligned_cols=244 Identities=18% Similarity=0.182 Sum_probs=178.7
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-------HHHHHh---cCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeC--Cc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-------ALMATV---NSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRG--SK 87 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-------~~~~~~---~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~ 87 (274)
.++|.....+|.|++ |.||+|.. ++++.. ........+.+|+.+++++ +||||+++++++... ..
T Consensus 6 ~~~y~~~~~lg~g~~--~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 6 LRKYEILQKLGKGAY--GIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhHHHHhHhhcCCCC--eeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 567888889999999 99998821 112111 1223345567899999999 999999999998653 36
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 899999997 599999875 2789999999999999999999999 999999999999999999999999998864
Q ss_pred cC----------------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH--------
Q 048314 168 LS----------------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW-------- 222 (274)
Q Consensus 168 ~~----------------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~-------- 222 (274)
.. +..|+|||.+.. ..++.++|+||||+++|+|++|+.||...............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 32 345999998754 45788999999999999999999999643111100000000
Q ss_pred ---HHHHHhhhhhhhhhcCC-----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 223 ---VYKCFINRELNKLVRGT-----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 223 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
+................ ......+..+.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000000 1111246788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=243.93 Aligned_cols=221 Identities=18% Similarity=0.165 Sum_probs=174.3
Q ss_pred CCCCCCCCcchhHHHH------HHHHHhcC-----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCC
Q 048314 30 NDRNSPRSKSVWSCMR------ALMATVNS-----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPW 98 (274)
Q Consensus 30 ~g~g~~~~g~vy~~~~------~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 98 (274)
+|.|++ |.||++.. .++|.... ....+.+.+|+.++++++||||+++++.+.+....++++||++++
T Consensus 1 lg~g~~--~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAY--GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCc--eEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 578889 89998822 11121111 123445778999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---------
Q 048314 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--------- 169 (274)
Q Consensus 99 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--------- 169 (274)
+|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 79 ~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 79 DLASLLEN--VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99999986 34789999999999999999999999 99999999999999999999999999875422
Q ss_pred ----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 ----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 ----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+..|++||.......+.++|+||||++++++++|..||.... ..... .....+ ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~-----~~~~~~-------~~ 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIF-----QNILNG-------KI 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHH-----HHHhcC-------Cc
Confidence 346999999988888899999999999999999999996431 11000 000000 00
Q ss_pred ccCHH--HHHHHHHHHHHhhccCCCCCCCh---hhHHh
Q 048314 240 EVDKK--NLENLVKVGLWCVQDEPALRPSM---KCVVM 272 (274)
Q Consensus 240 ~~~~~--~~~~~~~li~~cl~~dp~~Rps~---~evl~ 272 (274)
..+.. .+..+.+++.+||+.+|++|||+ .++++
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 12222 26788999999999999999999 66553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=249.85 Aligned_cols=244 Identities=16% Similarity=0.118 Sum_probs=177.2
Q ss_pred ccccccCCCCCCCCcchhHHHHH--------HHHHhcC-----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeC--Ccc
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMRA--------LMATVNS-----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--SKP 88 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~~--------~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 88 (274)
|...+.+|.|++ |.||+|... ++|.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 y~~~~~ig~g~~--g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 2 YEIEGCIGRGTY--GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred ceEEEEeccCCc--EEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 556678999999 999998321 1222221 12235567899999999999999999999887 789
Q ss_pred eEEEEeCCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC----CCcEEEec
Q 048314 89 STEAALDLPWDLAYIIFCSA---ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE----FWTAKISD 161 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~----~~~~kl~d 161 (274)
++||||+.+ +|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++. ++.+|++|
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 999999874 7777765321 23689999999999999999999999 9999999999999999 89999999
Q ss_pred cccceecC--------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCCh------hhHHHH
Q 048314 162 FGLAKLLS--------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKP------EEIILT 220 (274)
Q Consensus 162 ~g~~~~~~--------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~------~~~~~~ 220 (274)
||++.... +..|+|||.+.+. .++.++|+||||+++++|++|..||....... ....+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 99876532 3459999987654 57889999999999999999999997542221 001111
Q ss_pred HHHHHHH----------hh-hhhhh---hhcCCccC-----------HHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 221 NWVYKCF----------IN-RELNK---LVRGTEVD-----------KKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 221 ~~~~~~~----------~~-~~~~~---~~~~~~~~-----------~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
....... .. ..... .......+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1100000 00 00000 00000011 0234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=268.20 Aligned_cols=223 Identities=18% Similarity=0.190 Sum_probs=187.0
Q ss_pred cccCCCCCCCCcchhHH----------HHHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 27 SSLNDRNSPRSKSVWSC----------MRALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~----------~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
..++|.|.| |.||+| ..+.+|.+.+. +...++++|+-+|.++.|||++||+|+|..+. +.||++
T Consensus 701 ~kvLGsgAf--GtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 701 DKVLGSGAF--GTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hceeccccc--eeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 566999999 999999 11222333322 44567889999999999999999999998766 889999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|++.|+|.||++. ....+.-+..+.|+.||++|+.|||.+ +++||||-.+|+|+..-..+|+.|||+++...
T Consensus 778 ~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999998 556789999999999999999999999 99999999999999999999999999998765
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
-..|||-|.+....|+.++|||||||++||++| |..|++.... ..+.++++..
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI~dlle~g 916 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEIPDLLEKG 916 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHhhHHHhcc
Confidence 235888899999999999999999999999886 8899875411 1222222211
Q ss_pred ---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 240 ---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 240 ---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..|.-++.++.-++.+||..|+..||+++++.+.
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~ 953 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEE 953 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHH
Confidence 4788889999999999999999999999998754
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=240.58 Aligned_cols=231 Identities=17% Similarity=0.115 Sum_probs=181.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcC-------CCCCCcHHHHHHHHhcCCCCccceEeEEEEeC--C
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS-------PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--S 86 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 86 (274)
.+|...+.+|.|++ |.||++.. .++|.... ......+.+|+.++++++|+||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~--g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 79 (264)
T cd06653 2 VNWRLGKLLGRGAF--GEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEK 79 (264)
T ss_pred CceeeeeeEccCCC--eEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCC
Confidence 36778899999999 99999821 11111111 01123567899999999999999999998764 4
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++++||+++++|.+++.. ...+++...+.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||+++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 57899999999999999975 34589999999999999999999999 99999999999999999999999999886
Q ss_pred ec--------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 167 LL--------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 167 ~~--------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
.. ++..|+|||.+....++.++|+||||++++++++|+.||.... ..... .+. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~--------~~~-~ 222 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE---AMAAI--------FKI-A 222 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC---HHHHH--------HHH-H
Confidence 42 2456999999988888899999999999999999999996331 10000 000 0
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.. -.....+...+..+.+++.+||+ +|..|||+.++++.
T Consensus 223 ~~-~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 223 TQ-PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cC-CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 00 01113556677889999999999 57999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=254.82 Aligned_cols=240 Identities=18% Similarity=0.183 Sum_probs=177.7
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeC-----C
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG-----S 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 86 (274)
+++|...+.+|.|++ |.||+|. ..++|... ......++.+|+.++++++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~--g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAY--GMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCC--eEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 467888999999999 9999982 11222221 112334567899999999999999999987643 3
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++++||+. ++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++++|||++.
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 5799999997 488888753 5699999999999999999999999 99999999999999999999999999886
Q ss_pred ecC--------------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh--
Q 048314 167 LLS--------------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN-- 229 (274)
Q Consensus 167 ~~~--------------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 229 (274)
... +..|+|||.+.. ..++.++|+||+|+++|+|++|+.||...... .....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~----~~~~~~~~~~~~~~ 230 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL----HQLNLILGVLGTPS 230 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCC
Confidence 432 456999998654 46789999999999999999999999643111 111111110000
Q ss_pred -hhhhh--------hhc----CCccC-----HHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 230 -RELNK--------LVR----GTEVD-----KKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 230 -~~~~~--------~~~----~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..... ... ....+ ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 000 00011 1235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=242.84 Aligned_cols=241 Identities=20% Similarity=0.156 Sum_probs=178.3
Q ss_pred cccccCCCCCCCCcchhHHHHH------HHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 25 CRSSLNDRNSPRSKSVWSCMRA------LMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 25 ~~~~~~g~g~~~~g~vy~~~~~------~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
.....+|.|++ |.||+|... ++|... .....+.+..|+.++++++|+||+++++++.+.+..++|+||
T Consensus 2 ~~~~~ig~g~~--~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 2 EKLEKLGEGTY--GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred eeehcccccCc--ceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 34567999999 999988221 112111 112334567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
++ ++|.+++... ...+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++|+|||.+....
T Consensus 80 ~~-~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 80 CD-MDLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred cC-cCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 97 5999999863 25699999999999999999999999 99999999999999999999999999886532
Q ss_pred ------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH-------HHHHHhh-----h
Q 048314 170 ------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW-------VYKCFIN-----R 230 (274)
Q Consensus 170 ------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~-----~ 230 (274)
+..|+|||.+... .++.++|+||||++++++++|..||............... .+....+ .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 3458999988766 7889999999999999999999998643211100000000 0000000 0
Q ss_pred hhhhhhcCC--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 231 ELNKLVRGT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 231 ~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
......... .........+.+++..||..||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000 001112567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=257.43 Aligned_cols=234 Identities=14% Similarity=0.133 Sum_probs=191.5
Q ss_pred hHHHHhhhccccccCCCCCCCCcchhHH------HHHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 16 SLCTKLRNFCRSSLNDRNSPRSKSVWSC------MRALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 16 ~l~~~~~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
......+.|.....||+|.| +.|-.+ ..+++|.+... .....+.+|+++|..++||||||++++....
T Consensus 50 ~~~~~vg~y~i~~tig~g~f--~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~ 127 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNF--AKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE 127 (596)
T ss_pred cccccccceeeeeeecccee--EEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec
Confidence 44555677888999999999 988887 22222322222 2234467999999999999999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
..+++||||+.+|.+.+++.. .+.+.......++.|+++|++|||++ .|+|||||.+|++++.+.++||+|||++
T Consensus 128 ~~lylV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred ceeEEEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccc
Confidence 999999999999999999986 45667799999999999999999999 9999999999999999999999999999
Q ss_pred eecC----------CCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 166 KLLS----------DKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 166 ~~~~----------~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
.+.. ++.|.|||+..+..| ++++|+||+|+++|.|++|..||+...... -..+
T Consensus 203 ~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~----------------Lr~r 266 (596)
T KOG0586|consen 203 TFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE----------------LRPR 266 (596)
T ss_pred eeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc----------------ccch
Confidence 7654 677999999988776 589999999999999999999998542211 1111
Q ss_pred hhcCC-ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 235 LVRGT-EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 235 ~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+... .+|.-.+.++.++++++|..+|.+|++++++.+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 12222 456666778899999999999999999999854
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=245.89 Aligned_cols=229 Identities=18% Similarity=0.163 Sum_probs=176.4
Q ss_pred ccccccCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
|.....+|.|++ |.||+|.. .+++..... .....+.+|+.++++++|||++++++++.+....++||
T Consensus 23 ~~~~~~lg~g~~--g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSF--GAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred hhcceeeccCCC--eEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 444566999999 99999821 112222111 11234678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+. |++.+++.. ....+++..+..++.|++.|+.|||+. +++|+|++|+||+++.++.++|+|||.+....
T Consensus 101 e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~ 175 (313)
T cd06633 101 EYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN 175 (313)
T ss_pred ecCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCCC
Confidence 9996 588888865 345699999999999999999999999 99999999999999999999999999876432
Q ss_pred ----CCCcCCCcccc---cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 ----DKGCMAPECYK---RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 ----~~~~~ape~~~---~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|+|||.+. ...++.++|+||||+++|+|++|..||....... ... .. .... .+....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~----~~~---~~-~~~~-----~~~~~~ 242 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALY---HI-AQND-----SPTLQS 242 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHH---HH-HhcC-----CCCCCc
Confidence 45699999874 3557889999999999999999999986431110 000 00 0000 011122
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+..+.+++.+||+.+|++|||+.+++.
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 234457899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=247.64 Aligned_cols=244 Identities=18% Similarity=0.144 Sum_probs=176.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC----
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS---- 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 86 (274)
.++|...+.+|.|++ |.||++.. .++|..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~--~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTF--GEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCC--EEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 578888999999999 99999821 112222111 12345678999999999999999999875433
Q ss_pred ----cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 87 ----KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 87 ----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
..++|+||+.+ +|.+.+.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999874 78777765 345799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecC----------------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHH
Q 048314 163 GLAKLLS----------------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219 (274)
Q Consensus 163 g~~~~~~----------------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~ 219 (274)
|++.... ++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9886432 3449999987654 5788999999999999999999999643211110000
Q ss_pred HHHHHHHHhhh------hhhh----hhcCC-c-----cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 220 TNWVYKCFINR------ELNK----LVRGT-E-----VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 220 ~~~~~~~~~~~------~~~~----~~~~~-~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
... ....... .... ..... . ........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKL-CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHH-hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000 0000000 0000 00000 0 00122357889999999999999999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=250.99 Aligned_cols=243 Identities=15% Similarity=0.149 Sum_probs=181.0
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC-----c
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS-----K 87 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 87 (274)
+|.....+|.|++ |.||+|.. .++|.... ....+.+.+|+.++++++|+||+++++++.+.. .
T Consensus 1 ~y~i~~~ig~g~~--~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAY--GVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCC--eEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 3566788999999 99998821 11221111 234456889999999999999999999987765 7
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.+++|||++ ++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||.+..
T Consensus 79 ~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 79 VYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred eEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 899999997 589999875 34799999999999999999999999 999999999999999999999999999875
Q ss_pred cC--------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH-------H
Q 048314 168 LS--------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY-------K 225 (274)
Q Consensus 168 ~~--------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-------~ 225 (274)
.. +..|+|||.+... .++.++|+||||+++++|++|..||...........+..... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 43 3348999999877 788999999999999999999999964421110000000000 0
Q ss_pred HHhhhhhhhhhc---CC------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 226 CFINRELNKLVR---GT------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 226 ~~~~~~~~~~~~---~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..........+. .. ......+..+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000001110 00 0112245778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=242.32 Aligned_cols=231 Identities=14% Similarity=0.097 Sum_probs=178.2
Q ss_pred ccccccCCCCCCCCcchhHHHH---------HHHHHhc------CCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCc
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR---------ALMATVN------SPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 87 (274)
|...+.+|.|+| |.||.+.. .++|... .....+.+.+|+.+++++ +|+||+++++++..+..
T Consensus 2 y~~~~~lg~G~~--g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 2 FELLKVLGTGAY--GKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred ceeeeeeccCCc--ceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 556778999999 99997522 1112111 112335567899999999 48999999999998889
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 80 LHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999999975 45689999999999999999999999 999999999999999999999999998764
Q ss_pred cC------------CCCcCCCcccccC--CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 168 LS------------DKGCMAPECYKRT--PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 168 ~~------------~~~~~ape~~~~~--~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
.. +..|++||.+... .++.++|+||||+++|+|++|..||.............. .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~------~ 225 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---RI------L 225 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH---Hh------h
Confidence 32 4569999988753 467899999999999999999999964322111111111 00 0
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
. ...+.+......+.+++.+||+.||++|| ++.++++
T Consensus 226 ~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 226 K--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred c--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 01123445567889999999999999997 6677664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=235.72 Aligned_cols=234 Identities=18% Similarity=0.145 Sum_probs=181.6
Q ss_pred cccCCCCCCCCcchhHH------HHHHHHHhcC--CCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceEEEEeCCC
Q 048314 27 SSLNDRNSPRSKSVWSC------MRALMATVNS--PYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPSTEAALDLP 97 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~------~~~~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 97 (274)
+.++|+|.+ +.|-.+ .--++|++.+ ...+++..+|++++.+.+ |+||++|+.||.++..+|||||-|.|
T Consensus 83 ~e~LGeGAy--asVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAY--ASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccc--eeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 467899999 888766 2222333333 266788899999999998 99999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC---cEEEeccccceecC-----
Q 048314 98 WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKISDFGLAKLLS----- 169 (274)
Q Consensus 98 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~---~~kl~d~g~~~~~~----- 169 (274)
|+|..+++. ...+++.+..++..+|+.||.+||.+ ||.|||+||+|||..... -+||+||.+...+.
T Consensus 161 GplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 161 GPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred chHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999999986 56799999999999999999999999 999999999999986443 46999998865432
Q ss_pred -------------CCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHH----HHHHHHHHH
Q 048314 170 -------------DKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEII----LTNWVYKCF 227 (274)
Q Consensus 170 -------------~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~ 227 (274)
+..|||||++- ...|+.++|.||+|+++|-|++|.+||...-......+ -..+...
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~-- 313 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK-- 313 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH--
Confidence 23599999763 23588999999999999999999999986543332211 1111111
Q ss_pred hhhhhhhhhcCC-ccCH----HHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 INRELNKLVRGT-EVDK----KNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 ~~~~~~~~~~~~-~~~~----~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
-...+-++. ++|. ..+.+.++++...|..|+.+|-++.++++
T Consensus 314 ---LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 314 ---LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ---HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111222222 3433 44678899999999999999999998875
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=245.64 Aligned_cols=227 Identities=16% Similarity=0.142 Sum_probs=183.1
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHH-----hcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMAT-----VNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~-----~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 90 (274)
+|.....+|.|++ |.||++.. .+++. .......+.+.+|+.++++++ ||||+++++++.+.+..++
T Consensus 2 ~y~~~~~lg~g~~--~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 2 DFKFGKIIGEGSF--STVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CceEeeeecCCCc--eEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 5667788999999 99998821 11111 111122345678999999999 9999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
||||+.+++|.+++.. .+.+++..+..++.|++.||.+||+. +++|+|++|+||+++.++.++++|||++....
T Consensus 80 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 80 VLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999999986 34799999999999999999999999 99999999999999999999999999876432
Q ss_pred ------------------------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHH
Q 048314 170 ------------------------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219 (274)
Q Consensus 170 ------------------------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~ 219 (274)
+..|++||.......+.++|+||||++++++++|..||.... ....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHHH
Confidence 356899999888888999999999999999999999997442 11110
Q ss_pred HHHHHHHHhhhhhhhhhcC-CccCHHHHHHHHHHHHHhhccCCCCCCCh----hhHHh
Q 048314 220 TNWVYKCFINRELNKLVRG-TEVDKKNLENLVKVGLWCVQDEPALRPSM----KCVVM 272 (274)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~----~evl~ 272 (274)
. ..... ...+...+..+.+++.+||+.||++|||+ .++++
T Consensus 232 ~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 Q-------------KILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H-------------HHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 00011 12344556789999999999999999999 88875
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=246.50 Aligned_cols=236 Identities=18% Similarity=0.189 Sum_probs=178.0
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcce
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 89 (274)
..++|...+.+|.|.+ |.||++.. .++|..... .....+..|+.++.+.. ||||+++++++.+....+
T Consensus 13 ~~~~~~~~~~lg~g~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTC--GQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred CcchheeeeEeeccCC--eEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3467777889999999 99999822 122222211 12234567777777775 999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++|||+. ++|.+++.. ....+++..+..++.|++.|+.|||+ . +++|+||+|+||+++.++.++|+|||.+...
T Consensus 91 ~v~e~~~-~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 91 ICMELMS-TCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEeeccC-cCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9999985 578888765 34579999999999999999999997 5 8999999999999999999999999988643
Q ss_pred C----------CCCcCCCcccccCC----CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 S----------DKGCMAPECYKRTP----ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ~----------~~~~~ape~~~~~~----~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
. +..|+|||.+.... ++.++|+||||+++|+|++|+.||...... ...+. ... ......
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~----~~~-~~~~~~ 238 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLT----KIL-QEEPPS 238 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHH----HHh-cCCCCC
Confidence 2 35799999987543 788999999999999999999999642111 00010 000 000000
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
. +.....+.++.+++.+||+.||++|||+.++++.
T Consensus 239 ~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 L----PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 1112345779999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=248.48 Aligned_cols=251 Identities=16% Similarity=0.163 Sum_probs=181.9
Q ss_pred hhhhHHHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEE
Q 048314 13 ARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVA 82 (274)
Q Consensus 13 ~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~ 82 (274)
...++-..+++|...+.+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~--g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAY--GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCC--eEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 34456667889999999999999 99998821 112222111 1234567899999999999999999988
Q ss_pred EeC------CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc
Q 048314 83 MRG------SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 156 (274)
Q Consensus 83 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~ 156 (274)
... ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 643 3467888876 7899988864 4689999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecC--------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH-----
Q 048314 157 AKISDFGLAKLLS--------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW----- 222 (274)
Q Consensus 157 ~kl~d~g~~~~~~--------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~----- 222 (274)
++|+|||++.... +..|+|||.+.. ..++.++|+||||+++|+|++|+.||...............
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 159 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred EEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999999986532 457999998765 46788999999999999999999999543111100000000
Q ss_pred --HHHHHhhhhhhhhh---cC--C----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 223 --VYKCFINRELNKLV---RG--T----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 223 --~~~~~~~~~~~~~~---~~--~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.............+ .. . ......+..+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00000000000000 00 0 001123567899999999999999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=249.21 Aligned_cols=244 Identities=15% Similarity=0.137 Sum_probs=179.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC---
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS--- 86 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 86 (274)
..++|.....+|.|++ |.||++. ..++|..... ...+.+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 13 VPDRYRDLKQVGSGAY--GTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred cccceEEEEEeeecCC--eEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3567888899999999 9999982 1122222111 11234678999999999999999999987544
Q ss_pred ---cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccc
Q 048314 87 ---KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG 163 (274)
Q Consensus 87 ---~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g 163 (274)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 6799988864 4689999999999999999999999 99999999999999999999999999
Q ss_pred cceecC--------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH-------HHHHH
Q 048314 164 LAKLLS--------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW-------VYKCF 227 (274)
Q Consensus 164 ~~~~~~--------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~-------~~~~~ 227 (274)
.+.... +..|++||.+.. ..++.++|+||+|++++++++|..||............... .....
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 164 LARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 986533 567899998875 35788999999999999999999999643211110000000 00000
Q ss_pred hhhhhhhhhcC------C---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 INRELNKLVRG------T---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 ~~~~~~~~~~~------~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
........... . ......+..+.+++.+|++.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 0 111234557899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=250.41 Aligned_cols=243 Identities=16% Similarity=0.123 Sum_probs=174.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeC-------
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG------- 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 85 (274)
.++|.....+|.|++ |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~--g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSN--GLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCC--EEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 367888899999999 99998821 112222211 2345577899999999999999999876543
Q ss_pred -------CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc-CCCcE
Q 048314 86 -------SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWTA 157 (274)
Q Consensus 86 -------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-~~~~~ 157 (274)
...++||||++ ++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++ .++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35789999997 589988864 4689999999999999999999999 999999999999997 45678
Q ss_pred EEeccccceec--------------CCCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH
Q 048314 158 KISDFGLAKLL--------------SDKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW 222 (274)
Q Consensus 158 kl~d~g~~~~~--------------~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~ 222 (274)
+++|||.+... .+..|+|||.+.. ..++.++|+|||||++|+|++|+.||..............-
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998643 1346999997754 45788999999999999999999999643111100000000
Q ss_pred -------HHHHHhhhhhhhh---hcCCc-----cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 223 -------VYKCFINRELNKL---VRGTE-----VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 223 -------~~~~~~~~~~~~~---~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
......+...... ..... .....+.++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000 00000 11123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=235.04 Aligned_cols=221 Identities=19% Similarity=0.161 Sum_probs=176.5
Q ss_pred CCCCCCCCcchhHHHHH------HHHHhcC-----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCC
Q 048314 30 NDRNSPRSKSVWSCMRA------LMATVNS-----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPW 98 (274)
Q Consensus 30 ~g~g~~~~g~vy~~~~~------~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 98 (274)
+|.|++ |.||++... +++.... ....+.+.+|+.++++++||||+++++.+.+++..+++|||++++
T Consensus 1 lg~G~~--~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSF--GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCc--eEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 588999 899987211 1111111 123346789999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---------
Q 048314 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--------- 169 (274)
Q Consensus 99 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--------- 169 (274)
+|.+++.. ...+++.....++.|++.|+.|||+. +++|+||+|.||+++.++.++++|||.+....
T Consensus 79 ~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 79 ELFSHLSK--EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 99999986 34689999999999999999999998 99999999999999999999999999876432
Q ss_pred --CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHH
Q 048314 170 --DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLE 247 (274)
Q Consensus 170 --~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (274)
+..|++||.......+.++|+||||+++|++++|..||..... . .... . ... .....+...+.
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~-~~~~---~-~~~-------~~~~~~~~~~~ 218 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---K-EIYE---K-ILK-------DPLRFPEFLSP 218 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---H-HHHH---H-Hhc-------CCCCCCCCCCH
Confidence 4569999999887888999999999999999999999964311 1 0000 0 000 11124444567
Q ss_pred HHHHHHHHhhccCCCCCCCh---hhHHh
Q 048314 248 NLVKVGLWCVQDEPALRPSM---KCVVM 272 (274)
Q Consensus 248 ~~~~li~~cl~~dp~~Rps~---~evl~ 272 (274)
.+.+++.+||..||++|||+ .++++
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 88999999999999999999 67664
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=250.10 Aligned_cols=223 Identities=17% Similarity=0.172 Sum_probs=175.3
Q ss_pred ccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEEeCC
Q 048314 24 FCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
|....-+|.|.| +.+-.+. .-.+|++.. ...+..+|+.++... +||||+++.+.+.+..+.++|||++.
T Consensus 324 y~~~~~~~~gs~--s~~~~~~~~~t~~~~~vkii~~--~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 324 YEFREELGEGSF--SAVKYCESSPTDQEPAVKIISK--RADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hccccccCCCCc--cceeeeeccccccchhheeccc--cccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 333444888888 6666551 111222322 134455777666665 49999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE-cCCCcEEEeccccceecC------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM-DEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~-~~~~~~kl~d~g~~~~~~------ 169 (274)
++-+.+.+.. ...+. ..+..|+.+|+.|+.|||++ |++||||||+|||+ ++.++++|+|||.++...
T Consensus 400 g~ell~ri~~--~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp 473 (612)
T KOG0603|consen 400 GGELLRRIRS--KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTP 473 (612)
T ss_pred ccHHHHHHHh--cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchhhccc
Confidence 9888777764 22233 77888999999999999999 99999999999999 689999999999987654
Q ss_pred --CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHH
Q 048314 170 --DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLE 247 (274)
Q Consensus 170 --~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (274)
+..|.|||++....|+..+|+||||++||+|++|..||...... . .+...+....++...+.
T Consensus 474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~-------------ei~~~i~~~~~s~~vS~ 537 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---I-------------EIHTRIQMPKFSECVSD 537 (612)
T ss_pred chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---H-------------HHHHhhcCCccccccCH
Confidence 45689999999889999999999999999999999999866332 1 12222222234467788
Q ss_pred HHHHHHHHhhccCCCCCCChhhHHh
Q 048314 248 NLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 248 ~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..++|+.+||+.||.+||+|.++..
T Consensus 538 ~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 538 EAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHHHHHhccCChhhCcChhhhcc
Confidence 9999999999999999999999864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=264.00 Aligned_cols=237 Identities=14% Similarity=0.050 Sum_probs=189.9
Q ss_pred hhhhHHHHhhhccccccCCCCCCCCcchhHH------HHHHHHHhc-----CCCCCCcHHHHHHHHhcCCCCccceEeEE
Q 048314 13 ARSSLCTKLRNFCRSSLNDRNSPRSKSVWSC------MRALMATVN-----SPYSPSRPLTLTSIVSRVSWTTDIEVSSV 81 (274)
Q Consensus 13 ~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 81 (274)
..+++.....||....+||+|.| |.|..+ .+-++|.++ ...+..-|+.|..+|.--+.++|+++.-.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaF--GEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAF--GEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhccccc--ceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 34567778899999999999999 888776 222223222 23466778999999999999999999999
Q ss_pred EEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEec
Q 048314 82 AMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISD 161 (274)
Q Consensus 82 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 161 (274)
|.+..++|+|||||+||+|-..|.. ...+|+...+.++..|+.||.-+|+. |+|||||||+|||++..|++||+|
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk--~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSK--FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhh--cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999999986 34899999999999999999999999 999999999999999999999999
Q ss_pred ccccee------------cCCCCcCCCccccc-----CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH
Q 048314 162 FGLAKL------------LSDKGCMAPECYKR-----TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224 (274)
Q Consensus 162 ~g~~~~------------~~~~~~~ape~~~~-----~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 224 (274)
||.+-. .+||.|.+||+++. +.|+..+|.||+||++|||+.|..||..+..-.+..
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~------- 291 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG------- 291 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH-------
Confidence 998743 34899999999862 568999999999999999999999997542111111
Q ss_pred HHHhhhhhhhhhcCCccC--HHHHHHHHHHHHHhhccCCCCCCC---hhhH
Q 048314 225 KCFINRELNKLVRGTEVD--KKNLENLVKVGLWCVQDEPALRPS---MKCV 270 (274)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dp~~Rps---~~ev 270 (274)
..+... +.+ .+| ...+++..+||...+. +|+.|-. +.++
T Consensus 292 KIm~hk---~~l---~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedi 335 (1317)
T KOG0612|consen 292 KIMNHK---ESL---SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDI 335 (1317)
T ss_pred HHhchh---hhc---CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHH
Confidence 111110 001 133 4578899999999774 5888876 6554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=235.20 Aligned_cols=237 Identities=19% Similarity=0.179 Sum_probs=194.5
Q ss_pred hhhHHHHhhhccccccCCCCCCCCcchhHH-----------HHHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEe
Q 048314 14 RSSLCTKLRNFCRSSLNDRNSPRSKSVWSC-----------MRALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVS 79 (274)
Q Consensus 14 ~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~-----------~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~ 79 (274)
..+|.....+|.-+.++-+|.| |.||.| ..+.+|.++.. .....++.|.-.+..+.|||+..+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtF--Gri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTF--GRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred HHhhhhhhhheechhhhhcCch--hheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 4556666777888999999999 999999 22334433332 3456678999999999999999999
Q ss_pred EEEEe-CCcceEEEEeCCCCCHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc
Q 048314 80 SVAMR-GSKPSTEAALDLPWDLAYIIFCS------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD 152 (274)
Q Consensus 80 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~ 152 (274)
+++.+ ...+++++.++.-|+|..|+... ..+.++..+.+.++.|++.|++|||++ +++|.||..+|++++
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 99965 56789999999999999999832 224478888999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHH
Q 048314 153 EFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEII 218 (274)
Q Consensus 153 ~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~ 218 (274)
+...+||+|-.+++-.. ...||+||.+....|+..+|+||||+++|||++ |+.|+...+
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID------- 503 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID------- 503 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-------
Confidence 99999999998887543 236999999999999999999999999999876 888885331
Q ss_pred HHHHHHHHHhhhhhhhhhc-CC--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 219 LTNWVYKCFINRELNKLVR-GT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..++..++. +. .+|..|++++..+|..||..+|++|||++|+..
T Consensus 504 ----------PfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 504 ----------PFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ----------HHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 111222222 22 578899999999999999999999999999865
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=242.71 Aligned_cols=241 Identities=16% Similarity=0.117 Sum_probs=172.8
Q ss_pred ccccccCCCCCCCCcchhHHHHH--------HHHHhcCC----CCCCcHHHHHHHHhcCC-CCccceEeEEEEeC----C
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMRA--------LMATVNSP----YSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRG----S 86 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~~--------~~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~----~ 86 (274)
|.....+|.|+| |.||++... ++|..... ...+.+.+|+.++++++ ||||+++++.+... .
T Consensus 2 y~~~~~lg~G~~--g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 2 YELIKELGQGAY--GIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred ceEEEEccccCC--eEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 556778999999 999988321 12211111 12345678999999995 99999999976432 4
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++++||+. ++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 5688889876 689999874 45799999999999999999999999 99999999999999999999999999886
Q ss_pred ec---------------CCCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH-------
Q 048314 167 LL---------------SDKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV------- 223 (274)
Q Consensus 167 ~~---------------~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~------- 223 (274)
.. ++..|+|||.+.. ..++.++|+||+|+++|++++|..||................
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 42 2456999998765 467899999999999999999999986432110000000000
Q ss_pred HHHHhhhhhhhhhc---CC------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 224 YKCFINRELNKLVR---GT------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 224 ~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.............. .. .........+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 00 011123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=230.84 Aligned_cols=253 Identities=17% Similarity=0.128 Sum_probs=183.9
Q ss_pred hhHHHHhhhccccccCCCCCCCCcchhHH-----------HHHHHHHhcCCC--C-CCcHHHHHHHHhcCCCCccceEeE
Q 048314 15 SSLCTKLRNFCRSSLNDRNSPRSKSVWSC-----------MRALMATVNSPY--S-PSRPLTLTSIVSRVSWTTDIEVSS 80 (274)
Q Consensus 15 ~~l~~~~~~f~~~~~~g~g~~~~g~vy~~-----------~~~~~~~~~~~~--~-~~~~~~e~~~l~~l~h~niv~l~~ 80 (274)
++-......|.....||+|.+ |.||++ ..++|+....+. . .....+|+..++.++|||++.+..
T Consensus 17 r~rve~l~~ye~ig~Ig~GTY--G~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~ 94 (438)
T KOG0666|consen 17 RERVEDLFEYEGIGKIGRGTY--GKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVK 94 (438)
T ss_pred hhhHHHHHHhhccceeccccc--ceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHH
Confidence 333344566777899999999 999999 334444444331 1 233579999999999999999999
Q ss_pred EEEe-CCcceEEEEeCCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC--
Q 048314 81 VAMR-GSKPSTEAALDLPWDLAYIIFCSA---ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-- 154 (274)
Q Consensus 81 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-- 154 (274)
++.+ +...+|++||+.+ +|...++-+. ...++-..++.++-||+.|+.|||++ =++||||||.||++..+
T Consensus 95 Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgp 170 (438)
T KOG0666|consen 95 VFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGP 170 (438)
T ss_pred HHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCC
Confidence 9877 7789999999875 8888887542 24589999999999999999999999 79999999999999877
Q ss_pred --CcEEEeccccceecC--------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCCh---
Q 048314 155 --WTAKISDFGLAKLLS--------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKP--- 214 (274)
Q Consensus 155 --~~~kl~d~g~~~~~~--------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~--- 214 (274)
|.+||+|+|+++... |.-|+|||.+.+. .|++..|+|+.||+..||++-.+.|.......
T Consensus 171 erG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~ 250 (438)
T KOG0666|consen 171 ERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTK 250 (438)
T ss_pred ccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccC
Confidence 899999999998654 3459999999886 58999999999999999999888775431111
Q ss_pred --hhHHHHHHHHHHHhhh---------hhh-----------hhhcCC------ccCHHHHHHHHHHHHHhhccCCCCCCC
Q 048314 215 --EEIILTNWVYKCFINR---------ELN-----------KLVRGT------EVDKKNLENLVKVGLWCVQDEPALRPS 266 (274)
Q Consensus 215 --~~~~~~~~~~~~~~~~---------~~~-----------~~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps 266 (274)
.......-+...+... .++ +..++- ......++...+|+..+|+.||.+|.|
T Consensus 251 ~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt 330 (438)
T KOG0666|consen 251 NPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT 330 (438)
T ss_pred CCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc
Confidence 0111111111110000 000 000000 000011234789999999999999999
Q ss_pred hhhHHhh
Q 048314 267 MKCVVMM 273 (274)
Q Consensus 267 ~~evl~~ 273 (274)
+.+.++.
T Consensus 331 a~qAleh 337 (438)
T KOG0666|consen 331 AEQALEH 337 (438)
T ss_pred HHHHhcc
Confidence 9998863
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=237.41 Aligned_cols=225 Identities=16% Similarity=0.191 Sum_probs=186.8
Q ss_pred HHhhhccccccCCCCCCCCcchhHH----------HHHHHHH-hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSC----------MRALMAT-VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~----------~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
...++|.-.+++|+|.| |+|..| ++..+|. +..+.....-+.|-++|...+||.+..+--.+...++
T Consensus 165 vTm~dFdfLKvLGkGTF--GKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTF--GKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred eccchhhHHHHhcCCcc--ceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 35578888999999999 999877 3333332 3344556667789999999999999888777888999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
+|+||||+.||.|.-+|.+ ++.+++...+.+...|+.||.|||++ +|++||+|.+|.+++.+|++||+|||+++.
T Consensus 243 lCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchh
Confidence 9999999999999988875 67899999999999999999999999 999999999999999999999999999964
Q ss_pred -----------cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 168 -----------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 168 -----------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
.+++.|+|||++....|+..+|.|.+|+++|||++|+.||...+.. .+...+. ..
T Consensus 318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~----kLFeLIl-------~e--- 383 (516)
T KOG0690|consen 318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE----KLFELIL-------ME--- 383 (516)
T ss_pred cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh----HHHHHHH-------hh---
Confidence 3478999999999999999999999999999999999999754221 1111111 11
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCC
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRP 265 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 265 (274)
...+|...+++.+.|+...|.+||.+|-
T Consensus 384 -d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 -DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1135566677888999999999999995
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=250.45 Aligned_cols=244 Identities=17% Similarity=0.171 Sum_probs=179.0
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc--
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK-- 87 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 87 (274)
..++|.....+|.|++ |.||+|.. .++|.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~--g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAY--GQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCc--eEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4567888899999999 99998821 11222221 1223456689999999999999999998765544
Q ss_pred ----ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccc
Q 048314 88 ----PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG 163 (274)
Q Consensus 88 ----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g 163 (274)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5699999874 4699999999999999999999999 99999999999999999999999999
Q ss_pred cceecC--------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH-------HHHH
Q 048314 164 LAKLLS--------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV-------YKCF 227 (274)
Q Consensus 164 ~~~~~~--------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~ 227 (274)
++.... +..|+|||.+.. ..++.++|+||||+++|++++|+.||...........+.... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 164 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 987543 456999998765 357889999999999999999999996431110000000000 0000
Q ss_pred hhhhhhhhhcC---C------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 INRELNKLVRG---T------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 ~~~~~~~~~~~---~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
........+.. . ......+..+.+++.+||+.||++|||+.+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000 0 011123578999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=264.96 Aligned_cols=238 Identities=21% Similarity=0.255 Sum_probs=181.5
Q ss_pred hHHHHhhhccccccCCCCCCCCcchhHH-------HHHHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEe--
Q 048314 16 SLCTKLRNFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR-- 84 (274)
Q Consensus 16 ~l~~~~~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-- 84 (274)
..+....+|..-.++|+|+| |.||++ ..|+||+.-.. .......+|+.+|++|+|||||+++..|.+
T Consensus 473 ~~SRY~~DFEEL~lLGkGGF--G~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 473 QFSRYLNDFEELELLGKGGF--GSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred chhhHhhhhHHHHHhcCCCC--ceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 34678899999999999999 999999 55666644432 334556799999999999999999764320
Q ss_pred ------------------C-------------------------------------------------------------
Q 048314 85 ------------------G------------------------------------------------------------- 85 (274)
Q Consensus 85 ------------------~------------------------------------------------------------- 85 (274)
.
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 0
Q ss_pred --------------------------------------CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHH
Q 048314 86 --------------------------------------SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKG 127 (274)
Q Consensus 86 --------------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~ 127 (274)
-.+||-||||..-++++++.++.... .-...++++++|+.|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEG 709 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHH
Confidence 01378899999988888888643221 467789999999999
Q ss_pred HHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----------------------------CCCcCCCcc
Q 048314 128 ILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-----------------------------DKGCMAPEC 178 (274)
Q Consensus 128 l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-----------------------------~~~~~ape~ 178 (274)
|.|+|+. |||||||||.||+++.+..+||+|||++.... |.-|+|||.
T Consensus 710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 9999999 99999999999999999999999999997621 345999999
Q ss_pred cccC---CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHH
Q 048314 179 YKRT---PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLW 255 (274)
Q Consensus 179 ~~~~---~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 255 (274)
+... .|+.|+|+||+|++++||+. ||.+. -+..... ..+.++.++.. ..+.....+.-..+|++
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---MERa~iL----~~LR~g~iP~~---~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS---MERASIL----TNLRKGSIPEP---ADFFDPEHPEEASLIRW 853 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCch---HHHHHHH----HhcccCCCCCC---cccccccchHHHHHHHH
Confidence 8764 49999999999999999974 56543 1111111 11122222221 12344556677899999
Q ss_pred hhccCCCCCCChhhHHh
Q 048314 256 CVQDEPALRPSMKCVVM 272 (274)
Q Consensus 256 cl~~dp~~Rps~~evl~ 272 (274)
|++.||.+||||.|+|+
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=233.47 Aligned_cols=184 Identities=16% Similarity=0.029 Sum_probs=152.2
Q ss_pred HHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 048314 60 PLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPI 139 (274)
Q Consensus 60 ~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i 139 (274)
+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++.. ...+++.....++.|++.||.|||+. ++
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i 106 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK--FLNIPEECVKRWAAEMVVALDALHRE---GI 106 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 34555556666799999999999999999999999999999999975 34699999999999999999999999 99
Q ss_pred ccCCCCCCceEEcCCCcEEEeccccceecC--------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccC
Q 048314 140 LHCDIKPQNILMDEFWTAKISDFGLAKLLS--------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDA 211 (274)
Q Consensus 140 ~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~ 211 (274)
+|+|+||+||+++.++.++++|||.+.... +..|+|||......++.++|+||+|+++|+|++|..|+....
T Consensus 107 ~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~ 186 (237)
T cd05576 107 VCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP 186 (237)
T ss_pred eccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCc
Confidence 999999999999999999999999764332 456999999988888999999999999999999998875321
Q ss_pred CChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCCh
Q 048314 212 SKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSM 267 (274)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 267 (274)
... ... .....+...+..+.+++.+||+.||++|||+
T Consensus 187 ~~~------------------~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 187 SGI------------------NTH-TTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred hhc------------------ccc-cccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 100 000 0001333456788999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-33 Score=241.32 Aligned_cols=241 Identities=21% Similarity=0.272 Sum_probs=177.2
Q ss_pred cccCCCCCCCCcchhHHHH----HHHHHhcCCCCCCcHHHHHHHHhc--CCCCccceEeEEEEeCC----cceEEEEeCC
Q 048314 27 SSLNDRNSPRSKSVWSCMR----ALMATVNSPYSPSRPLTLTSIVSR--VSWTTDIEVSSVAMRGS----KPSTEAALDL 96 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~----~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~~~ 96 (274)
..++|+|.| |.||||.. +++|++.- ++.+.|.+|-++.+- ++|+||+++++.-.... .++||+||-+
T Consensus 215 ~eli~~Grf--g~V~KaqL~~~~VAVKifp~-~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 215 LELIGRGRF--GCVWKAQLDNRLVAVKIFPE-QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHHhhcCcc--ceeehhhccCceeEEEecCH-HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 567999999 99999922 11222221 355678888888775 67999999999876544 7899999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC------EPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
+|||.+||.. ..++|....+++..++.||+|||+.. +++|.|||+|+.|||+.++.++-|+|||++....
T Consensus 292 kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 292 KGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred CCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 9999999986 46999999999999999999999765 5689999999999999999999999999997543
Q ss_pred ------------CCCcCCCcccccCC-C-----ccccceeehhHhHHHHhhcCCCccccCCChhhHHH---------HHH
Q 048314 170 ------------DKGCMAPECYKRTP-I-----SVKADVYGYGIVLLETICCWENMEIDASKPEEIIL---------TNW 222 (274)
Q Consensus 170 ------------~~~~~ape~~~~~~-~-----~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~---------~~~ 222 (274)
|.+|||||++.+.. + -.+.||||+|.++|||+++...+++...++....+ .+.
T Consensus 369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~ 448 (534)
T KOG3653|consen 369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEE 448 (534)
T ss_pred CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHH
Confidence 67899999987642 1 24799999999999999987666432222211111 111
Q ss_pred HHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 223 VYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
++........+..+...=........+.+.+..||..||+.|.|+.-|-++
T Consensus 449 mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR 499 (534)
T KOG3653|consen 449 MQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEER 499 (534)
T ss_pred HHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence 222111111111111000011335678999999999999999999887665
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=251.86 Aligned_cols=244 Identities=17% Similarity=0.149 Sum_probs=194.5
Q ss_pred hhhhhHHHHhhhccccccCCCCCCCCcchhHH------HHHHHHHhcCC-CCCCcHHHHHHHHhcCC-CCccceEeEEEE
Q 048314 12 IARSSLCTKLRNFCRSSLNDRNSPRSKSVWSC------MRALMATVNSP-YSPSRPLTLTSIVSRVS-WTTDIEVSSVAM 83 (274)
Q Consensus 12 ~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 83 (274)
..++-+...+..|.....+|.|.+ |.||++ ..+++|+..-. ...++...|.++|+.+. |||++.++|++.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gty--gkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTY--GKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccc--eeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 344555566777888899999999 888887 33444433332 34555668999999886 999999999985
Q ss_pred e-----CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEE
Q 048314 84 R-----GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158 (274)
Q Consensus 84 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~k 158 (274)
- +++++||||||.+||..|.+++..+..+.|..+.-+++.++.|+.+||.+ .++|||+|-.|||+..++.+|
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 3 67899999999999999999987777899999999999999999999999 999999999999999999999
Q ss_pred Eeccccceec-----------CCCCcCCCcccccC-----CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH
Q 048314 159 ISDFGLAKLL-----------SDKGCMAPECYKRT-----PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW 222 (274)
Q Consensus 159 l~d~g~~~~~-----------~~~~~~ape~~~~~-----~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~ 222 (274)
|.|||++... +++.|||||++... .|+..+|+||+|++..||..|.+|+..- .+...
T Consensus 164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm-HPmra------ 236 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM-HPMRA------ 236 (953)
T ss_pred EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc-chhhh------
Confidence 9999998643 37899999988643 4678999999999999999999998522 11000
Q ss_pred HHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 223 VYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
++. ...+.+.-+ ..|..++.++.++|..||.+|-++||++.++++
T Consensus 237 LF~--IpRNPPPkL---krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 LFL--IPRNPPPKL---KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hcc--CCCCCCccc---cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 000 011111000 247788999999999999999999999999875
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-33 Score=226.88 Aligned_cols=237 Identities=18% Similarity=0.187 Sum_probs=182.2
Q ss_pred HhhhccccccCCCCCCCCcchhHHHHH-------HHHH--hcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcce
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMRA-------LMAT--VNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~~-------~~~~--~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 89 (274)
..++..+...+|.|.- |.|+++... +|.. ..+++..++.+..+.++.+.+ .|.||+.+|+|..+...+
T Consensus 90 dindl~~l~dlGsGtc--G~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTC--GQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred ChHHhhhHHhhcCCCc--cceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 3455556777999999 999998221 2222 223355677788888887766 799999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+.||.|. -.++..+.+ -.+++|+..+-++...++.||.||-++ ++|+|||+||+|||++..|++|++|||++..+.
T Consensus 168 IcMelMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 168 ICMELMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceee
Confidence 9999884 355666655 556799999999999999999999876 599999999999999999999999999986543
Q ss_pred ----------CCCcCCCccccc---CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 170 ----------DKGCMAPECYKR---TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 170 ----------~~~~~ape~~~~---~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
.+.|||||.+-. ..|+..+||||||++++||+||..||.......+.. ..+.+.. ...+
T Consensus 244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l-------tkvln~e-PP~L 315 (391)
T KOG0983|consen 244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL-------TKVLNEE-PPLL 315 (391)
T ss_pred cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH-------HHHHhcC-CCCC
Confidence 567999998853 368899999999999999999999998653332221 1111111 1222
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
++ ....+..+.+++..||++|+.+||-..++++.
T Consensus 316 ~~---~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PG---HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Cc---ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 21 12257889999999999999999999998863
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-33 Score=222.83 Aligned_cols=241 Identities=16% Similarity=0.162 Sum_probs=180.8
Q ss_pred ccccccCCCCCCCCcchhHH-------HHHHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEe--------C
Q 048314 24 FCRSSLNDRNSPRSKSVWSC-------MRALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--------G 85 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 85 (274)
|.....+|.|.| |.|+++ .+++++.+- ...-....++|+++|..++|+|++.++..|.. .
T Consensus 19 yek~~kigqGtf--geVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 19 YEKLAKIGQGTF--GEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred HHHHHhcCCchH--HHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 344667999999 999998 445555433 22345566899999999999999999998853 3
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
..++|||.+|.+ +|...|.+ ....++..++.++..++..||.|+|.. .|+|||+|++|+|++.++.++|+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 358999999975 88888876 556799999999999999999999999 9999999999999999999999999999
Q ss_pred eecC---------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh-
Q 048314 166 KLLS---------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI- 228 (274)
Q Consensus 166 ~~~~---------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 228 (274)
+... |..|++||.+.+. .|+++.|+|.-||++.||.+|.+.++.. .+-....+...+.....
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn-teqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN-TEQQQLHLISQLCGSITK 250 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC-hHHHHHHHHHHHhccCCc
Confidence 6544 3458999988764 6899999999999999999999998754 22222222221111111
Q ss_pred -------hhhhhhhh-------------cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 229 -------NRELNKLV-------------RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 229 -------~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+-.+-..+ ..+..|-....+..+|+..++..||.+||++.++++
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00000001 000111112246789999999999999999999876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=231.93 Aligned_cols=227 Identities=19% Similarity=0.239 Sum_probs=175.9
Q ss_pred cccCCCCCCCCcchhHH-------HHHHHH-HhcC-CCC------CCcHHHHHHHHhcCCCCccceEeEEEE-eCCcceE
Q 048314 27 SSLNDRNSPRSKSVWSC-------MRALMA-TVNS-PYS------PSRPLTLTSIVSRVSWTTDIEVSSVAM-RGSKPST 90 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~-------~~~~~~-~~~~-~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~l 90 (274)
..++|+|+| +.||++ .++++. .++. ..+ .+...+|..+-+.|.||-||++|+++. +.+.+|-
T Consensus 468 LhLLGrGGF--SEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCT 545 (775)
T KOG1151|consen 468 LHLLGRGGF--SEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCT 545 (775)
T ss_pred HHHhccccH--HHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccccee
Confidence 678999999 999999 222211 1111 111 122358999999999999999999984 6778999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC---CCcEEEecccccee
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKISDFGLAKL 167 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~d~g~~~~ 167 (274)
|+|||+|.+|+-||.+ ..-+++++.+.|+.||+.||.||... +++|||-||||.|||+.+ .|.+||.|||+++.
T Consensus 546 VLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 546 VLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 9999999999999986 56789999999999999999999986 789999999999999854 47789999999987
Q ss_pred cC------------------CCCcCCCcccccC----CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH
Q 048314 168 LS------------------DKGCMAPECYKRT----PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225 (274)
Q Consensus 168 ~~------------------~~~~~ape~~~~~----~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (274)
+. +..|++||++-.+ ..+.++||||.||++|+++.|+.||....+.- .
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--d-------- 692 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--D-------- 692 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--H--------
Confidence 54 4568999988654 36889999999999999999999997542111 0
Q ss_pred HHhhhhhhhhhcCC----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHH
Q 048314 226 CFINRELNKLVRGT----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVV 271 (274)
Q Consensus 226 ~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl 271 (274)
.+. ...++... +..+..+.+..++|++||++.-++|....++.
T Consensus 693 ILq---eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 693 ILQ---ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHh---hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111 11222222 12234556789999999999999999888775
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-33 Score=227.71 Aligned_cols=233 Identities=17% Similarity=0.132 Sum_probs=175.8
Q ss_pred cccCCCCCCCCcchhHH------HHHHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEEeCC
Q 048314 27 SSLNDRNSPRSKSVWSC------MRALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~------~~~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
...||.|.| |.|+|- ..+++|.++.. .+..+++.|..+..+- +.||||++||.++.++..++.||+|.
T Consensus 69 lg~iG~G~f--G~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 69 LGEIGNGAF--GTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHhcCCcc--hhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 556999999 999988 33334444432 3456678888866655 58999999999999999999999996
Q ss_pred CCCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 97 PWDLAYIIFC---SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 97 ~gsL~~~l~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
-||+.+... -.+..++++.+-.+..-.+.||.||-.. ..|||||+||+|||++..|.+||+|||++..+.
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA 223 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA 223 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence 477666542 2456799999999999999999999876 589999999999999999999999999985432
Q ss_pred ------CCCcCCCcccccC--CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 ------DKGCMAPECYKRT--PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 ------~~~~~ape~~~~~--~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
...|||||.+... .|+.++|+||+|++|+|+.||..|+..-. .+.+.+.. +..+..+ ++....-
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------svfeql~~-Vv~gdpp-~l~~~~~ 295 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------SVFEQLCQ-VVIGDPP-ILLFDKE 295 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------HHHHHHHH-HHcCCCC-eecCccc
Confidence 4569999988643 48899999999999999999999996321 11111111 1111111 1111112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+.+..+..+|..||.+|-..||+..++.+
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 2345678999999999999999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=223.65 Aligned_cols=231 Identities=16% Similarity=0.204 Sum_probs=195.1
Q ss_pred hhhccccccCCCCCCCCcchhHH----------HHHHHHH-hcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC----------MRALMAT-VNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~----------~~~~~~~-~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 88 (274)
.++|.-..+||+|++ .+|-.+ ++.++|. ++..++.++...|-.+..+. +||.+|.+..++...+.+
T Consensus 249 l~df~ll~vigrgsy--akvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSY--AKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccceeeeeecCcch--hhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 357777889999999 888877 5566654 44446777778898888876 599999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee-
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL- 167 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~- 167 (274)
++|.||++||+|--++++ .+.+|+...+.+...|+.||.|||++ ||++||||.+|+|++..+++||+|+|.++.
T Consensus 327 ffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999999888875 56799999999999999999999999 999999999999999999999999999864
Q ss_pred ----------cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 168 ----------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 168 ----------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
.+++.|.|||++.+..|+..+|.|++|++++||+.|+.||+..+....+.+..++++..+....+
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi----- 476 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI----- 476 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-----
Confidence 33789999999999999999999999999999999999999776666556666665555433322
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCC
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRP 265 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rp 265 (274)
.+|...+.....+++.-|++||.+|-
T Consensus 477 --riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 --RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --cccceeehhhHHHHHHhhcCCcHHhc
Confidence 25556666777888889999999985
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=238.29 Aligned_cols=236 Identities=14% Similarity=0.161 Sum_probs=187.5
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHH------HHHHHHHhcC-C---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSC------MRALMATVNS-P---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~-~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
+++.-+-|. +.++|.|-| |.||-| ..+++|.+.+ + ...+.+++|+.+|.+++||.||.+...|...+
T Consensus 560 ~stvYQif~-devLGSGQF--G~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e 636 (888)
T KOG4236|consen 560 ISTVYQIFA-DEVLGSGQF--GTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE 636 (888)
T ss_pred HHHHHHhhh-HhhccCCcc--eeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc
Confidence 444445555 889999999 999988 2222222221 1 33466789999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC---CcEEEeccc
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF---WTAKISDFG 163 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~---~~~kl~d~g 163 (274)
..++|||-+.|-=|+..|.. ..+.|++..-+.+..||+-||+|||.. +|+|+||||+|+|+... -.+||+|||
T Consensus 637 rvFVVMEKl~GDMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFG 712 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFG 712 (888)
T ss_pred eEEEEehhhcchHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccc
Confidence 99999999865555555554 778899999999999999999999999 99999999999999654 468999999
Q ss_pred cceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 164 LAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 164 ~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
+++.++ |+.|+|||+++...|...-|+||.|+++|.-++|..||.......+. +++ -
T Consensus 713 fARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ----------IQN---A 779 (888)
T KOG4236|consen 713 FARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ----------IQN---A 779 (888)
T ss_pred ceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH----------hhc---c
Confidence 998765 88999999999999999999999999999999999999643111110 011 1
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+.|.....+.++..+++|...|+..-.+|-|+.+-+.
T Consensus 780 aFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 780 AFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 123344455567788999999999999999999887653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=253.66 Aligned_cols=139 Identities=17% Similarity=0.155 Sum_probs=117.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|.....||.|+| |.||+|.. .++|.+... .....+.+|+.++..++||||+++++++...+..+
T Consensus 3 ~~~y~i~~~LG~G~f--g~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAF--GKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCC--eEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence 357778889999999 99998821 122222211 11245678999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
+||||+.+++|.+++.. .+.+++...+.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999975 35689999999999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=236.87 Aligned_cols=225 Identities=16% Similarity=0.102 Sum_probs=185.2
Q ss_pred hhccccccCCCCCCCCcchhHH----------HHHHHH-HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC----------MRALMA-TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~----------~~~~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
.++....-+|-|+| |+|-.+ ++.++| .+.+....+....|-++|...+.|.||++|.-|.+....|+
T Consensus 420 ~dl~~iaTLGvGgF--GRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 420 SDLKRIATLGVGGF--GRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhcccCcc--ceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 45555777999999 988765 233322 23333445556799999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
.||-|-||.|...|.. .+.++..+...++..+++|+.|||++ +||+|||||+|++++.+|.+||.|||+++.++
T Consensus 498 LmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 498 LMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999999985 57899999999999999999999999 99999999999999999999999999997544
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
|+.|.|||++.....+..+|.||+|+++|||++|.+||+..+ .....+.+ .+-++...
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d----pmktYn~I---------LkGid~i~ 639 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD----PMKTYNLI---------LKGIDKIE 639 (732)
T ss_pred CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc----hHHHHHHH---------Hhhhhhhh
Confidence 789999999999999999999999999999999999997541 11111111 12223334
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCC
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPS 266 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps 266 (274)
+|........+||+.....+|.+|--
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhc
Confidence 66666778889999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=221.34 Aligned_cols=201 Identities=21% Similarity=0.179 Sum_probs=164.3
Q ss_pred CCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 048314 57 PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECE 136 (274)
Q Consensus 57 ~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~ 136 (274)
.+.+.+|++.+++++|+|++++++++......++++||+++++|.+++... ..+++..++.++.+++.++.+||+.
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~-- 106 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR--GRLSEDEARFYARQILSALEYLHSN-- 106 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHc--
Confidence 467889999999999999999999999999999999999999999999762 2389999999999999999999999
Q ss_pred CCcccCCCCCCceEEcCCCcEEEeccccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCC
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWEN 206 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p 206 (274)
+++|+|++|.||+++.++.++++|||.+.... ...|++||......++.++|+||||++++++++|..|
T Consensus 107 -~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p 185 (244)
T smart00220 107 -GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPP 185 (244)
T ss_pred -CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999986543 4569999999877888999999999999999999999
Q ss_pred ccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 207 MEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
|...... ...... ...... .........+..+.+++.+||..+|++|||+.++++.
T Consensus 186 ~~~~~~~---~~~~~~----~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 186 FPGDDQL---LELFKK----IGKPKP----PFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CCCCCcH---HHHHHH----HhccCC----CCccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 9642111 111110 000000 0000111155789999999999999999999999863
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=205.75 Aligned_cols=239 Identities=16% Similarity=0.147 Sum_probs=176.9
Q ss_pred ccccccCCCCCCCCcchhHH------HHHHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 24 FCRSSLNDRNSPRSKSVWSC------MRALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
|.....||+|.+ |.|+++ ..++.|.++- ...++..++|+.+|+.++|+|||+++++...+....+|+|
T Consensus 4 ydkmekigegty--gtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 4 YDKMEKIGEGTY--GTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred hHHHHhhcCCcc--eeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 334556999999 999999 1112222221 1335667899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
||. .+|..|... -++.++....+.++.|++.||.++|++ +++|||+||.|.++..++.+|++|||+++-.+
T Consensus 82 ~cd-qdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 82 FCD-QDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred Hhh-HHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 996 489988876 457799999999999999999999999 99999999999999999999999999998665
Q ss_pred -------CCCcCCCcccccC-CCccccceeehhHhHHHHhhc-CCCccccCCChhhHHHHHHHHHH--Hhhhh---hhhh
Q 048314 170 -------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICC-WENMEIDASKPEEIILTNWVYKC--FINRE---LNKL 235 (274)
Q Consensus 170 -------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~ 235 (274)
+.-|.+|.++.+. .|+...|+||-||++.|+... ++.|... .-... +...++.. ..+.. +..+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddq--lkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQ--LKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHH--HHHHHHHhCCCccccCCccccC
Confidence 4458899988775 478999999999999999875 4445432 11111 11111111 11111 1111
Q ss_pred hcCC------------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 VRGT------------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ~~~~------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
-|-. .+-+.....-.++++..+..+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111 111122234568999999999999999998875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=225.03 Aligned_cols=222 Identities=18% Similarity=0.166 Sum_probs=182.1
Q ss_pred hhhccccccCCCCCCCCcchhHH-------HHHH---HHH-hcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC-------MRAL---MAT-VNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~-------~~~~---~~~-~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 88 (274)
..+|+-..++|+|+| |+|..+ ..++ +|. +....+.+--+.|-++|.-.. -|.++++..++...+++
T Consensus 348 ~tDFnFl~VlGKGSF--GKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSF--GKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred ecccceEEEeccCcc--ceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 346777899999999 999877 2222 221 112245566678888887654 67889999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee-
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL- 167 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~- 167 (274)
|.||||+.||+|--++++ -+.+-++..+.++..|+-||-+||++ +|++||||.+|++++.++++||+|||.++.
T Consensus 426 yFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999999886 56788999999999999999999999 999999999999999999999999999864
Q ss_pred ----------cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 168 ----------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 168 ----------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
.+|+.|+|||++...+|+..+|.||||++||||+.|.+||+..+.. .+. ..+.+
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----elF------------~aI~e 564 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELF------------QAIME 564 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH----HHH------------HHHHH
Confidence 3378999999999999999999999999999999999999865221 111 11111
Q ss_pred CC-ccCHHHHHHHHHHHHHhhccCCCCCC
Q 048314 238 GT-EVDKKNLENLVKVGLWCVQDEPALRP 265 (274)
Q Consensus 238 ~~-~~~~~~~~~~~~li~~cl~~dp~~Rp 265 (274)
.. .+|...+.+..+++...|.+.|.+|-
T Consensus 565 hnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 HNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11 36777788889999999999999985
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=226.82 Aligned_cols=239 Identities=22% Similarity=0.193 Sum_probs=177.1
Q ss_pred hhccccccCCCCCCCCcchhHH----HHHHHHHhcCCCCCCcHHHHHHHHh--cCCCCccceEeEEEEeC----CcceEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC----MRALMATVNSPYSPSRPLTLTSIVS--RVSWTTDIEVSSVAMRG----SKPSTE 91 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~----~~~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~----~~~~lv 91 (274)
+...-...||+|.| |.||+| ..+++|++.+.+..+ +.+|.++.+ .++|+||+.+++.-..+ .+++||
T Consensus 211 rqI~L~e~IGkGRy--GEVwrG~wrGe~VAVKiF~srdE~S-WfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRF--GEVWRGRWRGEDVAVKIFSSRDERS-WFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred heeEEEEEecCccc--cceeeccccCCceEEEEecccchhh-hhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 33444678999999 999999 445566666654444 555666555 57999999999986432 378999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDE-----CEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-----~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
++|=++|||.|||.+ ..++-...++++..++.||++||.. .+|.|-|||||+.|||+..++.+-|+|+|++.
T Consensus 288 TdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 999999999999975 5799999999999999999999954 37889999999999999999999999999986
Q ss_pred ecC---------------CCCcCCCcccccCC------CccccceeehhHhHHHHhhc----------CCCcccc-CCCh
Q 048314 167 LLS---------------DKGCMAPECYKRTP------ISVKADVYGYGIVLLETICC----------WENMEID-ASKP 214 (274)
Q Consensus 167 ~~~---------------~~~~~ape~~~~~~------~~~~~Di~s~G~~l~el~~g----------~~p~~~~-~~~~ 214 (274)
... |.+|||||++.... .-..+||||||.++||+.-+ ..||... +..+
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 433 56799999886432 12569999999999998742 2455321 1111
Q ss_pred hhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhH
Q 048314 215 EEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCV 270 (274)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ev 270 (274)
... -+...+--......+.++-.+.+....+.++|+.||..||..|-|+=.+
T Consensus 445 s~e----eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 445 SFE----EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred CHH----HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 111 1112222223333333334566778899999999999999999887544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=238.06 Aligned_cols=230 Identities=21% Similarity=0.194 Sum_probs=169.0
Q ss_pred hhccccccCCCCCCCCcchhHH-----HHHHHHHhcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC-----MRALMATVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~-----~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
.-|+...++|.|.-|+. ||+| .+|+|..... ..+-..+||..|+.-. |||||++++.-.+....|+..|.|
T Consensus 509 ~~~~~~eilG~Gs~Gt~-Vf~G~ye~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 509 LFFSPKEILGYGSNGTV-VFRGVYEGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeeccHHHcccCCCCcE-EEEEeeCCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 34666777877777443 6777 3444443333 2233458999999886 999999999999999999999998
Q ss_pred CCCCHHHHHHhC-CCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-----CCcEEEeccccceec
Q 048314 96 LPWDLAYIIFCS-AER-NPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-----FWTAKISDFGLAKLL 168 (274)
Q Consensus 96 ~~gsL~~~l~~~-~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-----~~~~kl~d~g~~~~~ 168 (274)
. .||++++... .+. ...-...+.+..|++.||++||+. +|+||||||.||||.. ...++|+|||+++..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5 6999999873 111 112144577889999999999998 9999999999999975 256899999999764
Q ss_pred C--------------CCCcCCCcccccCCCccccceeehhHhHHHHhhc-CCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 169 S--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICC-WENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 169 ~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
. +.+|.|||++....-+..+||+|+||++|++++| .+||..... .+.++ ..++.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NI--------l~~~~- 730 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANI--------LTGNY- 730 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhh--------hcCcc-
Confidence 3 6789999999988888899999999999998886 899963310 00000 00100
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+..= +...++ ...+||.+|++.+|..|||+.+|+.
T Consensus 731 ~L~~L-~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 731 TLVHL-EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ceeee-ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00000 111122 7889999999999999999999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=228.74 Aligned_cols=194 Identities=19% Similarity=0.157 Sum_probs=161.2
Q ss_pred hccccccCCCCCCCCcchhHH----------HHHH-HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC----------MRAL-MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~----------~~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
-|-..+-||-|.| |.|-.+ ++.. |+.+-.+........|..||.....+.||+||-.|.+++.+|+|
T Consensus 630 mFvkik~iGvGAF--GeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAF--GEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ceEEEeeeccccc--ceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4556788999999 888766 1111 22222223445566899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|+|++||++-.+|-+ -+.|++...+.++.++.-|+.+.|.. |+|||||||+||||+.+|++||+|||++....
T Consensus 708 MdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 999999999999875 56799999999999999999999998 99999999999999999999999999985322
Q ss_pred ---------------------------------------------------CCCcCCCcccccCCCccccceeehhHhHH
Q 048314 170 ---------------------------------------------------DKGCMAPECYKRTPISVKADVYGYGIVLL 198 (274)
Q Consensus 170 ---------------------------------------------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~ 198 (274)
++.|+|||++....|+..+|.||.||+||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 45699999999999999999999999999
Q ss_pred HHhhcCCCccccCCChhhHHHHHHH
Q 048314 199 ETICCWENMEIDASKPEEIILTNWV 223 (274)
Q Consensus 199 el~~g~~p~~~~~~~~~~~~~~~~~ 223 (274)
||+.|+.||-...-......+.+|.
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWR 887 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehh
Confidence 9999999997553333344445553
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=232.78 Aligned_cols=242 Identities=17% Similarity=0.099 Sum_probs=168.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH----------------------HHHHHhcC----------------CCCCCcHH
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR----------------------ALMATVNS----------------PYSPSRPL 61 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~----------------------~~~~~~~~----------------~~~~~~~~ 61 (274)
..++|...+.||+|+| |.||+|.. +++|.+.. ....+.+.
T Consensus 143 ~~d~F~i~~~LG~GgF--G~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 143 SSDDFQLRDKLGGGNF--GITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred cccCceEeeEeecCCC--eEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 3568999999999999 99998831 01111110 01123344
Q ss_pred HHHHHHhcCCCCcc-----ceEeEEEEe--------CCcceEEEEeCCCCCHHHHHHhCC--------------------
Q 048314 62 TLTSIVSRVSWTTD-----IEVSSVAMR--------GSKPSTEAALDLPWDLAYIIFCSA-------------------- 108 (274)
Q Consensus 62 ~e~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~-------------------- 108 (274)
.|+.++.+++|.|+ ++++++|.. .+..+|||||+++++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57778888877654 778888753 356899999999999999997421
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------------CCCcC
Q 048314 109 --ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------------DKGCM 174 (274)
Q Consensus 109 --~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------------~~~~~ 174 (274)
...++|..++.++.|++.+|.|||+. +++||||||+||+++.++.++|+|||++.... ++.|+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 11246788899999999999999999 99999999999999999999999999985431 46799
Q ss_pred CCcccccCC--------------------C--ccccceeehhHhHHHHhhcCC-CccccCCChhhH-----HHHHHHHHH
Q 048314 175 APECYKRTP--------------------I--SVKADVYGYGIVLLETICCWE-NMEIDASKPEEI-----ILTNWVYKC 226 (274)
Q Consensus 175 ape~~~~~~--------------------~--~~~~Di~s~G~~l~el~~g~~-p~~~~~~~~~~~-----~~~~~~~~~ 226 (274)
+||.+.... + ..+.|+||+||++++|++|.. |+........+. .+..|. .
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~ 455 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--M 455 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--h
Confidence 999875322 1 124699999999999999875 654221111000 011110 0
Q ss_pred HhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCC---CCCCChhhHHhh
Q 048314 227 FINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEP---ALRPSMKCVVMM 273 (274)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp---~~Rps~~evl~~ 273 (274)
..... .+ -......+...++++.+||..+| .+|+|++|+++.
T Consensus 456 ~~~~~----~~-~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 YKGQK----YD-FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hcccC----CC-cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00000 00 01223456789999999999866 689999999863
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=238.75 Aligned_cols=241 Identities=18% Similarity=0.078 Sum_probs=152.0
Q ss_pred HhhhccccccCCCCCCCCcchhHHHHH----------HHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEE------EE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMRA----------LMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSV------AM 83 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~~----------~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~ 83 (274)
..++|...+.||+|+| |.||+|... ++|........+.+..| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~F--G~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAF--GVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCC--eEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678888999999999 999998321 11111111111111111 1222223333333222 23
Q ss_pred eCCcceEEEEeCCCCCHHHHHHhCCCC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC
Q 048314 84 RGSKPSTEAALDLPWDLAYIIFCSAER------------------NPYWNQRVRIALDVAKGILYLHDECEPPILHCDIK 145 (274)
Q Consensus 84 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~ 145 (274)
+....++|+||+++++|.+++...... ......+..++.|++.||.|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 566789999999999999999753210 012334567899999999999999 99999999
Q ss_pred CCceEEcC-CCcEEEeccccceec------------CCCCcCCCcccccC----------------------CCccccce
Q 048314 146 PQNILMDE-FWTAKISDFGLAKLL------------SDKGCMAPECYKRT----------------------PISVKADV 190 (274)
Q Consensus 146 ~~nil~~~-~~~~kl~d~g~~~~~------------~~~~~~ape~~~~~----------------------~~~~~~Di 190 (274)
|+|||++. ++.+||+|||+++.. .++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 578999999998643 25689999965322 13345699
Q ss_pred eehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh-hhhhhhhhcCC---------ccCHHHHHHHHHHHHHhhccC
Q 048314 191 YGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI-NRELNKLVRGT---------EVDKKNLENLVKVGLWCVQDE 260 (274)
Q Consensus 191 ~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~d 260 (274)
|||||++|||+++..++... ...+...+..... .......+.+. +.........++|+.+||+.|
T Consensus 363 wSlGviL~el~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 99999999999876654321 1111100000000 00001111111 011112234568999999999
Q ss_pred CCCCCChhhHHh
Q 048314 261 PALRPSMKCVVM 272 (274)
Q Consensus 261 p~~Rps~~evl~ 272 (274)
|++|||+.|+++
T Consensus 438 P~kR~ta~e~L~ 449 (566)
T PLN03225 438 GRQRISAKAALA 449 (566)
T ss_pred cccCCCHHHHhC
Confidence 999999999986
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=217.30 Aligned_cols=246 Identities=18% Similarity=0.180 Sum_probs=181.4
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-CCCCcHHHHHHHHhcCC-----C---CccceEeEEEEe--
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-YSPSRPLTLTSIVSRVS-----W---TTDIEVSSVAMR-- 84 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~-- 84 (274)
++|...+.+|=|.| ++||.+.. +++|+.++. .-.+..+.||++|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHF--STVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHF--STVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEecccccc--ceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 45666888999999 99999921 122233332 33455679999999985 2 248999999864
Q ss_pred --CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC--------
Q 048314 85 --GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-------- 154 (274)
Q Consensus 85 --~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-------- 154 (274)
+.+.|||+|+. |-+|..++.....++++...++.|+.|++.||.|||..| +|||.||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence 45899999987 568999999888899999999999999999999999998 99999999999998110
Q ss_pred --------------------------------------------------------------------------------
Q 048314 155 -------------------------------------------------------------------------------- 154 (274)
Q Consensus 155 -------------------------------------------------------------------------------- 154 (274)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------Cc
Q 048314 155 ------------------------------------------------------------------------------WT 156 (274)
Q Consensus 155 ------------------------------------------------------------------------------~~ 156 (274)
..
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 01
Q ss_pred EEEeccccceecC--------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhh---HHHHH----
Q 048314 157 AKISDFGLAKLLS--------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEE---IILTN---- 221 (274)
Q Consensus 157 ~kl~d~g~~~~~~--------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~---~~~~~---- 221 (274)
+||+|||-+.+.. |..|+|||++.+..|+..+||||++|+++||+||.-.|.++...... ..+..
T Consensus 393 vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~EL 472 (590)
T KOG1290|consen 393 VKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMEL 472 (590)
T ss_pred EEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHH
Confidence 2444444443321 45599999999999999999999999999999999999876443311 11111
Q ss_pred ---HHHHHHhhhh-----------h-----------hhhh-cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 222 ---WVYKCFINRE-----------L-----------NKLV-RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 222 ---~~~~~~~~~~-----------~-----------~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+.....+. + .+++ +.-..+.+.+.++.+++.-||+.+|++||||++.++
T Consensus 473 LG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 473 LGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 1111111111 1 1111 111578888999999999999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=241.65 Aligned_cols=186 Identities=16% Similarity=0.176 Sum_probs=139.7
Q ss_pred HhcCCC-CccceEeEEE-------EeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 048314 67 VSRVSW-TTDIEVSSVA-------MRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP 138 (274)
Q Consensus 67 l~~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ 138 (274)
.+.++| +||.+++++| .+...++.++|++ +++|.+++.. ....+++..++.++.||+.||.|||++ +
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 446677 7899999987 2334567888876 5699999975 345699999999999999999999999 9
Q ss_pred cccCCCCCCceEEcC-------------------CCcEEEeccccceec---------------------------CCCC
Q 048314 139 ILHCDIKPQNILMDE-------------------FWTAKISDFGLAKLL---------------------------SDKG 172 (274)
Q Consensus 139 i~h~dl~~~nil~~~-------------------~~~~kl~d~g~~~~~---------------------------~~~~ 172 (274)
|+||||||+|||++. ++.+|++|||+++.. +++.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999953 456778888876521 2445
Q ss_pred cCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHH
Q 048314 173 CMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKV 252 (274)
Q Consensus 173 ~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (274)
|+|||++....++.++|||||||++|||++|..|+... ....... .. ....+ ..........++
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~-----~~----~~~~~--~~~~~~~~~~~~ 244 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMSSL-----RH----RVLPP--QILLNWPKEASF 244 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHH-----HH----hhcCh--hhhhcCHHHHHH
Confidence 99999999889999999999999999999988876421 0001000 00 00111 111123445788
Q ss_pred HHHhhccCCCCCCChhhHHhh
Q 048314 253 GLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 253 i~~cl~~dp~~Rps~~evl~~ 273 (274)
+.+||+.||.+|||+.|+++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 899999999999999999863
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=200.01 Aligned_cols=241 Identities=14% Similarity=0.165 Sum_probs=177.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHHH------HHHHhcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEe--CCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMRA------LMATVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMR--GSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~~------~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 91 (274)
..+|...+.+|+|.+ +.|+.|... ++|.++ +-..+...+|+++|..|. ||||+++++...+ ...+.|+
T Consensus 37 ~ddYeivrk~GRGKY--SEVFeg~~~~~~eK~ViKiLK-PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKY--SEVFEGINITNNEKCVIKILK-PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccH--hhHhcccccCCCceEEEeeec-hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 456666788999999 999999321 122111 122345779999999999 9999999999876 4568999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-CCcEEEeccccceecC-
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKISDFGLAKLLS- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~d~g~~~~~~- 169 (274)
+||..+-++..... .|+...++.++.+++.||.|+|+. ||+|||+||.|++++. ...++|+|+|++-+..
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999977776653 588889999999999999999999 9999999999999984 5679999999996643
Q ss_pred ---------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHH-H---------HHHHHHH--H
Q 048314 170 ---------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEII-L---------TNWVYKC--F 227 (274)
Q Consensus 170 ---------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~-~---------~~~~~~~--~ 227 (274)
+..|..||.+-. ..|+..-|+|||||++..|+..+.||........... + ...+... .
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 344678998765 4588999999999999999999999976544333221 1 1111100 0
Q ss_pred hhhhhhhhhcCC-----------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 INRELNKLVRGT-----------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 ~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+....+++... +.-.-.+++..+++...|..|..+|||+.|...
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111122222111 011112478899999999999999999999764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=195.84 Aligned_cols=193 Identities=25% Similarity=0.328 Sum_probs=165.0
Q ss_pred CCCCCCCCcchhHHHHH------HHHHhcCCCC---CCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCH
Q 048314 30 NDRNSPRSKSVWSCMRA------LMATVNSPYS---PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDL 100 (274)
Q Consensus 30 ~g~g~~~~g~vy~~~~~------~~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 100 (274)
+|.|.+ |.||++... ++|....... .+.+.+|+.+++.++|++++++++++......++++|++++++|
T Consensus 1 l~~g~~--~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGF--GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCc--eEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 578888 899988332 1222222211 25688999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-CCcEEEeccccceecC----------
Q 048314 101 AYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKISDFGLAKLLS---------- 169 (274)
Q Consensus 101 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~d~g~~~~~~---------- 169 (274)
.+++... ...+++..+..++.+++.++.+||+. +++|+|++|.||+++. +..++++|||.+....
T Consensus 79 ~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 79 KDLLKEN-EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 9999862 24689999999999999999999999 9999999999999999 8999999999887543
Q ss_pred -CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHH
Q 048314 170 -DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLE 247 (274)
Q Consensus 170 -~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (274)
...|++||..... ..+.+.|+|++|++++++ .
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~ 188 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------P 188 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------H
Confidence 4568999988776 778999999999999998 3
Q ss_pred HHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 248 NLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 248 ~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+.+++..|++.||++|||+.++++.|
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 578899999999999999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=189.61 Aligned_cols=157 Identities=21% Similarity=0.161 Sum_probs=120.2
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec------CCC
Q 048314 98 WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------SDK 171 (274)
Q Consensus 98 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------~~~ 171 (274)
|||.+++.. .+..+++..++.++.|++.||.|||+. + ||+||+++.++.+++ ||.+... +++
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~ 68 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDP 68 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccccCCCcc
Confidence 789999986 345699999999999999999999998 5 999999999999999 9988653 367
Q ss_pred CcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHH--HH
Q 048314 172 GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLE--NL 249 (274)
Q Consensus 172 ~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 249 (274)
.|+|||++....++.++|||||||++|||++|+.||....... ..+.... .............+..... .+
T Consensus 69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 141 (176)
T smart00750 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILL-----NGMPADDPRDRSNLESVSAARSF 141 (176)
T ss_pred cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHH-----HHhccCCccccccHHHHHhhhhH
Confidence 8999999999999999999999999999999999996431111 1111111 1111000000012222333 69
Q ss_pred HHHHHHhhccCCCCCCChhhHHhh
Q 048314 250 VKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 250 ~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.+++.+||+.||++|||+.|+++.
T Consensus 142 ~~~i~~cl~~~p~~Rp~~~~ll~~ 165 (176)
T smart00750 142 ADFMRVCASRLPQRREAANHYLAH 165 (176)
T ss_pred HHHHHHHHhcccccccCHHHHHHH
Confidence 999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-29 Score=201.83 Aligned_cols=242 Identities=20% Similarity=0.191 Sum_probs=182.1
Q ss_pred hccccccCCCCCCCCcchhHH-------HHHHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC-----c
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC-------MRALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS-----K 87 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 87 (274)
+....+=||-|.| |.||.+ .++.+|..+. --+.+++.+|+++|.-++|.|++..++...... .
T Consensus 54 Di~PDRPIGYGAF--GVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 54 DIQPDRPIGYGAF--GVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cCCCCCcccccce--eEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 4455788999999 999966 3334443322 234577889999999999999999988765432 4
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.|+++|+|. .+|...+.. .+.++-..++-+.-||+.||.|||+. +|+||||||.|.|+..+..+||+|||+++.
T Consensus 132 iYV~TELmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 132 LYVLTELMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 688999885 478888874 67899999999999999999999999 999999999999999999999999999987
Q ss_pred cC------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH--------HH
Q 048314 168 LS------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY--------KC 226 (274)
Q Consensus 168 ~~------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--------~~ 226 (274)
.. +..|.|||++.+. .|+...||||.||++.|++.++..|+.. .+.....+..-+. +.
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq-~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA-GPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc-ChHHHHHHHHHHhCCCcHHHHHH
Confidence 55 5579999998875 5899999999999999999888888765 3333332221111 00
Q ss_pred HhhhhhhhhhcCC------------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 227 FINRELNKLVRGT------------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 227 ~~~~~~~~~~~~~------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..++....+++.. ..+.....+..++...++..||..|.+.++.+..
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 1112223333322 1122334566788889999999999999887643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=198.92 Aligned_cols=210 Identities=20% Similarity=0.140 Sum_probs=160.3
Q ss_pred CCCCcHHHHHHHHhcCCCCccceEeEEEEeC------CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH
Q 048314 55 YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG------SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGI 128 (274)
Q Consensus 55 ~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l 128 (274)
...++.-+|...+..++|+||++++.++.-. ...++|||+|. +||.+++.. .++-.++..++-|++-|+
T Consensus 57 ~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~i 131 (369)
T KOG0665|consen 57 THAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGI 131 (369)
T ss_pred ccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHH
Confidence 4456667899999999999999999998643 35699999996 599999873 578889999999999999
Q ss_pred HHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----------CCCcCCCcccccCCCccccceeehhHhHH
Q 048314 129 LYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLL 198 (274)
Q Consensus 129 ~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~ 198 (274)
+|||+. +|+||||||+||++..+..+|+.|||+++... +..|.|||.+.+..+...+||||.||++.
T Consensus 132 k~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~g 208 (369)
T KOG0665|consen 132 KHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (369)
T ss_pred HHHHhc---ceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHH
Confidence 999999 99999999999999999999999999997644 44689999999888999999999999999
Q ss_pred HHhhcCCCccccCCChhhHHHHH---------------HHHHHHhh------hhhhhhhcCC------ccCHHHHHHHHH
Q 048314 199 ETICCWENMEIDASKPEEIILTN---------------WVYKCFIN------RELNKLVRGT------EVDKKNLENLVK 251 (274)
Q Consensus 199 el~~g~~p~~~~~~~~~~~~~~~---------------~~~~~~~~------~~~~~~~~~~------~~~~~~~~~~~~ 251 (274)
||++|.-.|...+.-........ .......+ ....+.+... +.+......+.+
T Consensus 209 Eli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ard 288 (369)
T KOG0665|consen 209 ELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARD 288 (369)
T ss_pred HHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHH
Confidence 99999988864311111000000 00000000 0001111111 223334567889
Q ss_pred HHHHhhccCCCCCCChhhHHh
Q 048314 252 VGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 252 li~~cl~~dp~~Rps~~evl~ 272 (274)
++.+||-.||++|.|+.++|.
T Consensus 289 ll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 289 LLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHhhccChhhcccHHHHhc
Confidence 999999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=217.64 Aligned_cols=235 Identities=16% Similarity=0.090 Sum_probs=185.7
Q ss_pred HHhhhccccccCCCCCCCCcchhHHH------HHHHHHhc--CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCM------RALMATVN--SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
....+|.-...+|.|.+ |.|||+. .+++|.++ ...+.+-..+|+-+++..+|||||-++|.+......++
T Consensus 12 nP~ddyellqrvgsgTy--gdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTY--GDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcc--cchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 34567777888999999 9999992 22233222 22445556689999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee---
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL--- 167 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~--- 167 (274)
.||||.+|+|++..+. .+++++.++..+++..+.||.|||+. +=+|||+|-.||++.+.+.+|++|||.+..
T Consensus 90 cMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 9999999999999875 57899999999999999999999999 999999999999999999999999999853
Q ss_pred --------cCCCCcCCCcccc---cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 168 --------LSDKGCMAPECYK---RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 168 --------~~~~~~~ape~~~---~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
++++.|||||+.. .+.|...+|+|++|+...|+-.-.+|.... .+-. .+ ....+. ..
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-hpmr--~l-----~LmTkS----~~ 232 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-HPMR--AL-----FLMTKS----GF 232 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-chHH--HH-----HHhhcc----CC
Confidence 4488999999874 456889999999999999987666664311 0000 00 111111 11
Q ss_pred cCC--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 RGT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 ~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
++. +.+..+.+.+-++++.|+.++|++|||+..++.
T Consensus 233 qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 345677889999999999999999999988764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-28 Score=189.51 Aligned_cols=189 Identities=22% Similarity=0.190 Sum_probs=149.9
Q ss_pred HhhhccccccCCCCCCCCcchhH------HHHHHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcce
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWS------CMRALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~------~~~~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 89 (274)
..++.....-+|+|.+ |.|-+ |.++++|.+... +..++.++|+.+..+. ..|.+|.++|...+.+..+
T Consensus 44 ~ad~L~~i~elGrGay--G~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAY--GVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred chhhhhhhhhhcCCcc--chhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 3344444566999999 54433 344443333322 3445567888876664 5899999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 90 TEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
+.||.|. -||+.|..+- .++.+++..+-+++..+.+||.|||++ ..++|||+||+|||++.+|.+|++|||.+..
T Consensus 122 IcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999986 5888777643 556799999999999999999999997 5899999999999999999999999999865
Q ss_pred cC----------CCCcCCCccccc----CCCccccceeehhHhHHHHhhcCCCccccCCC
Q 048314 168 LS----------DKGCMAPECYKR----TPISVKADVYGYGIVLLETICCWENMEIDASK 213 (274)
Q Consensus 168 ~~----------~~~~~ape~~~~----~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~ 213 (274)
+. ...|||||.+.. ..|+.++||||+|+++.||.+++.||..-..+
T Consensus 199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 43 456999998753 36889999999999999999999999755333
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=211.18 Aligned_cols=181 Identities=18% Similarity=0.167 Sum_probs=151.8
Q ss_pred hhhccccccCCCCCCCCcchhHH----------HHHHHH--H-hcCC-CCC--CcHHHHHHHHhcCC---CCccceEeEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC----------MRALMA--T-VNSP-YSP--SRPLTLTSIVSRVS---WTTDIEVSSV 81 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~----------~~~~~~--~-~~~~-~~~--~~~~~e~~~l~~l~---h~niv~l~~~ 81 (274)
..+|...+.+|.|.| |.|+.+ .+++.| + .... .++ -..-.||.+|+.++ |+||+|++.+
T Consensus 560 ~s~yttlq~lG~GAy--GkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAY--GKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccceeeeecccccc--ceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 345777888999999 999988 222222 1 1111 111 11237999999998 9999999999
Q ss_pred EEeCCcceEEEEeC-CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEe
Q 048314 82 AMRGSKPSTEAALD-LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKIS 160 (274)
Q Consensus 82 ~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~ 160 (274)
|++++..+|+||-= ++.+|.+++.. +..+++.+..-++.|++.|+++||+. +|+|||||-+|+.++.+|.+||+
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence 99999999999964 56789999985 56799999999999999999999999 99999999999999999999999
Q ss_pred ccccceec---------CCCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCcc
Q 048314 161 DFGLAKLL---------SDKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENME 208 (274)
Q Consensus 161 d~g~~~~~---------~~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~ 208 (274)
|||.+... +|..|.|||++.+.+| +...|||++|++||.++....||.
T Consensus 713 dfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99998654 3778999999999887 578999999999999999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-27 Score=208.22 Aligned_cols=183 Identities=16% Similarity=0.103 Sum_probs=151.9
Q ss_pred hhhccccccCCCCCCCCcchhHH------HHHHHHHhcCCCC-CCcHHHHHHHHhcCC------CCccceEeEEEEeCCc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC------MRALMATVNSPYS-PSRPLTLTSIVSRVS------WTTDIEVSSVAMRGSK 87 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~~~~-~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~ 87 (274)
-..|......|+|.| +.|..+ .-+++|++++.+. -+.=+.|+++|.+|+ -.|.++++.-|...++
T Consensus 431 D~RY~V~~~~GkGvF--s~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVF--STVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred cceeEEEecccccee--eeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 345666788999999 999888 2233445554322 233468999999996 2568999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC-CcEEEeccccc
Q 048314 88 PSTEAALDLPWDLAYIIFCS-AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKISDFGLA 165 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~d~g~~ 165 (274)
+|||+|-. ..+|.++|... .+-+|....+..++.|+..||..|-.. +++|.||||+|||+... ..+||||||.+
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccc
Confidence 99999965 57999999875 334689999999999999999999998 99999999999999754 46799999999
Q ss_pred eecC---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccc
Q 048314 166 KLLS---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEI 209 (274)
Q Consensus 166 ~~~~---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~ 209 (274)
.... +..|.|||++.+.+|++..|+||.||+||||.||+..|..
T Consensus 585 ~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 7765 3359999999999999999999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=193.33 Aligned_cols=243 Identities=16% Similarity=0.154 Sum_probs=182.0
Q ss_pred HhhhccccccCCCCCCCCcchhHHHHHH---------HHHhcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcce
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMRAL---------MATVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~~~---------~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 89 (274)
..+.|...+.||.|+| +.||++...- .|.+.....+++..+|+++|..+. +.||+++.+++..+++..
T Consensus 34 ~~~~~~~v~kigeGsF--ssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSF--SSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccch--hhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 3456667899999999 9999993322 333444467888999999999997 999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-CCcEEEeccccceec
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKISDFGLAKLL 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~d~g~~~~~ 168 (274)
+|+||+++-...+++.. ++...+..++..+..||.++|+. ||+|||+||.|++... .+.-.|.|||++...
T Consensus 112 ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHH
Confidence 99999999999999875 78999999999999999999999 9999999999999974 355678999998611
Q ss_pred C-------------------------------------------------------CCCcCCCcccccC-CCccccceee
Q 048314 169 S-------------------------------------------------------DKGCMAPECYKRT-PISVKADVYG 192 (274)
Q Consensus 169 ~-------------------------------------------------------~~~~~ape~~~~~-~~~~~~Di~s 192 (274)
. |++|.|||++... ..+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 0 5679999998765 4678999999
Q ss_pred hhHhHHHHhhcCCCccccCCChhhH----HHHHH--HHH-HHhhhh------------------hh----hhhcCC----
Q 048314 193 YGIVLLETICCWENMEIDASKPEEI----ILTNW--VYK-CFINRE------------------LN----KLVRGT---- 239 (274)
Q Consensus 193 ~G~~l~el~~g~~p~~~~~~~~~~~----~~~~~--~~~-~~~~~~------------------~~----~~~~~~---- 239 (274)
.|++++-+++++.||.......... .+..+ +.. ....+. .. +.+.+.
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 9999999999999996432211110 00000 000 000000 00 001110
Q ss_pred ----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 ----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+..+..+.+++.+|++.||.+|.|+++.|.
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 111222347899999999999999999999885
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=184.87 Aligned_cols=179 Identities=17% Similarity=0.149 Sum_probs=150.2
Q ss_pred cccccCCCCCCCCcchhHHHHH------HHHHhcCC--C-CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 25 CRSSLNDRNSPRSKSVWSCMRA------LMATVNSP--Y-SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 25 ~~~~~~g~g~~~~g~vy~~~~~------~~~~~~~~--~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
.....+|.|++ +.||++... ++|..... . ..+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 2 ~~~~~i~~g~~--~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 2 ELGKKLGEGAF--GKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred ceeeEeecCCC--eEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 34567899999 999999221 12222221 1 3456778999999999999999999999989999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecCC-----
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----- 170 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~~----- 170 (274)
++++|.+++.... ..+++..+..++.+++.++.+||+. +++|+|+++.|++++.++.++++|||.+.....
T Consensus 80 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 80 EGGDLFDYLRKKG-GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999999998632 2289999999999999999999999 999999999999999999999999998875542
Q ss_pred -------CCcCCCccc-ccCCCccccceeehhHhHHHHhhcCCCccc
Q 048314 171 -------KGCMAPECY-KRTPISVKADVYGYGIVLLETICCWENMEI 209 (274)
Q Consensus 171 -------~~~~ape~~-~~~~~~~~~Di~s~G~~l~el~~g~~p~~~ 209 (274)
..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 348999988 556678899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=191.78 Aligned_cols=198 Identities=21% Similarity=0.280 Sum_probs=157.9
Q ss_pred HhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc-ccCCCC
Q 048314 67 VSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPI-LHCDIK 145 (274)
Q Consensus 67 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i-~h~dl~ 145 (274)
|+.+.|.|+.+++|.+.+++..++|.+||..|+|.|.+.. ....++|.....+.++++.||.|+|.. ++ .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 4678999999999999999999999999999999999987 567799999999999999999999987 54 999999
Q ss_pred CCceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCC-------CccccceeehhHhHHHHhhcCC
Q 048314 146 PQNILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTP-------ISVKADVYGYGIVLLETICCWE 205 (274)
Q Consensus 146 ~~nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~-------~~~~~Di~s~G~~l~el~~g~~ 205 (274)
+.|++++..|.+|++|||+..... ..-|.|||.+.... .+.++|+||||++++|++++..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987763 23489999987631 3677999999999999999999
Q ss_pred CccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH-HHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 206 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK-KNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 206 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
||...........+...+.. .-.+..+|.-... +..+.+..++..||..+|++||+++++-..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 99865333332222222111 1112222221111 444579999999999999999999998653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-25 Score=179.66 Aligned_cols=234 Identities=14% Similarity=0.113 Sum_probs=165.2
Q ss_pred hhhccccccCCCCCCCCcchhHH------HHHH-HHHhcCCCCCCcHHHHHHHHhcCC-CCccceEeEE-EEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC------MRAL-MATVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSV-AMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~------~~~~-~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~~~~~~lv 91 (274)
.+.|.....+|.|-| |.+-.+ ..++ +..-+.....++|.+|...--.|. |.||+.-|.+ |...+...++
T Consensus 23 ~d~y~I~k~lgeG~F--gkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRF--GKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccce--eeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 466777889999999 887766 2222 222233245677888887666665 8999999886 4567778899
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc--CCCcEEEeccccceecC
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD--EFWTAKISDFGLAKLLS 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~--~~~~~kl~d~g~~~~~~ 169 (274)
+||++.|+|.+-+. ..++.+..-+.++.|+++|+.|+|+. +++|||||.+|||+- +...+|++|||.....+
T Consensus 101 qE~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999988774 35688888999999999999999999 999999999999984 44589999999987665
Q ss_pred --------CCCcCCCccccc---C--CCccccceeehhHhHHHHhhcCCCccccCCC-hhhHHHHHHHHHHHhhhhhhhh
Q 048314 170 --------DKGCMAPECYKR---T--PISVKADVYGYGIVLLETICCWENMEIDASK-PEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 170 --------~~~~~ape~~~~---~--~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
...|.+||.+.. + ...+..|+|.||++++.+++|..||+..... ........|..... ...++.
T Consensus 175 ~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~--~~~P~~ 252 (378)
T KOG1345|consen 175 TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN--PALPKK 252 (378)
T ss_pred ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--ccCchh
Confidence 345788886642 2 2357899999999999999999999843111 11222222322211 111111
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhH
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCV 270 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ev 270 (274)
++ ..++.+..+-++-|..+|++|--+.++
T Consensus 253 F~------~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 253 FN------PFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred hc------ccCHHHHHHHHHhcCCcccccchhHHH
Confidence 11 123445566666778888887444433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=171.00 Aligned_cols=202 Identities=20% Similarity=0.199 Sum_probs=158.5
Q ss_pred CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 048314 56 SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC 135 (274)
Q Consensus 56 ~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~ 135 (274)
..++|-.|.-.|+-+.||||+.++|.|...+++.++..||+.|||+..+++...-..+..+.++++.+++.|++|||+.
T Consensus 230 isrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl- 308 (448)
T KOG0195|consen 230 ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL- 308 (448)
T ss_pred hcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-
Confidence 4567889999999999999999999999999999999999999999999975555578899999999999999999987
Q ss_pred CCCcccCCCCCCceEEcCCCcEEEe--ccccc----eecCCCCcCCCcccccCCCc---cccceeehhHhHHHHhhcCCC
Q 048314 136 EPPILHCDIKPQNILMDEFWTAKIS--DFGLA----KLLSDKGCMAPECYKRTPIS---VKADVYGYGIVLLETICCWEN 206 (274)
Q Consensus 136 ~~~i~h~dl~~~nil~~~~~~~kl~--d~g~~----~~~~~~~~~ape~~~~~~~~---~~~Di~s~G~~l~el~~g~~p 206 (274)
.+-|..-.|.+..++++++.+.+|+ |-.++ .....+.|++||.++..+-+ ..+|+|||.+++||+.|+.-|
T Consensus 309 ep~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevp 388 (448)
T KOG0195|consen 309 EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVP 388 (448)
T ss_pred chhhhhhhcccceEEecchhhhheecccceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccc
Confidence 3335555789999999999887764 32222 22337889999999876533 579999999999999999999
Q ss_pred ccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHH
Q 048314 207 MEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVV 271 (274)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl 271 (274)
|.....-..... . ..+-++. .+|+..+..+.+|+.-|.+.||.+||.+..++
T Consensus 389 fadlspmecgmk-------i-----aleglrv-~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 389 FADLSPMECGMK-------I-----ALEGLRV-HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cccCCchhhhhh-------h-----hhccccc-cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 963311111100 0 0111122 36777888899999999999999999988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.2e-22 Score=183.72 Aligned_cols=201 Identities=17% Similarity=0.139 Sum_probs=155.7
Q ss_pred HHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 048314 60 PLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPI 139 (274)
Q Consensus 60 ~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i 139 (274)
...|+.+-..++|||++..+..+.+.....-.||||++ +|..++.. ...+....+-.++.|++.|++|+|+. |+
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~---Gi 441 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSM---GL 441 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhc---Cc
Confidence 34577777789999998888877776655555999998 99999975 34688889999999999999999999 99
Q ss_pred ccCCCCCCceEEcCCCcEEEeccccceecC---------------CCCcCCCcccccCCCc-cccceeehhHhHHHHhhc
Q 048314 140 LHCDIKPQNILMDEFWTAKISDFGLAKLLS---------------DKGCMAPECYKRTPIS-VKADVYGYGIVLLETICC 203 (274)
Q Consensus 140 ~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---------------~~~~~ape~~~~~~~~-~~~Di~s~G~~l~el~~g 203 (274)
.|||+|++|+++..++.+|++|||.+.... +..|+|||.+....|. ...||||.|+++..|++|
T Consensus 442 ahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~ 521 (601)
T KOG0590|consen 442 AHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILG 521 (601)
T ss_pred eeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecC
Confidence 999999999999999999999999986543 4569999999998886 469999999999999999
Q ss_pred CCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 204 WENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 204 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+.||........... .............+.......+.....++.+||+.||.+|.|+++|++
T Consensus 522 ~~~Wk~a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 522 RFPWKVAKKSDNSFK------TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred CCccccccccccchh------hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 999975422211100 000000000000111233345677889999999999999999999986
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=162.03 Aligned_cols=234 Identities=14% Similarity=0.030 Sum_probs=171.3
Q ss_pred hccccccCCCCCCCCcchhHHHH-------HHHHHhcC--CCCCCcHHHHHHHHhcCCC----CccceEeEEE-EeCCcc
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR-------ALMATVNS--PYSPSRPLTLTSIVSRVSW----TTDIEVSSVA-MRGSKP 88 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~-------~~~~~~~~--~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~ 88 (274)
.|.....+|+|+| |.||.|.. .++|.... ......+..|+.++..+.. +++.++++.. ..+...
T Consensus 19 ~~~i~~~iG~G~f--G~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGF--GAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCC--ceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 7888999999999 99999942 12221111 1222267799999999873 6899999888 477788
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC-----CcEEEeccc
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-----WTAKISDFG 163 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-----~~~kl~d~g 163 (274)
++||+.+ |.||.++......+.++..+...++.|++.+|.++|+. |++||||||.|+++... ..+.+.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999976 67999998775557899999999999999999999999 99999999999999765 468999999
Q ss_pred cce--ec-------------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH
Q 048314 164 LAK--LL-------------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW 222 (274)
Q Consensus 164 ~~~--~~-------------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~ 222 (274)
+++ .. +|..|.++.+......+.+.|+||++.++.++..|..||...........+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 997 21 144577777777778889999999999999999999999654332222111111
Q ss_pred HHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 223 VYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.... .... .....+..+.++...+-..+..++|....+.+
T Consensus 253 ~~~~--------~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 253 PRKL--------LTDR--FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hhhh--------cccc--ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 1111 0000 11223445556666666678888888776654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-21 Score=166.55 Aligned_cols=147 Identities=18% Similarity=0.119 Sum_probs=111.5
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHHHH-------HHHHhcCC-------CCCCcHHHHHHHHhcCCCCccce-EeEE
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCMRA-------LMATVNSP-------YSPSRPLTLTSIVSRVSWTTDIE-VSSV 81 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~~~-------~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~-l~~~ 81 (274)
.....++|.....+|+|+| |.||++... ++|..... ...+.+.+|+++|++++|+|++. ++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~f--g~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVF--STVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cccccCCceEccEEeecCc--EEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 3445677888999999999 999998211 12221111 11334789999999999999985 443
Q ss_pred EEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCC-CCCceEEcCCCcEEEe
Q 048314 82 AMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDI-KPQNILMDEFWTAKIS 160 (274)
Q Consensus 82 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl-~~~nil~~~~~~~kl~ 160 (274)
.+..++||||+++++|... . ... ...++.+++.+|.|||+. +|+|||| ||+||+++.++.++|+
T Consensus 90 ---~~~~~LVmE~~~G~~L~~~--~-~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 90 ---TGKDGLVRGWTEGVPLHLA--R-PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred ---cCCcEEEEEccCCCCHHHh--C-ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEE
Confidence 2468999999999999632 1 111 146788999999999999 9999999 9999999988999999
Q ss_pred ccccceecC-------------------CCCcCCCccccc
Q 048314 161 DFGLAKLLS-------------------DKGCMAPECYKR 181 (274)
Q Consensus 161 d~g~~~~~~-------------------~~~~~ape~~~~ 181 (274)
|||+++... ++.|++||.+..
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999987443 345889998853
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.6e-19 Score=151.98 Aligned_cols=241 Identities=19% Similarity=0.158 Sum_probs=174.3
Q ss_pred ccccccCCCCCCCCcchhHHHHH---HHHHhcCC-----CCCCcHHHHHHHHhcCCCC-ccceEeEEEEeCCcceEEEEe
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMRA---LMATVNSP-----YSPSRPLTLTSIVSRVSWT-TDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~~---~~~~~~~~-----~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 94 (274)
|.....+|.|.| +.||++... +.+..... .....+.+|+.+++.+.|+ |++++++.+......++++++
T Consensus 2 ~~~~~~l~~g~~--~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSF--GEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCC--eEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 344567889999 999998333 11111111 1355678999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC-cEEEeccccceecC---
Q 048314 95 DLPWDLAYIIFCSAE-RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKISDFGLAKLLS--- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~d~g~~~~~~--- 169 (274)
+.++++.+++..... ..++......+..|++.++.|+|+. +++|||+||+|++++... .++++|||.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977765211 2689999999999999999999999 999999999999999888 79999999875321
Q ss_pred --------------CCCcCCCccccc---CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 170 --------------DKGCMAPECYKR---TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 170 --------------~~~~~ape~~~~---~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
+..|++||.+.. .......|+||+|++++++++|..|+...................... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 456999999887 577889999999999999999999975442210011111111110000 00
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHH
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVV 271 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl 271 (274)
...... ..+......+.+++..|+..+|..|.+..+..
T Consensus 236 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 273 (384)
T COG0515 236 ASPLSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273 (384)
T ss_pred ccccCc-cccchhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence 000000 00022235788999999999999999987754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.7e-19 Score=150.74 Aligned_cols=181 Identities=16% Similarity=0.138 Sum_probs=133.7
Q ss_pred CCCccceEeEEEEe---------------------------CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHH
Q 048314 71 SWTTDIEVSSVAMR---------------------------GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALD 123 (274)
Q Consensus 71 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~ 123 (274)
+|||||++.+.|.+ +..+|+||.-.+ .+|.+++.. ...+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc---CCCchHHHHHHHHH
Confidence 59999999998764 124699998765 499999975 45677777779999
Q ss_pred HHHHHHHHhcCCCCCcccCCCCCCceEEc--CC--CcEEEeccccceecC-----------------CCCcCCCcccccC
Q 048314 124 VAKGILYLHDECEPPILHCDIKPQNILMD--EF--WTAKISDFGLAKLLS-----------------DKGCMAPECYKRT 182 (274)
Q Consensus 124 i~~~l~~lh~~~~~~i~h~dl~~~nil~~--~~--~~~kl~d~g~~~~~~-----------------~~~~~ape~~~~~ 182 (274)
+++|+.|||.+ ++-|||+|++|||+. ++ -.+.++|||++---. +-.-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 999999999999983 33 356789999874322 2346899987543
Q ss_pred C------CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHh
Q 048314 183 P------ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWC 256 (274)
Q Consensus 183 ~------~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 256 (274)
+ --.++|.|+.|.+.||++....||...+.-. + ....+++---| ..|..+++.+.+++...
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~----L--------~~r~Yqe~qLP-alp~~vpp~~rqlV~~l 493 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML----L--------DTRTYQESQLP-ALPSRVPPVARQLVFDL 493 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe----e--------chhhhhhhhCC-CCcccCChHHHHHHHHH
Confidence 2 1368999999999999999999997421100 0 00111110001 36677888899999999
Q ss_pred hccCCCCCCChhhHH
Q 048314 257 VQDEPALRPSMKCVV 271 (274)
Q Consensus 257 l~~dp~~Rps~~evl 271 (274)
|+.||.+|||..-..
T Consensus 494 L~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 494 LKRDPSKRVSPNIAA 508 (598)
T ss_pred hcCCccccCCccHHH
Confidence 999999999965433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-19 Score=161.36 Aligned_cols=208 Identities=17% Similarity=0.069 Sum_probs=165.9
Q ss_pred CCCCCCCCcchhHHHH-------------HH-HHHhcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceEEEEe
Q 048314 30 NDRNSPRSKSVWSCMR-------------AL-MATVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 30 ~g~g~~~~g~vy~~~~-------------~~-~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
+|.|.+ |.|+.+.+ .. ++....+ .......|..++..++ ||.+|++.-.+..+...+++++|
T Consensus 2 lg~g~~--gkvfLvrk~~g~da~~~yamkvl~k~t~~~~-~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 2 LGQGSY--GKVFLVRKAGGADAGHLYAMKVLKKATLKVR-DRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCcCCC--cchHHHHHhccccccchhhhhcccccccccc-cccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 577888 88877711 11 1122222 2225668999999998 99999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec------
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------ 168 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------ 168 (274)
..+|.|-..+.. ...+.+.....+...++.+++++|+. ++++||+|++||+++.+|++++.|||+++..
T Consensus 79 ~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999988877764 45678888888899999999999999 9999999999999999999999999998753
Q ss_pred -CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc-CCccCHHHH
Q 048314 169 -SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTEVDKKNL 246 (274)
Q Consensus 169 -~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 246 (274)
++..|||||+.. .....+|.||||++.+||++|..||... ....+.. .-..|....
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il~~~~~~p~~l~ 211 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRILKAELEMPRELS 211 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHhhhccCCchhhh
Confidence 277899999998 5678899999999999999999999741 1111222 114666777
Q ss_pred HHHHHHHHHhhccCCCCCCCh
Q 048314 247 ENLVKVGLWCVQDEPALRPSM 267 (274)
Q Consensus 247 ~~~~~li~~cl~~dp~~Rps~ 267 (274)
....+++..++..+|.+|--.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhcc
Confidence 888889999999999888543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-18 Score=141.09 Aligned_cols=131 Identities=14% Similarity=0.042 Sum_probs=98.4
Q ss_pred ccccccCCCCCCCCcchhHHHHH---HHHHhcC--CCCCCcHHHHHHHHhcC-----CCCccceEeEEEEeCC---cce-
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMRA---LMATVNS--PYSPSRPLTLTSIVSRV-----SWTTDIEVSSVAMRGS---KPS- 89 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~~---~~~~~~~--~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 89 (274)
.+...+||.|++ |.||.-... ++|.... ....+.+.+|+.+++.+ .||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~--~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRH--RKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCc--eEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 345788999999 999964111 1221111 12345678999999999 5799999999998763 433
Q ss_pred EEEEe--CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCcccCCCCCCceEEcC----CCcEEEecc
Q 048314 90 TEAAL--DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGI-LYLHDECEPPILHCDIKPQNILMDE----FWTAKISDF 162 (274)
Q Consensus 90 lv~e~--~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l-~~lh~~~~~~i~h~dl~~~nil~~~----~~~~kl~d~ 162 (274)
+|+|| +.+|+|.+++.+ ..+++. ..++.+++.++ .|||++ +|+||||||+||+++. +..++|+|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 558999999975 236655 35577888777 999999 9999999999999973 347999995
Q ss_pred cc
Q 048314 163 GL 164 (274)
Q Consensus 163 g~ 164 (274)
+.
T Consensus 154 ~G 155 (210)
T PRK10345 154 IG 155 (210)
T ss_pred CC
Confidence 43
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.3e-18 Score=135.50 Aligned_cols=168 Identities=10% Similarity=-0.036 Sum_probs=119.8
Q ss_pred cccccCCCCCCCCcchhHHH----HHHHHHhcCCCC-CC-----cHHHHHHHHhcCC-CCccceEeEEEEeCCcceEEEE
Q 048314 25 CRSSLNDRNSPRSKSVWSCM----RALMATVNSPYS-PS-----RPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 25 ~~~~~~g~g~~~~g~vy~~~----~~~~~~~~~~~~-~~-----~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 93 (274)
.....+++++| |.||... +++.+....... .+ .+.+|+++|+++. |+++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f--~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTF--GRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCc--ceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34677999999 9999662 222111111111 11 3678999999996 5889999987 34699999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCC-CCCceEEcCCCcEEEeccccceecC---
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDI-KPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl-~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
|+.|.+|.+.+.. . ...++.|++.+|.++|+. |++|||| ||.||+++.++.++|+|||++....
T Consensus 79 yI~G~~L~~~~~~---~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 79 YLAGAAMYQRPPR---G------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eecCccHHhhhhh---h------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999998755421 1 135778999999999999 9999999 7999999999999999999997543
Q ss_pred ---------------------CCCcCCCcccccC-CCc-cccceeehhHhHHHHhhcCCCcccc
Q 048314 170 ---------------------DKGCMAPECYKRT-PIS-VKADVYGYGIVLLETICCWENMEID 210 (274)
Q Consensus 170 ---------------------~~~~~ape~~~~~-~~~-~~~Di~s~G~~l~el~~g~~p~~~~ 210 (274)
++.+++|+-.... ..+ ...+.++.|.-+|.++||+.+...+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 2223344322111 122 3455668999999999998887544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.2e-19 Score=144.33 Aligned_cols=163 Identities=10% Similarity=-0.019 Sum_probs=119.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH----HHHHHhcCC-CCCC----------cHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR----ALMATVNSP-YSPS----------RPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~----~~~~~~~~~-~~~~----------~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
.++|...+++|.|+| |.||.... .++|..... ...+ .+.+|+..+.++.|++|.....++...
T Consensus 30 ~~~y~~~~~l~~~~f--~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDD--TKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCc--eEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467888999999999 99997511 112222211 1111 156899999999999999998876532
Q ss_pred --------CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcE
Q 048314 86 --------SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 157 (274)
Q Consensus 86 --------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~ 157 (274)
+..+|+|||++|.+|.++.. ++. ....+++.++..+|+. +++|+|++|.|++++.++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 35799999999999988742 232 3456999999999999 999999999999999888 9
Q ss_pred EEeccccceecCCCCcCCCcccccCCCccccceeehhHhHHHH
Q 048314 158 KISDFGLAKLLSDKGCMAPECYKRTPISVKADVYGYGIVLLET 200 (274)
Q Consensus 158 kl~d~g~~~~~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el 200 (274)
+++|||........ .....++....+..++|+||||+++.-.
T Consensus 174 ~liDfg~~~~~~e~-~a~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 174 RIIDLSGKRCTAQR-KAKDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEEECCCcccccch-hhHHHHHHHhHhcccccccceeEeehHH
Confidence 99999987544211 1111133444567899999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-19 Score=167.84 Aligned_cols=227 Identities=15% Similarity=0.089 Sum_probs=158.0
Q ss_pred hccccccCCCCCCCCcchhHH-----HHHHHHHhcCC--CCCCcHH---HHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC-----MRALMATVNSP--YSPSRPL---TLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~-----~~~~~~~~~~~--~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
++...+.+|.+.| =+|.++ .+++|..++.. .+.+.|. .|++ ..-.+|||.+.+--+-..+.-.|||=
T Consensus 24 e~~~~~~LGstRF--lKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRF--LKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhh--hhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 5666777888888 677666 21111111111 2334444 4555 45568999998887766666778888
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
+|..+ +|+|.+.. ..-+..-+.+.++-|++.||.-+|.. ||.|+|||.+|||+..=..+.|+||..-+..-
T Consensus 101 qyvkh-nLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHhh-hhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 98865 89999975 23367778888999999999999999 99999999999999887788999987654321
Q ss_pred ---------------CCCcCCCccccc----------CC-CccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHH
Q 048314 170 ---------------DKGCMAPECYKR----------TP-ISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNW 222 (274)
Q Consensus 170 ---------------~~~~~ape~~~~----------~~-~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 222 (274)
...|.|||.+-. .. .+++.||||+||++.|+++ |++||... +.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----------QL 244 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----------QL 244 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----------HH
Confidence 124899997643 12 5788999999999999976 68888532 11
Q ss_pred HHHHHh-hhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 223 VYKCFI-NRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 223 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
....-. .......+.. + ....+.+++..|++.||++|-|+++.|+.
T Consensus 245 ~aYr~~~~~~~e~~Le~--I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 245 LAYRSGNADDPEQLLEK--I---EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhHhccCccCHHHHHHh--C---cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111100 0001111111 1 11368899999999999999999999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=5e-18 Score=136.64 Aligned_cols=100 Identities=12% Similarity=-0.040 Sum_probs=80.2
Q ss_pred HHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCcc
Q 048314 62 TLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYL-HDECEPPIL 140 (274)
Q Consensus 62 ~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~~i~ 140 (274)
+|++.+.++.++++.....+.. ...+|||||++++++...... ...++......++.|++.+|.++ |+. +++
T Consensus 68 ~E~~~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---gii 140 (190)
T cd05147 68 KEMRNLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLV 140 (190)
T ss_pred HHHHHHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 4999999998887744332222 223899999998877655432 35789999999999999999999 688 999
Q ss_pred cCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 141 HCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 141 h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
|||+||+||+++ ++.++|+|||++....
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 999999999998 4689999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.8e-17 Score=146.14 Aligned_cols=161 Identities=20% Similarity=0.187 Sum_probs=122.8
Q ss_pred cceEEEEeCCCCCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 87 KPSTEAALDLPWDLAYIIFCS-AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
.+++.|++|...+|.+||.++ .....++.....++.|++.|+.| + +.+|+|+||.||.+..+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 579999999999999999854 33458999999999999999999 6 9999999999999999999999999987
Q ss_pred eecC-----------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHH
Q 048314 166 KLLS-----------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCF 227 (274)
Q Consensus 166 ~~~~-----------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (274)
.... +..||+||.+.+..|+.++||||+|++++|++. -...+... . ....+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-------~----t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-------A----TLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-------H----hhhhh
Confidence 5432 567999999999999999999999999999985 22222110 0 00111
Q ss_pred hhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhH
Q 048314 228 INRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCV 270 (274)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ev 270 (274)
.++.+++. .....+.-.+|+.+++...|.+||++.++
T Consensus 473 r~g~ip~~------~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RDGIIPPE------FLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCCCChH------HhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 12211110 01112344689999999999999977664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.1e-17 Score=130.94 Aligned_cols=101 Identities=13% Similarity=-0.055 Sum_probs=81.2
Q ss_pred HHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCc
Q 048314 61 LTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPI 139 (274)
Q Consensus 61 ~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i 139 (274)
..|...+.++.|+++.....+... ..+|||||++++++...... ...++......++.|++.++.++|+ . ++
T Consensus 67 ~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~---gi 139 (190)
T cd05145 67 EKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEA---GL 139 (190)
T ss_pred HHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhC---CE
Confidence 468899999999987444433333 24899999998755443222 3467888999999999999999999 8 99
Q ss_pred ccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 140 LHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 140 ~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+|||+||+||+++ ++.++++|||++....
T Consensus 140 vHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 140 VHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred ecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 9999999999998 7899999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-16 Score=132.10 Aligned_cols=185 Identities=15% Similarity=0.035 Sum_probs=152.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 93 (274)
.-.|.....||.|.| |..+.|.. +++|.-..+.....+..|.+..+.|. -++|...+-+..++-+-.||+|
T Consensus 27 G~hyrVGkKIGeGsF--G~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSF--GVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcc--eeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 446888899999999 99999922 22333333345566789999999887 5999999988888888899999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC-----CcEEEeccccceec
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-----WTAKISDFGLAKLL 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-----~~~kl~d~g~~~~~ 168 (274)
+. |.||+|.+.- -++.++.+++.-++.|++.-+.|+|++ .+|.|||||+|.||... -.+-++|||+++..
T Consensus 105 LL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 76 6799999876 567899999999999999999999999 99999999999999743 34789999999753
Q ss_pred C------------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCC
Q 048314 169 S------------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDAS 212 (274)
Q Consensus 169 ~------------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~ 212 (274)
. |.+||+-..-.+.+.+...|+=|+|-++...+-|..||+....
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 3 4568888777778888999999999888888899999986533
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.5e-16 Score=127.90 Aligned_cols=182 Identities=16% Similarity=0.047 Sum_probs=143.1
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcCCC-CccceEeEEEEeCCcceEEEEe
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRVSW-TTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~ 94 (274)
+.|.-.+-||.|+| |..|.|. .+++|.-.+.-.-.....|.++...|++ ..|..+..+..+...-.|||++
T Consensus 15 gky~lvrkiGsGSF--GdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSF--GDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCch--hheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 45666788999999 9999992 2223322232334457789999999986 6788888888888899999997
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC---cEEEeccccceecC--
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKISDFGLAKLLS-- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~---~~kl~d~g~~~~~~-- 169 (274)
. |.||++.+.- -.+.++.++++-++-|++.-+.|+|.+ +.+||||||+|.|..-+. .+-++|||+++...
T Consensus 93 L-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 93 L-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred c-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 6 6799998864 456799999999999999999999999 999999999999987544 46799999997532
Q ss_pred ----------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCcccc
Q 048314 170 ----------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEID 210 (274)
Q Consensus 170 ----------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~ 210 (274)
|..|.+-....+...+...|+=|+|-++...--|..||+..
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 33465555444555678899999998888888899999865
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-16 Score=147.96 Aligned_cols=131 Identities=15% Similarity=0.111 Sum_probs=104.8
Q ss_pred hhccccccCCCCCCCCcchhHH----HHHHHH-HhcCC---------CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC----MRALMA-TVNSP---------YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~----~~~~~~-~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
..|.....+|+|+| |.||+| ...+++ ..... ...+++.+|++++.+++|+|++....++.+...
T Consensus 333 ~~~~~~~~iG~G~~--g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAE--ADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCc--EEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34455788999999 999995 111111 11110 112456789999999999999988888877778
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++++|.+++. ....++.+++.+|.+||+. +++|||+||+||++ .++.++++|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999885 3467899999999999999 99999999999999 677899999999865
Q ss_pred c
Q 048314 168 L 168 (274)
Q Consensus 168 ~ 168 (274)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.9e-16 Score=126.60 Aligned_cols=128 Identities=16% Similarity=0.117 Sum_probs=103.1
Q ss_pred ccCCCCCCCCcchhHHH----HHHHHHhcCCC----------CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 28 SLNDRNSPRSKSVWSCM----RALMATVNSPY----------SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~----~~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
..+|+|.+ |.||+|. .+++|...... ...++.+|+.++..+.|+|+.....++.+.+..+++||
T Consensus 2 ~~l~~G~~--~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAE--AEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCce--EEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 46899999 9999992 22222222111 01346689999999999998777777777788899999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
|++|++|.+++... .+ .+..++.+++.+|.++|+. +++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999752 22 7888999999999999999 999999999999998 78899999998755
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.5e-16 Score=125.65 Aligned_cols=124 Identities=16% Similarity=0.140 Sum_probs=96.1
Q ss_pred cCCCCCCCCcchhHHH----HHHHHHhcCC-CC---------CCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 29 LNDRNSPRSKSVWSCM----RALMATVNSP-YS---------PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~----~~~~~~~~~~-~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
++|+|++ |.||+|. .+++|..... .. .+++.+|++++..++|+++.....++...+..+++|||
T Consensus 1 ~ig~G~~--~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAE--AIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCce--EEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 5899999 9999994 2222221111 00 13355899999999988765555555566778999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
++|++|.+++.... . .++.+++.+|.++|+. +++|+|++|.|++++ ++.++++|||.+..
T Consensus 79 ~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999886411 1 7899999999999999 999999999999998 78999999998755
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.4e-16 Score=129.33 Aligned_cols=154 Identities=18% Similarity=0.189 Sum_probs=103.6
Q ss_pred ceEEEEeCCCCCHHHHHHh---CCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 88 PSTEAALDLPWDLAYIIFC---SAER--NPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~---~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
.+++|+-+ .++|.+++.. .... .+....+..+..|++..+++||+. |++|+||+|+|++++.+|.+.|+||
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcCh
Confidence 36788876 4688888652 1111 244555677789999999999999 9999999999999999999999999
Q ss_pred ccceecC--------CCCcCCCccccc--------CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH
Q 048314 163 GLAKLLS--------DKGCMAPECYKR--------TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226 (274)
Q Consensus 163 g~~~~~~--------~~~~~ape~~~~--------~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (274)
+.....+ +..|.+||.... ..++.+.|.|++|+++|.|.+|..||..........
T Consensus 190 ~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~--------- 260 (288)
T PF14531_consen 190 SSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE--------- 260 (288)
T ss_dssp GGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG---------
T ss_pred HHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc---------
Confidence 8765444 345888886643 246889999999999999999999997441111000
Q ss_pred HhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCC
Q 048314 227 FINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALR 264 (274)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 264 (274)
..+.. -. +.++.+..||..+|+.||.+|
T Consensus 261 -------~~f~~--C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 261 -------WDFSR--CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -------GGGTT--SS----HHHHHHHHHHT-SSGGGS
T ss_pred -------ccchh--cC-CcCHHHHHHHHHHccCCcccC
Confidence 01111 22 667889999999999999988
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.9e-15 Score=126.59 Aligned_cols=191 Identities=16% Similarity=0.187 Sum_probs=134.9
Q ss_pred HHHHhcCCCCccceEeEEEEe-----CCcceEEEEeCCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 048314 64 TSIVSRVSWTTDIEVSSVAMR-----GSKPSTEAALDLPWDLAYIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECE 136 (274)
Q Consensus 64 ~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~ 136 (274)
..-|-++-|.|||+++.|+.+ .....++.|||..|++.+||++.+ ...+......+|+.||..||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 344556679999999999865 345789999999999999998642 23488888899999999999999995 8
Q ss_pred CCcccCCCCCCceEEcCCCcEEEecccccee---------------cCCCCcCCCcccccCCCccccceeehhHhHHHHh
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKL---------------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETI 201 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~---------------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~ 201 (274)
++++|+++..+.|.+..++-+|+..-..... .+.++|.+||.-.....+..+|||+||...++|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 8999999999999999888887753222111 1145788888666556678899999999999987
Q ss_pred hcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 202 CCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+.--.....+.. . ....+.+.+-. .....-.+++..|++-.|..||+|.+++-
T Consensus 277 ilEiq~tnseS~~--~----------~ee~ia~~i~~-----len~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKV--E----------VEENIANVIIG-----LENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCccee--e----------hhhhhhhheee-----ccCccccCcCcccccCCCCCCcchhhhhc
Confidence 6643321110100 0 00011111100 00011246778899999999999998763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.2e-16 Score=150.63 Aligned_cols=186 Identities=17% Similarity=0.131 Sum_probs=140.8
Q ss_pred hhhhHHHHhhhccccccCCCCCCCCcchhHHHHHHHH----HhcCCCCCCcHHHHHHHHhcCC---CCccceEeEEEEeC
Q 048314 13 ARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMRALMA----TVNSPYSPSRPLTLTSIVSRVS---WTTDIEVSSVAMRG 85 (274)
Q Consensus 13 ~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~~~~~----~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 85 (274)
+.+++..-...|.....+|.|++ |.||+|.---.+ ++.++...=+|--=.+++.+|+ -+-|..+.....-.
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y--~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSY--GSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ccceeeecceeEEEEeeeccccc--eEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 34455555667888999999999 999999221111 1111112222333344566665 23344444444556
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc-------CCCcEE
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-------EFWTAK 158 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-------~~~~~k 158 (274)
+.-+||+||.+.|+|.+++. ..+.++|...+.++.|++.-+..||.. +|||+||||+|+++. ....++
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred CcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 66789999999999999997 467799999999999999999999999 999999999999984 345689
Q ss_pred EeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCC
Q 048314 159 ISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWE 205 (274)
Q Consensus 159 l~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~ 205 (274)
|+|||.+--+. +..+-++|+..+.+|++..|.|.++.+++-|+.|+-
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999985332 456789999999999999999999999999998853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.6e-15 Score=140.72 Aligned_cols=201 Identities=19% Similarity=0.182 Sum_probs=135.3
Q ss_pred hHHHHhhhccccccCCCCCCCCcchhHHHHHHHHHhcCCCCCCcHHHHHHHHhcCCCCccc-eEeEEEEeCCcceEEEEe
Q 048314 16 SLCTKLRNFCRSSLNDRNSPRSKSVWSCMRALMATVNSPYSPSRPLTLTSIVSRVSWTTDI-EVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 16 ~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 94 (274)
.....-.+|...+++..|.+ |.||.+.. +..+.+|.. +++-.|+| |=+. ..-+.++.|
T Consensus 77 ~~~p~e~df~~IklisngAy--gavylvrh--------~~trqrfa~------kiNkq~lilRnil--t~a~npfvv--- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAY--GAVYLVRH--------KETRQRFAM------KINKQNLILRNIL--TFAGNPFVV--- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCC--Cceeeeec--------cccccchhh------cccccchhhhccc--cccCCccee---
Confidence 34445679999999999999 99998721 111122211 11211211 1011 111233444
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
|+-...+.. -+.++.. ++.++.|||+. +|+|||+||+|.++..-|++|+.|||+++...
T Consensus 136 ---gDc~tllk~--~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKN--IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhccc--CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 455555654 2334422 27789999999 99999999999999999999999999986432
Q ss_pred ---------------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh
Q 048314 170 ---------------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI 228 (274)
Q Consensus 170 ---------------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (274)
++.|.|||++....|+..+|.|++|+++||.+.|.-||..+ .+ +..+..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd-tp--eelfg~------- 269 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TP--EELFGQ------- 269 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC-CH--HHHHhh-------
Confidence 67899999999999999999999999999999999999754 11 111111
Q ss_pred hhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCC
Q 048314 229 NRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRP 265 (274)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 265 (274)
-+.+.+.-.+-+.....+..+++.+.|+.+|..|-
T Consensus 270 --visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 270 --VISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred --hhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 11111111122445567889999999999999984
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.6e-15 Score=122.94 Aligned_cols=141 Identities=11% Similarity=-0.035 Sum_probs=103.2
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHH-H------HHHHHhcCCCC-----------C---------------CcHHHH
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCM-R------ALMATVNSPYS-----------P---------------SRPLTL 63 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~-~------~~~~~~~~~~~-----------~---------------~~~~~e 63 (274)
+......|...+.+|.|++ |.||++. . .++|....... . ..+..|
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~--g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 100 (237)
T smart00090 23 LLNRGILSAIGGCISTGKE--ANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE 100 (237)
T ss_pred HHhcCchHHhCCeeccCcc--eeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence 4444556778899999999 9999985 1 11222221100 0 113479
Q ss_pred HHHHhcCCCCc--cceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-cc
Q 048314 64 TSIVSRVSWTT--DIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP-IL 140 (274)
Q Consensus 64 ~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~-i~ 140 (274)
+.++.++.+.+ +.+.+++ ...++||||+++++|...+.. ...+.......++.|++.++.+||+. + ++
T Consensus 101 ~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---g~ii 171 (237)
T smart00090 101 FRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKE---GELV 171 (237)
T ss_pred HHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhc---CCEE
Confidence 99999997633 4455543 235899999999888776532 33466667788999999999999999 9 99
Q ss_pred cCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 141 HCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 141 h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
|+|+||+||+++ ++.++++|||.+....
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999998 7889999999876544
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-13 Score=113.66 Aligned_cols=103 Identities=15% Similarity=0.077 Sum_probs=83.4
Q ss_pred CCCcHHHHHHHHhcCCCCcc--ceEeEEEEeCC----cceEEEEeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH
Q 048314 56 SPSRPLTLTSIVSRVSWTTD--IEVSSVAMRGS----KPSTEAALDLP-WDLAYIIFCSAERNPYWNQRVRIALDVAKGI 128 (274)
Q Consensus 56 ~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l 128 (274)
...++.+|+.++.+++|++| ++.+++..... ..++|||++++ .+|.+++.. ..++.. .+.+++.++
T Consensus 83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l 155 (239)
T PRK01723 83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLI 155 (239)
T ss_pred hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHH
Confidence 34567889999999998885 77887754322 23599999997 699999864 345544 356899999
Q ss_pred HHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 129 LYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 129 ~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
.+||+. ||+|+|+||.|||++.++.++++|||.+...
T Consensus 156 ~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 156 ARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred HHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 999999 9999999999999998889999999987653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.6e-14 Score=114.45 Aligned_cols=138 Identities=10% Similarity=-0.030 Sum_probs=100.2
Q ss_pred hhhHHHHhhhccccccCCCCCCCCcchhHHHH-----HHHHHhcCC------------------------CCCCcHHHHH
Q 048314 14 RSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSP------------------------YSPSRPLTLT 64 (274)
Q Consensus 14 ~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~------------------------~~~~~~~~e~ 64 (274)
..++......+...+.+|.|++ |.||++.. .++|..... ........|+
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~--g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 84 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKE--SDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEF 84 (198)
T ss_pred HHHHHHcCchhhcCCccccCcc--eEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHH
Confidence 3455555555777889999999 99998822 111111100 0011245788
Q ss_pred HHHhcCCCCc--cceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccC
Q 048314 65 SIVSRVSWTT--DIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHC 142 (274)
Q Consensus 65 ~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~ 142 (274)
.++.++.|++ +++.++. ...++||||+++++|...... .....++.+++.++.++|+. +++|+
T Consensus 85 ~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~ 149 (198)
T cd05144 85 AALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHG 149 (198)
T ss_pred HHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcC
Confidence 8999988874 4555542 456999999999998765431 23457889999999999999 99999
Q ss_pred CCCCCceEEcCCCcEEEeccccceec
Q 048314 143 DIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 143 dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
|++|.||+++.++.++++|||.+...
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCccccC
Confidence 99999999999999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-13 Score=106.25 Aligned_cols=130 Identities=16% Similarity=0.027 Sum_probs=102.5
Q ss_pred cccCCCCCCCCcchhHHHH----HHHHHhcCCCCCCcHHHHHHHHhcCCC--CccceEeEEEEeCCcceEEEEeCCCCCH
Q 048314 27 SSLNDRNSPRSKSVWSCMR----ALMATVNSPYSPSRPLTLTSIVSRVSW--TTDIEVSSVAMRGSKPSTEAALDLPWDL 100 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~----~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 100 (274)
.+.+|.|.+ +.||++.. .++|..........+..|+.++..++| .++++++++....+..++++||++++++
T Consensus 3 ~~~i~~g~~--~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLT--NRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccc--cceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 356889999 99998832 112222221113468899999999987 5899999998888889999999988766
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 101 AYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 101 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
..+ +......++.+++.++..+|.....+++|+|++|.|++++..+.+++.|||.+..
T Consensus 81 ~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 5566778899999999999986334799999999999999988999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.1e-14 Score=132.58 Aligned_cols=232 Identities=20% Similarity=0.171 Sum_probs=165.8
Q ss_pred hccccccCCCCCCCCcchhHH-------HHHHHHHhcCC-CCC---CcHHHHHHHHhcCC-CCccceEeEEEEeCCcceE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC-------MRALMATVNSP-YSP---SRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~~~~-~~~---~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 90 (274)
.|....-+|.|.+ +.|-.. ...+.+.+... ... +....|..+-..+. |+|++++++...+....++
T Consensus 21 ~~~~~~~ig~gs~--~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 21 QYKLSRSIGKGSF--SSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccc--chhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4444556888888 555544 11112222211 112 22234777777777 9999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHh-cCCCCCcccCCCCCCceEEcCCC-cEEEecccccee
Q 048314 91 EAALDLPWDLAYIIFCSAER-NPYWNQRVRIALDVAKGILYLH-DECEPPILHCDIKPQNILMDEFW-TAKISDFGLAKL 167 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~-~l~~~~~~~~~~~i~~~l~~lh-~~~~~~i~h~dl~~~nil~~~~~-~~kl~d~g~~~~ 167 (274)
.++|..++++.+.+.. ... ..+....-.++.|+..++.|+| .. ++.|+|++|+|.+++..+ ..+++|||++..
T Consensus 99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999888842 233 5677788889999999999999 77 999999999999999998 999999999864
Q ss_pred cC---------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhh
Q 048314 168 LS---------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRE 231 (274)
Q Consensus 168 ~~---------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (274)
.. ++.|.|||...+. -..+..|+||.|+++..+++|..|+......... ...|... ..
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~~~~----~~ 248 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSWKSN----KG 248 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--ceeeccc----cc
Confidence 32 5679999988774 3468899999999999999999999754222211 1111100 00
Q ss_pred hhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhH
Q 048314 232 LNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCV 270 (274)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ev 270 (274)
. ..............+++..++..+|..|.+.+++
T Consensus 249 ~----~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 249 R----FTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred c----cccCccccCChhhhhcccccccCCchhccccccc
Confidence 0 0011233445567788888999999999998876
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.8e-13 Score=119.27 Aligned_cols=229 Identities=21% Similarity=0.177 Sum_probs=165.5
Q ss_pred hhccccccCCC--CCCCCcchhHH---------HHHHHH---HhcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCC
Q 048314 22 RNFCRSSLNDR--NSPRSKSVWSC---------MRALMA---TVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGS 86 (274)
Q Consensus 22 ~~f~~~~~~g~--g~~~~g~vy~~---------~~~~~~---~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 86 (274)
..|....-+|. |.+ |.||++ ..+.++ -........+=.+|+...+.++ |+|.++.+..+.+.+
T Consensus 114 ~~~~~~~~~g~~~g~~--~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSK--GSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhcccccccccCCCCC--ceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 45566777888 999 999988 112222 1111233444567888888887 999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCcccCCCCCCceEEcCC-CcEEEec
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAK----GILYLHDECEPPILHCDIKPQNILMDEF-WTAKISD 161 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~----~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~d 161 (274)
..++-+|+|. .+|.++... ...-++....+....+... ||.++|+. .++|-|+||.||.+..+ ..++++|
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred cceeeecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 9999999886 788888876 3344777777887778777 99999999 99999999999999998 7889999
Q ss_pred cccceecC----------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH
Q 048314 162 FGLAKLLS----------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225 (274)
Q Consensus 162 ~g~~~~~~----------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (274)
||+...++ ...|++||..++ .++...|+|++|.+..+.+++..++...... .|.
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W~-- 336 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS-------SWS-- 336 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC-------Ccc--
Confidence 99876554 235899996654 5688999999999999999887776433111 110
Q ss_pred HHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 226 CFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..++...+.++-.....++...+.+|+..+|-.|++...+..
T Consensus 337 -----~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 -----QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 011111111122222344555888999999999999887754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=4e-12 Score=101.86 Aligned_cols=96 Identities=11% Similarity=-0.053 Sum_probs=68.7
Q ss_pred HHHHHHhcCCCCc--cceEeEEEEeCCcceEEEEeCCCCCHHHH-HHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCC
Q 048314 62 TLTSIVSRVSWTT--DIEVSSVAMRGSKPSTEAALDLPWDLAYI-IFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEP 137 (274)
Q Consensus 62 ~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~ 137 (274)
.|...+.++.+.. +.+.++. ...++||||++++++... +.. .... .....++.+++.++.++|. .
T Consensus 66 ~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~---~~~~-~~~~~~~~~~~~~l~~lh~~~--- 134 (187)
T cd05119 66 KEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKD---VRLL-EDPEELYDQILELMRKLYREA--- 134 (187)
T ss_pred HHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhh---hhhc-ccHHHHHHHHHHHHHHHhhcc---
Confidence 4555555554432 4444443 246999999998543221 111 0011 5678899999999999999 8
Q ss_pred CcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+++|+|++|+||+++ ++.++++|||.+....
T Consensus 135 ~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 135 GLVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 999999999999999 8899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.1e-11 Score=111.64 Aligned_cols=230 Identities=17% Similarity=0.106 Sum_probs=163.3
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHH--------HHHHHHhc---CCCCCCcHHHHHHHHhcCC-CCccceEeEEEEe
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCM--------RALMATVN---SPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMR 84 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~--------~~~~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 84 (274)
....+.+|+....+|.|.| +.|+++. .+++...+ ...+...-+.|+.+...+. |.++++....|..
T Consensus 260 ~s~~~~df~~v~~i~~~~~--~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNF--SSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred ceeecCCcceeEEccCCcc--ccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 4556778999999999999 8888852 12222111 1112222246666666665 8999998888887
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC-CcEEEeccc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKISDFG 163 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~d~g 163 (274)
..+.++-.|||.++++..... ....+....++++..|++.++.++|+. .++|.|++|+||++..+ +..++.|||
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cccccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence 777889999999998887774 245678888999999999999999998 99999999999999886 888999999
Q ss_pred cceecC--------CCCcC--CCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 164 LAKLLS--------DKGCM--APECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 164 ~~~~~~--------~~~~~--ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
++.... ..++. ++.......+..+.|++|||..+.+.++|...-... . . ..
T Consensus 413 ~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~--------~----------~~ 473 (524)
T KOG0601|consen 413 CWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-V--------Q----------SL 473 (524)
T ss_pred cccccceecccccccccccccchhhccccccccccccccccccccccccCcccCccc-c--------c----------ce
Confidence 886322 22333 454555667889999999999999988875543221 0 0 00
Q ss_pred hhhcCC-ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 KLVRGT-EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 ~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+..+. +........+..+...+...++..||++.++..
T Consensus 474 ~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 474 TIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred eeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 001110 112222366777888899999999999887643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.6e-10 Score=104.07 Aligned_cols=133 Identities=11% Similarity=0.104 Sum_probs=105.3
Q ss_pred HHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 048314 60 PLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPI 139 (274)
Q Consensus 60 ~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i 139 (274)
..+-++.|+.++||||++++..+...+..|||+|-+. -|..++.+ +....+.--+.||+.||.+||+.| ++
T Consensus 56 ~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~--~l 126 (690)
T KOG1243|consen 56 AKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDC--NL 126 (690)
T ss_pred HHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccC--Ce
Confidence 4567888999999999999999999999999999885 47888876 334444555789999999998664 99
Q ss_pred ccCCCCCCceEEcCCCcEEEeccccceecCCC-----------CcCCCcccccCCCccccceeehhHhHHHHhhc
Q 048314 140 LHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-----------GCMAPECYKRTPISVKADVYGYGIVLLETICC 203 (274)
Q Consensus 140 ~h~dl~~~nil~~~~~~~kl~d~g~~~~~~~~-----------~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g 203 (274)
+|++|.-+.+++...|.-||++|.+....... .|..|+.+.... -..|.|-||++++|++.|
T Consensus 127 vHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 127 VHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 99999999999999999999998876543311 134444332211 346999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.9e-10 Score=109.36 Aligned_cols=194 Identities=16% Similarity=0.105 Sum_probs=139.6
Q ss_pred CcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 048314 58 SRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEP 137 (274)
Q Consensus 58 ~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 137 (274)
+..+.+-.++-..++|-+++..--+.......|+++|..+++|..-|+. -+..+..-.......+.+++.+||+.
T Consensus 849 ~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~--- 923 (1205)
T KOG0606|consen 849 ESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSS--- 923 (1205)
T ss_pred cccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccc---
Confidence 3334444444334456555544444456678999999999999999986 33456556666777888999999998
Q ss_pred CcccCCCCCCceEEcCCCcEEEeccccceecC------------------------------------------CCCcCC
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKLLS------------------------------------------DKGCMA 175 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------------------------------------------~~~~~a 175 (274)
.+.|+|++|.|.++..+++.++++|+.....+ ++.|.+
T Consensus 924 ~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~la 1003 (1205)
T KOG0606|consen 924 LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLA 1003 (1205)
T ss_pred hhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccC
Confidence 79999999999999999999999987322111 456999
Q ss_pred CcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHH
Q 048314 176 PECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLW 255 (274)
Q Consensus 176 pe~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 255 (274)
||...+......+|.|++|+.++|.++|..||..... ...+ . ......+....-+...+....+++..
T Consensus 1004 Pe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp---q~~f-----~----ni~~~~~~~p~g~~~~s~~aq~~~~~ 1071 (1205)
T KOG0606|consen 1004 PEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP---QQIF-----E----NILNRDIPWPEGPEEGSYEAQDLINR 1071 (1205)
T ss_pred CcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch---hhhh-----h----ccccCCCCCCCCccccChhhhhhhhh
Confidence 9999999999999999999999999999999974411 1100 0 00111111113455667788899999
Q ss_pred hhccCCCCCCChh
Q 048314 256 CVQDEPALRPSMK 268 (274)
Q Consensus 256 cl~~dp~~Rps~~ 268 (274)
.+..+|.+|..+.
T Consensus 1072 ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1072 LLTEEPTQRLGAK 1084 (1205)
T ss_pred hhccCchhccCcc
Confidence 9999999998765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.4e-10 Score=87.48 Aligned_cols=123 Identities=11% Similarity=-0.088 Sum_probs=82.3
Q ss_pred cCCCCCCCCcchhHHH----HHHHHHhcCC-CCCCcHHHHHHHHhcCCCCcc-ceEeEEEEeCCcceEEEEeCCCCCHHH
Q 048314 29 LNDRNSPRSKSVWSCM----RALMATVNSP-YSPSRPLTLTSIVSRVSWTTD-IEVSSVAMRGSKPSTEAALDLPWDLAY 102 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~----~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 102 (274)
-++.|.. +.+|++. ..++|..... .....+..|+.++..+.+.++ .+++.+. ....++||||+++.++.+
T Consensus 5 ~l~~G~~--~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 5 PLKGGMT--NKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred ecCCccc--CceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 3566766 7788651 1112222221 123456789999999876554 4555543 334589999999987754
Q ss_pred HHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 103 IIFCSAERNPYWNQRVRIALDVAKGILYLHDEC--EPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 103 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
.. . .......+++.+|+.||+.. ..+++|+|++|.||+++ ++.++++||+.+.
T Consensus 81 ~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 ED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 30 1 11345678999999999981 11259999999999998 5679999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=9.5e-09 Score=80.53 Aligned_cols=100 Identities=16% Similarity=0.077 Sum_probs=79.4
Q ss_pred CCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 048314 57 PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECE 136 (274)
Q Consensus 57 ~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~ 136 (274)
.++..+|+.+++++.--.|.--+=+..+.+...|+|||.+|-.|.+.+... ...++..+-.-+.-||..
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~-- 111 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA-- 111 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc--
Confidence 345678999999987655544444556677788999999999999999752 255677777778889999
Q ss_pred CCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+|+|+||+++|+.+.+.. +-++|||++....
T Consensus 112 -givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 112 -GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred -CeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 999999999999998764 8999999986543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.7e-08 Score=81.09 Aligned_cols=97 Identities=11% Similarity=-0.011 Sum_probs=74.3
Q ss_pred HHHHHHhcCCC--CccceEeEEEEeCCcceEEEEeCCCCCHHH-HHHhCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCC
Q 048314 62 TLTSIVSRVSW--TTDIEVSSVAMRGSKPSTEAALDLPWDLAY-IIFCSAERNPYWNQRVRIALDVAKGILYL-HDECEP 137 (274)
Q Consensus 62 ~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~ 137 (274)
+|++.|+++.. -++.+.+++ ..-+|||||+.+..+.. .+. ...++......+..+++.++..+ |..
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~--- 144 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKEC--- 144 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhC---
Confidence 79999999874 456777765 45789999997654422 222 22455566677889999999988 888
Q ss_pred CcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+++|+|+++.||++.+ +.+.++|||.+....
T Consensus 145 glVHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 145 NLVHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CeecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999999999974 679999999876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.6e-08 Score=84.19 Aligned_cols=106 Identities=14% Similarity=-0.029 Sum_probs=83.7
Q ss_pred cHHHHHHHHhcCCCCcc--ceEeEEEEe-----CCcceEEEEeCCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH
Q 048314 59 RPLTLTSIVSRVSWTTD--IEVSSVAMR-----GSKPSTEAALDLPW-DLAYIIFCSAERNPYWNQRVRIALDVAKGILY 130 (274)
Q Consensus 59 ~~~~e~~~l~~l~h~ni--v~l~~~~~~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~ 130 (274)
.+.+|...+.++...+| +..+++... ...-++|+|++++- +|.+++........+......++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 47789998888864444 566666543 23468999999875 89999864333455667788899999999999
Q ss_pred HhcCCCCCcccCCCCCCceEEcC-------CCcEEEecccccee
Q 048314 131 LHDECEPPILHCDIKPQNILMDE-------FWTAKISDFGLAKL 167 (274)
Q Consensus 131 lh~~~~~~i~h~dl~~~nil~~~-------~~~~kl~d~g~~~~ 167 (274)
||+. |++|+|+++.||+++. +..+.++||+.+..
T Consensus 154 LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9999 9999999999999975 46789999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.3e-08 Score=92.22 Aligned_cols=104 Identities=19% Similarity=0.109 Sum_probs=75.5
Q ss_pred cHHHHHHHHhcCC----CCccceEeEEEEe-CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 048314 59 RPLTLTSIVSRVS----WTTDIEVSSVAMR-GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAK-GILYLH 132 (274)
Q Consensus 59 ~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~-~l~~lh 132 (274)
+|.+|+..+.++. |.+-+.+-.++.+ .+..+|||||++|++|.++.... ....+ ...++..++. .+..+|
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~-~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD-EAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH-hcCCC---HHHHHHHHHHHHHHHHH
Confidence 3566777776653 4444555444433 34579999999999999887642 11222 3456666655 467889
Q ss_pred cCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 133 DECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 133 ~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
.. |++|+|++|.||++..++.++++|||++....
T Consensus 275 ~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 88 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.9e-08 Score=77.67 Aligned_cols=110 Identities=17% Similarity=0.129 Sum_probs=82.1
Q ss_pred CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 048314 56 SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLP-WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDE 134 (274)
Q Consensus 56 ~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~ 134 (274)
...+..+|++.|.++.--.|.----++.+...-.|+|||.++ .++.+++...-...........++..+-..+.-||.+
T Consensus 53 tr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n 132 (229)
T KOG3087|consen 53 TRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN 132 (229)
T ss_pred HHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC
Confidence 355677899999988754553333345566667899999976 5899998864333333333478899999999999999
Q ss_pred CCCCcccCCCCCCceEEcCCC---cEEEeccccceec
Q 048314 135 CEPPILHCDIKPQNILMDEFW---TAKISDFGLAKLL 168 (274)
Q Consensus 135 ~~~~i~h~dl~~~nil~~~~~---~~kl~d~g~~~~~ 168 (274)
+++|+||+.+||++..++ .+-++|||++...
T Consensus 133 ---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 133 ---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999999999999986543 4579999998654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.7e-09 Score=95.40 Aligned_cols=138 Identities=16% Similarity=0.244 Sum_probs=97.0
Q ss_pred HHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--------------------CCCcCCCcccc
Q 048314 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--------------------DKGCMAPECYK 180 (274)
Q Consensus 121 ~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--------------------~~~~~ape~~~ 180 (274)
+.+++.|+.|+|.. .+++|+++.|++|.+..++.-|++.|+.+.... ...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34555899999987 589999999999999999999999988764322 23589999999
Q ss_pred cCCCccccceeehhHhHHHHhhc-CCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhcc
Q 048314 181 RTPISVKADVYGYGIVLLETICC-WENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQD 259 (274)
Q Consensus 181 ~~~~~~~~Di~s~G~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 259 (274)
....+.++|++|+|+++|.+..| +..+...+...... ... . ....... ..+...+.++.+-+.+++..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~----~--~~~~~~~----~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSR----N--LLNAGAF----GYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhh----c--ccccccc----cccccCcHHHHHHHHHHhcC
Confidence 87788999999999999998844 44444332111110 000 0 0000000 13344556777788889999
Q ss_pred CCCCCCChhhHH
Q 048314 260 EPALRPSMKCVV 271 (274)
Q Consensus 260 dp~~Rps~~evl 271 (274)
++.-||++.++.
T Consensus 252 ~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 252 DSAVRPTLDLLL 263 (700)
T ss_pred CcccCcchhhhh
Confidence 999999887764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.6e-07 Score=82.63 Aligned_cols=135 Identities=13% Similarity=0.117 Sum_probs=106.4
Q ss_pred HHHHHHHhcCCCCccceEeEEEE----eCCcceEEEEeCCC-CCHHHHHHhCC-------------CCCCCHHHHHHHHH
Q 048314 61 LTLTSIVSRVSWTTDIEVSSVAM----RGSKPSTEAALDLP-WDLAYIIFCSA-------------ERNPYWNQRVRIAL 122 (274)
Q Consensus 61 ~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~l~~~~-------------~~~l~~~~~~~~~~ 122 (274)
..-+++++++.|+|+|++-.++. .+..+++||.|.++ ++|.+...... +...++..+|.++.
T Consensus 321 t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~ 400 (655)
T KOG3741|consen 321 TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYIS 400 (655)
T ss_pred hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHH
Confidence 34588899999999999988875 35678999999865 78888776431 22367899999999
Q ss_pred HHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecCCCCcCCCcccccCCCccccceeehhHhHHHHhh
Q 048314 123 DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPECYKRTPISVKADVYGYGIVLLETIC 202 (274)
Q Consensus 123 ~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~ 202 (274)
|+..||.++|+. |+--+-|.+.+|++.++..++++..|......... .+| +. .-.+.|.-.||.+++.|.+
T Consensus 401 QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-~~~--le---~~Qq~D~~~lG~ll~aLAt 471 (655)
T KOG3741|consen 401 QLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-TEP--LE---SQQQNDLRDLGLLLLALAT 471 (655)
T ss_pred HHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCCC-Ccc--hh---HHhhhhHHHHHHHHHHHhh
Confidence 999999999999 99889999999999999899998888765543221 111 11 1246788899999999999
Q ss_pred cC
Q 048314 203 CW 204 (274)
Q Consensus 203 g~ 204 (274)
|.
T Consensus 472 ~~ 473 (655)
T KOG3741|consen 472 GT 473 (655)
T ss_pred cc
Confidence 84
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.4e-07 Score=75.57 Aligned_cols=109 Identities=21% Similarity=0.108 Sum_probs=87.1
Q ss_pred CCCCcHHHHHHHHhcCCCCc--cceEeEEEEeCC----cceEEEEeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHH
Q 048314 55 YSPSRPLTLTSIVSRVSWTT--DIEVSSVAMRGS----KPSTEAALDLP-WDLAYIIFCSAERNPYWNQRVRIALDVAKG 127 (274)
Q Consensus 55 ~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~ 127 (274)
....+..+|...+.++...+ +.+.+++..... .-++|+|++++ -+|.+++.... .++......++.+++..
T Consensus 53 ~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 53 LRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARL 130 (206)
T ss_pred ccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHH
Confidence 34556788988888876544 477777766532 34899999987 48999998622 26677788999999999
Q ss_pred HHHHhcCCCCCcccCCCCCCceEEcCCC---cEEEeccccceec
Q 048314 128 ILYLHDECEPPILHCDIKPQNILMDEFW---TAKISDFGLAKLL 168 (274)
Q Consensus 128 l~~lh~~~~~~i~h~dl~~~nil~~~~~---~~kl~d~g~~~~~ 168 (274)
++-||+. |++|+|+++.|||+..+. .+.++||+.++..
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 999999999999998876 7899999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.5e-08 Score=79.21 Aligned_cols=134 Identities=13% Similarity=0.055 Sum_probs=95.9
Q ss_pred cCCCCCCCCcchhHHHH-----HHHHHhcCCC---CCCcHHHHHHHHhcCCC--CccceEeEEEEeC---CcceEEEEeC
Q 048314 29 LNDRNSPRSKSVWSCMR-----ALMATVNSPY---SPSRPLTLTSIVSRVSW--TTDIEVSSVAMRG---SKPSTEAALD 95 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~-----~~~~~~~~~~---~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~ 95 (274)
.++.|.. +.+|++.. .++|...... ....+..|++++..+.+ .++.+++.+..+. +..++||||+
T Consensus 5 ~l~~G~~--n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 5 QLSGGQS--NLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ecCCCcc--ceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 3667777 77887522 1222222211 35677899999999986 3468888887654 3678999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC---------------------------------------- 135 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---------------------------------------- 135 (274)
++.++.+.+.. ..++......++.+++..|..||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99888776531 34677778888888888888888531
Q ss_pred -------------CCCcccCCCCCCceEEcC--CCcEEEecccccee
Q 048314 136 -------------EPPILHCDIKPQNILMDE--FWTAKISDFGLAKL 167 (274)
Q Consensus 136 -------------~~~i~h~dl~~~nil~~~--~~~~kl~d~g~~~~ 167 (274)
...++|+|+.+.||+++. +..+.++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135789999999999988 56689999987643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=2e-07 Score=74.54 Aligned_cols=98 Identities=18% Similarity=0.084 Sum_probs=66.1
Q ss_pred HHHHHHHHhcCCCC--ccceEeEEEEeCCcceEEEEeCC--CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH-HhcC
Q 048314 60 PLTLTSIVSRVSWT--TDIEVSSVAMRGSKPSTEAALDL--PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILY-LHDE 134 (274)
Q Consensus 60 ~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~-lh~~ 134 (274)
..+|.+.|.++..- ++.+.+.+ ..-+|||||++ |..+...... .++......++.+++..+.. +|..
T Consensus 55 ~~~E~~~L~~l~~~Gv~vP~p~~~----~~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~ 126 (188)
T PF01163_consen 55 AKKEFRNLKRLYEAGVPVPKPYDY----NRNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKA 126 (188)
T ss_dssp HHHHHHHHHHCCCTT-SS--EEEE----ETTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHCCccCCcEEEE----eCCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhc
Confidence 45799999999865 56777755 24589999998 6555544432 12234456677777775554 5788
Q ss_pred CCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 135 CEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 135 ~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
|++|+|+++.||++..+ .+.++|||.+....
T Consensus 127 ---givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 127 ---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp ---TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred ---CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 99999999999999887 89999999876654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.6e-07 Score=84.27 Aligned_cols=100 Identities=15% Similarity=0.036 Sum_probs=67.9
Q ss_pred HHHHHHHHhcCC----CCccceEeEEEEe-CCcceEEEEeCCCCCHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHH
Q 048314 60 PLTLTSIVSRVS----WTTDIEVSSVAMR-GSKPSTEAALDLPWDLAYIIFCSAER----NPYWNQRVRIALDVAKGILY 130 (274)
Q Consensus 60 ~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~----~l~~~~~~~~~~~i~~~l~~ 130 (274)
+.+|+..+.++. +.+.+.+-.++++ ....+|||||+.|+.+.++-.....+ .+.......++.|+
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi------ 276 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV------ 276 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH------
Confidence 456666666653 4555666666655 45678999999999998753211111 13333333344444
Q ss_pred HhcCCCCCcccCCCCCCceEEcCCC----cEEEeccccceecC
Q 048314 131 LHDECEPPILHCDIKPQNILMDEFW----TAKISDFGLAKLLS 169 (274)
Q Consensus 131 lh~~~~~~i~h~dl~~~nil~~~~~----~~kl~d~g~~~~~~ 169 (274)
+.. |++|+|++|.||+++.++ .+++.|||+.....
T Consensus 277 -f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 345 999999999999999887 89999999987655
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.2e-06 Score=72.95 Aligned_cols=181 Identities=12% Similarity=0.077 Sum_probs=114.8
Q ss_pred ceEEEEeCCC-CCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEec-
Q 048314 88 PSTEAALDLP-WDLAYIIFCS----AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISD- 161 (274)
Q Consensus 88 ~~lv~e~~~~-gsL~~~l~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d- 161 (274)
.-+.|...++ .-+.+++.-. ......|...++.++.++.+.+-||.. |..-+|+.++|+|+++++.+.|.|
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 4567776644 3444444311 234489999999999999999999999 999999999999999999988876
Q ss_pred --cccc-------eecCCCCcCCCcccccC-----CCccccceeehhHhHHHHhhc-CCCccccCCC-----hhhHHHHH
Q 048314 162 --FGLA-------KLLSDKGCMAPECYKRT-----PISVKADVYGYGIVLLETICC-WENMEIDASK-----PEEIILTN 221 (274)
Q Consensus 162 --~g~~-------~~~~~~~~~ape~~~~~-----~~~~~~Di~s~G~~l~el~~g-~~p~~~~~~~-----~~~~~~~~ 221 (274)
|.+. ...+...|++||.-.-. .-+...|.|.+|+++++++.| ++||...... +.+..+..
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 3322 12335679999965422 346789999999999998776 9999754211 11111111
Q ss_pred HHHHHHhhhhhhhhhcCCccCHH-HHHHHHHHHHHhhcc--CCCCCCChhhHH
Q 048314 222 WVYKCFINRELNKLVRGTEVDKK-NLENLVKVGLWCVQD--EPALRPSMKCVV 271 (274)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~--dp~~Rps~~evl 271 (274)
..+..-.+......-.+...|.. .++++..+-.+|+.. ++.-|||++--+
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 11111011111111112223332 245667777788876 356799987533
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.7e-06 Score=66.22 Aligned_cols=110 Identities=9% Similarity=-0.083 Sum_probs=84.8
Q ss_pred CCCCcHHHHHHHHhcCCCCc--cceEeEEEEe----CCcceEEEEeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHH
Q 048314 55 YSPSRPLTLTSIVSRVSWTT--DIEVSSVAMR----GSKPSTEAALDLP-WDLAYIIFCSAERNPYWNQRVRIALDVAKG 127 (274)
Q Consensus 55 ~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~ 127 (274)
.....|.+|...+.++...+ +.+.+..... .-+-+||+|-+++ -+|.+++.+..-...+...+..++.+++..
T Consensus 61 ~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ 140 (216)
T PRK09902 61 FGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALA 140 (216)
T ss_pred CCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHH
Confidence 45667889999999987433 4555522222 1245899997654 689999876444456788888999999999
Q ss_pred HHHHhcCCCCCcccCCCCCCceEEcCCCc--EEEecccccee
Q 048314 128 ILYLHDECEPPILHCDIKPQNILMDEFWT--AKISDFGLAKL 167 (274)
Q Consensus 128 l~~lh~~~~~~i~h~dl~~~nil~~~~~~--~kl~d~g~~~~ 167 (274)
++-||+. |+.|+|+-+.||+++.++. +.++||..++.
T Consensus 141 ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 141 FKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9999999 9999999999999986566 89999987654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.21 E-value=6.9e-06 Score=65.87 Aligned_cols=100 Identities=15% Similarity=0.047 Sum_probs=80.2
Q ss_pred HHHHHHhcCCC-CccceEeEEEEeCCcceEEEEeCCCCCHHHH---HHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 048314 62 TLTSIVSRVSW-TTDIEVSSVAMRGSKPSTEAALDLPWDLAYI---IFCSAERNPYWNQRVRIALDVAKGILYLHDECEP 137 (274)
Q Consensus 62 ~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 137 (274)
.|.-+|+.+++ +++++++|.|. .++|.||...+++... +.+ -...+|..+.+++.+++..+.+++.....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58888888886 69999999994 4779999987655321 111 12369999999999999999999985444
Q ss_pred CcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.+.-.|++++|+.+.+++.+|+.|......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 678889999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.89 E-value=3.4e-05 Score=75.43 Aligned_cols=183 Identities=16% Similarity=0.094 Sum_probs=125.9
Q ss_pred HHHHHHhcCCCCccceEeEEEEeCC----cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 048314 62 TLTSIVSRVSWTTDIEVSSVAMRGS----KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEP 137 (274)
Q Consensus 62 ~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 137 (274)
-|...+.++.|+|+++.++|-.+.- ...+..|+|+.-++.+.++. -+..+..+.+.+..++..||+|+|+.
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 4677888899999999999976533 23455588988888888875 45688899999999999999999998
Q ss_pred CcccCCCCCC---ceEEcCCCcEEEe--ccccceecCC----------CCcCCCcccccCCCcc--ccceeehhHhHHHH
Q 048314 138 PILHCDIKPQ---NILMDEFWTAKIS--DFGLAKLLSD----------KGCMAPECYKRTPISV--KADVYGYGIVLLET 200 (274)
Q Consensus 138 ~i~h~dl~~~---nil~~~~~~~kl~--d~g~~~~~~~----------~~~~ape~~~~~~~~~--~~Di~s~G~~l~el 200 (274)
...|.-+..+ +-..+..+...++ ||+.++.... ..+-++|......... ..|+|.+|.....+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 6666555544 2333444555555 7777665542 2355666555544443 47999999999998
Q ss_pred hhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 201 ICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 201 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..|..+-..... ...+.+. .....+.+....|+..++++|+++.+++..
T Consensus 386 ~~~~~i~~~~~~-------------------~~~~l~~-----~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 386 SQGEDISEKSAV-------------------PVSLLDV-----LSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred hhcCcccccccc-------------------hhhhhcc-----ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 887655432200 0011111 111156778888999999999999998764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.86 E-value=4.6e-05 Score=63.62 Aligned_cols=95 Identities=14% Similarity=-0.022 Sum_probs=64.4
Q ss_pred HHHHHHHhcCCCC--ccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 048314 61 LTLTSIVSRVSWT--TDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP 138 (274)
Q Consensus 61 ~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ 138 (274)
.+|.++|.+|.-. .+.+-+++ +.-.+||||..|--|...- +.....-.++..|+.-+.-.-.. |
T Consensus 157 ~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---G 222 (304)
T COG0478 157 EREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---G 222 (304)
T ss_pred HHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---C
Confidence 4799999998754 56776655 5678999999885554332 11222223333333333322345 9
Q ss_pred cccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 139 ILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 139 i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
++|+|+++-||+++.++.+.++||--+....
T Consensus 223 iVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 223 IVHGDLSEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred ccccCCchheEEEecCCCEEEEeCcccccCC
Confidence 9999999999999999999999997654433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=3e-06 Score=77.86 Aligned_cols=140 Identities=15% Similarity=0.028 Sum_probs=102.8
Q ss_pred HHHHHHHHhcCCCCc-cceEeEEEEeCCcceEEEEeCCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 048314 60 PLTLTSIVSRVSWTT-DIEVSSVAMRGSKPSTEAALDLPW-DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEP 137 (274)
Q Consensus 60 ~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 137 (274)
..-++++|.+++||| .+..++-+..++..+++++++..+ |-..-+.. .+..+...+...+++.-..+++++|+.
T Consensus 280 ~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~--- 355 (829)
T KOG0576|consen 280 RRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSS--- 355 (829)
T ss_pred hHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccc---
Confidence 346889999999999 777777778888899999999876 22221111 112244444555667777899999986
Q ss_pred CcccCCCCCCceEEcCCCcEEEeccccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCc
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENM 207 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~ 207 (274)
.=+|+| ||+..+ ...+..+|+...... ++.+++||......+..+.|.|+.+.-..++.-|.+|-
T Consensus 356 ~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 356 YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 567887 666544 567888888764332 67899999999999999999999998777777777665
Q ss_pred c
Q 048314 208 E 208 (274)
Q Consensus 208 ~ 208 (274)
.
T Consensus 431 ~ 431 (829)
T KOG0576|consen 431 S 431 (829)
T ss_pred C
Confidence 4
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.78 E-value=5.9e-05 Score=62.34 Aligned_cols=136 Identities=10% Similarity=0.038 Sum_probs=77.2
Q ss_pred ccCCCCCCCCcchhHH--HHHHHHHhcCCCCCCcHHHHHHHHhcCCCCc--cceEeEEEEeCCcceEEEEeCCCCC-HHH
Q 048314 28 SLNDRNSPRSKSVWSC--MRALMATVNSPYSPSRPLTLTSIVSRVSWTT--DIEVSSVAMRGSKPSTEAALDLPWD-LAY 102 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~--~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs-L~~ 102 (274)
..++.|.. +.+|+. ...+.+............+|.++++.+..-+ +.+.++++.+.+...+|||+++|.. +..
T Consensus 7 ~~i~~G~t--~~~y~~~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~ 84 (226)
T TIGR02172 7 TQTGEGGN--GESYTHKTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSR 84 (226)
T ss_pred eeecCCCC--cceeEecCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhh
Confidence 45788888 888883 1112222222223345678999999987544 4788888877777889999998853 211
Q ss_pred HH---------------------HhCCCCCCCHHHHHH-HHH----------HHHHH-HHHHhcC-CCCCcccCCCCCCc
Q 048314 103 II---------------------FCSAERNPYWNQRVR-IAL----------DVAKG-ILYLHDE-CEPPILHCDIKPQN 148 (274)
Q Consensus 103 ~l---------------------~~~~~~~l~~~~~~~-~~~----------~i~~~-l~~lh~~-~~~~i~h~dl~~~n 148 (274)
.+ +.......+...... +.. .+... ..+|... ....++|+|+.|.|
T Consensus 85 ~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~N 164 (226)
T TIGR02172 85 IISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGN 164 (226)
T ss_pred hhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCc
Confidence 11 110001111111111 000 01111 1222111 12357899999999
Q ss_pred eEEcCCCcEEEeccccce
Q 048314 149 ILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 149 il~~~~~~~kl~d~g~~~ 166 (274)
+++++++ +.++||+.+.
T Consensus 165 ii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 165 LITSGKG-TYWIDLGDFG 181 (226)
T ss_pred EEEcCCC-cEEEechhcC
Confidence 9999877 9999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00013 Score=59.53 Aligned_cols=67 Identities=19% Similarity=0.069 Sum_probs=52.9
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..+|+|||++|..|.++.. ++. .+...+.+++.-+|+. |+.|+|..|.|+++.+++ ++++|++..+
T Consensus 117 ~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred EEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 4578999999988876643 222 2446677889999999 999999999999998654 8999998754
Q ss_pred e
Q 048314 167 L 167 (274)
Q Consensus 167 ~ 167 (274)
.
T Consensus 183 ~ 183 (229)
T PF06176_consen 183 M 183 (229)
T ss_pred c
Confidence 4
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0013 Score=53.15 Aligned_cols=99 Identities=14% Similarity=0.036 Sum_probs=70.8
Q ss_pred CCCcHHHHHHHHhcCC------CCccceEeEEEEeCCcceEEEEeCCC------CCHHHHHHhCCCCCCCHHHHHHHHHH
Q 048314 56 SPSRPLTLTSIVSRVS------WTTDIEVSSVAMRGSKPSTEAALDLP------WDLAYIIFCSAERNPYWNQRVRIALD 123 (274)
Q Consensus 56 ~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~l~~~~~~~~~~~ 123 (274)
..+++.+|+.....+. +.+|.+++|+..++--+-+|+|.+.+ .+|.+++.. +.++. .....+.+
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L~~ 129 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQALDE 129 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHHHH
Confidence 4566777877776666 78899999999998889999998632 368888864 34555 34434443
Q ss_pred HHHHHHHHhcCCCCCcccCCCCCCceEEcCC---C-cEEEec-ccc
Q 048314 124 VAKGILYLHDECEPPILHCDIKPQNILMDEF---W-TAKISD-FGL 164 (274)
Q Consensus 124 i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~---~-~~kl~d-~g~ 164 (274)
. ..||-+. .|+.+|++|.||++... . .+.++| ||.
T Consensus 130 f---~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 130 F---KRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred H---HHHHHHc---CCeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 3 4566677 89999999999998633 2 466776 454
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0023 Score=53.36 Aligned_cols=47 Identities=6% Similarity=-0.186 Sum_probs=36.0
Q ss_pred CCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceEEEEeCCCCCHHHH
Q 048314 57 PSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPSTEAALDLPWDLAYI 103 (274)
Q Consensus 57 ~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 103 (274)
.....+|+.++..+. +--+.+++++....+..++|||+++|.++...
T Consensus 35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 345778999988875 33467888887777778999999998777643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0038 Score=57.68 Aligned_cols=103 Identities=16% Similarity=0.088 Sum_probs=70.8
Q ss_pred HHHHHHHhcCC----CCccceEeEEEEe-CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 048314 61 LTLTSIVSRVS----WTTDIEVSSVAMR-GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC 135 (274)
Q Consensus 61 ~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~ 135 (274)
.+|+..+.+++ ...=+++-.++++ .+...|+|||+.|-.+.+.... +..+++-+.+.....++.. .-+-..
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l-~~~g~d~k~ia~~~~~~f~--~q~~~d- 284 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL-KSAGIDRKELAELLVRAFL--RQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH-HhcCCCHHHHHHHHHHHHH--HHHHhc-
Confidence 45666666653 3334666666665 4567999999999999888644 2245564444333333322 222223
Q ss_pred CCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 136 EPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 136 ~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
|+.|.|..|.|+++..++.+-+.|||......
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 99999999999999999999999999987655
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0039 Score=61.32 Aligned_cols=42 Identities=5% Similarity=-0.187 Sum_probs=33.9
Q ss_pred CcHHHHHHHHhcCC-CCcc--ceEeEEEEeC---CcceEEEEeCCCCC
Q 048314 58 SRPLTLTSIVSRVS-WTTD--IEVSSVAMRG---SKPSTEAALDLPWD 99 (274)
Q Consensus 58 ~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv~e~~~~gs 99 (274)
..+.+|+++|+.+. |.++ .+++.+|.+. +.+++||||++|..
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 45779999999996 6665 8889888764 56899999998754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0039 Score=57.58 Aligned_cols=104 Identities=14% Similarity=0.034 Sum_probs=66.6
Q ss_pred HHHHHHHHhcC----CCCc---cceEeEEEEe-CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH
Q 048314 60 PLTLTSIVSRV----SWTT---DIEVSSVAMR-GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYL 131 (274)
Q Consensus 60 ~~~e~~~l~~l----~h~n---iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~l 131 (274)
|.+|++...++ .|-+ =|++-.++++ .....|+||||+|..+.|.-.- ...+++-..+..-+.+... .-+
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~--~qI 317 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYL--EQI 317 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHH--HHH
Confidence 55666655544 3545 2334455554 3467999999999877766543 2345555544433333322 222
Q ss_pred hcCCCCCcccCCCCCCceEEcC----CCcEEEeccccceecC
Q 048314 132 HDECEPPILHCDIKPQNILMDE----FWTAKISDFGLAKLLS 169 (274)
Q Consensus 132 h~~~~~~i~h~dl~~~nil~~~----~~~~kl~d~g~~~~~~ 169 (274)
-.. |.+|.|-.|.||++.. +..+.+-|+|+.....
T Consensus 318 f~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 318 FKT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred Hhc---CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 233 9999999999999983 6788999999987665
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0014 Score=51.43 Aligned_cols=125 Identities=12% Similarity=-0.031 Sum_probs=81.6
Q ss_pred ccccCCCCCCCCcchhHHHHH----HHHHhcCCCCCCcHHHHHHHHhcCCCCcc-ceEeEEEEeCCcceEEEEeCCCCCH
Q 048314 26 RSSLNDRNSPRSKSVWSCMRA----LMATVNSPYSPSRPLTLTSIVSRVSWTTD-IEVSSVAMRGSKPSTEAALDLPWDL 100 (274)
Q Consensus 26 ~~~~~g~g~~~~g~vy~~~~~----~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 100 (274)
...++++|.. |.||.|.-. +.|.-+....+..+..|+++|..++-.++ .+++.+.. -++.|||..|.+|
T Consensus 26 v~~~L~KG~~--s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTT--SVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccc--cEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence 3677999999 999998322 22222333455667899999999987665 66776643 3445999998888
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC-CCceEEcCCCcEEEeccccceec
Q 048314 101 AYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIK-PQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 101 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~-~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
.+.-.. .+-.++.. ++....-|-.. ||-|..++ |...++.++..+-|+||..++..
T Consensus 100 ~~~~~~-----~~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 100 GKLEIG-----GDRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhc-----ccHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 776543 13333333 33333333334 88888885 44555555668999999988643
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0018 Score=58.94 Aligned_cols=161 Identities=17% Similarity=0.109 Sum_probs=89.0
Q ss_pred HHHHHHHhcCCCCccceEeEEEEe-CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 048314 61 LTLTSIVSRVSWTTDIEVSSVAMR-GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPI 139 (274)
Q Consensus 61 ~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i 139 (274)
+--..+++.+.|+|..+.+.+-.. .....+|+|++ +.||++.+..+. +-. .... .+ ++
T Consensus 30 lgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~------~s~~--------~~---~~ 88 (725)
T KOG1093|consen 30 LGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKD------ESLL--------AH---GV 88 (725)
T ss_pred hhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cch------hhhc--------cc---cc
Confidence 345667888899999988877643 34578999987 469999997632 110 0000 11 33
Q ss_pred ccCCCCCCceEEcCCCcEEEeccccceecCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHH
Q 048314 140 LHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219 (274)
Q Consensus 140 ~h~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~ 219 (274)
.|-+ +. ..+| .+. +. | | .+..+|+||||+|.++.++..|...+... .....
T Consensus 89 ~~~~-----~~-------~~td-~~~----t~-~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~----~~s~~ 139 (725)
T KOG1093|consen 89 LHLN-----II-------YITD-HFL----TK-Y--P-----SPIGPKSDVWSLGFIILELYLGISLEAEL----TESEY 139 (725)
T ss_pred ceeh-----hh-------hccc-ccc----cc-C--C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHH----HHHHH
Confidence 3322 11 1222 000 00 0 1 11225999999999999999887766422 11111
Q ss_pred HHHHHHH-HhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHH
Q 048314 220 TNWVYKC-FINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVV 271 (274)
Q Consensus 220 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl 271 (274)
...+... ..+...........+-..+...+.++...|+...|..||...++.
T Consensus 140 l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 140 LEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 1111111 111111111111123345566788999999999999999766654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0023 Score=53.13 Aligned_cols=30 Identities=30% Similarity=0.533 Sum_probs=25.5
Q ss_pred CCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++|+|+.+.|++++++....++||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 358999999999999887667899999753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.00052 Score=69.41 Aligned_cols=146 Identities=8% Similarity=-0.110 Sum_probs=100.8
Q ss_pred HHHHHHhcCCCCccceEeEEEE--eCCcceEEEEeCCCCCHHHHHHhCCCCC--CCHHHHHHHHHHHHHHHHHHhcCCCC
Q 048314 62 TLTSIVSRVSWTTDIEVSSVAM--RGSKPSTEAALDLPWDLAYIIFCSAERN--PYWNQRVRIALDVAKGILYLHDECEP 137 (274)
Q Consensus 62 ~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~--l~~~~~~~~~~~i~~~l~~lh~~~~~ 137 (274)
.|..-++...|+++.....--. +....+.+++|+..|.+.+.+-...++. +....+...-.+...+..-.|+..+.
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 4555566678998877655432 3456789999999999999887642222 23222222223325555555554333
Q ss_pred --CcccCCCCCCceEEcCCCcEEEeccccceecC-----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcC
Q 048314 138 --PILHCDIKPQNILMDEFWTAKISDFGLAKLLS-----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCW 204 (274)
Q Consensus 138 --~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~ 204 (274)
--+|+++++-|.++..+..+++.++|+.+... ++.|+.|+....-.++.++|+|..|+.+|+.--|.
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 36799999999999999999999999988322 33456666666667888899999999999887666
Q ss_pred CCc
Q 048314 205 ENM 207 (274)
Q Consensus 205 ~p~ 207 (274)
.+|
T Consensus 1438 ~~f 1440 (2724)
T KOG1826|consen 1438 AYF 1440 (2724)
T ss_pred HHH
Confidence 665
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.014 Score=48.44 Aligned_cols=97 Identities=14% Similarity=-0.076 Sum_probs=62.4
Q ss_pred HHHHHHhcCCCC--ccceEeEEEEeCCcceEEEEeCCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCC
Q 048314 62 TLTSIVSRVSWT--TDIEVSSVAMRGSKPSTEAALDLPW-DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEP 137 (274)
Q Consensus 62 ~e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~ 137 (274)
.|...|+++.-. .+.+-+++ ..-.|||||+... .-.-.|.. -++.......+..+++..+.-|-. .
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a--- 186 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEA--- 186 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhc---
Confidence 566666665422 22333332 1347999998542 22222221 222333566677788887776665 5
Q ss_pred CcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+++|+||+.=|||+. ++.+.++|+|-+....
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999999 7899999999875544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.045 Score=44.64 Aligned_cols=110 Identities=15% Similarity=0.017 Sum_probs=58.2
Q ss_pred CcHHHHHHHHhcCCCC--ccceEeEEEEe---CCcceEEEEeCCCCCHHH----------------HHH---hC--CCCC
Q 048314 58 SRPLTLTSIVSRVSWT--TDIEVSSVAMR---GSKPSTEAALDLPWDLAY----------------IIF---CS--AERN 111 (274)
Q Consensus 58 ~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~gsL~~----------------~l~---~~--~~~~ 111 (274)
.....|..+++.+... .+.+++.++.. ....+++|+++++.++.. .+. .. ....
T Consensus 35 ~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~ 114 (239)
T PF01636_consen 35 ERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSP 114 (239)
T ss_dssp HHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCC
T ss_pred HHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccc
Confidence 3456788888887643 35677775533 345789999999988877 221 11 1112
Q ss_pred CCHHHHH--H-------H------------HHHHHH-HHHHHhcC----CCCCcccCCCCCCceEEc-CCCcEEEecccc
Q 048314 112 PYWNQRV--R-------I------------ALDVAK-GILYLHDE----CEPPILHCDIKPQNILMD-EFWTAKISDFGL 164 (274)
Q Consensus 112 l~~~~~~--~-------~------------~~~i~~-~l~~lh~~----~~~~i~h~dl~~~nil~~-~~~~~kl~d~g~ 164 (274)
+.+.... . . ...+.. .+..+++. ....++|+|+.+.||+++ .++.+.++||+.
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~ 194 (239)
T PF01636_consen 115 FADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFED 194 (239)
T ss_dssp HTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT
T ss_pred cccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEeccc
Confidence 2211100 0 0 011122 22333321 123799999999999999 556668999987
Q ss_pred cee
Q 048314 165 AKL 167 (274)
Q Consensus 165 ~~~ 167 (274)
+..
T Consensus 195 a~~ 197 (239)
T PF01636_consen 195 AGW 197 (239)
T ss_dssp -EE
T ss_pred ceE
Confidence 643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.032 Score=48.09 Aligned_cols=99 Identities=9% Similarity=-0.040 Sum_probs=66.1
Q ss_pred cccCCCCCCCCcchhHH----HHHHHHHhcCCCCCCcHHHHHHHHhcCCC---CccceEeEEEEe---CCcceEEEEeCC
Q 048314 27 SSLNDRNSPRSKSVWSC----MRALMATVNSPYSPSRPLTLTSIVSRVSW---TTDIEVSSVAMR---GSKPSTEAALDL 96 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~----~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e~~~ 96 (274)
..-+|+|.. +.||.- -+.++|..........+..|...|+.+.- -.+.+++++|.. .+..++|||+++
T Consensus 19 ~~~i~~G~~--~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPY--AALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccc--eeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 445899999 889973 12233332221234578899999998863 357899988854 366899999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDE 134 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~ 134 (274)
++++.+. . .+......+..+++.+|+-||+.
T Consensus 97 G~~~~~~-~------~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 97 GVSVEAP-A------RTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred CEecCCC-C------CCHHHHHHHHHHHHHHHHHHhCC
Confidence 8877651 1 22233445566777888888874
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.16 E-value=0.18 Score=43.76 Aligned_cols=33 Identities=30% Similarity=0.523 Sum_probs=28.8
Q ss_pred CCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+.++|+|+.+.|++++...-+-+.||+.+....
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 479999999999999998889999999886543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.086 Score=45.79 Aligned_cols=135 Identities=10% Similarity=0.019 Sum_probs=82.5
Q ss_pred hhHHHHhhhccccccCCCCCCCCcchhHH-------------------HHHHHHH---hcCCCCCCc-------HHHHHH
Q 048314 15 SSLCTKLRNFCRSSLNDRNSPRSKSVWSC-------------------MRALMAT---VNSPYSPSR-------PLTLTS 65 (274)
Q Consensus 15 ~~l~~~~~~f~~~~~~g~g~~~~g~vy~~-------------------~~~~~~~---~~~~~~~~~-------~~~e~~ 65 (274)
+-|+...--.+-.+-||-|.- +.+|.| .+.++.. .+...+..+ ..+|..
T Consensus 85 ktL~~R~~v~svGnqIGVGKE--SDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 85 KTLSNRGSVESVGNQIGVGKE--SDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred HHHHhcchhhhhccccccccc--cceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 334433334555778999988 889987 1111110 011111121 136888
Q ss_pred HHhcCCCCc--cceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCC
Q 048314 66 IVSRVSWTT--DIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCD 143 (274)
Q Consensus 66 ~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 143 (274)
.|+.|.... +.+-+ +.+.-++|||++.+..|.+.-+- .+.+++..-+..+ +.-|-.+ |+||+|
T Consensus 163 fmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~---Iv~la~~---GlIHgD 227 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGL---IVRLANH---GLIHGD 227 (465)
T ss_pred HHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeeec-----CChHHHHHHHHHH---HHHHHHc---Cceecc
Confidence 888775321 33333 44667999999988777655432 2334444333333 3334455 999999
Q ss_pred CCCCceEEcCCCcEEEeccccce
Q 048314 144 IKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 144 l~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..-=||++.++..++++||--..
T Consensus 228 FNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cchheeEEecCCCEEEeechHhh
Confidence 99999999999999999997553
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.25 Score=40.62 Aligned_cols=100 Identities=18% Similarity=0.144 Sum_probs=65.7
Q ss_pred HHHHHHhcCC-C-CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHH
Q 048314 45 RALMATVNSP-Y-SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIAL 122 (274)
Q Consensus 45 ~~~~~~~~~~-~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~ 122 (274)
...||....+ . ...-|.++.+++.+++ .|+++..- ..-..-++.|+|-... .++.. ++.
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------i~~~N----~i~ 148 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------INFSN----FIT 148 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------cchhH----HHH
Confidence 3334444443 2 3455678899998874 47887732 3345679999985321 11111 111
Q ss_pred HHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 123 DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 123 ~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
--+.+|.-.|+. ..+.+|+|..|+||+-+..|.+||.|-+.
T Consensus 149 agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 149 AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 223567778854 45899999999999999999999999775
|
The function of this family is unknown. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=93.49 E-value=0.35 Score=39.12 Aligned_cols=85 Identities=13% Similarity=0.047 Sum_probs=59.9
Q ss_pred CcHHHHHHHHhcCC---CCcc--ceEeEEEEeC------------------CcceEEEEeCCCCCHHHHHHhCCCCCCCH
Q 048314 58 SRPLTLTSIVSRVS---WTTD--IEVSSVAMRG------------------SKPSTEAALDLPWDLAYIIFCSAERNPYW 114 (274)
Q Consensus 58 ~~~~~e~~~l~~l~---h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~ 114 (274)
+.|..|.+...+|+ +.++ |+++||..=. ....||.||.+... .+..
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~ 167 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI 167 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch
Confidence 45778999988886 3456 9999997311 12367888876532 1222
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 115 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
. -+.+|.+-+..+|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 168 ~----~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 R----DIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred h----HHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 2 345666677889998 9999999999986 3488999864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=90.47 E-value=0.85 Score=39.15 Aligned_cols=68 Identities=1% Similarity=-0.253 Sum_probs=37.5
Q ss_pred ccCCCCCCCCcchhHH----HHHHHHHhcCCCCCCcHHHHHHHHhcCC---CCccceEeEEEEeCCcceEEEEeCCCC
Q 048314 28 SLNDRNSPRSKSVWSC----MRALMATVNSPYSPSRPLTLTSIVSRVS---WTTDIEVSSVAMRGSKPSTEAALDLPW 98 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~----~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 98 (274)
.-++.|.+ ...|+. ...++|... ......|..|..-|+.|. --.+.+.+++....+..+|++||.+.+
T Consensus 23 ~~v~GG~i--~~a~~~~~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDI--NEAYRLDTDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSS--SEEEEEETTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCCh--hheEEEECCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 34677777 666644 112222222 334566888988888884 344789999988777789999998665
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.57 E-value=0.32 Score=42.14 Aligned_cols=32 Identities=22% Similarity=0.274 Sum_probs=27.0
Q ss_pred CCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 136 EPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 136 ~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
+.+++|+|+.+.||+++++....++||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 34899999999999999776678999997643
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=89.49 E-value=0.99 Score=40.04 Aligned_cols=55 Identities=20% Similarity=0.226 Sum_probs=46.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 112 PYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 112 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
-.|.+...++.+.+.-++-+... -..-||++...||+++ +|.+.|+||.+++...
T Consensus 318 ~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl~~ 372 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY 372 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeeccc
Confidence 46888888888887777666654 3789999999999999 9999999999998543
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=89.46 E-value=0.53 Score=39.00 Aligned_cols=45 Identities=11% Similarity=-0.153 Sum_probs=33.9
Q ss_pred CCcHHHHHHHHhcCCC---CccceEeEEEEeCCcceEEEEeCCCCCHH
Q 048314 57 PSRPLTLTSIVSRVSW---TTDIEVSSVAMRGSKPSTEAALDLPWDLA 101 (274)
Q Consensus 57 ~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 101 (274)
...|..|+.-|..+.- -++.+.+.+-.+.++.++|+||.+-|.+.
T Consensus 52 ~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 52 LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 4557788776666654 44678888888899999999999776554
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=88.81 E-value=1.1 Score=38.54 Aligned_cols=31 Identities=26% Similarity=0.248 Sum_probs=26.7
Q ss_pred CCCcccCCCCCCceEEcCC----CcEEEeccccce
Q 048314 136 EPPILHCDIKPQNILMDEF----WTAKISDFGLAK 166 (274)
Q Consensus 136 ~~~i~h~dl~~~nil~~~~----~~~kl~d~g~~~ 166 (274)
...++|+|+.+.||+++.+ ..+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4578999999999999874 789999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=88.33 E-value=0.98 Score=38.96 Aligned_cols=31 Identities=29% Similarity=0.429 Sum_probs=27.0
Q ss_pred CCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 136 EPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 136 ~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
+.+++|+|+.+.|++++.+..+.++||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3489999999999999988777899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=87.45 E-value=0.99 Score=37.07 Aligned_cols=29 Identities=28% Similarity=0.332 Sum_probs=25.5
Q ss_pred CCcccCCCCCCceEEcC-CCcEEEeccccc
Q 048314 137 PPILHCDIKPQNILMDE-FWTAKISDFGLA 165 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~-~~~~kl~d~g~~ 165 (274)
..++|+|+.+.||++++ +..+.++||..+
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a 199 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYA 199 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence 36999999999999997 578999999865
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=86.25 E-value=0.63 Score=39.79 Aligned_cols=31 Identities=26% Similarity=0.321 Sum_probs=26.8
Q ss_pred CCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.+++|+|+.|.|++++++..+.+.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999887788999987643
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=85.93 E-value=1.9 Score=37.08 Aligned_cols=29 Identities=24% Similarity=0.324 Sum_probs=24.8
Q ss_pred CCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
.+++|+|+.+.|++++. ..+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 567899998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=85.60 E-value=1.9 Score=37.72 Aligned_cols=28 Identities=36% Similarity=0.567 Sum_probs=25.0
Q ss_pred cccCCCCCCceEEcCCCc-EEEeccccce
Q 048314 139 ILHCDIKPQNILMDEFWT-AKISDFGLAK 166 (274)
Q Consensus 139 i~h~dl~~~nil~~~~~~-~kl~d~g~~~ 166 (274)
+||+|+.+.||+++.+.. +.+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998874 8999999764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=84.28 E-value=0.85 Score=38.14 Aligned_cols=29 Identities=24% Similarity=0.297 Sum_probs=24.9
Q ss_pred CcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++|+|+.+.|+++++++ +.++||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999998876 78999987643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=83.77 E-value=5.9 Score=35.52 Aligned_cols=28 Identities=29% Similarity=0.176 Sum_probs=23.2
Q ss_pred CcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
...|.|+-+.||+..+ ..+.++||..+.
T Consensus 228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 228 LFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeccCCcccEEecC-CCEEEEEecccc
Confidence 6789999999998754 468999998764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=83.48 E-value=3.6 Score=36.72 Aligned_cols=99 Identities=10% Similarity=0.013 Sum_probs=63.2
Q ss_pred HHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCC-HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 048314 62 TLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWD-LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPIL 140 (274)
Q Consensus 62 ~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~ 140 (274)
.|++.|.+++...|..---... ..-.|||+|+.+-. -.-.| +.-.++...+..+-.+++.-+.-|-..| +++
T Consensus 215 KE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LV 287 (520)
T KOG2270|consen 215 KEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKC--RLV 287 (520)
T ss_pred HHHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHh--cee
Confidence 4677777765544321110001 13479999985421 11112 2334677777777788888777776666 999
Q ss_pred cCCCCCCceEEcCCCcEEEeccccceec
Q 048314 141 HCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 141 h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
|.||+--|+|+.. |.+.++|.+-+...
T Consensus 288 HADLSEfN~Lyhd-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 288 HADLSEFNLLYHD-GKLYIIDVSQSVEH 314 (520)
T ss_pred ccchhhhhheEEC-CEEEEEEccccccC
Confidence 9999999999865 57888888766443
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=82.95 E-value=1.2 Score=35.61 Aligned_cols=29 Identities=21% Similarity=0.261 Sum_probs=24.9
Q ss_pred CcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
..+|+|+.|.|+++.+++ ++++|++.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 578999999999998776 88999997643
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=81.34 E-value=1.1 Score=36.26 Aligned_cols=30 Identities=33% Similarity=0.472 Sum_probs=21.0
Q ss_pred CcccCCCCCCceEE-cCCCcEEEecccccee
Q 048314 138 PILHCDIKPQNILM-DEFWTAKISDFGLAKL 167 (274)
Q Consensus 138 ~i~h~dl~~~nil~-~~~~~~kl~d~g~~~~ 167 (274)
.+.|+|+.+.||++ ..++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 68899999999999 8889999999987644
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=80.91 E-value=2.9 Score=36.07 Aligned_cols=31 Identities=19% Similarity=0.281 Sum_probs=27.3
Q ss_pred CCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.+++|+|+.+.|+++++++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4799999999999999988899999987644
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 274 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-28 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-17 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-16 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-16 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-04 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 274 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-61 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 3e-51 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 8e-50 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-37 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 8e-35 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 8e-35 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-32 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-31 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 8e-31 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-30 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-29 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-28 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-28 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-28 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-28 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-27 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-27 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-26 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 5e-17 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-17 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-16 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-16 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-16 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 6e-16 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-16 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-15 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-15 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-15 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-15 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-15 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 9e-15 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-14 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-14 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-14 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-14 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-14 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-14 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-14 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-14 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 8e-14 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 8e-14 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 8e-14 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-13 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-13 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-13 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-13 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-13 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 8e-13 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-12 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-12 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-12 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-12 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-12 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-12 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-12 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-11 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-11 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-11 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-11 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-11 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-11 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-11 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-11 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-11 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-11 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-11 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-11 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-11 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-11 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 6e-11 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-11 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 7e-11 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-11 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-10 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-10 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-10 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-10 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-10 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-10 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-10 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-10 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-10 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-10 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-10 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-10 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-10 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-10 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-10 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-10 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-10 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-10 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 4e-10 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-10 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-10 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-10 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-10 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 5e-10 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 6e-10 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-10 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 6e-10 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-10 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 6e-10 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 6e-10 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 7e-10 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-10 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-09 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-09 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-09 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-09 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-09 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-09 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-09 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-09 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-09 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-09 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-09 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-09 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-09 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-09 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-09 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-09 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-09 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-09 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-09 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-09 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 4e-09 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 5e-09 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-09 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 5e-09 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 6e-09 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 6e-09 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 6e-09 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 6e-09 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 6e-09 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 6e-09 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-09 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 7e-09 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-09 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 8e-09 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-09 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 8e-09 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 9e-09 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 9e-09 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-08 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-08 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-08 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-08 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-08 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-08 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-08 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-08 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-08 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-08 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-08 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-08 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-08 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-08 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-08 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-08 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-08 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-08 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-08 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-08 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-08 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-08 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-08 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-08 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-08 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 4e-08 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 5e-08 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-08 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 6e-08 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 6e-08 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 7e-08 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 7e-08 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 8e-08 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 8e-08 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 8e-08 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 9e-08 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 9e-08 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 9e-08 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 9e-08 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-07 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-07 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-07 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-07 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-07 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-07 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-07 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-07 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-07 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-07 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-07 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-07 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-07 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-07 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 5e-07 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 7e-07 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 7e-07 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-07 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 9e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-06 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-06 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-06 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-06 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-06 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-06 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-06 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-06 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-06 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-06 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-06 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-06 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 5e-06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-06 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 7e-06 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-06 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 3e-05 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-05 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 6e-05 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 6e-05 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-04 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-04 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 5e-04 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 5e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 5e-04 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 8e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-61
Identities = 71/195 (36%), Positives = 100/195 (51%), Gaps = 22/195 (11%)
Query: 100 LAYIIFCSAERNPY--WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 157
+A + E P W +R RIAL A+G+ YLHD C+P I+H D+K NIL+DE + A
Sbjct: 114 VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173
Query: 158 KISDFGLAKLLSDK------------GCMAPECYKRTPISVKADVYGYGIVLLETICCWE 205
+ DFGLAKL+ K G +APE S K DV+GYG++LLE I
Sbjct: 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233
Query: 206 NMEIDASKP---EEIILTNWVYKCFINRELNKLV---RGTEVDKKNLENLVKVGLWCVQD 259
D ++ ++++L +WV ++L LV + +E L++V L C Q
Sbjct: 234 A--FDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQS 291
Query: 260 EPALRPSMKCVVMML 274
P RP M VV ML
Sbjct: 292 SPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-51
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 24/192 (12%)
Query: 100 LAYIIFCSAERNP-YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158
L + C P W+ R +IA A GI +LH+ +H DIK NIL+DE +TAK
Sbjct: 117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAK 173
Query: 159 ISDFGLAKLLSDK-------------GCMAPECYKRTPISVKADVYGYGIVLLETICCWE 205
ISDFGLA+ MAPE R I+ K+D+Y +G+VLLE I
Sbjct: 174 ISDFGLARASEKFAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP 232
Query: 206 NMEIDASKPEEIILTNWVYKCFIN-RELNKLV--RGTEVDKKNLENLVKVGLWCVQDEPA 262
+D + +++L + + + + + + D ++E + V C+ ++
Sbjct: 233 A--VDEHREPQLLLD-IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKN 289
Query: 263 LRPSMKCVVMML 274
RP +K V +L
Sbjct: 290 KRPDIKKVQQLL 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 8e-50
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 24/179 (13%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
W QR+ I + A+G+ YLH I+H D+K NIL+DE + KI+DFG++K ++
Sbjct: 138 WEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 172 -----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKP-EEIIL 219
G + PE + + ++ K+DVY +G+VL E +C I S P E + L
Sbjct: 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA--IVQSLPREMVNL 252
Query: 220 TNWVYKCFINRELNKLV----RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
W + N +L ++V ++ ++L + C+ RPSM V+ L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 43/195 (22%), Positives = 72/195 (36%), Gaps = 35/195 (17%)
Query: 114 WNQRVRIALDVAKGILYLHDE-------CEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
WN+ IA +A+G+ YLH++ +P I H DIK +N+L+ TA I+DFGLA
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 167 LLSD-------------KGCMAPE-----CYKRTPISVKADVYGYGIVLLETICCWENME 208
+ MAPE + ++ D+Y G+VL E +
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 209 IDASKPEEIILTNWVYKCFINRELNKLV---------RGTEVDKKNLENLVKVGLWCVQD 259
+ + + ++ ++V R + L + C
Sbjct: 240 GPV-DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 260 EPALRPSMKCVVMML 274
+ R S CV +
Sbjct: 299 DAEARLSAGCVGERI 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-35
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 27/173 (15%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT-AKISDFGLAKLL---- 168
+ L ++G+ YLH ++H D+KP N+L+ T KI DFG A +
Sbjct: 101 AAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM 160
Query: 169 -SDKGC---MAPECYKRTPISVKADVYGYGIVLLETICC---WENMEIDASKPEEIILTN 221
++KG MAPE ++ + S K DV+ +GI+L E I ++ + A + +
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 220
Query: 222 WVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
+ + K +E+L+ C +P+ RPSM+ +V ++
Sbjct: 221 T-----------RPPLIKNLPKP-IESLMT---RCWSKDPSQRPSMEEIVKIM 258
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-35
Identities = 48/175 (27%), Positives = 87/175 (49%), Gaps = 31/175 (17%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
+R+ +A DVAKG+ YLH PPI+H ++K N+L+D+ +T K+ DFGL++L +
Sbjct: 136 ERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194
Query: 174 -----------MAPECYKRTPISVKADVYGYGIVLLETICC---WENMEIDASKPEEIIL 219
MAPE + P + K+DVY +G++L E W N+ P +++
Sbjct: 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN-----PAQVVA 249
Query: 220 TNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
+ + +L ++ + + +++ C +EP RPS ++ +L
Sbjct: 250 A-------VGFKCKRLEIPRNLNPQ-VAAIIE---GCWTNEPWKRPSFATIMDLL 293
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-32
Identities = 39/182 (21%), Positives = 76/182 (41%), Gaps = 47/182 (25%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
+Q V+ ALD+A+G+ +LH EP I + +++++DE TA+IS + G
Sbjct: 110 QSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR 168
Query: 174 ------MAPECYKRTPISV---KADVYGYGIVLLETICC---WENMEIDASKPEEIILTN 221
+APE ++ P AD++ + ++L E + + ++ EI +
Sbjct: 169 MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-----SNMEIGM-- 221
Query: 222 WVYKCFINRELNKLVRGTEVDKKNL---------ENLVKVGLWCVQDEPALRPSMKCVVM 272
+V + L ++ K+ C+ ++PA RP +V
Sbjct: 222 ------------------KVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263
Query: 273 ML 274
+L
Sbjct: 264 IL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-31
Identities = 45/190 (23%), Positives = 71/190 (37%), Gaps = 54/190 (28%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF--------WTAKISDFGLA 165
+ V A+ +A+G+ YLHDE PI+H D+K NIL+ + KI+DFGLA
Sbjct: 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
Query: 166 KLLSDKGC---------MAPECYKRTPISVKADVYGYGIVLLETICC---WENMEIDASK 213
+ MAPE + + S +DV+ YG++L E + + ++
Sbjct: 164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID----- 218
Query: 214 PEEIILTNWVYKCFINRELNKLVRGTEVDKKNL---------ENLVKVGLWCVQDEPALR 264
+ V L E K+ C +P R
Sbjct: 219 GLAVAY--------------------GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258
Query: 265 PSMKCVVMML 274
PS ++ L
Sbjct: 259 PSFTNILDQL 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-31
Identities = 41/179 (22%), Positives = 70/179 (39%), Gaps = 33/179 (18%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-----TAKISDFGLAKLL 168
W+ ++R+ LD+A GI Y+ + PPI+H D++ NI + AK++DFGL++
Sbjct: 121 WSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179
Query: 169 -----SDKGC---MAPE--CYKRTPISVKADVYGYGIVLLETICC---WENMEIDASKPE 215
G MAPE + + KAD Y + ++L + ++
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-----SYG 234
Query: 216 EIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
+I N + + + L V C +P RP +V L
Sbjct: 235 KIKFINMI--REEGLRP-------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 38/204 (18%), Positives = 68/204 (33%), Gaps = 43/204 (21%)
Query: 114 WNQRVRIALDVAKGILYLHDE------CEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167
W R+A V +G+ YLH E +P I H D+ +N+L+ T ISDFGL+
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 168 LSDKGC-------------------MAPE-------CYKRTPISVKADVYGYGIVLLETI 201
L+ MAPE + D+Y G++ E
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 202 C-CWENMEIDASKPEEIILTNWVYKCFINRELNKLV----------RGTEVDKKNLENLV 250
C + ++ ++ V ++ LV + + + +L
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 251 KVGLWCVQDEPALRPSMKCVVMML 274
+ C + R + + +
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERM 313
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 44/180 (24%), Positives = 73/180 (40%), Gaps = 34/180 (18%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
+ + IA A+G+ YLH I+H D+K NI + E T KI DFGLA S
Sbjct: 119 MKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 174 -------------MAPECYK---RTPISVKADVYGYGIVLLETICC---WENMEIDASKP 214
MAPE + P S ++DVY +GIVL E + + N+
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI-----NN 230
Query: 215 EEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
+ I+ + + + K+ + ++ C++ + RPS ++ +
Sbjct: 231 RDQIIEMVGRG---SLSPDLSKVRSNCPKR----MKRLMAECLKKKRDERPSFPRILAEI 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 40/189 (21%), Positives = 68/189 (35%), Gaps = 48/189 (25%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
N+ +IA ++ KG+ YLH ILH D+K +N+ D I+DFGL +
Sbjct: 129 VNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQA 184
Query: 174 ----------------MAPECYKRT---------PISVKADVYGYGIVLLETICC---WE 205
+APE ++ P S +DV+ G + E ++
Sbjct: 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244
Query: 206 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRP 265
E II W + ++ + + + L+C E RP
Sbjct: 245 TQP-----AEAII---WQ--------MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERP 288
Query: 266 SMKCVVMML 274
+ ++ ML
Sbjct: 289 TFTKLMDML 297
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 43/194 (22%), Positives = 72/194 (37%), Gaps = 33/194 (17%)
Query: 114 WNQRVRIALDVAKGILYLHDE-----CEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168
+RI L +A G+ +LH E +P I H D+K +NIL+ + I+D GLA +
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 169 SDKGC---------------MAPECYKRTPISV------KADVYGYGIVLLETI-CCWEN 206
S MAPE T + D++ +G+VL E N
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
Query: 207 MEIDASKP--EEIILTNWVYKCFINRELNKLVR----GTEVDKKNLENLVKVGLWCVQDE 260
++ KP +++ + ++ R L +L K+ C
Sbjct: 224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283
Query: 261 PALRPSMKCVVMML 274
P+ R + + L
Sbjct: 284 PSARLTALRIKKTL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 40/202 (19%), Positives = 65/202 (32%), Gaps = 49/202 (24%)
Query: 114 WNQRVRIALDVAKGILYLHDE-----CEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168
+++A G+ +LH E +P I H D+K +NIL+ + T I+D GLA
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 169 SDKGC---------------MAPE------CYKRTPISVKADVYGYGIVLLETICC---- 203
M PE + AD+Y +G++L E
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 204 ---------WENMEIDASKPEEIILTNWVYKCFINR--ELNKLVRGTEVDKKNLENLVKV 252
+ ++ S P + V C E ++ + L+
Sbjct: 253 GIVEEYQLPYHDL--VPSDPSYEDMREIV--CIKKLRPSFPNRWSSDECLRQ-MGKLMT- 306
Query: 253 GLWCVQDEPALRPSMKCVVMML 274
C PA R + V L
Sbjct: 307 --ECWAHNPASRLTALRVKKTL 326
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 43/196 (21%), Positives = 68/196 (34%), Gaps = 37/196 (18%)
Query: 114 WNQRVRIALDVAKGILYLHDE-----CEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168
+++AL A G+ +LH E +P I H D+K +NIL+ + T I+D GLA
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197
Query: 169 SDKGC---------------MAPE------CYKRTPISVKADVYGYGIVLLETICCWENM 207
MAPE K +AD+Y G+V E
Sbjct: 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257
Query: 208 EIDASKPEEIILTNWVYKCFINRELNKLV---------RGTEVDKKNLENLVKVGLWCVQ 258
I + ++ + V E+ K+V + L + K+ C
Sbjct: 258 GI--HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 315
Query: 259 DEPALRPSMKCVVMML 274
A R + + L
Sbjct: 316 ANGAARLTALRIKKTL 331
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 46/192 (23%), Positives = 66/192 (34%), Gaps = 52/192 (27%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
W+QRV A D+A G+ YLH I+H D+ N L+ E ++DFGLA+L+ D+
Sbjct: 107 WSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 174 -------------------------MAPECYKRTPISVKADVYGYGIVLLETICC---WE 205
MAPE K DV+ +GIVL E I
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223
Query: 206 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGT---EVDKKNLENLVKVGLWCVQDEPA 262
+ + VRG + + + C +P
Sbjct: 224 DYL------------------PRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPE 265
Query: 263 LRPSMKCVVMML 274
RPS + L
Sbjct: 266 KRPSFVKLEHWL 277
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-17
Identities = 34/162 (20%), Positives = 60/162 (37%), Gaps = 36/162 (22%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
+ + KG+ Y+H + +++ D+KP NI + + KI DFGL L + G
Sbjct: 126 ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI 228
M+PE + D+Y G++L E + E
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-------CDTAFE-----------T 224
Query: 229 NRELNKLVRGTEVDK--KNLENLVKVGLWCVQDEPALRPSMK 268
++ L G D K + L++ + +P RP+
Sbjct: 225 SKFFTDLRDGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTS 263
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-17
Identities = 30/91 (32%), Positives = 41/91 (45%), Gaps = 12/91 (13%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKISDFGLAKLLSDKGC---- 173
+ KG+ +LH PPI+H D+K NI + + KI D GLA L
Sbjct: 133 SWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI 191
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE Y+ DVY +G+ +LE
Sbjct: 192 GTPEFMAPEMYEE-KYDESVDVYAFGMCMLE 221
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 35/164 (21%), Positives = 57/164 (34%), Gaps = 42/164 (25%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
D + +LH + ++H D+KP NI + K+ DFGL L G
Sbjct: 161 GYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE 217
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI 228
MAPE + ADV+ G+ +LE C E P
Sbjct: 218 GDPRYMAPELL-QGSYGTAADVFSLGLTILEVACNME-------LP------------HG 257
Query: 229 NRELNKLVRGTEVDK------KNLENLVKVGLWCVQDEPALRPS 266
+L +G + L +++ ++ +P LR +
Sbjct: 258 GEGWQQLRQGYLPPEFTAGLSSELRSVLV---MMLEPDPKLRAT 298
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-16
Identities = 26/94 (27%), Positives = 40/94 (42%), Gaps = 15/94 (15%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---- 173
V I + + H H D+KP+NIL+ A + DFG+A +D+
Sbjct: 137 VAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG 193
Query: 174 --------MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE + + + +AD+Y VL E
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYE 227
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-16
Identities = 35/98 (35%), Positives = 45/98 (45%), Gaps = 15/98 (15%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
+ + + GI + HD I+H DIKPQNIL+D T KI DFG+AK LS+
Sbjct: 110 VDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166
Query: 174 ------------MAPECYKRTPISVKADVYGYGIVLLE 199
+PE K D+Y GIVL E
Sbjct: 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYE 204
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-16
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 35/175 (20%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----- 170
+++ D A G+ YL + +H D+ +N L+ E KISDFG+++ +D
Sbjct: 214 TLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270
Query: 171 -KGC-------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW 222
G APE S ++DV+ +GI+L WE + P
Sbjct: 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL------WETFS-LGASP-------- 315
Query: 223 VYKCFINRE-LNKLVRGTEVDKKNL--ENLVKVGLWCVQDEPALRPSMKCVVMML 274
Y N++ + +G + L + + ++ C EP RPS + L
Sbjct: 316 -YPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 6e-16
Identities = 42/288 (14%), Positives = 73/288 (25%), Gaps = 71/288 (24%)
Query: 27 SSLNDRNSPRSKSVWS----CMRALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVA 82
+ L R + W S L+S + + I
Sbjct: 59 AKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF 118
Query: 83 MRGSKPSTEAALDLPWDLAYII--FCS--------AERNPYWNQRVRIALD----VAKGI 128
+ L YI C R ++ + L +A+ +
Sbjct: 119 STKNTVGQLQPSSPKVYL-YIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAV 177
Query: 129 LYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC--------------- 173
+LH + ++H D+KP NI K+ DFGL +
Sbjct: 178 EFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234
Query: 174 --------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225
M+PE S K D++ G++L E + S E +
Sbjct: 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE-------LLYSFSTQMERVRI----- 282
Query: 226 CFINRELNKLVRGT-----EVDKKNLENLVKVGLWCVQDEPALRPSMK 268
+ + +V+ + P RP
Sbjct: 283 ------ITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEAT 321
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 25/114 (21%), Positives = 48/114 (42%), Gaps = 16/114 (14%)
Query: 99 DLAYIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 156
DL+ +I ++ +R + + + + ++H ++H DIKP N+ +
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGV 174
Query: 157 AKISDFGLAKLLSDKGC-----------MAPECYKRTPISVKADVYGYGIVLLE 199
K+ D GL + S K M+PE + K+D++ G +L E
Sbjct: 175 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-15
Identities = 30/90 (33%), Positives = 53/90 (58%), Gaps = 11/90 (12%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK------G 172
++++ V KG+ YL ++ + I+H D+KP NIL++ K+ DFG++ L D G
Sbjct: 135 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 192
Query: 173 C---MAPECYKRTPISVKADVYGYGIVLLE 199
M+PE + T SV++D++ G+ L+E
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 31/120 (25%), Positives = 54/120 (45%), Gaps = 16/120 (13%)
Query: 99 DLAYIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDEF 154
DLA +I + Y ++ R+ + + H + +LH D+KP N+ +D
Sbjct: 93 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152
Query: 155 WTAKISDFGLAKLLSDKGC-----------MAPECYKRTPISVKADVYGYGIVLLETICC 203
K+ DFGLA++L+ M+PE R + K+D++ G +L E +C
Sbjct: 153 QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE-LCA 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-15
Identities = 25/96 (26%), Positives = 46/96 (47%), Gaps = 17/96 (17%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---- 173
+ + D + + + H + I+H D+KP NI++ K+ DFG+A+ ++D G
Sbjct: 119 IEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 174 ----------MAPECYKRTPISVKADVYGYGIVLLE 199
++PE + + ++DVY G VL E
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 23/93 (24%), Positives = 41/93 (44%), Gaps = 12/93 (12%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
+ + L++ + YLH +++ D+KP+NI++ E K+ D G ++ G
Sbjct: 181 VAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY 236
Query: 174 -------MAPECYKRTPISVKADVYGYGIVLLE 199
APE + P +V D+Y G L
Sbjct: 237 LYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAA 268
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-15
Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 16/95 (16%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK------- 171
+IA+ + K + +LH + ++H D+KP N+L++ K+ DFG++ L D
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 172 GC---MAPE----CYKRTPISVKADVYGYGIVLLE 199
GC MAPE + SVK+D++ GI ++E
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 20/114 (17%), Positives = 45/114 (39%), Gaps = 21/114 (18%)
Query: 107 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
S ++ + R+++ L V + + LH ++H ++P +I++D+ ++ F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 167 LLSDK-------GCMAPE-----------CYKRTPISVKADVYGYGIVLLETIC 202
+ G PE +RT ++ D + G+V+ C
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 34/172 (19%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---- 173
V +A +A G+ Y+ +H D++ NIL+ E K++DFGLA+L+ D
Sbjct: 283 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 174 --------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225
APE ++K+DV+ +GI+L E P Y
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILL------TELTTK-GRVP---------YP 383
Query: 226 CFINRE-LNKLVRGTEVDKKNL--ENLVKVGLWCVQDEPALRPSMKCVVMML 274
+NRE L+++ RG + E+L + C + EP RP+ + + L
Sbjct: 384 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 35/172 (20%), Positives = 68/172 (39%), Gaps = 34/172 (19%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD------K 171
+ +A ++ + YL + +H ++ +N L+ E K++DFGL++L++
Sbjct: 321 LYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377
Query: 172 GC------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225
G APE S+K+DV+ +G++L WE P Y
Sbjct: 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL------WEIATY-GMSP---------YP 421
Query: 226 CFINRE-LNKLVRGTEVDKKNL--ENLVKVGLWCVQDEPALRPSMKCVVMML 274
+ L + +++ E + ++ C Q P+ RPS +
Sbjct: 422 GIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 26/91 (28%), Positives = 36/91 (39%), Gaps = 20/91 (21%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEF-WTAKISDFGLAKLLSDKGC----------- 173
+G+ YLH ILH D+K N+L+ A + DFG A L G
Sbjct: 161 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE P K D++ ++L
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 4e-14
Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 34/172 (19%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---- 173
V +A +A G+ Y+ +H D++ NIL+ E K++DFGLA+L+ D
Sbjct: 366 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422
Query: 174 --------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225
APE ++K+DV+ +GI+L E P Y
Sbjct: 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILL------TELTTK-GRVP---------YP 466
Query: 226 CFINRE-LNKLVRGTEVDKKNL--ENLVKVGLWCVQDEPALRPSMKCVVMML 274
+NRE L+++ RG + E+L + C + EP RP+ + + L
Sbjct: 467 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-14
Identities = 33/178 (18%), Positives = 54/178 (30%), Gaps = 52/178 (29%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
I L +A+ + +LH + ++H D+KP NI K+ DFGL +
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 174 ------------------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPE 215
M+PE S K D++ G++L E + S
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE-------LLYPFSTQM 231
Query: 216 EIILTNWVYKCFINRELNKLVRGT-----EVDKKNLENLVKVGLWCVQDEPALRPSMK 268
E + T L + +V+ + P RP
Sbjct: 232 ERVRT-----------LTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAI 275
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-14
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 17/96 (17%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK------- 171
++ + + K + YL ++ ++H D+KP NIL+DE K+ DFG++ L D
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185
Query: 172 GC---MAPE-----CYKRTPISVKADVYGYGIVLLE 199
GC MAPE + ++ADV+ GI L+E
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 8e-14
Identities = 16/106 (15%), Positives = 38/106 (35%), Gaps = 20/106 (18%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG- 172
+ R+++ L V + + LH ++H ++P +I++D+ ++ F
Sbjct: 210 HHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV 266
Query: 173 ------CMAPE----------CYKRTPISVKADVYGYGIVLLETIC 202
PE + T ++ D + G+ + C
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 8e-14
Identities = 27/111 (24%), Positives = 44/111 (39%), Gaps = 28/111 (25%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
+I + + ++H +PPI+H D+K +N+L+ T K+ DFG A +S
Sbjct: 140 KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 174 ------------------MAPE---CYKRTPISVKADVYGYGIVLLETICC 203
PE Y PI K D++ G +L +C
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL-LCF 248
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 8e-14
Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 15/96 (15%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
+ + + ++HD ILH DIK QNI + + T ++ DFG+A++L+
Sbjct: 129 DWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
Query: 174 ------MAPECYKRTPISVKADVYGYGIVLLETICC 203
++PE + P + K+D++ G VL E +C
Sbjct: 186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYE-LCT 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 34/95 (35%), Positives = 47/95 (49%), Gaps = 16/95 (16%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK------- 171
+I L K + +L + + I+H DIKP NIL+D K+ DFG++ L D
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA 186
Query: 172 GC---MAPE----CYKRTPISVKADVYGYGIVLLE 199
GC MAPE R V++DV+ GI L E
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 10/96 (10%), Positives = 26/96 (27%), Gaps = 13/96 (13%)
Query: 117 RVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG---- 172
+ + + L + ++H P N+ + + D + +G
Sbjct: 196 LHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS 252
Query: 173 ---CMAPE---CYKRTPISVKADVYGYGIVLLETIC 202
AP + + + G+ + C
Sbjct: 253 VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 21/108 (19%), Positives = 33/108 (30%), Gaps = 27/108 (25%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
+ L + +G+ +H H D+KP NIL+ + + D G
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 174 ---------------MAPE---CYKRTPISVKADVYGYGIVLLETICC 203
APE I + DV+ G VL +
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA-MMF 241
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 17/88 (19%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFW-TAKISDFGLAKLLSDKGC----------- 173
+G+ YLHD I+H DIK N+L++ + KISDFG +K L+
Sbjct: 133 EGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQY 189
Query: 174 MAPECYKRTPI--SVKADVYGYGIVLLE 199
MAPE + P AD++ G ++E
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIE 217
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-13
Identities = 25/96 (26%), Positives = 48/96 (50%), Gaps = 15/96 (15%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---- 173
+ + +A+G+ ++ +H D++ NIL+ KI+DFGLA+++ D
Sbjct: 287 IDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343
Query: 174 --------MAPECYKRTPISVKADVYGYGIVLLETI 201
APE ++K+DV+ +GI+L+E +
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 8e-13
Identities = 36/185 (19%), Positives = 63/185 (34%), Gaps = 57/185 (30%)
Query: 113 YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG 172
YW + + + +H I+H D+KP N L+ + K+ DFG+A +
Sbjct: 160 YWKN-------MLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 208
Query: 173 C-------------MAPECYKRTP-----------ISVKADVYGYGIVLLETICC---WE 205
M PE K IS K+DV+ G +L ++
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
Query: 206 NMEIDASKPEEIILTNWVYKC--FINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPAL 263
+ SK II N + ++L +++ C++ +P
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC-----------------CLKRDPKQ 311
Query: 264 RPSMK 268
R S+
Sbjct: 312 RISIP 316
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 36/185 (19%), Positives = 63/185 (34%), Gaps = 57/185 (30%)
Query: 113 YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG 172
YW + + + +H I+H D+KP N L+ + K+ DFG+A +
Sbjct: 132 YWKN-------MLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 180
Query: 173 C-------------MAPECYKRTP-----------ISVKADVYGYGIVLLETICC---WE 205
M PE K IS K+DV+ G +L ++
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240
Query: 206 NMEIDASKPEEIILTNWVYKC--FINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPAL 263
+ SK II N + ++L +++ C++ +P
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC-----------------CLKRDPKQ 283
Query: 264 RPSMK 268
R S+
Sbjct: 284 RISIP 288
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 35/185 (18%), Positives = 64/185 (34%), Gaps = 57/185 (30%)
Query: 113 YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG 172
YW + + + +H I+H D+KP N L+ + K+ DFG+A +
Sbjct: 113 YWKN-------MLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 161
Query: 173 C-------------MAPE-----------CYKRTPISVKADVYGYGIVLLETICC---WE 205
M PE ++ IS K+DV+ G +L ++
Sbjct: 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221
Query: 206 NMEIDASKPEEIILTNWVYKC--FINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPAL 263
+ SK II N + ++L +++ C++ +P
Sbjct: 222 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC-----------------CLKRDPKQ 264
Query: 264 RPSMK 268
R S+
Sbjct: 265 RISIP 269
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 25/91 (27%), Positives = 43/91 (47%), Gaps = 14/91 (15%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
+ V + + YLH + ++H DIK +IL+ K+SDFG +S
Sbjct: 146 VCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE R+ + + D++ GI+++E
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 23/91 (25%), Positives = 41/91 (45%), Gaps = 14/91 (15%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
+ + + + +LH ++H DIK NIL+ + K++DFG ++ +
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE R K D++ GI+ +E
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 38/179 (21%), Positives = 61/179 (34%), Gaps = 46/179 (25%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-----FWTAKISDFGLAKLLSDK-- 171
+ G+ +LH I+H D+KP NIL+ A ISDFGL K L+
Sbjct: 122 TLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 172 ------------GCMAPECYKRTPI---SVKADVYGYGIVLLETICC-----WENMEIDA 211
G +APE + D++ G V I ++++ A
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238
Query: 212 SKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCV 270
IL + + + + L++ + +P RPS K V
Sbjct: 239 -----NIL--------LGACSLDCLHPEKHEDVIARELIE---KMIAMDPQKRPSAKHV 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 3e-12
Identities = 26/93 (27%), Positives = 43/93 (46%), Gaps = 16/93 (17%)
Query: 123 DVAKGILYLHDECEPPILHCDIKPQNILMD---EFWTAKISDFGLAKLLSDKG-----C- 173
D++ + YLH+ I+H D+KP+NI++ + KI D G AK L
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETIC 202
+APE ++ +V D + +G + E I
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-12
Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 17/98 (17%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--SDKGC 173
++ +LDV + + YL +H D+ +N+L+ E AK+SDFGL K +
Sbjct: 290 CLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346
Query: 174 ------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
APE + S K+DV+ +GI+L WE
Sbjct: 347 KLPVKWTAPEALREKKFSTKSDVWSFGILL------WE 378
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 30/95 (31%), Positives = 42/95 (44%), Gaps = 13/95 (13%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG----C- 173
I V Y+H+E I H D+KP NILMD+ K+SDFG ++ + DK
Sbjct: 155 CIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRG 212
Query: 174 ----MAPE--CYKRTPISVKADVYGYGIVLLETIC 202
M PE + + K D++ GI L
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-11
Identities = 32/182 (17%), Positives = 58/182 (31%), Gaps = 61/182 (33%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-------------------FWTAKI 159
+ L V +G+ Y+H ++H DIKP NI + KI
Sbjct: 119 DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175
Query: 160 SDFGLAKLLSD----KGC---MAPE-CYKRTPISVKADVYGYGIVLLETICC---WENME 208
D G +S +G +A E + KAD++ + ++ N +
Sbjct: 176 GDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235
Query: 209 ----IDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALR 264
I + I +++E +L++ + +P R
Sbjct: 236 QWHEIRQGRLPRIPQV-------LSQEFTELLK-----------------VMIHPDPERR 271
Query: 265 PS 266
PS
Sbjct: 272 PS 273
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 14/91 (15%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
I KG+ YLH +H DIK NIL++ AK++DFG+A L+D
Sbjct: 130 ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 186
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE + + AD++ GI +E
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-11
Identities = 28/107 (26%), Positives = 42/107 (39%), Gaps = 29/107 (27%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC----- 173
R+ + + + Y+H + I+H D+KP NI +DE KI DFGLAK +
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 174 --------------------MAPE-CYKRTPISVKADVYGYGIVLLE 199
+A E + K D+Y GI+ E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 14/91 (15%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
I ++ KG+ YLH E +H DIK N+L+ E K++DFG+A L+D
Sbjct: 124 ILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 180
Query: 174 -----MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE K++ KAD++ GI +E
Sbjct: 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 36/159 (22%), Positives = 60/159 (37%), Gaps = 22/159 (13%)
Query: 99 DLAYIIFCSAERNPYWN-QRVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 156
D+ Y I+ E NP + R + G+ +LH I++ D+KP+N+L+D+
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGN 327
Query: 157 AKISDFGLAKLLSDKG------C-----MAPECYKRTPISVKADVYGYGIVLLETICCW- 204
+ISD GLA L MAPE D + G+ L E I
Sbjct: 328 VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
Query: 205 ----ENMEIDASKPEEIILTNWV-YKCFINRELNKLVRG 238
+++ + ++ +L V Y +
Sbjct: 388 PFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-11
Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 17/101 (16%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC- 173
+ ++ + KG+ YL + +H D+ +NIL++ KI DFGL K+L
Sbjct: 114 IKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170
Query: 174 -------------MAPECYKRTPISVKADVYGYGIVLLETI 201
APE + SV +DV+ +G+VL E
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 4e-11
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 16/95 (16%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---- 173
+ + VAKG+ +L +H D+ +NIL+ E KI DFGLA+ +
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 174 ---------MAPECYKRTPISVKADVYGYGIVLLE 199
MAPE ++++DV+ +G++L E
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 287
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-11
Identities = 24/106 (22%), Positives = 41/106 (38%), Gaps = 25/106 (23%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKISDFGLAKLLSDKG-- 172
+ DV G+ +L + I+H +IKP NI+ D K++DFG A+ L D
Sbjct: 116 IVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 173 ---C-----MAPECYKRTPI--------SVKADVYGYGIVLLETIC 202
+ P+ Y+R + D++ G+
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-11
Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 17/101 (16%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC- 173
+ ++ + KG+ YL + +H D+ +NIL++ KI DFGL K+L
Sbjct: 145 IKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201
Query: 174 -------------MAPECYKRTPISVKADVYGYGIVLLETI 201
APE + SV +DV+ +G+VL E
Sbjct: 202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-11
Identities = 29/97 (29%), Positives = 54/97 (55%), Gaps = 15/97 (15%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD---- 170
N+ + +A +A+G+ ++ + +H D++ NIL+ + + KI+DFGLA+L+ D
Sbjct: 109 NKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165
Query: 171 --KGC------MAPECYKRTPISVKADVYGYGIVLLE 199
+G APE ++K+DV+ +GI+L E
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 202
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-11
Identities = 24/103 (23%), Positives = 46/103 (44%), Gaps = 22/103 (21%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---- 173
+ + +AKG+ YL + ++H ++ +N+L+ +++DFG+A LL
Sbjct: 118 LNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
Query: 174 ---------MAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
MA E + ++DV+ YG+ + WE M
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV------WELM 211
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-11
Identities = 39/174 (22%), Positives = 76/174 (43%), Gaps = 34/174 (19%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----- 170
Q + + DV +G+ +L +H D+ +N L+D K+SDFG+ + + D
Sbjct: 105 QLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161
Query: 171 -KGC------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV 223
G APE + S K+DV+ +GI++ WE + P
Sbjct: 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILM------WEVFSL-GKMP--------- 205
Query: 224 YKCFINRE-LNKLVRGTEVDKKNL--ENLVKVGLWCVQDEPALRPSMKCVVMML 274
Y + N E + K+ +G + + +L + + ++ C + P RP+ + ++ +
Sbjct: 206 YDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 6e-11
Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 22/103 (21%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-SDKGC--- 173
+ + +AKG+ YL D ++H D+ +N+L+ KI+DFGLAKLL +++
Sbjct: 120 LNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 174 ---------MAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
MA E + ++DV+ YG+ + WE M
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTV------WELM 213
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-11
Identities = 35/140 (25%), Positives = 56/140 (40%), Gaps = 20/140 (14%)
Query: 116 QRVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK--- 171
R A ++ G+ LH E I++ D+KP+NIL+D+ +ISD GLA + +
Sbjct: 286 ARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342
Query: 172 -------GCMAPECYKRTPISVKADVYGYGIVLLETICCW-----ENMEIDASKPEEIIL 219
G MAPE K + D + G +L E I +I + E ++
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
Query: 220 TNWV-YKCFINRELNKLVRG 238
Y + + L
Sbjct: 403 EVPEEYSERFSPQARSLCSQ 422
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-11
Identities = 24/106 (22%), Positives = 41/106 (38%), Gaps = 25/106 (23%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKISDFGLAKLLSDKG-- 172
+ DV G+ +L + I+H +IKP NI+ D K++DFG A+ L D
Sbjct: 116 IVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 173 ---C-----MAPECYKRTPI--------SVKADVYGYGIVLLETIC 202
+ P+ Y+R + D++ G+
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 7e-11
Identities = 22/93 (23%), Positives = 40/93 (43%), Gaps = 12/93 (12%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG----C- 173
++A + Y H + ++H DIKP+N+L+ KI+DFG + C
Sbjct: 113 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG 169
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETIC 202
+ PE + K D++ G++ E +
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-11
Identities = 32/181 (17%), Positives = 69/181 (38%), Gaps = 30/181 (16%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC- 173
Q+++ A+ + KG+ YL +H D+ +N+L++ KI DFGL K +
Sbjct: 126 KQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182
Query: 174 -------------MAPECYKRTPISVKADVYGYGIVLLETICCWENM----EIDASKPEE 216
APEC ++ + +DV+ +G+ L E + +
Sbjct: 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL------HELLTYCDSDSSPMALF 236
Query: 217 IILTNWVYKCFINRELNKLV-RGTEVDKKNL--ENLVKVGLWCVQDEPALRPSMKCVVMM 273
+ + + L + G + + + ++ C + +P+ R S + ++
Sbjct: 237 LKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296
Query: 274 L 274
Sbjct: 297 F 297
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-11
Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 17/98 (17%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-SDKGC--- 173
+ + + KG+ YL +H D+ +NIL++ KI+DFGLAKLL DK
Sbjct: 130 LLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 174 ----------MAPECYKRTPISVKADVYGYGIVLLETI 201
APE S ++DV+ +G+VL E
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-10
Identities = 25/85 (29%), Positives = 39/85 (45%), Gaps = 14/85 (16%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG------C---- 173
+ G YLH ++H D+K N+ ++E KI DFGLA + G C
Sbjct: 124 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 180
Query: 174 -MAPECYKRTPISVKADVYGYGIVL 197
+APE + S + DV+ G ++
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIM 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-10
Identities = 28/102 (27%), Positives = 51/102 (50%), Gaps = 21/102 (20%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----- 170
+ + LDV +G+ YL + C ++H D+ +N L+ E K+SDFG+ + + D
Sbjct: 105 TLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161
Query: 171 -KGC------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
G +PE + + S K+DV+ +G+++ WE
Sbjct: 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM------WE 197
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-10
Identities = 26/90 (28%), Positives = 41/90 (45%), Gaps = 14/90 (15%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG------C---- 173
+ G+LYLH ILH D+ N+L+ KI+DFGLA L C
Sbjct: 121 IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 174 -MAPECYKRTPISVKADVYGYGIVLLETIC 202
++PE R+ +++DV+ G + +
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLI 207
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-10
Identities = 24/102 (23%), Positives = 42/102 (41%), Gaps = 21/102 (20%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-- 173
V +L + K + YL +H DI +NIL+ K+ DFGL++ + D+
Sbjct: 114 TLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK 170
Query: 174 ----------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
M+PE + +DV+ + + + WE
Sbjct: 171 ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCM------WE 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 16/87 (18%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGCM------ 174
+ +G+ YLH I+H D+KPQNIL+ KI DFG+++ + +
Sbjct: 140 ILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGT 196
Query: 175 ----APECYKRTPISVKADVYGYGIVL 197
APE PI+ D++ GI+
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 44/176 (25%), Positives = 72/176 (40%), Gaps = 36/176 (20%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----- 170
Q V + +A G+ YL + +H D+ +NIL++ K+SDFGL+++L D
Sbjct: 148 QLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204
Query: 171 ---KGC------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
G APE + +DV+ +GIV+ WE M +P
Sbjct: 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM------WEVMTY-GERP------- 250
Query: 222 WVYKCFINRE-LNKLVRGTEVDKKNL--ENLVKVGLWCVQDEPALRPSMKCVVMML 274
Y N E + + G + + ++ + C Q E A RP +V +L
Sbjct: 251 --YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 23/105 (21%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC- 173
Q V + V G+ YL D +H D+ +N+L+D K+SDFGL+++L D
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 174 -------------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
APE S +DV+ +G+V+ WE
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM------WE 246
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 28/108 (25%), Positives = 47/108 (43%), Gaps = 23/108 (21%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
+ + V+ G+ YL ++ +H ++ +N+L+ AKISDFGL+K L
Sbjct: 435 VSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491
Query: 174 --------------MAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
APEC S ++DV+ YG+ + WE +
Sbjct: 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM------WEAL 533
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 28/119 (23%), Positives = 41/119 (34%), Gaps = 38/119 (31%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMD-------------EFWTAKISDFGLA 165
+ +A G+ +LH I+H D+KPQNIL+ E ISDFGL
Sbjct: 119 SLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 166 KLLSDKGC---------------MAPE-------CYKRTPISVKADVYGYGIVLLETIC 202
K L APE + ++ D++ G V +
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 33/174 (18%), Positives = 64/174 (36%), Gaps = 34/174 (19%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-- 173
+ A ++ + YL + +H DI +N+L+ K+ DFGL++ + D
Sbjct: 492 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548
Query: 174 ----------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV 223
MAPE + +DV+ +G+ + WE + KP
Sbjct: 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM------WEILMH-GVKP--------- 592
Query: 224 YKCFINRE-LNKLVRGTEVDKKNL--ENLVKVGLWCVQDEPALRPSMKCVVMML 274
++ N + + ++ G + L + C +P+ RP + L
Sbjct: 593 FQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 29/108 (26%), Positives = 47/108 (43%), Gaps = 23/108 (21%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
+ + V+ G+ YL ++ +H D+ +N+L+ AKISDFGL+K L
Sbjct: 109 VSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165
Query: 174 --------------MAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
APEC S ++DV+ YG+ + WE +
Sbjct: 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM------WEAL 207
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 32/135 (23%), Positives = 53/135 (39%), Gaps = 22/135 (16%)
Query: 84 RGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCD 143
R + + + + + A VAKG+ +L + +H D
Sbjct: 141 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197
Query: 144 IKPQNILMDEFWTAKISDFGLAKLLSD------KGC-------MAPECYKRTPISVKADV 190
+ +N+L+ KI DFGLA+ + +G MAPE ++K+DV
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 257
Query: 191 YGYGIVLLETICCWE 205
+ YGI+L WE
Sbjct: 258 WSYGILL------WE 266
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 38/174 (21%), Positives = 75/174 (43%), Gaps = 34/174 (19%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----- 170
Q + + DV + + YL + LH D+ +N L+++ K+SDFGL++ + D
Sbjct: 121 QLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177
Query: 171 -KGC------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV 223
G PE + S K+D++ +G+++ WE + P
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM------WEIYSL-GKMP--------- 221
Query: 224 YKCFINRE-LNKLVRGTEVDKKNL--ENLVKVGLWCVQDEPALRPSMKCVVMML 274
Y+ F N E + +G + + +L E + + C ++ RP+ K ++ +
Sbjct: 222 YERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 28/104 (26%), Positives = 42/104 (40%), Gaps = 23/104 (22%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-- 173
R A+ VA+G+ YL + +H D+ +N+L+ KI DFGL + L
Sbjct: 122 TLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 178
Query: 174 ------------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
APE K S +D + +G+ L WE
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL------WE 216
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 23/105 (21%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC- 173
+ + V+ G+ YL + +H D+ +N+L+ AKISDFGL+K L
Sbjct: 117 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 174 -------------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
APEC S K+DV+ +G+++ WE
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM------WE 212
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 17/88 (19%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKISDFGLAKLLSDKGCM----- 174
+ G+ YLH + I H D+KP+NI++ K+ DFGLA + D
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180
Query: 175 -----APECYKRTPISVKADVYGYGIVL 197
APE P+ ++AD++ G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 14/90 (15%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG------C---- 173
+ G YLH ++H D+K N+ ++E KI DFGLA + G C
Sbjct: 150 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 206
Query: 174 -MAPECYKRTPISVKADVYGYGIVLLETIC 202
+APE + S + DV+ G ++ +
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 236
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 22/101 (21%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD------K 171
+ + VAKG+ +L +H D+ +NIL+ KI DFGLA+ + + K
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 172 GC-------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
G MAPE + ++DV+ YGI L WE
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFL------WE 239
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 23/107 (21%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC- 173
Q V + +A G+ YL D +H D+ +NIL++ K+SDFGL ++L D
Sbjct: 147 IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203
Query: 174 -------------MAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
+PE + +DV+ YGIVL WE M
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL------WEVM 244
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 22/103 (21%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---- 173
+ + +AKG+ YL D ++H D+ +N+L+ KI+DFGLAKLL +
Sbjct: 120 LNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 174 ---------MAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
MA E + ++DV+ YG+ + WE M
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTV------WELM 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-10
Identities = 23/102 (22%), Positives = 42/102 (41%), Gaps = 21/102 (20%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD----- 170
+ A ++ + YL + +H DI +N+L+ K+ DFGL++ + D
Sbjct: 117 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173
Query: 171 -KGC------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
MAPE + +DV+ +G+ + WE
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM------WE 209
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-10
Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 17/99 (17%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--SDKG 172
+ ++ +LDV + + YL +H D+ +N+L+ E AK+SDFGL K +
Sbjct: 117 DCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173
Query: 173 C------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
APE + S K+DV+ +GI+L WE
Sbjct: 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILL------WE 206
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 5e-10
Identities = 20/128 (15%), Positives = 38/128 (29%), Gaps = 28/128 (21%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA-----------KISDFG 163
+ A+ + I +HD I+H DIKP N ++ + + D G
Sbjct: 172 GLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 164 LAKLLSD--------KGC-----MAPECYKRTPISVKADVYGYGIVLLETICCWENMEID 210
+ + C E P + + D +G + + M++
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYC-MLFGTYMKVK 287
Query: 211 ASKPEEII 218
E
Sbjct: 288 NEGGECKP 295
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-10
Identities = 25/96 (26%), Positives = 47/96 (48%), Gaps = 15/96 (15%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD------K 171
+ +A ++ + YL + +H D+ +N L+ E K++DFGL++L++
Sbjct: 114 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170
Query: 172 GC------MAPECYKRTPISVKADVYGYGIVLLETI 201
G APE S+K+DV+ +G++L E
Sbjct: 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 13/90 (14%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
+ +G+ YLH ++H D+K NIL+ E K+ DFG A +++
Sbjct: 159 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY 215
Query: 174 -MAPE---CYKRTPISVKADVYGYGIVLLE 199
MAPE K DV+ GI +E
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-10
Identities = 44/176 (25%), Positives = 74/176 (42%), Gaps = 41/176 (23%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD-----KG 172
V +A+G+ YL +H D+ +N+L+ E KI+DFGLA+ +++ K
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 173 C--------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
MAPE + ++DV+ +G+++ WE + P Y
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM------WEIFTL-GGSP---------Y 306
Query: 225 KCFINRELNKLVR-GTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
EL KL++ G +DK L ++ C P+ RP+ K +V L
Sbjct: 307 PGIPVEELFKLLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 359
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 6e-10
Identities = 37/139 (26%), Positives = 61/139 (43%), Gaps = 19/139 (13%)
Query: 116 QRVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG-- 172
+R A ++ G+ ++H+ +++ D+KP NIL+DE +ISD GLA S K
Sbjct: 292 ADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
Query: 173 --C-----MAPE-CYKRTPISVKADVYGYGIVLLETICCW----ENMEIDASKPEEIILT 220
MAPE K AD + G +L + + ++ D + + + LT
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 408
Query: 221 NWV-YKCFINRELNKLVRG 238
V + EL L+ G
Sbjct: 409 MAVELPDSFSPELRSLLEG 427
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-10
Identities = 32/147 (21%), Positives = 56/147 (38%), Gaps = 27/147 (18%)
Query: 109 ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168
+ Q + A + +G+ YLH + +H D+ +N+L+D KI DFGLAK +
Sbjct: 128 RHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184
Query: 169 SDKGC--------------MAPECYKRTPISVKADVYGYGIVLLETICCWENM----EID 210
+ APEC K +DV+ +G+ L +E +
Sbjct: 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL------YELLTHCDSSQ 238
Query: 211 ASKPEEIILTNWVYKCFINRELNKLVR 237
+ + + L L +L+
Sbjct: 239 SPPTKFLELIGIAQGQMTVLRLTELLE 265
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 6e-10
Identities = 26/91 (28%), Positives = 43/91 (47%), Gaps = 15/91 (16%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNIL---MDEFWTAKISDFGLAKLLSDK---- 171
+ V + YLH+ I+H D+KP+N+L +E I+DFGL+K+ +
Sbjct: 110 LVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166
Query: 172 -----GCMAPECYKRTPISVKADVYGYGIVL 197
G +APE + P S D + G++
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-10
Identities = 26/102 (25%), Positives = 45/102 (44%), Gaps = 17/102 (16%)
Query: 115 NQRVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG- 172
+ V++ ++ + YL ++ I+H D+KP NIL+DE I+DF +A +L +
Sbjct: 114 EETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 173 ----C-----MAPECYKRTPI---SVKADVYGYGIVLLETIC 202
MAPE + S D + G+ E +
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-10
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 17/88 (19%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKISDFGLAKLLSDKGCM----- 174
+ G+ YLH + I H D+KP+NI++ K+ DFGLA + D
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180
Query: 175 -----APECYKRTPISVKADVYGYGIVL 197
APE P+ ++AD++ G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 7e-10
Identities = 23/88 (26%), Positives = 39/88 (44%), Gaps = 12/88 (13%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG----C-----M 174
+A + Y H+ ++H DIKP+N+LM KI+DFG + C +
Sbjct: 123 LADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL 179
Query: 175 APECYKRTPISVKADVYGYGIVLLETIC 202
PE + K D++ G++ E +
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 31/176 (17%), Positives = 64/176 (36%), Gaps = 36/176 (20%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT--------AKISDFGLAKL 167
++ +A +A + +L + ++H ++ +NIL+ K+SD G++
Sbjct: 114 WKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
Query: 168 LSDKGC-------MAPECYK-RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219
+ K + PEC + +++ D + +G L WE KP
Sbjct: 171 VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTL------WEICSG-GDKP----- 218
Query: 220 TNWVYKCFINRE-LNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
++ L ++ L + C+ EP RPS + ++ L
Sbjct: 219 ----LSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-09
Identities = 23/88 (26%), Positives = 40/88 (45%), Gaps = 17/88 (19%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKISDFGLAKLLSDKGCM----- 174
+ G+ YLH + I H D+KP+NI++ K+ DFG+A +
Sbjct: 117 ILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG 173
Query: 175 -----APECYKRTPISVKADVYGYGIVL 197
APE P+ ++AD++ G++
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 22/101 (21%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD------K 171
+ + VA+G+ +L + +H D+ +N+L+ AKI DFGLA+ + + K
Sbjct: 167 LHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 172 GC-------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
G MAPE +V++DV+ YGI+L WE
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILL------WE 258
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 41/176 (23%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD-----KG 172
+++A ++A G+ YL+ +H D+ +N ++ E +T KI DFG+ + + + KG
Sbjct: 141 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 173 C--------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
M+PE K + +DV+ +G+VL WE + A +P Y
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL------WEIATL-AEQP---------Y 241
Query: 225 KCFINRE-LNKLVRGTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
+ N + L ++ G +DK L L+ C Q P +RPS ++ +
Sbjct: 242 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELM---RMCWQYNPKMRPSFLEIISSI 294
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 41/176 (23%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD-----KG 172
VR +D+A G+ YL +H D+ +N ++ E T ++DFGL++ + +G
Sbjct: 140 VRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 173 C--------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
C +A E +V +DV+ +G+ + WE M P Y
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTM------WEIMTR-GQTP---------Y 240
Query: 225 KCFINRE-LNKLVRGTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
N E N L+ G + + + + +L+ C +P RPS C+ M L
Sbjct: 241 AGIENAEIYNYLIGGNRLKQPPECMEEVYDLM---YQCWSADPKQRPSFTCLRMEL 293
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 26/96 (27%), Positives = 42/96 (43%), Gaps = 19/96 (19%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
I ++ +G+ +LH ++H DIK QN+L+ E K+ DFG++ L
Sbjct: 134 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 190
Query: 174 -----MAPE-----CYKRTPISVKADVYGYGIVLLE 199
MAPE K+D++ GI +E
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 22/93 (23%), Positives = 39/93 (41%), Gaps = 17/93 (18%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGC-- 173
I + + ++HD ++H D+KP+N+L ++ KI DFG A+L
Sbjct: 110 YIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 174 ---------MAPECYKRTPISVKADVYGYGIVL 197
APE + D++ G++L
Sbjct: 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 32/114 (28%), Positives = 56/114 (49%), Gaps = 24/114 (21%)
Query: 107 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
S +RNP + L VA+G+ YL ++ +H D+ +N ++DE +T K++DFGLA+
Sbjct: 116 SPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLAR 172
Query: 167 LLSD-------KGC--------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
+ D + A E + + K+DV+ +G++L WE
Sbjct: 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLL------WE 220
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 17/88 (19%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGC------- 173
+ + + Y HD I+H D+KP +L+ + K+ FG+A L + G
Sbjct: 139 ILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195
Query: 174 ----MAPECYKRTPISVKADVYGYGIVL 197
MAPE KR P DV+G G++L
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 41/176 (23%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---- 173
V +A+G+ YL + +H D+ +N+L+ E KI+DFGLA+ +++
Sbjct: 160 VSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 174 ---------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
MAPE + ++DV+ +G+++ WE + P Y
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM------WEIFTL-GGSP---------Y 260
Query: 225 KCFINRELNKLVR-GTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
EL KL++ G +DK L ++ C P+ RP+ K +V L
Sbjct: 261 PGIPVEELFKLLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 313
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 14/100 (14%)
Query: 117 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG--- 172
R R ++ + YLH E +++ D+K +N+++D+ KI+DFGL K G
Sbjct: 249 RARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 306
Query: 173 ---C-----MAPECYKRTPISVKADVYGYGIVLLETICCW 204
C +APE + D +G G+V+ E +C
Sbjct: 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 20/97 (20%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
I +V +G+ YLH +H D+K NIL+ E + +I+DFG++ L+ G
Sbjct: 126 ILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 174 ----------MAPECYKRT-PISVKADVYGYGIVLLE 199
MAPE ++ KAD++ +GI +E
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-09
Identities = 24/87 (27%), Positives = 43/87 (49%), Gaps = 16/87 (18%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGCM------ 174
+ + I Y H I+H ++KP+N+L+ + K++DFGLA ++D
Sbjct: 114 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170
Query: 175 ----APECYKRTPISVKADVYGYGIVL 197
+PE K+ P S D++ G++L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 42/180 (23%), Positives = 75/180 (41%), Gaps = 43/180 (23%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-- 173
+ L VAKG+ +L + +H D+ +N ++DE +T K++DFGLA+ + DK
Sbjct: 193 DLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249
Query: 174 -------------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILT 220
MA E + + K+DV+ +G++L WE M + P
Sbjct: 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL------WELMTR-GAPP------ 296
Query: 221 NWVYKCFINRE-LNKLVRGTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
Y + L++G + + L ++ L C + +RPS +V +
Sbjct: 297 ---YPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRI 350
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-09
Identities = 25/88 (28%), Positives = 39/88 (44%), Gaps = 17/88 (19%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKISDFGLAKLLSDKGCM----- 174
+ G+ YLH I H D+KP+NI++ KI DFGLA +
Sbjct: 123 ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 175 -----APECYKRTPISVKADVYGYGIVL 197
APE P+ ++AD++ G++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-09
Identities = 23/95 (24%), Positives = 41/95 (43%), Gaps = 19/95 (20%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM---- 174
+I + + I LH I+H D+KP+NIL+D+ K++DFG + L +
Sbjct: 128 KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 175 ------APE------CYKRTPISVKADVYGYGIVL 197
APE + D++ G+++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-09
Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 37/177 (20%)
Query: 116 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC-- 173
+ L VAKG+ YL + +H D+ +N ++DE +T K++DFGLA+ + DK
Sbjct: 129 DLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185
Query: 174 -------------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILT 220
MA E + + K+DV+ +G++L WE M + P
Sbjct: 186 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL------WELMTR-GAPP------ 232
Query: 221 NWVYKCFINRE-LNKLVRGTEVDKKN--LENLVKVGLWCVQDEPALRPSMKCVVMML 274
Y + L++G + + + L +V L C + +RPS +V +
Sbjct: 233 ---YPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-09
Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 41/176 (23%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD------K 171
+ +A VA G++YL +H D+ +N L+ + KI DFG+++ +
Sbjct: 161 LAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 172 GC-------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
G M PE + ++DV+ +G+VL WE +P +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVL------WEIFTY-GKQP---------W 261
Query: 225 KCFINRELNKLVR-GTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
N E + G E+++ + ++ C Q EP R S+K V L
Sbjct: 262 YQLSNTEAIDCITQGRELERPRACPPEVYAIM---RGCWQREPQQRHSIKDVHARL 314
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-09
Identities = 26/96 (27%), Positives = 43/96 (44%), Gaps = 19/96 (19%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
+ + + + +LH + I+H D+K N+LM +++DFG++
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178
Query: 174 -----MAPE-----CYKRTPISVKADVYGYGIVLLE 199
MAPE K TP KAD++ GI L+E
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 25/86 (29%), Positives = 39/86 (45%), Gaps = 15/86 (17%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTA--KISDFGLAKLLSDKGCM------- 174
+ +GI ++H ILH D+KP+NIL KI DFGLA+ + +
Sbjct: 196 ICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP 252
Query: 175 ---APECYKRTPISVKADVYGYGIVL 197
APE +S D++ G++
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-09
Identities = 17/41 (41%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
+G+ +LH ++H D+KPQNIL+ K++DFGLA+
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 29/89 (32%), Positives = 41/89 (46%), Gaps = 17/89 (19%)
Query: 123 DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG------C--- 173
D+ KGI YLH + I+H DIKP N+L+ E KI+DFG++
Sbjct: 145 DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201
Query: 174 --MAPEC---YKRTPISVKADVYGYGIVL 197
MAPE ++ DV+ G+ L
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 22/101 (21%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD------K 171
+ + VAKG+ +L +H D+ +NIL+ E KI DFGLA+ + K
Sbjct: 151 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 172 GC-------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
G MAPE ++++DV+ +G++L WE
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL------WE 242
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 36/176 (20%), Positives = 70/176 (39%), Gaps = 41/176 (23%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD-----KG 172
++ +D+A G+ YL + LH D+ +N ++ + T ++DFGL+K + +G
Sbjct: 150 LKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 173 C--------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
+A E + K+DV+ +G+ + WE P Y
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM------WEIATR-GMTP---------Y 250
Query: 225 KCFINRE-LNKLVRGTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
N E + L+ G + + L ++ C + +P RP+ + + L
Sbjct: 251 PGVQNHEMYDYLLHGHRLKQPEDCLDELYEIM---YSCWRTDPLDRPTFSVLRLQL 303
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 6e-09
Identities = 19/41 (46%), Positives = 29/41 (70%), Gaps = 3/41 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166
+G+ +LH C I+H D+KP+NIL+ T K++DFGLA+
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 54.8 bits (133), Expect = 6e-09
Identities = 16/45 (35%), Positives = 27/45 (60%), Gaps = 3/45 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
KG+ + H +LH D+KPQN+L++ K+++FGLA+
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 24/87 (27%), Positives = 42/87 (48%), Gaps = 16/87 (18%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGCM------ 174
+ + + YLH+ I+H D+KP+N+L KI+DFGL+K++ + M
Sbjct: 157 ILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGT 213
Query: 175 ----APECYKRTPISVKADVYGYGIVL 197
APE + + D++ GI+
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-09
Identities = 29/101 (28%), Positives = 46/101 (45%), Gaps = 22/101 (21%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC---- 173
V A VA+G+ YL +H D+ +N+L+ E KI+DFGLA+ +
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 174 ---------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
MAPE + ++DV+ +G++L WE
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL------WE 285
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 6e-09
Identities = 17/45 (37%), Positives = 28/45 (62%), Gaps = 3/45 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
+G+ + H+ ILH D+KPQN+L+++ K+ DFGLA+
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 6e-09
Identities = 28/100 (28%), Positives = 46/100 (46%), Gaps = 15/100 (15%)
Query: 117 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG--- 172
R R ++ + YLH +++ DIK +N+++D+ KI+DFGL K G
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162
Query: 173 ---C-----MAPECYKRTPISVKADVYGYGIVLLETICCW 204
C +APE + D +G G+V+ E +C
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-09
Identities = 38/176 (21%), Positives = 74/176 (42%), Gaps = 41/176 (23%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD------K 171
+ IA +A G++YL + +H D+ +N L+ KI DFG+++ +
Sbjct: 136 LHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 172 GC-------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
G M PE + ++DV+ +G++L WE +P +
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL------WEIFTY-GKQP---------W 236
Query: 225 KCFINRE-LNKLVRGTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
N E + + +G +++ K + +++ L C Q EP R ++K + +L
Sbjct: 237 FQLSNTEVIECITQGRVLERPRVCPKEVYDVM---LGCWQREPQQRLNIKEIYKIL 289
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-09
Identities = 16/45 (35%), Positives = 27/45 (60%), Gaps = 3/45 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
+G+ + H +LH D+KPQN+L++ K++DFGLA+
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 8e-09
Identities = 17/45 (37%), Positives = 27/45 (60%), Gaps = 3/45 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
+G+ + H ILH D+KPQN+L++ K++DFGLA+
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 8e-09
Identities = 24/87 (27%), Positives = 43/87 (49%), Gaps = 16/87 (18%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGCM------ 174
+ + I Y H I+H ++KP+N+L+ + K++DFGLA ++D
Sbjct: 137 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 193
Query: 175 ----APECYKRTPISVKADVYGYGIVL 197
+PE K+ P S D++ G++L
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 8e-09
Identities = 19/100 (19%), Positives = 33/100 (33%), Gaps = 23/100 (23%)
Query: 120 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC------ 173
I V K + Y+H +H +K +IL+ +S + G
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 174 ------------MAPECYKRTPI--SVKADVYGYGIVLLE 199
++PE ++ K+D+Y GI E
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 25/86 (29%), Positives = 42/86 (48%), Gaps = 15/86 (17%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM--DEFWTAKISDFGLAKLLSDKGCM------- 174
+G+ ++H+ I+H DIKP+NI+ + + KI DFGLA L+ +
Sbjct: 158 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA 214
Query: 175 ---APECYKRTPISVKADVYGYGIVL 197
APE R P+ D++ G++
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 9e-09
Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 3/45 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
GI Y HD +LH D+KPQN+L++ KI+DFGLA+
Sbjct: 111 NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 9e-09
Identities = 39/176 (22%), Positives = 72/176 (40%), Gaps = 41/176 (23%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD------K 171
+ A +++G+ YL + ++H D+ +NIL+ E KISDFGL++ + + +
Sbjct: 153 ISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR 209
Query: 172 GC-------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
MA E + ++DV+ +G++L WE + + P Y
Sbjct: 210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL------WEIVTL-GGNP---------Y 253
Query: 225 KCFINRE-LNKLVRGTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
N L G +++ + + L+ L C + EP RP + L
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLM---LQCWKQEPDKRPVFADISKDL 306
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 19/88 (21%), Positives = 43/88 (48%), Gaps = 17/88 (19%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGC------- 173
+ + +L+ H ++H ++KP+N+L+ + K++DFGLA + +
Sbjct: 119 ILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175
Query: 174 ----MAPECYKRTPISVKADVYGYGIVL 197
++PE ++ P D++ G++L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 1e-08
Identities = 19/45 (42%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
+G+ Y H + +LH D+KPQN+L++E K++DFGLA+ S
Sbjct: 111 RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-08
Identities = 21/45 (46%), Positives = 28/45 (62%), Gaps = 3/45 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
+G+ YLH ILH D+KP N+L+DE K++DFGLAK
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 26/94 (27%), Positives = 42/94 (44%), Gaps = 18/94 (19%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKISDFGLAKLLSDKG-- 172
+ + K + YLH + ++H D+KP NIL + +I DFG AK L +
Sbjct: 120 AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 173 ----C-----MAPECYKRTPISVKADVYGYGIVL 197
C +APE +R D++ G++L
Sbjct: 177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 39/179 (21%), Positives = 67/179 (37%), Gaps = 44/179 (24%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKISDFGLAKLLSDKGC- 173
+ +A D+A G YL + +H DI +N L+ AKI DFG+A+ +
Sbjct: 143 LHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 174 ------------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
M PE + + K D + +G++L WE + P
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL------WEIFSL-GYMP------- 245
Query: 222 WVYKCFINRE-LNKLVRGTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
Y N+E L + G +D + ++ C Q +P RP+ ++ +
Sbjct: 246 --YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERI 299
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 23/91 (25%), Positives = 39/91 (42%), Gaps = 15/91 (16%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDK---- 171
I D+ I +LH I H D+KP+N+L ++ K++DFG AK +
Sbjct: 132 EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT 188
Query: 172 -----GCMAPECYKRTPISVKADVYGYGIVL 197
+APE D++ G+++
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 10/92 (10%), Positives = 22/92 (23%), Gaps = 19/92 (20%)
Query: 108 AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167
A+ +P +R +A H + P + + ++
Sbjct: 122 ADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATM-- 176
Query: 168 LSDKGCMAPECYKRTPISVKADVYGYGIVLLE 199
+ + D+ G G L
Sbjct: 177 --------------PDANPQDDIRGIGASLYA 194
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 19/54 (35%), Positives = 27/54 (50%), Gaps = 3/54 (5%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPECY 179
G+ Y+H ILH D+K N+L+ K++DFGLA+ S P Y
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 23/86 (26%), Positives = 38/86 (44%), Gaps = 15/86 (17%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM--DEFWTAKISDFGLAKLLSDKGCM------- 174
V + + +LH I H DI+P+NI+ T KI +FG A+ L
Sbjct: 111 VCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167
Query: 175 ---APECYKRTPISVKADVYGYGIVL 197
APE ++ +S D++ G ++
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 15/101 (14%)
Query: 116 QRVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG-- 172
R R A ++ +++LHD+ I++ D+K N+L+D K++DFG+ K G
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 173 ----C-----MAPECYKRTPISVKADVYGYGIVLLETICCW 204
C +APE + D + G++L E +C
Sbjct: 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 19/95 (20%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGCM- 174
+ + YLH+ I+H D+KP+N+L+ +E KI+DFG +K+L + M
Sbjct: 243 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299
Query: 175 ---------APE---CYKRTPISVKADVYGYGIVL 197
APE + D + G++L
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 19/47 (40%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG 172
GI + H I+H DIKP+NIL+ + K+ DFG A+ L+ G
Sbjct: 135 NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 24/86 (27%), Positives = 43/86 (50%), Gaps = 16/86 (18%)
Query: 130 YLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG--------C-----MAP 176
YLH + I+H D+KP+NIL++E +I+DFG AK+LS + ++P
Sbjct: 145 YLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 177 ECYKRTPISVKADVYGYGIVLLETIC 202
E +D++ G ++ + +
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 23/85 (27%), Positives = 37/85 (43%), Gaps = 14/85 (16%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM--------- 174
+ + YL + I+H DIK +NI++ E +T K+ DFG A L
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 175 -APECYKRTP-ISVKADVYGYGIVL 197
APE P + +++ G+ L
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 14/82 (17%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM----------AP 176
+ Y H + I+H D+K +N+L+D KI+DFG + + G + AP
Sbjct: 126 AVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182
Query: 177 ECYKRTP-ISVKADVYGYGIVL 197
E ++ + DV+ G++L
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVIL 204
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 15/47 (31%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG 172
+ + + H +H D+KP+NIL+ + K+ DFG A+LL+
Sbjct: 113 QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 23/95 (24%), Positives = 41/95 (43%), Gaps = 19/95 (20%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM---- 174
I + + + +LH I+H D+KP+NIL+D+ ++SDFG + L +
Sbjct: 204 SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC 260
Query: 175 ------APE------CYKRTPISVKADVYGYGIVL 197
APE + D++ G++L
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 22/100 (22%), Positives = 44/100 (44%), Gaps = 15/100 (15%)
Query: 117 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG--- 172
R + +++ + YLH+ I++ D+K N+L+D K++D+G+ K G
Sbjct: 111 HARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167
Query: 173 ---C-----MAPECYKRTPISVKADVYGYGIVLLETICCW 204
C +APE + D + G+++ E +
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 22/100 (22%), Positives = 44/100 (44%), Gaps = 15/100 (15%)
Query: 117 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG--- 172
R + +++ + YLH+ I++ D+K N+L+D K++D+G+ K G
Sbjct: 154 HARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210
Query: 173 ---C-----MAPECYKRTPISVKADVYGYGIVLLETICCW 204
C +APE + D + G+++ E +
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 25/100 (25%), Positives = 44/100 (44%), Gaps = 15/100 (15%)
Query: 117 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG--- 172
A ++A G+ +L + I++ D+K N+++D KI+DFG+ K G
Sbjct: 443 HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499
Query: 173 ---C-----MAPECYKRTPISVKADVYGYGIVLLETICCW 204
C +APE P D + +G++L E +
Sbjct: 500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 20/45 (44%), Positives = 26/45 (57%), Gaps = 2/45 (4%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEF-WTAKISDFGLAKLLS 169
+ I LH + H DIKP N+L++E T K+ DFG AK LS
Sbjct: 140 RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 4e-08
Identities = 25/100 (25%), Positives = 44/100 (44%), Gaps = 15/100 (15%)
Query: 117 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG--- 172
A ++A G+ +L + I++ D+K N+++D KI+DFG+ K G
Sbjct: 122 HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178
Query: 173 ---C-----MAPECYKRTPISVKADVYGYGIVLLETICCW 204
C +APE P D + +G++L E +
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 21/81 (25%), Positives = 40/81 (49%), Gaps = 11/81 (13%)
Query: 130 YLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG---C-----MAPECYKR 181
YLH +++ D+KP+N+L+D+ +++DFG AK + + C +APE
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILS 212
Query: 182 TPISVKADVYGYGIVLLETIC 202
+ D + G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYEMAA 233
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 19/95 (20%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGCM- 174
+ + YLH+ I+H D+KP+N+L+ +E KI+DFG +K+L + M
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 175 ---------APE---CYKRTPISVKADVYGYGIVL 197
APE + D + G++L
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-08
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 14/95 (14%)
Query: 121 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG------C- 173
A ++ G+ +LH + I++ D+K NIL+D+ KI+DFG+ K C
Sbjct: 124 AAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG 180
Query: 174 ----MAPECYKRTPISVKADVYGYGIVLLETICCW 204
+APE + D + +G++L E +
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 27/92 (29%), Positives = 41/92 (44%), Gaps = 14/92 (15%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG------C---- 173
+A + YLH I++ D+KP+NIL+D ++DFGL K + C
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE 204
Query: 174 -MAPECYKRTPISVKADVYGYGIVLLETICCW 204
+APE + P D + G VL E +
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-08
Identities = 17/50 (34%), Positives = 24/50 (48%), Gaps = 8/50 (16%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTA-----KISDFGLAKLLSD 170
G+ + H LH D+KPQN+L+ + KI DFGLA+
Sbjct: 143 NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-08
Identities = 46/176 (26%), Positives = 70/176 (39%), Gaps = 41/176 (23%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--SD---KG 172
+ IA VA G+ YL + +H D+ +N L+ E KI+DFGL++ + +D
Sbjct: 177 LCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 233
Query: 173 C--------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
M PE + ++DV+ YG+VL WE +P Y
Sbjct: 234 GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL------WEIFSY-GLQP---------Y 277
Query: 225 KCFINRELNKLVR-GTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
+ E+ VR G + L NL+ C PA RPS + +L
Sbjct: 278 YGMAHEEVIYYVRDGNILACPENCPLELYNLM---RLCWSKLPADRPSFCSIHRIL 330
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 6e-08
Identities = 23/89 (25%), Positives = 42/89 (47%), Gaps = 14/89 (15%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG------C-----MA 175
+ +LH + I++ D+KP+NI+++ K++DFGL K G C MA
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 176 PECYKRTPISVKADVYGYGIVLLETICCW 204
PE R+ + D + G ++ + +
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 7e-08
Identities = 25/98 (25%), Positives = 39/98 (39%), Gaps = 22/98 (22%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM--DEFWTAKISDFGLAKLLSDKGC--- 173
I + + YLH++ I H DIKP+N L ++ + K+ DFGL+K
Sbjct: 172 NIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 174 ------------MAPE--CYKRTPISVKADVYGYGIVL 197
+APE K D + G++L
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 7e-08
Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 22/101 (21%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD------K 171
V + +A G+ YL ++H D+ +N+L+ + KISD GL + +
Sbjct: 131 VHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 172 GC-------MAPECYKRTPISVKADVYGYGIVLLETICCWE 205
G MAPE S+ +D++ YG+VL WE
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL------WE 222
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 8e-08
Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 19/103 (18%)
Query: 115 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD--KG 172
Q + A DVA+G+ YL + +H D+ +NIL+ E + AKI+DFGL++ K
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 173 C--------MAPECYKRTPISVKADVYGYGIVLLETICCWENM 207
MA E + + +DV+ YG++L WE +
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL------WEIV 235
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-08
Identities = 24/82 (29%), Positives = 41/82 (50%), Gaps = 14/82 (17%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM----------AP 176
+ Y H ++H D+KP+N+L+D AKI+DFGL+ ++SD + AP
Sbjct: 123 AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
Query: 177 ECYKRTP-ISVKADVYGYGIVL 197
E + D++ G++L
Sbjct: 180 EVISGRLYAGPEVDIWSCGVIL 201
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 8e-08
Identities = 34/85 (40%), Positives = 43/85 (50%), Gaps = 17/85 (20%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG--------C----- 173
G++YLH I H DIKP+N+L+DE KISDFGLA + C
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 174 MAPECYKRTP-ISVKADVYGYGIVL 197
+APE KR + DV+ GIVL
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVL 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-08
Identities = 19/45 (42%), Positives = 26/45 (57%), Gaps = 4/45 (8%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMD-EFWTAKISDFGLAKLLS 169
+ + Y+H I H DIKPQN+L+D K+ DFG AK+L
Sbjct: 152 RSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-08
Identities = 22/63 (34%), Positives = 29/63 (46%), Gaps = 14/63 (22%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMD-EFWTAKISDFGLAKLLSDKGCM---------- 174
+ + Y+H I H DIKPQN+L+D + K+ DFG AK L
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 175 APE 177
APE
Sbjct: 224 APE 226
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 9e-08
Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 14/82 (17%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM----------AP 176
I Y H I+H D+KP+N+L+D+ KI+DFGL+ +++D + AP
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 176
Query: 177 ECYKRTP-ISVKADVYGYGIVL 197
E + DV+ GIVL
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVL 198
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-08
Identities = 27/92 (29%), Positives = 45/92 (48%), Gaps = 17/92 (18%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGC-- 173
I V G+ YLH I+H D+KP+N+L+ ++ KI DFGL+ + ++
Sbjct: 140 VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196
Query: 174 --------MAPECYKRTPISVKADVYGYGIVL 197
+APE ++ K DV+ G++L
Sbjct: 197 ERLGTAYYIAPEVLRK-KYDEKCDVWSIGVIL 227
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG------C---- 173
+A + +LH I++ D+KP+NIL+DE K++DFGL+K D C
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 174 -MAPECYKRTPISVKADVYGYGIVLLETICCW 204
MAPE R + AD + +G+++ E +
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 19/46 (41%), Positives = 24/46 (52%), Gaps = 7/46 (15%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTA----KISDFGLAKL 167
GI YLH +LH D+KP NIL+ KI+D G A+L
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 40/179 (22%), Positives = 68/179 (37%), Gaps = 44/179 (24%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKISDFGLAKLLSDKGC- 173
+ +A D+A G YL + +H DI +N L+ AKI DFG+A+ + G
Sbjct: 184 LHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 174 ------------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
M PE + + K D + +G++L WE + P
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL------WEIFSL-GYMP------- 286
Query: 222 WVYKCFINRE-LNKLVRGTEVDK-----KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
Y N+E L + G +D + ++ C Q +P RP+ ++ +
Sbjct: 287 --YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERI 340
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 27/92 (29%), Positives = 40/92 (43%), Gaps = 17/92 (18%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGC-- 173
RI V GI Y+H I+H D+KP+N+L+ + +I DFGL+
Sbjct: 130 RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK 186
Query: 174 --------MAPECYKRTPISVKADVYGYGIVL 197
+APE K DV+ G++L
Sbjct: 187 DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVIL 217
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 19/44 (43%), Positives = 26/44 (59%), Gaps = 3/44 (6%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
G+ YLH + I+H DIKP N+L+ T KIS G+A+ L
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-07
Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 11/81 (13%)
Query: 130 YLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG---C-----MAPECYKR 181
YLH + I++ D+KP+NIL+D+ KI+DFG AK + D C +APE
Sbjct: 121 YLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVST 177
Query: 182 TPISVKADVYGYGIVLLETIC 202
P + D + +GI++ E +
Sbjct: 178 KPYNKSIDWWSFGILIYEMLA 198
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 24/92 (26%), Positives = 41/92 (44%), Gaps = 15/92 (16%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA--KISDFGLAKLLSDKGCM- 174
V V KG+ ++H+ +H D+KP+NI+ + K+ DFGL L K +
Sbjct: 258 VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314
Query: 175 ---------APECYKRTPISVKADVYGYGIVL 197
APE + P+ D++ G++
Sbjct: 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 16/95 (16%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDE------FWTAKISDFGLAKLLSDKG 172
+I+ + G+ Y+H C I+H DIKP+N+LM+ KI+D G A +
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 173 CM--------APECYKRTPISVKADVYGYGIVLLE 199
+PE P AD++ ++ E
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 34/85 (40%), Positives = 43/85 (50%), Gaps = 17/85 (20%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG--------C----- 173
G++YLH I H DIKP+N+L+DE KISDFGLA + C
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 174 MAPECYKRTP-ISVKADVYGYGIVL 197
+APE KR + DV+ GIVL
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVL 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 14/82 (17%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM----------AP 176
G+ Y H ++H D+KP+N+L+D AKI+DFGL+ ++SD + AP
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 184
Query: 177 ECYKRTP-ISVKADVYGYGIVL 197
E + D++ G++L
Sbjct: 185 EVISGRLYAGPEVDIWSSGVIL 206
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 29/92 (31%), Positives = 42/92 (45%), Gaps = 17/92 (18%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGC-- 173
RI V GI Y+H I+H D+KP+NIL+ ++ KI DFGL+
Sbjct: 125 RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 174 --------MAPECYKRTPISVKADVYGYGIVL 197
+APE + K DV+ G++L
Sbjct: 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 29/87 (33%), Positives = 42/87 (48%), Gaps = 17/87 (19%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGC------- 173
+ GI YLH I+H DIKP+NIL+ + KI DFGL+ S
Sbjct: 155 ILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 174 ---MAPECYKRTPISVKADVYGYGIVL 197
+APE K+ + K DV+ G+++
Sbjct: 212 AYYIAPEVLKK-KYNEKCDVWSCGVIM 237
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 23/92 (25%), Positives = 37/92 (40%), Gaps = 16/92 (17%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGCM- 174
I + + I YLH I H D+KP+N+L K++DFG AK + +
Sbjct: 165 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 175 ---------APECYKRTPISVKADVYGYGIVL 197
APE D++ G+++
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 21/63 (33%), Positives = 30/63 (47%), Gaps = 14/63 (22%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMD-EFWTAKISDFGLAKLLSDKGCM---------- 174
+ + ++H I H DIKPQN+L++ + T K+ DFG AK L
Sbjct: 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR 208
Query: 175 APE 177
APE
Sbjct: 209 APE 211
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 22/95 (23%), Positives = 32/95 (33%), Gaps = 22/95 (23%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG-------C-----M 174
I +H +H DIKP NIL+D +++DFG L G +
Sbjct: 174 AIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 175 APECYKRTPISVKADVYG-------YGIVLLETIC 202
+PE + YG G+ E
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 25/85 (29%), Positives = 36/85 (42%), Gaps = 14/85 (16%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKISDFGLAKLLSDKG----C----- 173
V + + + H+ +LH DIK +NIL+D K+ DFG LL D
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 214
Query: 174 MAPECYKRTP-ISVKADVYGYGIVL 197
PE + A V+ GI+L
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 7e-07
Identities = 23/62 (37%), Positives = 29/62 (46%), Gaps = 13/62 (20%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM----------A 175
GI +LH I+H D+KP NI++ T KI DFGLA+ M A
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 176 PE 177
PE
Sbjct: 195 PE 196
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 7e-07
Identities = 27/132 (20%), Positives = 55/132 (41%), Gaps = 23/132 (17%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL-LSDKG------C-----M 174
+ +LH I++ DIK +NIL+D ++DFGL+K ++D+ C M
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 175 APE--CYKRTPISVKADVYGYGIVLLETICCW-----ENMEIDASKPEEIILTNWV-YKC 226
AP+ + D + G+++ E + + + ++ IL + Y
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287
Query: 227 FINRELNKLVRG 238
++ L++
Sbjct: 288 EMSALAKDLIQR 299
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 7e-07
Identities = 28/87 (32%), Positives = 40/87 (45%), Gaps = 17/87 (19%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGCM------ 174
V GI Y+H I+H D+KP+NIL+ ++ KI DFGL+ M
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT 186
Query: 175 ----APECYKRTPISVKADVYGYGIVL 197
APE + K DV+ G++L
Sbjct: 187 AYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 9e-07
Identities = 23/62 (37%), Positives = 29/62 (46%), Gaps = 13/62 (20%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM----------A 175
GI +LH I+H D+KP NI++ T KI DFGLA+ M A
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 176 PE 177
PE
Sbjct: 232 PE 233
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 17/40 (42%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165
G+ Y+H ILH D+KP N L+++ + K+ DFGLA
Sbjct: 167 VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 17/62 (27%), Positives = 26/62 (41%), Gaps = 13/62 (20%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCM----------A 175
G+ LH+ ++H D+ P NIL+ + I DF LA+ + A
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRA 201
Query: 176 PE 177
PE
Sbjct: 202 PE 203
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 21/111 (18%), Positives = 40/111 (36%), Gaps = 27/111 (24%)
Query: 116 QRVRIALDVAK--------GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167
+ A+ + +H +H D+KP N+L+D+ K++DFG
Sbjct: 161 SNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217
Query: 168 LSDKG-------C-----MAPECYKRTPISVK----ADVYGYGIVLLETIC 202
++ +G ++PE K D + G+ L E +
Sbjct: 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 20/93 (21%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKG-------C-----M 174
I +H +H DIKP NILMD +++DFG L + G +
Sbjct: 187 AIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 175 APECYKRTPISVK-----ADVYGYGIVLLETIC 202
+PE + D + G+ + E +
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 13/91 (14%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA--KISDFGLAKLLSDKGCM-- 174
+ A + + + LH I+HCD+KP+NIL+ + + K+ DFG + +
Sbjct: 204 KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI 260
Query: 175 ------APECYKRTPISVKADVYGYGIVLLE 199
APE + D++ G +L E
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAE 291
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 27/85 (31%), Positives = 38/85 (44%), Gaps = 14/85 (16%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKISDFGLAKLLSDKG----C----- 173
V I + H ++H DIK +NIL+D AK+ DFG LL D+
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVY 204
Query: 174 MAPECYKRTP-ISVKADVYGYGIVL 197
PE R ++ A V+ GI+L
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILL 229
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 22/92 (23%), Positives = 35/92 (38%), Gaps = 17/92 (18%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGCM- 174
RI DV + Y H + H D+KP+N L K+ DFGLA M
Sbjct: 110 RIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166
Query: 175 ---------APECYKRTPISVKADVYGYGIVL 197
+P+ + + D + G+++
Sbjct: 167 TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 25/84 (29%), Positives = 33/84 (39%), Gaps = 16/84 (19%)
Query: 127 GILYLHDECEPPILHCDIKPQNILMDEFWTA--KISDFGLAKLLSDKG-----C-----M 174
G+ Y H I H D+K +N L+D KI DFG +K +
Sbjct: 128 GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184
Query: 175 APECYKRTP-ISVKADVYGYGIVL 197
APE R ADV+ G+ L
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTL 208
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 17/87 (19%)
Query: 124 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGCM------ 174
+ + Y H + ++H D+KP+NIL KI DFGLA+L
Sbjct: 133 MMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT 189
Query: 175 ----APECYKRTPISVKADVYGYGIVL 197
APE +KR ++ K D++ G+V+
Sbjct: 190 ALYMAPEVFKR-DVTFKCDIWSAGVVM 215
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 18/45 (40%), Positives = 28/45 (62%), Gaps = 3/45 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
+G+ Y+H I+H D+KP N+ ++E KI DFGLA+ +D
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 15/59 (25%), Positives = 29/59 (49%), Gaps = 3/59 (5%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPECYKRTPI 184
+ + LH ++H D+KP N+L++ K+ DFGLA+++ + E +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 4e-06
Identities = 41/302 (13%), Positives = 86/302 (28%), Gaps = 91/302 (30%)
Query: 11 WIARS--------SLCTKLRNFCRSSL-ND------RNSPRSKSVWSCMRALMATVNSPY 55
++ S+ T++ R L ND N R + +AL+ +
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 56 -----------SPSRPLTLTSIVSR-----------VSWTTDIEVSSVAMRGSKPSTEAA 93
+ + V + W + + + S E
Sbjct: 153 VLIDGVLGSGKT-----WVALDVCLSYKVQCKMDFKIFW---LNL------KNCNSPETV 198
Query: 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGIL--YLHDECEPPILHCDIKPQNILM 151
L++ L Y I + + +++ + + L L + L +++
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL--------LVL 250
Query: 152 DEFWTAKISD-FGL-AKLL---SDKGCM-APECYKRTPISVKADVYGYGIVLLETICC-W 204
AK + F L K+L K T IS+ ++++ +
Sbjct: 251 LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310
Query: 205 ENMEIDASKPEEIILTN-----------------WVYKCFINRELNKLVRGTEVDKKNLE 247
+ P E++ TN W + + +KL T + + +L
Sbjct: 311 LDCRPQDL-PREVLTTNPRRLSIIAESIRDGLATWDN--WKHVNCDKL---TTIIESSLN 364
Query: 248 NL 249
L
Sbjct: 365 VL 366
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 5e-06
Identities = 17/45 (37%), Positives = 27/45 (60%), Gaps = 3/45 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
+G+ Y+H +LH D+KP N+L++ KI DFGLA++
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 18/45 (40%), Positives = 26/45 (57%), Gaps = 3/45 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
KG+ Y+H I+H D+KP N+ ++E KI DFGLA+
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 5e-06
Identities = 17/74 (22%), Positives = 30/74 (40%), Gaps = 3/74 (4%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPECYKRTPIS 185
G ++H E I+H D+KP N L+++ + K+ DFGLA+ ++ +
Sbjct: 140 LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 186 VKADVYGYGIVLLE 199
L
Sbjct: 197 PGPHNKNLKKQLTS 210
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 6e-06
Identities = 17/45 (37%), Positives = 26/45 (57%), Gaps = 3/45 (6%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170
KG+ Y+H ++H D+KP N+ ++E KI DFGLA+
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 18/64 (28%), Positives = 30/64 (46%), Gaps = 3/64 (4%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPECYKRTPIS 185
K I YLH +LH D+KP NIL++ K++DFGL++ + + +
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 186 VKAD 189
+
Sbjct: 177 TENF 180
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 7e-06
Identities = 20/61 (32%), Positives = 31/61 (50%), Gaps = 6/61 (9%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLSDKGCMA 175
+ DVA + +LH++ I H D+KP+NIL ++ KI DF L + G +
Sbjct: 115 VVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 176 P 176
P
Sbjct: 172 P 172
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 6/51 (11%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAK 166
I + + I YLH I H D+KP+N+L K++DFG AK
Sbjct: 121 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 15/54 (27%), Positives = 27/54 (50%), Gaps = 8/54 (14%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK-----ISDFGLAK 166
+ IA+ + + Y+H + +++ D+KP+N L+ I DF LAK
Sbjct: 108 LMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 12/54 (22%), Positives = 24/54 (44%), Gaps = 8/54 (14%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK-----ISDFGLAK 166
A + + +H++ +++ DIKP N L+ + + DFG+ K
Sbjct: 109 AMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 6e-05
Identities = 15/41 (36%), Positives = 24/41 (58%), Gaps = 4/41 (9%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMD-EFWTAKISDFGLA 165
K + Y H I+H D+KP N+++D E ++ D+GLA
Sbjct: 141 KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 178
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 6e-05
Identities = 17/46 (36%), Positives = 28/46 (60%), Gaps = 4/46 (8%)
Query: 126 KGILYLHDECEPPILHCDIKPQNILMD-EFWTAKISDFGLAKLLSD 170
+G+ Y+H +LH D+KP N+ ++ E KI DFGLA+++
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 10/56 (17%), Positives = 26/56 (46%), Gaps = 5/56 (8%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI--SDFGLAKLLSDKG 172
++A + + +LH+ +H ++ +NI +D +++ + +G A G
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 18/49 (36%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA--KISDFGLA 165
+ A + +L+L E I+HCD+KP+NIL+ + KI DFG +
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 12/56 (21%), Positives = 27/56 (48%), Gaps = 5/56 (8%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI--SDFGLAKLLSDKG 172
++ + + + Y+H+ +H DIK N+L+ ++ +D+GL+ G
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 18/52 (34%), Positives = 25/52 (48%), Gaps = 6/52 (11%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK---ISDFGLAK 166
+ +A + I Y+H + +H D+KP N LM I DFGLAK
Sbjct: 108 LLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 13/53 (24%), Positives = 23/53 (43%), Gaps = 5/53 (9%)
Query: 130 YLHDECEPPILHCDIKPQNILMDEFWTAKI--SDFGLAKLLSDKGCMAPECYK 180
Y+H+ +H DIK N+L++ ++ D+GLA +G
Sbjct: 167 YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 39.9 bits (92), Expect = 5e-04
Identities = 20/142 (14%), Positives = 42/142 (29%), Gaps = 19/142 (13%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
I + + H D+ N+L+ + K+ K + C
Sbjct: 160 LATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC 217
Query: 174 MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233
+ V Y + + I + ++ +D E++ + Y+ I R +
Sbjct: 218 ---------GLQVSIIDYTLSRLERDGIVVFCDVSMD----EDLFTGDGDYQFDIYRLMK 264
Query: 234 KLVRGTEVDKKNLENLVKVGLW 255
K + N+ LW
Sbjct: 265 KENNNRWGEYHPYSNV----LW 282
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 5e-04
Identities = 20/132 (15%), Positives = 51/132 (38%), Gaps = 21/132 (15%)
Query: 113 YWNQRVRIALDVAKGIL--------YLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164
+ + L K I+ YLH +C I+H DIKP+NIL+ +++ +
Sbjct: 136 IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILL------SVNEQYI 187
Query: 165 AKLLSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224
+L ++ ++R+ + +E ++ ++ + +
Sbjct: 188 RRLAAE-----ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGN 242
Query: 225 KCFINRELNKLV 236
C++++ + +
Sbjct: 243 ACWVHKHFTEDI 254
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 19/52 (36%), Positives = 26/52 (50%), Gaps = 6/52 (11%)
Query: 118 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK---ISDFGLAK 166
+ +A + + ++H + LH DIKP N LM A I DFGLAK
Sbjct: 106 LMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 274 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.33 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.83 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.67 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.39 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.05 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.93 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.86 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.66 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.22 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.06 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.33 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 95.22 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.15 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 92.9 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 89.82 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 88.37 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.54 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 85.25 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.83 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 81.14 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-55 Score=374.63 Aligned_cols=235 Identities=20% Similarity=0.201 Sum_probs=186.4
Q ss_pred hhccccccCCCCCCCCcchhHHHH---HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR---ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~---~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
+++.....||+|+| |.||+|.. .++|.++.. ...+.|.+|+.+|++++|||||+++|+|.+ +.++|||||
T Consensus 36 ~~l~l~~~iG~G~f--G~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSF--GTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSS--SEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCC--cEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 34455677999999 99999921 112222211 223568899999999999999999998865 568999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec------
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL------ 168 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~------ 168 (274)
|++|+|.++|.. ....++|..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 113 ~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 999999999986 456799999999999999999999999 9999999999999999999999999998642
Q ss_pred -------CCCCcCCCccccc---CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 169 -------SDKGCMAPECYKR---TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 169 -------~~~~~~ape~~~~---~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+|+.|||||++.. .+|+.++|||||||++|||++|+.||..... .. .+. .....+ ...+
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-~~--~~~----~~~~~~----~~~p 257 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-RD--QII----FMVGRG----YASP 257 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HH--HHH----HHHHTT----CCCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-HH--HHH----HHHhcC----CCCC
Confidence 3788999999864 4689999999999999999999999964311 11 111 111111 1111
Q ss_pred C--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 239 T--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 239 ~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ..+..++..+.+|+.+||+.||++|||+.||++.|
T Consensus 258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 1 34556778999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=378.50 Aligned_cols=231 Identities=18% Similarity=0.171 Sum_probs=188.8
Q ss_pred cccccCCCCCCCCcchhHHHH-----------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 25 CRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 25 ~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
.-...||+|+| |.||+|.. +++|.+... ...++|.+|+.+|++++|||||+++|+|.+++..+|
T Consensus 29 ~~~~~lG~G~f--G~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 29 RFMEELGEDRF--GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp EEEEEEEECSS--CEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEeeEeccCCC--cEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 33467999999 99999831 123333222 223568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc
Q 048314 91 EAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 156 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~ 156 (274)
|||||++|||.++|.... ...++|..++.++.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 999999999999997532 23599999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceec-------------CCCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHH
Q 048314 157 AKISDFGLAKLL-------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNW 222 (274)
Q Consensus 157 ~kl~d~g~~~~~-------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 222 (274)
+||+|||+++.. +++.|+|||++....++.++|||||||++|||+| |..||.... ...+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~----~~~~~-- 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----NQDVV-- 257 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC----HHHHH--
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC----HHHHH--
Confidence 999999998643 2567999999999999999999999999999998 899996431 11111
Q ss_pred HHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 223 VYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+.++. ..+.|..++..+.+|+.+||+.||++||||.||+++|
T Consensus 258 --~~i~~~~------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 258 --EMIRNRQ------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp --HHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HHHHcCC------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 1111111 1135667888999999999999999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=378.82 Aligned_cols=234 Identities=18% Similarity=0.231 Sum_probs=190.1
Q ss_pred hhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
++|...+.||+|+| |.||+|.. +++|.+... ...++|.+|+++|++++|||||+++|+|.+++..
T Consensus 13 ~~~~l~~~lG~G~f--G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAF--GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--C--CCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCC--cEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 46666788999999 99999821 223333222 2245688999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcE
Q 048314 89 STEAALDLPWDLAYIIFCS-----------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 157 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~ 157 (274)
+||||||++|||.++|... ....++|..++.++.|++.||.|||++ +|+||||||+|||++.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 9999999999999999763 234699999999999999999999999 99999999999999999999
Q ss_pred EEeccccceec-------------CCCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHH
Q 048314 158 KISDFGLAKLL-------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWV 223 (274)
Q Consensus 158 kl~d~g~~~~~-------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 223 (274)
||+|||+++.. +++.|+|||++....|+.++|||||||++|||+| |+.||... ... .+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~---~~~-~~~--- 240 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL---SNN-EVI--- 240 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS---CHH-HHH---
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---CHH-HHH---
Confidence 99999998642 2567999999999999999999999999999998 89999643 111 111
Q ss_pred HHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 224 YKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+. ..+.|..+++++.+|+.+||+.||++|||++||++.|
T Consensus 241 -~~i~~~~------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L 284 (299)
T 4asz_A 241 -ECITQGR------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLL 284 (299)
T ss_dssp -HHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HHHHcCC------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 1111111 1135667788999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-55 Score=379.78 Aligned_cols=234 Identities=18% Similarity=0.181 Sum_probs=188.8
Q ss_pred hhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
++|.....||+|+| |.||+|. .+++|.+... ...++|.+|+++|++++|||||+++|+|.+.+..
T Consensus 41 ~d~~l~~~LG~G~f--G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAF--GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSS--EEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCC--cEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45666677999999 9999982 1223333322 2245688999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC
Q 048314 89 STEAALDLPWDLAYIIFCSA-------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~ 155 (274)
+||||||++|+|.+++.... ...++|..++.++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence 99999999999999997642 24599999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceec-------------CCCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHH
Q 048314 156 TAKISDFGLAKLL-------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTN 221 (274)
Q Consensus 156 ~~kl~d~g~~~~~-------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~ 221 (274)
.+||+|||+++.. +++.|||||++....++.++|||||||++|||+| |+.||.... . ..+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---~-~~~~- 270 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---N-TEAI- 270 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---H-HHHH-
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---H-HHHH-
Confidence 9999999998743 2567999999999999999999999999999998 899996431 1 1111
Q ss_pred HHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 222 WVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+..+. ..+.|..+++++.+|+.+||+.||++|||+.||+++|
T Consensus 271 ---~~i~~g~------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L 314 (329)
T 4aoj_A 271 ---DCITQGR------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314 (329)
T ss_dssp ---HHHHHTC------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred ---HHHHcCC------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 1111111 1135667788999999999999999999999998765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-54 Score=373.15 Aligned_cols=233 Identities=19% Similarity=0.201 Sum_probs=187.1
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
.++|...+.||+|+| |.||++. ..++|.+... ...+.+.+|+++|++++|||||++++++.+++..||
T Consensus 23 me~Y~~~~~lG~G~f--g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSF--GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCEEEEEEC--------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEeEEEecCCC--eEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 357778889999999 9999992 1222322221 123457899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
|||||++|+|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999999875556789999999999999999999999 9999999999999999999999999999754
Q ss_pred ---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+|+.|+|||++.+..|+.++|||||||++|||++|+.||... ... .+ +.. ..++.. .
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~-~~---~~~-i~~~~~------~ 243 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMK-NL---VLK-IISGSF------P 243 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHH-HH---HHH-HHHTCC------C
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHH-HH---HHH-HHcCCC------C
Confidence 388999999999999999999999999999999999999643 111 11 111 111111 1
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+...+.++.+||.+||+.||++|||++|+++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 244556788999999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=365.78 Aligned_cols=230 Identities=17% Similarity=0.150 Sum_probs=190.2
Q ss_pred hhccccccCCCCCCCCcchhHH-------HHHHHHH-hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC-------MRALMAT-VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
..|.....||+|+| |.||+| .+|+|.. .......+.+.+|+.+|++++|||||++++++.+++..|||||
T Consensus 74 ~~y~~~~~iG~G~f--G~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGST--GIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcC--eEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 34777788999999 999999 2233322 2223455668899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL----- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~----- 168 (274)
||++|+|.+++.. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 152 y~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 152 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 9999999999975 4699999999999999999999999 9999999999999999999999999998753
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-cc
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-EV 241 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 241 (274)
+|+.|+|||++....|+.++||||+||++|||++|..||... . ...+.. .+.+. ..+. ..
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~-~~~~~~----~i~~~-----~~~~~~~ 292 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---P-PLKAMK----MIRDN-----LPPRLKN 292 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---C-HHHHHH----HHHHS-----SCCCCSC
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---C-HHHHHH----HHHcC-----CCCCCCc
Confidence 367899999999999999999999999999999999999643 1 111111 11111 1111 23
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+...++++.+||.+||+.||++|||++|+++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3455678999999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=357.70 Aligned_cols=227 Identities=19% Similarity=0.184 Sum_probs=179.3
Q ss_pred ccccCCCCCCCCcchhHHH-------HHHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEe----CCcceEE
Q 048314 26 RSSLNDRNSPRSKSVWSCM-------RALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR----GSKPSTE 91 (274)
Q Consensus 26 ~~~~~g~g~~~~g~vy~~~-------~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv 91 (274)
-...||+|+| |.||+|. +++|.... .....++|.+|+++|++++|||||+++++|.+ ++..+||
T Consensus 30 ~~~~iG~G~f--g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 30 FDIEIGRGSF--KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEECSS--EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeeEEecCcC--cEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3456999999 9999981 22221111 11223568899999999999999999999865 3457999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cccCCCCCCceEEcC-CCcEEEeccccceec
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDE-FWTAKISDFGLAKLL 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~~-~~~~kl~d~g~~~~~ 168 (274)
||||++|+|.+++.. .+.+++..+..++.|++.||.|||++ + |+||||||+|||++. ++.+||+|||+++..
T Consensus 108 mEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999986 45799999999999999999999998 7 999999999999974 789999999999643
Q ss_pred ---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+|+.|||||++.+ .|+.++|||||||++|||++|+.||..... . ..+. .....+ ..+.
T Consensus 183 ~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-~--~~~~----~~i~~~-----~~~~ 249 (290)
T 3fpq_A 183 RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-A--AQIY----RRVTSG-----VKPA 249 (290)
T ss_dssp CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-H--HHHH----HHHTTT-----CCCG
T ss_pred CCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-H--HHHH----HHHHcC-----CCCC
Confidence 4889999998864 699999999999999999999999964311 1 1111 111111 1111
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+...++++.+|+.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233344567999999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=361.12 Aligned_cols=229 Identities=16% Similarity=0.146 Sum_probs=191.1
Q ss_pred hhhccccccCCCCCCCCcchhHH-------HHHH----HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC-------MRAL----MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~-------~~~~----~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.||+|+| |.||++ .+|+ +.........+.+.+|+++|++++|||||++++++.+++..|
T Consensus 31 ~~dy~i~~~lG~G~f--g~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSF--STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEecccC--eEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 367999999999999 999999 1111 112223334566889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
||||||++|+|.+++.. .+.+++...+.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 ivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp EEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 99999999999999986 46799999999999999999999999 9999999999999999999999999999753
Q ss_pred ------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 169 ------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 169 ------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
+|+.|+|||++.+..|+.++||||+||++|+|++|+.||... ... .+. ....+..
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~-~~~----~~i~~~~----- 250 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEG-LIF----AKIIKLE----- 250 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHH-HHH----HHHHHTC-----
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHH-HHH----HHHHcCC-----
Confidence 377899999999999999999999999999999999999643 111 111 1111111
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHH
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVV 271 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl 271 (274)
..+|...++++.+|+.+||+.||++|||++|++
T Consensus 251 --~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 124555667899999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=362.34 Aligned_cols=231 Identities=18% Similarity=0.109 Sum_probs=188.7
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
.+.|.....||+|+| |.||++. ..++|.+.. .....+|+.+|++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~f--G~Vy~a~~~~~g~~vAiK~i~~---~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSF--GEVHRMKDKQTGFQCAVKKVRL---EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEET---TTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCC--eEEEEEEECCCCCEEEEEEECH---HHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 345666677999999 9999992 122333322 12235899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC-cEEEeccccceec-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKISDFGLAKLL----- 168 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~d~g~~~~~----- 168 (274)
|++|+|.+++.. .+.+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 132 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999986 45799999999999999999999999 999999999999999887 5999999999642
Q ss_pred -----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 -----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 -----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
+|+.|||||++.+..|+.++|||||||++|||++|+.||.......... . +..... .
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-------~-i~~~~~----~ 274 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-------K-IASEPP----P 274 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-------H-HHHSCC----G
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------H-HHcCCC----C
Confidence 4788999999999999999999999999999999999997542211110 0 011110 0
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
....+...++.+.+++.+||+.||++|||+.|+++.
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~ 310 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRK 310 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 113455677889999999999999999999999865
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=367.02 Aligned_cols=230 Identities=17% Similarity=0.144 Sum_probs=190.2
Q ss_pred hhccccccCCCCCCCCcchhHH-------HHHHHHHh-cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC-------MRALMATV-NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
+.|.....||+|+| |.||+| .+|+|... ......+.+.+|+.+|++++|||||++++++.+.+..|||||
T Consensus 151 ~~y~~~~~iG~G~f--G~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGST--GIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcC--cEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 45777888999999 999999 22333221 222445668899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL----- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~----- 168 (274)
||++|+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 229 y~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 229 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999999975 4699999999999999999999999 9999999999999999999999999998753
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-cc
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-EV 241 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 241 (274)
+|+.|||||++....|+.++|||||||++|||++|..||... . ...+.. .+... ..+. ..
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~-~~~~~~----~i~~~-----~~~~~~~ 369 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---P-PLKAMK----MIRDN-----LPPRLKN 369 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---C-HHHHHH----HHHHS-----CCCCCSC
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---C-HHHHHH----HHHcC-----CCCCCcc
Confidence 278899999999999999999999999999999999999643 1 111111 11111 1111 23
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+...+.++.+||.+||+.||++|||++|+++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3455678999999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=348.79 Aligned_cols=229 Identities=19% Similarity=0.197 Sum_probs=181.4
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcC-----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNS-----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.||+|+| |.||++. ..++|.+.. ....+++.+|+++|++++|||||++++++.+++..+
T Consensus 12 ig~Y~i~~~lG~G~f--g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSF--GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89 (275)
T ss_dssp --CCEEEEEEEC-----CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred eeCeEEEEEEecCcC--eEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 368888999999999 9999992 112222221 122345789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
+||||| +|+|.+++.. .+.+++...+.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999999 6899999986 45799999999999999999999999 9999999999999999999999999999753
Q ss_pred ---------CCCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 169 ---------SDKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+|+.|+|||++.+..+ +.++||||+||++|+|++|+.||... ... .+. ....++ .
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~-~~~----~~i~~~-------~ 228 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIP-VLF----KNISNG-------V 228 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHH-HHH----HHHHHT-------C
T ss_pred CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHH-HHH----HHHHcC-------C
Confidence 3788999999988776 57999999999999999999999643 111 111 111111 1
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...|...++++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 229 YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1244556778999999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=366.19 Aligned_cols=236 Identities=17% Similarity=0.196 Sum_probs=190.0
Q ss_pred hhhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCC---CCCCcHHHHHHHHhcCCC-CccceEeEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSP---YSPSRPLTLTSIVSRVSW-TTDIEVSSVAMRG 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~ 85 (274)
.++|...+.||+|+| |.||+|. .+++|.+... ...+.|.+|+++|++++| ||||+++|+|.+.
T Consensus 63 ~~~~~l~~~LG~G~f--G~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAF--GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSS--EEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCC--eEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 456777888999999 9999982 1222322222 123457899999999975 9999999999765
Q ss_pred -CcceEEEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceE
Q 048314 86 -SKPSTEAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNIL 150 (274)
Q Consensus 86 -~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil 150 (274)
+..+||||||++|+|.++|.... ...++|..++.++.|++.||.|||++ +|+||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence 56899999999999999997532 23489999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhh
Q 048314 151 MDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEE 216 (274)
Q Consensus 151 ~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~ 216 (274)
++.++.+||+|||+++... ++.|||||++....|+.++|||||||++|||+| |..||........
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~- 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 9999999999999997542 567999999999999999999999999999998 8999964422111
Q ss_pred HHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 217 IILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+ .....++. + .+.|..+++++.+++.+||+.||++|||+.||++.|
T Consensus 297 --~----~~~i~~g~-----~-~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 297 --F----CRRLKEGT-----R-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp --H----HHHHHHTC-----C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --H----HHHHHcCC-----C-CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 1 11111111 1 135566778999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=355.90 Aligned_cols=229 Identities=18% Similarity=0.112 Sum_probs=184.3
Q ss_pred hhccccccCCCCCCCCcchhHHHH---------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
++|...+.||+|+| |.||++.. .++|.+.. .....++.+|+.+|++++|||||++++++.+++..
T Consensus 24 ~~Y~i~~~lG~G~f--g~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSF--GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGG--CEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCC--eEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 57888999999999 99998721 12332221 13345688999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++|||||++|+|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999999986 45799999999999999999999999 9999999999999999999999999999742
Q ss_pred -----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 -----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 -----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
+|+.|+|||++....|+.++||||+||++|||++|+.||... ... .+.. ...+.
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~-~~~~----~i~~~------- 241 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRK-ETMT----MILKA------- 241 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHH-HHHH----HHHHC-------
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHH-HHHH----HHHcC-------
Confidence 378899999999999999999999999999999999999643 111 1111 11111
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCCh-----hhHHh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSM-----KCVVM 272 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~evl~ 272 (274)
....|...++++.+|+.+||+.||++|||+ +|+++
T Consensus 242 ~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 113455667889999999999999999995 57764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=356.44 Aligned_cols=246 Identities=18% Similarity=0.148 Sum_probs=180.4
Q ss_pred hccccccCCCCCCCCcchhHH----HHHHHHHhcCCCCCCcHH--HHHHHHhcCCCCccceEeEEEEeCC----cceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSC----MRALMATVNSPYSPSRPL--TLTSIVSRVSWTTDIEVSSVAMRGS----KPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~----~~~~~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 92 (274)
++.-...||+|+| |.||+| ..+++|.+... ..+.+. .|+..+.+++|||||+++|+|.+++ .++|||
T Consensus 4 ~i~L~~~iG~G~f--G~Vy~~~~~g~~VAvK~l~~~-~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRF--GEVWRGKWRGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSS--SEEEEEEETTEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCC--eEEEEEEECCEEEEEEEECcc-chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4455678999999 999998 11222222221 222333 4666667899999999999998654 579999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC-----EPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-----~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
|||++|||.+++.. ..++|..+..++.|++.||.|||+++ .++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999986 46999999999999999999999752 34899999999999999999999999999864
Q ss_pred c---------------CCCCcCCCcccccC------CCccccceeehhHhHHHHhhcCCCccccCCCh---hhH----HH
Q 048314 168 L---------------SDKGCMAPECYKRT------PISVKADVYGYGIVLLETICCWENMEIDASKP---EEI----IL 219 (274)
Q Consensus 168 ~---------------~~~~~~ape~~~~~------~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~---~~~----~~ 219 (274)
. +|+.|+|||++.+. .++.++|||||||++|||++|..|+....... ... ..
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 2 37789999998754 36789999999999999999988875321110 000 00
Q ss_pred HHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 220 TNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+............+.....+...+..+.+|+.+||+.||++||||.||++.|
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 292 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 0011111111111111111122345677899999999999999999999998865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=341.21 Aligned_cols=231 Identities=16% Similarity=0.207 Sum_probs=176.2
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC-----
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS----- 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 86 (274)
.++|...+.||+|+| |.||++. ..++|.+... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~f--g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGF--GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC----EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCC--eEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 457888999999999 9999982 1122222211 12345789999999999999999999987544
Q ss_pred -------cceEEEEeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEE
Q 048314 87 -------KPSTEAALDLPWDLAYIIFCSAE-RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158 (274)
Q Consensus 87 -------~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~k 158 (274)
..++|||||++|+|.+++..... ...++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 36899999999999999986322 2367788899999999999999999 999999999999999999999
Q ss_pred Eeccccceec-----------------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChh
Q 048314 159 ISDFGLAKLL-----------------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPE 215 (274)
Q Consensus 159 l~d~g~~~~~-----------------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~ 215 (274)
|+|||+++.. +|+.|||||++.+..|+.++|||||||++|||++ ||... ..
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~---~~ 232 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ---ME 232 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH---HH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc---cH
Confidence 9999998642 5788999999999999999999999999999995 66422 11
Q ss_pred hHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 216 EIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.... + ....+... + +......+.+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~---~-~~~~~~~~-----p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVRT---L-TDVRNLKF-----P-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH---H-HHHHTTCC-----C-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH---H-HHHhcCCC-----C-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1000 0 00011100 0 112234456789999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=334.27 Aligned_cols=241 Identities=15% Similarity=0.124 Sum_probs=186.0
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH---------HHHHHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcc
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 88 (274)
...+.|...+.||+|+| |.||++.. .++|.+.......++.+|+++|+.+ +|||||++++++.+.++.
T Consensus 18 ~l~~~Y~i~~~lG~G~f--g~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTF--SSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSS--EEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccC--cEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34567888999999999 99998821 2233333333445677999999998 599999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC-CcEEEecccccee
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKISDFGLAKL 167 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~d~g~~~~ 167 (274)
++|||||++|+|.+++. .+++..++.++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999984 489999999999999999999999 99999999999999876 7999999999863
Q ss_pred ---------------------------------------cCCCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCc
Q 048314 168 ---------------------------------------LSDKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENM 207 (274)
Q Consensus 168 ---------------------------------------~~~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~ 207 (274)
.+|+.|+|||++.+. .|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 247889999998775 4889999999999999999999999
Q ss_pred cccCCChhhHHHHHHHHHHHhhhh-------------------------hhhhhc------------------CCccCHH
Q 048314 208 EIDASKPEEIILTNWVYKCFINRE-------------------------LNKLVR------------------GTEVDKK 244 (274)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~------------------~~~~~~~ 244 (274)
.......... ..+........ ..+.+. ..+....
T Consensus 248 ~~~~~~~~~l---~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 248 YKASDDLTAL---AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SCCSSHHHHH---HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCHHHHH---HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 6542221111 11100000000 000000 0011123
Q ss_pred HHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 245 NLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.++++.+|+.+||+.||++|||++|+++
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 3567899999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=334.69 Aligned_cols=239 Identities=16% Similarity=0.169 Sum_probs=182.1
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEe------C
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR------G 85 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~ 85 (274)
++|...+.||+|+| |.||+|. ..++|.+... ...+.+.+|+++|++++|||||++++++.. .
T Consensus 54 ~~Y~~~~~lG~G~f--G~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 54 DEYEIIETIGNGAY--GVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp SSEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCeEEEEEEecccC--eEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 35777889999999 9999991 1222322222 123456789999999999999999999754 3
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
+..|||||||. |+|.+++.. .+.+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 57899999996 789999975 56799999999999999999999999 9999999999999999999999999998
Q ss_pred eec---------------CCCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh
Q 048314 166 KLL---------------SDKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN 229 (274)
Q Consensus 166 ~~~---------------~~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (274)
+.. +|+.|+|||++.+. .++.++||||+||++|||++|+.||.... .......+......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~----~~~~l~~I~~~~g~ 281 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN----YVHQLQLIMMVLGT 281 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS----HHHHHHHHHHHHCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC----HHHHHHHHHHhcCC
Confidence 642 37789999998765 56899999999999999999999996431 11111111111000
Q ss_pred h-----------hhhhhh---cCC-ccC-----HHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 230 R-----------ELNKLV---RGT-EVD-----KKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 230 ~-----------~~~~~~---~~~-~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
. .....+ .+. ..+ ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 000000 000 111 123567899999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=343.40 Aligned_cols=233 Identities=21% Similarity=0.207 Sum_probs=186.6
Q ss_pred hhhccccccCCCCCCCCcchhHH-------HHHH----HHHhcCCCCCCcHH---HHHHHHhcCCCCccceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC-------MRAL----MATVNSPYSPSRPL---TLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~-------~~~~----~~~~~~~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
.++|...++||+|+| |.||++ .+|+ +..+.......... +++.+++.++|||||++++++.+.+
T Consensus 188 lddf~i~k~LG~G~f--G~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGF--GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp GGGEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEecccC--eEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 478988999999999 999998 1111 11222222222233 4467778889999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..|||||||+||+|.++|.. .+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 266 ~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999999986 46799999999999999999999999 99999999999999999999999999997
Q ss_pred ec---------CCCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 167 LL---------SDKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 167 ~~---------~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
.. +|+.|+|||++.. ..|+.++|+||+||++|||++|..||......... .+.. ... .
T Consensus 341 ~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i~~----~i~-------~ 408 (689)
T 3v5w_A 341 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR----MTL-------T 408 (689)
T ss_dssp ECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HHHH----HHH-------H
T ss_pred ecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHH----hhc-------C
Confidence 53 3788999999975 57999999999999999999999999754222211 1110 000 1
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCC-----hhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPS-----MKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~evl~ 272 (274)
.+...|...++++.+||.+||+.||++|++ ++||++
T Consensus 409 ~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 409 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 112355566788999999999999999998 577754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=322.05 Aligned_cols=263 Identities=29% Similarity=0.449 Sum_probs=212.3
Q ss_pred hhhhhhhHHHHhhhccccccCCCCCCCCcchhHHHH-----HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEE
Q 048314 10 AWIARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSV 81 (274)
Q Consensus 10 ~~~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~ 81 (274)
..|+..++....++|...+.+|.|+| |.||+|.. .++|.+... .....+.+|+.++++++||||++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGF--GKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSS--SEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ceecHHHHHHHhhccccceeEecCCC--cEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 45789999999999999999999999 99999821 122222211 234468899999999999999999999
Q ss_pred EEeCCcceEEEEeCCCCCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEE
Q 048314 82 AMRGSKPSTEAALDLPWDLAYIIFCSAE--RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159 (274)
Q Consensus 82 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl 159 (274)
+.+.+..++||||+.+|+|.+++..... ..+++..++.++.|++.||.|||+.+.++++|+||||+||+++.++.++|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999987432 34999999999999999999999986678999999999999999999999
Q ss_pred eccccceec------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccC-CChhhHHHHHHHHHH
Q 048314 160 SDFGLAKLL------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDA-SKPEEIILTNWVYKC 226 (274)
Q Consensus 160 ~d~g~~~~~------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~ 226 (274)
+|||++... +++.|+|||.+....++.++||||||+++|+|++|..||.... ..........|....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999998754 3667999999988889999999999999999999999996321 011111223333333
Q ss_pred HhhhhhhhhhcCC---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 227 FINRELNKLVRGT---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 227 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..........+.. ..+...+..+.+++.+||+.||++|||+.||+++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 2333333333322 46778889999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=347.03 Aligned_cols=234 Identities=14% Similarity=0.101 Sum_probs=188.4
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
++|...+.||+|+| |.||++.. .++|.+... ...+.+.+|+.+|++++|||||++++++.+.+..+||||
T Consensus 157 ~~Y~i~~~lG~G~f--g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAF--GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccC--eEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 57888889999999 99999821 112222222 223456799999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC--CcEEEeccccceec---
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF--WTAKISDFGLAKLL--- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~--~~~kl~d~g~~~~~--- 168 (274)
||++|+|.+++.. ..+.+++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 235 ~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 235 FMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred ecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999975 345799999999999999999999999 99999999999999854 78999999999764
Q ss_pred -------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 169 -------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 169 -------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+|+.|+|||++.+..|+.++||||+||++|||++|..||.... ... +. ..+.... .--+...
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~---~~~-~~----~~i~~~~---~~~~~~~ 379 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDE-TL----RNVKSCD---WNMDDSA 379 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHH-HH----HHHHTTC---CCCCSGG
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHH-HH----HHHHhCC---CCCCccc
Confidence 3788999999999999999999999999999999999996431 111 11 0111110 0001112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+.++.+||.+||+.||++|||+.|+++
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2345678899999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=321.80 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=207.0
Q ss_pred hhhhhHHHHhhhccccccCCCCCCCCcchhHHHH-----HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEe
Q 048314 12 IARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR 84 (274)
Q Consensus 12 ~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 84 (274)
++..++...+++|.....+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVF--GKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSS--SEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred ecHHHHHHHHhccCccceeecCCC--eeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 456667778899999999999999 99999832 112222111 223457799999999999999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAE--RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999976432 3599999999999999999999999 9999999999999999999999999
Q ss_pred ccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh
Q 048314 163 GLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN 229 (274)
Q Consensus 163 g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (274)
|++.... ++.|+|||.+....++.++||||||+++|+|++|+.||..... ........|.......
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLAEWAVESHNN 262 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS-SSCCCHHHHTHHHHTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc-HHHHHHHHHhhhcccc
Confidence 9986432 5679999999888899999999999999999999999975422 2222233333333333
Q ss_pred hhhhhhhcCC---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 230 RELNKLVRGT---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 230 ~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
......+++. ..+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 3334444433 45678889999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=315.97 Aligned_cols=235 Identities=18% Similarity=0.195 Sum_probs=190.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-------------HHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-------------ALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAM 83 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-------------~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 83 (274)
.++|...+.||+|+| |.||++.. .++|..... ...+.+.+|+.+++++ +||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~f--g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCF--GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSS--SEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCC--eeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 356777888999999 99998831 222322221 1234577999999999 8999999999999
Q ss_pred eCCcceEEEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCce
Q 048314 84 RGSKPSTEAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 149 (274)
Q Consensus 84 ~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 149 (274)
+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence 9999999999999999999998643 23589999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChh
Q 048314 150 LMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPE 215 (274)
Q Consensus 150 l~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~ 215 (274)
+++.++.+||+|||+++... ++.|+|||.+....++.++||||||+++|||++ |..||..... .
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--~ 312 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--E 312 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--G
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--H
Confidence 99999999999999987543 346999999998899999999999999999999 9999964311 1
Q ss_pred hHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 216 EIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. +. .....+ .....+..++..+.+++.+||+.||++|||+.|+++.|
T Consensus 313 ~--~~----~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 313 E--LF----KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp G--HH----HHHHTT------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H--HH----HHHhcC------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1 00 011111 01134556678899999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=309.83 Aligned_cols=234 Identities=21% Similarity=0.282 Sum_probs=190.2
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcC--CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS--PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.++|.....+|.|+| |.||++.. .++|.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 9 ~~~~~~~~~lG~G~~--g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCF--GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSS--EEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCC--EEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 467788899999999 99999821 11222211 123455789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 87 EYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp ECCTTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999987 456799999999999999999999999 9999999999999999999999999998643
Q ss_pred ---------------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhH--HHHHHHHH
Q 048314 169 ---------------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEI--ILTNWVYK 225 (274)
Q Consensus 169 ---------------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~ 225 (274)
+++.|+|||.+....++.++||||||+++|+|++|..|+.......... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~--- 239 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF--- 239 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH---
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc---
Confidence 4566999999999899999999999999999999999986432211110 00000
Q ss_pred HHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 226 CFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
... ..+..++..+.+++.+||+.||++|||+.++++.|
T Consensus 240 ------~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 240 ------LDR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp ------HHH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------ccc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 000 12334556789999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=322.17 Aligned_cols=236 Identities=18% Similarity=0.176 Sum_probs=194.6
Q ss_pred HhhhccccccCCCCCCCCcchhHH----HHHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC-cceEEEEe
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSC----MRALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS-KPSTEAAL 94 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~----~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 94 (274)
..++|...+.||.|+| |.||+| ...++|........+.|.+|+.+|++++||||+++++++.+.. ..++||||
T Consensus 191 ~~~~~~~~~~lG~G~f--g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEF--GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CGGGEEEEEEEEECSS--EEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ChHHeEEEeeecCcCC--eeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 3467777889999999 999998 2222333444446677899999999999999999999987765 78999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
+++|+|.+++.......+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 345 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 345 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccC
Confidence 9999999999875445589999999999999999999999 99999999999999999999999999987543
Q ss_pred ---CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHH
Q 048314 170 ---DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKN 245 (274)
Q Consensus 170 ---~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (274)
+..|+|||.+....++.++||||||+++|||++ |..||........ . .....+ . ....+..+
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~----~----~~i~~~-----~-~~~~p~~~ 411 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----V----PRVEKG-----Y-KMDAPDGC 411 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH----H----HHHHTT-----C-CCCCCTTC
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----H----HHHHcC-----C-CCCCCCcC
Confidence 467999999999899999999999999999998 9999964421110 0 011111 0 11355667
Q ss_pred HHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 246 LENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 246 ~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+..+.++|.+||+.||++|||+.++++.|
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 78999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=327.83 Aligned_cols=236 Identities=16% Similarity=0.175 Sum_probs=193.9
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
...+|.....||.|+| |.||+|.. .++|... .....+.|.+|+.+|++++||||++++++|.+.+..++||
T Consensus 218 ~~~~~~~~~~lG~G~f--g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 218 ERTDITMKHKLGGGQY--GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CGGGEEEEEESGGGTT--SSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred CHHHceeeeEecCCCC--eEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 4566777889999999 99999821 1222222 2234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++|+|.+++.......+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999876566799999999999999999999999 99999999999999999999999999987643
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+..|+|||.+....++.++||||||+++|||++ |..||...... . +. ..... .. ..
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~--~~----~~~~~-----~~-~~ 438 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q--VY----ELLEK-----DY-RM 438 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G--HH----HHHHT-----TC-CC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--H--HH----HHHHc-----CC-CC
Confidence 246999999998889999999999999999999 89998643111 1 00 10111 00 11
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+..++..+.+++.+||+.||++|||+.+|++.|
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L 473 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 34556778899999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=304.22 Aligned_cols=233 Identities=16% Similarity=0.139 Sum_probs=189.4
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHh--cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATV--NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
..++|.....+|.|+| |.||++.. .++|.. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 18 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGAS--GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETT--EEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCC--eEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 3567888999999999 99999821 112221 1223345577999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|||+.+|+|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 96 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999999999986 3699999999999999999999999 9999999999999999999999999987643
Q ss_pred --------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 169 --------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 169 --------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+++.|+|||.+....++.++||||||+++|+|++|..||.... ...... ..... ......
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~----~~~~~-----~~~~~~ 237 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PLRALY----LIATN-----GTPELQ 237 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHH----HHHHH-----CSCCCS
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHH----HHHhC-----CCCCCC
Confidence 3667999999999899999999999999999999999996431 111000 00000 001112
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+...+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 34456678999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=312.08 Aligned_cols=233 Identities=19% Similarity=0.206 Sum_probs=189.7
Q ss_pred hhccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
++|...+.+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 49 ~~y~i~~~lG~G~~--g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 49 SRIHIEKIIGSGDS--GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGEEEEEEEEETTT--EEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hHeEEeeEEEeCCC--cEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 45666789999999 99998832 223332221 12345789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 127 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999976 446799999999999999999999999 99999999999999999999999999997643
Q ss_pred --------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 170 --------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 170 --------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
+..|+|||.+....++.++||||||+++|+|++ |..||.... .. .+.. .....
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~-~~~~----~~~~~---- 270 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT---NR-DVIS----SVEEG---- 270 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC---HH-HHHH----HHHTT----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC---HH-HHHH----HHHcC----
Confidence 235999999988889999999999999999998 999996431 11 1100 00000
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+...+..+.+++.+||+.||++|||+.||++.|
T Consensus 271 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 271 --YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11134556678899999999999999999999999865
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=301.72 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=204.4
Q ss_pred chhhhhhhHHHHhhhcccc------ccCCCCCCCCcchhHHHH----HHHHHhcCC------CCCCcHHHHHHHHhcCCC
Q 048314 9 SAWIARSSLCTKLRNFCRS------SLNDRNSPRSKSVWSCMR----ALMATVNSP------YSPSRPLTLTSIVSRVSW 72 (274)
Q Consensus 9 ~~~~~~~~l~~~~~~f~~~------~~~g~g~~~~g~vy~~~~----~~~~~~~~~------~~~~~~~~e~~~l~~l~h 72 (274)
...|++.++...+++|... ..+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~--g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGF--GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSS--EEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCC--eEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4568999999999999987 88999999 99999821 112222111 113456799999999999
Q ss_pred CccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE
Q 048314 73 TTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSA-ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 151 (274)
Q Consensus 73 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~ 151 (274)
|||+++++++.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999997532 34699999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceec-------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHH
Q 048314 152 DEFWTAKISDFGLAKLL-------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEII 218 (274)
Q Consensus 152 ~~~~~~kl~d~g~~~~~-------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~ 218 (274)
+.++.++|+|||++... +++.|+|||.+.+ .++.++||||||+++|+|++|..||...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 99999999999987643 2567999998764 578899999999999999999999975433221111
Q ss_pred HHHHHHHHHhhhhhhhhhcCC--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 219 LTNWVYKCFINRELNKLVRGT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...... .....+...+++. ..+...+..+.+++.+||+.||.+|||+.+|++.|
T Consensus 246 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 246 IKEEIE--DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp HHHHHH--TTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHhh--hhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 111100 0111122333332 35677888999999999999999999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=319.12 Aligned_cols=235 Identities=18% Similarity=0.174 Sum_probs=190.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
..++|...+.+|.|+| |.||+|.. .++|..... ...+.+.+|+++|++++||||+++++++.+.+..++
T Consensus 112 ~~~~~~~~~~lG~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNF--GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CGGGEEEEEEEEEETT--EEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred chHHeEEeeEeccCCC--CeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 3456777889999999 99999822 122222221 123568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 190 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999999986 334699999999999999999999999 99999999999999999999999999987532
Q ss_pred ------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 170 ------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 170 ------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
+..|+|||.+....++.++||||||+++|||++ |..||.... . .... .....+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~---~-~~~~----~~~~~~------ 331 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---N-QQTR----EFVEKG------ 331 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC---H-HHHH----HHHHTT------
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---H-HHHH----HHHHcC------
Confidence 235999999988889999999999999999998 999986431 1 0011 111111
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+.+..++..+.+++.+||+.||++|||+.+|++.|
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 369 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 01134555678899999999999999999999998864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=315.53 Aligned_cols=233 Identities=21% Similarity=0.211 Sum_probs=183.1
Q ss_pred hhccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
++|...+.||.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 45 ~~~~~~~~lG~G~f--g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 45 TNISIDKVVGAGEF--GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGCCCCEEEEECSS--SEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhceeeeEEeeCCC--eEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 57788899999999 99998832 122222221 12345789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 123 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999986 445799999999999999999999999 99999999999999999999999999987543
Q ss_pred --------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 170 --------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 170 --------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
+..|+|||.+....++.++||||||+++|||++ |..||.... .. .+. .....+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~---~~-~~~----~~i~~~---- 266 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---NQ-DVI----KAVDEG---- 266 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC---HH-HHH----HHHHTT----
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC---HH-HHH----HHHHcC----
Confidence 246999999998899999999999999999997 999996431 11 111 001110
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. ...+..++..+.+++.+||+.||++|||+.+|++.|
T Consensus 267 -~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L 304 (373)
T 2qol_A 267 -YR-LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304 (373)
T ss_dssp -EE-CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -CC-CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence 01 123445678899999999999999999999998864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=310.25 Aligned_cols=233 Identities=12% Similarity=0.122 Sum_probs=189.4
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
....++|...+.+|+|+| |.||++. ..++|.+... ...+++.+|+++|++++||||+++++++.+.+.
T Consensus 11 ~~~~~~y~~~~~lG~G~~--g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNF--AKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp CCEETTEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCccCCEEEEEEEeeCCC--EEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 344578888999999999 9999882 1222222111 223456799999999999999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp EEEEECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred EEEEEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 9999999999999999976 35699999999999999999999999 999999999999999999999999999864
Q ss_pred c----------CCCCcCCCcccccCCCc-cccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 168 L----------SDKGCMAPECYKRTPIS-VKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 168 ~----------~~~~~~ape~~~~~~~~-~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
. +++.|+|||.+.+..+. .++||||+||++|+|++|..||.... . ..+.. ....+
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~-~~~~~----~i~~~------ 229 (328)
T 3fe3_A 164 FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---L-KELRE----RVLRG------ 229 (328)
T ss_dssp GSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---H-HHHHH----HHHHC------
T ss_pred cCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---H-HHHHH----HHHhC------
Confidence 3 36779999999887764 79999999999999999999996431 1 11110 01111
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....|...+..+.+++.+||+.||.+|||+.|+++
T Consensus 230 -~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 230 -KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11244456678999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=300.28 Aligned_cols=234 Identities=15% Similarity=0.187 Sum_probs=190.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----HHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
.++|...+.+|.|+| |.||++.. .++|... .....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQF--GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSS--CEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCc--cEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 356777889999999 99999822 1222222 223445688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 87 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 87 MEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 999999999976 445699999999999999999999999 99999999999999999999999999987543
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||.+....++.++|+||+|+++|+|++ |..||.... ... ... ..... . ....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~---~~~-~~~----~~~~~-----~-~~~~ 228 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSE-VVE----DISTG-----F-RLYK 228 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHH-HHH----HHHTT-----C-CCCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC---HHH-HHH----HHhcC-----c-cCCC
Confidence 345999999988889999999999999999999 899986431 111 100 00000 0 1123
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l 261 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 261 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 444567899999999999999999999999865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.23 Aligned_cols=244 Identities=21% Similarity=0.256 Sum_probs=189.7
Q ss_pred hhhhHHHHhhhccccccCCCCCCCCcchhHHH----HHHHHHhcCCC----CCCcHHHHHHHHhcCCCCccceEeEEEEe
Q 048314 13 ARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCM----RALMATVNSPY----SPSRPLTLTSIVSRVSWTTDIEVSSVAMR 84 (274)
Q Consensus 13 ~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~----~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 84 (274)
...++....++|.....+|.|+| |.||++. ..++|...... ..+.+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~--g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSF--GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSS--EEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CcccccCChhHceeeeEeecCCC--eEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 34444555678888999999999 9999982 11222222221 12357799999999999999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cccCCCCCCceEEcCCCcEEEec
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAE-RNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDEFWTAKISD 161 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~~~~~~kl~d 161 (274)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. + ++||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECC
Confidence 9999999999999999999986321 2399999999999999999999999 8 99999999999999999999999
Q ss_pred cccceec-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh
Q 048314 162 FGLAKLL-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR 230 (274)
Q Consensus 162 ~g~~~~~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
||++... +++.|+|||.+....++.++||||||+++|+|++|..||.... .. .....
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~---~~-~~~~~-------- 250 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN---PA-QVVAA-------- 250 (309)
T ss_dssp CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC---HH-HHHHH--------
T ss_pred CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HH-HHHHH--------
Confidence 9998542 3678999999999889999999999999999999999996431 11 00000
Q ss_pred hhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 231 ELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..........+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 251 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 251 -VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp -HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 0001111235556678899999999999999999999998864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=323.84 Aligned_cols=238 Identities=16% Similarity=0.238 Sum_probs=191.7
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHHH-----HHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
.....++|...+.||.|+| |.||+|.. .++|... .....+.|.+|+.+|++++||||+++++++. .+..++
T Consensus 183 ~~i~~~~~~~~~~lG~G~f--g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQF--GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp SBCCGGGEEEEEEEECCSS--EEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred eeechHHeEEEEEcccCCc--eEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3344567777889999999 99999821 1222222 2234567889999999999999999999986 567899
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
||||+++|+|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999999864334689999999999999999999999 99999999999999999999999999997543
Q ss_pred -----------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 170 -----------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 170 -----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
+..|+|||.+....++.++||||||+++|||++ |..||.... . ..+.. ....+ .
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~---~-~~~~~----~i~~~-----~- 402 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---N-PEVIR----ALERG-----Y- 402 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---H-HHHHH----HHHHT-----C-
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC---H-HHHHH----HHHcC-----C-
Confidence 346999999998899999999999999999999 999996431 1 11111 11111 0
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+.+..++..+.+++.+||+.||++|||+.+|++.|
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L 439 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 1124556678899999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=302.34 Aligned_cols=243 Identities=16% Similarity=0.123 Sum_probs=194.1
Q ss_pred hhhhhhhHHHHhhh----------ccccccCCCCCCCCcchhHHH------HHHHHHhcCC--CCCCcHHHHHHHHhcCC
Q 048314 10 AWIARSSLCTKLRN----------FCRSSLNDRNSPRSKSVWSCM------RALMATVNSP--YSPSRPLTLTSIVSRVS 71 (274)
Q Consensus 10 ~~~~~~~l~~~~~~----------f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~--~~~~~~~~e~~~l~~l~ 71 (274)
..++..++..+++. |.....+|+|+| |.||++. ..++|..... ...+.+.+|+.++++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~--g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGST--GIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCC--eEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence 34678888887764 566678999999 9999882 1223322222 23345779999999999
Q ss_pred CCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE
Q 048314 72 WTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 151 (274)
Q Consensus 72 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~ 151 (274)
||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||++
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 99999999999999999999999999999999864 4699999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceec-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHH
Q 048314 152 DEFWTAKISDFGLAKLL-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILT 220 (274)
Q Consensus 152 ~~~~~~kl~d~g~~~~~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~ 220 (274)
+.++.+||+|||++... +++.|+|||.+....++.++||||||+++|+|++|..||.... .. ...
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~-~~~ 250 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PV-QAM 250 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HH-HHH
T ss_pred CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HH-HHH
Confidence 99999999999987653 2567999999998889999999999999999999999996431 11 111
Q ss_pred HHHHHHHhhhhhhhhhcCC-ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 221 NWVYKCFINRELNKLVRGT-EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
. ..... ..+. ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~----~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 251 K----RLRDS-----PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp H----HHHHS-----SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H----HHhcC-----CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 01111 1111 1223445779999999999999999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=301.83 Aligned_cols=230 Identities=17% Similarity=0.162 Sum_probs=189.4
Q ss_pred hhhccccccCCCCCCCCcchhHHH-------HHHH----HHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-------RALM----ATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.+|+|+| |.||++. +++| .........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 4 ~~~y~~~~~lG~G~f--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTF--GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred hHHeEEEEEEecCCC--eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 468888999999999 9999871 1111 11112234556789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
+||||+++|+|.+++.. .+.+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 82 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999999985 45799999999999999999999999 9999999999999999999999999998642
Q ss_pred ----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 169 ----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 169 ----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+++.|+|||++....++.++|+||||+++|||++|..||.... .. .+.. .... ..
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~-~~~~----~i~~-------~~ 221 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HE-RLFE----LILM-------EE 221 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HH-HHHH----HHHH-------CC
T ss_pred cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HH-HHHH----HHHc-------CC
Confidence 2677999999998899999999999999999999999996431 11 1110 0111 11
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
...|...+..+.+++.+||+.||++|| ++.|+++
T Consensus 222 ~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 134555678899999999999999999 8999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=298.49 Aligned_cols=235 Identities=15% Similarity=0.183 Sum_probs=190.3
Q ss_pred HhhhccccccCCCCCCCCcchhHHH-----HHHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM-----RALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~-----~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
..++|...+.+|.|+| |.||++. ..++|... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQF--GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETT--EEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCC--ceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3467888899999999 9999882 11222222 22344567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 84 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 84 YISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred ccCCCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999999986 344699999999999999999999999 99999999999999999999999999987543
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+..|+|||.+....++.++||||||+++|+|++ |..||.... ...... . .... ....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~----~-~~~~------~~~~ 225 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT---NSEVVL----K-VSQG------HRLY 225 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHH----H-HHTT------CCCC
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC---hHHHHH----H-HHcC------CCCC
Confidence 235999999988889999999999999999998 999996431 110000 0 0000 0112
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 3344567899999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=305.40 Aligned_cols=235 Identities=17% Similarity=0.144 Sum_probs=186.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
.++|.....+|.|+| |.||++.. .++|.+... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~--g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEF--GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCC--eEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 467788899999999 99999821 112222211 223446799999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC--CCcEEEeccccceec---
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE--FWTAKISDFGLAKLL--- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~--~~~~kl~d~g~~~~~--- 168 (274)
||++|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++...
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 82 FISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred eCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999975 345799999999999999999999999 9999999999999987 789999999998764
Q ss_pred -------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 169 -------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 169 -------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+++.|+|||.+....++.++||||||+++|+|++|..||... .....+.. ..+.... .+...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~-----i~~~~~~---~~~~~ 226 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIEN-----IMNAEYT---FDEEA 226 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHH-----HHHTCCC---CCHHH
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC---CHHHHHHH-----HHcCCCC---CChhh
Confidence 367899999998888899999999999999999999999643 11111110 1111000 00001
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+.++.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1134578899999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=300.51 Aligned_cols=237 Identities=14% Similarity=0.146 Sum_probs=189.1
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHH-----HHHHHHhcC-CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCM-----RALMATVNS-PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~-----~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
....++|...+.+|.|+| |.||++. ..++|.... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQF--GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp BCCGGGEEEEEECC---C--EEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred cCCHHHHHhHhhcCCCCC--ceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 344567888899999999 9999882 112222222 23446688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 98 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 98 TEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp ECCCTTCBHHHHHHC-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred EeccCCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 999999999999976 345699999999999999999999999 99999999999999999999999999987543
Q ss_pred ----------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 170 ----------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 170 ----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
++.|+|||.+....++.++|+||||+++|+|++ |..||..... . .... . +.... .
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~-~~~~----~-----~~~~~-~ 239 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---S-ETAE----H-----IAQGL-R 239 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---H-HHHH----H-----HHTTC-C
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---h-HHHH----H-----Hhccc-C
Confidence 346999999998889999999999999999998 9999964311 1 0000 0 00100 1
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 123344567899999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=306.48 Aligned_cols=233 Identities=17% Similarity=0.200 Sum_probs=188.0
Q ss_pred hhhccccccCCCCCCCCcchhHHHH----------HHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR----------ALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
.++|...+.+|.|+| |.||+|.. .++|... .....+.+.+|+.++++++||||++++++|.+..
T Consensus 14 ~~~y~~~~~lG~G~~--g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAF--GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGGEEEEEEEEEETT--EEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHHcccceEEeeCCC--eEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 467888999999999 99999831 1122211 1123456789999999999999999999998755
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++++||+.+|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred eEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 7899999999999999987 456799999999999999999999999 999999999999999999999999999864
Q ss_pred cC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 168 LS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 168 ~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
.. +..|+|||.+....++.++||||||+++|||++ |..||....... +. ......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~----~~~~~~--- 235 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----IS----SILEKG--- 235 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HH----HHHHTT---
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HH----HHHHcC---
Confidence 32 347999999999999999999999999999999 999996431111 00 000110
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 236 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 273 (327)
T 3poz_A 236 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp ---CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred ---CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 01124455677899999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=298.70 Aligned_cols=239 Identities=12% Similarity=0.003 Sum_probs=190.5
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 93 (274)
.++|...+.||.|+| |.||+|. ..++|........+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNF--GELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CT--TSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCC--ceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 367888999999999 9999983 12233444445567799999999999 89999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc-----EEEeccccceec
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT-----AKISDFGLAKLL 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~-----~kl~d~g~~~~~ 168 (274)
|+ +++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++. +||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 89999999863 56799999999999999999999999 9999999999999998887 999999998743
Q ss_pred ------------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh
Q 048314 169 ------------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR 230 (274)
Q Consensus 169 ------------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
+++.|+|||.+....++.++||||||+++|||++|..||.................. ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-~~~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT-KRAT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH-HHHS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh-hccC
Confidence 256799999999989999999999999999999999999754222211111111000 0000
Q ss_pred hhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 231 ELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.... .....+ .+.+++..||+.||.+|||+++|.+.|
T Consensus 240 ~~~~------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l 276 (330)
T 2izr_A 240 PIEV------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLF 276 (330)
T ss_dssp CHHH------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred CHHH------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHH
Confidence 0000 011123 899999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=311.86 Aligned_cols=235 Identities=18% Similarity=0.212 Sum_probs=187.3
Q ss_pred hhhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
.++|...+.||.|+| |.||+|. ..++|.+... .....+.+|+.++++++||||+++++++.+.+
T Consensus 70 ~~~~~~~~~LG~G~f--g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAF--GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSS--SCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCC--EEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 356777888999999 9999984 1222222211 12234779999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC---cEE
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAE-----RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAK 158 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~---~~k 158 (274)
..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999986432 3599999999999999999999999 999999999999998544 599
Q ss_pred Eeccccceec-------------CCCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHH
Q 048314 159 ISDFGLAKLL-------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVY 224 (274)
Q Consensus 159 l~d~g~~~~~-------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 224 (274)
|+|||+++.. +++.|+|||.+....++.++|||||||++|||++ |..||.... .. .+..
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~-~~~~--- 297 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQ-EVLE--- 297 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HH-HHHH---
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HH-HHHH---
Confidence 9999998632 2557999999988899999999999999999998 999996431 11 1111
Q ss_pred HHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 225 KCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
....+. ....+...+..+.+++.+||+.||++|||+.+|++.|
T Consensus 298 -~i~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l 340 (367)
T 3l9p_A 298 -FVTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340 (367)
T ss_dssp -HHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HHHcCC------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 111110 1123445667899999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=301.47 Aligned_cols=238 Identities=17% Similarity=0.180 Sum_probs=194.6
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
....++|...+.+|.|+| |.||++.. .++|... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~~~~~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQY--GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp BCCGGGEEEEEESGGGTT--CSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccccceeEEeecCCCCc--eeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 345678888999999999 99999822 1122222 22334567899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
||||+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999876667799999999999999999999999 99999999999999999999999999987543
Q ss_pred -----------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 170 -----------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 170 -----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
++.|+|||.+....++.++||||||+++|+|++ |..||....... ... . .....
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----~~~----~-----~~~~~- 229 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYE----L-----LEKDY- 229 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHH----H-----HHTTC-
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH----H-----HhccC-
Confidence 346999999988889999999999999999999 899986432111 000 0 00000
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l 266 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence 1124455668899999999999999999999998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=293.64 Aligned_cols=240 Identities=12% Similarity=0.011 Sum_probs=192.6
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 93 (274)
.++|...+.+|.|++ |.||+|. ..++|........+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSF--GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSS--CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCC--EEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 356888899999999 9999983 22233444455677899999999999 69999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc-----EEEeccccceec
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT-----AKISDFGLAKLL 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~-----~kl~d~g~~~~~ 168 (274)
|+ +++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++. ++|+|||++...
T Consensus 87 ~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 9999999986 345699999999999999999999999 9999999999999987765 999999998643
Q ss_pred ------------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh
Q 048314 169 ------------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR 230 (274)
Q Consensus 169 ------------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
+++.|+|||.+....++.++||||||+++|+|++|+.||...........+.... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~ 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG-EKKQST 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH-HHHHHS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH-hhccCc
Confidence 2567999999998889999999999999999999999997643222221111111 100000
Q ss_pred hhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 231 ELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.... .....+..+.+++.+||+.||++|||+.+|++.|
T Consensus 241 ~~~~------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l 278 (298)
T 1csn_A 241 PLRE------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278 (298)
T ss_dssp CHHH------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred cHHH------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 0111 1223457899999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=320.11 Aligned_cols=235 Identities=19% Similarity=0.231 Sum_probs=188.5
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH-----HHHHHhcC-CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNS-PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
..++|.....+|.|+| |.||+|.. .++|.... ....+.|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus 182 ~~~~~~~~~~lG~G~f--g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CGGGEEEEEEEEECSS--CEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ChhHceeeeeecCCCC--eEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3456777888999999 99999821 22222222 2344678899999999999999999999876 67899999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++|+|.+++.......+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999999754345699999999999999999999999 99999999999999999999999999987542
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+..|+|||.+....++.++||||||+++|||++ |..||.... .. ... .....+ . ..+
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~---~~-~~~----~~i~~~-----~-~~~ 401 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NR-EVL----DQVERG-----Y-RMP 401 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HH-HHH----HHHHTT-----C-CCC
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC---HH-HHH----HHHHcC-----C-CCC
Confidence 346999999998899999999999999999999 899996431 11 010 111111 0 113
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+..++..+.+++.+||+.||++|||+++|++.|
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L 435 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 4556778899999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=310.08 Aligned_cols=236 Identities=19% Similarity=0.187 Sum_probs=191.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHH-------------HHHHHHhcCCCC---CCcHHHHHHHHhcC-CCCccceEeEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM-------------RALMATVNSPYS---PSRPLTLTSIVSRV-SWTTDIEVSSVA 82 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~-------------~~~~~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~l~~~~ 82 (274)
..++|...+.||+|+| |.||++. ..++|....... .+.+.+|+++++++ +||||+++++++
T Consensus 67 ~~~~y~i~~~LG~G~~--g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAF--GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CGGGEEEEEEEEECSS--EEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhheEeeeEEecCCC--eEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 3467888899999999 9999883 122333332211 24577999999999 899999999999
Q ss_pred EeCCcceEEEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 048314 83 MRGSKPSTEAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQN 148 (274)
Q Consensus 83 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~n 148 (274)
.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 99999999999999999999998743 24599999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCCh
Q 048314 149 ILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKP 214 (274)
Q Consensus 149 il~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~ 214 (274)
|+++.++.+||+|||++.... +..|+|||.+....++.++||||||+++|+|++ |..||....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~--- 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 999999999999999987543 346999999998899999999999999999999 999996431
Q ss_pred hhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 215 EEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. .+. ....... ....+...+..+.+++.+||+.||++|||+.||++.|
T Consensus 299 ~~-~~~----~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 299 VE-ELF----KLLKEGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp HH-HHH----HHHHTTC------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH-HHH----HHHHcCC------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11 111 1111110 1123445667899999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=308.41 Aligned_cols=248 Identities=20% Similarity=0.248 Sum_probs=183.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH----HHHHHhcC-CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC----cceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR----ALMATVNS-PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS----KPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~----~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 91 (274)
.++|...+.+|.|+| |.||+|.. .++|.... ......+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~--g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRF--GCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTT--CEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCc--eEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467888899999999 99999921 11222111 112223456899999999999999999998754 36999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------CCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC-------EPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-------~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
|||+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ ..+++||||||+||+++.++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999999999976 45999999999999999999999752 22899999999999999999999999999
Q ss_pred ceec-------------CCCCcCCCcccccC-----CCccccceeehhHhHHHHhhcCCCccccCCChhh---HH-----
Q 048314 165 AKLL-------------SDKGCMAPECYKRT-----PISVKADVYGYGIVLLETICCWENMEIDASKPEE---II----- 218 (274)
Q Consensus 165 ~~~~-------------~~~~~~ape~~~~~-----~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~---~~----- 218 (274)
++.. +++.|+|||.+... .++.++||||||+++|||++|+.||......... ..
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 8542 26679999998763 4567899999999999999999999753221100 00
Q ss_pred -HHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 219 -LTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+ ..................+...+..+.+++.+||+.||++|||+.||++.|
T Consensus 258 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 313 (322)
T 3soc_A 258 SLEDM-QEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313 (322)
T ss_dssp CHHHH-HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred chhhh-hhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 0000 000000000111111112335667899999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=304.03 Aligned_cols=244 Identities=11% Similarity=0.038 Sum_probs=185.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC-------------CCCCcHHHHHHHHhcCCCCcc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP-------------YSPSRPLTLTSIVSRVSWTTD 75 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni 75 (274)
..++|...+.||.|+| |.||+|.. .++|..... .....+..|+..++.++||||
T Consensus 33 ~~~~y~~~~~lG~G~~--g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGF--GCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TCCEEEEEEECCCC-C--CEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred CCCeEEEEEEEecCCC--eEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 3458888999999999 99999821 112211111 011223456667778889999
Q ss_pred ceEeEEEEeC----CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE
Q 048314 76 IEVSSVAMRG----SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 151 (274)
Q Consensus 76 v~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~ 151 (274)
+++++++.+. ...++||||+ +++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||++
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 9999998764 4589999999 9999999987 446799999999999999999999999 99999999999999
Q ss_pred c--CCCcEEEeccccceec------------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccC
Q 048314 152 D--EFWTAKISDFGLAKLL------------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDA 211 (274)
Q Consensus 152 ~--~~~~~kl~d~g~~~~~------------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~ 211 (274)
+ .++.+||+|||+++.. +++.|+|||.+....++.++||||||+++|||++|..||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 8899999999999643 4678999999998889999999999999999999999997542
Q ss_pred CChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 212 SKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
....... ..... ....+..++++...+...+..+.+++..||+.||++|||+.+|++.|
T Consensus 266 ~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 266 KDPKYVR---DSKIR-YRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp TCHHHHH---HHHHH-HHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred cCHHHHH---HHHHH-hhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 2221111 11111 11112222221111223457899999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=298.92 Aligned_cols=248 Identities=11% Similarity=0.092 Sum_probs=190.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC--cce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS--KPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~ 89 (274)
.++|.....+|.|+| |.||+|.. .++|.... ....+.+.+|++++++++||||+++++++.+.+ ..+
T Consensus 8 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGAT--ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCC--eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 356788899999999 99999821 12222221 123455679999999999999999999998755 679
Q ss_pred EEEEeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE----cCCCcEEEecccc
Q 048314 90 TEAALDLPWDLAYIIFCSAE-RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKISDFGL 164 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~----~~~~~~kl~d~g~ 164 (274)
+||||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999986422 2399999999999999999999999 99999999999998 7788899999999
Q ss_pred ceec----------CCCCcCCCcccc--------cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH
Q 048314 165 AKLL----------SDKGCMAPECYK--------RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226 (274)
Q Consensus 165 ~~~~----------~~~~~~ape~~~--------~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (274)
+... +++.|+|||++. ...++.++||||||+++|||++|..||..............-....
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 9754 256799999886 4678899999999999999999999997543333222221111111
Q ss_pred Hhhhhhh--------------hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 227 FINRELN--------------KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 227 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
....... ..-.....+......+.+++.+||+.||++|||++|+++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h 303 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence 0000000 0001113567888999999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=304.93 Aligned_cols=232 Identities=14% Similarity=0.136 Sum_probs=187.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH----------HHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR----------ALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
++|...+.+|.|+| |.||+|.. .++|.... ....+.+.+|+.++++++||||+++++++. .+..
T Consensus 13 ~~y~~~~~lG~G~~--g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVF--GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTEEEEEEEECCSS--CEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred hHceeeeeeeecCC--ceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 46777889999999 99999821 22222222 234466789999999999999999999886 4568
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||||+.+|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEECCTTCBSHHHHHS-SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEEeCCCCCHHHHHHH-ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999999986 345799999999999999999999999 9999999999999999999999999998754
Q ss_pred C-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 S-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
. +..|+|||.+....++.++||||||+++|+|++ |..||....... +.. .....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~----~~~~~---- 233 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----VPD----LLEKG---- 233 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH----HHH----HHHTT----
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH----HHH----HHHcC----
Confidence 2 347999999998899999999999999999999 999997542111 110 01110
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 234 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l 271 (325)
T 3kex_A 234 --ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF 271 (325)
T ss_dssp --CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHH
T ss_pred --CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 01123344556789999999999999999999998864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=296.92 Aligned_cols=229 Identities=18% Similarity=0.141 Sum_probs=188.7
Q ss_pred hhhccccccCCCCCCCCcchhHHH----------HHH-HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM----------RAL-MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~----------~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.+|.|+| |.||++. +.+ +.........+.+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSF--GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred hHHcEEEEEEeeCCC--EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 467888999999999 9999871 111 111112234455778999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 83 lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999999986 45799999999999999999999999 9999999999999999999999999998754
Q ss_pred -------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC-Cc
Q 048314 169 -------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TE 240 (274)
Q Consensus 169 -------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 240 (274)
+++.|+|||++....++.++|+||||+++|||++|..||.... ... .. ..+... ..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~-~~------------~~i~~~~~~ 221 (318)
T 1fot_A 158 DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMK-TY------------EKILNAELR 221 (318)
T ss_dssp SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHH-HH------------HHHHHCCCC
T ss_pred CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHH-HH------------HHHHhCCCC
Confidence 3678999999998899999999999999999999999996431 111 10 011111 12
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
.+...+.++.+++.+||+.||++|| +++|+++
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 4445667899999999999999999 8888875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=304.38 Aligned_cols=234 Identities=17% Similarity=0.137 Sum_probs=186.2
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCC--------CCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPY--------SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
.+.|.....+|.|+| |.||++.. .++|.+.... ..+.+.+|+.+|++++||||+++++++.+.+
T Consensus 11 ~~~y~~~~~LG~G~f--g~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQF--AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp GGTEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred hhceEEeeEEeeCcC--EEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 456888899999999 99999821 1222222211 1245779999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC----cEEEecc
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW----TAKISDF 162 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~----~~kl~d~ 162 (274)
..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||++..++ .+||+||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999975 45799999999999999999999999 999999999999998776 7999999
Q ss_pred ccceec----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 163 GLAKLL----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 163 g~~~~~----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
|++... +++.|+|||++....++.++|+||||+++|+|++|..||... .....+.. +.....
T Consensus 164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~-----i~~~~~ 235 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLAN-----ITAVSY 235 (361)
T ss_dssp SSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHH-----HHTTCC
T ss_pred CCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHH-----HHhcCC
Confidence 998753 366799999999888999999999999999999999999643 11111100 011000
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
-.+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 ---DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000111234567899999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=306.42 Aligned_cols=238 Identities=16% Similarity=0.169 Sum_probs=187.7
Q ss_pred hhhccccccCCCCCCCCcchhHHH-------HHHH---H-HhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-------RALM---A-TVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~---~-~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 88 (274)
.++|...+.||+|+| |.||++. +++| + ........+.+.+|..++.++ +||||+++++++.+.+..
T Consensus 51 ~~~y~~~~~LG~G~f--G~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSY--AKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred hhHcEEEEEEeeCCC--eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 468888999999999 9999881 1111 1 112224456678999999887 799999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 129 ~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999999986 45799999999999999999999999 9999999999999999999999999998642
Q ss_pred -----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhH-HHHHHHHHHHhhhhhhhhh
Q 048314 169 -----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEI-ILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 169 -----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (274)
+++.|+|||++....++.++|+|||||++|||++|..||.......... .....+......
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~------- 276 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------- 276 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-------
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-------
Confidence 2678999999999999999999999999999999999996432211110 000111111111
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCCh------hhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSM------KCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~------~evl~ 272 (274)
.....|...+..+.+++.+||+.||++||++ .|+++
T Consensus 277 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 277 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 1113555667889999999999999999996 56654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=304.91 Aligned_cols=243 Identities=18% Similarity=0.180 Sum_probs=186.8
Q ss_pred hhhccccccCCCCCCCCcchhHHH----------HHHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEe--CC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM----------RALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--GS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~----------~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~ 86 (274)
.++|...+.+|.|+| |.||++. ..++|..... ...+.+.+|+.++++++||||+++++++.+ ..
T Consensus 9 ~~~~~~~~~lg~G~~--g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNF--GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSS--EEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCC--EEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 367777889999999 9999873 1122222221 122457799999999999999999999865 35
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHH-CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred ceEEEEEeCCCCCHHHHHHh-cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 58999999999999999987 344699999999999999999999999 99999999999999999999999999987
Q ss_pred ecC--------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH----Hh
Q 048314 167 LLS--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC----FI 228 (274)
Q Consensus 167 ~~~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----~~ 228 (274)
... +..|+|||.+....++.++||||||+++|+|++|..|+.... .. ........ ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~---~~--~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP---AE--FMRMIGNDKQGQMI 237 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH---HH--HHHHHCTTCCTHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh---HH--HHhhhcCccccchh
Confidence 543 234999999998899999999999999999999999985321 00 00000000 00
Q ss_pred hhhhhh-hhc--CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 229 NRELNK-LVR--GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 229 ~~~~~~-~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...... ... ..+.+..++..+.+++.+||+.||++|||+.|+++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 000001 111 1134556778999999999999999999999998864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=303.36 Aligned_cols=240 Identities=18% Similarity=0.185 Sum_probs=192.6
Q ss_pred hHHHHhhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEE
Q 048314 16 SLCTKLRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSV 81 (274)
Q Consensus 16 ~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~ 81 (274)
+..-..++|...+.+|.|+| |.||++.. .++|...... ..+.+.+|+.++++++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEF--GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSS--SEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCC--eeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 33444677888899999999 99999831 2223222211 12456789999999999999999999
Q ss_pred EEeCCcceEEEEeCCCCCHHHHHHhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 048314 82 AMRGSKPSTEAALDLPWDLAYIIFCSAE----------------------RNPYWNQRVRIALDVAKGILYLHDECEPPI 139 (274)
Q Consensus 82 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i 139 (274)
+.+.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. ++
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i 171 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KL 171 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CC
Confidence 9999999999999999999999987432 2389999999999999999999999 99
Q ss_pred ccCCCCCCceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCC
Q 048314 140 LHCDIKPQNILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWE 205 (274)
Q Consensus 140 ~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~ 205 (274)
+|+||||+||+++.++.++|+|||++.... ++.|+|||.+....++.++||||||+++|+|++ |..
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987542 345999999988889999999999999999999 999
Q ss_pred CccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 206 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 206 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
||...... . +. ...... .....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 252 p~~~~~~~--~--~~----~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l 306 (314)
T 2ivs_A 252 PYPGIPPE--R--LF----NLLKTG------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306 (314)
T ss_dssp SSTTCCGG--G--HH----HHHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCHH--H--HH----HHhhcC------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99643111 1 00 111111 01124455678899999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=291.06 Aligned_cols=235 Identities=18% Similarity=0.218 Sum_probs=185.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCC---------CCCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPY---------SPSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
.++|...+.+|.|+| |.||++.. .++|...... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 18 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGF--GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp STTEEEEEECCCCSS--SCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hccceehhccccCCc--eeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 467888899999999 99998822 2222222111 115677999999999999999999998655
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cccCCCCCCceEEcCCCc-----EE
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDEFWT-----AK 158 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~~~~~-----~k 158 (274)
. ++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. + ++|+||||+||+++.++. +|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred C--eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 4 799999999999999976 456799999999999999999999999 8 999999999999987776 99
Q ss_pred Eeccccceec--------CCCCcCCCcccc--cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh
Q 048314 159 ISDFGLAKLL--------SDKGCMAPECYK--RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI 228 (274)
Q Consensus 159 l~d~g~~~~~--------~~~~~~ape~~~--~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (274)
|+|||++... +++.|+|||.+. ...++.++||||||+++|+|++|..||......... ..... .
T Consensus 170 l~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~----~ 243 (287)
T 4f0f_A 170 VADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMI----R 243 (287)
T ss_dssp ECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHH----H
T ss_pred eCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHH----h
Confidence 9999998643 367899999984 445788999999999999999999999754222111 11100 0
Q ss_pred hhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 229 NRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ... ....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 244 ~----~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 244 E----EGL-RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp H----SCC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred c----cCC-CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 0 001 1134556678899999999999999999999999865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=305.52 Aligned_cols=237 Identities=19% Similarity=0.201 Sum_probs=181.3
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
...++|...+.+|.|+| |.||+|.. .++|........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~--g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGAT--SIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCC--EEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34567888999999999 99999821 22333444345567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC---CCcEEEeccccceec-
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKISDFGLAKLL- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~d~g~~~~~- 168 (274)
||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++...
T Consensus 128 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 128 ELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999975 45699999999999999999999999 9999999999999975 889999999998643
Q ss_pred ---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+++.|+|||.+.+..++.++|||||||++|+|++|..||...... ..+ .....+... ....
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~----~~~i~~~~~---~~~~ 272 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD---QFM----FRRILNCEY---YFIS 272 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH---HHH----HHHHHTTCC---CCCT
T ss_pred cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc---HHH----HHHHHhCCC---ccCC
Confidence 266799999999888999999999999999999999999643211 101 011111110 0011
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122345678999999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=299.24 Aligned_cols=235 Identities=20% Similarity=0.162 Sum_probs=185.0
Q ss_pred hhhccccccCCCCCCCCcchhHHH-------HHHH----HHhcC--CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-------RALM----ATVNS--PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~----~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
.+.|.....||.|+| |.||++. +++| ..... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 23 ~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPF--SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp HHHEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccceEEeeEEeeCCC--EEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 457888999999999 9999981 1111 11111 1234567899999999999999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc---EEEecc
Q 048314 88 PSTEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT---AKISDF 162 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~---~kl~d~ 162 (274)
.++|||||++|+|.+++... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999999888653 234589999999999999999999999 9999999999999976544 999999
Q ss_pred ccceec-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhh
Q 048314 163 GLAKLL-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRE 231 (274)
Q Consensus 163 g~~~~~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (274)
|++... +++.|+|||.+....++.++|||||||++|+|++|..||... .. . +. .......
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~-~-~~----~~i~~~~ 248 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT---KE-R-LF----EGIIKGK 248 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---HH-H-HH----HHHHHTC
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc---HH-H-HH----HHHHcCC
Confidence 998653 256799999999888999999999999999999999999643 11 1 10 1111110
Q ss_pred hhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 232 LNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. .........+..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK---MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC---CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 000001123578899999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=301.75 Aligned_cols=228 Identities=18% Similarity=0.154 Sum_probs=187.3
Q ss_pred hhhccccccCCCCCCCCcchhHHH-------HHHH----HHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-------RALM----ATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.+|.|+| |.||++. +++| .........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 8 i~~Y~i~~~lG~G~~--g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 8 IGPYIIRETLGEGSF--GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp ETTEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCEEEEEEEecCCC--eEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 367888899999999 9999882 1111 11222234556889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
+||||+ +|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 lv~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EEECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEEECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 999999 6899999876 35799999999999999999999999 9999999999999999999999999998643
Q ss_pred ---------CCCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 169 ---------SDKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+++.|+|||.+.+..+ +.++||||||+++|+|++|..||........ ...+...
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~~ 223 (336)
T 3h4j_B 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNSC 223 (336)
T ss_dssp TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCSS
T ss_pred CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHcC
Confidence 3678999999987776 6899999999999999999999974421110 0011111
Q ss_pred -CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 239 -TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 239 -~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1345556778999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=306.92 Aligned_cols=250 Identities=12% Similarity=0.051 Sum_probs=187.6
Q ss_pred HHHhhhccccccCCCC--CCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 18 CTKLRNFCRSSLNDRN--SPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g--~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
....++|...+.+|+| +| |.||++.. .++|.+... ...+.+.+|+.++++++|||||++++++.+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDL--MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTT--EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cCCCCcEEEEecccCCcCCc--eEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 3456788889999999 88 99999821 122222211 1224456899999999999999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
+..++|||||++|+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 9999999999999999999876557799999999999999999999999 9999999999999999999999999986
Q ss_pred eec------------------CCCCcCCCccccc--CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH
Q 048314 166 KLL------------------SDKGCMAPECYKR--TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225 (274)
Q Consensus 166 ~~~------------------~~~~~~ape~~~~--~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (274)
... ++..|+|||.+.. ..++.++|||||||++|+|++|..||..................
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 432 2456999999987 57899999999999999999999999754222211110000000
Q ss_pred HHhh-------------------hhhhh------------hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 226 CFIN-------------------RELNK------------LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 226 ~~~~-------------------~~~~~------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.... ..... .....+.+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0000 00000 00000233445678999999999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=302.52 Aligned_cols=237 Identities=15% Similarity=0.068 Sum_probs=183.7
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
..++|...+.+|.|+| |.||++.. .++|.+. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNF--GVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CTTTEEEEEEESSSTT--SSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCcEEEEEEeccCCC--EEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 3467888999999999 99998821 2223222 2334566789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc--EEEeccccceec--
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT--AKISDFGLAKLL-- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~--~kl~d~g~~~~~-- 168 (274)
||+.+|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++. +||+|||+++..
T Consensus 96 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 96 EYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999999975 35699999999999999999999999 9999999999999987665 999999988632
Q ss_pred --------CCCCcCCCcccccCCCccc-cceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 --------SDKGCMAPECYKRTPISVK-ADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 --------~~~~~~ape~~~~~~~~~~-~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+++.|+|||.+....++.+ +||||||+++|+|++|+.||.............. ... .. . ...
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---~~~-~~---~--~~~ 241 (361)
T 3uc3_A 171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ---RIL-SV---K--YSI 241 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH---HHH-TT---C--CCC
T ss_pred cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH---HHh-cC---C--CCC
Confidence 3678999999988777655 8999999999999999999975422221111111 000 00 0 000
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+.+...+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 242 PDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 112234578899999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=306.72 Aligned_cols=241 Identities=17% Similarity=0.175 Sum_probs=192.0
Q ss_pred hHHHHhhhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCCCC---CCcHHHHHHHHhcC-CCCccceEeE
Q 048314 16 SLCTKLRNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSPYS---PSRPLTLTSIVSRV-SWTTDIEVSS 80 (274)
Q Consensus 16 ~l~~~~~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~l~~ 80 (274)
+..-..++|.....+|.|+| |.||++. ..++|....... .+.+.+|+.++.++ +||||+++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~--g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAF--GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSS--EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeeceeecCCCC--ceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 34445688999999999999 9999983 222333332211 23478999999999 7899999999
Q ss_pred EEEeCCc-ceEEEEeCCCCCHHHHHHhCCC--------------------------------------------------
Q 048314 81 VAMRGSK-PSTEAALDLPWDLAYIIFCSAE-------------------------------------------------- 109 (274)
Q Consensus 81 ~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------- 109 (274)
++.+.+. .++||||+++|+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 9987554 8999999999999999986432
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 110 --------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 110 --------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
..+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 1289999999999999999999999 99999999999999999999999999987542
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||.+....++.++||||||+++|+|++ |..||........ +. ...... .....
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~----~~~~~~------~~~~~ 317 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FC----RRLKEG------TRMRA 317 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---HH----HHHHHT------CCCCC
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---HH----HHHHcC------CCCCC
Confidence 446999999998899999999999999999998 9999965422211 11 111111 01123
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 350 (359)
T 3vhe_A 318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350 (359)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 445667899999999999999999999999865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=297.04 Aligned_cols=234 Identities=15% Similarity=0.149 Sum_probs=181.7
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
..++|...+.+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++. .+.
T Consensus 13 ~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 13 QRERIELGRCIGEGQF--GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp CGGGEEEEEEEEECSS--SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred ehHHeEEEeEeeecCC--eeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 4567888899999999 99998832 112221111 12345779999999999999999999974 567
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp CEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 8999999999999999986 345699999999999999999999999 999999999999999999999999999865
Q ss_pred cC------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 168 LS------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 168 ~~------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
.. ++.|+|||.+....++.++||||||+++|+|++ |..||....... .. ......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~----~~----~~i~~~---- 233 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VI----GRIENG---- 233 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HH----HHHHTT----
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH----HH----HHHHcC----
Confidence 43 346999999988889999999999999999996 899996431111 00 000110
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 234 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 271 (281)
T 1mp8_A 234 --ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271 (281)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 01124456678899999999999999999999998864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=299.95 Aligned_cols=230 Identities=16% Similarity=0.109 Sum_probs=189.2
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-------HHH----HHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-------ALM----ATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-------~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.+|.|+| |.||++.. ++| .........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 40 ~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSF--GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHCEEEEEeecCcC--cEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 367888899999999 99998821 111 11122234456789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 118 lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999999986 35699999999999999999999999 99999999999999999999999999987543
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
++.|+|||++....++.++|+||||+++|+|++|..||.... .. .+. ..+..+ ....
T Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~-~~~----~~i~~~-------~~~~ 257 (350)
T 1rdq_E 193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PI-QIY----EKIVSG-------KVRF 257 (350)
T ss_dssp SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH-HHH----HHHHHC-------CCCC
T ss_pred CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HH-HHH----HHHHcC-------CCCC
Confidence 678999999998889999999999999999999999996431 11 110 111111 1124
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCC-----hhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPS-----MKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps-----~~evl~ 272 (274)
+...+..+.+++.+||+.||++||+ ++|+++
T Consensus 258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 4556788999999999999999998 888865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=312.92 Aligned_cols=236 Identities=13% Similarity=0.111 Sum_probs=186.6
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
..++|.....+|.|+| |.||++.. .++|.+... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 9 ~~~~Y~i~~~LG~G~f--g~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 9 FTEEYQLFEELGKGAF--SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHEEEEEEEEEC----CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccCCeEEEEEeccCCC--eEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 3578888999999999 99998821 112222221 12345679999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc---CCCcEEEeccccce
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD---EFWTAKISDFGLAK 166 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~---~~~~~kl~d~g~~~ 166 (274)
+|||||.+|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.+||+|||++.
T Consensus 87 lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999999986 45699999999999999999999999 999999999999998 46789999999986
Q ss_pred ec-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 167 LL-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 167 ~~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
.. +++.|+|||.+....++.++||||+||++|+|++|..||.... .. .+. .....+..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~-~~~----~~i~~~~~--- 230 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QH-RLY----QQIKAGAY--- 230 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HH-HHH----HHHHHTCC---
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HH-HHH----HHHHhCCC---
Confidence 43 2677999999998889999999999999999999999996431 11 111 11111111
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
-.+.+.....++.+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00111223456789999999999999999999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=300.92 Aligned_cols=233 Identities=19% Similarity=0.172 Sum_probs=188.8
Q ss_pred hhhccccccCCCCCCCCcchhHHH-------HHHH----HHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-------RALM----ATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.||+|+| |.||++. +++| .........+.+.+|+.+|++++|||||++++++.+.+..+
T Consensus 14 ~~~y~i~~~LG~G~f--G~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 14 FDHFEILRAIGKGSF--GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp GGGEEEEEEEECCTT--CCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hHHeEEEEEEeeCCC--eEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467888999999999 9999881 1111 11122234556789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
+||||+.+|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 92 lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999999985 45799999999999999999999999 9999999999999999999999999998754
Q ss_pred ---------CCCCcCCCccccc---CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 169 ---------SDKGCMAPECYKR---TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 169 ---------~~~~~~ape~~~~---~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
+++.|+|||++.. ..++.++|+|||||++|+|++|..||........... ... ...
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~-~~~----~~~------- 234 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI-VHT----FET------- 234 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH-HHH----HHH-------
T ss_pred CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH-HHH----Hhh-------
Confidence 2677999999864 3588999999999999999999999975422221111 110 000
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCC-hhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPS-MKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~evl~ 272 (274)
.....+...+..+.+++.+||+.||++||+ +.+|.+
T Consensus 235 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111345566788999999999999999998 777654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=303.95 Aligned_cols=237 Identities=18% Similarity=0.174 Sum_probs=190.7
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEEe
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMR 84 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 84 (274)
..++|...+.+|.|+| |.||+|.. .++|..... ...+.+.+|+.+++++ +||||+++++++.+
T Consensus 43 ~~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAF--GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSS--EEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCC--ceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 3567888899999999 99998842 223332221 3456678999999999 89999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCC
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAE---------------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCD 143 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 143 (274)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++|+|
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 9999999999999999999986432 2389999999999999999999999 999999
Q ss_pred CCCCceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccc
Q 048314 144 IKPQNILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEI 209 (274)
Q Consensus 144 l~~~nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~ 209 (274)
|||+||+++.++.++|+|||++.... ++.|+|||.+....++.++||||||+++|+|++ |..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999986432 346999999988889999999999999999998 9999975
Q ss_pred cCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 210 DASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...... +.. ..... .. ...+...+..+.+++.+||+.||.+|||+.++++.|
T Consensus 278 ~~~~~~---~~~----~~~~~-----~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 278 IPVDAN---FYK----LIQNG-----FK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCCSHH---HHH----HHHTT-----CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcHHH---HHH----HHhcC-----CC-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 422211 111 11110 11 123445578899999999999999999999998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=304.52 Aligned_cols=238 Identities=18% Similarity=0.179 Sum_probs=191.9
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEE
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAM 83 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~ 83 (274)
....++|...+.+|.|+| |.||++.. .++|...... ..+.+.+|+.++++++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAF--GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSS--CEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCC--eeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 334578888999999999 99999832 1222222211 1345779999999999999999999999
Q ss_pred eCCcceEEEEeCCCCCHHHHHHhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 048314 84 RGSKPSTEAALDLPWDLAYIIFCSAE----------------------RNPYWNQRVRIALDVAKGILYLHDECEPPILH 141 (274)
Q Consensus 84 ~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h 141 (274)
+.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 99999999999999999999987421 5699999999999999999999999 9999
Q ss_pred CCCCCCceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCc
Q 048314 142 CDIKPQNILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENM 207 (274)
Q Consensus 142 ~dl~~~nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~ 207 (274)
+||||+||+++.++.+||+|||++.... +..|+|||.+....++.++||||||+++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999999985421 456999999988889999999999999999999 99999
Q ss_pred cccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 208 EIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.... .. .+. ....++.. ...+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 278 ~~~~---~~-~~~----~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 278 YGMA---HE-EVI----YYVRDGNI------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp TTSC---HH-HHH----HHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCC---hH-HHH----HHHhCCCc------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 6431 11 111 11111111 124455667899999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=299.18 Aligned_cols=235 Identities=17% Similarity=0.148 Sum_probs=186.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-C-------CCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-Y-------SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
.+.|.....+|.|+| |.||++.. .++|.+... . ..+.+.+|+.+|++++||||+++++++.+.+
T Consensus 10 ~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQF--AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp HHHEEEEEEEECCSS--EEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccceEeceEEeeCCC--eEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 466888899999999 99999821 122222211 1 2345779999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC----cEEEecc
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW----TAKISDF 162 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~----~~kl~d~ 162 (274)
..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++ .+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999999975 45799999999999999999999999 999999999999998877 7999999
Q ss_pred ccceec----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 163 GLAKLL----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 163 g~~~~~----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
|++... +++.|+|||++....++.++||||||+++|+|++|..||... .....+.. .....
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~-----~~~~~- 233 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLAN-----VSAVN- 233 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHH-----HHHTC-
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC---CHHHHHHH-----HHhcC-
Confidence 998754 267799999998888999999999999999999999999643 11111110 00000
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
...+.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 234 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 --YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000001112335678999999999999999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=297.94 Aligned_cols=246 Identities=14% Similarity=0.105 Sum_probs=188.4
Q ss_pred hHHHHhhhccccccCCCCCCCCcchhHHHH-----HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 16 SLCTKLRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 16 ~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
......++|...+.+|.|+| |.||++.. .++|.+... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~--g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTY--GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp CEECSSCEEEEEEEEEECSS--CEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred eecchHhhhHhhhhccCCCC--eEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 33444688888999999999 99999832 112222211 11245679999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++||||++ |+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 93 CLTLVFEFME-KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp CEEEEEECCS-EEHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEcCCC-CCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCce
Confidence 9999999998 589888876 445699999999999999999999999 99999999999999999999999999987
Q ss_pred ecC-----------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh--
Q 048314 167 LLS-----------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL-- 232 (274)
Q Consensus 167 ~~~-----------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 232 (274)
... ++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...........+. ........
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~ 243 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF----SILGTPNPRE 243 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH----HHHCCCCTTT
T ss_pred ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----HHHCCCChHH
Confidence 543 567999999876 468999999999999999999999997543222111111 10000000
Q ss_pred -------hh-------hhcCC---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 -------NK-------LVRGT---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 -------~~-------~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. ..... ......+.++.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 00000 011233467899999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=294.86 Aligned_cols=236 Identities=17% Similarity=0.194 Sum_probs=186.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHH----HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeC--CcceE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR----ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--SKPST 90 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~----~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 90 (274)
.++|.....+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 9 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHS--GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETT--EEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCc--ceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 457778899999999 99999822 112222221 1124578999999999999999999999876 78899
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
||||+++|+|.+++.......+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.++++||+++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999875445699999999999999999999998 8 999999999999999999999988776432
Q ss_pred ------CCCCcCCCcccccCCCc---cccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ------SDKGCMAPECYKRTPIS---VKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~---~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+++.|+|||.+....++ .++||||||+++|+|++|..||.... ...... .. ..... ..
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~----~~-----~~~~~-~~ 230 (271)
T 3kmu_A 164 QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---NMEIGM----KV-----ALEGL-RP 230 (271)
T ss_dssp SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC---HHHHHH----HH-----HHSCC-CC
T ss_pred cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC---hHHHHH----HH-----HhcCC-CC
Confidence 36789999999865544 47999999999999999999996431 110000 00 00001 11
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+...+..+.+++..||+.||++|||+.|+++.|
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 24556678899999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=301.98 Aligned_cols=233 Identities=16% Similarity=0.181 Sum_probs=186.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH----------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR----------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
.++|...+.+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~--g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAF--GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSS--EEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCC--eEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 467888999999999 99999821 122222221 23455779999999999999999999998765
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++++||+.+|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 91 ~~~v~~~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEECCCSSCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred ceEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 8899999999999999987 456799999999999999999999999 999999999999999999999999999875
Q ss_pred cC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 168 LS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 168 ~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
.. +..|+|||.+....++.++||||||+++|+|++ |..||....... +. ......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~----~~~~~~--- 235 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----IS----SILEKG--- 235 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HH----HHHHTT---
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HH----HHHHcC---
Confidence 42 346999999998899999999999999999999 999996441111 00 000010
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+...+..+.+++.+||+.||.+|||+.|+++.|
T Consensus 236 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 273 (327)
T 3lzb_A 236 ---ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp ---CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 01124445667899999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=298.21 Aligned_cols=233 Identities=15% Similarity=0.185 Sum_probs=185.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-------------HHHHHhcC--CCCCCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-------------ALMATVNS--PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-------------~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
.++|...+.+|.|+| |.||+|.. .++|.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTF--TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETT--EEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCC--ceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 357778899999999 99999821 22222211 12345678999999999999999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc--------E
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT--------A 157 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~--------~ 157 (274)
+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++. +
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCCEEEEECCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999999987 334599999999999999999999999 9999999999999988876 9
Q ss_pred EEeccccceecC-------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh
Q 048314 158 KISDFGLAKLLS-------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN 229 (274)
Q Consensus 158 kl~d~g~~~~~~-------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (274)
+|+|||.+.... +..|+|||.+.. ..++.++||||||+++|+|++|..|+........ ...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~-------- 229 (289)
T 4fvq_A 161 KLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---KLQ-------- 229 (289)
T ss_dssp EECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH--------
T ss_pred eeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH---HHH--------
Confidence 999999986543 678999999987 6789999999999999999996555532211110 000
Q ss_pred hhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 230 RELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
........+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 230 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 230 ----FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp ----HHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ----HhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 00011123333456789999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=308.90 Aligned_cols=243 Identities=13% Similarity=0.033 Sum_probs=192.6
Q ss_pred hhhHHHHhhhccccccCCCCCCCCcchhHHH-------HHH----HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEE
Q 048314 14 RSSLCTKLRNFCRSSLNDRNSPRSKSVWSCM-------RAL----MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVA 82 (274)
Q Consensus 14 ~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~----~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 82 (274)
..++...+++|...+.||+|+| |.||++. +++ +.........+.+.+|+.++..++||||++++++|
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~f--G~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAF--GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhcccCChhheEEEEEEEeCCC--EEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3445556788999999999999 9999981 111 11122234566789999999999999999999999
Q ss_pred EeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 83 MRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 83 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
.+.+..++|||||++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999986 346799999999999999999999999 9999999999999999999999999
Q ss_pred ccceec------------CCCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH
Q 048314 163 GLAKLL------------SDKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225 (274)
Q Consensus 163 g~~~~~------------~~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (274)
|+++.. +++.|+|||++. ...++.++|+|||||++|||++|+.||.... ...... .
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~---~~~~~~----~ 292 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYG----K 292 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHH----H
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC---hhHHHH----h
Confidence 998542 367899999987 4568999999999999999999999997431 111111 1
Q ss_pred HHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCC--CCChhhHHh
Q 048314 226 CFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPAL--RPSMKCVVM 272 (274)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~evl~ 272 (274)
...... ....+ ......++++.+|+.+||..+|++ ||+++|+++
T Consensus 293 i~~~~~--~~~~p-~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 293 IMNHKE--RFQFP-TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHTHHH--HCCCC-SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhccc--cccCC-cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 100000 00001 111235678899999999988888 999999976
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=296.14 Aligned_cols=233 Identities=15% Similarity=0.191 Sum_probs=182.3
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC----
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS---- 86 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 86 (274)
..++|...+.+|.|+| |.||++.. .++|.+... ...+.+.+|+.+|++++||||+++++++.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~--g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGF--GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-C--SEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCC--eEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 3578888999999999 99998821 223333221 22355789999999999999999999986643
Q ss_pred -----------------------------------------------------cceEEEEeCCCCCHHHHHHhCCC-CCC
Q 048314 87 -----------------------------------------------------KPSTEAALDLPWDLAYIIFCSAE-RNP 112 (274)
Q Consensus 87 -----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~-~~l 112 (274)
..++|||||++|+|.+++..... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 27999999999999999987432 236
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-----------------------C
Q 048314 113 YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-----------------------S 169 (274)
Q Consensus 113 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-----------------------~ 169 (274)
++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++... +
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 7788999999999999999999 9999999999999999999999999998653 3
Q ss_pred CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHH
Q 048314 170 DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENL 249 (274)
Q Consensus 170 ~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (274)
++.|+|||.+....++.++||||||+++|+|++|..|+... .... ...... ............+
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------~~~~----~~~~~~------~~~~~~~~~~~~~ 302 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------VRII----TDVRNL------KFPLLFTQKYPQE 302 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------HHHH----HHHHTT------CCCHHHHHHCHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------HHHH----HHhhcc------CCCcccccCChhH
Confidence 56799999999889999999999999999999987765311 0000 000000 0001223445678
Q ss_pred HHHHHHhhccCCCCCCChhhHHhh
Q 048314 250 VKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 250 ~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.+++.+||+.||++|||+.|+++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 999999999999999999999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=291.88 Aligned_cols=234 Identities=15% Similarity=0.191 Sum_probs=189.5
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----HHHHHhcC-CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNS-PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
.++|.....+|.|+| |.||++.. .++|.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQF--GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETT--EEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCc--eeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 356777889999999 99999822 12222222 22345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 85 MEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CTTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 999999999986 345689999999999999999999999 99999999999999999999999999987542
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||.+....++.++|+||||+++|+|++ |..||.... .. ... ...... . ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~-~~~----~~i~~~-----~-~~~~ 226 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NS-EVV----EDISTG-----F-RLYK 226 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HH-HHH----HHHHTT-----C-CCCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HH-HHH----HHHhcC-----C-cCCC
Confidence 346999999988889999999999999999999 899986431 11 110 001110 0 1123
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 344567899999999999999999999999865
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=304.23 Aligned_cols=255 Identities=17% Similarity=0.112 Sum_probs=194.9
Q ss_pred cchhhhhhhHHHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcC-CCCCCcHHHHHHHHhcCC-----CCcc
Q 048314 8 TSAWIARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS-PYSPSRPLTLTSIVSRVS-----WTTD 75 (274)
Q Consensus 8 ~~~~~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~-~~~~~~~~~e~~~l~~l~-----h~ni 75 (274)
...-+++.+.....++|...+.+|.|+| |.||++.. .++|.+.. ....+.+..|+.++++++ ||||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTF--GRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred cceeeeeecceEecCEEEEEEEEcccCC--eEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 3444666777777889999999999999 99998822 12222221 122344567999999987 9999
Q ss_pred ceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC--
Q 048314 76 IEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-- 153 (274)
Q Consensus 76 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-- 153 (274)
+++++++...+..++||||+ +++|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY 174 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence 99999999999999999999 89999999986656799999999999999999999999 9999999999999975
Q ss_pred -----------------------CCcEEEeccccceecC--------CCCcCCCcccccCCCccccceeehhHhHHHHhh
Q 048314 154 -----------------------FWTAKISDFGLAKLLS--------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC 202 (274)
Q Consensus 154 -----------------------~~~~kl~d~g~~~~~~--------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~ 202 (274)
++.+||+|||++.... ++.|+|||++....++.++|||||||++|+|++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 7889999999997543 667999999999999999999999999999999
Q ss_pred cCCCccccCCChhhHHHHHHHHHHHh-----------hhhhhhhhcCC--------c----------------cCHHHHH
Q 048314 203 CWENMEIDASKPEEIILTNWVYKCFI-----------NRELNKLVRGT--------E----------------VDKKNLE 247 (274)
Q Consensus 203 g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~--------~----------------~~~~~~~ 247 (274)
|+.||..... .. ....+..... ........... . .+....+
T Consensus 255 g~~pf~~~~~---~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 255 GSLLFRTHEH---ME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp SSCSCCCSSH---HH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred CCCCCCCCcH---HH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 9999974311 11 1111111000 00000000000 0 0001126
Q ss_pred HHHHHHHHhhccCCCCCCChhhHHh
Q 048314 248 NLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 248 ~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+.+++.+||+.||++|||++|+++
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhc
Confidence 7889999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=297.49 Aligned_cols=226 Identities=18% Similarity=0.145 Sum_probs=187.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----------CCCCcHHHHHHHHhcCCCCccceEeEEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----------YSPSRPLTLTSIVSRVSWTTDIEVSSVAM 83 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 83 (274)
..++|...+.||.|+| |.||++.. .++|.+... ...+.+.+|+.++++++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~--g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAF--GFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp HHHHEEEEEECSSSSS--CSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccceEEEeEEEecCC--EEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3568888999999999 99999921 122222221 13446779999999999999999999999
Q ss_pred eCCcceEEEEeCCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 84 RGSKPSTEAALDLPW-DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 84 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
+.+..++||||+.+| +|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 999999999999776 99999985 45799999999999999999999999 9999999999999999999999999
Q ss_pred ccceec----------CCCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhh
Q 048314 163 GLAKLL----------SDKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRE 231 (274)
Q Consensus 163 g~~~~~----------~~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (274)
|++... +++.|+|||.+....+ +.++||||||+++|+|++|..||.... ..
T Consensus 175 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------------------~~ 236 (335)
T 3dls_A 175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------------------ET 236 (335)
T ss_dssp TTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------------------GG
T ss_pred ccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------------------HH
Confidence 998754 3678999999988776 789999999999999999999996320 00
Q ss_pred hhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 232 LNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.... ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~---~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 VEAA---IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTTC---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred Hhhc---cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 12233356789999999999999999999999863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=303.15 Aligned_cols=231 Identities=18% Similarity=0.183 Sum_probs=187.2
Q ss_pred HhhhccccccCCCCCCCCcchhHHH-------HHHH---H-HhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM-------RALM---A-TVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~---~-~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 87 (274)
..++|...+.||+|+| |.||++. +++| + ........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lG~G~f--g~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSF--GKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp --CCEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred chhheEEEEEEeeCCC--EEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 3478888999999999 9999881 1111 1 111223445577899999988 69999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 9999999999999999986 35799999999999999999999999 999999999999999999999999999874
Q ss_pred c-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 168 L-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 168 ~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
. +++.|+|||++....++.++|+|||||++|||++|..||.... .. .+. ....+
T Consensus 174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~-~~~----~~i~~------- 238 (353)
T 3txo_A 174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---ED-DLF----EAILN------- 238 (353)
T ss_dssp SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---HH-HHH----HHHHH-------
T ss_pred cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC---HH-HHH----HHHHc-------
Confidence 2 3678999999988889999999999999999999999996431 11 111 11111
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCCh------hhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSM------KCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~------~evl~ 272 (274)
.....+...+..+.+++.+||+.||++||++ .|+++
T Consensus 239 ~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 DEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1112444566789999999999999999998 66764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=304.73 Aligned_cols=236 Identities=15% Similarity=0.129 Sum_probs=187.6
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCC----CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPY----SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
...++|.....+|.|+| |.||++.. .++|.+.... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 26 ~~~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAF--SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp HHHHHEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CcccCeEEeeEEecCCC--eEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34578888999999999 99999821 1222222221 124567899999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC---CcEEEeccccc
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF---WTAKISDFGLA 165 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~---~~~kl~d~g~~ 165 (274)
++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.+ +.+||+|||++
T Consensus 104 ~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 999999999999999975 45799999999999999999999999 99999999999999764 45999999998
Q ss_pred eec----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 166 KLL----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 166 ~~~----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
... +++.|+|||++....++.++|||||||++|+|++|..||.... . ..+. .....+..
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~-~~~~----~~i~~~~~--- 247 (362)
T 2bdw_A 179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---Q-HRLY----AQIKAGAY--- 247 (362)
T ss_dssp BCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---H-HHHH----HHHHHTCC---
T ss_pred eEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---H-HHHH----HHHHhCCC---
Confidence 643 3678999999998889999999999999999999999996431 1 1111 11111110
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 248 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011112344678999999999999999999999976
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=306.62 Aligned_cols=240 Identities=15% Similarity=0.079 Sum_probs=191.5
Q ss_pred hhHHHHhhhccccccCCCCCCCCcchhHHH-------HHH----HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEE
Q 048314 15 SSLCTKLRNFCRSSLNDRNSPRSKSVWSCM-------RAL----MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAM 83 (274)
Q Consensus 15 ~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~----~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 83 (274)
.++....++|...+.||+|+| |.||++. +++ +.........+.+.+|+.+++.++||||+++++++.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~f--G~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAF--GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HhcccCccccEEEEEEEcCCC--EEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 445556678999999999999 9999881 111 112223345677889999999999999999999999
Q ss_pred eCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccc
Q 048314 84 RGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG 163 (274)
Q Consensus 84 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g 163 (274)
+.+..++|||||++|+|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999999999975 4689999999999999999999999 99999999999999999999999999
Q ss_pred cceec------------CCCCcCCCcccccCC----CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH
Q 048314 164 LAKLL------------SDKGCMAPECYKRTP----ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF 227 (274)
Q Consensus 164 ~~~~~------------~~~~~~ape~~~~~~----~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (274)
+++.. +++.|+|||++.... ++.++|+|||||++|||++|..||.... ...... . +
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~----~-i 285 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYS----K-I 285 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHH----H-H
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC---hhhHHH----H-H
Confidence 98543 367899999997654 7899999999999999999999997431 111111 1 1
Q ss_pred hhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCC--CCChhhHHhh
Q 048314 228 INRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPAL--RPSMKCVVMM 273 (274)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~evl~~ 273 (274)
.+... .... +.+...+..+.+|+.+||+.+|.+ ||++.||++.
T Consensus 286 ~~~~~-~~~~--p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 286 MNHKN-SLTF--PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HTHHH-HCCC--CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred Hhccc-cccC--CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 11100 0000 112235678999999999999988 9999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=299.12 Aligned_cols=234 Identities=20% Similarity=0.189 Sum_probs=186.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|...+.+|+|+| |.||++.. .++|.+... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~y~i~~~lG~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAY--GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCC--EEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467888999999999 99999821 122222221 2346788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 84 LEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999999974 45699999999999999999999999 9999999999999999999999999998643
Q ss_pred ----------CCCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 ----------SDKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 ----------~~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
+++.|+|||.+....+ +.++||||||+++|+|++|..||......... ...+. .. ....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~-----~~--~~~~- 228 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWK-----EK--KTYL- 228 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHHHH-----TT--CTTS-
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHHh-----cc--cccC-
Confidence 3667999999987765 78999999999999999999999754222111 11110 00 0000
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
......+..+.+++.+||+.||++|||+.|+++.
T Consensus 229 --~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1123445778999999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=296.24 Aligned_cols=238 Identities=20% Similarity=0.261 Sum_probs=184.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH----HHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR----ALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDL 96 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~----~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 96 (274)
.++|...+.+|+|+| |.||++.. .++|........+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 7 ~~~~~~~~~lg~G~~--g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAF--GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSS--SEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred HhHeeeeeEeecCCC--ceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 356777899999999 99999821 12223333334456789999999999999999999876 44899999999
Q ss_pred CCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc-EEEeccccceec------
Q 048314 97 PWDLAYIIFCSAE-RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT-AKISDFGLAKLL------ 168 (274)
Q Consensus 97 ~gsL~~~l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~-~kl~d~g~~~~~------ 168 (274)
+|+|.+++..... ..+++..++.++.|++.||.|||+....+++||||||+||+++.++. +||+|||++...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN 162 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccccc
Confidence 9999999986332 24789999999999999999999921129999999999999988876 799999998643
Q ss_pred --CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHH
Q 048314 169 --SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNL 246 (274)
Q Consensus 169 --~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (274)
+++.|+|||.+....++.++||||||+++|+|++|+.||.......... .+.. ... .....+...+
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~~~~-~~~------~~~~~~~~~~ 230 (307)
T 2eva_A 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI-----MWAV-HNG------TRPPLIKNLP 230 (307)
T ss_dssp --CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH-----HHHH-HTT------CCCCCBTTCC
T ss_pred CCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH-----HHHH-hcC------CCCCcccccC
Confidence 3678999999998889999999999999999999999997542221111 0000 010 0112334456
Q ss_pred HHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 247 ENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 247 ~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+.+++.+||+.||++|||+.++++.|
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~L 258 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKIM 258 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 7899999999999999999999998864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=296.46 Aligned_cols=242 Identities=18% Similarity=0.169 Sum_probs=181.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHH----HHHHHhcCCCCCCcHHHHHHHHhc--CCCCccceEeEEEEeC----CcceE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR----ALMATVNSPYSPSRPLTLTSIVSR--VSWTTDIEVSSVAMRG----SKPST 90 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~----~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~l 90 (274)
.++|...+.+|.|+| |.||+|.. .++|... ....+.+..|.+++.. ++||||+++++++.+. ...++
T Consensus 7 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~vavK~~~-~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRY--GEVWRGSWQGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSS--EEEEEEEETTEEEEEEEEC-GGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCC--cEEEEEEECCEEEEEEEec-cccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 467888999999999 99999821 1122221 1233445567777666 7899999999997653 45799
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLH--------DECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh--------~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
||||+++|+|.+++.. ..+++..++.++.|++.||.||| +. +++||||||+||+++.++.+||+||
T Consensus 84 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred ehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999999954 57999999999999999999999 87 9999999999999999999999999
Q ss_pred cccee---------------cCCCCcCCCcccccC------CCccccceeehhHhHHHHhhc----------CCCccccC
Q 048314 163 GLAKL---------------LSDKGCMAPECYKRT------PISVKADVYGYGIVLLETICC----------WENMEIDA 211 (274)
Q Consensus 163 g~~~~---------------~~~~~~~ape~~~~~------~~~~~~Di~s~G~~l~el~~g----------~~p~~~~~ 211 (274)
|++.. .+++.|+|||.+... .++.++||||||+++|||++| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 99853 236789999998876 455799999999999999999 77775432
Q ss_pred CChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 212 SKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
........ ...................+...+..+.+++.+||+.||++|||+.||++.|
T Consensus 238 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 238 PNDPSFED---MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp CSSCCHHH---HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred CCCcchhh---hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 11111100 0000000000000111123346778999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=289.30 Aligned_cols=233 Identities=21% Similarity=0.250 Sum_probs=182.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHH----HHHHHhcC------CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR----ALMATVNS------PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~----~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
.++|...+.+|.|+| |.||++.. .++|.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~--g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGF--GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETT--EEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCC--eEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 467888899999999 99999821 11111111 1123457799999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---cccCCCCCCceEEcC--------CCcEEE
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP---ILHCDIKPQNILMDE--------FWTAKI 159 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~---i~h~dl~~~nil~~~--------~~~~kl 159 (274)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+. + ++|+||||+||+++. ++.++|
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999953 5799999999999999999999999 7 999999999999985 678999
Q ss_pred eccccceec---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh
Q 048314 160 SDFGLAKLL---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR 230 (274)
Q Consensus 160 ~d~g~~~~~---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
+|||.+... +++.|+|||.+....++.++||||||+++|+|++|..||.... ... ... .. .
T Consensus 158 ~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~-~~~---~~-~-- 227 (271)
T 3dtc_A 158 TDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID---GLA-VAY---GV-A-- 227 (271)
T ss_dssp CCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC---HHH-HHH---HH-H--
T ss_pred ccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHH-HHH---hh-h--
Confidence 999998643 3678999999988889999999999999999999999996431 110 000 00 0
Q ss_pred hhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 231 ELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
... .....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 228 -~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 228 -MNK--LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp -TSC--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -cCC--CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 000 01124556678899999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=322.33 Aligned_cols=235 Identities=19% Similarity=0.231 Sum_probs=189.8
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH-----HHHHHhcC-CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNS-PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
..++|.....||.|+| |.||+|.. .++|.+.. ....+.|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus 265 ~~~~~~~~~~lG~G~f--g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CGGGEEEEEEEEECSS--EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred chhhhhhheecccCCC--eEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456777888999999 99999821 22232222 2344678999999999999999999999876 67899999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+.+|+|.+++.......+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999754345699999999999999999999999 99999999999999999999999999987543
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+..|+|||.+....++.++||||||+++|||++ |..||.... .. .+. .....+ . ...
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~---~~-~~~----~~i~~~-----~-~~~ 484 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NR-EVL----DQVERG-----Y-RMP 484 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC---HH-HHH----HHHHTT-----C-CCC
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HH-HHH----HHHHcC-----C-CCC
Confidence 346999999998899999999999999999999 899996431 11 111 111111 0 112
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+..++..+.++|.+||+.||++|||+.+|++.|
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L 518 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 4456678899999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=300.56 Aligned_cols=241 Identities=18% Similarity=0.246 Sum_probs=183.5
Q ss_pred hhHHHHhhhccccccCCCCCCCCcchhHHHH---------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEE
Q 048314 15 SSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSV 81 (274)
Q Consensus 15 ~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~ 81 (274)
.++....++|...+.+|.|+| |.||+|.. .++|.... ....+.+.+|+.++++++||||++++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEF--GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp CTTBCC---CEEEEEEEEETT--EEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hhcccChhHeEEeceecccCC--eEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 344445678888999999999 99999821 12222221 1223557899999999999999999999
Q ss_pred EEeCCcc------eEEEEeCCCCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE
Q 048314 82 AMRGSKP------STEAALDLPWDLAYIIFCSA----ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 151 (274)
Q Consensus 82 ~~~~~~~------~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~ 151 (274)
+.+.... ++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli 170 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCML 170 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEE
Confidence 9876654 99999999999999997532 12599999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhH
Q 048314 152 DEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEI 217 (274)
Q Consensus 152 ~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~ 217 (274)
+.++.+||+|||++.... ++.|+|||.+....++.++||||||+++|+|++ |..||.......
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--- 247 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--- 247 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---
Confidence 999999999999986532 346999999998889999999999999999999 899986432111
Q ss_pred HHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 218 ILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. ....... ....+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 248 -~~----~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 293 (323)
T 3qup_A 248 -IY----NYLIGGN------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293 (323)
T ss_dssp -HH----HHHHTTC------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -HH----HHHhcCC------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00 0000000 1124455667899999999999999999999988754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=293.46 Aligned_cols=235 Identities=22% Similarity=0.190 Sum_probs=185.9
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCC-CC----CCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP-YS----PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~-~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.+|.|+| |.||++. ..++|..... .. .+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 11 ~~y~i~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 11 ERYKIVDKLGGGGM--STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp TTEEEEEEEEEETT--EEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred ccEEEEEEEccCCC--EEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 56788899999999 9999882 1122222111 11 2456799999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
||||+++++|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999986 35799999999999999999999999 9999999999999999999999999998642
Q ss_pred ----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 169 ----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 169 ----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+++.|+|||.+....++.++||||||+++|+|++|..||.... ..... ...... ......
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~---~~~~~----~~~~~~-~~~~~~-- 233 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET---AVSIA----IKHIQD-SVPNVT-- 233 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC---HHHHH----HHHHSS-CCCCHH--
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---hHHHH----HHHhhc-cCCCcc--
Confidence 3678999999998889999999999999999999999996431 11000 000000 000000
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCC-ChhhHHhh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRP-SMKCVVMM 273 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~evl~~ 273 (274)
...+...+..+.+++.+||+.||++|| ++.++.+.
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~ 269 (294)
T 4eqm_A 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269 (294)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHH
T ss_pred hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHH
Confidence 012334567899999999999999999 77777654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=290.89 Aligned_cols=229 Identities=15% Similarity=0.173 Sum_probs=187.5
Q ss_pred HhhhccccccCCCCCCCCcchhHHHHH------HHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEe---------
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMRA------LMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--------- 84 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~~------~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 84 (274)
..++|...+.+|.|+| |.||++... ++|... ...+.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGF--GQVFKAKHRIDGKTYVIKRVK--YNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSS--CCEEEEEETTTCCEEEEEEEE--CCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCc--eEEEEEEEcCCCeEEEEEEec--cccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3567888999999999 999998321 122222 234678899999999999999999998854
Q ss_pred -------CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcE
Q 048314 85 -------GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 157 (274)
Q Consensus 85 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~ 157 (274)
....++||||+++|+|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 34579999999999999999875556799999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH
Q 048314 158 KISDFGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF 227 (274)
Q Consensus 158 kl~d~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (274)
+|+|||++.... ++.|+|||.+....++.++||||||+++|+|++|..|+... . .. ....
T Consensus 162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~---~~-~~~~ 231 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------S---KF-FTDL 231 (284)
T ss_dssp EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------H---HH-HHHH
T ss_pred EECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------H---HH-HHHh
Confidence 999999986543 56799999999888999999999999999999999887421 0 00 0001
Q ss_pred hhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 228 INRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. ...+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 232 ~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l 269 (284)
T 2a19_B 232 RD---------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269 (284)
T ss_dssp HT---------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hc---------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11 112333456789999999999999999999998864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=296.11 Aligned_cols=237 Identities=18% Similarity=0.190 Sum_probs=187.5
Q ss_pred HHhhhccccccCCCCCCCCcchhHHH----HHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeC-CcceEEEE
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCM----RALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG-SKPSTEAA 93 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~----~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 93 (274)
...++|.....+|.|++ |.||++. ..++|........+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 18 ~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEF--GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CCGGGEEEEEEEEECSS--CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CChhhceEEeEEecCCC--ceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 34578888999999999 9999882 12233334434566788999999999999999999997654 57899999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccccc
Confidence 99999999999864333489999999999999999999999 99999999999999999999999999986543
Q ss_pred ----CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHH
Q 048314 170 ----DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKK 244 (274)
Q Consensus 170 ----~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (274)
+..|+|||.+....++.++|+||||+++|+|++ |..||....... .. ...... . ....+..
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~-----~~~~~~-----~-~~~~~~~ 238 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV-----PRVEKG-----Y-KMDAPDG 238 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH-----HHHTTT-----C-CCCCCTT
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-----HHHhcC-----C-CCCCccc
Confidence 467999999988889999999999999999998 999996431110 00 000010 0 1124455
Q ss_pred HHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 245 NLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 245 ~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+..+.+++.+||+.||++|||+.|+++.|
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHHHHH
Confidence 678899999999999999999999998864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=306.22 Aligned_cols=236 Identities=17% Similarity=0.157 Sum_probs=187.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.++|.....||.|+| |.||+|.. .++|..... .....+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 50 ~~~y~i~~~LG~G~~--g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAF--GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCC--EEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 457888899999999 99999821 122222221 12235679999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc--CCCcEEEeccccceec--
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD--EFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~--~~~~~kl~d~g~~~~~-- 168 (274)
||+.+|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++ .++.+||+|||++...
T Consensus 128 E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 128 EFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp ECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999975 345699999999999999999999999 999999999999997 4577999999998754
Q ss_pred --------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 169 --------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 169 --------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+++.|+|||++....++.++|||||||++|+|++|..||.... ....+.. .... ....+..
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~-----i~~~---~~~~~~~ 272 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQN-----VKRC---DWEFDED 272 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHH-----HHHC---CCCCCSS
T ss_pred CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHH-----HHhC---CCCCCcc
Confidence 3677999999998889999999999999999999999996431 1111100 0000 0001111
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 223456789999999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=299.77 Aligned_cols=232 Identities=20% Similarity=0.218 Sum_probs=184.0
Q ss_pred hccccccCCCCCCCCcchhHHHH----------HHHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR----------ALMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
+|...+.||.|+| |.||+|.. .++|...... ....+.+|+.++++++||||+++++++.+.+..+
T Consensus 45 ~~~~~~~lG~G~~--g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 45 CVTRQKVIGAGEF--GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TEEEEEEEEECSS--SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HhhcccEEecCCC--eEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3344688999999 99999821 2223222211 1234679999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 123 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999999986 446799999999999999999999999 99999999999999999999999999987543
Q ss_pred --------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 170 --------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 170 --------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
+..|+|||.+....++.++||||||+++|+|++ |..||.... . ..+. ....++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~-~~~~----~~~~~~---- 266 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---N-HEVM----KAINDG---- 266 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---H-HHHH----HHHHTT----
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC---H-HHHH----HHHHCC----
Confidence 346999999988889999999999999999998 999996431 1 1111 111111
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ....+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 267 -~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 304 (333)
T 1mqb_A 267 -F-RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304 (333)
T ss_dssp -C-CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred -C-cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0 1123445677899999999999999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=299.52 Aligned_cols=234 Identities=18% Similarity=0.129 Sum_probs=187.7
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHH-------HHHH----HHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEe
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCM-------RALM----ATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMR 84 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~----~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 84 (274)
.....++|...+.+|+|+| |.||++. +++| .........+.+..|..++..+ +||||+++++++.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~f--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSF--GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp ----CTTEEEEEEEEECSS--SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCChHHeEEEEEEeeCCC--eEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 3445688999999999999 9999882 1111 1111123445567899999876 89999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
.+..++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChh
Confidence 9999999999999999999986 35699999999999999999999999 999999999999999999999999999
Q ss_pred ceec-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 165 AKLL-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 165 ~~~~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
++.. +++.|+|||++.+..++.++|+|||||++|||++|..||.... .. .+.. ....
T Consensus 165 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~-~~~~----~i~~---- 232 (345)
T 1xjd_A 165 CKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EE-ELFH----SIRM---- 232 (345)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH-HHHH----HHHH----
T ss_pred hhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HH-HHHH----HHHh----
Confidence 8642 2677999999998889999999999999999999999996431 11 1111 1111
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChh-hHHh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK-CVVM 272 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-evl~ 272 (274)
.....+...+..+.+++.+||+.||++||++. ++++
T Consensus 233 ---~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 233 ---DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11124445667899999999999999999997 7654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=307.96 Aligned_cols=230 Identities=16% Similarity=0.158 Sum_probs=181.2
Q ss_pred hhhccccccCCCCCCCCcchhHHH-------HHHH----HHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-------RALM----ATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.||.|+| |.||++. +++| ...........+.+|+.++++++||||+++++++.+.+..+
T Consensus 147 ~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTF--GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp GGGEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred hHHcEEeEEEeeCcC--EEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 467888999999999 9999871 1111 12223345567889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 225 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999999986 4579999999999999999999998 8 9999999999999999999999999998642
Q ss_pred -----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 -----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 -----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
+++.|+|||++....++.++|||||||++|||++|..||.... .. .+... ... .
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~-~~~~~----i~~-------~ 364 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HE-KLFEL----ILM-------E 364 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH-HHHHH----HHH-------C
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HH-HHHHH----HHh-------C
Confidence 2678999999998899999999999999999999999996431 11 11110 000 1
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
....+...+..+.+++.+||+.||.+|| |+.|+++
T Consensus 365 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1124445667899999999999999999 9999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=304.75 Aligned_cols=229 Identities=17% Similarity=0.135 Sum_probs=178.1
Q ss_pred cccCCCCCCCCcchhHHH------HHHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCCC
Q 048314 27 SSLNDRNSPRSKSVWSCM------RALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPW 98 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~------~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 98 (274)
...||.|+| |.||+|. ..++|.+... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 94 ~~~lG~G~~--g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRF--GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-------CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcC--EEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 567999999 9999982 1222222222 23456789999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE--cCCCcEEEeccccceec--------
Q 048314 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM--DEFWTAKISDFGLAKLL-------- 168 (274)
Q Consensus 99 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~--~~~~~~kl~d~g~~~~~-------- 168 (274)
+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||++ +.++.+||+|||++...
T Consensus 172 ~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 172 ELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp EEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred cHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 99999976 345699999999999999999999999 99999999999999 56789999999998754
Q ss_pred --CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHH
Q 048314 169 --SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNL 246 (274)
Q Consensus 169 --~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (274)
+++.|+|||++....++.++|||||||++|+|++|..||.... ....+... .... .-.+.......+
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i-----~~~~---~~~~~~~~~~~~ 316 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNI-----LACR---WDLEDEEFQDIS 316 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHH-----HHTC---CCSCSGGGTTSC
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH-----Hhcc---CCCChhhhccCC
Confidence 3677999999988889999999999999999999999996431 11111111 0000 000011122346
Q ss_pred HHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 247 ENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 247 ~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+.+++.+||+.||++|||+.|+++
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 78999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=320.35 Aligned_cols=225 Identities=18% Similarity=0.193 Sum_probs=184.2
Q ss_pred cCCCCCCCCcchhHHHH--------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeCCC
Q 048314 29 LNDRNSPRSKSVWSCMR--------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLP 97 (274)
Q Consensus 29 ~~g~g~~~~g~vy~~~~--------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 97 (274)
.||.|+| |.||+|.. +++|..... ...+.+.+|+++|++++|||||+++++|.+ +..++|||||++
T Consensus 343 ~LG~G~f--G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNF--GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSS--SEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCC--cEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 5899999 99998821 223333322 234567899999999999999999999876 568999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--------
Q 048314 98 WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-------- 169 (274)
Q Consensus 98 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-------- 169 (274)
|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 420 g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 420 GPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp CBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred CcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 999999976 456699999999999999999999999 99999999999999999999999999987542
Q ss_pred ------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 ------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 ------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|+|||++....++.++||||||+++|||++ |..||..... .. +. ..+..+ .....+
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~~---~~----~~i~~~------~~~~~p 561 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PE---VM----AFIEQG------KRMECP 561 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-HH---HH----HHHHTT------CCCCCC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-HH---HH----HHHHcC------CCCCCC
Confidence 256999999998899999999999999999998 9999975421 11 11 111111 011355
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..++..+.++|..||+.||++|||+.+|++.|
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L 593 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 56778999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=297.50 Aligned_cols=228 Identities=21% Similarity=0.217 Sum_probs=178.7
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-CC---CCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-YS---PSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-~~---~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.+|.|+| |.||+|.. .++|..... .. ...+..|+..+.++ +||||++++++|.+.+..++
T Consensus 57 ~~y~~~~~LG~G~~--g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSY--GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETT--EEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeheeccCCC--eEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 78888999999999 99999821 122222221 11 12344566666555 89999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
||||+ +++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEECC-CCBHHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEecc-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 99999 6799999987 345799999999999999999999999 99999999999999999999999999986543
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
++.|+|||++.+ .++.++||||||+++|||++|..|+... .. +....... .+..
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~-------~~~~~~~~-----~~~~ 272 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EG-------WQQLRQGY-----LPPE 272 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HH-------HHHHTTTC-----CCHH
T ss_pred CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cH-------HHHHhccC-----CCcc
Confidence 668999998875 7899999999999999999997776422 00 00011110 0111
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.+...+..+.+++.+||+.||++|||++|+++.
T Consensus 273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 222345789999999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=295.04 Aligned_cols=238 Identities=20% Similarity=0.217 Sum_probs=181.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH---HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR---ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~---~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
.++|.....+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~--g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSF--GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSS--EEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCC--eEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 456777899999999 99999821 112222211 1124577999999999999999999965 4566899999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL----- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~----- 168 (274)
|+.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 100 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 9999999999975 456799999999999999999999999 9999999999999999999999999998632
Q ss_pred --------CCCCcCCCcccc---cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 --------SDKGCMAPECYK---RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 --------~~~~~~ape~~~---~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
+++.|+|||.+. ...++.++||||||+++|+|++|..||....... .+. .......... +
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~----~~~~~~~~~~--~ 246 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QII----EMVGRGSLSP--D 246 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH---HHH----HHHHHTSCCC--C
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH---HHH----HHhcccccCc--c
Confidence 267899999886 5568889999999999999999999997542111 111 1111111111 0
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.......++..+.+++.+||+.||++|||+.++++.|
T Consensus 247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 1123445678899999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=291.34 Aligned_cols=231 Identities=19% Similarity=0.158 Sum_probs=179.5
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----------------------------CCCCcHHHHHHH
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----------------------------YSPSRPLTLTSI 66 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----------------------------~~~~~~~~e~~~ 66 (274)
.++|...+.||.|+| |.||++.. .++|..... ...+.+.+|+.+
T Consensus 12 ~~~y~~~~~lG~G~~--g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSY--GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp ETTEEEEEEEEC--C--CEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred ecceEEEeEEeecCC--EEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 467888999999999 99999811 112211111 124668899999
Q ss_pred HhcCCCCccceEeEEEEe--CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCC
Q 048314 67 VSRVSWTTDIEVSSVAMR--GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDI 144 (274)
Q Consensus 67 l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl 144 (274)
+++++||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.|++.||.|||+. +++||||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 999999999999999986 567899999999999988653 35799999999999999999999999 9999999
Q ss_pred CCCceEEcCCCcEEEeccccceec-----------CCCCcCCCcccccCC---CccccceeehhHhHHHHhhcCCCcccc
Q 048314 145 KPQNILMDEFWTAKISDFGLAKLL-----------SDKGCMAPECYKRTP---ISVKADVYGYGIVLLETICCWENMEID 210 (274)
Q Consensus 145 ~~~nil~~~~~~~kl~d~g~~~~~-----------~~~~~~ape~~~~~~---~~~~~Di~s~G~~l~el~~g~~p~~~~ 210 (274)
||+||+++.++.+||+|||++... +++.|+|||.+.... ++.++||||||+++|+|++|..||...
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999998653 256799999987654 367899999999999999999999643
Q ss_pred CCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 211 ASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
. . ..+. ....... . ..+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~---~-~~~~----~~~~~~~----~-~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 R---I-MCLH----SKIKSQA----L-EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp S---H-HHHH----HHHHHCC----C-CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c---H-HHHH----HHHhccc----C-CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 1 1110 1111110 0 00112245578999999999999999999999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=296.98 Aligned_cols=234 Identities=19% Similarity=0.181 Sum_probs=188.4
Q ss_pred hhccccccCCCCCCCCcchhHHHH--------HHHHHhc---CCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcce
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR--------ALMATVN---SPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~--------~~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 89 (274)
++|...+.+|.|+| |.||++.. .++|... .....+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNF--GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGG--CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCC--ceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 67777899999999 99999821 1222222 224456788999999999 8999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC
Q 048314 90 TEAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~ 155 (274)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence 9999999999999998632 24699999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHH
Q 048314 156 TAKISDFGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVY 224 (274)
Q Consensus 156 ~~kl~d~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 224 (274)
.+||+|||++.... +..|+|||.+....++.++||||||+++|+|++ |..||.... .. .+.
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~-~~~---- 251 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CA-ELY---- 251 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HH-HHH----
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc---HH-HHH----
Confidence 99999999986432 457999999988888999999999999999998 999996431 10 000
Q ss_pred HHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 225 KCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.... ... ....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 252 ~~~~-----~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 252 EKLP-----QGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp HHGG-----GTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhh-----cCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1111 101 1123445667899999999999999999999998764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=287.96 Aligned_cols=232 Identities=20% Similarity=0.220 Sum_probs=175.2
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH------HHHHH-----hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMAT-----VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
...++|...+.+|.|+| |.||++.. .++|. .......+.+.+|+.++++++||||+++++++.+.+.
T Consensus 8 ~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSF--AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp SSGGGEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccccceeeeeecCCCc--eEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 34578888999999999 99999821 11111 1111233567899999999999999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+..
T Consensus 86 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 9999999999999999986 346799999999999999999999999 999999999999999999999999999875
Q ss_pred cC-----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 168 LS-----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 168 ~~-----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
.. ++.|+|||.+....++.++|+||||+++|+|++|..||........ .....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~ 225 (278)
T 3cok_A 162 LKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------LNKVV 225 (278)
T ss_dssp CC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CC
T ss_pred ccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------HHHHh
Confidence 43 5679999999888889999999999999999999999975422110 00111
Q ss_pred -cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 -RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 -~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.....+...+..+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111234455678999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=298.04 Aligned_cols=237 Identities=17% Similarity=0.197 Sum_probs=191.0
Q ss_pred HhhhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCCC---CCCcHHHHHHHHhcC-CCCccceEeEEEEe
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSPY---SPSRPLTLTSIVSRV-SWTTDIEVSSVAMR 84 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 84 (274)
..++|...+.+|.|+| |.||++. ..++|...... ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAF--GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSS--EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCC--cceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 3467888899999999 9999883 12233322221 235577999999999 89999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAE----------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQN 148 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~n 148 (274)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 9999999999999999999987432 2489999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCCh
Q 048314 149 ILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKP 214 (274)
Q Consensus 149 il~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~ 214 (274)
|+++.++.+||+|||++.... +..|+|||.+....++.++||||||+++|+|++ |..||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 999999999999999987543 245999999988889999999999999999998 999996542221
Q ss_pred hhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 215 EEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ... .... ... ...+...+..+.+++.+||+.||.+|||+.|+++.|
T Consensus 256 ~---~~~----~~~~-----~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 256 K---FYK----MIKE-----GFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp H---HHH----HHHH-----TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H---HHH----Hhcc-----CCC-CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 1 111 0111 011 123345567899999999999999999999999865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=290.68 Aligned_cols=241 Identities=18% Similarity=0.167 Sum_probs=185.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH-----HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
++|.....+|.|+| |.||++.. .++|.+... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~G~~--g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTY--GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETT--EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCC--EEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 45777889999999 99999832 112222111 23456779999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec----
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL---- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~---- 168 (274)
||+++ +|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 80 e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp ECCSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EecCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 99985 99999986 346799999999999999999999999 9999999999999999999999999988542
Q ss_pred -------CCCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh---hhhh---
Q 048314 169 -------SDKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR---ELNK--- 234 (274)
Q Consensus 169 -------~~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--- 234 (274)
+++.|+|||.+... .++.++||||||+++|+|++|..||.... ....+.. ........ ....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~-~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMR-IFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHH-HHHHHCCCCTTTSTTGGG
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH-HHHHHCCCChhhchhhhc
Confidence 26779999998754 58999999999999999999999996431 1111111 11110000 0000
Q ss_pred --hhcCC----------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 235 --LVRGT----------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 235 --~~~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..++. ......+..+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 1122346788999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=288.51 Aligned_cols=232 Identities=16% Similarity=0.133 Sum_probs=189.3
Q ss_pred HhhhccccccCCCCCCCCcchhHHH-------HHHH----HHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM-------RALM----ATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
+.++|...+.+|.|++ |.||++. +++| .........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 7 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKF--GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ecccEEEeeEEecCCC--eEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 4578888999999999 9999981 1111 1111112345578999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999999986 35699999999999999999999999 9999999999999999999999999987543
Q ss_pred ---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+++.|+|||.+....++.++||||||+++|+|++|..||.... ..... .... . ...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~-----~~~~-----~--~~~ 224 (279)
T 3fdn_A 160 PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETY-----KRIS-----R--VEF 224 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH-----HHHH-----H--TCC
T ss_pred CcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHH-----HHHH-----h--CCC
Confidence 3678999999988888999999999999999999999996431 11100 0000 0 011
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 2444566789999999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=313.49 Aligned_cols=237 Identities=21% Similarity=0.208 Sum_probs=193.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHH-------HHH----HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM-------RAL----MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~----~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
..++|...+.||+|+| |.||++. +++ +.........+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 182 ~~~~f~~~~~LG~G~f--G~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGF--GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CGGGEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEeeCCC--EEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 3467888999999999 9999881 111 11122223445578999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||||+++|+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999999875555699999999999999999999999 9999999999999999999999999998754
Q ss_pred C----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 169 S----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 169 ~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
. ++.|+|||++....++.++|+|||||++|||++|..||...........+.... .. .+
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i----~~-------~~ 405 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----KE-------VP 405 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH----HH-------CC
T ss_pred ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh----hc-------cc
Confidence 2 677999999998889999999999999999999999997543222111111111 00 11
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
...+...+..+.+++.+||+.||++|| |++||++
T Consensus 406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 134455678899999999999999999 7888875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=297.43 Aligned_cols=238 Identities=16% Similarity=0.162 Sum_probs=186.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 88 (274)
.++|...+.||+|+| |.||++.. .++|.+... ...+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus 8 ~~~y~~~~~lG~G~f--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSY--AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp GGGEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhheEEEEEEEecCC--eEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 467888999999999 99998821 112222211 1123466899999987 799999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 86 ~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999999986 35799999999999999999999999 9999999999999999999999999998642
Q ss_pred -----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhH-HHHHHHHHHHhhhhhhhhh
Q 048314 169 -----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEI-ILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 169 -----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (274)
+++.|+|||++....++.++|+|||||++|||++|..||.......... .............
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~------ 234 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------ 234 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC------
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC------
Confidence 3678999999998899999999999999999999999996432221110 0011111111111
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCCh------hhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSM------KCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~------~evl~ 272 (274)
....|...+..+.+++.+||+.||++||++ .|+++
T Consensus 235 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 235 -QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 113455567789999999999999999996 56654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=296.47 Aligned_cols=231 Identities=19% Similarity=0.161 Sum_probs=187.6
Q ss_pred HhhhccccccCCCCCCCCcchhHHH-------HHHH----HHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM-------RALM----ATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~----~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 87 (274)
..++|...+.||+|+| |.||++. +++| .........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 18 ~~~~y~~~~~lG~G~f--g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSF--GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETT--EEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred chHHcEEEEEEeeCCC--EEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 4578999999999999 9999881 1111 1111223445677999999988 79999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999999986 35699999999999999999999999 999999999999999999999999999864
Q ss_pred c-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 168 L-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 168 ~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
. +++.|+|||++....++.++|+|||||++|||++|..||.... .. .+.. .+..
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~-~~~~----~i~~------- 235 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---ED-ELFQ----SIME------- 235 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HH-HHHH----HHHH-------
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HH-HHHH----HHHh-------
Confidence 2 2677999999998899999999999999999999999996431 11 1111 0111
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCC-----hhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPS-----MKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~evl~ 272 (274)
.....|...+..+.+++.+||+.||++||+ +.++++
T Consensus 236 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 236 HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111345566788999999999999999996 467654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=292.98 Aligned_cols=233 Identities=16% Similarity=0.176 Sum_probs=186.3
Q ss_pred Hhhhccccc-cCCCCCCCCcchhHHHH--------HHHHHhcCCC----CCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 20 KLRNFCRSS-LNDRNSPRSKSVWSCMR--------ALMATVNSPY----SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 20 ~~~~f~~~~-~~g~g~~~~g~vy~~~~--------~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
..++|.... .+|.|+| |.||+|.. .++|...... ..+.+.+|+.++++++||||+++++++ +.+
T Consensus 14 ~~~~y~~~~~~lg~G~~--g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNF--GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSS--EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred cchhhhhccCccccccC--eeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 345666666 8999999 99999811 1222222211 134577999999999999999999998 667
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 78999999999999999986 45699999999999999999999999 99999999999999999999999999987
Q ss_pred ecC--------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhh
Q 048314 167 LLS--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRE 231 (274)
Q Consensus 167 ~~~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (274)
... +..|+|||.+....++.++||||||+++|+|++ |..||.... . ..+. ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~-~~~~----~~~~~~- 236 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---G-SEVT----AMLEKG- 236 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---H-HHHH----HHHHTT-
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC---H-HHHH----HHHHcC-
Confidence 543 245999999988888999999999999999999 999996431 1 1111 111111
Q ss_pred hhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 232 LNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 237 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 274 (291)
T 1xbb_A 237 -----ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 274 (291)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11124456678899999999999999999999998864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=292.33 Aligned_cols=235 Identities=17% Similarity=0.252 Sum_probs=188.0
Q ss_pred HhhhccccccCCCCCCCCcchhHHH-----HHHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM-----RALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~-----~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
..++|.....+|.|+| |.||+|. ..++|... .....+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 11 ~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQF--GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETT--EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred CHHhhhheeeecCCCC--eEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 3567888899999999 9999982 11222222 2234566789999999999999999999986 456899999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999999753333699999999999999999999999 99999999999999999999999999987543
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+..|+|||.+....++.++||||||+++|+|++ |..||.... .. .+.. ..... . ...
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~-~~~~----~~~~~-----~-~~~ 230 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NP-EVIQ----NLERG-----Y-RMV 230 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HH-HHHH----HHHTT-----C-CCC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC---HH-HHHH----HHhcc-----c-CCC
Confidence 346999999988888999999999999999999 899986431 11 1110 00110 0 112
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 3445667899999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=306.22 Aligned_cols=230 Identities=17% Similarity=0.167 Sum_probs=187.2
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHH-----HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMA-----TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|.....+|.|+| |.||+|.. .++| ........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 15 ~~~Y~l~~~LG~G~f--g~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 15 IGHYILGDTLGVGTF--GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp ETTEEEEEEEECCSS--SCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEeeCCC--eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 367778899999999 99998811 1111 1112223456789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
+||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 93 lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 93 MVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999999975 45799999999999999999999999 9999999999999999999999999998754
Q ss_pred ---------CCCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 169 ---------SDKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+++.|+|||.+.+..+ +.++||||+|+++|+|++|..||....... +. ....++.
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----~~----~~i~~~~------- 232 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT----LF----KKICDGI------- 232 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----HH----HHHHTTC-------
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----HH----HHHhcCC-------
Confidence 2678999999987765 689999999999999999999997442110 10 1111110
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0233445678999999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=292.56 Aligned_cols=241 Identities=20% Similarity=0.219 Sum_probs=172.7
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|.....+|.|+| |.||+|. ..++|.+... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTY--ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp -----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCC--EEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 457888899999999 9999982 1222322221 2345678999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 92 AALDLPWDLAYIIFCSA----ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
|||++ |+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99998 69999997532 24589999999999999999999999 999999999999999999999999999875
Q ss_pred cC-----------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh-----
Q 048314 168 LS-----------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR----- 230 (274)
Q Consensus 168 ~~-----------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 230 (274)
.. ++.|+|||.+.. ..++.++|||||||++|+|++|..||.... ....+ ..+.......
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~-~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN---DEEQL-KLIFDIMGTPNESLW 233 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH-HHHHHHHCSCCTTTC
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHH-HHHHHHhCCCChhHh
Confidence 32 567999999876 468999999999999999999999996431 11111 1111110000
Q ss_pred -hh---hh---------------hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 231 -EL---NK---------------LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 231 -~~---~~---------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. .. .+.+ ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQP-HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGG-GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcc-cccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 00 0000 011134568999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=293.13 Aligned_cols=241 Identities=12% Similarity=0.087 Sum_probs=179.0
Q ss_pred hhccccccCCCCCCCCcchhHHHHH---------HHHHhcCC-------------CCCCcHHHHHHHHhcCCCCccceEe
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMRA---------LMATVNSP-------------YSPSRPLTLTSIVSRVSWTTDIEVS 79 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~~---------~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~ 79 (274)
++|...+.+|+|+| |.||+|... ++|..... ...+.+.+|+..++.++||||++++
T Consensus 37 ~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 37 NQWVLGKKIGSGGF--GLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp CEEEEEEEC--------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred ceEEEEeeEeecCC--eEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 57888899999999 999988221 11111111 0223356788889999999999999
Q ss_pred EEEEe----CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC
Q 048314 80 SVAMR----GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155 (274)
Q Consensus 80 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~ 155 (274)
+++.+ ....++||||+ +++|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 99987 77899999999 9999999976 23799999999999999999999999 999999999999998877
Q ss_pred --cEEEeccccceec------------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChh
Q 048314 156 --TAKISDFGLAKLL------------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPE 215 (274)
Q Consensus 156 --~~kl~d~g~~~~~------------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~ 215 (274)
.+||+|||+++.. ++..|+|||.+....++.++||||||+++|||++|..||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999643 36789999999988899999999999999999999999964322221
Q ss_pred hHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 216 EIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
... . ....... .....+.....+...+..+.+++.+||+.||++|||+.+|++.|
T Consensus 269 ~~~--~-~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 323 (345)
T 2v62_A 269 AVQ--T-AKTNLLD-ELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL 323 (345)
T ss_dssp HHH--H-HHHHHHH-TTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHH--H-HHHhhcc-cccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 111 1 0010000 11111100001114456899999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=291.10 Aligned_cols=241 Identities=15% Similarity=0.148 Sum_probs=183.3
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCC----CCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYS----PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
++|...+.+|.|+| |.||++.. .++|....... .+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 2 ~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTY--GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSS--SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCC--eEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 46777889999999 99999921 22232222211 24567999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|||+.+ ++.+++.. ..+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 80 ~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred EecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 999975 66666655 356799999999999999999999999 99999999999999999999999999997543
Q ss_pred ---------CCCcCCCcccccCC-CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh---h---hh
Q 048314 170 ---------DKGCMAPECYKRTP-ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR---E---LN 233 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~-~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~~ 233 (274)
++.|+|||.+.+.. ++.++||||||+++|+|++|..|+....... .....+....... . ..
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHCCCCTTTCTTGG
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCChhhhhhhc
Confidence 56699999987765 7999999999999999999988875432211 1111111111000 0 00
Q ss_pred hhhcC------------CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 KLVRG------------TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 ~~~~~------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+. .......+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 0122345678899999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=305.17 Aligned_cols=231 Identities=22% Similarity=0.267 Sum_probs=178.5
Q ss_pred ccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEe-CCcceE
Q 048314 24 FCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR-GSKPST 90 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l 90 (274)
|.....||+|+| |.||+|.. .++|..... ...+++.+|+.++++++||||++++++|.+ .+..++
T Consensus 91 ~~~~~~LG~G~f--g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 91 VHFNEVIGRGHF--GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEECCSS--SEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eecCcEeeeCCC--eEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 444678999999 99998831 122222221 123457899999999999999999999865 567899
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999976 445689999999999999999999999 99999999999999999999999999986432
Q ss_pred --------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 170 --------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 170 --------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
+..|+|||.+....++.++||||||+++|||++ |.+||......... . ....+
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~----~----~~~~~---- 312 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT----V----YLLQG---- 312 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH----H----HHHTT----
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH----H----HHHcC----
Confidence 346999999998899999999999999999999 56676543211110 0 00111
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+..++..+.+++.+||+.||++|||+.|+++.|
T Consensus 313 --~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 350 (373)
T 3c1x_A 313 --RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350 (373)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 01123445667899999999999999999999998864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=288.40 Aligned_cols=244 Identities=17% Similarity=0.144 Sum_probs=183.9
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-------CCCCcHHHHHHHHhcCC---CCccceEeEEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-------YSPSRPLTLTSIVSRVS---WTTDIEVSSVAM 83 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 83 (274)
..++|.....+|.|+| |.||++.. .++|.+... .....+.+|+.++++++ ||||+++++++.
T Consensus 7 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAY--GTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp ---CCEEEEEECCSSS--CCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccceEEEEEEecCCC--eEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 3568888999999999 99999831 122222211 11235668888887765 999999999998
Q ss_pred eCC-----cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEE
Q 048314 84 RGS-----KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158 (274)
Q Consensus 84 ~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~k 158 (274)
+.. ..++||||+. |+|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 755 4799999997 6999999875555699999999999999999999999 999999999999999999999
Q ss_pred EeccccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh
Q 048314 159 ISDFGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI 228 (274)
Q Consensus 159 l~d~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (274)
|+|||++.... ++.|+|||.+....++.++|||||||++|+|++|..||.... ....+.. ......
T Consensus 161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~-i~~~~~ 236 (308)
T 3g33_A 161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS---EADQLGK-IFDLIG 236 (308)
T ss_dssp ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS---HHHHHHH-HHHHHC
T ss_pred EeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH-HHHHhC
Confidence 99999986432 678999999998899999999999999999999999996431 1111111 111100
Q ss_pred hhhhhh----------hhcCC------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 229 NRELNK----------LVRGT------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 229 ~~~~~~----------~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
...... ...+. ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000 00000 0112345788999999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=304.95 Aligned_cols=243 Identities=14% Similarity=0.035 Sum_probs=190.4
Q ss_pred hhhhHHHHhhhccccccCCCCCCCCcchhHHHH-------HHH----HHhcCCCCCCcHHHHHHHHhcCCCCccceEeEE
Q 048314 13 ARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR-------ALM----ATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSV 81 (274)
Q Consensus 13 ~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-------~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 81 (274)
...+.....++|...+.||+|+| |.||++.. ++| .........+.+.+|+.++.+++||||++++++
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~f--G~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAF--SEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCC--eEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 44555666789999999999999 99998811 111 111112345678899999999999999999999
Q ss_pred EEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEec
Q 048314 82 AMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISD 161 (274)
Q Consensus 82 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 161 (274)
+.+.+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSK-FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHH-HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999999986 234799999999999999999999999 999999999999999999999999
Q ss_pred cccceec------------CCCCcCCCcccc-------cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH
Q 048314 162 FGLAKLL------------SDKGCMAPECYK-------RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW 222 (274)
Q Consensus 162 ~g~~~~~------------~~~~~~ape~~~-------~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~ 222 (274)
||+++.. +++.|+|||++. ...++.++|+|||||++|||++|+.||.... .......
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~- 281 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS---TAETYGK- 281 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHH-
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC---HHHHHHH-
Confidence 9998643 367899999987 3568899999999999999999999996431 1111111
Q ss_pred HHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCC---CChhhHHh
Q 048314 223 VYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALR---PSMKCVVM 272 (274)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R---ps~~evl~ 272 (274)
. .... ........+...+.++.++|.+||. +|++| |+++|+++
T Consensus 282 ---i-~~~~--~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 282 ---I-VHYK--EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ---H-HTHH--HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ---H-Hhcc--cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0 0000 0000001223456789999999999 99998 68999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=298.79 Aligned_cols=250 Identities=18% Similarity=0.200 Sum_probs=191.4
Q ss_pred cccccchhhhhhhHHHHhhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC---CCCCcHHHHHHHHhc
Q 048314 4 QTSSTSAWIARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP---YSPSRPLTLTSIVSR 69 (274)
Q Consensus 4 ~~~~~~~~~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~---~~~~~~~~e~~~l~~ 69 (274)
+++.++..-...++ ..++|...+.+|.|+| |.||+|.. .++|..... ....++.+|+.++++
T Consensus 14 ~~~~sss~~~~~~~--~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~ 89 (327)
T 2yfx_A 14 FAGKTSSISDLKEV--PRKNITLIRGLGHGAF--GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89 (327)
T ss_dssp ETTEEECGGGSCBC--CGGGCEEEEECC--CS--SCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHH
T ss_pred ccCCccchhhcccC--ChhheEEEEEEcCCCC--eeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhh
Confidence 33444444334333 3468888999999999 99999842 122222211 122356789999999
Q ss_pred CCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCC
Q 048314 70 VSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAE-----RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDI 144 (274)
Q Consensus 70 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl 144 (274)
++||||+++++++.+.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++|+||
T Consensus 90 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dl 166 (327)
T 2yfx_A 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDI 166 (327)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred CCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcC
Confidence 9999999999999999999999999999999999987432 3489999999999999999999999 9999999
Q ss_pred CCCceEEc---CCCcEEEeccccceec-------------CCCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCc
Q 048314 145 KPQNILMD---EFWTAKISDFGLAKLL-------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENM 207 (274)
Q Consensus 145 ~~~nil~~---~~~~~kl~d~g~~~~~-------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~ 207 (274)
||+||+++ .+..++|+|||++... ++..|+|||.+....++.++||||||+++|+|++ |..||
T Consensus 167 kp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 246 (327)
T 2yfx_A 167 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246 (327)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99999998 4456999999987532 2457999999988889999999999999999998 88998
Q ss_pred cccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 208 EIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.... .. .... ...... ....+...+..+.+++.+||+.||.+|||+.++++.|
T Consensus 247 ~~~~---~~-~~~~----~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 299 (327)
T 2yfx_A 247 PSKS---NQ-EVLE----FVTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299 (327)
T ss_dssp TTCC---HH-HHHH----HHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcC---HH-HHHH----HHhcCC------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 6431 11 1111 011110 1123445667899999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=296.53 Aligned_cols=234 Identities=15% Similarity=0.111 Sum_probs=168.3
Q ss_pred cccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceEEEEeCCCCC
Q 048314 27 SSLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPSTEAALDLPWD 99 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 99 (274)
.+.||.|+| |.||++.. .++|.+.. .....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~--g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSF--SICRKCVHKKSNQAFAVKIISK-RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETT--EEEEEEEETTTCCEEEEEEEEG-GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCC--eEEEEEEECCCCCEEEEEEECh-hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 578999999 99999822 11222211 12345678999999998 9999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC---cEEEeccccceecC-------
Q 048314 100 LAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKISDFGLAKLLS------- 169 (274)
Q Consensus 100 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~---~~kl~d~g~~~~~~------- 169 (274)
|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++ .+||+|||++....
T Consensus 93 L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 167 (325)
T 3kn6_A 93 LFERIKK--KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167 (325)
T ss_dssp HHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccc
Confidence 9999986 46799999999999999999999999 999999999999997655 89999999987532
Q ss_pred ----CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHH
Q 048314 170 ----DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKN 245 (274)
Q Consensus 170 ----~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (274)
++.|+|||.+....++.++||||||+++|+|++|..||................ .....+. ...+.+.....
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~i~~~~---~~~~~~~~~~~ 243 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGD---FSFEGEAWKNV 243 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH-HHHTTTC---CCCCSHHHHTS
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH-HHHHcCC---CCCCcccccCC
Confidence 567999999998899999999999999999999999997542111000000000 1111100 00000111234
Q ss_pred HHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 246 LENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 246 ~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+.++.+++.+||+.||++|||+.|+++
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 678999999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=296.89 Aligned_cols=236 Identities=18% Similarity=0.198 Sum_probs=186.4
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 92 (274)
-.++|.....+|.|+| |.||++.. .++|.+.. ......+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~~avK~~~~--~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSY--SVCKRCIHKATNMEFAVKIIDK--SKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEEET--TTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCC--EEEEEEEECCCCCEEEEEEEEc--ccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567888899999999 99999822 12222222 334567899999888 6999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC----CcEEEeccccceec
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF----WTAKISDFGLAKLL 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~----~~~kl~d~g~~~~~ 168 (274)
|||.+|+|.+++.. .+.+++..+..++.|++.||.|||+. +++||||||+||++... +.+||+|||++...
T Consensus 96 E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999985 45799999999999999999999999 99999999999998433 35999999998753
Q ss_pred C-----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 S-----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 ~-----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
. ++.|+|||.+....++.++|+||||+++|+|++|..||...........+ .....+. ...
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~-----~~i~~~~---~~~ 242 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL-----ARIGSGK---FSL 242 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH-----HHHHHCC---CCC
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH-----HHHccCC---ccc
Confidence 2 56799999998878899999999999999999999999753222111111 1111111 111
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11223455678999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=296.56 Aligned_cols=245 Identities=20% Similarity=0.252 Sum_probs=195.6
Q ss_pred hhhhhhHHHHhhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCCC---CCCcHHHHHHHHhcCCCCccc
Q 048314 11 WIARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSPY---SPSRPLTLTSIVSRVSWTTDI 76 (274)
Q Consensus 11 ~~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv 76 (274)
.+...+.....++|...+.+|.|+| |.||+|.. .++|...... ....+.+|+.++++++||||+
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 91 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSF--GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSS--SEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred ccChhhhcchhhheeeeeEeccCCc--eEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3455666777889999999999999 99998721 1222222211 123477999999999999999
Q ss_pred eEeEEEEeCCcceEEEEeCCCCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 048314 77 EVSSVAMRGSKPSTEAALDLPWDLAYIIFCSA--------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQN 148 (274)
Q Consensus 77 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~n 148 (274)
++++++.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~N 168 (322)
T 1p4o_A 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARN 168 (322)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGG
T ss_pred eeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccce
Confidence 99999999999999999999999999997531 14579999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCCh
Q 048314 149 ILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKP 214 (274)
Q Consensus 149 il~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~ 214 (274)
|+++.++.+||+|||++.... ++.|+|||.+....++.++||||||+++|+|++ |..||....
T Consensus 169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--- 245 (322)
T 1p4o_A 169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--- 245 (322)
T ss_dssp EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---
T ss_pred EEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC---
Confidence 999999999999999986432 456999999988889999999999999999999 888886431
Q ss_pred hhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 215 EEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. ... ........ ...+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 246 ~~-~~~----~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 246 NE-QVL----RFVMEGGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp HH-HHH----HHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH-HHH----HHHHcCCc------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11 111 11111100 123445667899999999999999999999998864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=286.13 Aligned_cols=229 Identities=15% Similarity=0.117 Sum_probs=185.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-------HHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-------ALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-------~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.++|...+.+|.|+| |.||++.. ++++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSW--GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCC--EEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 567888999999999 99998821 1221111 1234566789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE---cCCCcEEEeccccceec-
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~d~g~~~~~- 168 (274)
||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||++ +.++.++|+|||.+...
T Consensus 86 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 86 ELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred eccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999986 45699999999999999999999999 99999999999999 78899999999998653
Q ss_pred ---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+++.|+|||.+.+ .++.++||||||+++|+|++|..||.... ...... ..... ..
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~-----~~~~~-------~~ 224 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVML-----KIREG-------TF 224 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH-----HHHHC-------CC
T ss_pred CccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHH-----HHHhC-------CC
Confidence 2667999998865 48999999999999999999999996431 111110 00110 00
Q ss_pred ccCH----HHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDK----KNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~----~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1222 24578999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=287.14 Aligned_cols=241 Identities=14% Similarity=0.055 Sum_probs=185.6
Q ss_pred HhhhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEE-EeCCcceEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVA-MRGSKPSTEA 92 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 92 (274)
..++|...+.+|.|+| |.||+|. ..++|........+.+.+|+.++++++|+|++..++++ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSF--GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSS--SEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCC--eEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 3467888999999999 9999983 12233334445667799999999999998887777766 5677789999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE---cCCCcEEEeccccceec-
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~d~g~~~~~- 168 (274)
||+ +++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||++ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 8999999985 345699999999999999999999999 99999999999999 78899999999998643
Q ss_pred -----------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhh
Q 048314 169 -----------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRE 231 (274)
Q Consensus 169 -----------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (274)
+++.|+|||.+....++.++||||||+++|+|++|+.||................... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-MSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-HHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-ccch
Confidence 2567999999998899999999999999999999999997543222111111111000 0000
Q ss_pred hhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 232 LNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
... .....+..+.+++.+||+.||++|||+.+|++.|
T Consensus 239 ~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 275 (296)
T 4hgt_A 239 IEV------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHH------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred hhh------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence 000 1122357899999999999999999999998864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=320.32 Aligned_cols=225 Identities=17% Similarity=0.197 Sum_probs=182.3
Q ss_pred ccCCCCCCCCcchhHHHH--------HHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR--------ALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~--------~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.||.|+| |.||+|.. .++|.+.. ....+++.+|+++|++++|||||+++++|.+ +..++|||||
T Consensus 375 ~~LG~G~f--G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNF--GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSS--EEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCC--EEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 36999999 99998821 12222221 1223568899999999999999999999864 5588999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
.+|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 452 ~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 452 ELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp TTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999999976 45799999999999999999999999 99999999999999999999999999986532
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+..|+|||++....++.++||||||+++|||++ |..||..... . .+. .....+ ....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~-~~~----~~i~~~------~~~~ 592 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---S-EVT----AMLEKG------ERMG 592 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---H-HHH----HHHHTT------CCCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---H-HHH----HHHHcC------CCCC
Confidence 345999999998899999999999999999998 9999964311 1 111 111111 1113
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+..++.++.++|..||+.||++|||+++|+++|
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L 626 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 626 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 4556778999999999999999999999998865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=291.30 Aligned_cols=234 Identities=15% Similarity=0.149 Sum_probs=187.3
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
..++|...+.+|+|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++.+ +.
T Consensus 10 ~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFF--GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSS--SEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred cccceEEEEEEEecCC--eeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 4578888999999999 99999831 222222221 123557789999999999999999999765 45
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+..
T Consensus 87 ~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp CEEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CEEEEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 7999999999999999986 345699999999999999999999999 999999999999999999999999999865
Q ss_pred cC------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 168 LS------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 168 ~~------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
.. +..|+|||.+....++.++||||||+++|+|++ |+.||....... ... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~~~----~~~~~---- 230 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIG----VLEKG---- 230 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----HHH----HHHHT----
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH----HHH----HHhcC----
Confidence 33 346999999988889999999999999999998 999996431111 000 00111
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+...++.+.+++.+||+.||++|||+.|+++.|
T Consensus 231 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 268 (281)
T 3cc6_A 231 --DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268 (281)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 11123444567899999999999999999999998864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=294.16 Aligned_cols=237 Identities=22% Similarity=0.249 Sum_probs=185.3
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEe-
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR- 84 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~- 84 (274)
......|.....+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHF--GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp CGGGEEEEEEEEEEEETT--EEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred CccceehhhcceeeecCC--ceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 334456777889999999 99998831 112222211 122457799999999999999999999754
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
++..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred CCceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccc
Confidence 5678999999999999999976 456689999999999999999999999 999999999999999999999999999
Q ss_pred ceecC---------------CCCcCCCcccccCCCccccceeehhHhHHHHhhc-CCCccccCCChhhHHHHHHHHHHHh
Q 048314 165 AKLLS---------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICC-WENMEIDASKPEEIILTNWVYKCFI 228 (274)
Q Consensus 165 ~~~~~---------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (274)
+.... ++.|+|||.+....++.++|+||||+++|+|++| .+||......... . . ..
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~----~---~-~~ 246 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT----V---Y-LL 246 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH----H---H-HH
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH----H---H-Hh
Confidence 86432 3469999999888899999999999999999995 4555432111110 0 0 00
Q ss_pred hhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 229 NRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. .....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 247 ~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 286 (298)
T 3f66_A 247 QG------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286 (298)
T ss_dssp TT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cC------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00 01123444567899999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=292.58 Aligned_cols=230 Identities=15% Similarity=0.108 Sum_probs=181.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHH---------HHHHHhcC------CCCCCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNS------PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
.++|.....||+|+| |.||++.. .++|.... ......+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 16 PECFELLRVLGKGGY--GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp GGGEEEEEEEEEETT--EEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred HHHeEEEEEEEeCCC--EEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 468888999999999 99997622 11222221 12345577899999999999999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
+..++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999999986 35689999999999999999999999 9999999999999999999999999988
Q ss_pred eec-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 166 KLL-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 166 ~~~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
+.. +++.|+|||.+....++.++|+||||+++|+|++|..||.... ... ... . ....
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~-~~~---~-i~~~---- 236 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKK-TID---K-ILKC---- 236 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHH-HHH---H-HHHT----
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHH-HHH---H-HHhC----
Confidence 642 3678999999988889999999999999999999999996431 111 100 0 0110
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
....+...+..+.+++.+||+.||++|| ++.|+++
T Consensus 237 ---~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 ---KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1124445667899999999999999999 7778875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=295.72 Aligned_cols=232 Identities=18% Similarity=0.161 Sum_probs=184.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.+.|...+.+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 53 ~~~y~~~~~lG~G~~--g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSF--GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhheeeeeEEccCCC--EEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 456888899999999 99998821 122222211 11235779999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
+||||+. |+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 131 lv~e~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EEEECCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEEecCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9999997 689888865 346799999999999999999999999 9999999999999999999999999998654
Q ss_pred ------CCCCcCCCcccc---cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 169 ------SDKGCMAPECYK---RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 169 ------~~~~~~ape~~~---~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+++.|+|||.+. ...++.++||||||+++|||++|..||.... ....+ ...... ..+.
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~---~~~~~----~~~~~~------~~~~ 272 (348)
T 1u5q_A 206 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSAL----YHIAQN------ESPA 272 (348)
T ss_dssp SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHH----HHHHHS------CCCC
T ss_pred CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHH----HHHHhc------CCCC
Confidence 367899999884 4578899999999999999999999996431 11101 111110 1111
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+...+..+.+++.+||+.||++|||+.++++
T Consensus 273 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 223445678999999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=294.82 Aligned_cols=245 Identities=16% Similarity=0.115 Sum_probs=191.9
Q ss_pred hhhhhhhHHHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhc-CCCCCCcHHHHHHHHhcC-CCCccceEeEE
Q 048314 10 AWIARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN-SPYSPSRPLTLTSIVSRV-SWTTDIEVSSV 81 (274)
Q Consensus 10 ~~~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 81 (274)
.-+...++....++|...+.+|.|+| |.||+|.. .++|... .....+.+.+|+.+++++ +||||++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTY--GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCC--EEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 34667777888899999999999999 99999822 2223222 224456778999999999 79999999999
Q ss_pred EEe------CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC
Q 048314 82 AMR------GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155 (274)
Q Consensus 82 ~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~ 155 (274)
+.. .+..++||||+++|+|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCC
Confidence 976 46789999999999999999875556799999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceec-----------CCCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHH
Q 048314 156 TAKISDFGLAKLL-----------SDKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219 (274)
Q Consensus 156 ~~kl~d~g~~~~~-----------~~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~ 219 (274)
.++|+|||++... +++.|+|||.+. ...++.++||||||+++|+|++|..||.... ....+
T Consensus 167 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~ 243 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH---PMRAL 243 (326)
T ss_dssp CEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC---HHHHH
T ss_pred CEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHH
Confidence 9999999988643 256799999986 4568899999999999999999999996431 11100
Q ss_pred HHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 220 TNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
. .. ... ..+...+...+..+.+++.+||+.||++|||+.++++
T Consensus 244 ~----~~-~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 F----LI-PRN-----PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp H----HH-HHS-----CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H----Hh-hcC-----ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 00 000 0111123344678999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=294.10 Aligned_cols=242 Identities=15% Similarity=0.202 Sum_probs=186.7
Q ss_pred hhccccccCCCCCCCCcchhHHH----------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeC--C
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM----------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--S 86 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~----------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 86 (274)
+.|...+.+|.|+| |.||++. ..++|..... ...+.+.+|+.++++++||||+++++++.+. .
T Consensus 21 ~~~~~~~~lg~G~~--g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHF--GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSS--EEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCc--eEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 45777889999999 9999874 1122222211 2235578999999999999999999999876 6
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 68999999999999999965 345699999999999999999999999 99999999999999999999999999987
Q ss_pred ecC--------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH---HHhh
Q 048314 167 LLS--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK---CFIN 229 (274)
Q Consensus 167 ~~~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 229 (274)
... +..|+|||.+....++.++||||||+++|+|++|..|+.... .. ....... ....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~-~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM----AL-FLKMIGPTHGQMTV 249 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH----HH-HHHHHCSCCGGGHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh----hH-HhhccCCcccccCH
Confidence 543 334999999988889999999999999999999999874320 00 0000000 0000
Q ss_pred hhhhhhh-c--CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 230 RELNKLV-R--GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 230 ~~~~~~~-~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
......+ . ....+...+..+.+++.+||+.||.+|||+.++++.|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 0011111 1 1134556678899999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=302.06 Aligned_cols=240 Identities=18% Similarity=0.192 Sum_probs=191.0
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEE
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSV 81 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~ 81 (274)
..-..++|...+.+|.|+| |.||++.. .++|..... ...+.+.+|+.+++++ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~--g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAF--GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSS--EEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCC--cceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3344567888899999999 99999831 222222222 1234577999999999 89999999999
Q ss_pred EEeCCcceEEEEeCCCCCHHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCce
Q 048314 82 AMRGSKPSTEAALDLPWDLAYIIFCSA------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 149 (274)
Q Consensus 82 ~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 149 (274)
+.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 195 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV 195 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGC
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceE
Confidence 999999999999999999999997531 34689999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChh
Q 048314 150 LMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPE 215 (274)
Q Consensus 150 l~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~ 215 (274)
+++.++.++|+|||++.... +..|+|||.+....++.++||||||+++|+|++ |..||........
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 99999999999999987432 346999999988889999999999999999998 8899865422211
Q ss_pred hHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 216 EIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+.. ..... . ....+...+..+.+++.+||+.||.+|||+.||++.|
T Consensus 276 ---~~~----~~~~~-----~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 276 ---FYK----LVKDG-----Y-QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp ---HHH----HHHHT-----C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---HHH----HHhcC-----C-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 111 11110 0 1123344567899999999999999999999998864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=297.81 Aligned_cols=235 Identities=17% Similarity=0.176 Sum_probs=188.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-------------HHHHHhcCCC---CCCcHHHHHHHHhcC-CCCccceEeEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-------------ALMATVNSPY---SPSRPLTLTSIVSRV-SWTTDIEVSSVAM 83 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-------------~~~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 83 (274)
.++|...+.+|.|+| |.||++.. .++|...... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~--g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAF--GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSS--CEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCc--eeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 467888899999999 99998832 1122222211 123467999999999 8999999999999
Q ss_pred eCCcceEEEEeCCCCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCce
Q 048314 84 RGSKPSTEAALDLPWDLAYIIFCSAE--------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 149 (274)
Q Consensus 84 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 149 (274)
+.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 99999999999999999999986431 2489999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChh
Q 048314 150 LMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPE 215 (274)
Q Consensus 150 l~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~ 215 (274)
+++.++.+||+|||++.... ++.|+|||.+....++.++||||||+++|+|++ |..||.... .
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~ 265 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---V 265 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---H
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---H
Confidence 99999999999999987543 345999999988889999999999999999999 999996431 1
Q ss_pred hHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 216 EIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. .+.. ...... ....+...+..+.+++.+||+.||.+|||+.|+++.|
T Consensus 266 ~-~~~~----~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 266 E-ELFK----LLKEGH------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp H-HHHH----HHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H-HHHH----HHhcCC------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1 1111 111110 1124445667899999999999999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=288.70 Aligned_cols=235 Identities=18% Similarity=0.138 Sum_probs=185.8
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
..++|.....+|.|+| |.||+|.. .++|........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSY--GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC------CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCC--eEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3457888899999999 99999821 223334444456778899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
|+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 105 ~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999999974 346799999999999999999999999 99999999999999999999999999986432
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
++.|+|||.+....++.++||||||+++|+|++|..||.... ..... .. ...... .....+
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~----~~-~~~~~~----~~~~~~ 248 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH---PMRAI----FM-IPTNPP----PTFRKP 248 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC---HHHHH----HH-HHHSCC----CCCSSG
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---hHHHH----HH-HhcCCC----cccCCc
Confidence 556999999998889999999999999999999999996431 11000 00 000000 000123
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+..+.+++.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 345678999999999999999999999976
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=301.34 Aligned_cols=236 Identities=14% Similarity=0.096 Sum_probs=180.7
Q ss_pred hhcccc-ccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHh-cCCCCccceEeEEEEe----CCcce
Q 048314 22 RNFCRS-SLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVS-RVSWTTDIEVSSVAMR----GSKPS 89 (274)
Q Consensus 22 ~~f~~~-~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~~ 89 (274)
++|... .+||.|+| |.||++.. .++|.+. ....+.+|+.++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~--g~V~~~~~~~~~~~vAiK~~~---~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGIN--GKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEE---CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccC--eEEEEEEECCCCCEEEEEEeC---cchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 445443 68999999 99999822 1222222 2345678999875 4579999999999865 56789
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC---CCcEEEeccccce
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKISDFGLAK 166 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~d~g~~~ 166 (274)
+|||||++|+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999875455799999999999999999999999 9999999999999987 7899999999987
Q ss_pred ecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 167 LLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 167 ~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
... ++.|+|||++....++.++|||||||++|+|++|..||............. .....+ ...
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~----~~i~~~---~~~ 285 (400)
T 1nxk_A 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----TRIRMG---QYE 285 (400)
T ss_dssp ECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH----HHHHHT---CCC
T ss_pred ccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH----HHHHcC---ccc
Confidence 543 667999999998899999999999999999999999997542211100000 001111 000
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+.......+.++.+++.+||+.||++|||+.|+++
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111112345678999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=291.41 Aligned_cols=233 Identities=19% Similarity=0.253 Sum_probs=184.1
Q ss_pred hccccccCCCCCCCCcchhHHH---------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc-e
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM---------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP-S 89 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~---------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~ 89 (274)
.|...+.+|.|+| |.||+|. ..++|..... ...+.+.+|+.++++++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHF--GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETT--EEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCC--ceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 4445688999999 9999883 1222222221 1234577999999999999999999999776554 9
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+||||+.+|+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 100 ~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999999986 456789999999999999999999999 99999999999999999999999999986432
Q ss_pred ---------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 170 ---------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 170 ---------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
+..|+|||.+....++.++||||||+++|+|++|..|+......... .. .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~---~~----~~~~~---- 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL---TH----FLAQG---- 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH---HH----HHHTT----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH---HH----HhhcC----
Confidence 35699999999889999999999999999999976665433221111 00 00000
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+...+..+.+++.+||+.||.+|||+.++++.|
T Consensus 245 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l 282 (298)
T 3pls_A 245 --RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282 (298)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 01123445567899999999999999999999998864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=291.84 Aligned_cols=239 Identities=18% Similarity=0.233 Sum_probs=183.7
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHH---------HHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEE
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCM---------RALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAM 83 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~---------~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 83 (274)
+....++|...+.+|.|+| |.||+|. ..++|..... ...+.+.+|+.++++++||||+++++++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEF--GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CC--CCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred cccCHHHeeeccceeecCC--eEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3344567777889999999 9999872 1222222211 11245779999999999999999999997
Q ss_pred eCC-----cceEEEEeCCCCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC
Q 048314 84 RGS-----KPSTEAALDLPWDLAYIIFCS----AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 154 (274)
Q Consensus 84 ~~~-----~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 154 (274)
+.+ ..++||||+++|+|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 754 359999999999999999542 335699999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHH
Q 048314 155 WTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILT 220 (274)
Q Consensus 155 ~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~ 220 (274)
+.+||+|||++.... ++.|+|||.+....++.++||||||+++|+|++ |..||....... ..
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~ 259 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----MY 259 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HH
Confidence 999999999986532 346999999998889999999999999999999 888886431111 00
Q ss_pred HHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 221 NWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ...... ....+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 260 ~----~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 303 (313)
T 3brb_A 260 D----YLLHGH------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303 (313)
T ss_dssp H----HHHTTC------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred H----HHHcCC------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0 001100 1123445667899999999999999999999998864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=285.89 Aligned_cols=240 Identities=14% Similarity=0.057 Sum_probs=188.3
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEE-EeCCcceEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVA-MRGSKPSTEAA 93 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 93 (274)
.++|...+.+|.|+| |.||+|. ..++|........+.+.+|+.++++++|+|++..++++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSF--GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETT--EEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCC--eEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 467888999999999 9999983 12233344445567789999999999998877777666 56777899999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE---cCCCcEEEeccccceec--
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~d~g~~~~~-- 168 (274)
|+ +++|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+||++ +.++.+||+|||.+...
T Consensus 86 ~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 8999999985 345799999999999999999999999 99999999999999 47889999999998642
Q ss_pred ----------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 169 ----------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 169 ----------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
+++.|+|||.+....++.++||||||+++|+|++|+.||...........+....... .....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-MSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-HHSCH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc-cCCch
Confidence 2567999999998889999999999999999999999997542222111111111100 00000
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ......+..+.+++.+||+.||++|||+.+|++.|
T Consensus 240 ~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 275 (296)
T 3uzp_A 240 E------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp H------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred H------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence 0 01123457899999999999999999999998864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=290.67 Aligned_cols=233 Identities=17% Similarity=0.176 Sum_probs=186.1
Q ss_pred hhhccccc-cCCCCCCCCcchhHHHH--------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 21 LRNFCRSS-LNDRNSPRSKSVWSCMR--------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~~-~~g~g~~~~g~vy~~~~--------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
.++|.... .+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++ +.+..
T Consensus 8 ~~~~~i~~~~lg~G~~--g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNF--GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTT--EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred HHHhhhhhccccccCc--eeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 34455544 8999999 99998831 112222221 1234577999999999999999999999 55679
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999999975 445699999999999999999999999 9999999999999999999999999998754
Q ss_pred C--------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 169 S--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 169 ~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
. +..|+|||.+....++.++|+||||+++|+|++ |..||...... .+.. .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~----~i~~~--- 229 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMA----FIEQG--- 229 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHH----HHHTT---
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----HHHH----HHhcC---
Confidence 3 356999999988888999999999999999998 99999644211 1111 11111
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 230 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 230 ---KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ---CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 01134556678999999999999999999999998864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=292.23 Aligned_cols=234 Identities=15% Similarity=0.173 Sum_probs=181.9
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCC-----CCcHHHHHHHHhcCCCCccceEeEEEEeCCc--
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYS-----PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK-- 87 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 87 (274)
.++|...+.+|.|+| |.||++. ..++|.+..... .+.+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 11 SDRYELGEILGFGGM--SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp TTTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEEEccCCC--EEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 467888899999999 9999883 122232222211 1346799999999999999999999876544
Q ss_pred --ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 88 --PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 88 --~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
.++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cccEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999986 35799999999999999999999999 9999999999999999999999999998
Q ss_pred eec--------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhh
Q 048314 166 KLL--------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRE 231 (274)
Q Consensus 166 ~~~--------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (274)
... +++.|+|||.+....++.++||||||+++|+|++|..||.... ...... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~---~~~~~~----~~~~~~~ 236 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAY----QHVREDP 236 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHH----HHHHCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHH----HHhcCCC
Confidence 642 3678999999998889999999999999999999999996431 111000 1000000
Q ss_pred hhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 232 LNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. +.......+..+.+++.+||+.||++||+..+++.
T Consensus 237 ~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 237 IP----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CC----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CC----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 00 00112234678999999999999999998887764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=292.80 Aligned_cols=241 Identities=17% Similarity=0.107 Sum_probs=185.5
Q ss_pred hHHHHhhhccccccCCCCCCCCcchhHHH-------HHHHH----Hhc--CCCCCCcHHHHHHHHhcCCCCccceEeEEE
Q 048314 16 SLCTKLRNFCRSSLNDRNSPRSKSVWSCM-------RALMA----TVN--SPYSPSRPLTLTSIVSRVSWTTDIEVSSVA 82 (274)
Q Consensus 16 ~l~~~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~~----~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 82 (274)
.+....++|.....+|.|+| |.||++. +++|. ... .....+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSY--GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhhheeecceeeecCC--eEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 35566788999999999999 9999881 11111 111 223345678999999999999999999999
Q ss_pred EeCCcceEEEEeCCCCCHHHHHHhCC--------------------------------------CCCCCHHHHHHHHHHH
Q 048314 83 MRGSKPSTEAALDLPWDLAYIIFCSA--------------------------------------ERNPYWNQRVRIALDV 124 (274)
Q Consensus 83 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~~~~~i 124 (274)
.+.+..++||||+++|+|.+++.... ...+++..++.++.|+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 99999999999999999999995210 1124677888999999
Q ss_pred HHHHHHHhcCCCCCcccCCCCCCceEEcCCC--cEEEeccccceec---------------CCCCcCCCccccc--CCCc
Q 048314 125 AKGILYLHDECEPPILHCDIKPQNILMDEFW--TAKISDFGLAKLL---------------SDKGCMAPECYKR--TPIS 185 (274)
Q Consensus 125 ~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~--~~kl~d~g~~~~~---------------~~~~~~ape~~~~--~~~~ 185 (274)
+.||.|||+. +++|+||||+||+++.++ .+||+|||++... +++.|+|||.+.. ..++
T Consensus 178 ~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 178 FSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence 9999999999 999999999999998666 8999999998643 2567999999865 5788
Q ss_pred cccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCC
Q 048314 186 VKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRP 265 (274)
Q Consensus 186 ~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 265 (274)
.++||||||+++|+|++|..||.... ....... . .... ...+.+.....+..+.+++.+||+.||.+||
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~----~-~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVN---DADTISQ----V-LNKK---LCFENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH----H-HHCC---CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCC---hHHHHHH----H-Hhcc---cccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 99999999999999999999996431 1111110 0 0000 0001112223467899999999999999999
Q ss_pred ChhhHHh
Q 048314 266 SMKCVVM 272 (274)
Q Consensus 266 s~~evl~ 272 (274)
|+.|+++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=306.97 Aligned_cols=236 Identities=19% Similarity=0.205 Sum_probs=189.8
Q ss_pred hhhccccccCCCCCCCCcchhHHH-------HHH----HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-------RAL----MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-------~~~----~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...++||+|+| |.||++. +++ +.........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 184 ~~~f~~~~~LG~G~f--G~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGF--GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp GGGEEEEEEEEECSS--SEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCC--eEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 367777889999999 9999881 111 111222234456789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 90 TEAALDLPWDLAYIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999998643 34699999999999999999999999 999999999999999999999999999864
Q ss_pred c-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 168 L-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 168 ~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
. +++.|+|||++.+..++.++|+|||||++|||++|..||...........+... ...
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~----i~~------- 407 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR----VLE------- 407 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH----HHH-------
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH----Hhh-------
Confidence 3 367899999999989999999999999999999999999754222111111111 000
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCCh-----hhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSM-----KCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~evl~ 272 (274)
.....+...+..+.+++.+||+.||++||++ .++++
T Consensus 408 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 408 QAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1113455667889999999999999999975 55653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=286.81 Aligned_cols=234 Identities=15% Similarity=0.139 Sum_probs=185.7
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
.++|.....+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 5 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAF--SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhcCcCC--eEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 467888999999999 99999821 112222111 122456789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc---EEEecccccee
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT---AKISDFGLAKL 167 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~---~kl~d~g~~~~ 167 (274)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++. ++|+|||.+..
T Consensus 83 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999999886 35699999999999999999999999 9999999999999976554 99999999864
Q ss_pred cC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 168 LS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 168 ~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
.. ++.|+|||.+....++.++||||||+++|+|++|..||.... .. .... ....... -.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~-~~~~----~~~~~~~---~~ 226 (284)
T 3kk8_A 158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QH-RLYA----QIKAGAY---DY 226 (284)
T ss_dssp CCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH-HHHH----HHHHTCC---CC
T ss_pred cccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hh-HHHH----HHHhccc---cC
Confidence 33 567999999998889999999999999999999999996431 11 1111 1111110 01
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11122345678999999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=285.67 Aligned_cols=234 Identities=18% Similarity=0.170 Sum_probs=182.4
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|...+.+|.|+| |.||++. ..++|... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAF--GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCC--eEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 467888899999999 9999872 11222211 122345678999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE---cCCCcEEEeccccce
Q 048314 92 AALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAK 166 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~d~g~~~ 166 (274)
|||+++|+|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||++ +.++.++|+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999999653 235799999999999999999999999 99999999999999 456789999999986
Q ss_pred ecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 167 LLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 167 ~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
... ++.|+|||.+. ..++.++||||||+++|+|++|..||.... ... ... . .... ...
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~---~~~-~~~---~-~~~~---~~~ 243 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS---LEE-VQQ---K-ATYK---EPN 243 (285)
T ss_dssp C----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-HHH---H-HHHC---CCC
T ss_pred ecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC---HHH-HHh---h-hccC---Ccc
Confidence 432 56799999875 467899999999999999999999996431 110 000 0 0000 000
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. ......++.+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 YA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 011123567889999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=288.81 Aligned_cols=238 Identities=16% Similarity=0.140 Sum_probs=182.1
Q ss_pred hhccc-cccCCCCCCCCcchhHHH------HHHHHHhcCC--CCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEE
Q 048314 22 RNFCR-SSLNDRNSPRSKSVWSCM------RALMATVNSP--YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 22 ~~f~~-~~~~g~g~~~~g~vy~~~------~~~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 91 (274)
+.|.. .+.+|+|+| |.||++. ..++|.+... ...+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 12 ~~y~i~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAH--ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSS--EEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCce--EEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 34554 478999999 9999982 1223333222 2345578999999985 699999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc---EEEeccccceec
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT---AKISDFGLAKLL 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~---~kl~d~g~~~~~ 168 (274)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++. +||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999986 35699999999999999999999999 9999999999999987765 999999987542
Q ss_pred ------------------CCCCcCCCccccc-----CCCccccceeehhHhHHHHhhcCCCccccCCChhhHH-------
Q 048314 169 ------------------SDKGCMAPECYKR-----TPISVKADVYGYGIVLLETICCWENMEIDASKPEEII------- 218 (274)
Q Consensus 169 ------------------~~~~~~ape~~~~-----~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~------- 218 (274)
+++.|+|||.+.. ..++.++||||||+++|+|++|..||...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 3667999999875 4578899999999999999999999975422110000
Q ss_pred HHHHHHHHHhhhhhhhhhcCCccCH----HHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 219 LTNWVYKCFINRELNKLVRGTEVDK----KNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
............. ...+. ..+..+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGK-------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCC-------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccC-------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000011111110 01222 245689999999999999999999999873
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=298.04 Aligned_cols=245 Identities=18% Similarity=0.157 Sum_probs=187.4
Q ss_pred hhccccccCCCCCCCCcchhHHHH----------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEE--eCCc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR----------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAM--RGSK 87 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~----------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~ 87 (274)
++|...+.+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++. +...
T Consensus 23 ~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNF--GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETT--EEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCC--eEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 56777889999999 99998741 112222221 12244789999999999999999999987 4566
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEEeecCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 8999999999999999986 234699999999999999999999999 999999999999999999999999999975
Q ss_pred cC--------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 168 LS--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 168 ~~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
.. +..|+|||.+....++.++||||||+++|+|++|..||...... ..................
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE--FLRMMGCERDVPALSRLL 254 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHCC----CCHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch--hhhhcccccccccHHHHH
Confidence 43 33499999998888999999999999999999999998643100 000000000000000011
Q ss_pred hhhc---CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+. ....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 298 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1111 1134556778899999999999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=284.12 Aligned_cols=230 Identities=14% Similarity=0.118 Sum_probs=188.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHH-----HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMA-----TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|.....+|.|++ |.||++.. .++| ........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 13 ~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKF--GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp GGGEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhceeeheecCCCC--eEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 467888999999999 99999821 1111 1111223356789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 91 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999999986 34699999999999999999999999 99999999999999999999999999886432
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
++.|+|||.+....++.++|+||||+++|+|++|..||.... ... .. ...... ...
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~-~~----~~~~~~-------~~~ 230 (284)
T 2vgo_A 166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HTE-TH----RRIVNV-------DLK 230 (284)
T ss_dssp SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHH-HH----HHHHTT-------CCC
T ss_pred ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---HhH-HH----HHHhcc-------ccC
Confidence 567999999998889999999999999999999999996431 111 00 000000 112
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 44455678999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=286.01 Aligned_cols=231 Identities=18% Similarity=0.170 Sum_probs=179.9
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEe----CCcc
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR----GSKP 88 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 88 (274)
.|.....+|.|+| |.||+|.. .+++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 27 ~~~~~~~lg~G~~--g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 27 FLKFDIEIGRGSF--KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eEEeeeeccCCCC--eEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3455668999999 99999821 1111111 11223457799999999999999999999865 4568
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cccCCCCCCceEEc-CCCcEEEeccccc
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMD-EFWTAKISDFGLA 165 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~-~~~~~kl~d~g~~ 165 (274)
++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. + ++|+||||+||+++ .++.++|+|||++
T Consensus 105 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999999986 35699999999999999999999998 8 99999999999997 7889999999998
Q ss_pred eec---------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 166 KLL---------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 166 ~~~---------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
... +++.|+|||.+. +.++.++||||||+++|+|++|..||....... ... .... ...
T Consensus 180 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~----~~~~-----~~~ 246 (290)
T 1t4h_A 180 TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIY----RRVT-----SGV 246 (290)
T ss_dssp GGCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHH----HHHT-----TTC
T ss_pred ccccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH---HHH----HHHh-----ccC
Confidence 543 367899999876 458999999999999999999999996431111 110 0011 111
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.+...+...++.+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1112333345679999999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=297.74 Aligned_cols=227 Identities=18% Similarity=0.148 Sum_probs=176.5
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHh-----cCCCCCCcHHHHHHH-HhcCCCCccceEeEEEEeCCc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATV-----NSPYSPSRPLTLTSI-VSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~-----~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~ 87 (274)
..++|...+.||+|+| |.||++.. .++|.+ ......+.+.+|..+ ++.++||||+++++++.+.+.
T Consensus 36 ~~~~y~~~~~lG~G~f--g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSF--GKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp CGGGEEEEEEEECCTT--CEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred ChhheEEEEEEeeCCC--eEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4578898999999999 99998821 111211 112334556677776 567899999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++|+|.+++.. .+.+++...+.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 114 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 9999999999999999986 45789999999999999999999999 999999999999999999999999999864
Q ss_pred c-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 168 L-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 168 ~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
. +++.|+|||++....++.++|+|||||++|||++|..||.... ... +. ..+.+.
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~-~~----~~i~~~------ 254 (373)
T 2r5t_A 189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAE-MY----DNILNK------ 254 (373)
T ss_dssp GBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---HHH-HH----HHHHHS------
T ss_pred cccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHH-HH----HHHHhc------
Confidence 2 3678999999998899999999999999999999999996431 111 10 011111
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 268 (274)
+...+...+..+.+++.+||+.||.+||++.
T Consensus 255 -~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 255 -PLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp -CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred -ccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 1123445567899999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.08 Aligned_cols=234 Identities=20% Similarity=0.186 Sum_probs=186.4
Q ss_pred HhhhccccccCCCCCCCCcchhHHH-------HHHH---HHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM-------RALM---ATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
..++|...+.||.|+| |.||++. +++| +........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 20 ~~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSF--GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHEEEEEEEECCSS--SEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhcceEEeEEEeecCC--EEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 3567888999999999 9999982 1111 11222234566789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc---CCCcEEEeccccce
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD---EFWTAKISDFGLAK 166 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~---~~~~~kl~d~g~~~ 166 (274)
+|||||.+|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++ .++.+||+|||++.
T Consensus 98 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999999976 35799999999999999999999999 999999999999995 45679999999986
Q ss_pred ec----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 167 LL----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 167 ~~----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
.. +++.|+|||++.+ .++.++||||+||++|+|++|..||... .....+ .....+. ..
T Consensus 173 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~-----~~i~~~~---~~ 240 (486)
T 3mwu_A 173 CFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDIL-----KRVETGK---YA 240 (486)
T ss_dssp TBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH-----HHHHHTC---CC
T ss_pred ECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHH-----HHHHhCC---CC
Confidence 43 3678999999875 5899999999999999999999999643 111111 1111111 00
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+.+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111122345678999999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=291.37 Aligned_cols=235 Identities=17% Similarity=0.139 Sum_probs=187.0
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCC--------CCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPY--------SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
.++|...+.+|.|+| |.||++.. .++|...... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 11 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQF--AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp HHHEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hccEEEeeEeeecCC--EEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 567888899999999 99999821 1222222211 1234779999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC----cEEEecc
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW----TAKISDF 162 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~----~~kl~d~ 162 (274)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999999985 45799999999999999999999999 999999999999999887 7999999
Q ss_pred ccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 163 GLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 163 g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
|++.... ++.|+|||.+....++.++|+||||+++|+|++|..||.... ....+.. ......
T Consensus 164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~-----i~~~~~ 235 (321)
T 2a2a_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLAN-----ITSVSY 235 (321)
T ss_dssp TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHH-----HHTTCC
T ss_pred ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHHH-----HHhccc
Confidence 9986532 567999999998889999999999999999999999996431 1111100 000000
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
-.+.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 ---DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00001112345678999999999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=294.81 Aligned_cols=242 Identities=18% Similarity=0.192 Sum_probs=185.9
Q ss_pred hccccccCCCCCCCCcchhHHH----------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeC--Cc
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM----------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG--SK 87 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~----------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 87 (274)
.|...+.||.|+| |.||++. ..++|..... ...+.+.+|+.++++++||||+++++++.+. ..
T Consensus 32 ~~~~~~~lG~G~~--g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 32 YLKKIRDLGEGHF--GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GEEEEEEEEECSS--EEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHhhhheecCCCC--eEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 3477889999999 9996541 1222222222 1134477999999999999999999999874 56
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 8999999999999999975 3599999999999999999999999 999999999999999999999999999875
Q ss_pred cC--------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 168 LS--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 168 ~~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
.. +..|+|||.+....++.++||||||+++|+|++|..||....... .....+...........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF--LELIGIAQGQMTVLRLT 261 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHHCSCCHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh--hhhhcccccchhHHHHH
Confidence 43 334999999988889999999999999999999999996431100 00000000000001111
Q ss_pred hhhc---CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+. ....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 305 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1111 1134556678999999999999999999999998864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=306.18 Aligned_cols=235 Identities=17% Similarity=0.160 Sum_probs=182.5
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH------HHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
...+.|.....||.|+| |.||++.. .++|.+. .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 34 ~~~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAY--GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp CHHHHEEEEEEEECC-----EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred chhcCeEEeeEEecCCC--EEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34567888999999999 99998821 1222222 123455678999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC---CCcEEEeccccc
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKISDFGLA 165 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~d~g~~ 165 (274)
++|||||++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++
T Consensus 112 ~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 999999999999999876 35699999999999999999999999 9999999999999975 455999999998
Q ss_pred eec----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 166 KLL----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 166 ~~~----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
... +++.|+|||++. ..++.++||||+||++|+|++|..||... .... +. .....+..
T Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~-~~----~~i~~~~~--- 254 (494)
T 3lij_A 187 AVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ---TDQE-IL----RKVEKGKY--- 254 (494)
T ss_dssp EECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHH-HH----HHHHHTCC---
T ss_pred eECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHH-HH----HHHHhCCC---
Confidence 653 367899999876 46899999999999999999999999643 1111 11 11111110
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+.+.....+..+.+++.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0011112244678999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=286.49 Aligned_cols=234 Identities=16% Similarity=0.195 Sum_probs=187.2
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.++|.....+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAF--SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCC--ceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 467888899999999 99998721 122222221 23455789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE---cCCCcEEEeccccceecC
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~d~g~~~~~~ 169 (274)
||+++++|.+++.. .+.+++..++.++.|++.||.|||+. +++|+||||+||++ +.++.++|+|||.+....
T Consensus 86 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 86 QLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EcCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999975 35689999999999999999999999 99999999999999 778899999999986533
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
++.|+|||.+....++.++||||||+++|+|++|..||.... .. .+. .....+.. ..+..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~-~~~----~~i~~~~~---~~~~~ 229 (304)
T 2jam_A 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ES-KLF----EKIKEGYY---EFESP 229 (304)
T ss_dssp CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HH-HHH----HHHHHCCC---CCCTT
T ss_pred CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HH-HHH----HHHHcCCC---CCCcc
Confidence 678999999998889999999999999999999999996431 11 111 11111100 00112
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 FWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 33445678999999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=291.53 Aligned_cols=245 Identities=17% Similarity=0.154 Sum_probs=181.7
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
-....++|...+.+|.|+| |.||++. ..++|.+... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTY--GEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp ---CGGGEEEEEEEEECSS--SEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred cccchhhEEEEEEEEecCC--eEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 3455678999999999999 9999982 1122222211 22456779999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE-----cCCCcEEEec
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM-----DEFWTAKISD 161 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~-----~~~~~~kl~d 161 (274)
..++||||+. |+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||++ +.++.+||+|
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEEEEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECc
Confidence 9999999998 599999986 45699999999999999999999999 99999999999999 4555699999
Q ss_pred cccceecC-----------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh-
Q 048314 162 FGLAKLLS-----------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI- 228 (274)
Q Consensus 162 ~g~~~~~~-----------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 228 (274)
||++.... +..|+|||.+... .++.++|||||||++|+|++|..||... .....+.........
T Consensus 181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD---SEIDQLFKIFEVLGLP 257 (329)
T ss_dssp TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCC
T ss_pred CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC---CHHHHHHHHHHHhCCC
Confidence 99986432 6779999998774 4899999999999999999999999643 111111111110000
Q ss_pred -hhhhh------hhhc------CC----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 229 -NRELN------KLVR------GT----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 229 -~~~~~------~~~~------~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..... .... .. ..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 0000 00 011124578899999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=286.80 Aligned_cols=230 Identities=16% Similarity=0.156 Sum_probs=187.5
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.+|+|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 14 ~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGF--AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEeecCC--EEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 467888999999999 99999821 112211111 12345678999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 92 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 92 VVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEEECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999999875 35799999999999999999999999 99999999999999999999999999987542
Q ss_pred -----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 170 -----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 170 -----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
++.|+|||.+....++.++|+||||+++|+|++|..||.... ...... . ... ..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~----~-~~~-------~~ 231 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYL----R-IKK-------NE 231 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHH----H-HHT-------TC
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH----H-Hhh-------cc
Confidence 567999999988889999999999999999999999996431 110000 0 000 01
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1234455678999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=291.74 Aligned_cols=239 Identities=18% Similarity=0.171 Sum_probs=186.0
Q ss_pred hHHHHhhhccccccCCCCCCCCcchhHHHH---HHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 16 SLCTKLRNFCRSSLNDRNSPRSKSVWSCMR---ALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 16 ~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~---~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
+.....++|.....+|.|+| |.||+|.. .++|... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~--g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRF--GQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSS--SEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCc--eEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 33344577888999999999 99999821 1111111 223456788999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++ ++.++|+|||++...
T Consensus 105 ~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred EEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999976 345699999999999999999999999 999999999999998 679999999986543
Q ss_pred ----------------CCCCcCCCccccc---------CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH
Q 048314 169 ----------------SDKGCMAPECYKR---------TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV 223 (274)
Q Consensus 169 ----------------~~~~~~ape~~~~---------~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 223 (274)
++..|+|||.+.. ..++.++||||||+++|+|++|..||.... .....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~---- 252 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---AEAII---- 252 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC---HHHHH----
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHH----
Confidence 2456999998864 347889999999999999999999996431 11100
Q ss_pred HHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 224 YKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..... ...+...+...+..+.+++.+||+.||++|||+.+++++|
T Consensus 253 -~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 297 (319)
T 2y4i_B 253 -WQMGT-----GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297 (319)
T ss_dssp -HHHHT-----TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred -HHhcc-----CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 00011 1111112223456789999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=293.17 Aligned_cols=240 Identities=15% Similarity=0.145 Sum_probs=183.7
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
++|...+.+|.|+| |.||++.. .++|.+.. ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTY--ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCC--EEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 46777889999999 99999821 12222221 123345678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+. |+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 80 e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 80 EYLD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp ECCS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cccc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 9997 599999987 445699999999999999999999999 99999999999999999999999999986433
Q ss_pred --------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh---hhhh----
Q 048314 170 --------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN---RELN---- 233 (274)
Q Consensus 170 --------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~---- 233 (274)
++.|+|||.+.+ ..++.++||||||+++|+|++|..||.... .. .....+...... ....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~-~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST---VE-EQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HH-HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HH-HHHHHHHHHhCCCChHhchhhhc
Confidence 667999999876 568999999999999999999999996431 11 111111111100 0000
Q ss_pred -----hhhcCC-------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 -----KLVRGT-------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 -----~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+. ......+..+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 112234567899999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=287.13 Aligned_cols=232 Identities=17% Similarity=0.169 Sum_probs=184.8
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 88 (274)
..++|...+.+|.|+| |.||++.. .++|..... .....+.+|+..+.++ +||||+++++++.+.+..
T Consensus 9 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEF--GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred ccchhhhhhhhcCCCc--eEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 3578888999999999 99999822 122222221 1234467899999999 899999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc--------------
Q 048314 89 STEAALDLPWDLAYIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-------------- 152 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-------------- 152 (274)
++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence 99999999999999998632 25699999999999999999999999 999999999999998
Q ss_pred -----CCCcEEEeccccceecC-------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHH
Q 048314 153 -----EFWTAKISDFGLAKLLS-------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219 (274)
Q Consensus 153 -----~~~~~kl~d~g~~~~~~-------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~ 219 (274)
....++|+|||.+.... ++.|+|||.+... .++.++||||||+++++|++|.+|+... .. .
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~---~ 237 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQ---W 237 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HH---H
T ss_pred ccccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hH---H
Confidence 44478999999987654 5679999998765 5678999999999999999998876432 10 0
Q ss_pred HHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 220 TNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
........ ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 238 -----~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 -----HEIRQGRL------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----HHHHTTCC------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----HHHHcCCC------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 00111111 12344556789999999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=288.09 Aligned_cols=244 Identities=15% Similarity=0.150 Sum_probs=184.6
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCC----CCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYS----PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
++|...+.+|.|+| |.||++.. .++|....... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 3 ~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSY--GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeecCC--eEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 56778899999999 99999822 12222222211 23456899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 81 FEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999998875 45699999999999999999999999 99999999999999999999999999987543
Q ss_pred ---------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH-------HHHhhhhh
Q 048314 170 ---------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY-------KCFINREL 232 (274)
Q Consensus 170 ---------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 232 (274)
+..|+|||.+.+ ..++.++||||||+++|+|++|..||................. ........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 556999999876 5689999999999999999999999964421111110100000 00000000
Q ss_pred -hh--hhcCCc------cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 -NK--LVRGTE------VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 -~~--~~~~~~------~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. .-++.. .....+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 000000 01234567899999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=301.26 Aligned_cols=245 Identities=12% Similarity=0.109 Sum_probs=189.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC--cce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS--KPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~ 89 (274)
.++|.....+|.|+| |.||+|.. .++|.+.. ....+.+.+|++++++++||||+++++++.+.+ ..+
T Consensus 8 ~~~y~i~~~LG~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGAT--ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCC--eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 356788899999999 99999821 12222221 123455679999999999999999999998755 679
Q ss_pred EEEEeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE----cCCCcEEEecccc
Q 048314 90 TEAALDLPWDLAYIIFCSAE-RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKISDFGL 164 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~----~~~~~~kl~d~g~ 164 (274)
+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999986422 2399999999999999999999999 99999999999998 7778899999999
Q ss_pred ceec----------CCCCcCCCccccc--------CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH
Q 048314 165 AKLL----------SDKGCMAPECYKR--------TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226 (274)
Q Consensus 165 ~~~~----------~~~~~~ape~~~~--------~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (274)
++.. ++..|+|||++.. ..++.++||||||+++|||++|+.||.....+........ ..
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~---~~ 239 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY---KI 239 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH---HH
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH---HH
Confidence 9753 3678999998864 4577899999999999999999999975433322221111 11
Q ss_pred Hhhhhhh-----------------hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 227 FINRELN-----------------KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 227 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
....... ..-.....+......+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 1110000 0000113457788899999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=295.00 Aligned_cols=244 Identities=12% Similarity=0.082 Sum_probs=188.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHHH---------HHHHhc--CCCCCCcHHHHHHHHhcCCCCccce------------
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMRA---------LMATVN--SPYSPSRPLTLTSIVSRVSWTTDIE------------ 77 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~~---------~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~------------ 77 (274)
.++|...+.+|.|+| |.||++... ..+.+. .....+.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~--g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQ--GILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp SCEEEEEEEEEEETT--EEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred CCeEEEEEEecCCCC--eEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 367888899999999 999999321 011111 1123367899999999999999988
Q ss_pred ---EeEEEEe-CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC
Q 048314 78 ---VSSVAMR-GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 153 (274)
Q Consensus 78 ---l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~ 153 (274)
+++++.. .+..++||||+ +++|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence 6778776 77889999999 99999999875456799999999999999999999999 9999999999999999
Q ss_pred CC--cEEEeccccceec------------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCC
Q 048314 154 FW--TAKISDFGLAKLL------------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASK 213 (274)
Q Consensus 154 ~~--~~kl~d~g~~~~~------------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~ 213 (274)
++ .++|+|||++... +++.|+|||.+....++.++||||||+++|+|++|..||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 88 8999999998542 356899999999888999999999999999999999999754222
Q ss_pred hhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 214 PEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
... +....... .................+..+.+++.+||+.||++|||+.+|++.|
T Consensus 275 ~~~--~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 275 TED--IMKQKQKF--VDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp HHH--HHHHHHHH--HHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHH--HHHHHHhc--cCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 211 11111110 1111111111111123357899999999999999999999998864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=287.76 Aligned_cols=235 Identities=15% Similarity=0.153 Sum_probs=186.5
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEe--CCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--GSKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 88 (274)
.++|.....+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++.+ .+..
T Consensus 5 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSY--GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSS--SEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCC--cEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 567888999999999 99999822 122222211 122446799999999999999999998854 5678
Q ss_pred eEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----cccCCCCCCceEEcCCCcEEEec
Q 048314 89 STEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPP-----ILHCDIKPQNILMDEFWTAKISD 161 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~-----i~h~dl~~~nil~~~~~~~kl~d 161 (274)
++||||+++++|.+++... ....+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.++|+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 9999999999999999853 234599999999999999999999998 7 99999999999999999999999
Q ss_pred cccceec-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh
Q 048314 162 FGLAKLL-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR 230 (274)
Q Consensus 162 ~g~~~~~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
||.+... ++..|+|||.+....++.++||||||+++|+|++|..||.... ...+. .....+
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~----~~i~~~ 231 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----QKELA----GKIREG 231 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHH----HHHHHT
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC----HHHHH----HHHhhc
Confidence 9998643 3667999999988889999999999999999999999996431 11111 111111
Q ss_pred hhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 231 ELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. ...+...+..+.+++.+||+.||++|||+.||++.+
T Consensus 232 ~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 232 KF------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred cc------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 11 124445668899999999999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.33 Aligned_cols=230 Identities=18% Similarity=0.185 Sum_probs=182.2
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH-----HHHHHhcCCC----CCCcHHHHHHHHhcCCC--CccceEeEEEEeCCcc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSPY----SPSRPLTLTSIVSRVSW--TTDIEVSSVAMRGSKP 88 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~~----~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~ 88 (274)
..+.|...+.||.|+| |.||++.. .++|.+.... ..+.+.+|+.+|.+++| |||+++++++.+.+..
T Consensus 7 ~~~~y~i~~~lG~G~~--g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGS--SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSS--EEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCC--eEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 4567888999999999 99998822 1222222211 12456789999999986 9999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++||| +.+|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++ ++.+||+|||++...
T Consensus 85 ~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEEC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEEe-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99999 568899999986 45799999999999999999999999 999999999999997 578999999998643
Q ss_pred -------------CCCCcCCCccccc-----------CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH
Q 048314 169 -------------SDKGCMAPECYKR-----------TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224 (274)
Q Consensus 169 -------------~~~~~~ape~~~~-----------~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 224 (274)
+++.|+|||.+.. ..++.++||||||+++|+|++|..||..... ...
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~------ 228 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QIS------ 228 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---HHH------
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---HHH------
Confidence 3778999999864 5688999999999999999999999964311 100
Q ss_pred HHHhhhhhhhhhcC---CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 225 KCFINRELNKLVRG---TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 225 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.....+++ ...+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 229 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 01111111 12344445788999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=287.53 Aligned_cols=237 Identities=17% Similarity=0.140 Sum_probs=182.4
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
...++|...+.+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGM--GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp ---CCEEEEEEEEECSS--SEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred cEeccEEEEEEEcCCCC--eeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 34577888999999999 99999821 112221111 112457799999999999999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 109 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 9999999999999999986 35699999999999999999999999 999999999999999999999999998754
Q ss_pred c------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 168 L------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 168 ~------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
. ++..|+|||.+....++.++||||||+++|+|++|..||... ... .+. .... . ..
T Consensus 184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~-~~~----~~~~-~---~~ 251 (309)
T 2h34_A 184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD---QLS-VMG----AHIN-Q---AI 251 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC---HHH-HHH----HHHH-S---CC
T ss_pred ccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc---hHH-HHH----HHhc-c---CC
Confidence 3 256799999999888999999999999999999999999643 111 110 1000 0 00
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCC-ChhhHHhhC
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRP-SMKCVVMML 274 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~evl~~L 274 (274)
..+...+...+..+.+++.+||+.||++|| |++++++.|
T Consensus 252 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l 291 (309)
T 2h34_A 252 PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAA 291 (309)
T ss_dssp CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHH
Confidence 011123345567899999999999999999 899988754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=292.19 Aligned_cols=230 Identities=16% Similarity=0.147 Sum_probs=187.7
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.||+|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 40 ~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGF--AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEeeCCC--eEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 467888999999999 99999821 112211111 12345678999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 118 lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 118 VVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999999876 35799999999999999999999999 99999999999999999999999999987542
Q ss_pred -----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 170 -----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 170 -----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+..|+|||.+....++.++||||||+++|+|++|..||.... ..... ...... .
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~-----~~~~~~-------~ 257 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETY-----LRIKKN-------E 257 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH-----HHHHHT-------C
T ss_pred cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHH-----HHHhcC-------C
Confidence 567999999988889999999999999999999999996431 11100 000110 1
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1234455678899999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=282.21 Aligned_cols=233 Identities=16% Similarity=0.138 Sum_probs=183.5
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
.|....++|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 23 ~~~~~~~lg~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTY--GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSS--SEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCc--EEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 3444568999999 99999831 122222222 2345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-CCcEEEeccccceecC---
Q 048314 95 DLPWDLAYIIFCSA-ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~d~g~~~~~~--- 169 (274)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++. ++.++|+|||.+....
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999998742 23577999999999999999999999 9999999999999987 8999999999986532
Q ss_pred --------CCCcCCCcccccCC--CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 170 --------DKGCMAPECYKRTP--ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 170 --------~~~~~ape~~~~~~--~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
+..|+|||.+.... ++.++||||||+++|+|++|..||......... .. . .. ......
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~----~---~~---~~~~~~ 245 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--MF----K---VG---MFKVHP 245 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--HH----H---HH---HHCCCC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--HH----h---hc---cccccc
Confidence 56799999987653 788999999999999999999999643211110 00 0 00 000111
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 345566788999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=283.48 Aligned_cols=239 Identities=17% Similarity=0.201 Sum_probs=182.9
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
..++|...+.+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 30 ~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQF--SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SGGGEEEEEEEECC----CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEEEeecCCCC--ceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 3467888999999999 99998821 122222211 1234567999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 89 STEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
++||||+.+++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 9999999999999999753 345699999999999999999999999 99999999999999999999999999976
Q ss_pred ec-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 167 LL-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 167 ~~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
.. ++..|+|||.+....++.++||||||+++|+|++|..||......... +. .......
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~----~~~~~~~---- 254 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--LC----KKIEQCD---- 254 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH--HH----HHHHTTC----
T ss_pred eecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH--HH----HHhhccc----
Confidence 43 256799999999888999999999999999999999999643221110 10 0011110
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+...+...+..+.+++.+||+.||++|||+.+|++.|
T Consensus 255 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l 292 (310)
T 2wqm_A 255 -YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292 (310)
T ss_dssp -SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 11112234567899999999999999999999998764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=295.43 Aligned_cols=228 Identities=18% Similarity=0.184 Sum_probs=180.2
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----HHHHHhcCCC----CCCcHHHHHHHHhcCC--CCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSPY----SPSRPLTLTSIVSRVS--WTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~~----~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.||.|+| |.||++.. .++|.+.... ..+.+.+|+.+|++++ ||||+++++++...+..+
T Consensus 55 ~~~y~~~~~LG~G~f--g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGS--SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSS--EEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCC--eEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 345888899999999 99999822 1222222211 1245779999999997 599999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
+||| +.+++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++ ++.+||+|||++...
T Consensus 133 lv~E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEEE-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEEe-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9999 678899999986 34789999999999999999999999 999999999999995 578999999998643
Q ss_pred ------------CCCCcCCCccccc-----------CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH
Q 048314 169 ------------SDKGCMAPECYKR-----------TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225 (274)
Q Consensus 169 ------------~~~~~~ape~~~~-----------~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (274)
+++.|+|||++.. ..++.++|||||||++|+|++|..||..... ...
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~------- 275 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QIS------- 275 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHH-------
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH---HHH-------
Confidence 3677999999864 3688999999999999999999999964311 100
Q ss_pred HHhhhhhhhhhcCC---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 226 CFINRELNKLVRGT---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 226 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....++++. ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 276 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 276 -----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp -----HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 011111111 233334578899999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=295.80 Aligned_cols=245 Identities=18% Similarity=0.178 Sum_probs=187.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|...+.+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNG--GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCC--eEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 357888999999999 99999821 222222221 1124577999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEEecccccee---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL--- 167 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~--- 167 (274)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+ . +++|+||||+||+++.++.++|+|||++..
T Consensus 110 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp ECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EECCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999999986 3469999999999999999999998 5 899999999999999999999999998853
Q ss_pred ------cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHH------------------
Q 048314 168 ------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV------------------ 223 (274)
Q Consensus 168 ------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~------------------ 223 (274)
.+++.|+|||.+....++.++||||||+++|+|++|..||................
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 34788999999998889999999999999999999999997432111000000000
Q ss_pred ----HHHH----hhhhhhhhhc---CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 224 ----YKCF----INRELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 224 ----~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.... .......... +...+...+..+.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000 0000000111 11122234678999999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=292.30 Aligned_cols=243 Identities=19% Similarity=0.202 Sum_probs=186.6
Q ss_pred hhhccccccCCCCCCCCcchhHHH----------HHHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC--
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM----------RALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS-- 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~----------~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 86 (274)
.++|...+.+|.|+| |.||++. ..++|..... ...+.+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNF--GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSS--EEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCC--eEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 456777889999999 9999873 1122222221 12245779999999999999999999987644
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHH-STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEECCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 78999999999999999987 345699999999999999999999999 99999999999999999999999999987
Q ss_pred ecC--------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH----HHh
Q 048314 167 LLS--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK----CFI 228 (274)
Q Consensus 167 ~~~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~~ 228 (274)
... +..|+|||.+....++.++||||||+++|+|++|..|+... ... ....... ...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~---~~~--~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAE--FMRMIGNDKQGQMI 268 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH---HHH--HHHHHCTTCCTHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC---HHH--HHHhhccccchhhh
Confidence 543 23499999998888899999999999999999999998632 000 0000000 000
Q ss_pred hhhhhhhhc---CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 229 NRELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 229 ~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...+...+. ..+.+...+..+.+++.+||+.||++|||+.||++.|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L 317 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 000111111 1124556678899999999999999999999998864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=286.87 Aligned_cols=246 Identities=20% Similarity=0.147 Sum_probs=181.9
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcC-------CCCCCcHHHHHHHHhcCCCCccceEeEEEEe
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS-------PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR 84 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 84 (274)
....++|...+.+|.|+| |.||++.. .++|.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQF--ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp -------CEEEEEEEETT--EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred HHHhcccEEEeEEeecCC--EEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 345678888999999999 99999811 11221111 1123567899999999999999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
.+..++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred CCceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 9999999999985 89999876 445689999999999999999999999 999999999999999999999999999
Q ss_pred ceecC-----------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh--h
Q 048314 165 AKLLS-----------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN--R 230 (274)
Q Consensus 165 ~~~~~-----------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 230 (274)
+.... ++.|+|||.+... .++.++||||||+++|+|++|.+||... .....+.......... .
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~---~~~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD---SDLDQLTRIFETLGTPTEE 235 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCTT
T ss_pred ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHHcCCCChh
Confidence 86532 5679999998654 5789999999999999999999998643 1111111111110000 0
Q ss_pred hhh------hhhcCC---c-----cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 231 ELN------KLVRGT---E-----VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 231 ~~~------~~~~~~---~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
... +.+... . .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 000000 0 113345789999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=286.40 Aligned_cols=235 Identities=17% Similarity=0.136 Sum_probs=186.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcC--CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS--PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
..++|.....+|.|+| |.||++.. .++|.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAF--GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTT--CCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCC--eEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4567888899999999 99999821 11222221 13345678999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee----
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL---- 167 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~---- 167 (274)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 95 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EECCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999999876 345699999999999999999999999 999999999999999999999999998632
Q ss_pred -------cCCCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 168 -------LSDKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 168 -------~~~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
.++..|+|||.+. ...++.++||||||+++|+|++|..||.... ...... .. .....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~----~~-~~~~~--- 239 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN---PMRVLL----KI-AKSDP--- 239 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHH----HH-HHSCC---
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC---HHHHHH----HH-hccCC---
Confidence 3467899999883 5678899999999999999999999996431 111000 00 01000
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.....+...+..+.+++.+||+.||++|||+.++++
T Consensus 240 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 -PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 001234455678999999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=309.62 Aligned_cols=230 Identities=19% Similarity=0.167 Sum_probs=189.9
Q ss_pred HhhhccccccCCCCCCCCcchhHHH-------HHHH----HHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM-------RALM----ATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~----~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 87 (274)
..++|.....||+|+| |.||++. +++| .........+.+..|..++..+ +||||+++++++.+.+.
T Consensus 339 ~~~~f~~~~~LG~G~f--G~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSF--GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTT--BCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccceEEEEEEccCCC--EEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 3467888899999999 9999881 2221 1122334566678999999988 69999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 417 ~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999999986 35799999999999999999999999 999999999999999999999999999874
Q ss_pred c-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 168 L-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 168 ~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
. +++.|+|||++....++.++|+||||+++|||++|..||.... .. .+ ...+.
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~-~~------------~~~i~ 555 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---ED-EL------------FQSIM 555 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HH-HH------------HHHHH
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---HH-HH------------HHHHH
Confidence 2 3778999999999999999999999999999999999997431 11 11 11111
Q ss_pred cCC-ccCHHHHHHHHHHHHHhhccCCCCCCCh-----hhHHh
Q 048314 237 RGT-EVDKKNLENLVKVGLWCVQDEPALRPSM-----KCVVM 272 (274)
Q Consensus 237 ~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~evl~ 272 (274)
... .+|...+.++.+|+.+||+.||++||++ .||++
T Consensus 556 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 556 EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred hCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111 3555677889999999999999999998 67754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=289.64 Aligned_cols=238 Identities=13% Similarity=0.108 Sum_probs=183.6
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhc--CCCCCCcHHHHHHHHhcCCCCccceEeEEEEe----CCc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN--SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR----GSK 87 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~ 87 (274)
..++|.....+|.|+| |.||++.. .++|.+. .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 27 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGF--SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TTEEEEEEEEEEC--C--EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CCeEEEEEEEecCCCC--eEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 4567888999999999 99998821 1122111 11234557799999999999999999999873 346
Q ss_pred ceEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 88 PSTEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
.++||||+.+|+|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 89999999999999999853 345699999999999999999999999 9999999999999999999999999987
Q ss_pred eecC--------------------CCCcCCCcccccCC---CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH
Q 048314 166 KLLS--------------------DKGCMAPECYKRTP---ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW 222 (274)
Q Consensus 166 ~~~~--------------------~~~~~ape~~~~~~---~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~ 222 (274)
.... ++.|+|||.+.... ++.++||||||+++|+|++|..||.......... .
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~-- 257 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV--A-- 257 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH--H--
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh--h--
Confidence 6532 67799999987543 6889999999999999999999995320000000 0
Q ss_pred HHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 223 VYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. ..... ..+.+...+..+.+++.+||+.||.+|||+.++++.|
T Consensus 258 --~~-----~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 258 --LA-----VQNQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp --HH-----HHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HH-----hhccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 00 00000 0112334567899999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.57 Aligned_cols=248 Identities=19% Similarity=0.172 Sum_probs=182.2
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHHH----HHHHHhcCCCCCCcHHHHHHHHhcC--CCCccceEeEEEEeC----Cc
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCMR----ALMATVNSPYSPSRPLTLTSIVSRV--SWTTDIEVSSVAMRG----SK 87 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~~----~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~~ 87 (274)
....++|...+.+|.|+| |.||+|.. .++|.... .....+..|.+++... +||||+++++++.+. ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~vavK~~~~-~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRY--GEVWMGKWRGEKVAVKVFFT-TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETT--EEEEEEEETTEEEEEEEEEG-GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCC--eEEEEEEECCceEEEEEEec-cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 334578999999999999 99999822 11111111 1223345666666654 899999999999887 67
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC-----EPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-----~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ ..+++||||||+||+++.++.+||+||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 8999999999999999976 36999999999999999999999752 238999999999999999999999999
Q ss_pred ccceec---------------CCCCcCCCcccccCCCccc------cceeehhHhHHHHhhc----------CCCccccC
Q 048314 163 GLAKLL---------------SDKGCMAPECYKRTPISVK------ADVYGYGIVLLETICC----------WENMEIDA 211 (274)
Q Consensus 163 g~~~~~---------------~~~~~~ape~~~~~~~~~~------~Di~s~G~~l~el~~g----------~~p~~~~~ 211 (274)
|++... +++.|+|||.+.....+.. +||||||+++|||++| ..||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 998542 3667999999987665554 9999999999999999 55554321
Q ss_pred CChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 212 SKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
....... . ...................+..++..+.+++.+||+.||++|||+.||++.|
T Consensus 267 ~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 267 PSDPSYE--D-MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp CSSCCHH--H-HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CCCCchh--h-hHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 1111100 0 0000000000000000012337788999999999999999999999999865
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=279.43 Aligned_cols=230 Identities=16% Similarity=0.152 Sum_probs=183.5
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHH-----HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMA-----TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|.....+|.|++ |.||++.. .++| ........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 10 ~~~y~i~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTF--GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp ETTEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred eccEEEEeeecCCCC--eEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 467888899999999 99998821 1111 1112234456789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 88 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999999986 35689999999999999999999999 99999999999999999999999999986543
Q ss_pred ----------CCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 170 ----------DKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 170 ----------~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
++.|+|||.+....+ +.++|+||||+++|+|++|..||.... .. .+. ...... .
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~-~~~----~~~~~~-------~ 227 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VP-TLF----KKIRGG-------V 227 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HH-HHH----HHHHHC-------C
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HH-HHH----HHhhcC-------c
Confidence 567999999987765 689999999999999999999996431 11 110 111110 0
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1233445677899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=285.34 Aligned_cols=231 Identities=19% Similarity=0.170 Sum_probs=187.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.+.|...+.+|.|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSF--GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSS--SEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCC--eEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 356888899999999 99999821 222322222 2235577999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 99 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999999964 5799999999999999999999999 99999999999999999999999999986532
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
++.|+|||.+....++.++|+||||+++|+|++|..||.... .. .... ..... ....
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~-~~~~----~~~~~------~~~~ 238 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH---PM-KVLF----LIPKN------NPPT 238 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HH-HHHH----HHHHS------CCCC
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC---HH-HHHH----HhhcC------CCCC
Confidence 556999999998889999999999999999999999996431 11 1110 00110 1112
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 334456789999999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=294.47 Aligned_cols=241 Identities=19% Similarity=0.189 Sum_probs=175.2
Q ss_pred HhhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC----CCCCcHHHHHHHHhcCC-CCccceEeEEEEeCC--
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP----YSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGS-- 86 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-- 86 (274)
..++|...+.+|.|+| |.||++. ..++|.+... ...+++.+|+.+++++. ||||+++++++...+
T Consensus 7 ~~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAY--GIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHTTEEEEEC---------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred ccCceEEEEEeeeCCC--eEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3568888999999999 9999982 1122222111 22344668999999998 999999999997544
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++|||||. |+|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 6899999997 699999976 4699999999999999999999999 99999999999999999999999999986
Q ss_pred ec--------------------------------CCCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCC
Q 048314 167 LL--------------------------------SDKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASK 213 (274)
Q Consensus 167 ~~--------------------------------~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~ 213 (274)
.. +++.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~- 236 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST- 236 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 43 3567999999876 5789999999999999999999999964311
Q ss_pred hhhHHHHHHHHHHHhh---hhhh---------------hhh-----cCC-------------ccCHHHHHHHHHHHHHhh
Q 048314 214 PEEIILTNWVYKCFIN---RELN---------------KLV-----RGT-------------EVDKKNLENLVKVGLWCV 257 (274)
Q Consensus 214 ~~~~~~~~~~~~~~~~---~~~~---------------~~~-----~~~-------------~~~~~~~~~~~~li~~cl 257 (274)
...+.... ..... .... ... ... ..+...++.+.+|+.+||
T Consensus 237 --~~~~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 237 --MNQLERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp --HHHHHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred --HHHHHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 11111110 00000 0000 000 000 011133567899999999
Q ss_pred ccCCCCCCChhhHHhh
Q 048314 258 QDEPALRPSMKCVVMM 273 (274)
Q Consensus 258 ~~dp~~Rps~~evl~~ 273 (274)
+.||++|||++|+++.
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=304.40 Aligned_cols=233 Identities=18% Similarity=0.162 Sum_probs=186.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcC-----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS-----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.+|.|+| |.||++.. .++|.+.. ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSF--GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCceEEeeEEecCCC--EEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467888899999999 99998821 12222221 123445789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE---cCCCcEEEeccccce
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAK 166 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~d~g~~~ 166 (274)
+||||+.+|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||++ ..++.+||+|||++.
T Consensus 103 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999999975 45799999999999999999999999 99999999999999 567899999999886
Q ss_pred ec----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 167 LL----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 167 ~~----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
.. +++.|+|||.+.+ .++.++||||+||++|+|++|..||... .... +. .....+.. .
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~-~~----~~i~~~~~---~ 245 (484)
T 3nyv_A 178 HFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA---NEYD-IL----KKVEKGKY---T 245 (484)
T ss_dssp HBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHH-HH----HHHHHCCC---C
T ss_pred EcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC---CHHH-HH----HHHHcCCC---C
Confidence 43 3678999998865 6899999999999999999999999643 1111 11 11111110 0
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+.+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 011122345678999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=283.24 Aligned_cols=234 Identities=18% Similarity=0.166 Sum_probs=182.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHH---------HHHHHhcC-----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNS-----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
.++|...+.+|.|+| |.||+|.. .++|.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSF--GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp GGGEEEEEECC------CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhHeeeeeeecCCCc--eeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 467888899999999 99999831 12222211 122345779999999999999999999998765
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 95 -~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred -ceeeEecccCCCHHHHHHh-ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999999986 335699999999999999999999999 99999999999999999999999999987
Q ss_pred ecC--------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhh
Q 048314 167 LLS--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRE 231 (274)
Q Consensus 167 ~~~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (274)
... +..|+|||.+....++.++||||||+++|+|++ |..||.... .. .+.. .. ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~-~~~~---~~-~~~- 240 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GS-QILH---KI-DKE- 240 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HH-HHHH---HH-HTS-
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC---HH-HHHH---HH-Hcc-
Confidence 543 335999999988888999999999999999999 999996431 11 1100 00 000
Q ss_pred hhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 232 LNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
......+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 241 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 279 (291)
T 1u46_A 241 ----GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279 (291)
T ss_dssp ----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ----CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 011123445678899999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=291.06 Aligned_cols=242 Identities=17% Similarity=0.176 Sum_probs=190.7
Q ss_pred hhHHHHhhhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCCC---CCCcHHHHHHHHhcC-CCCccceEe
Q 048314 15 SSLCTKLRNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSPY---SPSRPLTLTSIVSRV-SWTTDIEVS 79 (274)
Q Consensus 15 ~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~ 79 (274)
.+.....++|...+.+|.|+| |.||++. ..++|...... ..+.+.+|+.++.++ +||||++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAF--GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSS--EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cceecchhheeeeeEEcCCCc--eeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 344445678888999999999 9999983 12233322221 123567999999999 699999999
Q ss_pred EEEEeCC-cceEEEEeCCCCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCC
Q 048314 80 SVAMRGS-KPSTEAALDLPWDLAYIIFCSAE--------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDI 144 (274)
Q Consensus 80 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl 144 (274)
+++.+.+ ..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++|+||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9997754 58999999999999999986432 1289999999999999999999999 9999999
Q ss_pred CCCceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCcccc
Q 048314 145 KPQNILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEID 210 (274)
Q Consensus 145 ~~~nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~ 210 (274)
||+||+++.++.+||+|||.+.... ++.|+|||.+....++.++||||||+++|+|++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999999986532 346999999988889999999999999999998 99999654
Q ss_pred CCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 211 ASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..... +. ....... ....+...+..+.+++.+||+.||.+|||+.|+++.|
T Consensus 255 ~~~~~---~~----~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 255 KIDEE---FC----RRLKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp CCSHH---HH----HHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred chhHH---HH----HHhccCc------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 22211 11 1111110 1123444567899999999999999999999998864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=305.05 Aligned_cols=235 Identities=17% Similarity=0.167 Sum_probs=182.6
Q ss_pred HHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---------------CCCCcHHHHHHHHhcCCCCccce
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---------------YSPSRPLTLTSIVSRVSWTTDIE 77 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~niv~ 77 (274)
...++|.....||.|+| |.||+|.. .++|.+... ...+.+.+|+.++++++||||++
T Consensus 33 ~i~~~Y~~~~~lG~G~~--g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAY--GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CGGGTEEEEEEEEC--C--EEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CcccceEEEeEecccCC--eEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34577888999999999 99998821 112211111 12345679999999999999999
Q ss_pred EeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC--
Q 048314 78 VSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-- 155 (274)
Q Consensus 78 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-- 155 (274)
+++++.+....++|||||++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCC
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCC
Confidence 99999999999999999999999999976 35699999999999999999999999 999999999999998765
Q ss_pred -cEEEeccccceec----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH
Q 048314 156 -TAKISDFGLAKLL----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224 (274)
Q Consensus 156 -~~kl~d~g~~~~~----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 224 (274)
.+||+|||++... +++.|+|||.+. ..++.++||||+|+++|+|++|..||.... ... +.
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~-~~---- 256 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQD-II---- 256 (504)
T ss_dssp SSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-HH----
T ss_pred ccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHH-HH----
Confidence 6999999998653 367899999886 468999999999999999999999996431 111 11
Q ss_pred HHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 225 KCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.....+... .+.......+..+.+++.+||+.||.+|||+.|+++
T Consensus 257 ~~i~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYY---FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCC---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCC---CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111111000 000011233578999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.99 Aligned_cols=245 Identities=18% Similarity=0.139 Sum_probs=185.1
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHHH----HHHHHhcCCCCCCcHHHHHHHHhc--CCCCccceEeEEEEeCC----c
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCMR----ALMATVNSPYSPSRPLTLTSIVSR--VSWTTDIEVSSVAMRGS----K 87 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~~----~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~ 87 (274)
....++|.....+|.|+| |.||++.. .++|... ....+.+.+|++++.. ++||||+++++++.+.+ .
T Consensus 38 ~~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~vavK~~~-~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRF--GEVWRGKWRGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETT--EEEEEEEETTEEEEEEEEC-GGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCC--cEEEEEEEcCccEEEEEeC-chhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 334578999999999999 99999822 1122221 1233456788888887 78999999999998765 7
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCcccCCCCCCceEEcCCCcEEE
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLH--------DECEPPILHCDIKPQNILMDEFWTAKI 159 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh--------~~~~~~i~h~dl~~~nil~~~~~~~kl 159 (274)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +. +++|+||||+||+++.++.+||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEE
T ss_pred eEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEE
Confidence 8999999999999999976 46999999999999999999999 77 9999999999999999999999
Q ss_pred eccccceec---------------CCCCcCCCcccccC------CCccccceeehhHhHHHHhhc----------CCCcc
Q 048314 160 SDFGLAKLL---------------SDKGCMAPECYKRT------PISVKADVYGYGIVLLETICC----------WENME 208 (274)
Q Consensus 160 ~d~g~~~~~---------------~~~~~~ape~~~~~------~~~~~~Di~s~G~~l~el~~g----------~~p~~ 208 (274)
+|||++... +++.|+|||.+... .++.++||||||+++|+|++| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 999998542 25679999998765 234789999999999999999 66775
Q ss_pred ccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 209 IDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
......... ..+. ...........+...-.+...+..+.+++.+||+.||++|||+.||++.|
T Consensus 269 ~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 269 DLVPSDPSV--EEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp TTSCSSCCH--HHHH-HHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccCcCcccH--HHHH-HHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 331111110 0000 11111111000000012346778999999999999999999999999865
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=294.61 Aligned_cols=235 Identities=15% Similarity=0.148 Sum_probs=179.3
Q ss_pred HhhhccccccCCCCCCCCcchhHHH------HHHHHHhc----------CCCCCCcHHHHHHHHhcCCCCccceEeEEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM------RALMATVN----------SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAM 83 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 83 (274)
..++|...+.+|.|+| |.||++. ..++|.+. .......+.+|+.+|++++||||+++++++.
T Consensus 133 ~~~~y~~~~~LG~G~~--g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGAC--GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHTTEEEEEEEEECSS--SEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhccEEEEeEEeeCCC--eEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3567888899999999 9999981 11111111 1123456889999999999999999999975
Q ss_pred eCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC---CcEEEe
Q 048314 84 RGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF---WTAKIS 160 (274)
Q Consensus 84 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~---~~~kl~ 160 (274)
.+..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.+ ..+||+
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -cCceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 4558999999999999999875 46799999999999999999999999 99999999999999654 459999
Q ss_pred ccccceecC----------CCCcCCCccccc---CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH
Q 048314 161 DFGLAKLLS----------DKGCMAPECYKR---TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF 227 (274)
Q Consensus 161 d~g~~~~~~----------~~~~~ape~~~~---~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (274)
|||+++... ++.|+|||.+.. ..++.++||||||+++|+|++|..||.......... . ..
T Consensus 285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~---~----~i 357 (419)
T 3i6u_A 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---D----QI 357 (419)
T ss_dssp CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH---H----HH
T ss_pred ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH---H----HH
Confidence 999986543 678999999853 568899999999999999999999997542221110 0 00
Q ss_pred hhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 INRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+... ...+.....+..+.+++.+||+.||++|||++|+++
T Consensus 358 ~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 TSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HTTCCC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCC---CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111000 000011124578999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=295.58 Aligned_cols=240 Identities=15% Similarity=0.088 Sum_probs=189.4
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcCCC-CccceEeEEEEeCCcceEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRVSW-TTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 93 (274)
.++|.....||.|+| |.||+|. ..++|........+.+.+|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~f--G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSF--GEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSS--CEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCC--EEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 467888999999999 9999983 1223344444566779999999999997 555666666677888999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE---cCCCcEEEeccccceec--
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~d~g~~~~~-- 168 (274)
|+ +++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 8999999985 346799999999999999999999999 99999999999999 58899999999998643
Q ss_pred ----------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 169 ----------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 169 ----------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
++..|+|||.+....++.++|||||||++|||++|..||...........+....... .....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-VATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-HHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-ccccH
Confidence 2567999999999999999999999999999999999997653332222221111111 11111
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.. .....+.++.+++..||+.||++||++.+|++.|
T Consensus 238 ~~------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L 273 (483)
T 3sv0_A 238 EA------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLF 273 (483)
T ss_dssp HH------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HH------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 11 1123357899999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=283.22 Aligned_cols=234 Identities=16% Similarity=0.160 Sum_probs=185.5
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--------CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--------YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
.++|.....+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 4 EDHYEMGEELGSGQF--AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp HHHEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhHHhhcccCc--eEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 357888899999999 99999821 112222111 12345779999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC----cEEEecc
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW----TAKISDF 162 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~----~~kl~d~ 162 (274)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred eEEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999999975 35699999999999999999999999 999999999999998776 7999999
Q ss_pred ccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 163 GLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 163 g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
|.+.... ++.|+|||.+....++.++|+||||+++|+|++|..||.... ....+.. ......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~-----~~~~~~ 228 (283)
T 3bhy_A 157 GIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLTN-----ISAVNY 228 (283)
T ss_dssp TTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHH-----HHTTCC
T ss_pred ccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHHH-----hHhccc
Confidence 9987542 567999999988889999999999999999999999996431 1111100 000000
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 ---DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ---CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000111233567899999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.73 Aligned_cols=183 Identities=17% Similarity=0.157 Sum_probs=155.1
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-CCCCcHHHHHHHHhcC------CCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-YSPSRPLTLTSIVSRV------SWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~ 88 (274)
++|...+.||.|+| |.||+|.. .++|.+... ...+.+.+|+.+++.+ +|+||+++++++...+..
T Consensus 97 ~ry~~~~~LG~G~f--g~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 97 YRYEVLKVIGKGSF--GQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTEEEEEEEEESSS--EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred CcEEEEEEcccCcc--EEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 45777899999999 99999821 122222221 1123456788888876 577999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc--EEEeccccce
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT--AKISDFGLAK 166 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~--~kl~d~g~~~ 166 (274)
++||||+. ++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 6999999986666799999999999999999999999 9999999999999998877 9999999986
Q ss_pred ecC--------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCcccc
Q 048314 167 LLS--------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEID 210 (274)
Q Consensus 167 ~~~--------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~ 210 (274)
... ++.|+|||++....++.++|||||||++|||++|..||...
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 533 66799999999989999999999999999999999999644
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=288.42 Aligned_cols=243 Identities=16% Similarity=0.181 Sum_probs=185.0
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCC----CCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYS----PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
..++|.....+|.|+| |.||++.. .++|....... .+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSY--GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTT--SSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeEEeecCC--EEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 3467778899999999 99999822 12222222211 233568999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL- 168 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~- 168 (274)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+...
T Consensus 101 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99999999999988764 45799999999999999999999999 9999999999999999999999999998643
Q ss_pred ----------CCCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH----------HH
Q 048314 169 ----------SDKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK----------CF 227 (274)
Q Consensus 169 ----------~~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----------~~ 227 (274)
++..|+|||.+... .++.++||||||+++|+|++|..||..... ...+...... .+
T Consensus 176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD---IDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHHH
T ss_pred CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCChhhhhHh
Confidence 25679999998765 688999999999999999999999965421 1111111100 00
Q ss_pred hhhh-hhhh-----hcCC---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 INRE-LNKL-----VRGT---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 ~~~~-~~~~-----~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.... .... .... ......+..+.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0000 0000 011234678999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=292.28 Aligned_cols=243 Identities=17% Similarity=0.088 Sum_probs=181.3
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeC------
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG------ 85 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 85 (274)
....++|...+.||.|+| |.||++.. .++|.+. .+.....+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~f--g~V~~a~~~~~~~~vAiK~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSF--GIVCEVFDIESGKRFALKKVL--QDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-C--EEEEEEEETTTCCEEEEEEEE--CCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccC--EEEEEEEECCCCCEEEEEEEe--cCcchHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 445678999999999999 99999821 1122222 2344456899999999999999999998543
Q ss_pred --------------------------------CcceEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHH
Q 048314 86 --------------------------------SKPSTEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYL 131 (274)
Q Consensus 86 --------------------------------~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~l 131 (274)
...++||||++ |+|.+.+... ....+++..++.++.|++.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33789999998 5888877642 456799999999999999999999
Q ss_pred hcCCCCCcccCCCCCCceEEc-CCCcEEEeccccceecC----------CCCcCCCcccccC-CCccccceeehhHhHHH
Q 048314 132 HDECEPPILHCDIKPQNILMD-EFWTAKISDFGLAKLLS----------DKGCMAPECYKRT-PISVKADVYGYGIVLLE 199 (274)
Q Consensus 132 h~~~~~~i~h~dl~~~nil~~-~~~~~kl~d~g~~~~~~----------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~e 199 (274)
|+. +++||||||+||+++ .++.+||+|||.+.... +..|+|||.+.+. .++.++||||+||++|+
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 999 999999999999997 68899999999997542 5679999988764 48999999999999999
Q ss_pred HhhcCCCccccCCChhhHHHHHHHHHHHhh---h-------hhhhhhc----CC----ccCHHHHHHHHHHHHHhhccCC
Q 048314 200 TICCWENMEIDASKPEEIILTNWVYKCFIN---R-------ELNKLVR----GT----EVDKKNLENLVKVGLWCVQDEP 261 (274)
Q Consensus 200 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~----~~----~~~~~~~~~~~~li~~cl~~dp 261 (274)
|++|..||.... ....+..... .... . ......- .. ..+...+..+.+++.+||+.||
T Consensus 235 ll~g~~pf~~~~---~~~~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 235 LILGKPLFSGET---SIDQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHSSCSSCCSS---HHHHHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHhCCCCCCCCC---hHHHHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999997431 1111111111 0000 0 0000000 00 1334456789999999999999
Q ss_pred CCCCChhhHHh
Q 048314 262 ALRPSMKCVVM 272 (274)
Q Consensus 262 ~~Rps~~evl~ 272 (274)
++|||+.|+++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.36 Aligned_cols=232 Identities=19% Similarity=0.153 Sum_probs=182.4
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHH------HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEE--eCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMA------TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAM--RGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~------~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~ 86 (274)
.++|.....+|.|+| |.||++.. .++| ........+.+.+|+.++++++||||+++++++. +..
T Consensus 4 ~~~y~i~~~lg~G~~--g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSY--GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp -CCBCCCCEEEECSS--CEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccceeEeeEEecCCC--eEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 467888999999999 99998821 0111 1111233456789999999999999999999984 456
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++||||+.++ |.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 789999999876 88888876667899999999999999999999999 99999999999999999999999999986
Q ss_pred ec-------------CCCCcCCCcccccCC--CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhh
Q 048314 167 LL-------------SDKGCMAPECYKRTP--ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRE 231 (274)
Q Consensus 167 ~~-------------~~~~~~ape~~~~~~--~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (274)
.. +++.|+|||.+.... ++.++||||||+++|+|++|..||.... .. ... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~-~~~----~~i~~~- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IY-KLF----ENIGKG- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HH-HHH----HHHHHC-
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HH-HHH----HHHhcC-
Confidence 53 256799999987643 3679999999999999999999997431 11 010 111111
Q ss_pred hhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 232 LNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
....+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 229 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 ------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 112344566789999999999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=300.64 Aligned_cols=244 Identities=16% Similarity=0.164 Sum_probs=171.8
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeC-----C
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG-----S 86 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 86 (274)
++|...+.||.|+| |.||++. ..++|.+... ...+++.+|+.+|++++|||||++++++... .
T Consensus 53 ~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 53 DRYEIRHLIGTGSY--GHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp TTEEECCC---------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCeEEeeEeeecCC--eEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 67888999999999 9999981 1122222211 1234577999999999999999999998543 5
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++||||+. |+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred eEEEEEeccc-cchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 6899999974 799999975 46799999999999999999999999 99999999999999999999999999987
Q ss_pred ecC--------------------------------------CCCcCCCccc-ccCCCccccceeehhHhHHHHhh-----
Q 048314 167 LLS--------------------------------------DKGCMAPECY-KRTPISVKADVYGYGIVLLETIC----- 202 (274)
Q Consensus 167 ~~~--------------------------------------~~~~~ape~~-~~~~~~~~~Di~s~G~~l~el~~----- 202 (274)
... ++.|+|||++ ....++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 542 6679999976 45679999999999999999998
Q ss_pred ------cCCCccccCCCh----------------hhHHHHHHHHHHHhh-----------hhhhhhhcC---C------c
Q 048314 203 ------CWENMEIDASKP----------------EEIILTNWVYKCFIN-----------RELNKLVRG---T------E 240 (274)
Q Consensus 203 ------g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~-----------~~~~~~~~~---~------~ 240 (274)
|+++|......+ ........+...... ......+.. . .
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 555553321000 000111111111000 000000000 0 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.....+..+.+|+.+||+.||++|||++|+++.
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 122346788999999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=286.03 Aligned_cols=239 Identities=14% Similarity=0.147 Sum_probs=184.4
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEe--CCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMR--GSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 91 (274)
.++|...+.||.|+| |.||++. ..++|... ....+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKY--SEVFEAINITNNEKVVVKILK-PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEC-SCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCC--eEEEEEEECCCCcEEEEEEec-ccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 366778899999999 9999982 11222222 234566889999999998 9999999999987 6678999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC-cEEEeccccceecC-
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKISDFGLAKLLS- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~d~g~~~~~~- 169 (274)
|||+.+++|.+++.. +++..++.++.|++.||.|||+. +++||||||+||+++.++ .++|+|||++....
T Consensus 112 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999999853 89999999999999999999999 999999999999999766 89999999997533
Q ss_pred ---------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh---
Q 048314 170 ---------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV--- 236 (274)
Q Consensus 170 ---------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 236 (274)
+..|+|||.+.. ..++.++||||||+++|+|++|..||......... +.... ...........+
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--l~~~~-~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIA-KVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHH-HHHCHHHHHHHHHHT
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH--HHHHH-HhcCCchhhhHHHHh
Confidence 556999999876 56899999999999999999999999644222111 11111 110111110000
Q ss_pred ------------c-----------CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 237 ------------R-----------GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 237 ------------~-----------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
. ....+...+..+.+++.+||+.||++|||++|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 001122246789999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=278.80 Aligned_cols=234 Identities=20% Similarity=0.176 Sum_probs=186.6
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
..++|.....+|.|++ |.||++.. .++|.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 5 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAY--GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSS--SEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCC--cEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 3467888999999999 99998821 11222211 1223557799999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 83 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 83 FLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999999999864 45699999999999999999999999 9999999999999999999999999998643
Q ss_pred -----------CCCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 169 -----------SDKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 169 -----------~~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
++..|+|||.+....+ +.++|+||||+++|+|++|..||......... ...+ .... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~-----~~~~--~-- 226 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW-----KEKK--T-- 226 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HHHH-----HTTC--T--
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHh-----hhcc--c--
Confidence 2567999999987665 78999999999999999999999754222111 1111 0000 0
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
........+..+.+++.+||+.||++|||+.|+++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00112244567899999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=287.29 Aligned_cols=241 Identities=17% Similarity=0.137 Sum_probs=181.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEe------
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR------ 84 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 84 (274)
.++|...+.+|.|+| |.||++.. .++|.+... .....+.+|+.++++++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTF--GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCST--TSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCC--cEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 467888999999999 99999821 122222211 223356799999999999999999999977
Q ss_pred --CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 85 --GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 85 --~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
.+..++||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred cCCceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999974 88888876 345699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecC---------------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH
Q 048314 163 GLAKLLS---------------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226 (274)
Q Consensus 163 g~~~~~~---------------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (274)
|++.... ++.|+|||.+.+ ..++.++||||||+++|+|++|..||.... .. .....+...
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~-~~~~~i~~~ 244 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT---EQ-HQLALISQL 244 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HH-HHHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC---hH-HHHHHHHHH
Confidence 9986532 566999998876 457999999999999999999999997431 11 111111111
Q ss_pred Hhhh---hhhh-----h------hcCCccCH-------HHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 227 FINR---ELNK-----L------VRGTEVDK-------KNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 227 ~~~~---~~~~-----~------~~~~~~~~-------~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.... .... . ........ ..++.+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000 0000 0 00000000 11456899999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=294.48 Aligned_cols=247 Identities=17% Similarity=0.147 Sum_probs=186.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-CCCCcHHHHHHHHhcCC--------CCccceEeEEEE--
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-YSPSRPLTLTSIVSRVS--------WTTDIEVSSVAM-- 83 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~-- 83 (274)
.++|...+.||.|+| |.||++.. .++|.+... ...+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHF--STVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCC--eeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 367888899999999 99999921 122222221 22345678999999986 788999999987
Q ss_pred --eCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC------
Q 048314 84 --RGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW------ 155 (274)
Q Consensus 84 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~------ 155 (274)
+....++||||+ +++|.+++.......+++..++.++.|++.||.|||+++ +++||||||+||+++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 456789999999 567777776645567999999999999999999999853 899999999999998765
Q ss_pred -------------------------------------------cEEEeccccceec--------CCCCcCCCcccccCCC
Q 048314 156 -------------------------------------------TAKISDFGLAKLL--------SDKGCMAPECYKRTPI 184 (274)
Q Consensus 156 -------------------------------------------~~kl~d~g~~~~~--------~~~~~~ape~~~~~~~ 184 (274)
.+||+|||.+... ++..|+|||++....+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCC
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCC
Confidence 7999999998754 3678999999998889
Q ss_pred ccccceeehhHhHHHHhhcCCCccccCCChh--hHHHHHHHHHHHhh--------hhhh-h-------------------
Q 048314 185 SVKADVYGYGIVLLETICCWENMEIDASKPE--EIILTNWVYKCFIN--------RELN-K------------------- 234 (274)
Q Consensus 185 ~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~--------~~~~-~------------------- 234 (274)
+.++|||||||++|+|++|..||........ .......+...... .... .
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 9999999999999999999999975433221 11111111111100 0000 0
Q ss_pred ---hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 235 ---LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 235 ---~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.......+...+..+.+|+.+||+.||++|||++|+++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00111346677889999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=311.90 Aligned_cols=234 Identities=15% Similarity=0.144 Sum_probs=187.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
..++|...+.||+|+| |.||+|.. .++|..... ...+.+.+|+.++++++||||+++++++. .+.
T Consensus 388 ~~~~y~i~~~LG~G~f--G~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQF--GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp CGGGEEEEEEEECCSS--CCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccEEEeeEEeeCCC--EEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3456777888999999 99999832 112222111 11255789999999999999999999985 456
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 465 ~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred eEEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 8999999999999999986 345699999999999999999999999 999999999999999999999999999875
Q ss_pred cC------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 168 LS------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 168 ~~------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
.. ++.|+|||.+....++.++||||||+++|||++ |..||.... .. .... ...++
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~---~~-~~~~----~i~~~---- 608 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NN-DVIG----RIENG---- 608 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HH-HHHH----HHHHT----
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC---HH-HHHH----HHHcC----
Confidence 43 346999999988889999999999999999997 899996431 11 1111 11111
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.....+...+..+.+++.+||+.||++|||+.+|++.|
T Consensus 609 --~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L 646 (656)
T 2j0j_A 609 --ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646 (656)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 11124556678899999999999999999999998864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.64 Aligned_cols=236 Identities=17% Similarity=0.200 Sum_probs=186.0
Q ss_pred hhhcccc-ccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcc
Q 048314 21 LRNFCRS-SLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~-~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 88 (274)
.+.|... +.||.|+| |.||++.. .++|.+... .....+.+|+.++.++. ||||+++++++.+.+..
T Consensus 27 ~~~y~~~~~~lG~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKF--AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHEEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhEEeeccceeCCCCC--eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 4444444 78999999 99999821 122222211 22345779999999996 69999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC---CCcEEEeccccc
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKISDFGLA 165 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~d~g~~ 165 (274)
++||||+.+|+|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 9999999999999999764556799999999999999999999999 9999999999999987 789999999998
Q ss_pred eec----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 166 KLL----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 166 ~~~----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
... +++.|+|||.+....++.++||||||+++|+|++|..||.... ....... .... ..
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~-----i~~~---~~ 250 (327)
T 3lm5_A 182 RKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYLN-----ISQV---NV 250 (327)
T ss_dssp EEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH-----HHHT---CC
T ss_pred cccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHH-----HHhc---cc
Confidence 754 3668999999998899999999999999999999999996431 1111000 0000 00
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
-.+.......+..+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0111233355678999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=287.90 Aligned_cols=251 Identities=18% Similarity=0.113 Sum_probs=178.0
Q ss_pred hhhhHHHHhhhccccccCCCCCCCCcchhHHH-------HHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 13 ARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCM-------RALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 13 ~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
+..+.....++|...+.+|.|+| |.||+|. +++|...........+.+|++.++.++||||+++++++.+.
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 14 ADERSRKEMDRFQVERMAGQGTF--GTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp SSHHHHHHHTTEEEC------------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhhhchhhccceEEEEEEecCCC--eEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 44556677889999999999999 9999882 22232333334566778899999999999999999999764
Q ss_pred Cc-------ceEEEEeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCcccCCCCCCceEEcC-
Q 048314 86 SK-------PSTEAALDLPWDLAYIIFC--SAERNPYWNQRVRIALDVAKGILYLH--DECEPPILHCDIKPQNILMDE- 153 (274)
Q Consensus 86 ~~-------~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~~~~i~h~dl~~~nil~~~- 153 (274)
+. .++||||+++ +|.+.+.. .....+++..++.++.|++.||.||| +. +++||||||+||+++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence 33 7899999986 55555442 14567899999999999999999999 88 9999999999999996
Q ss_pred CCcEEEeccccceecC----------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH
Q 048314 154 FWTAKISDFGLAKLLS----------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW 222 (274)
Q Consensus 154 ~~~~kl~d~g~~~~~~----------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~ 222 (274)
++.+||+|||++.... ++.|+|||.+... .++.++||||||+++|+|++|..||.... ....+...
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~~ 244 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN---SAGQLHEI 244 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH
T ss_pred CCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC---hHHHHHHH
Confidence 8999999999987543 5679999998654 48999999999999999999999997542 11111111
Q ss_pred HHHHHh--hhhhh---------hhhcCC---------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 223 VYKCFI--NRELN---------KLVRGT---------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 223 ~~~~~~--~~~~~---------~~~~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...... ..... ...... ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 110000 00000 000000 112235678999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=291.08 Aligned_cols=235 Identities=14% Similarity=0.105 Sum_probs=187.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHH---------HHHHHhc------CCCCCCcHHHHHHHHhcC-CCCccceEeEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVN------SPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMR 84 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 84 (274)
.++|...+.||.|+| |.||++.. .++|.+. .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 53 ~~~y~~~~~lG~G~~--g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAY--GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp GGGEEEEEEEEETTT--EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccceEEEEEeccCCC--EEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 368888999999999 99997632 1122221 113345677899999999 59999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
.+..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred CceEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999999986 35699999999999999999999999 999999999999999999999999999
Q ss_pred ceec------------CCCCcCCCccccc--CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh
Q 048314 165 AKLL------------SDKGCMAPECYKR--TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR 230 (274)
Q Consensus 165 ~~~~------------~~~~~~ape~~~~--~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
++.. +++.|+|||++.. ..++.++||||||+++|+|++|..||...........+.... .
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----~-- 279 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI----L-- 279 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH----H--
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH----h--
Confidence 8643 3678999999875 347889999999999999999999997543222211111110 0
Q ss_pred hhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCC-----ChhhHHhh
Q 048314 231 ELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRP-----SMKCVVMM 273 (274)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~~ 273 (274)
......+...+..+.+++.+||+.||++|| |+.|+++.
T Consensus 280 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 280 -----KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -----HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 011134555667899999999999999999 99999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=286.20 Aligned_cols=246 Identities=16% Similarity=0.134 Sum_probs=187.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-------HHHHHhcCC-CCCCcHHHHHHHHhcCCCCc------cceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-------ALMATVNSP-YSPSRPLTLTSIVSRVSWTT------DIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-------~~~~~~~~~-~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~ 86 (274)
.++|...+.+|.|+| |.||++.. .++|..... ...+.+.+|+.+++.++|+| ++++++++.+.+
T Consensus 13 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAF--GKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETT--EEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCC--eEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 357888899999999 99998732 112222211 12345678999999987765 999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-------------
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE------------- 153 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~------------- 153 (274)
..++||||+ +++|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 88999999875556799999999999999999999999 9999999999999987
Q ss_pred ------CCcEEEeccccceecC--------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHH
Q 048314 154 ------FWTAKISDFGLAKLLS--------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219 (274)
Q Consensus 154 ------~~~~kl~d~g~~~~~~--------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~ 219 (274)
++.+||+|||.+.... ++.|+|||.+....++.++||||||+++|||++|..||...........+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 246 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred ccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 6679999999987543 66799999999888999999999999999999999999754211110000
Q ss_pred HHHHHH----HHhh-------------------------hhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhH
Q 048314 220 TNWVYK----CFIN-------------------------RELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCV 270 (274)
Q Consensus 220 ~~~~~~----~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ev 270 (274)
...... .... ............+...+..+.+++.+||+.||++|||+.|+
T Consensus 247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 326 (339)
T 1z57_A 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326 (339)
T ss_dssp HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence 000000 0000 00000000012344667889999999999999999999999
Q ss_pred Hh
Q 048314 271 VM 272 (274)
Q Consensus 271 l~ 272 (274)
++
T Consensus 327 l~ 328 (339)
T 1z57_A 327 LK 328 (339)
T ss_dssp TT
T ss_pred hc
Confidence 86
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=298.78 Aligned_cols=239 Identities=18% Similarity=0.137 Sum_probs=179.0
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC----
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS---- 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 86 (274)
.++|...+.||.|+| |.||++. ..++|.+.. ....+++.+|+.+|+.++||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~--g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQ--GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp ETTEEEEEEEEECSS--CEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCCC--eEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 456777899999999 9999882 112222221 122345679999999999999999999996543
Q ss_pred --cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 87 --KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 87 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
..++||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999975 57777643 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh------
Q 048314 165 AKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI------ 228 (274)
Q Consensus 165 ~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 228 (274)
++... ++.|+|||++.+..++.++||||+||++|||++|+.||..... ...+.. +.....
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~-i~~~lg~p~~~~ 286 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNK-VIEQLGTPCPEF 286 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH-HHHHHCSCCHHH
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH-HHHhcCCCCHHH
Confidence 86532 6779999999998999999999999999999999999964321 111111 000000
Q ss_pred ----hhhhhhhhcCC---------------------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 229 ----NRELNKLVRGT---------------------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 229 ----~~~~~~~~~~~---------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.......+... ......+.++.+|+.+||+.||++|||++|+++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00001111100 0111236789999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=285.10 Aligned_cols=241 Identities=21% Similarity=0.213 Sum_probs=175.9
Q ss_pred HhhhccccccCCCCCCCCcchhHHHHH------HHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMRA------LMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~~------~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
..++|.....+|.|++ |.||++... ++|.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 13 NRDDYELQEVIGSGAT--AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp CCCCCEEEEECC---C--CCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred chhhhhhhheeccccc--eEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 3567888999999999 999998321 1221111 1345667899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 91 EAALDLPWDLAYIIFCS------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
||||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999999742 245699999999999999999999999 999999999999999999999999998
Q ss_pred ceec----------------CCCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH
Q 048314 165 AKLL----------------SDKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF 227 (274)
Q Consensus 165 ~~~~----------------~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (274)
+... +++.|+|||.+.. ..++.++||||||+++|+|++|..||....... ... ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~----~~~ 240 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLM----LTL 240 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH----HHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHH----HHh
Confidence 7532 3567999998865 468899999999999999999999997542111 110 000
Q ss_pred hhh--hhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 INR--ELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 ~~~--~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
... ...............+..+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000 000001111122344578999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=283.03 Aligned_cols=247 Identities=17% Similarity=0.187 Sum_probs=189.7
Q ss_pred hHHHHhhhccccccCCCCCCCCcchhHHHH-------HHHHHhc----CCCCCCcHHHHHHHHhcC---CCCccceEeEE
Q 048314 16 SLCTKLRNFCRSSLNDRNSPRSKSVWSCMR-------ALMATVN----SPYSPSRPLTLTSIVSRV---SWTTDIEVSSV 81 (274)
Q Consensus 16 ~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-------~~~~~~~----~~~~~~~~~~e~~~l~~l---~h~niv~l~~~ 81 (274)
.+....++|...+.+|.|+| |.||++.. .++|... .......+.+|+.+++.+ +||||++++++
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~ 82 (326)
T 1blx_A 5 GLCRADQQYECVAEIGEGAY--GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 82 (326)
T ss_dssp CCCCGGGTEEEEEEEEEETT--EEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred cccCchhceeeeeeeccccc--EEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeee
Confidence 34556788999999999999 99999832 1222222 112345677888888776 89999999999
Q ss_pred EE-----eCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc
Q 048314 82 AM-----RGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 156 (274)
Q Consensus 82 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~ 156 (274)
+. .....++||||+. |+|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp EEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred eeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCC
Confidence 87 4567899999998 6999999886556799999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH
Q 048314 157 AKISDFGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226 (274)
Q Consensus 157 ~kl~d~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (274)
++|+|||.+.... +..|+|||.+....++.++||||||+++|+|++|..||.... ....+.. +...
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~-i~~~ 234 (326)
T 1blx_A 159 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS---DVDQLGK-ILDV 234 (326)
T ss_dssp EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHH-HHHH
T ss_pred EEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHH-HHHH
Confidence 9999999986533 667999999998889999999999999999999999997431 1111111 1111
Q ss_pred Hhh---hhhhh-------hhcCC------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 227 FIN---RELNK-------LVRGT------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 227 ~~~---~~~~~-------~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
... ..... ..... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00000 00000 122345678899999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=293.57 Aligned_cols=249 Identities=18% Similarity=0.184 Sum_probs=178.6
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH----HHHHHhcCCCCCCcHHHHHHH--HhcCCCCccceEeEEEEe-----CCcc
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR----ALMATVNSPYSPSRPLTLTSI--VSRVSWTTDIEVSSVAMR-----GSKP 88 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~----~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~~ 88 (274)
..++|.....+|.|+| |.||+|.. .++|.+.. .....+..|.++ +..++||||+++++.+.. ....
T Consensus 11 ~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~vavK~~~~-~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRY--GAVYKGSLDERPVAVKVFSF-ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSS--EEEEEEEETTEEEEEEEEEG-GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCC--eEEEEEEECCeEEEEEEeec-cchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3467888999999999 99999821 11121111 122334445444 445899999999986643 2356
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC------EPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
++||||+++|+|.+++.. ...++..++.++.|++.||.|||+.+ ..+++||||||+||+++.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 899999999999999976 34599999999999999999999863 238999999999999999999999999
Q ss_pred ccceec-------------------CCCCcCCCccccc-------CCCccccceeehhHhHHHHhhcCCCccccCCChhh
Q 048314 163 GLAKLL-------------------SDKGCMAPECYKR-------TPISVKADVYGYGIVLLETICCWENMEIDASKPEE 216 (274)
Q Consensus 163 g~~~~~-------------------~~~~~~ape~~~~-------~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~ 216 (274)
|++... ++..|+|||++.+ ..++.++||||||+++|||++|..||.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 999643 3567999999876 34667899999999999999998877543221110
Q ss_pred H-HHH---------HHHHHHHhhhhhhhhh-cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 217 I-ILT---------NWVYKCFINRELNKLV-RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 217 ~-~~~---------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ... ...............+ .........+..+.+++.+||+.||++|||+.|+++.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 0 000 0000000000000000 00022345677899999999999999999999998864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=291.18 Aligned_cols=251 Identities=16% Similarity=0.099 Sum_probs=188.9
Q ss_pred hhhhhhHHHHhhhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCC------------CCcHHHHHHHHhcCCC
Q 048314 11 WIARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYS------------PSRPLTLTSIVSRVSW 72 (274)
Q Consensus 11 ~~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~------------~~~~~~e~~~l~~l~h 72 (274)
.....++....++|...+.+|.|+| |.||++. +++|........ .+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 88 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSY--GAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETT--EEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHHhccceEEeEEeccCCC--EEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCC
Confidence 3566788888999999999999999 9999982 122211111111 1457899999999999
Q ss_pred CccceEeEEEEeC-----CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCC
Q 048314 73 TTDIEVSSVAMRG-----SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQ 147 (274)
Q Consensus 73 ~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ 147 (274)
|||+++++++... ...++||||+. |+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+
T Consensus 89 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 163 (362)
T 3pg1_A 89 PNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG 163 (362)
T ss_dssp TTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred cCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence 9999999998543 35799999998 689999875 445799999999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeccccceecC----------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhh
Q 048314 148 NILMDEFWTAKISDFGLAKLLS----------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEE 216 (274)
Q Consensus 148 nil~~~~~~~kl~d~g~~~~~~----------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~ 216 (274)
||+++.++.++|+|||++.... ++.|+|||.+.. ..++.++||||||+++|+|++|+.||.... ..
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~ 240 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST---FY 240 (362)
T ss_dssp GEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HH
T ss_pred HEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC---HH
Confidence 9999999999999999986432 567999998876 678999999999999999999999997431 11
Q ss_pred HHHHHHHHHHHh-----------hhhhhhhhcCC----------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 217 IILTNWVYKCFI-----------NRELNKLVRGT----------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 217 ~~~~~~~~~~~~-----------~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+.. ...... .......+... ..+...++.+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 NQLNK-IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHH-HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHH-HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111 111000 00000111000 112234567999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=289.87 Aligned_cols=239 Identities=16% Similarity=0.147 Sum_probs=177.5
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCC----CCCcHHHHHHHHhcCCCCccceEeEEEEeCC----
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPY----SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS---- 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 86 (274)
.++|...+.+|.|+| |.||++.. .++|.+.... ..+++.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~--g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAY--GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC--------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCC--eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 467888899999999 99999821 1222222111 1244678999999999999999999997653
Q ss_pred --cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 87 --KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 87 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899999976 4699999999999999999999999 999999999999999999999999999
Q ss_pred ceecC--------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH--------
Q 048314 165 AKLLS--------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF-------- 227 (274)
Q Consensus 165 ~~~~~--------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 227 (274)
++... +..|+|||.+.. ..++.++||||+||++++|++|+.||..... ...+.. .....
T Consensus 175 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~-i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 175 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKE-IMKVTGTPPAEFV 250 (367)
T ss_dssp CEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH-HHHHHCCCCHHHH
T ss_pred ccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH-HHHhcCCCCHHHH
Confidence 87543 567999999876 6789999999999999999999999974311 111111 10000
Q ss_pred ---hhhhhhhhhc------CC---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 ---INRELNKLVR------GT---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 ---~~~~~~~~~~------~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
........+. .. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000000 00 122344678999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=290.75 Aligned_cols=234 Identities=15% Similarity=0.084 Sum_probs=185.1
Q ss_pred hhhHHHHhhhccccccCCCCCCCCcchhHHH-----HHH------HHHhcCCCCCCcHHHHHHHHhcCC---CCccceEe
Q 048314 14 RSSLCTKLRNFCRSSLNDRNSPRSKSVWSCM-----RAL------MATVNSPYSPSRPLTLTSIVSRVS---WTTDIEVS 79 (274)
Q Consensus 14 ~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~-----~~~------~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~ 79 (274)
..++....++|.....+|.|+| |.||+|. ... +|.. ......++..|+.++.+++ |+||++++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~--g~Vy~~~~~~~~~~~~~~~vavK~~-~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAF--AQVYEATQGDLNDAKNKQKFVLKVQ-KPANPWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSS--EEEEEEEC-------CCCCEEEEEE-SSCCHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred ceeEEECCEEEEEEEEeeccCC--EEEEEEEecCCcccccCcEEEEEEe-CCCChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 3444455677888889999999 9999992 111 1111 1234456778888888887 89999999
Q ss_pred EEEEeCCcceEEEEeCCCCCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC---
Q 048314 80 SVAMRGSKPSTEAALDLPWDLAYIIFCS---AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE--- 153 (274)
Q Consensus 80 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~--- 153 (274)
+++.+.+..++|||||++|+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGT
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccccc
Confidence 9999999999999999999999999743 245699999999999999999999999 9999999999999988
Q ss_pred --------CCcEEEeccccceec-------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCC
Q 048314 154 --------FWTAKISDFGLAKLL-------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDAS 212 (274)
Q Consensus 154 --------~~~~kl~d~g~~~~~-------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~ 212 (274)
++.+||+|||++... +++.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 899999999999543 27789999999998899999999999999999999999964321
Q ss_pred ChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCC-ChhhHHh
Q 048314 213 KPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRP-SMKCVVM 272 (274)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~evl~ 272 (274)
... ........ . ...+.+.+++..|++.+|.+|+ ++.++.+
T Consensus 291 ~~~---------------~~~~~~~~--~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 291 GEC---------------KPEGLFRR--L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp TEE---------------EECSCCTT--C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred Cce---------------eechhccc--c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 110 01111111 1 2256778899999999999995 5666554
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=279.33 Aligned_cols=234 Identities=15% Similarity=0.145 Sum_probs=180.8
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhc----------CCCCCCcHHHHHHHHhcCCCCccceEeEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN----------SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR 84 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 84 (274)
.++|.....+|.|+| |.||++.. .++|.+. .......+.+|+.++++++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGAC--GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhceeEeeEEecCCC--EEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 567888999999999 99999821 1122211 11234568899999999999999999999876
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc---EEEec
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT---AKISD 161 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~---~kl~d 161 (274)
.. .++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++. +||+|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred Cc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 55 8999999999999999975 46799999999999999999999999 9999999999999986554 99999
Q ss_pred cccceecC----------CCCcCCCcccc---cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh
Q 048314 162 FGLAKLLS----------DKGCMAPECYK---RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI 228 (274)
Q Consensus 162 ~g~~~~~~----------~~~~~ape~~~---~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (274)
||++.... ++.|+|||.+. ...++.++||||||+++|+|++|..||......... ... ..
T Consensus 161 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~----~~ 233 (322)
T 2ycf_A 161 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQ----IT 233 (322)
T ss_dssp CTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH---HHH----HH
T ss_pred CccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH---HHH----HH
Confidence 99987643 67899999874 456889999999999999999999999754222111 110 01
Q ss_pred hhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 229 NRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+.... ........+..+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~---~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYNF---IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCcccc---CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 110000 00011234578899999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=287.19 Aligned_cols=240 Identities=15% Similarity=0.134 Sum_probs=186.7
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----HHHH----HhcCCCCC--------------CcHHHHHHHHhcCCCCccce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----ALMA----TVNSPYSP--------------SRPLTLTSIVSRVSWTTDIE 77 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~----~~~~~~~~--------------~~~~~e~~~l~~l~h~niv~ 77 (274)
.++|.....+|.|+| |.||++.. ++|. ........ +.+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKF--NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSS--CCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCC--eEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 467888999999999 99998821 1111 11111001 66889999999999999999
Q ss_pred EeEEEEeCCcceEEEEeCCCCCHHHH------HHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceE
Q 048314 78 VSSVAMRGSKPSTEAALDLPWDLAYI------IFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNIL 150 (274)
Q Consensus 78 l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil 150 (274)
+++++.+.+..++||||+++|+|.++ +.......+++..++.++.|++.||.|||+ . +++|+||+|+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 99999999999999999999999999 655335779999999999999999999999 8 9999999999999
Q ss_pred EcCCCcEEEeccccceec---------CCCCcCCCcccccC-CCcc-ccceeehhHhHHHHhhcCCCccccCCChhhHHH
Q 048314 151 MDEFWTAKISDFGLAKLL---------SDKGCMAPECYKRT-PISV-KADVYGYGIVLLETICCWENMEIDASKPEEIIL 219 (274)
Q Consensus 151 ~~~~~~~kl~d~g~~~~~---------~~~~~~ape~~~~~-~~~~-~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~ 219 (274)
++.++.++|+|||.+... ++..|+|||.+... .++. ++||||||+++|+|++|..||........ +
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE---L 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH---H
T ss_pred EcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---H
Confidence 999999999999998763 25679999999877 5665 99999999999999999999975422111 1
Q ss_pred HHHHHHHHhhhhhhhhhc------CC------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 220 TNWVYKCFINRELNKLVR------GT------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~------~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
. ............. +. ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 262 ~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 F----NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H----HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H----HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 1111110000000 00 011345678999999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=299.81 Aligned_cols=227 Identities=12% Similarity=0.074 Sum_probs=174.2
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcC-----CCCCCcHHHHH---HHHhcCCCCccceEe-------
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNS-----PYSPSRPLTLT---SIVSRVSWTTDIEVS------- 79 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~-----~~~~~~~~~e~---~~l~~l~h~niv~l~------- 79 (274)
.++|...+.||.|+| |.||+|.. .++|.+.. ....+.+.+|+ +.+++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~--g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 72 PRTLVRGTVLGQEDP--YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CEEEEEEEEEEEETT--EEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CceEEEcceeecCCC--EEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 456777899999999 99999831 22333221 12235567999 556666899999998
Q ss_pred EEEEeCC-----------------cceEEEEeCCCCCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 048314 80 SVAMRGS-----------------KPSTEAALDLPWDLAYIIFCSA-----ERNPYWNQRVRIALDVAKGILYLHDECEP 137 (274)
Q Consensus 80 ~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 137 (274)
+++.+.+ ..++||||+ +|+|.+++.... ...+++..++.++.|++.||.|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 225 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 225 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 6666553 378999999 689999998531 11244688899999999999999999
Q ss_pred CcccCCCCCCceEEcCCCcEEEeccccceecC-------CCCcCCCcccccC-----------CCccccceeehhHhHHH
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKLLS-------DKGCMAPECYKRT-----------PISVKADVYGYGIVLLE 199 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-------~~~~~ape~~~~~-----------~~~~~~Di~s~G~~l~e 199 (274)
+|+||||||+||+++.++.+||+|||+++... .+.|+|||++... .++.++|||||||++||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 99999999999999999999999999987543 2789999999877 78999999999999999
Q ss_pred HhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 200 TICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 200 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
|++|+.||...... .....+.. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 306 lltg~~Pf~~~~~~----------------~~~~~~~~---~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 306 IWCADLPITKDAAL----------------GGSEWIFR---SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHSSCCC----------------------CCSGGGGS---SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHCCCCCcccccc----------------cchhhhhh---hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999643110 01111111 11234577899999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=286.10 Aligned_cols=235 Identities=17% Similarity=0.192 Sum_probs=184.1
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCC----------CCcHHHHHHHHhcC-CCCccceEeEEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYS----------PSRPLTLTSIVSRV-SWTTDIEVSSVA 82 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~----------~~~~~~e~~~l~~l-~h~niv~l~~~~ 82 (274)
..++|.....||.|++ |.||++.. .++|....... .+.+.+|+.+++++ +||||+++++++
T Consensus 92 ~~~~y~~~~~lg~G~~--g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVS--SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhcccceEEecCCC--EEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 3467888899999999 99999821 22232222111 23467899999999 799999999999
Q ss_pred EeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 83 MRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 83 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEec
Confidence 999999999999999999999985 35699999999999999999999999 9999999999999999999999999
Q ss_pred ccceec----------CCCCcCCCccccc------CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH
Q 048314 163 GLAKLL----------SDKGCMAPECYKR------TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226 (274)
Q Consensus 163 g~~~~~----------~~~~~~ape~~~~------~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (274)
|++... +++.|+|||++.. ..++.++||||||+++|+|++|..||.... . ..... .
T Consensus 245 G~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~-~~~~~----~ 316 (365)
T 2y7j_A 245 GFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---Q-ILMLR----M 316 (365)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---H-HHHHH----H
T ss_pred CcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---H-HHHHH----H
Confidence 988653 2667999998863 357889999999999999999999996431 1 11111 1
Q ss_pred HhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 227 FINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+... ...+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 317 i~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IMEGQYQ---FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHTCCC---CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCC---CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111000 000001123467899999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=287.77 Aligned_cols=239 Identities=18% Similarity=0.128 Sum_probs=179.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC----
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS---- 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 86 (274)
.++|...+.+|.|+| |.||++.. .++|.+... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQ--GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp ETTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhheeEeeeeEecCC--EEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 467888999999999 99999821 122222221 11234678999999999999999999997654
Q ss_pred --cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 87 --KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 87 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
..++||||+. |+|.+++.. .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 6799999997 578888863 589999999999999999999999 999999999999999999999999999
Q ss_pred ceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH----------
Q 048314 165 AKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY---------- 224 (274)
Q Consensus 165 ~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---------- 224 (274)
+.... ++.|+|||.+....++.++|||||||++|+|++|..||..... ...+.....
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCCCHHHH
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHH
Confidence 86532 5679999999988899999999999999999999999964311 110000000
Q ss_pred --------HHHhhh----------hhhhhhcCC--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 225 --------KCFINR----------ELNKLVRGT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 225 --------~~~~~~----------~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+. .......+. +.+...+..+.+|+.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000 000000000 112234678999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=280.34 Aligned_cols=235 Identities=19% Similarity=0.243 Sum_probs=180.9
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEe--------
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR-------- 84 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 84 (274)
..++|...+.+|.|+| |.||++.. .++|... .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAF--GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccccchhhheeccCCc--EEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3568888999999999 99999831 1122111 11223457799999999999999999999865
Q ss_pred -----CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEE
Q 048314 85 -----GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159 (274)
Q Consensus 85 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl 159 (274)
.+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 3467999999999999999986 345688999999999999999999999 9999999999999999999999
Q ss_pred eccccceec-------------------------CCCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCC
Q 048314 160 SDFGLAKLL-------------------------SDKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASK 213 (274)
Q Consensus 160 ~d~g~~~~~-------------------------~~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~ 213 (274)
+|||.+... +++.|+|||.+... .++.++||||||+++|+|++ ||...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--- 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--- 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence 999988643 25679999998754 68899999999999999997 44321
Q ss_pred hhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 214 PEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
....... ..... .....+...+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 232 ~~~~~~~----~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 MERVNIL----KKLRS---VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHH----HHHHS---TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhHHHHH----Hhccc---cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111110 00110 01111123445566788999999999999999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=290.60 Aligned_cols=234 Identities=17% Similarity=0.135 Sum_probs=170.4
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCC-CCccceEeEEEEe----
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVS-WTTDIEVSSVAMR---- 84 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~---- 84 (274)
.....+|.....+|.|+| |.||++.. .++|.+... ...+.+.+|+.++.++. ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGF--AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EETTEEEEEEEEEECCSS--EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eccCceEEEEEEEccCCc--eEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 334457888999999999 99999831 122222111 22345679999999996 9999999999842
Q ss_pred ----CCcceEEEEeCCCCCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cccCCCCCCceEEcCCCcE
Q 048314 85 ----GSKPSTEAALDLPWDLAYIIFCS-AERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDEFWTA 157 (274)
Q Consensus 85 ----~~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~~~~~~ 157 (274)
....+++|||+. |+|.+++... ....+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence 345799999996 7999998753 345699999999999999999999998 8 9999999999999999999
Q ss_pred EEeccccceec-----------------------CCCCcCCCccc---ccCCCccccceeehhHhHHHHhhcCCCccccC
Q 048314 158 KISDFGLAKLL-----------------------SDKGCMAPECY---KRTPISVKADVYGYGIVLLETICCWENMEIDA 211 (274)
Q Consensus 158 kl~d~g~~~~~-----------------------~~~~~~ape~~---~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~ 211 (274)
||+|||++... +++.|+|||.+ ....++.++||||||+++|+|++|..||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999998653 35679999998 45678899999999999999999999996331
Q ss_pred CChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 212 SKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
... ...... ....+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 258 ~~~------------~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 258 KLR------------IVNGKY-----SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp --------------------C-----CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHH------------hhcCcc-----cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 100 000000 0012223335688999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=289.22 Aligned_cols=245 Identities=16% Similarity=0.134 Sum_probs=171.5
Q ss_pred hhccc-cccCCCCCCCCcchhHHHH--------HHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEe--CCcceE
Q 048314 22 RNFCR-SSLNDRNSPRSKSVWSCMR--------ALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--GSKPST 90 (274)
Q Consensus 22 ~~f~~-~~~~g~g~~~~g~vy~~~~--------~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 90 (274)
+.|.. ...||.|+| |.||+|.. .++|.+......+.+.+|+.+|++++||||+++++++.+ ....++
T Consensus 20 ~~y~~~g~~lG~G~~--g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTY--GHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-------EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCC--eEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34444 558999999 99999831 223333333345568899999999999999999999965 667899
Q ss_pred EEEeCCCCCHHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE----cCCCcEEE
Q 048314 91 EAALDLPWDLAYIIFCS-------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKI 159 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~----~~~~~~kl 159 (274)
||||+. |+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||++ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999987 5888888632 122499999999999999999999999 99999999999999 67789999
Q ss_pred eccccceecC--------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCCh-----hhHHH
Q 048314 160 SDFGLAKLLS--------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKP-----EEIIL 219 (274)
Q Consensus 160 ~d~g~~~~~~--------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~-----~~~~~ 219 (274)
+|||++.... ++.|+|||++... .++.++|||||||++|+|++|..||....... .....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 9999986432 6679999998874 58999999999999999999999996432210 00011
Q ss_pred HHHHHHHHhhh---hhhh-----------------hhcCC-------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 220 TNWVYKCFINR---ELNK-----------------LVRGT-------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 220 ~~~~~~~~~~~---~~~~-----------------~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+...+... .... ..... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11110100000 0000 00000 000011457889999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=284.47 Aligned_cols=242 Identities=14% Similarity=0.125 Sum_probs=185.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-------HHHHHhcCC-CCCCcHHHHHHHHhcCCCCc------cceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-------ALMATVNSP-YSPSRPLTLTSIVSRVSWTT------DIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-------~~~~~~~~~-~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~ 86 (274)
.++|...+.+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++|+| ++.+++++...+
T Consensus 18 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTF--GKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETT--EEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCC--eEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 467888999999999 99998821 122222221 22345678999999998766 899999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEE---------------
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM--------------- 151 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~--------------- 151 (274)
..++||||+ +++|.+++.......+++..++.++.|++.||.|||+. +++||||||+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 67788888775556799999999999999999999999 99999999999999
Q ss_pred ----cCCCcEEEeccccceec--------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHH
Q 048314 152 ----DEFWTAKISDFGLAKLL--------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219 (274)
Q Consensus 152 ----~~~~~~kl~d~g~~~~~--------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~ 219 (274)
+.++.+||+|||++... +++.|+|||++....++.++||||||+++|+|++|..||....... .+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~ 248 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE---HL 248 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH
T ss_pred cccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HH
Confidence 56789999999998753 3677999999998899999999999999999999999997542111 11
Q ss_pred HHHHHHHHhh---------------------------------hhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCC
Q 048314 220 TNWVYKCFIN---------------------------------RELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPS 266 (274)
Q Consensus 220 ~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 266 (274)
..+...... ............+...+..+.+++.+||+.||++|||
T Consensus 249 -~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 249 -VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp -HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred -HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 111110000 0000000000123455678999999999999999999
Q ss_pred hhhHHh
Q 048314 267 MKCVVM 272 (274)
Q Consensus 267 ~~evl~ 272 (274)
++|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=277.86 Aligned_cols=235 Identities=16% Similarity=0.174 Sum_probs=186.0
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCC-----------CCCcHHHHHHHHhcCC-CCccceEeEE
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPY-----------SPSRPLTLTSIVSRVS-WTTDIEVSSV 81 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~-----------~~~~~~~e~~~l~~l~-h~niv~l~~~ 81 (274)
..++|.....+|.|++ |.||++.. .++|...... ..+.+.+|+.+++++. ||||++++++
T Consensus 15 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 15 FYENYEPKEILGRGVS--SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp CTTTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhccceeeeecCCCc--eEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 3578888999999999 99999821 1222222111 1234678999999996 9999999999
Q ss_pred EEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEec
Q 048314 82 AMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISD 161 (274)
Q Consensus 82 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 161 (274)
+.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred eccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999999986 35799999999999999999999999 999999999999999999999999
Q ss_pred cccceec----------CCCCcCCCcccc------cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH
Q 048314 162 FGLAKLL----------SDKGCMAPECYK------RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK 225 (274)
Q Consensus 162 ~g~~~~~----------~~~~~~ape~~~------~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (274)
||.+... +++.|+|||.+. ...++.++||||||+++|+|++|..||.... .. ... .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~-~~~----~ 239 (298)
T 1phk_A 168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QM-LML----R 239 (298)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH-HHH----H
T ss_pred ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HH-HHH----H
Confidence 9998653 256799999885 3467889999999999999999999996431 11 111 1
Q ss_pred HHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 226 CFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....... ..+.+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNY---QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCC---CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCc---ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111110 0011122345678999999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=290.03 Aligned_cols=240 Identities=15% Similarity=0.090 Sum_probs=177.3
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc------ce
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK------PS 89 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~ 89 (274)
.+|...+.||.|+| |.||++. +++++... ..+...+|+.+++.++||||+++++++...+. .+
T Consensus 40 ~~Y~~~~~lG~G~~--g~V~~a~~~~~~~~aikk~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSF--GVVFQAKLVESDEVAIKKVLQ---DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETT--EEEEEEEETTTEEEEEEEEEC---CTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCC--eEEEEEEECCCCeEEEEEEec---CcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 46778899999999 9999882 22222222 23334589999999999999999999965433 78
Q ss_pred EEEEeCCCCCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc-CCCcEEEecccccee
Q 048314 90 TEAALDLPWDLAYIIFC-SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKISDFGLAKL 167 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-~~~~~kl~d~g~~~~ 167 (274)
+||||++++.+...... .....+++..++.++.|++.||.|||+. +++||||||+||+++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987544333321 1346799999999999999999999999 999999999999998 789999999999975
Q ss_pred cC----------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH------hhh
Q 048314 168 LS----------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF------INR 230 (274)
Q Consensus 168 ~~----------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~ 230 (274)
.. ++.|+|||.+.+. .++.++||||+||++|||++|..||..... ...+.......- ...
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG---IDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHHHh
Confidence 42 5669999988764 589999999999999999999999975421 111111111000 000
Q ss_pred hhhhhhc-------CC----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 231 ELNKLVR-------GT----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 231 ~~~~~~~-------~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+... +. ..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000 00 122235678999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.38 Aligned_cols=236 Identities=18% Similarity=0.182 Sum_probs=174.8
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCC----CCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYS----PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
..++|.....+|.|+| |.||++.. .++|....... .+.+.++...++.++||||+++++++.+.+..+
T Consensus 5 ~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAY--GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cHHhhhhHHhcCCCCC--eEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 3568888999999999 99999822 11222221111 112234555688899999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 90 TEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
+||||++ |+|.+++... ....+++..++.++.|++.||.|||+++ +++|+||||+||+++.++.+||+|||++..
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999997 5888887642 4467999999999999999999999842 899999999999999999999999999864
Q ss_pred c----------CCCCcCCCccc----ccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 168 L----------SDKGCMAPECY----KRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 168 ~----------~~~~~~ape~~----~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
. +++.|+|||.+ ....++.++||||||+++|+|++|..||......... +.. ....
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~----~~~~---- 229 (290)
T 3fme_A 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQ----VVEE---- 229 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HHH----HHHS----
T ss_pred ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HHH----Hhcc----
Confidence 3 36789999996 4556889999999999999999999999643221111 110 0000
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 230 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 --PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0111123345678999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=289.49 Aligned_cols=239 Identities=15% Similarity=0.091 Sum_probs=177.2
Q ss_pred hccccccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC------cceE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS------KPST 90 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l 90 (274)
.|...+.||.|+| |.||++.. .++|.+.. ..+...+|+++|++++|||||++++++...+ ..++
T Consensus 55 ~y~~~~~lG~G~f--g~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSF--GVVYQAKLCDSGELVAIKKVLQ--DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEC--CTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCC--EEEEEEEECCCCcEEEEEEecc--cchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5777889999999 99999822 12222222 3344558999999999999999999986421 3679
Q ss_pred EEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC-CcEEEecccccee
Q 048314 91 EAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKISDFGLAKL 167 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~d~g~~~~ 167 (274)
||||+++ +|.+.+... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999985 676666531 456799999999999999999999999 99999999999999955 6789999999975
Q ss_pred cC----------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH--hhhhhhh
Q 048314 168 LS----------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF--INRELNK 234 (274)
Q Consensus 168 ~~----------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 234 (274)
.. ++.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+...+...- ....+..
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~---~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS---GVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCSCCHHHHHH
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCHHHHHh
Confidence 32 5679999998764 68999999999999999999999997431 1111111111000 0000000
Q ss_pred -------hhcCC--------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 235 -------LVRGT--------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 235 -------~~~~~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+. .++...+.++.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000 012334578999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.30 Aligned_cols=246 Identities=18% Similarity=0.187 Sum_probs=184.4
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-CCCCcHHHHHHHHhcCC-----------CCccceEeEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-YSPSRPLTLTSIVSRVS-----------WTTDIEVSSVA 82 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~ 82 (274)
.++|.....+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++ ||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHF--STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCC--eEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 357888899999999 99999831 112222211 12345678999999887 88999999998
Q ss_pred EeCC----cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc------
Q 048314 83 MRGS----KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD------ 152 (274)
Q Consensus 83 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~------ 152 (274)
...+ ..++||||+ +++|.+++.......+++..++.++.|++.||.|||+++ +++||||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 7644 789999999 899999998766667999999999999999999999942 899999999999994
Q ss_pred CCCcEEEeccccceecC--------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChh---hHHHHH
Q 048314 153 EFWTAKISDFGLAKLLS--------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPE---EIILTN 221 (274)
Q Consensus 153 ~~~~~kl~d~g~~~~~~--------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~---~~~~~~ 221 (274)
..+.+||+|||++.... ++.|+|||.+....++.++||||||+++|+|++|..||........ ...+..
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp TEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred CcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 44589999999986543 6779999999988899999999999999999999999975422111 111111
Q ss_pred HHHHHHh--------hhh----------------------hhhhh-cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhH
Q 048314 222 WVYKCFI--------NRE----------------------LNKLV-RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCV 270 (274)
Q Consensus 222 ~~~~~~~--------~~~----------------------~~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ev 270 (274)
.. .... +.. ..... .....+...+..+.+++.+||+.||++|||++|+
T Consensus 253 ~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 331 (373)
T 1q8y_A 253 II-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 331 (373)
T ss_dssp HH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence 10 0000 000 00000 1113567788999999999999999999999999
Q ss_pred Hh
Q 048314 271 VM 272 (274)
Q Consensus 271 l~ 272 (274)
++
T Consensus 332 l~ 333 (373)
T 1q8y_A 332 VN 333 (373)
T ss_dssp HT
T ss_pred hh
Confidence 86
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=292.19 Aligned_cols=179 Identities=20% Similarity=0.242 Sum_probs=149.9
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeC-----
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG----- 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 85 (274)
.++|...+.||.|+| |.||++.. .++|.+... ...+++.+|+.+|++++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~--g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSY--GYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CTTEEEEEEEEEETT--EEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCEEEEEEEeecCC--EEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 467888999999999 99999921 222222221 1234577999999999999999999999765
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
...++||||+. |+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 56899999986 699999975 45799999999999999999999999 9999999999999999999999999998
Q ss_pred eecC---------------------------------CCCcCCCccc-ccCCCccccceeehhHhHHHHhhcCCCc
Q 048314 166 KLLS---------------------------------DKGCMAPECY-KRTPISVKADVYGYGIVLLETICCWENM 207 (274)
Q Consensus 166 ~~~~---------------------------------~~~~~ape~~-~~~~~~~~~Di~s~G~~l~el~~g~~p~ 207 (274)
+... ++.|+|||++ ....++.++||||+||++|||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 7532 5669999986 4566899999999999999999854444
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=284.67 Aligned_cols=244 Identities=17% Similarity=0.171 Sum_probs=182.3
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEeC-----
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRG----- 85 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 85 (274)
..++|...+.+|.|+| |.||++.. .++|.+.... ..+.+.+|++++++++||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAY--GMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CTTTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccEEEEEEeecCCC--eEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 3467888999999999 99999821 1222222211 124567999999999999999999999754
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
...++||||+. |+|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 36899999997 599999975 4699999999999999999999999 9999999999999999999999999998
Q ss_pred eec--------------CCCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH------
Q 048314 166 KLL--------------SDKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY------ 224 (274)
Q Consensus 166 ~~~--------------~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------ 224 (274)
... +++.|+|||.+.. ..++.++||||||+++|+|++|..||...........+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643 2567999998754 4589999999999999999999999965422111111110000
Q ss_pred -HHHhhhhhh----hhhcCCc-----cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 225 -KCFINRELN----KLVRGTE-----VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 225 -~~~~~~~~~----~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+.... ....... .....+.++.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 0000001 11234577899999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=284.91 Aligned_cols=238 Identities=14% Similarity=0.130 Sum_probs=165.0
Q ss_pred Hhhhccc-cccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHH-HHhcCCCCccceEeEEEEe----CCc
Q 048314 20 KLRNFCR-SSLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTS-IVSRVSWTTDIEVSSVAMR----GSK 87 (274)
Q Consensus 20 ~~~~f~~-~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~----~~~ 87 (274)
..++|.. ..++|.|+| |.||++.. .++|.+.. .....+|+. .++.++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~--g~V~~~~~~~~~~~vavK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVN--GKVLECFHRRTGQKCALKLLYD---SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEES---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCC--eEEEEEEECCCCCEEEEEEecC---cHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 3567776 457999999 99999822 11222221 122334443 4567789999999999876 445
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC---CCcEEEecccc
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKISDFGL 164 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~d~g~ 164 (274)
.++||||+++|+|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 89999999999999999975556799999999999999999999999 9999999999999975 45599999999
Q ss_pred ceecC---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 165 AKLLS---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 165 ~~~~~---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
+.... ++.|+|||.+....++.++||||||+++|+|++|..||............. .... ....
T Consensus 178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~---~~~~ 250 (336)
T 3fhr_A 178 AKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK----RRIR---LGQY 250 (336)
T ss_dssp CEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred ceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH----Hhhh---cccc
Confidence 87543 567999999988888999999999999999999999996432111000000 0000 0000
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111122345678999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=284.28 Aligned_cols=191 Identities=18% Similarity=0.194 Sum_probs=156.0
Q ss_pred hHHHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-CCCCcHHHHHHHHhcCC-CC-----ccceEeEEE
Q 048314 16 SLCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-YSPSRPLTLTSIVSRVS-WT-----TDIEVSSVA 82 (274)
Q Consensus 16 ~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~ 82 (274)
.-....++|...+.||.|+| |.||+|.. .++|.+... ...+.+.+|+.+++.++ |+ +|+++++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSF--GQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TTCEETTTEEEEEEEEEETT--EEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCC--EEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 33444678888899999999 99999921 122222211 11234567888888875 55 499999999
Q ss_pred EeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc--CCCcEEEe
Q 048314 83 MRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD--EFWTAKIS 160 (274)
Q Consensus 83 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~--~~~~~kl~ 160 (274)
...+..++||||+. |+|.+++.......+++..++.++.|++.||.|||++ ..+|+||||||+||++. .++.+||+
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999999996 5999999886556799999999999999999999952 12899999999999994 47889999
Q ss_pred ccccceecC--------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCcccc
Q 048314 161 DFGLAKLLS--------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEID 210 (274)
Q Consensus 161 d~g~~~~~~--------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~ 210 (274)
|||++.... ++.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 204 DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 204 DFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999987543 66799999999989999999999999999999999999743
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=274.65 Aligned_cols=233 Identities=18% Similarity=0.181 Sum_probs=183.6
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHh----cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATV----NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
.++|.....+|.|++ |.||++.. .++|.. ......+.+.+|++++++++||||+++++++.+.+..++
T Consensus 21 ~~~y~i~~~lg~G~~--g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSF--GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceeeEEEcCCCC--EEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 468888999999999 99999821 122221 122334567899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC---CCcEEEecccccee
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKISDFGLAKL 167 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~d~g~~~~ 167 (274)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++..
T Consensus 99 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 99 VGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999999875 34699999999999999999999999 9999999999999965 34799999998865
Q ss_pred cC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 168 LS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 168 ~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
.. ++.|+|||.+.+ .++.++|+||||+++|+|++|..||.... .. .+. .....+... .
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~-~~~----~~~~~~~~~---~ 241 (287)
T 2wei_A 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EY-DIL----KRVETGKYA---F 241 (287)
T ss_dssp BCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH-HHH----HHHHHCCCC---C
T ss_pred ecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HH-HHH----HHHHcCCCC---C
Confidence 43 346999998865 48899999999999999999999996431 11 111 111111100 0
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+.+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00111234578999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=280.77 Aligned_cols=232 Identities=22% Similarity=0.222 Sum_probs=184.9
Q ss_pred hhhhHHHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--------CCCCcHHHHHHHHhcCC--CCccc
Q 048314 13 ARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--------YSPSRPLTLTSIVSRVS--WTTDI 76 (274)
Q Consensus 13 ~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--------~~~~~~~~e~~~l~~l~--h~niv 76 (274)
+..+.....++|.....+|.|+| |.||+|.. .++|.+... ...+.+.+|+.++++++ ||||+
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGF--GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp ------CCTTTEEEEEECSSSSS--CEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred cccccCCccCceEEEEEEeeCCC--eEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 33444445678888999999999 99999821 122222111 23466789999999996 59999
Q ss_pred eEeEEEEeCCcceEEEEeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc-CC
Q 048314 77 EVSSVAMRGSKPSTEAALDLP-WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EF 154 (274)
Q Consensus 77 ~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-~~ 154 (274)
++++++.+.+..++|+|++.+ ++|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++ .+
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR 186 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence 999999999999999999976 899999986 45799999999999999999999999 999999999999998 78
Q ss_pred CcEEEeccccceecC---------CCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH
Q 048314 155 WTAKISDFGLAKLLS---------DKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224 (274)
Q Consensus 155 ~~~kl~d~g~~~~~~---------~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 224 (274)
+.+||+|||++.... ++.|+|||.+....+ +.++||||||+++|+|++|..||... ..
T Consensus 187 ~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~-------- 254 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EE-------- 254 (320)
T ss_dssp TEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HH--------
T ss_pred CCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----hh--------
Confidence 899999999987543 567999999887665 68899999999999999999999532 00
Q ss_pred HHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 225 KCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.... ....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 255 --~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 --IIRG-------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --HHHC-------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hhcc-------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01123344578899999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=288.38 Aligned_cols=239 Identities=16% Similarity=0.172 Sum_probs=169.2
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeC-----
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG----- 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 85 (274)
.++|...+.+|.|+| |.||++. ..++|.+... ...+++.+|+.++++++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~--g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAY--GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp ETTEEEEEECC------CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCceEEeeEEeecCC--eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 467888999999999 9999982 1122222211 1234567999999999999999999998654
Q ss_pred -CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 86 -SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 86 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
...++|+|++ +++|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999998 6899999864 5699999999999999999999999 999999999999999999999999999
Q ss_pred ceec--------CCCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH--------
Q 048314 165 AKLL--------SDKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF-------- 227 (274)
Q Consensus 165 ~~~~--------~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 227 (274)
++.. ++..|+|||.+.. ..++.++||||+||++|+|++|+.||..... . .....+....
T Consensus 179 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~-~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 179 ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---I-DQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---H-HHHHHHHHHHCSCCHHHH
T ss_pred cccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H-HHHHHHHHHhCCCCHHHH
Confidence 8653 3678999999876 5789999999999999999999999964311 1 1111111100
Q ss_pred ---hhhhhhhhhcC----Ccc-----CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 ---INRELNKLVRG----TEV-----DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 ---~~~~~~~~~~~----~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+......+.. ... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00001111110 001 1123567899999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=285.93 Aligned_cols=239 Identities=16% Similarity=0.149 Sum_probs=180.4
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCC----CCcHHHHHHHHhcCCCCccceEeEEEEeCCcc--
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYS----PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP-- 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-- 88 (274)
.++|...+.+|.|+| |.||+|. ..++|.+..... .+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAY--GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCC--eEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 367778899999999 9999982 112222222211 24567899999999999999999999876654
Q ss_pred ----eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 89 ----STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 89 ----~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
++||||+. ++|.+++. ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred ceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 68888874 3599999999999999999999999 999999999999999999999999999
Q ss_pred ceec--------CCCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH--------
Q 048314 165 AKLL--------SDKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF-------- 227 (274)
Q Consensus 165 ~~~~--------~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 227 (274)
+... +++.|+|||.+.. ..++.++||||||+++|+|++|..||.... ....+........
T Consensus 191 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 191 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp C--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCcHHHHH
Confidence 8643 3678999999877 678999999999999999999999997431 1111111110000
Q ss_pred --h----hhhhhhhhcCC-----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 --I----NRELNKLVRGT-----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 --~----~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
. ........... ......+..+.+++.+||+.||++|||++|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 00000000000 112234678999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=277.28 Aligned_cols=238 Identities=18% Similarity=0.174 Sum_probs=185.8
Q ss_pred hhhhhhHHHHhhhccccccCCCCCCCCcchhHHHH-----HHHHHhcCCC----CCCcHHHHHHHHhcCC--CCccceEe
Q 048314 11 WIARSSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSPY----SPSRPLTLTSIVSRVS--WTTDIEVS 79 (274)
Q Consensus 11 ~~~~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~~----~~~~~~~e~~~l~~l~--h~niv~l~ 79 (274)
.+.+..+....++|...+.+|.|+| |.||++.. .++|...... ..+.+.+|+.++.+++ ||||++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGS--SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSS--EEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCC--EEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 3455556666788999999999999 99998822 1222222211 1245679999999997 49999999
Q ss_pred EEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEE
Q 048314 80 SVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 159 (274)
Q Consensus 80 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl 159 (274)
+++.+.+..++||| +.+++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||++++ +.+||
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEE
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEE
Confidence 99999999999999 678899999986 45789999999999999999999999 9999999999999965 79999
Q ss_pred eccccceec-------------CCCCcCCCccccc-----------CCCccccceeehhHhHHHHhhcCCCccccCCChh
Q 048314 160 SDFGLAKLL-------------SDKGCMAPECYKR-----------TPISVKADVYGYGIVLLETICCWENMEIDASKPE 215 (274)
Q Consensus 160 ~d~g~~~~~-------------~~~~~~ape~~~~-----------~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~ 215 (274)
+|||++... +++.|+|||.+.. ..++.++||||||+++|+|++|..||.......
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI- 246 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-
Confidence 999998643 2667999999865 467889999999999999999999996431110
Q ss_pred hHHHHHHHHHHHhhhhhhhhhcC---CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 216 EIILTNWVYKCFINRELNKLVRG---TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. .....++ ...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 247 -~~-------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 -SK-------------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp -HH-------------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HH-------------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 00 0011111 1233344578999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=277.40 Aligned_cols=240 Identities=15% Similarity=0.121 Sum_probs=175.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEE---------
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAM--------- 83 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~--------- 83 (274)
.++|...+.+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGN--GLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-------CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCC--eEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 356778899999999 99999821 112222211 22345779999999999999999999873
Q ss_pred -----eCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc-CCCcE
Q 048314 84 -----RGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWTA 157 (274)
Q Consensus 84 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-~~~~~ 157 (274)
+.+..++||||+. |+|.+++.. +.+++..++.++.|++.||.|||+. +++|+||||+||+++ .++.+
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 699999964 5699999999999999999999999 999999999999997 56799
Q ss_pred EEeccccceecC--------------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHH
Q 048314 158 KISDFGLAKLLS--------------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW 222 (274)
Q Consensus 158 kl~d~g~~~~~~--------------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~ 222 (274)
||+|||.+.... +..|+|||.+.. ..++.++||||||+++|+|++|+.||..... ...+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~~ 237 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQLI 237 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHH
Confidence 999999987532 556999998865 6789999999999999999999999974421 1111111
Q ss_pred HHHHH--hhhhhh------------hhhcCC----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 223 VYKCF--INRELN------------KLVRGT----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 223 ~~~~~--~~~~~~------------~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..... ...... ....+. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000 000000 000010 112234678999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=281.65 Aligned_cols=239 Identities=17% Similarity=0.163 Sum_probs=182.4
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEeC-----C
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRG-----S 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 86 (274)
.++|...+.+|.|+| |.||++.. .++|...... ....+.+|+.++++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAY--GVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCC--eEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 568888999999999 99999821 1222222111 123456899999999999999999998654 6
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++||||+. |+|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 7899999997 699999976 4699999999999999999999999 99999999999999999999999999987
Q ss_pred ecC---------------------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHH
Q 048314 167 LLS---------------------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVY 224 (274)
Q Consensus 167 ~~~---------------------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 224 (274)
... ++.|+|||.+.. ..++.++||||||+++|+|++|..||..... ...+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~-~~ 236 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY---RHQLLL-IF 236 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHH-HH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHH-HH
Confidence 532 556999998764 6789999999999999999999999974421 111111 10
Q ss_pred HHHhh------------hhhhhhhcC-----C----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 225 KCFIN------------RELNKLVRG-----T----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 225 ~~~~~------------~~~~~~~~~-----~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..... ......+.. . ......+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 10000 000000000 0 111244678899999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=289.21 Aligned_cols=235 Identities=7% Similarity=-0.039 Sum_probs=165.1
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCC-----CCCcHHHH---HHHHhcCCCCccceEe-------
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPY-----SPSRPLTL---TSIVSRVSWTTDIEVS------- 79 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~-----~~~~~~~e---~~~l~~l~h~niv~l~------- 79 (274)
..+|...+.+|.|+| |.||+|.. .++|.+.... ..+.+.+| +..|+. +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 61 ERKLKLVEPLRVGDR--SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCC
T ss_pred ceeeeeeeeccCCCC--EEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeee
Confidence 345777889999999 99999931 1223232221 12334567 455555 799988755
Q ss_pred EEEEeCC-----------------cceEEEEeCCCCCHHHHHHhCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCC
Q 048314 80 SVAMRGS-----------------KPSTEAALDLPWDLAYIIFCSAERNPYWNQR------VRIALDVAKGILYLHDECE 136 (274)
Q Consensus 80 ~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~~~~~i~~~l~~lh~~~~ 136 (274)
+++...+ ..++|||||+ |+|.+++... ...+++..+ ..++.|++.||.|||++
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-- 213 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSK-- 213 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC--
Confidence 5554432 3799999999 8999999863 234566666 78889999999999999
Q ss_pred CCcccCCCCCCceEEcCCCcEEEeccccceecC--------CCCcCCCccccc--CCCccccceeehhHhHHHHhhcCCC
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--------DKGCMAPECYKR--TPISVKADVYGYGIVLLETICCWEN 206 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--------~~~~~ape~~~~--~~~~~~~Di~s~G~~l~el~~g~~p 206 (274)
+++||||||+||+++.++.+||+|||+++... ++.|+|||.+.. ..++.++|||||||++|+|++|+.|
T Consensus 214 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 214 -GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp -TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred -CCccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999987543 577999999987 6789999999999999999999999
Q ss_pred ccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 207 MEIDASKPEEIILTNWVYKCFINRELNKLVRGT---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
|.......... ............. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 293 f~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 97542110000 0000000000000 112345678999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=288.15 Aligned_cols=234 Identities=18% Similarity=0.178 Sum_probs=176.5
Q ss_pred HHhhhccccccCCCCCCCCcch-hHH----HHHHHHHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEE
Q 048314 19 TKLRNFCRSSLNDRNSPRSKSV-WSC----MRALMATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 19 ~~~~~f~~~~~~g~g~~~~g~v-y~~----~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 92 (274)
....+|.....||.|+| |.| |++ ...++|.+. ....+.+.+|+.+|+++ +|||||++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~--G~V~~~~~~~~~~vAvK~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAE--GTIVYRGMFDNRDVAVKRIL-PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGG--GCEEEEEESSSSEEEEEEEC-TTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcC--EEEEEEEEeCCeEEEEEEEC-HHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34457888999999999 874 433 222222222 23345577999999999 7999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc-----CCCcEEEecccccee
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-----EFWTAKISDFGLAKL 167 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-----~~~~~kl~d~g~~~~ 167 (274)
|||. |+|.+++... ...+++...+.++.|++.||.|||+. +|+||||||+||++. ....++|+|||+++.
T Consensus 98 E~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 98 ELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp ECCS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred ECCC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 9996 6999999863 34456666788999999999999999 999999999999994 334688999999864
Q ss_pred c--------------CCCCcCCCcccc---cCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhh
Q 048314 168 L--------------SDKGCMAPECYK---RTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFIN 229 (274)
Q Consensus 168 ~--------------~~~~~~ape~~~---~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (274)
. +++.|+|||++. ...++.++|||||||++|||++ |..||..... .... . ...
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--~~~~------~-~~~ 243 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--RQAN------I-LLG 243 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--HHHH------H-HTT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--HHHH------H-Hhc
Confidence 3 367899999987 3567789999999999999999 8888853311 0000 0 000
Q ss_pred hhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 230 RELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. .......+......+.+++.+||+.||++|||+.||++
T Consensus 244 ~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 AC---SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CC---CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC---CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 00111223455667899999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=276.94 Aligned_cols=228 Identities=19% Similarity=0.173 Sum_probs=177.3
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC--------CCCCcHHHHHHHHhcC----CCCccceEe
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP--------YSPSRPLTLTSIVSRV----SWTTDIEVS 79 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~--------~~~~~~~~e~~~l~~l----~h~niv~l~ 79 (274)
....++|...+.+|.|+| |.||+|.. .++|..... .....+.+|+.++.++ +||||++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGF--GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp ------CEEEEEEEEETT--EEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhhhhceEEeeEEEcCCC--EEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 444678999999999999 99999821 122222211 2345567899999998 899999999
Q ss_pred EEEEeCCcceEEEEe-CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc-CCCcE
Q 048314 80 SVAMRGSKPSTEAAL-DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWTA 157 (274)
Q Consensus 80 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-~~~~~ 157 (274)
+++.+.+..++|+|+ +.+++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++ .++.+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 999999999999999 789999999986 34699999999999999999999999 999999999999998 88999
Q ss_pred EEeccccceecC---------CCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH
Q 048314 158 KISDFGLAKLLS---------DKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF 227 (274)
Q Consensus 158 kl~d~g~~~~~~---------~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (274)
+|+|||++.... +..|+|||.+....+ +.++||||||+++|+|++|+.||... .. .
T Consensus 180 kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~----------~ 245 (312)
T 2iwi_A 180 KLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----QE----------I 245 (312)
T ss_dssp EECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HH----------H
T ss_pred EEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----HH----------H
Confidence 999999987543 567999999877665 45899999999999999999999532 00 0
Q ss_pred hhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 228 INRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
.. .....+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 LE-------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HH-------TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hh-------hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0112344556789999999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=279.97 Aligned_cols=239 Identities=16% Similarity=0.162 Sum_probs=181.0
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCC----CCcHHHHHHHHhcCCCCccceEeEEEEeCCc---
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYS----PSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK--- 87 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 87 (274)
.++|.....+|.|+| |.||++.. .++|....... .+.+.+|+.++++++||||+++++++.+.+.
T Consensus 23 ~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 23 PKTYVSPTHVGSGAY--GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp ETTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CceEEEeeeEecCCC--eEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 356788899999999 99999821 12222222111 2356789999999999999999999987654
Q ss_pred ---ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 88 ---PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 88 ---~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
.++||||+. ++|.+++. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred ceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 68888774 3599999999999999999999999 999999999999999999999999999
Q ss_pred ceec--------CCCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH---------
Q 048314 165 AKLL--------SDKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC--------- 226 (274)
Q Consensus 165 ~~~~--------~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 226 (274)
+... +++.|+|||.+.. ..++.++||||||+++|+|++|..||..... ...+.......
T Consensus 173 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 173 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCBCCHHHHT
T ss_pred ccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHHH
Confidence 8653 3678999998876 6788999999999999999999999975421 11111110000
Q ss_pred -Hhhhhhhhhhc-------C--CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 227 -FINRELNKLVR-------G--TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 227 -~~~~~~~~~~~-------~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..+......+. . .......+..+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000000 0 0123355688999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=287.32 Aligned_cols=231 Identities=18% Similarity=0.158 Sum_probs=170.0
Q ss_pred cccccCCCCCCCCcchhHH-----HHHHHHHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEEeCCCC
Q 048314 25 CRSSLNDRNSPRSKSVWSC-----MRALMATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAALDLPW 98 (274)
Q Consensus 25 ~~~~~~g~g~~~~g~vy~~-----~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 98 (274)
...+.+|.|+| |.||.. ...++|.... ...+.+.+|+.+++++ +|||||++++++.+.+..++|||||. |
T Consensus 18 ~~~~~LG~G~~--g~V~~~~~~~g~~vAvK~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 18 VSEKILGYGSS--GTVVFQGSFQGRPVAVKRMLI-DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEEECST--TCEEEEEESSSSEEEEEEEEG-GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eccCeEeeCCC--eEEEEEEEECCeEEEEEEEcH-HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 34688999999 988643 1111221111 1223467899999876 79999999999999999999999996 6
Q ss_pred CHHHHHHhCCCCC-----CCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCC-------------CcEEEe
Q 048314 99 DLAYIIFCSAERN-----PYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-------------WTAKIS 160 (274)
Q Consensus 99 sL~~~l~~~~~~~-----l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-------------~~~kl~ 160 (274)
+|.+++....... .++..++.++.|++.||.|||+. +|+||||||+||+++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 9999998632211 12334578999999999999999 99999999999999653 589999
Q ss_pred ccccceec---------------CCCCcCCCccccc-------CCCccccceeehhHhHHHHhh-cCCCccccCCChhhH
Q 048314 161 DFGLAKLL---------------SDKGCMAPECYKR-------TPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEI 217 (274)
Q Consensus 161 d~g~~~~~---------------~~~~~~ape~~~~-------~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~ 217 (274)
|||++... +++.|+|||++.. ..++.++|||||||++|||++ |..||..... . ..
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-~-~~ 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-R-ES 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT-H-HH
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh-h-HH
Confidence 99998643 3567999999865 568899999999999999998 8999964311 1 10
Q ss_pred HHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 218 ILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. ..............+...+.++.+++.+||+.||++|||+.||++
T Consensus 249 ~i--------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NI--------IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH--------HHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH--------hcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00 011000000011234567789999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=273.29 Aligned_cols=239 Identities=15% Similarity=0.166 Sum_probs=170.5
Q ss_pred hHHHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCCC----CcHHHHHHHHhcCCCCccceEeEEEEeC
Q 048314 16 SLCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYSP----SRPLTLTSIVSRVSWTTDIEVSSVAMRG 85 (274)
Q Consensus 16 ~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~ 85 (274)
+.....++|.....+|.|+| |.||++.. .++|........ +.+.++..+++.++||||+++++++.+.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~--g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTC--GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp EEECCGGGEEEEEEC--------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhhhhhccccccceeeecCC--eeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 34455678888899999999 99999822 122222221111 1223445578888999999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
+..++||||+ ++.+..+... ....+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999 5566666554 35679999999999999999999998 6 899999999999999999999999999
Q ss_pred ceec----------CCCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh
Q 048314 165 AKLL----------SDKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN 229 (274)
Q Consensus 165 ~~~~----------~~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (274)
+... +++.|+|||.+. ...++.++||||||+++|+|++|..||...... ..... .. ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~---~~-~~ 244 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---FEVLT---KV-LQ 244 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHH---HH-HH
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---HHHHH---HH-hc
Confidence 8543 367899999984 456788999999999999999999999643111 11100 00 11
Q ss_pred hhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 230 RELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 245 EEPPL----LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SCCCC----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCCC----CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 10000 0111234578999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=291.79 Aligned_cols=241 Identities=16% Similarity=0.113 Sum_probs=180.0
Q ss_pred hhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEe------C
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR------G 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~ 85 (274)
.++|.....+|.|+| |.||++.. .++|..... ...+.+.+|+.++++++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~f--G~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGF--GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSS--SBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCC--eEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 478899999999999 99999822 122222221 113457789999999999999999999755 6
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCc---EEEec
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAE-RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT---AKISD 161 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~---~kl~d 161 (274)
+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++. ++|+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence 778999999999999999986432 3699999999999999999999999 9999999999999986654 89999
Q ss_pred cccceec----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh-
Q 048314 162 FGLAKLL----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR- 230 (274)
Q Consensus 162 ~g~~~~~----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 230 (274)
||.+... +++.|+|||.+....++.++||||||+++|+|++|..||.....+. .|........
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~------~~~~~i~~~~~ 241 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV------QWHGKVREKSN 241 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH------HSSTTCC----
T ss_pred cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh------hhhhhhhcccc
Confidence 9998753 2567999999998899999999999999999999999996431100 0000000000
Q ss_pred ---hhhh-----------hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 231 ---ELNK-----------LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 231 ---~~~~-----------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.... .-.+...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~ 297 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence 0000 00111345567889999999999999999999988653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=264.63 Aligned_cols=221 Identities=14% Similarity=0.139 Sum_probs=171.4
Q ss_pred hhhcccc-ccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHH-hcCCCCccceEeEEEEe----CCcc
Q 048314 21 LRNFCRS-SLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIV-SRVSWTTDIEVSSVAMR----GSKP 88 (274)
Q Consensus 21 ~~~f~~~-~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 88 (274)
.++|... .++|.|+| |.||++.. .++|.+. ....+.+|+.++ +..+||||+++++++.+ ....
T Consensus 16 ~~~y~~~~~~lg~G~~--g~V~~~~~~~~~~~vaiK~~~---~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGIN--GKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEE---CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCC--eEEEEEEEcCCCcEEEEEEec---ccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3455554 78999999 99999822 1122222 245577899988 56689999999999876 6678
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC---CCcEEEeccccc
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKISDFGLA 165 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~d~g~~ 165 (274)
++||||+++|+|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++. ++.++|+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999999986556799999999999999999999999 9999999999999998 788999999998
Q ss_pred eecCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-ccC--
Q 048314 166 KLLSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-EVD-- 242 (274)
Q Consensus 166 ~~~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-- 242 (274)
.... ...++.++||||||+++|+|++|..||........ ............ ..+
T Consensus 168 ~~~~-----------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------------~~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 168 KETT-----------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SPGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp EECT-----------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCCSSCTTCCSSCHH
T ss_pred cccc-----------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------------hHHHHHHHhhccccCCch
Confidence 6543 34578899999999999999999999964311100 000000000000 122
Q ss_pred --HHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 243 --KKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 243 --~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+..+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 234678999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=273.20 Aligned_cols=233 Identities=20% Similarity=0.209 Sum_probs=167.0
Q ss_pred HhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCC---CCcHHHHHH-HHhcCCCCccceEeEEEEeCCcce
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYS---PSRPLTLTS-IVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~---~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
..++|.....+|.|+| |.||++.. .++|.+..... ...+..|+. +++.++||||+++++++.+.+..+
T Consensus 20 ~~~~y~~~~~lg~G~~--g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAY--GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CSCSEEC-CEEEECSS--EEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred CHHHhhehheeccCCC--EEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 3467888899999999 99999822 22232322211 223445655 777889999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 90 TEAALDLPWDLAYIIFC---SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
+||||+.+ +|.+++.. .....+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||++.
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 99999985 88888763 1346799999999999999999999984 289999999999999999999999999986
Q ss_pred ec----------CCCCcCCCccc----ccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 167 LL----------SDKGCMAPECY----KRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 167 ~~----------~~~~~~ape~~----~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
.. ++..|+|||.+ ....++.++||||||+++|+|++|..||....... ...
T Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------~~~ 239 (327)
T 3aln_A 175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---------------DQL 239 (327)
T ss_dssp C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------------
T ss_pred ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---------------HHH
Confidence 53 35679999998 45568899999999999999999999996431100 001
Q ss_pred hhhhcCC------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 233 NKLVRGT------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 233 ~~~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1111111 112245678999999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=264.58 Aligned_cols=214 Identities=14% Similarity=0.100 Sum_probs=168.0
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCCCC-C----CcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSPYS-P----SRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~-~----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|.....+|.|+| |.||+|.. .++|.+..... . +.+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~y~i~~~lg~G~~--g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPP--LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTT--CEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEEcccCC--eEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 56888999999999 99999822 12333332212 2 467899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecCC
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD 170 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 170 (274)
||||+.+++|.+++.. .........++.|++.||.|||+. +++||||||+||+++.++.++|++++
T Consensus 109 v~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999954 235567888999999999999999 99999999999999999999998554
Q ss_pred CCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-----ccCHHH
Q 048314 171 KGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-----EVDKKN 245 (274)
Q Consensus 171 ~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 245 (274)
|++ +++.++||||||+++|+|++|+.||.......... .....+... ..+...
T Consensus 175 --~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~ 232 (286)
T 3uqc_A 175 --TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-------------PAERDTAGQPIEPADIDRDI 232 (286)
T ss_dssp --CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-------------ECCBCTTSCBCCHHHHCTTS
T ss_pred --ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-------------HHHHHhccCCCChhhcccCC
Confidence 333 36899999999999999999999997542111000 000000000 122345
Q ss_pred HHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 246 LENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 246 ~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+..+.+++.+||+.||++| |+.|+++.|
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~~L 260 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLNLM 260 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHHHH
Confidence 6789999999999999999 999999865
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=291.24 Aligned_cols=218 Identities=13% Similarity=0.137 Sum_probs=171.2
Q ss_pred hhccccccCCCCCCCCcchhHHHH-------HHHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEeCCc----
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-------ALMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK---- 87 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-------~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 87 (274)
++|.....||.|+| |.||++.. .++|...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 80 ~~y~i~~~lg~G~~--g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGL--GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETT--EEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCC--eEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 67888899999999 99999822 1222222211 12346799999999999999999999987665
Q ss_pred -ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 88 -PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 88 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
.++||||+++++|.+++.. .+++..++.++.|++.||.|||+. +|+||||||+||+++.+ .+||+|||+++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999988753 799999999999999999999999 99999999999999886 89999999987
Q ss_pred ec-------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC
Q 048314 167 LL-------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 239 (274)
Q Consensus 167 ~~-------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (274)
.. +++.|+|||++.... +.++||||||+++|+|++|..|+....... +...
T Consensus 230 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------------~~~~ 287 (681)
T 2pzi_A 230 RINSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------------LPED 287 (681)
T ss_dssp ETTCCSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------------CCTT
T ss_pred hcccCCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------------cccc
Confidence 54 477899999887654 889999999999999999988875321100 0000
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCChhhHH
Q 048314 240 EVDKKNLENLVKVGLWCVQDEPALRPSMKCVV 271 (274)
Q Consensus 240 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl 271 (274)
......+..+.+++.+||+.||++||+..+.+
T Consensus 288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l 319 (681)
T 2pzi_A 288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEM 319 (681)
T ss_dssp CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred ccccccCHHHHHHHhhhccCChhhCCCHHHHH
Confidence 01112346789999999999999999765543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=268.26 Aligned_cols=231 Identities=13% Similarity=0.050 Sum_probs=167.8
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-----CCCCcHHHHHHHHhcCCC-Cccc--------
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-----YSPSRPLTLTSIVSRVSW-TTDI-------- 76 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-----~~~~~~~~e~~~l~~l~h-~niv-------- 76 (274)
+....++|...++||+|+| |.||++.. .++|..... ...+.+.+|+.++..++| +|..
T Consensus 73 ~~~~~~~~~~~~~LG~G~f--G~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDP--YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150 (413)
T ss_dssp SSSCCEEEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred CCCCceeEEEecccccCCC--EEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence 3344566778899999999 99999931 122322211 235567899999999987 3211
Q ss_pred -e------------EeEEEEe-----CCcceEEEEeCCCCCHHHHHH-----hCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 048314 77 -E------------VSSVAMR-----GSKPSTEAALDLPWDLAYIIF-----CSAERNPYWNQRVRIALDVAKGILYLHD 133 (274)
Q Consensus 77 -~------------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~~~~~i~~~l~~lh~ 133 (274)
. +..++.. ....+++|+++ +++|.+++. ......+++..++.++.|++.||.|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 1 1111111 22356777754 689999995 2233458899999999999999999999
Q ss_pred CCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-------CCCcCCCccc----------ccCCCccccceeehhHh
Q 048314 134 ECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-------DKGCMAPECY----------KRTPISVKADVYGYGIV 196 (274)
Q Consensus 134 ~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-------~~~~~ape~~----------~~~~~~~~~Di~s~G~~ 196 (274)
. +|+||||||+|||++.++.+||+|||+++... .+.|+|||++ ....++.++|||||||+
T Consensus 230 ~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 230 Y---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp T---TEECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred C---CcccCCcccceEEEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9 99999999999999999999999999986432 2789999998 44567889999999999
Q ss_pred HHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 197 LLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 197 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
+|||++|+.||...... .....++... ...+..+.+++.+||+.||++|||+.++++
T Consensus 307 l~elltg~~Pf~~~~~~----------------~~~~~~~~~~---~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAAL----------------GGSEWIFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGG----------------SCSGGGGSSC---CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchh----------------hhHHHHHhhc---ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999643110 0111111111 123467999999999999999999998865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=262.46 Aligned_cols=226 Identities=11% Similarity=0.030 Sum_probs=169.6
Q ss_pred hhhccccccCCCCCCCCcchhHHH----HHHHHHhcCC----------CCCCcHHHHHHHHhcCC---------CCccce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM----RALMATVNSP----------YSPSRPLTLTSIVSRVS---------WTTDIE 77 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~----~~~~~~~~~~----------~~~~~~~~e~~~l~~l~---------h~niv~ 77 (274)
.++|...+.||+|+| |.||++. ..++|.+... ...+.+.+|+.++++++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~--g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVF--GEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETT--EEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCc--eEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 467888899999999 9999982 1222222211 11155779999999886 788887
Q ss_pred EeEEEE------------------------------eCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHH
Q 048314 78 VSSVAM------------------------------RGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKG 127 (274)
Q Consensus 78 l~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~ 127 (274)
+.+.+. +.+..++|||||++|++.+.+.. ..+++..++.++.|++.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 777643 26789999999999976666643 568999999999999999
Q ss_pred HHHHh-cCCCCCcccCCCCCCceEEcCCC--------------------cEEEeccccceec------CCCCcCCCcccc
Q 048314 128 ILYLH-DECEPPILHCDIKPQNILMDEFW--------------------TAKISDFGLAKLL------SDKGCMAPECYK 180 (274)
Q Consensus 128 l~~lh-~~~~~~i~h~dl~~~nil~~~~~--------------------~~kl~d~g~~~~~------~~~~~~ape~~~ 180 (274)
|.||| +. +|+||||||+|||++.++ .+||+|||+++.. +++.|+|||++.
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhc
Confidence 99999 88 999999999999999876 8999999999754 478899999998
Q ss_pred cCCCccccceeehhHh-HHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh----cCCccCHHHHHHHHHHHHH
Q 048314 181 RTPISVKADVYGYGIV-LLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV----RGTEVDKKNLENLVKVGLW 255 (274)
Q Consensus 181 ~~~~~~~~Di~s~G~~-l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~ 255 (274)
+.. +.++||||++++ .+++++|..||... .|.... ......... .....+...++++.+|+.+
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 318 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----------LWLHYL-TDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRT 318 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----------HHHHHH-HHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHH
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcch----------hhhhHH-HHhhhhhhccCcccchhhhhhcCHHHHHHHHH
Confidence 666 889999998766 77888999998421 111010 000010100 1112344678899999999
Q ss_pred hhccCCCCCCChhhHH
Q 048314 256 CVQDEPALRPSMKCVV 271 (274)
Q Consensus 256 cl~~dp~~Rps~~evl 271 (274)
||+.| |++|++
T Consensus 319 ~L~~d-----sa~e~l 329 (336)
T 2vuw_A 319 MLNFS-----SATDLL 329 (336)
T ss_dssp GGGSS-----SHHHHH
T ss_pred HhccC-----CHHHHH
Confidence 99976 999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-29 Score=233.27 Aligned_cols=141 Identities=12% Similarity=0.036 Sum_probs=110.1
Q ss_pred CcHHHHHHHHhcC-CCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 048314 58 SRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECE 136 (274)
Q Consensus 58 ~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~ 136 (274)
++|.+|+++|+++ .|+||+++++++.+++..||||||++|++|.+.+.. .+.++.. +++.||+.||.|+|++
T Consensus 286 ~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~-- 358 (569)
T 4azs_A 286 YELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQ-- 358 (569)
T ss_dssp HHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHC--
Confidence 4588999999999 599999999999999999999999999999999986 4567754 4789999999999999
Q ss_pred CCcccCCCCCCceEEcCCCcEEEeccccceecC-----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCC
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWE 205 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~ 205 (274)
||+||||||+|||++.++.+||+|||+++... |+.|+|||++.+ .+..++|+||+|+.++++.++..
T Consensus 359 -GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 359 -GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred -CceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 99999999999999999999999999987543 567999998875 45778999999999888776654
Q ss_pred Cc
Q 048314 206 NM 207 (274)
Q Consensus 206 p~ 207 (274)
++
T Consensus 437 ~~ 438 (569)
T 4azs_A 437 NW 438 (569)
T ss_dssp HH
T ss_pred hh
Confidence 43
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-25 Score=207.55 Aligned_cols=164 Identities=15% Similarity=0.119 Sum_probs=128.3
Q ss_pred cccCCCCCCCCcchhHH----HHHHHHH-hcCCC---------CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 27 SSLNDRNSPRSKSVWSC----MRALMAT-VNSPY---------SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~----~~~~~~~-~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.+++|+|+| |.||++ ...++|. ..... ..+++.+|++++++++||||+++..++.+.+..++||
T Consensus 341 ~~~LG~G~f--g~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAE--ADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CC--EEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCC--EEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 568999999 999966 1111111 11111 1234689999999999999997777777888889999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
||+++++|.+++.. +..++.|++.||.|||++ +|+||||||+||+++. .+||+|||+++...
T Consensus 419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999964 568999999999999999 9999999999999998 99999999997654
Q ss_pred ---------------CCCcCCCccccc--CCCccccceeehhHhHHHHhhcCCCc
Q 048314 170 ---------------DKGCMAPECYKR--TPISVKADVYGYGIVLLETICCWENM 207 (274)
Q Consensus 170 ---------------~~~~~ape~~~~--~~~~~~~Di~s~G~~l~el~~g~~p~ 207 (274)
++.|+|||++.. ..|+...|+||..+-..+.+.++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 567999999976 45778899999998888877777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-21 Score=166.51 Aligned_cols=145 Identities=12% Similarity=0.029 Sum_probs=108.7
Q ss_pred hhHHHHhhhccccccCCCCCCCCcchhHHHH-----HHHHHhcCCC--------------------CCCcHHHHHHHHhc
Q 048314 15 SSLCTKLRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSPY--------------------SPSRPLTLTSIVSR 69 (274)
Q Consensus 15 ~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~~--------------------~~~~~~~e~~~l~~ 69 (274)
..+......|...+.+|.|+| |.||+|.. .++|...... ....+.+|+.+|++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~--g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKE--SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSS--EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHhCCeEEEecCEeccCCC--ceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 344444455555689999999 99998832 1222222110 12236799999999
Q ss_pred CCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCce
Q 048314 70 VSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 149 (274)
Q Consensus 70 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 149 (274)
++ | +++++++. .+..++||||+++|+|.+ +.. .....++.|++.||.|||+. +++||||||+||
T Consensus 161 l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI 224 (282)
T 1zar_A 161 LQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV 224 (282)
T ss_dssp TT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred cc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence 98 5 66666543 366799999999999988 421 22457999999999999999 999999999999
Q ss_pred EEcCCCcEEEeccccceecCCCCcCCCcccc
Q 048314 150 LMDEFWTAKISDFGLAKLLSDKGCMAPECYK 180 (274)
Q Consensus 150 l~~~~~~~kl~d~g~~~~~~~~~~~ape~~~ 180 (274)
+++ ++.++|+|||++... ..+.|||.+.
T Consensus 225 Ll~-~~~vkl~DFG~a~~~--~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVEV--GEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEET--TSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeEC--CCCCHHHHHH
Confidence 999 999999999999764 4568888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.5e-17 Score=139.14 Aligned_cols=131 Identities=12% Similarity=-0.052 Sum_probs=97.5
Q ss_pred hccccccCCCCCCCCcchhHHHH--------HHHHHhcCC-CCC-------------------------CcHHHHHHHHh
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCMR--------ALMATVNSP-YSP-------------------------SRPLTLTSIVS 68 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~~--------~~~~~~~~~-~~~-------------------------~~~~~e~~~l~ 68 (274)
-+.....||.|+| |.||+|.. .++|..... ... ..+.+|+.+|.
T Consensus 48 ~~~i~~~ig~G~~--g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 48 ITAMGGVISTGKE--ANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp EEEEEEEEEECSS--EEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecce--EEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 3455688999999 99999822 233322111 000 14678999999
Q ss_pred cCCCCcc--ceEeEEEEeCCcceEEEEeCCC-C----CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCcc
Q 048314 69 RVSWTTD--IEVSSVAMRGSKPSTEAALDLP-W----DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLH-DECEPPIL 140 (274)
Q Consensus 69 ~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~~i~ 140 (274)
+++|+|+ ++.+++ +..+|||||+.+ | +|.++... .++.....++.|++.+|.||| +. +++
T Consensus 126 ~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 9998864 455543 367999999942 4 78777543 234567889999999999999 88 999
Q ss_pred cCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 141 HCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 141 h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
||||||.|||++. .++|+|||++....
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999999988 89999999987653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.8e-14 Score=126.29 Aligned_cols=141 Identities=12% Similarity=0.032 Sum_probs=89.9
Q ss_pred hhhHHHHhhhccccccCCCCCCCCcchhHHH-----HHHHHHhcCC-------CCCCc---------HH--------HHH
Q 048314 14 RSSLCTKLRNFCRSSLNDRNSPRSKSVWSCM-----RALMATVNSP-------YSPSR---------PL--------TLT 64 (274)
Q Consensus 14 ~~~l~~~~~~f~~~~~~g~g~~~~g~vy~~~-----~~~~~~~~~~-------~~~~~---------~~--------~e~ 64 (274)
...|.....-|.....||.|++ |.||+|. ..++|..+.. ....+ .+ .|.
T Consensus 87 L~~L~~rg~iY~I~~~IG~Gk~--a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~ 164 (397)
T 4gyi_A 87 LHTHAARKDVYSVGSRIGVGKE--SDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEF 164 (397)
T ss_dssp HHHHHHTTSCSEEEEEEEECSS--EEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCEEEecCEeeeCCc--eEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHH
Confidence 3444554455777889999999 9999981 1222221110 00111 11 244
Q ss_pred HHHhcCCCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCC
Q 048314 65 SIVSRVSWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDI 144 (274)
Q Consensus 65 ~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl 144 (274)
..|.++.+.++.-..-+.. ...+|||||+++++|.++... +....++.|++.+|.+||+. +++||||
T Consensus 165 ~nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDL 231 (397)
T 4gyi_A 165 AFMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDF 231 (397)
T ss_dssp HHHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred HHHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCC
Confidence 4555554333211111111 234799999999888655321 12356789999999999999 9999999
Q ss_pred CCCceEEcCCC----------cEEEeccccceecC
Q 048314 145 KPQNILMDEFW----------TAKISDFGLAKLLS 169 (274)
Q Consensus 145 ~~~nil~~~~~----------~~kl~d~g~~~~~~ 169 (274)
||.|||++.++ .+.++||+-+....
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99999998765 38899999876544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=1.4e-10 Score=96.48 Aligned_cols=141 Identities=11% Similarity=-0.034 Sum_probs=102.9
Q ss_pred HHHhhhccccccCCCCCCCCcchhHHH----HHHHHHhcC--CCCCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceE
Q 048314 18 CTKLRNFCRSSLNDRNSPRSKSVWSCM----RALMATVNS--PYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 18 ~~~~~~f~~~~~~g~g~~~~g~vy~~~----~~~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 90 (274)
.....+|......+.|+. +.||+.. ..++|.... ......+.+|+.+++.+. +.++.++++++.+.+..++
T Consensus 10 ~~~l~~~~~~~~~~g~s~--~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSP--AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECCSCCSS--SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhccceeEeeccCCCC--CeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 344556766677777777 7888762 222222211 134567889999999985 6778999999999899999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC----------------------------------- 135 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~----------------------------------- 135 (274)
||||++|.+|.+.+.. ......++.+++.+++.||+..
T Consensus 88 v~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999999876421 1223467889999999999810
Q ss_pred ---------------------CCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 136 ---------------------EPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 136 ---------------------~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
...++|+|+++.||+++++..+.++||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 02589999999999998766667999987643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.83 E-value=7.9e-10 Score=91.48 Aligned_cols=134 Identities=15% Similarity=-0.022 Sum_probs=92.3
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----HHHHHhcCCCCCCcHHHHHHHHhcCCCCc--cceEeEEEEeCCcceEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSPYSPSRPLTLTSIVSRVSWTT--DIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e 93 (274)
..++....+.+.|.. +.||++.. .++|.... .....+.+|+.+++.+.+.+ +.+++++..+.+..++|||
T Consensus 19 ~~~~~~~~~~~gg~~--~~v~~~~~~~g~~~vlK~~~~-~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSD--AAVFRLSAQGRPVLFVKTDLS-GALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSS--CEEEEEECTTSCCEEEEEECS-CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCC--ceEEEEecCCCCeEEEEeCCc-ccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 344554444456666 77887631 12222222 24467889999999987544 5679998888888999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC-------------------------------------- 135 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-------------------------------------- 135 (274)
|++|.+|. ... .+ ...++.+++..|..||+..
T Consensus 96 ~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 96 EVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred ecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 99998884 211 12 2356777888888888641
Q ss_pred -----------------CCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 136 -----------------EPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 136 -----------------~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
...++|+|++|.||+++++..+.++||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998876677999998643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.67 E-value=4.4e-08 Score=85.27 Aligned_cols=137 Identities=10% Similarity=-0.005 Sum_probs=97.0
Q ss_pred cccCCCCCCCCcchhHHHH----HHHHHhc--CC---CCCCcHHHHHHHHhcCC--CCccceEeEEEEeC---CcceEEE
Q 048314 27 SSLNDRNSPRSKSVWSCMR----ALMATVN--SP---YSPSRPLTLTSIVSRVS--WTTDIEVSSVAMRG---SKPSTEA 92 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~----~~~~~~~--~~---~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 92 (274)
...++.|.+ +.+|+... .+++... .. .....+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 43 ~~~l~~G~s--n~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQS--NPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CC--SCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCccc--ceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 445777887 78887611 1111111 10 23457789999999987 45589999998776 4589999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC------------------------------------- 135 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------------------------------------- 135 (274)
||++|..+.+.. -..++...+..++.+++..|+.||+..
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999987774321 234788888999999999999999731
Q ss_pred ------------------CCCcccCCCCCCceEEcCCCc--EEEeccccceecC
Q 048314 136 ------------------EPPILHCDIKPQNILMDEFWT--AKISDFGLAKLLS 169 (274)
Q Consensus 136 ------------------~~~i~h~dl~~~nil~~~~~~--~kl~d~g~~~~~~ 169 (274)
...++|+|+++.||+++.++. +.++||+.+....
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 136999999999999987643 6899999886543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.39 E-value=2.8e-07 Score=78.27 Aligned_cols=175 Identities=15% Similarity=0.118 Sum_probs=110.7
Q ss_pred ccCCCCCCCCcchhHHHHHH-HHHhcCCCCCCcHHHHHHHHhcCC-CCc--cceEeEEEEeCC---cceEEEEeCCCCCH
Q 048314 28 SLNDRNSPRSKSVWSCMRAL-MATVNSPYSPSRPLTLTSIVSRVS-WTT--DIEVSSVAMRGS---KPSTEAALDLPWDL 100 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~~~-~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~~gsL 100 (274)
..++.|.. ..+|...... ++..........+.+|+.+|+.+. +.. +.+.+......+ ..++|||+++|.+|
T Consensus 26 ~~~~~G~~--n~v~~v~~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l 103 (304)
T 3sg8_A 26 EISGEGND--CIAYEINRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPL 103 (304)
T ss_dssp CEEEECSS--EEEEESTTSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEEC
T ss_pred EecCCCCc--ceEEEECCEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeEC
Confidence 34667777 7787653111 111111112345678999998874 333 456666554333 45899999999888
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 048314 101 AYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC--------------------------------------------- 135 (274)
Q Consensus 101 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--------------------------------------------- 135 (274)
.+.... .++...+..++.+++..++.||+..
T Consensus 104 ~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 179 (304)
T 3sg8_A 104 TPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD 179 (304)
T ss_dssp CHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred Cccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence 754432 4677778888888888888888621
Q ss_pred ----------CCCcccCCCCCCceEEcC--CCcEEEeccccceecCC-------CCc---CCCccccc-----CCC----
Q 048314 136 ----------EPPILHCDIKPQNILMDE--FWTAKISDFGLAKLLSD-------KGC---MAPECYKR-----TPI---- 184 (274)
Q Consensus 136 ----------~~~i~h~dl~~~nil~~~--~~~~kl~d~g~~~~~~~-------~~~---~ape~~~~-----~~~---- 184 (274)
.+.++|+|+++.||+++. ...+.++||+.+..... ... ..|+.... +..
T Consensus 180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~ 259 (304)
T 3sg8_A 180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPT 259 (304)
T ss_dssp HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHH
T ss_pred HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHH
Confidence 135799999999999988 55678999998765431 011 22221110 000
Q ss_pred -----ccccceeehhHhHHHHhhcCCCcc
Q 048314 185 -----SVKADVYGYGIVLLETICCWENME 208 (274)
Q Consensus 185 -----~~~~Di~s~G~~l~el~~g~~p~~ 208 (274)
..-.+.|+++.+++.+.+|..+|.
T Consensus 260 ~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 260 VLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 112468899999999999887773
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=3.3e-05 Score=64.02 Aligned_cols=103 Identities=11% Similarity=-0.041 Sum_probs=76.1
Q ss_pred cHHHHHHHHhcCC-CCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--
Q 048314 59 RPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC-- 135 (274)
Q Consensus 59 ~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-- 135 (274)
.+.+|..+|+.+. +--+.++++++.+.+..++|||++++.++.+..... ......+..+++..|+-||+..
T Consensus 65 ~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~ 138 (272)
T 4gkh_A 65 DVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVC 138 (272)
T ss_dssp HHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGG
T ss_pred HHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcc
Confidence 4568999988875 323788999999999999999999998887766431 1223345566666666666431
Q ss_pred -----------------------------------------------------CCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 136 -----------------------------------------------------EPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 136 -----------------------------------------------------~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
...++|+|+.+.||+++..+.+-++||
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDw 218 (272)
T 4gkh_A 139 NCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDV 218 (272)
T ss_dssp GCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCC
T ss_pred cCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEEC
Confidence 013789999999999998877789999
Q ss_pred cccee
Q 048314 163 GLAKL 167 (274)
Q Consensus 163 g~~~~ 167 (274)
+.+..
T Consensus 219 e~a~~ 223 (272)
T 4gkh_A 219 GRVGI 223 (272)
T ss_dssp TTCEE
T ss_pred ccccc
Confidence 87643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=6.1e-05 Score=63.88 Aligned_cols=106 Identities=16% Similarity=0.068 Sum_probs=72.3
Q ss_pred CcHHHHHHHHhcCCCC---ccceEeEEEE-eCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 048314 58 SRPLTLTSIVSRVSWT---TDIEVSSVAM-RGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD 133 (274)
Q Consensus 58 ~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~ 133 (274)
..+.+|+.+|+.+.+. .+.+.+.++. ..+..++|||+++|.++.+.... .++......++.+++..|+.||+
T Consensus 54 ~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~ 129 (306)
T 3tdw_A 54 DELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSA 129 (306)
T ss_dssp HHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhc
Confidence 4567999999998753 3567777774 45668999999999887763221 23444445555555555555553
Q ss_pred C---------------------------------------------------------CCCCcccCCCCCCceEEcC---
Q 048314 134 E---------------------------------------------------------CEPPILHCDIKPQNILMDE--- 153 (274)
Q Consensus 134 ~---------------------------------------------------------~~~~i~h~dl~~~nil~~~--- 153 (274)
. ....++|+|+.+.|++++.
T Consensus 130 ~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~ 209 (306)
T 3tdw_A 130 FPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSR 209 (306)
T ss_dssp SCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCS
T ss_pred CCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCC
Confidence 2 1225699999999999987
Q ss_pred CCc-EEEecccccee
Q 048314 154 FWT-AKISDFGLAKL 167 (274)
Q Consensus 154 ~~~-~kl~d~g~~~~ 167 (274)
++. +.++||+.+..
T Consensus 210 ~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 210 QTPLTGIIDFGDAAI 224 (306)
T ss_dssp SCCEEEECCCTTCEE
T ss_pred CCceEEEEehhhcCC
Confidence 344 58999997754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00017 Score=57.59 Aligned_cols=99 Identities=8% Similarity=-0.044 Sum_probs=65.4
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecCCCCcCCCc
Q 048314 98 WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPE 177 (274)
Q Consensus 98 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ape 177 (274)
-||.+.|.. .+.++++.++|.++.|.+.+|.-+-... .-..+-..|..|++..+|.+.+.+ ..+. .....+.+||
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-~~~~~~~~pe 107 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-AGEPPPVAGK 107 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------C
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-ccccCCCChh
Confidence 479999987 5688999999999999999987662210 111334456889999999987774 2211 1233466888
Q ss_pred ccccCCCccccceeehhHhHHHHhh
Q 048314 178 CYKRTPISVKADVYGYGIVLLETIC 202 (274)
Q Consensus 178 ~~~~~~~~~~~Di~s~G~~l~el~~ 202 (274)
... ...+.+.-|||+|+++|..+-
T Consensus 108 ~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 108 LGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp CSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred hcc-ccchHHHHHHHHHHHHHHHhh
Confidence 663 344677889999999998774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00027 Score=60.98 Aligned_cols=45 Identities=11% Similarity=-0.113 Sum_probs=34.1
Q ss_pred CCcHHHHHHHHhcCCC---CccceEeEEEEeC---CcceEEEEeCCCCCHH
Q 048314 57 PSRPLTLTSIVSRVSW---TTDIEVSSVAMRG---SKPSTEAALDLPWDLA 101 (274)
Q Consensus 57 ~~~~~~e~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e~~~~gsL~ 101 (274)
...+.+|+.+++.+.. -.+.+++.++.+. +..++||||++|.++.
T Consensus 71 ~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 71 TYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 3567899999998863 2478889887665 4578999999886554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.66 E-value=0.03 Score=47.46 Aligned_cols=109 Identities=12% Similarity=-0.075 Sum_probs=63.1
Q ss_pred CcHHHHHHHHhcCCCC--ccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCC---------------------C---CC
Q 048314 58 SRPLTLTSIVSRVSWT--TDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSA---------------------E---RN 111 (274)
Q Consensus 58 ~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~---~~ 111 (274)
+....|+.++..+... .+.+++.+..+.+ +++||++.+.++.+++.... . ..
T Consensus 57 ~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~ 134 (333)
T 3csv_A 57 GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELAR 134 (333)
T ss_dssp CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCB
T ss_pred ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCc
Confidence 5667888888877532 3567787744333 78999998777765543210 0 01
Q ss_pred CCHHHHH-------HHH-------------HHHHHHHHHHh---cCCCCCcccCCCCCCceEEcCC----CcEEEecccc
Q 048314 112 PYWNQRV-------RIA-------------LDVAKGILYLH---DECEPPILHCDIKPQNILMDEF----WTAKISDFGL 164 (274)
Q Consensus 112 l~~~~~~-------~~~-------------~~i~~~l~~lh---~~~~~~i~h~dl~~~nil~~~~----~~~kl~d~g~ 164 (274)
++..... .+. ..+...+..+. ......++|+|+.+.||+++.+ ..+.++||+.
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~ 214 (333)
T 3csv_A 135 LDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQD 214 (333)
T ss_dssp CCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTT
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCC
Confidence 2111110 000 01111122221 1113379999999999999874 6789999998
Q ss_pred ceec
Q 048314 165 AKLL 168 (274)
Q Consensus 165 ~~~~ 168 (274)
+...
T Consensus 215 a~~G 218 (333)
T 3csv_A 215 AKLG 218 (333)
T ss_dssp CEEE
T ss_pred cCcC
Confidence 7653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.33 E-value=0.034 Score=47.10 Aligned_cols=132 Identities=9% Similarity=-0.040 Sum_probs=78.2
Q ss_pred ccCCCCCCCCcchhHHHH----HHHHHhcCCCCCCcHHHHHHHHhcCC---CCccceEeEEEEeCCcceEEEEeCCCCCH
Q 048314 28 SLNDRNSPRSKSVWSCMR----ALMATVNSPYSPSRPLTLTSIVSRVS---WTTDIEVSSVAMRGSKPSTEAALDLPWDL 100 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~----~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gsL 100 (274)
.-++.|.+ ..+|+... .++|... ......+..|...|+.+. ...+++.+.++...+..++||||+++..+
T Consensus 42 ~~l~gG~~--n~~y~v~~~~~~~vlK~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEM--NEIWLINDEVQTVFVKINE-RSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSS--SEEEEEESSSCEEEEEEEE-GGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccc--eeeeEEEECCCeEEEEeCC-cccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 34677777 77776521 1111111 112344678988888875 25588999998888889999999988654
Q ss_pred H--------H---HHHhCCC-CC-------------------CCHHHHH---HHH----------------HHHHHHH-H
Q 048314 101 A--------Y---IIFCSAE-RN-------------------PYWNQRV---RIA----------------LDVAKGI-L 129 (274)
Q Consensus 101 ~--------~---~l~~~~~-~~-------------------l~~~~~~---~~~----------------~~i~~~l-~ 129 (274)
. . -|+.... .. -+|.... ++. ..++..+ .
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 2 1 2222111 10 1454322 111 1122222 2
Q ss_pred HHhc-CCCCCcccCCCCCCceEEcCCCcEEEeccc
Q 048314 130 YLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFG 163 (274)
Q Consensus 130 ~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g 163 (274)
.|.. ...+.++|+|+.+.|++++.++ +.+.|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3421 1245799999999999999887 8889974
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=95.22 E-value=0.062 Score=46.76 Aligned_cols=30 Identities=23% Similarity=0.322 Sum_probs=25.3
Q ss_pred CcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
.++|+|+.+.||++..+ .+.++||..+...
T Consensus 228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G 257 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 257 (397)
T ss_dssp EEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred ceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence 79999999999999765 4889999876543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.15 E-value=0.16 Score=42.22 Aligned_cols=29 Identities=28% Similarity=0.311 Sum_probs=24.4
Q ss_pred CcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++|+|+.+.|++ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 5899999999999 5566789999987754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=92.90 E-value=0.15 Score=42.98 Aligned_cols=31 Identities=23% Similarity=0.266 Sum_probs=27.1
Q ss_pred CCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4899999999999998777899999997643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=89.82 E-value=0.36 Score=42.26 Aligned_cols=31 Identities=10% Similarity=0.203 Sum_probs=27.2
Q ss_pred CcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
.++|+|+++.||+++.++ +.++||+.+....
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 899999999999998776 9999999886544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=88.37 E-value=0.033 Score=50.11 Aligned_cols=49 Identities=6% Similarity=-0.192 Sum_probs=32.7
Q ss_pred cchhHHH-HHHHHHhc---CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 38 KSVWSCM-RALMATVN---SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 38 g~vy~~~-~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
+.+|.+. .++++... ...+.+.|..|++++.+++|+|+|+++|||....
T Consensus 300 ~~~~~~~l~~~~~~~~~~~~~~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 300 PAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp SCHHHHHHHHHHHHHHCSCC-----CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred cchhhhHHHHHHHHhhhhcccccHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 5566553 33333222 2345788999999999999999999999998755
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.54 E-value=0.91 Score=35.96 Aligned_cols=121 Identities=12% Similarity=0.122 Sum_probs=78.5
Q ss_pred HHHHHhcCCCCccceEeEEEEeCCcceEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 048314 63 LTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALDL-PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILH 141 (274)
Q Consensus 63 e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h 141 (274)
|+..|.. .||+++.. .+-.+.+...+.++.-+ .-++.. + ..++...+++++..++.-..++++ -+|
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~~-----r~t 102 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNRT-----RYT 102 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGGS-----SEE
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhcC-----ceE
Confidence 4444433 68888866 45556666666666433 223333 2 247889999999999886655553 477
Q ss_pred CCCCCCceEEcCCCcEEEeccccceecCCCCcCCCcccccCCCcccccee-ehhHhHHHHhhcCCCcc
Q 048314 142 CDIKPQNILMDEFWTAKISDFGLAKLLSDKGCMAPECYKRTPISVKADVY-GYGIVLLETICCWENME 208 (274)
Q Consensus 142 ~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ape~~~~~~~~~~~Di~-s~G~~l~el~~g~~p~~ 208 (274)
--+.|+|++++.++.+++.-.|+... ++|. ..+ ..|.| .+=+++..+++++..|.
T Consensus 103 f~L~P~NL~f~~~~~p~i~~RGik~~------l~P~-----~~~-ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 103 FVLAPDELFFTRDGLPIAKTRGLQNV------VDPL-----PVS-EAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CCCSGGGEEECTTSCEEESCCEETTT------BSCC-----CCC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEecceEEEcCCCCEEEEEccCccC------CCCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 88999999999999999999887433 2232 111 12222 45566777777777764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=85.25 E-value=0.29 Score=40.94 Aligned_cols=31 Identities=19% Similarity=0.205 Sum_probs=26.2
Q ss_pred CCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.+++|+|+.+.||+++.+..+.++||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3799999999999998876668999987654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.83 E-value=3.1 Score=32.98 Aligned_cols=113 Identities=11% Similarity=0.075 Sum_probs=72.3
Q ss_pred CCCccceEeEEEEeCCcceEEEEeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCcccCCCCCCc
Q 048314 71 SWTTDIEVSSVAMRGSKPSTEAALDLP-WDLAYIIFCSAERNPYWNQRVRIALDVAKGIL-YLHDECEPPILHCDIKPQN 148 (274)
Q Consensus 71 ~h~niv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~-~lh~~~~~~i~h~dl~~~n 148 (274)
.||++ -..+-.+.+...+.++.-++ -++... . .++...+++++..++.-.. +++ .-+|--+.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~-----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-R-----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-H-----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-H-----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence 57877 22333566777777775433 344433 2 4788999999998887555 444 45778899999
Q ss_pred eEEcCCCcEEEeccccceecCCCCcCCCcccccCCCcccccee-ehhHhHHHHhhcCCCcc
Q 048314 149 ILMDEFWTAKISDFGLAKLLSDKGCMAPECYKRTPISVKADVY-GYGIVLLETICCWENME 208 (274)
Q Consensus 149 il~~~~~~~kl~d~g~~~~~~~~~~~ape~~~~~~~~~~~Di~-s~G~~l~el~~g~~p~~ 208 (274)
++++.++.+++...|+... ++|.-. ...|.| .+=+++..++.++..|.
T Consensus 115 L~f~~~~~p~i~hRGi~~~------lpP~e~------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES------LPPDEW------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTT------BSSCSC------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCccc------CCCCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999999997433 233211 112222 34455666666665553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=81.14 E-value=2.1 Score=35.61 Aligned_cols=29 Identities=28% Similarity=0.159 Sum_probs=24.8
Q ss_pred CCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
..++|+|+.+.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3689999999999998 4 889999987644
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 274 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-29 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-28 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-27 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-27 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-26 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-26 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-26 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-26 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-25 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-25 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-25 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-25 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-25 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-25 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-24 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-24 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-23 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-23 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-22 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-22 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-22 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-22 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-21 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-21 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-21 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-20 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-19 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-19 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-17 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-17 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-16 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-16 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-16 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-16 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-15 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-15 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-15 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-15 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-14 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-14 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-14 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-14 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-13 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-13 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-13 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-13 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-12 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-12 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-12 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-12 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-12 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-11 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-11 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-09 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-09 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-09 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-08 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-08 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 1e-29
Identities = 45/192 (23%), Positives = 75/192 (39%), Gaps = 29/192 (15%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158
L + + + + + IA A+G+ YLH I+H D+K NI + E T K
Sbjct: 89 SLYHHLHIIETKFE-MIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVK 144
Query: 159 ISDFGLAKLLSDK-------------GCMAPECYK---RTPISVKADVYGYGIVLLETIC 202
I DFGLA + S MAPE + + P S ++DVY +GIVL E +
Sbjct: 145 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204
Query: 203 CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPA 262
P I + R ++V + + ++ C++ +
Sbjct: 205 --------GQLPYSNINNRDQIIFMVGRGY-LSPDLSKVRSNCPKAMKRLMAECLKKKRD 255
Query: 263 LRPSMKCVVMML 274
RP ++ +
Sbjct: 256 ERPLFPQILASI 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-28
Identities = 41/199 (20%), Positives = 68/199 (34%), Gaps = 33/199 (16%)
Query: 109 ERNPYWNQRVRIALDVAKGILYLHDEC-----EPPILHCDIKPQNILMDEFWTAKISDFG 163
+++AL A G+ +LH E +P I H D+K +NIL+ + T I+D G
Sbjct: 94 RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153
Query: 164 LAKLLSD---------------KGCMAPECY------KRTPISVKADVYGYGIVLLETIC 202
LA K MAPE K +AD+Y G+V E
Sbjct: 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213
Query: 203 ---CWENMEIDASKPEEIILTNWVYKCFINRELNKLVR----GTEVDKKNLENLVKVGLW 255
E +++ ++ + + +R + L + K+
Sbjct: 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE 273
Query: 256 CVQDEPALRPSMKCVVMML 274
C A R + + L
Sbjct: 274 CWYANGAARLTALRIKKTL 292
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-27
Identities = 41/188 (21%), Positives = 76/188 (40%), Gaps = 28/188 (14%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158
L + + N+ + +A +A+G+ ++ E +H D++ NIL+ + + K
Sbjct: 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCK 149
Query: 159 ISDFGLAKLLSDK------------GCMAPECYKRTPISVKADVYGYGIVLLETICCWEN 206
I+DFGLA+L+ D APE ++K+DV+ +GI+L E +
Sbjct: 150 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209
Query: 207 MEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPS 266
+ PE I Y+ E L ++ C ++ P RP+
Sbjct: 210 PYPGMTNPEVIQNLERGYRMVRPDNCP-------------EELYQLMRLCWKERPEDRPT 256
Query: 267 MKCVVMML 274
+ +L
Sbjct: 257 FDYLRSVL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 7e-27
Identities = 40/186 (21%), Positives = 73/186 (39%), Gaps = 28/186 (15%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158
L + + ++ +LDV + + YL +H D+ +N+L+ E AK
Sbjct: 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 143
Query: 159 ISDFGLAKLLSDK--------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEID 210
+SDFGL K S APE + S K+DV+ +GI+L E
Sbjct: 144 VSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-P 202
Query: 211 ASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKN--LENLVKVGLWCVQDEPALRPSMK 268
++++ ++ +G ++D + + +V C + A+RPS
Sbjct: 203 RIPLKDVV--------------PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFL 248
Query: 269 CVVMML 274
+ L
Sbjct: 249 QLREQL 254
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-26
Identities = 43/190 (22%), Positives = 74/190 (38%), Gaps = 32/190 (16%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158
L + + Q V +A +A G+ Y+ +H D++ NIL+ E K
Sbjct: 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCK 153
Query: 159 ISDFGLAKLLSDK------------GCMAPECYKRTPISVKADVYGYGIVLLETICCWEN 206
++DFGLA+L+ D APE ++K+DV+ +GI+L E
Sbjct: 154 VADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213
Query: 207 MEIDASKPEEIILTNWVYKCFINRELNKLVRG--TEVDKKNLENLVKVGLWCVQDEPALR 264
E+ L+++ RG + E+L + C + EP R
Sbjct: 214 PY-PGMVNREV--------------LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 258
Query: 265 PSMKCVVMML 274
P+ + + L
Sbjct: 259 PTFEYLQAFL 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-26
Identities = 46/191 (24%), Positives = 79/191 (41%), Gaps = 30/191 (15%)
Query: 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155
L D A+ I S Q + A DVA+G+ YL + +H D+ +NIL+ E +
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENY 164
Query: 156 TAKISDFGLAKLLSDK----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWE 205
AKI+DFGL++ MA E + + +DV+ YG++L E +
Sbjct: 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 206 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKN--LENLVKVGLWCVQDEPAL 263
+ E KL +G ++K + + + C +++P
Sbjct: 225 TPYCGMTCAELY---------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYE 269
Query: 264 RPSMKCVVMML 274
RPS +++ L
Sbjct: 270 RPSFAQILVSL 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-26
Identities = 41/194 (21%), Positives = 72/194 (37%), Gaps = 31/194 (15%)
Query: 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155
+ + NP + L VAKG + +H D+ +N ++DE +
Sbjct: 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKF 167
Query: 156 TAKISDFGLAKLLSDK---------------GCMAPECYKRTPISVKADVYGYGIVLLET 200
T K++DFGLA+ + DK MA E + + K+DV+ +G++L E
Sbjct: 168 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227
Query: 201 ICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDE 260
+ D + + R L + + L +V L C +
Sbjct: 228 MTRGAPPYPDVN------TFDITVYLLQGRRL-------LQPEYCPDPLYEVMLKCWHPK 274
Query: 261 PALRPSMKCVVMML 274
+RPS +V +
Sbjct: 275 AEMRPSFSELVSRI 288
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 3e-26
Identities = 35/167 (20%), Positives = 71/167 (42%), Gaps = 16/167 (9%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD--- 170
++++ V KG+ YL ++ I+H D+KP NIL++ K+ DFG++ L D
Sbjct: 103 EQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 160
Query: 171 ------KGCMAPECYKRTPISVKADVYGYGIVLLETIC-----CWENMEIDASKPEEIIL 219
+ M+PE + T SV++D++ G+ L+E + + +
Sbjct: 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220
Query: 220 TNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPS 266
+ R + + +D + + ++ + V + P PS
Sbjct: 221 GDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (253), Expect = 5e-26
Identities = 41/176 (23%), Positives = 65/176 (36%), Gaps = 33/176 (18%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
+++ IA VA G+ YL E +H D+ +N L+ E KI+DFGL++ +
Sbjct: 139 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195
Query: 172 -----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILT 220
M PE + ++DV+ YG+VL E + EE+I
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-HEEVI-- 252
Query: 221 NWVYKCFINRELNKLVRGT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
+ G + L + C PA RPS + +L
Sbjct: 253 ------------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 8e-26
Identities = 32/191 (16%), Positives = 73/191 (38%), Gaps = 28/191 (14%)
Query: 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155
+ + + + LDV +G + E ++H D+ +N L+ E
Sbjct: 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACVIHRDLAARNCLVGENQ 138
Query: 156 TAKISDFGLAKLLSDK------------GCMAPECYKRTPISVKADVYGYGIVLLETICC 203
K+SDFG+ + + D +PE + + S K+DV+ +G+++ E
Sbjct: 139 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 198
Query: 204 WENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPAL 263
+ + S E + + ++ + R + ++ ++ C ++ P
Sbjct: 199 GKIPYENRSNSEVVEDISTGFRLYKPRLAS-------------THVYQIMNHCWKERPED 245
Query: 264 RPSMKCVVMML 274
RP+ ++ L
Sbjct: 246 RPAFSRLLRQL 256
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-25
Identities = 40/165 (24%), Positives = 61/165 (36%), Gaps = 24/165 (14%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM-DEFWTAKISDFGLAKLLSDK- 171
+ KG+ +LH PPI+H D+K NI + + KI D GLA L
Sbjct: 111 IKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169
Query: 172 --------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV 223
MAPE Y+ DVY +G+ +LE E +
Sbjct: 170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATS------------EYPYSECQ 216
Query: 224 YKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
I R + V+ DK + + ++ C++ R S+K
Sbjct: 217 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIK 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (250), Expect = 1e-25
Identities = 42/195 (21%), Positives = 69/195 (35%), Gaps = 32/195 (16%)
Query: 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155
+ + Q V + +A G+ YL D +H D+ +NIL++
Sbjct: 109 MENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNL 165
Query: 156 TAKISDFGLAKLLSDK----------------GCMAPECYKRTPISVKADVYGYGIVLLE 199
K+SDFGL++ L D APE + + +DV+ YGIV+ E
Sbjct: 166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225
Query: 200 TICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQD 259
+ E D + + I Y+ + L ++ L C Q
Sbjct: 226 VMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP-------------SALHQLMLDCWQK 272
Query: 260 EPALRPSMKCVVMML 274
+ RP +V L
Sbjct: 273 DRNHRPKFGQIVNTL 287
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.3 bits (247), Expect = 2e-25
Identities = 39/187 (20%), Positives = 72/187 (38%), Gaps = 33/187 (17%)
Query: 99 DLAYIIFCSAERNPY--WNQRVRIALDVAKGILYLHD--ECEPPILHCDIKPQNILMDEF 154
DLA +I + Y +R+ + + H + +LH D+KP N+ +D
Sbjct: 91 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 150
Query: 155 WTAKISDFGLAKLLSDK-----------GCMAPECYKRTPISVKADVYGYGIVLLETICC 203
K+ DFGLA++L+ M+PE R + K+D++ G +L E C
Sbjct: 151 QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE--LC 208
Query: 204 WENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT--EVDKKNLENLVKVGLWCVQDEP 261
A +E+ K+ G + + + L ++ + +
Sbjct: 209 ALMPPFTAFSQKEL--------------AGKIREGKFRRIPYRYSDELNEIITRMLNLKD 254
Query: 262 ALRPSMK 268
RPS++
Sbjct: 255 YHRPSVE 261
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 2e-25
Identities = 41/191 (21%), Positives = 70/191 (36%), Gaps = 30/191 (15%)
Query: 98 WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 157
+ Q V + +A G+ YL +H D+ +NIL++
Sbjct: 93 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC 149
Query: 158 KISDFGLAKLLSDK--------------GCMAPECYKRTPISVKADVYGYGIVLLETICC 203
K+SDFGL+++L D APE + +DV+ +GIV+ E +
Sbjct: 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 209
Query: 204 WENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPAL 263
E + S E + + +N R + ++ + C Q E A
Sbjct: 210 GERPYWELSNHE------------VMKAINDGFRL-PTPMDCPSAIYQLMMQCWQQERAR 256
Query: 264 RPSMKCVVMML 274
RP +V +L
Sbjct: 257 RPKFADIVSIL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 4e-25
Identities = 40/192 (20%), Positives = 67/192 (34%), Gaps = 35/192 (18%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158
L + E P + + V+ G+ YL + +H D+ +N+L+ AK
Sbjct: 94 PLHKFLVGKREEIP-VSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAK 149
Query: 159 ISDFGLAKLLSDK--------------GCMAPECYKRTPISVKADVYGYGIVLLETICCW 204
ISDFGL+K L APEC S ++DV+ YG+ + E +
Sbjct: 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 209
Query: 205 ENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT--EVDKKNLENLVKVGLWCVQDEPA 262
+ K E++ + +G E + L + C +
Sbjct: 210 Q-KPYKKMKGPEVM--------------AFIEQGKRMECPPECPPELYALMSDCWIYKWE 254
Query: 263 LRPSMKCVVMML 274
RP V +
Sbjct: 255 DRPDFLTVEQRM 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 6e-25
Identities = 37/174 (21%), Positives = 60/174 (34%), Gaps = 28/174 (16%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
+ + A VAKG+ +L +H D+ +N+L+ KI DFGLA+ +
Sbjct: 163 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 172 -----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILT 220
MAPE ++K+DV+ YGI+L E N
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF--- 276
Query: 221 NWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
+L + + E + + C + RPS + L
Sbjct: 277 ---------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 1e-24
Identities = 35/190 (18%), Positives = 72/190 (37%), Gaps = 33/190 (17%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158
L + R Q + + DV + + YL LH D+ +N L+++ K
Sbjct: 85 CLLNYLREMRHRFQ-TQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVK 140
Query: 159 ISDFGLAKLLSDK------------GCMAPECYKRTPISVKADVYGYGIVLLETICCWEN 206
+SDFGL++ + D PE + S K+D++ +G+++ E +
Sbjct: 141 VSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK- 199
Query: 207 MEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNL--ENLVKVGLWCVQDEPALR 264
M + E + +G + + +L E + + C ++ R
Sbjct: 200 MPYERFTNSETA--------------EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADER 245
Query: 265 PSMKCVVMML 274
P+ K ++ +
Sbjct: 246 PTFKILLSNI 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 95.9 bits (238), Expect = 6e-24
Identities = 37/190 (19%), Positives = 73/190 (38%), Gaps = 32/190 (16%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158
+L + + + +A ++ + YL + +H D+ +N L+ E K
Sbjct: 99 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVK 155
Query: 159 ISDFGLAKLLSDK------------GCMAPECYKRTPISVKADVYGYGIVLLETICC--W 204
++DFGL++L++ APE S+K+DV+ +G++L E
Sbjct: 156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 215
Query: 205 ENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALR 264
ID S+ E++ ++ E + E + ++ C Q P+ R
Sbjct: 216 PYPGIDLSQVYELLEKDYRM---------------ERPEGCPEKVYELMRACWQWNPSDR 260
Query: 265 PSMKCVVMML 274
PS +
Sbjct: 261 PSFAEIHQAF 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 1e-23
Identities = 37/177 (20%), Positives = 61/177 (34%), Gaps = 34/177 (19%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
+ + V+ G+ YL + +H D+ +N+L+ AKISDFGL+K L
Sbjct: 106 DKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162
Query: 172 ------------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219
APEC S K+DV+ +G+++ E + K E+
Sbjct: 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEV-- 219
Query: 220 TNWVYKCFINRELNKLVRGT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
L +G + + C + RP V + L
Sbjct: 220 ------------TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.7 bits (235), Expect = 1e-23
Identities = 28/166 (16%), Positives = 58/166 (34%), Gaps = 31/166 (18%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
+ ++A + Y H ++H DIKP+N+L+ KI+DFG +
Sbjct: 105 EQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161
Query: 172 -------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKP--EEIILTNW 222
+ PE + K D++ G++ E + E + + + I +
Sbjct: 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 221
Query: 223 VYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
+ F+ L+ ++ P+ RP ++
Sbjct: 222 TFPDFVTEGARDLIS-----------------RLLKHNPSQRPMLR 250
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.3 bits (231), Expect = 6e-23
Identities = 35/174 (20%), Positives = 62/174 (35%), Gaps = 28/174 (16%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
+ + VAKG+ +L +H D+ +NIL+ KI DFGLA+ + +
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 172 -----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILT 220
MAPE + ++DV+ YGI L E + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--- 257
Query: 221 NWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
++ K + + + C +P RP+ K +V ++
Sbjct: 258 ---------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 2e-22
Identities = 40/174 (22%), Positives = 65/174 (37%), Gaps = 28/174 (16%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
+ + VAKG+ +L +H D+ +NIL+ E KI DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 172 -----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILT 220
MAPE ++++DV+ +G++L E + EE
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-- 247
Query: 221 NWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
R L + R + + L C EP+ RP+ +V L
Sbjct: 248 ---------RRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 5e-22
Identities = 38/184 (20%), Positives = 68/184 (36%), Gaps = 29/184 (15%)
Query: 105 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164
+ + R A+ VA+G+ YL +H D+ +N+L+ KI DFGL
Sbjct: 101 LRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL 157
Query: 165 AKLLSDK--------------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEID 210
+ L APE K S +D + +G+ L E + I
Sbjct: 158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217
Query: 211 ASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCV 270
+ + + I++E +L R + +++ V + C +P RP+ +
Sbjct: 218 LNGSQILHK--------IDKEGERLPRPEDCP----QDIYNVMVQCWAHKPEDRPTFVAL 265
Query: 271 VMML 274
L
Sbjct: 266 RDFL 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 7e-22
Identities = 36/185 (19%), Positives = 70/185 (37%), Gaps = 33/185 (17%)
Query: 105 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164
+ N + + +AKG+ YL + ++H D+ +N+L+ KI+DFGL
Sbjct: 101 VREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGL 157
Query: 165 AKLLSDK-------------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDA 211
AKLL + MA E + ++DV+ YG+ + E + + + D
Sbjct: 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE-LMTFGSKPYDG 216
Query: 212 SKPEEIILTNWVYKCFINRELNKLVRGT--EVDKKNLENLVKVGLWCVQDEPALRPSMKC 269
EI + L +G ++ + + C + RP +
Sbjct: 217 IPASEIS--------------SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRE 262
Query: 270 VVMML 274
+++
Sbjct: 263 LIIEF 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (223), Expect = 7e-22
Identities = 39/189 (20%), Positives = 62/189 (32%), Gaps = 31/189 (16%)
Query: 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155
+ ER +Q + + YLH + I+H D+K NIL
Sbjct: 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDG 147
Query: 156 TAKISDFGLAKLLSDK-----------GCMAPEC-----YKRTPISVKADVYGYGIVLLE 199
K++DFG++ + MAPE K P KADV+ GI L+E
Sbjct: 148 DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207
Query: 200 TICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQD 259
P + V E L + + N ++ +K C++
Sbjct: 208 MAE--------IEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS-SNFKDFLK---KCLEK 255
Query: 260 EPALRPSMK 268
R +
Sbjct: 256 NVDARWTTS 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 90.1 bits (223), Expect = 1e-21
Identities = 34/165 (20%), Positives = 57/165 (34%), Gaps = 26/165 (15%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
+ + +G+ YLH ++H D+K NIL+ E K+ DFG A +++
Sbjct: 114 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170
Query: 172 -----GCMAPE---CYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV 223
MAPE K DV+ GI +E + + +
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230
Query: 224 YKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
+ ++ R N V C+Q P RP+ +
Sbjct: 231 SPALQSGHWSEYFR----------NFVD---SCLQKIPQDRPTSE 262
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.8 bits (217), Expect = 4e-21
Identities = 41/169 (24%), Positives = 62/169 (36%), Gaps = 29/169 (17%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
R + G++YLH I H DIKP+N+L+DE KISDFGLA +
Sbjct: 102 EPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158
Query: 172 -----------GCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219
+APE KR + DV+ GIVL + + D
Sbjct: 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG--ELPWDQPSDSCQEY 216
Query: 220 TNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
++W K K+ L+ + + P+ R ++
Sbjct: 217 SDWKEKKTYLNPWKKI-------DSAPLALLH---KILVENPSARITIP 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.1 bits (215), Expect = 7e-21
Identities = 34/173 (19%), Positives = 60/173 (34%), Gaps = 28/173 (16%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
+ A ++ + YL +H DI +N+L+ K+ DFGL++ + D
Sbjct: 107 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163
Query: 172 ----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
MAPE + +DV+ +G+ + E + KP + + N
Sbjct: 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV-------KPFQGVKNN 216
Query: 222 WVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
V N E + L + C +P+ RP + L
Sbjct: 217 DVIGRIENGERLPMPPNCP------PTLYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 3e-20
Identities = 40/191 (20%), Positives = 69/191 (36%), Gaps = 29/191 (15%)
Query: 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 156
+ +Y + E V A VA+G+ YL +H D+ +N+L+ E
Sbjct: 117 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNV 173
Query: 157 AKISDFGLAKLLSDK-------------GCMAPECYKRTPISVKADVYGYGIVLLETICC 203
KI+DFGLA+ + MAPE + ++DV+ +G++L E
Sbjct: 174 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233
Query: 204 WENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPAL 263
+ P + ++K + L + C P+
Sbjct: 234 GGS-------PYPGVPVEELFKLLKEGHR------MDKPSNCTNELYMMMRDCWHAVPSQ 280
Query: 264 RPSMKCVVMML 274
RP+ K +V L
Sbjct: 281 RPTFKQLVEDL 291
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 3e-19
Identities = 35/176 (19%), Positives = 71/176 (40%), Gaps = 29/176 (16%)
Query: 112 PYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK 171
P ++ +++A ++A G + +H D+ +N ++ E +T KI DFG+ + + +
Sbjct: 130 PSLSKMIQMAGEIADG---MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 172 -------------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEII 218
M+PE K + +DV+ +G+VL E E P + +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-------PYQGL 239
Query: 219 LTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274
V + + L + + L ++ C Q P +RPS ++ +
Sbjct: 240 SNEQVLRFVMEGGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.3 bits (203), Expect = 6e-19
Identities = 34/168 (20%), Positives = 65/168 (38%), Gaps = 30/168 (17%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
Q + + + + +LH ++H DIK NIL+ + K++DFG ++ +
Sbjct: 115 EGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 174 -----------MAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEI--ILT 220
MAPE R K D++ GI+ +E + E ++ + + I T
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE-MIEGEPPYLNENPLRALYLIAT 230
Query: 221 NWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
N + +L+ + R + + C+ + R S K
Sbjct: 231 NGTPELQNPEKLSAIFR----------DFLN---RCLDMDVEKRGSAK 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 77.8 bits (191), Expect = 3e-17
Identities = 28/167 (16%), Positives = 60/167 (35%), Gaps = 26/167 (15%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM--DEFWTAKISDFGLAKLLSDK 171
++ V V KG+ ++H+ +H D+KP+NI+ K+ DFGL L K
Sbjct: 123 EDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179
Query: 172 ----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTN 221
APE + P+ D++ G++ + P +
Sbjct: 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS--------GLSPFGGENDD 231
Query: 222 WVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
+ + + N ++ ++ ++ + +P R ++
Sbjct: 232 ETLRNVKSCDWNMDDSAFSGISEDGKDFIR---KLLLADPNTRMTIH 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 77.1 bits (189), Expect = 5e-17
Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 11/106 (10%)
Query: 105 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164
+ A +V L L I++ D+KP+NIL+D+ KI+DFG
Sbjct: 94 LLRKSQRFPNPVAKFYAAEVC---LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 150
Query: 165 AKLLSDK--------GCMAPECYKRTPISVKADVYGYGIVLLETIC 202
AK + D +APE P + D + +GI++ E +
Sbjct: 151 AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 196
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 76.7 bits (188), Expect = 1e-16
Identities = 34/180 (18%), Positives = 59/180 (32%), Gaps = 29/180 (16%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158
DL Y + S A ++ G+ ++H+ +++ D+KP NIL+DE +
Sbjct: 93 DLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVR 147
Query: 159 ISDFGLAKLLSDKG----------CMAPECYKRTPISVKADVYGYGIVLLETICC-WENM 207
ISD GLA S K K AD + G +L + +
Sbjct: 148 ISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207
Query: 208 EIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSM 267
+ EI + + L +L++ +Q + R
Sbjct: 208 QHKTKDKHEIDRMTLTMAVELPDSFS----------PELRSLLE---GLLQRDVNRRLGC 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.9 bits (186), Expect = 1e-16
Identities = 33/189 (17%), Positives = 68/189 (35%), Gaps = 35/189 (18%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW--- 155
+L I ++ + I + + I YLH I H D+KP+N+L
Sbjct: 95 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNA 151
Query: 156 TAKISDFGLAKLLSDK----------GCMAPECYKRTPISVKADVYGYGIVLLETICCW- 204
K++DFG AK + +APE D++ G+++ +C +
Sbjct: 152 ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211
Query: 205 -----ENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQD 259
+ I I + + + E++ + ++ L++ ++
Sbjct: 212 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS----------EEVKMLIR---NLLKT 258
Query: 260 EPALRPSMK 268
EP R ++
Sbjct: 259 EPTQRMTIT 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 75.1 bits (184), Expect = 2e-16
Identities = 28/171 (16%), Positives = 61/171 (35%), Gaps = 30/171 (17%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD--- 170
+ +I + + I LH I+H D+KP+NIL+D+ K++DFG + L
Sbjct: 109 EKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 165
Query: 171 -------KGCMAPECY------KRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEI 217
+APE + D++ G+++ + + K +
Sbjct: 166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--SPPFWHRKQMLM 223
Query: 218 ILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
+ ++ + +++LV + +P R + +
Sbjct: 224 ------LRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAE 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.9 bits (181), Expect = 5e-16
Identities = 23/97 (23%), Positives = 43/97 (44%), Gaps = 13/97 (13%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK------- 171
A+ + L I+H D+KP+NIL++E +I+DFG AK+LS +
Sbjct: 109 CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 172 ------GCMAPECYKRTPISVKADVYGYGIVLLETIC 202
++PE +D++ G ++ + +
Sbjct: 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.2 bits (179), Expect = 1e-15
Identities = 35/184 (19%), Positives = 67/184 (36%), Gaps = 37/184 (20%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158
DL Y I + + ++ A ++ G+ +L I++ D+K NIL+D+ K
Sbjct: 89 DLMYHIQSCHKFD--LSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIK 143
Query: 159 ISDFGLAKLLSDK-----------GCMAPECYKRTPISVKADVYGYGIVLLETICC---W 204
I+DFG+ K +APE + D + +G++L E + +
Sbjct: 144 IADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 203
Query: 205 ENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALR 264
+ + I + N Y ++ +E L+ EP R
Sbjct: 204 HGQDEEELF-HSIRMDNPFYPRWLEKEAKDLLVK-----------------LFVREPEKR 245
Query: 265 PSMK 268
++
Sbjct: 246 LGVR 249
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.7 bits (175), Expect = 2e-15
Identities = 39/166 (23%), Positives = 60/166 (36%), Gaps = 35/166 (21%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKISDFGLAKLLSDK- 171
V + + + +LH DIK +NIL+D K+ DFG LL D
Sbjct: 109 EELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 165
Query: 172 --------GCMAPECYKRTP-ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNW 222
PE + A V+ GI+L + +C E D EEII
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEIIRGQV 221
Query: 223 VYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
++ ++ E L+R WC+ P+ RP+ +
Sbjct: 222 FFRQRVSSECQHLIR-----------------WCLALRPSDRPTFE 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 3e-15
Identities = 39/201 (19%), Positives = 71/201 (35%), Gaps = 37/201 (18%)
Query: 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155
+ DL + E + + +G+ +LH ++H D+KPQNIL+
Sbjct: 97 VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSG 153
Query: 156 TAKISDFGLAKLLSDK----------GCMAPECYKRTPISVKADVYGYGIVLLE------ 199
K++DFGLA++ S + APE ++ + D++ G + E
Sbjct: 154 QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213
Query: 200 ------------TICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLE 247
I + + P ++ L + + + K V + K+L
Sbjct: 214 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 273
Query: 248 NLVKVGLWCVQDEPALRPSMK 268
C+ PA R S
Sbjct: 274 L------KCLTFNPAKRISAY 288
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (175), Expect = 3e-15
Identities = 38/200 (19%), Positives = 63/200 (31%), Gaps = 28/200 (14%)
Query: 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 153
D +I + L +G+ YLH ILH D+KP N+L+DE
Sbjct: 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDE 135
Query: 154 FWTAKISDFGLAKLLSD-----------KGCMAPECYKR-TPISVKADVYGYGIVLLETI 201
K++DFGLAK + APE V D++ G +L E +
Sbjct: 136 NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 195
Query: 202 C-------------CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLEN 248
E + EE ++ + + + ++
Sbjct: 196 LRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDD 255
Query: 249 LVKVGLWCVQDEPALRPSMK 268
L+ + P R +
Sbjct: 256 LLDLIQGLFLFNPCARITAT 275
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 71.0 bits (173), Expect = 6e-15
Identities = 28/204 (13%), Positives = 54/204 (26%), Gaps = 33/204 (16%)
Query: 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 153
+DL + R A + + +H E +++ DIKP N L+
Sbjct: 80 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGR 136
Query: 154 FWT-----AKISDFGLAKLLSDKGC------------------MAPECYKRTPISVKADV 190
+ + DFG+ K D M+ + S + D+
Sbjct: 137 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDL 196
Query: 191 YGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLV 250
G V + + + + + + L +L G E
Sbjct: 197 EALGHVFMYFLRGSLPWQ-GLKAATNKQKYERIGEKKQSTPLRELCAGFP------EEFY 249
Query: 251 KVGLWCVQDEPALRPSMKCVVMML 274
K + P + +
Sbjct: 250 KYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 70.3 bits (171), Expect = 1e-14
Identities = 30/192 (15%), Positives = 57/192 (29%), Gaps = 31/192 (16%)
Query: 104 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKIS 160
+F R + +A + I Y+H + +H D+KP N LM + I
Sbjct: 92 LFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYII 148
Query: 161 DFGLAKLLSDKGC------------------MAPECYKRTPISVKADVYGYGIVLLETIC 202
DFGLAK D + + S + D+ G VL+
Sbjct: 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 208
Query: 203 CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPA 262
+ + + + ++ + L +G + +C
Sbjct: 209 GSLPWQGLKAATKRQKYERI-SEKKMSTPIEVLCKGYP---SEFATYLN---FCRSLRFD 261
Query: 263 LRPSMKCVVMML 274
+P + +
Sbjct: 262 DKPDYSYLRQLF 273
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.3 bits (171), Expect = 1e-14
Identities = 38/199 (19%), Positives = 65/199 (32%), Gaps = 29/199 (14%)
Query: 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155
L DL + SA + +G+ + H +LH D+KPQN+L++
Sbjct: 83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEG 139
Query: 156 TAKISDFGLAKLLSDKG-----------CMAPECYKRTP-ISVKADVYGYGIVLLETICC 203
K++DFGLA+ APE S D++ G + E +
Sbjct: 140 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 204 ------------WENMEIDASKPEEIILTNWVYKCFINRELNKLVRG--TEVDKKNLENL 249
+ P+E++ K R ++V E+
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 250 VKVGLWCVQDEPALRPSMK 268
+ + +P R S K
Sbjct: 260 RSLLSQMLHYDPNKRISAK 278
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 70.5 bits (172), Expect = 1e-14
Identities = 33/170 (19%), Positives = 65/170 (38%), Gaps = 32/170 (18%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF--WTAKISDFGLAKLLSDK 171
+ + +G+ ++H E I+H DIKP+NI+ + + KI DFGLA L+
Sbjct: 126 EAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182
Query: 172 G----------CMAPECYKRTPISVKADVYGYGIVLLETICC---WENMEIDASKPEEII 218
APE R P+ D++ G++ + + + D + +
Sbjct: 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-DLETLQNVK 241
Query: 219 LTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
+W + ++ ++ +K +Q EP R ++
Sbjct: 242 RCDWEFDEDAFSSVS----------PEAKDFIK---NLLQKEPRKRLTVH 278
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.1 bits (166), Expect = 6e-14
Identities = 36/182 (19%), Positives = 62/182 (34%), Gaps = 27/182 (14%)
Query: 99 DLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD--EFWT 156
D+ I SA + V V + + +LH I H DI+P+NI+ T
Sbjct: 87 DIFERINTSAFELN-EREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSST 142
Query: 157 AKISDFGLAKLLSDK----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWEN 206
KI +FG A+ L APE ++ +S D++ G ++ +
Sbjct: 143 IKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG--I 200
Query: 207 MEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPS 266
A ++II + + E K + + V + E R +
Sbjct: 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEI------SIEAMDFVD---RLLVKERKSRMT 251
Query: 267 MK 268
Sbjct: 252 AS 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 66.7 bits (162), Expect = 1e-13
Identities = 28/167 (16%), Positives = 60/167 (35%), Gaps = 28/167 (16%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
+ + + D + + + + I+H D+KP NI++ K+ DFG+A+ ++D
Sbjct: 110 PKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166
Query: 172 ------------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIIL 219
++PE + + ++DVY G VL E + P +
Sbjct: 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG--EPPFTGDSPVSVAY 224
Query: 220 TNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPS 266
+ ++ + +L+ +V + P R
Sbjct: 225 QHVREDPIPPSARHEGL------SADLDAVVL---KALAKNPENRYQ 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.6 bits (159), Expect = 5e-13
Identities = 30/186 (16%), Positives = 59/186 (31%), Gaps = 34/186 (18%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSD--- 170
+ + +G+ Y+H +LH D+KP N+L++ KI DFGLA++
Sbjct: 108 NDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164
Query: 171 -----------KGCMAPEC-YKRTPISVKADVYGYGIVLLETIC-----CWENMEIDASK 213
+ APE + D++ G +L E + ++ +
Sbjct: 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 224
Query: 214 PEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVG-----------LWCVQDEPA 262
I+ + L + KN ++ + P
Sbjct: 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 284
Query: 263 LRPSMK 268
R ++
Sbjct: 285 KRIEVE 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.6 bits (159), Expect = 6e-13
Identities = 33/181 (18%), Positives = 56/181 (30%), Gaps = 29/181 (16%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI-LMDEFWTAKISDFGLAKLLSDKG 172
+ + + Y+H I H DIKPQN+ L + K+ DFG AK L
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 173 -----------CMAPECYKRTPISVKADVYGYGIVLLETIC-------------CWENME 208
+ T + DV+ G VL E + E ++
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 209 IDASKPEEIILT-NWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSM 267
+ + E I N Y F ++ + + + ++ P R +
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
Query: 268 K 268
Sbjct: 298 L 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (158), Expect = 8e-13
Identities = 25/105 (23%), Positives = 42/105 (40%), Gaps = 11/105 (10%)
Query: 110 RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169
R A+ + L +++ DIK +N+++D+ KI+DFGL K
Sbjct: 97 SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156
Query: 170 DKG-----------CMAPECYKRTPISVKADVYGYGIVLLETICC 203
G +APE + D +G G+V+ E +C
Sbjct: 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 64.3 bits (156), Expect = 1e-12
Identities = 28/165 (16%), Positives = 54/165 (32%), Gaps = 21/165 (12%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
R+ V + YLHD +DE ISDFGL+K+
Sbjct: 106 ERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165
Query: 172 --------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWV 223
G +APE + P S D + G++ +C P +
Sbjct: 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC--------GYPPFYDENDAKL 217
Query: 224 YKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
++ + E + + ++ ++ ++ +P R + +
Sbjct: 218 FEQILKAEYEFDSPYWDDISDSAKDFIR---HLMEKDPEKRFTCE 259
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.4 bits (153), Expect = 3e-12
Identities = 29/198 (14%), Positives = 55/198 (27%), Gaps = 30/198 (15%)
Query: 98 WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 157
F S + + KG+ + H +LH D+KPQN+L++
Sbjct: 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGEL 140
Query: 158 KISDFGLAKLLSDKG------------CMAPECYKRTPISVKADVYGYGIVLLETICC-- 203
K+++FGLA+ + S D++ G + E
Sbjct: 141 KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
Query: 204 ------------WENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVK 251
+ + EE + + + L +
Sbjct: 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260
Query: 252 VGL-WCVQDEPALRPSMK 268
L ++ P R S +
Sbjct: 261 DLLQNLLKCNPVQRISAE 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (152), Expect = 4e-12
Identities = 29/178 (16%), Positives = 67/178 (37%), Gaps = 28/178 (15%)
Query: 105 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA----KIS 160
F + + + + + G ++ I H D+KP+NI++ + KI
Sbjct: 103 FLAEKESLTEEEATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII 159
Query: 161 DFGLAKLLSDK----------GCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEID 210
DFGLA + +APE P+ ++AD++ G++ + + +
Sbjct: 160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYI-LLSGASPFLG 218
Query: 211 ASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMK 268
+K E + + V F + + ++ ++ + +P R +++
Sbjct: 219 DTKQETLANVSAVNYEFEDEYFSNT-------SALAKDFIR---RLLVKDPKKRMTIQ 266
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 63.3 bits (153), Expect = 4e-12
Identities = 21/97 (21%), Positives = 41/97 (42%), Gaps = 11/97 (11%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDKGC 173
A + YLH +++ D+KP+N+L+D+ +++DFG AK + +
Sbjct: 140 EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 174 --------MAPECYKRTPISVKADVYGYGIVLLETIC 202
+APE + D + G+++ E
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 61.8 bits (149), Expect = 9e-12
Identities = 35/201 (17%), Positives = 65/201 (32%), Gaps = 29/201 (14%)
Query: 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 153
+ + E L + GI Y H + +LH D+KPQN+L++
Sbjct: 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINR 135
Query: 154 FWTAKISDFGLAKLLSDKGC-----------MAPECYKRT-PISVKADVYGYGIVLLETI 201
KI+DFGLA+ AP+ + S D++ G + E +
Sbjct: 136 EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195
Query: 202 C-------------CWENMEIDASKPEEIILT-NWVYKCFINRELNKLVRGTEVDKKNLE 247
I + + + K N + + + K E
Sbjct: 196 NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDE 255
Query: 248 NLVKVGLWCVQDEPALRPSMK 268
+ + + ++ +P R + K
Sbjct: 256 SGIDLLSKMLKLDPNQRITAK 276
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.4 bits (148), Expect = 1e-11
Identities = 32/198 (16%), Positives = 58/198 (29%), Gaps = 36/198 (18%)
Query: 104 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG 163
+ + ++ R+ + G L+ ILH D+K N+L+ K++DFG
Sbjct: 106 LLSNVLVKFTLSEIKRVMQMLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162
Query: 164 LAKLLSDKGC----------------MAPECYKRTPISVKADVYGYGIVLLETIC----- 202
LA+ S D++G G ++ E
Sbjct: 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222
Query: 203 --------CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGL 254
++ S E+ Y+ + EL K + D+ L
Sbjct: 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282
Query: 255 ----WCVQDEPALRPSMK 268
+ +PA R
Sbjct: 283 DLIDKLLVLDPAQRIDSD 300
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.2 bits (145), Expect = 3e-11
Identities = 33/183 (18%), Positives = 59/183 (32%), Gaps = 34/183 (18%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK-- 171
++ + + KG+ Y+H H D+KP N+ ++E KI DFGLA+ +
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
Query: 172 ------GCMAPECY-KRTPISVKADVYGYGIVLLETIC-------------CWENMEIDA 211
APE + D++ G ++ E I E M++
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 212 SKPEEII------LTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRP 265
+ P E + K E NL++ + + R
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRV 293
Query: 266 SMK 268
+
Sbjct: 294 TAG 296
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 54.3 bits (129), Expect = 4e-09
Identities = 28/119 (23%), Positives = 46/119 (38%), Gaps = 16/119 (13%)
Query: 98 WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---- 153
+L +I R +I+ + G+ Y+H I+H DIKP+N+LM+
Sbjct: 108 ENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSP 165
Query: 154 --FWTAKISDFGLAKLLSDKGC--------MAPECYKRTPISVKADVYGYGIVLLETIC 202
KI+D G A + +PE P AD++ ++ E I
Sbjct: 166 ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (127), Expect = 6e-09
Identities = 25/104 (24%), Positives = 40/104 (38%), Gaps = 13/104 (12%)
Query: 109 ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168
+ + + + GI +LH I+H D+KP NI++ T KI DFGLA+
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169
Query: 169 SDK----------GCMAPECYKRTPISVKADVYGYGIVLLETIC 202
APE D++ G ++ E +
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 52.1 bits (124), Expect = 8e-09
Identities = 11/84 (13%), Positives = 27/84 (32%), Gaps = 6/84 (7%)
Query: 105 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164
+ + + + + I+H D+ N+L+ E I DF
Sbjct: 93 DAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQ 148
Query: 165 AKLLSDKGCMAPECYKRTPISVKA 188
+ + ++ E +R ++
Sbjct: 149 SVEVGEE--GWREILERDVRNIIT 170
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.0 bits (126), Expect = 1e-08
Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 12/103 (11%)
Query: 109 ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168
+ + + + +G+ Y+H I+H D+KP N+ ++E KI DFGLA+
Sbjct: 115 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171
Query: 169 SDK--------GCMAPECY-KRTPISVKADVYGYGIVLLETIC 202
D+ APE + D++ G ++ E +
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 52.2 bits (124), Expect = 2e-08
Identities = 21/101 (20%), Positives = 36/101 (35%), Gaps = 15/101 (14%)
Query: 114 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKISDFGLAKLLSDK- 171
++ K + Y H I+H D+KP N+++D E ++ D+GLA+
Sbjct: 128 DYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 172 ---------GCMAPECYKRTP-ISVKADVYGYGIVLLETIC 202
PE D++ G +L I
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.8 bits (123), Expect = 2e-08
Identities = 22/98 (22%), Positives = 41/98 (41%), Gaps = 14/98 (14%)
Query: 119 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLSDK------- 171
+ + V + +L L + I++ DIK +NIL+D ++DFGL+K
Sbjct: 130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189
Query: 172 -----GCMAPECY--KRTPISVKADVYGYGIVLLETIC 202
MAP+ + D + G+++ E +
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 274 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.72 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 94.89 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 89.79 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 88.0 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-54 Score=369.10 Aligned_cols=243 Identities=21% Similarity=0.212 Sum_probs=192.5
Q ss_pred hhhhhHHHHhhhccc---------cccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcC
Q 048314 12 IARSSLCTKLRNFCR---------SSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRV 70 (274)
Q Consensus 12 ~~~~~l~~~~~~f~~---------~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l 70 (274)
++++++..++++|.. .++||+|+| |.||+|.. .++|..... ...++|.+|+++|+++
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~f--g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEF--GEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSS--SEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCC--eEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 567777777777754 468999999 99999921 112222221 1234688999999999
Q ss_pred CCCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceE
Q 048314 71 SWTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNIL 150 (274)
Q Consensus 71 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil 150 (274)
+|||||+++|+|.+++..++|||||++|+|.+++.. ..+.++|..+..++.|++.||.|||++ +++||||||+|||
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNIL 160 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEE
Confidence 999999999999999999999999999999999886 456799999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeccccceecC----------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCC
Q 048314 151 MDEFWTAKISDFGLAKLLS----------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASK 213 (274)
Q Consensus 151 ~~~~~~~kl~d~g~~~~~~----------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~ 213 (274)
++.++.+||+|||+++... ++.|+|||.+....++.++|||||||++|||++ |..||....
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-- 238 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-- 238 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--
Confidence 9999999999999987532 456999999999999999999999999999998 899986431
Q ss_pred hhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 214 PEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
. ..+.. ....+ . ..+.+..++..+.+++.+||+.||++|||+.||++.|
T Consensus 239 -~-~~~~~----~i~~~-----~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 239 -N-QDVIN----AIEQD-----Y-RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp -H-HHHHH----HHHTT-----C-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred -H-HHHHH----HHHcC-----C-CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 1 11111 11111 0 1134556778899999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-53 Score=359.66 Aligned_cols=236 Identities=16% Similarity=0.170 Sum_probs=194.8
Q ss_pred hhhccccccCCCCCCCCcchhHHH-------HHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-------RALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
.++|...+.||+|+| |.||+|. +|+|....+....++|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus 16 ~~~~~~~~~iG~G~f--g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 16 RTDITMKHKLGGGQY--GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGGEEEEEETTTTTT--SSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHeEEeeEEeeCCC--eEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 457777888999999 9999991 2223222333455678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
||++|+|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999999876667899999999999999999999999 99999999999999999999999999997543
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
+..|+|||++....++.++|||||||++|||++|..|+...... . .+. .....+ . ..+.
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~--~~~----~~i~~~-----~-~~~~ 237 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-S--QVY----ELLEKD-----Y-RMER 237 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-H--HHH----HHHHTT-----C-CCCC
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-H--HHH----HHHhcC-----C-CCCC
Confidence 45699999999999999999999999999999987776533111 1 111 111111 1 1135
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+...++.+.+|+.+||+.||++|||++||++.|
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L 270 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 556778899999999999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=354.28 Aligned_cols=234 Identities=15% Similarity=0.172 Sum_probs=186.7
Q ss_pred hhccccccCCCCCCCCcchhHH------HHHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC------MRALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~------~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
.+|...+.||+|+| |.||+| .+++|+........++|.+|++++++++|||||+++|+|.+++..++|||||
T Consensus 5 ~~~~~~~~iG~G~f--g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQF--GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSS--CCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCC--eEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35666788999999 999998 2222322223345567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 83 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999999976 456799999999999999999999999 99999999999999999999999999986532
Q ss_pred ------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCH
Q 048314 170 ------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDK 243 (274)
Q Consensus 170 ------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (274)
+..|+|||.+....++.++|||||||++|||+++..|+...... ..+.. ....+ . ....|.
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~----~i~~~-----~-~~~~p~ 225 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVE----DISTG-----F-RLYKPR 225 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHH----HHHHT-----C-CCCCCT
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHH----HHHhc-----C-CCCCcc
Confidence 46799999999999999999999999999999965554332111 11111 11111 0 112445
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 244 KNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 244 ~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+++++.+++.+||+.||++|||++||++.|
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 6678899999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=354.14 Aligned_cols=236 Identities=19% Similarity=0.217 Sum_probs=187.0
Q ss_pred hhhccccccCCCCCCCCcchhHHH---HHHHHHhcC----CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM---RALMATVNS----PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~---~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
.++|...+.||+|+| |.||+|. ..++|.+.. ....+.|.+|+.+|++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~f--g~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSF--GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSS--CEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCC--cEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 356777888999999 9999992 112222221 1223567799999999999999999998754 56899999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL----- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~----- 168 (274)
||++|+|.+++.. .+..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 y~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999976 446799999999999999999999999 9999999999999999999999999998643
Q ss_pred --------CCCCcCCCccccc---CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 --------SDKGCMAPECYKR---TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 --------~~~~~~ape~~~~---~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
+++.|+|||++.. ..++.++|||||||++|||++|+.||..... ... +. .....+ ...
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-~~~--~~----~~~~~~----~~~ 228 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQ--II----FMVGRG----YLS 228 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHH--HH----HHHHHT----SCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-HHH--HH----HHHhcC----CCC
Confidence 2667999999864 3578999999999999999999999964311 111 11 111111 111
Q ss_pred CC--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 238 GT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 238 ~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+. ..+..+++.+.+++.+||+.||++|||++||++.|
T Consensus 229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 11 24556678899999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=347.86 Aligned_cols=228 Identities=16% Similarity=0.150 Sum_probs=190.7
Q ss_pred hhccccccCCCCCCCCcchhHH-------HHHHH----HHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC-------MRALM----ATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~-------~~~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.||+|+| |.||++ .+++| .........+.+.+|++++++++|||||++++++.+++..++
T Consensus 6 ~dy~i~~~iG~G~f--g~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKF--GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCCC--cEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 57888889999999 999998 11111 112223345567899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
|||||++|+|.+++.. .+.+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 84 vmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999999986 45799999999999999999999999 99999999999999999999999999987543
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCC-c
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-E 240 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (274)
|+.|+|||++.+..++.++|||||||++|||++|+.||... .... +. . .+.... .
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~-~~----~--------~i~~~~~~ 222 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQE-TY----K--------RISRVEFT 222 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHH-HH----H--------HHHTTCCC
T ss_pred CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHH-HH----H--------HHHcCCCC
Confidence 67899999999989999999999999999999999999643 1111 10 1 111111 2
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.|...++++.+++.+||+.||++|||++|+++
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 45556788999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=352.12 Aligned_cols=235 Identities=18% Similarity=0.260 Sum_probs=188.7
Q ss_pred hhhccccccCCCCCCCCcchhHHH-----HHHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-----RALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-----~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
.++|...+.||+|+| |.||+|. .+++|.+. .....+.|.+|+++|++++|||||+++|++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~f--g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQF--GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETT--EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCC--cEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 356777888999999 9999991 12223332 23445678999999999999999999998754 567999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
|++|+|.+++.......++|..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999988764445699999999999999999999999 99999999999999999999999999997643
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
++.|+|||++....++.++|||||||++|||++|..|+...... ..+.. ... ...+ ...|
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~---~~~~~----~i~-----~~~~-~~~p 232 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQ----NLE-----RGYR-MVRP 232 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH----HHH-----TTCC-CCCC
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH---HHHHH----HHH-----hcCC-CCCc
Confidence 45799999999889999999999999999999976665433111 11111 111 1111 1245
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...++++.+|+.+||+.||++|||++||+++|
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L 264 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence 56678899999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=355.58 Aligned_cols=233 Identities=18% Similarity=0.188 Sum_probs=188.1
Q ss_pred hhhcccccc-CCCCCCCCcchhHHHH--------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 21 LRNFCRSSL-NDRNSPRSKSVWSCMR--------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~~~-~g~g~~~~g~vy~~~~--------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
.+++....+ ||+|+| |.||+|.. +++|.+... ...++|.+|+++|++++|||||+++|+|.+ +..
T Consensus 7 ~~~~~~~~~~iG~G~f--g~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNF--GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGGEEEEEEEEECCTT--EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ccCeEECCcEEecccC--eEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 455665665 999999 99999821 122322222 223568899999999999999999999865 458
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++|||||++|+|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999999865 446799999999999999999999999 9999999999999999999999999999754
Q ss_pred C--------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 169 S--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 169 ~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
. ++.|+|||++....++.++|||||||++|||++ |..||..... . .+. ..+.++.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~---~~~----~~i~~~~-- 229 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-P---EVM----AFIEQGK-- 229 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-H---HHH----HHHHTTC--
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-H---HHH----HHHHcCC--
Confidence 3 456999999998899999999999999999998 8999964311 1 111 1111111
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+.|..++.++.+|+.+||+.||++|||+.+|++.|
T Consensus 230 ----~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L 266 (285)
T d1u59a_ 230 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266 (285)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ----CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 1135566778999999999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=350.23 Aligned_cols=225 Identities=17% Similarity=0.182 Sum_probs=182.7
Q ss_pred ccCCCCCCCCcchhHHHH--------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 28 SLNDRNSPRSKSVWSCMR--------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 28 ~~~g~g~~~~g~vy~~~~--------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
+.||+|+| |.||+|.. .++|.+... ...++|.+|+++|++++|||||+++|+|.+ +..+||||||
T Consensus 13 k~iG~G~f--G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNF--GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSS--EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcccCCC--eEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence 46999999 99999821 122322221 123468899999999999999999999865 4578999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++|+|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+|++|||+++...
T Consensus 90 ~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 90 ELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp TTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999999986 45799999999999999999999999 99999999999999999999999999997532
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
++.|+|||.+....++.++|||||||++|||++ |..||.... .. .+. ..+.++ ...+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--~~--~~~----~~i~~~------~~~~ 230 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GS--EVT----AMLEKG------ERMG 230 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HH--HHH----HHHHTT------CCCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--HH--HHH----HHHHcC------CCCC
Confidence 467999999999999999999999999999997 899996431 11 111 111111 1113
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.|..++.++.+|+.+||+.||++|||+++|+++|
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L 264 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence 5566778999999999999999999999997754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=347.44 Aligned_cols=231 Identities=16% Similarity=0.154 Sum_probs=189.4
Q ss_pred hhccccccCCCCCCCCcchhHH-------HHHHHHH-hcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC-------MRALMAT-VNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
++|.....||+|+| |.||+| .+|+|.. .......+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 20 ~~Y~~~~~iG~G~f--g~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGAS--GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSS--CEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcC--cEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 46888899999999 999999 2222221 1122334567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL----- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~----- 168 (274)
||++|+|.+++.. +.+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 98 y~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 9999999999875 4699999999999999999999999 9999999999999999999999999999754
Q ss_pred ------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 169 ------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 169 ------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+|+.|+|||++.+..++.++||||+||++|+|++|..||.... ....+ ....... ......+
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~----~~~~~~~-----~~~~~~~ 239 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PLRAL----YLIATNG-----TPELQNP 239 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHH----HHHHHHC-----SCCCSSG
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC---HHHHH----HHHHhCC-----CCCCCCc
Confidence 2677999999999999999999999999999999999996431 11111 1111110 0111234
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...++.+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 456788999999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=346.70 Aligned_cols=233 Identities=20% Similarity=0.164 Sum_probs=186.7
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|...+.||+|+| |.||+|. ..++|.+.. ....+++.+|+++|++++|||||++++++.+++..++|
T Consensus 4 ~~dy~~~~~lG~G~f--g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAY--GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcC--eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 357888899999999 9999981 122232222 13456789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
||||++|+|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 mEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 82 LEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999999964 56799999999999999999999999 9999999999999999999999999998743
Q ss_pred ----------CCCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 ----------SDKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 ----------~~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
+|+.|+|||++....+ +.++||||+||++|||++|+.||.......... .. ..... .
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--~~-----~~~~~-----~ 224 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SD-----WKEKK-----T 224 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--HH-----HHTTC-----T
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH--HH-----HhcCC-----C
Confidence 3678999999988775 678999999999999999999997542221111 00 00000 0
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
........++++.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00122344578899999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-52 Score=357.39 Aligned_cols=236 Identities=18% Similarity=0.184 Sum_probs=191.0
Q ss_pred hhhccccccCCCCCCCCcchhHHH-----------HHHHHHhcC---CCCCCcHHHHHHHHhcC-CCCccceEeEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNS---PYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRG 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 85 (274)
.++|...+.||+|+| |.||+|. .+++|.... ......+.+|+.+|+++ +|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~f--G~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAF--GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSS--EEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCC--eEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 357777889999999 9999982 122332221 23445678999999998 799999999999999
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCC
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAE---------------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDI 144 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl 144 (274)
+..++|||||++|+|.+++..... ..+++..++.++.|++.||.|||++ +|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999986421 3489999999999999999999999 9999999
Q ss_pred CCCceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCcccc
Q 048314 145 KPQNILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEID 210 (274)
Q Consensus 145 ~~~nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~ 210 (274)
||+||+++.++.+||+|||+++... ++.|+|||++....++.++|||||||++|||++ |..||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999986432 567999999999999999999999999999997 89999644
Q ss_pred CCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 211 ASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..... +. ....++ .+ .+.|..+++++.+||.+||+.||++|||++||+++|
T Consensus 271 ~~~~~---~~----~~~~~~-----~~-~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 271 PVDAN---FY----KLIQNG-----FK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp CCSHH---HH----HHHHTT-----CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHH---HH----HHHhcC-----CC-CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 22211 11 111111 11 135556778999999999999999999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=344.84 Aligned_cols=233 Identities=15% Similarity=0.151 Sum_probs=193.0
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAALD 95 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 95 (274)
++|.-.+.||+|+| |.||+|. +|+|.........+.|.+|++++++++|||||+++|+|.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~f--g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQF--GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETT--EEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCC--eEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57777889999999 9999982 222222233355677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC------
Q 048314 96 LPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------ 169 (274)
Q Consensus 96 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------ 169 (274)
++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 82 ANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999999876 456789999999999999999999999 99999999999999999999999999986533
Q ss_pred ------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 ------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 ------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
+..|+|||.+....++.++||||||+++|||++ |+.||.... .. .+. ..+.++ . ....|
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~-~~~----~~i~~~-----~-~~~~p 223 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NS-ETA----EHIAQG-----L-RLYRP 223 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HH-HHH----HHHHTT-----C-CCCCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC---HH-HHH----HHHHhC-----C-CCCCc
Confidence 456999999999999999999999999999998 788986431 11 111 111111 1 11345
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...++.+.+++.+||+.||++|||+.|+++.|
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 56678899999999999999999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=349.20 Aligned_cols=233 Identities=17% Similarity=0.126 Sum_probs=189.1
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcC--CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNS--PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
+.|.....||+|+| |.||+|. ..++|.+.. ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 12 d~Y~i~~~iG~G~f--g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAF--GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCC--cEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 35676788999999 9999992 222333322 2445678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec-----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL----- 168 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~----- 168 (274)
||++|+|.+++.+ ..+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 90 y~~~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 90 FCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp CCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred cCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 9999999999876 346799999999999999999999999 9999999999999999999999999998643
Q ss_pred ------CCCCcCCCcccc-----cCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 ------SDKGCMAPECYK-----RTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 ------~~~~~~ape~~~-----~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
+++.|+|||++. ...|+.++|||||||++|||++|+.||..... .. .+.. .......
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~-~~~~-----i~~~~~~---- 233 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MR-VLLK-----IAKSEPP---- 233 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GG-HHHH-----HHHSCCC----
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--HH-HHHH-----HHcCCCC----
Confidence 378899999884 44678999999999999999999999964311 11 1110 1111110
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+...++++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11234456788999999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=349.59 Aligned_cols=234 Identities=21% Similarity=0.231 Sum_probs=187.9
Q ss_pred hhccccccCCCCCCCCcchhHHH----------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM----------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~----------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
.+|...++||+|+| |.||+|. ..++|.+... ....+|.+|+++|++++|||||+++|+|.+.+..
T Consensus 7 ~~~~~~~~iG~G~f--G~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEF--GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSS--SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCC--eEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 46788899999999 9999982 1222322221 1234578999999999999999999999999999
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++|||||.+|++.+++.. ....++|..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 85 MIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999999876 456799999999999999999999999 9999999999999999999999999999753
Q ss_pred C--------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 S--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
. +..|+|||++....++.++|||||||++|||++|..|+..... .. .+. ....++
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~--~~~----~~i~~~---- 229 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NH--EVM----KAINDG---- 229 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HH--HHH----HHHHTT----
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-HH--HHH----HHHhcc----
Confidence 2 4569999999999999999999999999999997776653311 11 111 111111
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.+ .+.+..++..+.+|+.+||+.||++|||+.||+++|
T Consensus 230 -~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 230 -FR-LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp -CC-CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred -CC-CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 11 134556778899999999999999999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-51 Score=351.73 Aligned_cols=245 Identities=17% Similarity=0.166 Sum_probs=190.3
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.++|...+.||+|+| |.||+|. ..++|.+... ...+++.+|+.+|++++|||||+++++|.+.++.++|
T Consensus 5 ~d~y~~~~~iG~G~f--g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNG--GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSS--CCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCC--eEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 568998999999999 9999982 2223333322 2234577999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCCcEEEecccccee---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL--- 167 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~--- 167 (274)
||||++|+|.+++.+ .+.+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+++.
T Consensus 83 mEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999986 3579999999999999999999996 6 899999999999999999999999999864
Q ss_pred ------cCCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh-------------
Q 048314 168 ------LSDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI------------- 228 (274)
Q Consensus 168 ------~~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 228 (274)
.+|+.|+|||++.+..|+.++||||+||++|||++|+.||.....................
T Consensus 158 ~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 3478899999999999999999999999999999999999754322211110000000000
Q ss_pred -----h--------hhhhhhhc---CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 229 -----N--------RELNKLVR---GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 229 -----~--------~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
. ........ +.......+.++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 00000000 00111223578999999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=346.65 Aligned_cols=236 Identities=15% Similarity=0.150 Sum_probs=181.9
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEe--CCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR--GSKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 88 (274)
.++|...+.||+|+| |.||+|. ..++|.+... ...+.+.+|+++|++++|||||++++++.+ ++..
T Consensus 3 ~edy~~~~~iG~G~f--g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 3 AEDYEVLYTIGTGSY--GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGGEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred chhCEEeEEEecCCC--eEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 367888899999999 9999992 1222322222 112347799999999999999999999865 4568
Q ss_pred eEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 89 STEAALDLPWDLAYIIFCS--AERNPYWNQRVRIALDVAKGILYLHDEC--EPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
++|||||++|+|.+++... ....+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 9999999999999999743 3457999999999999999999999861 01399999999999999999999999999
Q ss_pred ceec-----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 165 AKLL-----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 165 ~~~~-----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
++.. +++.|+|||++....++.++|||||||++|||++|..||... ... .+. ....++..
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~---~~~-~~~----~~i~~~~~- 231 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQK-ELA----GKIREGKF- 231 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHH-HHH----HHHHHTCC-
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC---CHH-HHH----HHHHcCCC-
Confidence 8643 267899999999989999999999999999999999999643 111 111 11111111
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
...+...++++.+++.+||+.||++|||++|+++
T Consensus 232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1245566788999999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=340.99 Aligned_cols=226 Identities=19% Similarity=0.186 Sum_probs=178.6
Q ss_pred cccCCCCCCCCcchhHHHH------HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEe----CCcceEEE
Q 048314 27 SSLNDRNSPRSKSVWSCMR------ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR----GSKPSTEA 92 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~------~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 92 (274)
...||+|+| |.||+|.. .++|.+... ...+.+.+|+++|++++|||||++++++.+ ....++||
T Consensus 14 ~~~iG~G~f--g~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 14 DIEIGRGSF--KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEECSS--EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred eeEEecCcC--cEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 456999999 99999911 112222111 223457899999999999999999999865 34579999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cccCCCCCCceEEc-CCCcEEEeccccceec-
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMD-EFWTAKISDFGLAKLL- 168 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~-~~~~~kl~d~g~~~~~- 168 (274)
|||++|+|.+++.. ...+++..++.++.|++.||.|||++ + |+||||||+|||++ .++.+||+|||+++..
T Consensus 92 E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999986 45799999999999999999999998 7 99999999999996 5789999999999643
Q ss_pred --------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 169 --------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 169 --------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
+|+.|+|||++.. .++.++|||||||++|||++|+.||..... .. .+. .... ....+..
T Consensus 167 ~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-~~--~~~----~~i~-----~~~~~~~ 233 (270)
T d1t4ha_ 167 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-AA--QIY----RRVT-----SGVKPAS 233 (270)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HH--HHH----HHHT-----TTCCCGG
T ss_pred CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-HH--HHH----HHHH-----cCCCCcc
Confidence 3788999998865 689999999999999999999999964311 11 111 1111 1111222
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+...++++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 33345567999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=342.58 Aligned_cols=234 Identities=18% Similarity=0.188 Sum_probs=186.5
Q ss_pred hhccccccCCCCCCCCcchhHH----HHHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEe-CCcceEEEEeCC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC----MRALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR-GSKPSTEAALDL 96 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~----~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 96 (274)
++|.-.+.||+|+| |.||+| ...++|.+......+.+.+|++++++++|||||+++|+|.+ .+..++||||++
T Consensus 7 ~~~~~~~~lG~G~f--g~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEF--GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSS--CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCC--eEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 46666788999999 999998 22233444455566779999999999999999999999965 466899999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-------
Q 048314 97 PWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS------- 169 (274)
Q Consensus 97 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~------- 169 (274)
+|+|.+++.......++|..++.++.|++.||.|||+. +++||||||+||+++.++.+|++|||+++...
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~ 161 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 161 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCCcccc
Confidence 99999999764444699999999999999999999999 99999999999999999999999999997643
Q ss_pred -CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHH
Q 048314 170 -DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLE 247 (274)
Q Consensus 170 -~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (274)
+..|+|||++....++.++||||||+++|||++ |+.||.... ... +.. .+.++ .++ +.+...+.
T Consensus 162 ~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~--~~~----~i~~~-----~~~-~~~~~~~~ 227 (262)
T d1byga_ 162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKD--VVP----RVEKG-----YKM-DAPDGCPP 227 (262)
T ss_dssp CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGG--HHH----HHTTT-----CCC-CCCTTCCH
T ss_pred ccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--HHH--HHH----HHHcC-----CCC-CCCccCCH
Confidence 567999999998899999999999999999998 577765331 111 111 01111 111 35556678
Q ss_pred HHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 248 NLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 248 ~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
++.+|+.+||+.||++|||+.||+++|
T Consensus 228 ~~~~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 228 AVYEVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 899999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=343.23 Aligned_cols=228 Identities=16% Similarity=0.144 Sum_probs=189.5
Q ss_pred hhccccccCCCCCCCCcchhHH-------HHHHH----HHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC-------MRALM----ATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~-------~~~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
.+|...+.||+|+| |.||+| .+|+| .........+.+.+|+++|++++|||||++++++.+++..++
T Consensus 8 ~dy~i~~~lG~G~f--g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSF--STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEeeCCC--eEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 57888999999999 999998 11211 112222344568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec--
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL-- 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~-- 168 (274)
|||||++|+|.+++.. .+.+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 vmEy~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999999886 46799999999999999999999999 9999999999999999999999999999753
Q ss_pred -----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhc
Q 048314 169 -----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVR 237 (274)
Q Consensus 169 -----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (274)
+|+.|+|||++.+..++.++||||+||++|||++|..||... ... .+. ....+.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~-~~~----~~i~~~------- 225 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEY-LIF----QKIIKL------- 225 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHH-HHH----HHHHTT-------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHH-HHH----HHHHcC-------
Confidence 367899999999999999999999999999999999999643 111 110 111111
Q ss_pred CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHH
Q 048314 238 GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVV 271 (274)
Q Consensus 238 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl 271 (274)
...+|...++++.+||.+||+.||++|||++|++
T Consensus 226 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 226 EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 1124555678899999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-50 Score=343.96 Aligned_cols=234 Identities=17% Similarity=0.175 Sum_probs=180.8
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
.+.|.....||+|+| |.||+|. ..++|.+... ...+.+.+|+++|++++|||||++++++.+++..++|
T Consensus 8 ~d~Y~~~~~lG~G~f--g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAF--SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGG--GGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccC--eEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 355777899999999 9999981 1122222211 2345677999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc---CCCcEEEeccccceec
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD---EFWTAKISDFGLAKLL 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~---~~~~~kl~d~g~~~~~ 168 (274)
||||++|+|.+++.. .+.+++..+..++.|++.||.|||+. +++||||||+||++. .++.+||+|||+++..
T Consensus 86 mE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp ECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999999975 56799999999999999999999999 999999999999994 5789999999998643
Q ss_pred ----------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 169 ----------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 169 ----------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
+|+.|+|||++.+..++.++|||||||++|||++|..||.... . ..+.. ...... .-.+
T Consensus 161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~-~~~~~----~i~~~~---~~~~ 229 (307)
T d1a06a_ 161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---D-AKLFE----QILKAE---YEFD 229 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---H-HHHHH----HHHTTC---CCCC
T ss_pred cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---H-HHHHH----HHhccC---CCCC
Confidence 3788999999999999999999999999999999999996431 1 11111 111110 0111
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+.+...++++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1233456678999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=343.91 Aligned_cols=235 Identities=20% Similarity=0.236 Sum_probs=190.0
Q ss_pred hhhccccccCCCCCCCCcchhHHH-----HHHHHHhc-CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-----RALMATVN-SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-----~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 94 (274)
.++|.....||+|+| |.||+|. ..++|.+. .....+.|.+|+.+|++++|||||+++|+|.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~f--g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSS--CEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCC--eEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 367888889999999 9999991 12233332 32445678999999999999999999999854 568999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-----
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS----- 169 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~----- 169 (274)
|++|+|..++.......++|..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999999999865556799999999999999999999999 99999999999999999999999999986532
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
++.|+|||.+....++.++||||||+++|||++|..|+....... .+... ...+ . ..+.+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~---~~~~~----i~~~-----~-~~~~~ 236 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ----VERG-----Y-RMPCP 236 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HHTT-----C-CCCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH----HHhc-----C-CCCCC
Confidence 567999999999999999999999999999999877765432111 11111 1111 1 11355
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 243 KKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+++++.+++.+||+.||++|||+++|+++|
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 268 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 66778899999999999999999999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-50 Score=344.95 Aligned_cols=231 Identities=17% Similarity=0.157 Sum_probs=186.1
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCCC-----CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPY-----SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
..|...+.||+|+| |.||+|. ..++|.+.... ..+.+.+|+++|++++|||||++++++.+++..++
T Consensus 15 ~~y~~l~~lG~G~f--g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSF--GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSS--SEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeEEEecCCC--eEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 45888888999999 9999992 12223222211 12357799999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
|||||.+|+|..++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 93 v~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999999877765 46799999999999999999999999 99999999999999999999999999997543
Q ss_pred ------CCCcCCCccccc---CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 ------DKGCMAPECYKR---TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 ------~~~~~ape~~~~---~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
|+.|+|||++.. ..|+.++|||||||++|||++|..||.... ....+ ... ... ..+..
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~~----~~i-~~~-----~~~~~ 234 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSAL----YHI-AQN-----ESPAL 234 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHH----HHH-HHS-----CCCCC
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHHH----HHH-HhC-----CCCCC
Confidence 788999999864 458899999999999999999999996431 11100 011 011 11112
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.+...++.+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 33455678999999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=338.23 Aligned_cols=233 Identities=15% Similarity=0.157 Sum_probs=182.7
Q ss_pred hhhccccccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
.++|.....||+|+| |.||+|.. .++|..... ...+.|.+|+.+|++++|||||+++|++. .+..
T Consensus 6 ~~~~~l~~~iG~G~f--g~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQF--GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSS--SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCC--cEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 356777889999999 99999821 112222211 12345789999999999999999999986 4678
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++|||||++|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 83 ~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999999876 456799999999999999999999999 9999999999999999999999999998754
Q ss_pred C------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 169 S------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 169 ~------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
. ++.|+|||.+....++.++|||||||++|||++ |.+||..... .. +. ....++.
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~--~~----~~i~~~~---- 226 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--ND--VI----GRIENGE---- 226 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GG--HH----HHHHTTC----
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HH--HH----HHHHcCC----
Confidence 3 567999999999999999999999999999987 7888864311 11 10 1111111
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+.+...++.+.+||.+||+.||++|||+.||++.|
T Consensus 227 --~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L 263 (273)
T d1mp8a_ 227 --RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263 (273)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 1135566778999999999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-49 Score=346.32 Aligned_cols=235 Identities=14% Similarity=0.111 Sum_probs=188.7
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.++|.....||+|+| |.||+|. ..++|.+... ...+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 25 l~~Y~i~~~lG~G~f--g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAF--GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETT--EEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcC--eEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357888899999999 9999982 1123322222 22345679999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc--CCCcEEEeccccceecC-
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD--EFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~--~~~~~kl~d~g~~~~~~- 169 (274)
|||++|+|.+++.. ..+.+++..++.++.||+.||.|||++ +++||||||+|||+. .++.+||+|||+++...
T Consensus 103 E~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 103 EFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999999965 345799999999999999999999999 999999999999995 45789999999987543
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
|+.|+|||++.+..++.++||||+||++|+|++|..||... .....+. ...... ...+..
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~-----~i~~~~---~~~~~~ 247 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLR-----NVKSCD---WNMDDS 247 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH-----HHHHTC---CCSCCG
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHH-----HHHhCC---CCCCcc
Confidence 77899999999999999999999999999999999999643 1111111 111110 000111
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.....++++.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22345678999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=343.42 Aligned_cols=232 Identities=18% Similarity=0.210 Sum_probs=188.5
Q ss_pred hhccccccCCCCCCCCcchhHHH----------HHHHHHhcC---CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM----------RALMATVNS---PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~----------~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 88 (274)
.+|...++||+|+| |.||+|. ++++|.... ....++|.+|+++|++++|||||+++|+|.++ ..
T Consensus 9 ~dy~~~~~lG~G~f--G~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAF--GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSS--EEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCC--eEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 46888999999999 9999982 122222222 13345688999999999999999999999865 46
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
++++||+.+|+|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred eEEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 788999999999999887 456799999999999999999999999 9999999999999999999999999998753
Q ss_pred C-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhhhh
Q 048314 169 S-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINRELNK 234 (274)
Q Consensus 169 ~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (274)
. ++.|+|||.+..+.++.++|||||||++|||+| |..||.... ... +. ....++.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~--~~~--~~----~~i~~~~--- 230 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASE--IS----SILEKGE--- 230 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--GGG--HH----HHHHHTC---
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC--HHH--HH----HHHHcCC---
Confidence 2 568999999999999999999999999999998 688876431 111 11 1111110
Q ss_pred hhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 235 LVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 235 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+.|..++..+.+++.+||+.||++|||+.||++.|
T Consensus 231 ---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 231 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 1134556778899999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=336.00 Aligned_cols=230 Identities=17% Similarity=0.162 Sum_probs=191.5
Q ss_pred hhhccccccCCCCCCCCcchhHH-------HHHH----HHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcce
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC-------MRAL----MATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~-------~~~~----~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 89 (274)
.++|...+.||+|+| |.||+| .+|+ +.........+.+.+|+.+|++++|||||++++++.+++..+
T Consensus 4 l~dy~~~~~lG~G~f--g~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTF--GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred hHhcEEEEEEecCcC--eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 468899999999999 999998 1111 112223334566789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+|||||++|+|.+++.. .+.+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred cceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999999986 46799999999999999999999999 99999999999999999999999999997532
Q ss_pred -----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 170 -----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 170 -----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
|+.|+|||++.+..|+.++|+||+||++|||++|..||.... .. .+. ..... ..
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~-~~~----~~i~~-------~~ 221 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HE-RLF----ELILM-------EE 221 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HH-HHH----HHHHH-------CC
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HH-HHH----HHHhc-------CC
Confidence 678999999999999999999999999999999999997541 11 111 11111 11
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCC-----hhhHHh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPS-----MKCVVM 272 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~evl~ 272 (274)
...|...++++.+||.+||+.||++||+ +.|+++
T Consensus 222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1355566788999999999999999995 778765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=337.54 Aligned_cols=234 Identities=20% Similarity=0.202 Sum_probs=188.9
Q ss_pred hhccccccCCCCCCCCcchhHHHH--------HHHHHhc---CCCCCCcHHHHHHHHhcC-CCCccceEeEEEEeCCcce
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR--------ALMATVN---SPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~--------~~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 89 (274)
++|.....||+|+| |.||+|.. +++|... .....+.|.+|+++|+++ +|||||+++|+|.+++..+
T Consensus 10 ~~~~~~~~iG~G~f--g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNF--GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGG--CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCC--cEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 57777889999999 99999921 2222222 224567789999999998 6999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC
Q 048314 90 TEAALDLPWDLAYIIFCS--------------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 155 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~ 155 (274)
+||||+++|+|.+++... ....+++..++.++.|++.||.|+|+. +++||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence 999999999999999753 235699999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCC-CccccCCChhhHHHHHHHH
Q 048314 156 TAKISDFGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWE-NMEIDASKPEEIILTNWVY 224 (274)
Q Consensus 156 ~~kl~d~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~-p~~~~~~~~~~~~~~~~~~ 224 (274)
.+||+|||+++... +..|+|||.+....++.++|||||||++|||++|.. ||... .... +.
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--~~~~--~~---- 236 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAE--LY---- 236 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHH--HH----
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--CHHH--HH----
Confidence 99999999986432 678999999999999999999999999999999765 55422 1111 10
Q ss_pred HHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 225 KCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
..+.++ .+ .+.+...++++.+||.+||+.||++||||.||++.|
T Consensus 237 ~~i~~~-----~~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 237 EKLPQG-----YR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp HHGGGT-----CC-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhc-----CC-CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111111 11 134556778999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.6e-49 Score=344.63 Aligned_cols=235 Identities=16% Similarity=0.143 Sum_probs=189.5
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC--CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP--YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
.++|...+.||+|+| |.||+|. ..++|.+... .+.+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 28 ~d~Y~i~~~lG~G~f--g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAF--GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCC--eEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356888899999999 9999982 1223333222 12345678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc--CCCcEEEeccccceecC-
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD--EFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~--~~~~~kl~d~g~~~~~~- 169 (274)
|||++|+|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||++....
T Consensus 106 E~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 106 EFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp ECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999999998865 445699999999999999999999999 999999999999997 67899999999997643
Q ss_pred ---------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCc
Q 048314 170 ---------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTE 240 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (274)
++.|+|||++.+..++.++||||+||++|+|++|..||... ... .+.. ...... .-.+..
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~-~~~~----~i~~~~---~~~~~~ 250 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---DDL-ETLQ----NVKRCD---WEFDED 250 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHH-HHHH----HHHHCC---CCCCSS
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC---CHH-HHHH----HHHhCC---CCCCcc
Confidence 67899999999999999999999999999999999999643 111 1111 011110 111112
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 241 VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 241 ~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.....+.++.+||.+||+.||++|||+.|+++
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33456678999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=332.32 Aligned_cols=233 Identities=18% Similarity=0.154 Sum_probs=182.5
Q ss_pred hhccccccCCCCCCCCcchhHHH----------HHHHHHh----cCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM----------RALMATV----NSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~----------~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
++|.....||+|+| |.||+|. +++|... ......++|.+|+++|++++|||||+++|+|.+ +.
T Consensus 8 ~d~~~~~~iG~G~f--g~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSF--GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp GGEEEEEECC------CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred HHeEEEEEEecCCC--eEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 56777888999999 9999982 1222111 111223568899999999999999999999975 46
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.++|||||++|++.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+|++|||+++.
T Consensus 85 ~~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp CEEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred hheeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 7899999999999998876 345699999999999999999999999 999999999999999999999999999986
Q ss_pred cC--------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 168 LS--------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 168 ~~--------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
.. +..|+|||.+....++.++||||||+++|||++ |..||... ... ..... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~---~~~-~~~~~---i~~~--- 230 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGS-QILHK---IDKE--- 230 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC---CHH-HHHHH---HHTS---
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc---CHH-HHHHH---HHhC---
Confidence 43 346999999999999999999999999999998 89999633 111 11111 0001
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
-..+ +.+...+..+.+|+.+||+.||++|||+.||.+.|
T Consensus 231 --~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L 269 (273)
T d1u46a_ 231 --GERL-PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269 (273)
T ss_dssp --CCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --CCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 0111 24455677899999999999999999999998865
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=333.82 Aligned_cols=233 Identities=17% Similarity=0.152 Sum_probs=185.9
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCC--------CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP--------YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSK 87 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 87 (274)
+.|.....||+|+| |.||+|. ..++|.+... ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 10 d~Y~~~~~lG~G~f--g~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQF--AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GTEEEEEEEEECSS--EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCEEEeEEEecCCC--eEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45777889999999 9999982 1122222111 112457899999999999999999999999999
Q ss_pred ceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC----cEEEeccc
Q 048314 88 PSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW----TAKISDFG 163 (274)
Q Consensus 88 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~----~~kl~d~g 163 (274)
.++|||||++|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++ .+|++|||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999986 35799999999999999999999999 999999999999998766 49999999
Q ss_pred cceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 164 LAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 164 ~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
++.... ++.|+|||++....++.++|||||||++|||++|..||.... ....+. .......
T Consensus 163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~-----~i~~~~~- 233 (293)
T d1jksa_ 163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLA-----NVSAVNY- 233 (293)
T ss_dssp TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH-----HHHTTCC-
T ss_pred hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHHH-----HHHhcCC-
Confidence 987543 567999999998899999999999999999999999997431 111110 0011100
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
-.+...+...+..+.+|+.+||+.||++|||++|+++
T Consensus 234 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 --EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000112234578899999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-49 Score=337.77 Aligned_cols=239 Identities=19% Similarity=0.185 Sum_probs=192.2
Q ss_pred HHHHhhhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEE
Q 048314 17 LCTKLRNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVA 82 (274)
Q Consensus 17 l~~~~~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~ 82 (274)
+.-.+++|...+.||+|+| |.||+|. .+++|.+... ...++|.+|+.+|++++||||++++++|
T Consensus 8 ~e~p~~~~~~~~~lG~G~f--G~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAF--GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSS--CEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCC--eEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3345678888999999999 9999992 1223333322 1235688999999999999999999999
Q ss_pred EeCCcceEEEEeCCCCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 048314 83 MRGSKPSTEAALDLPWDLAYIIFCSA----------------------ERNPYWNQRVRIALDVAKGILYLHDECEPPIL 140 (274)
Q Consensus 83 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~ 140 (274)
.+.+..+++|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 99999999999999999999997532 23489999999999999999999999 999
Q ss_pred cCCCCCCceEEcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcC-CC
Q 048314 141 HCDIKPQNILMDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCW-EN 206 (274)
Q Consensus 141 h~dl~~~nil~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~-~p 206 (274)
||||||+|||++.++.+||+|||+++... ++.|+|||.+....++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999986432 45799999999999999999999999999999996 45
Q ss_pred ccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 207 MEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
|... . ..+ +.. .+.++.. .+.|...+.++.+|+.+||+.||++||||.||+++|
T Consensus 243 ~~~~-~-~~e--~~~----~v~~~~~------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 243 YYGM-A-HEE--VIY----YVRDGNI------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp TTTS-C-HHH--HHH----HHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCC-C-HHH--HHH----HHHcCCC------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 6432 1 111 111 1111111 134556678899999999999999999999998865
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.4e-48 Score=330.95 Aligned_cols=229 Identities=18% Similarity=0.123 Sum_probs=189.9
Q ss_pred hhccccccCCCCCCCCcchhHHH-------HHHHH----HhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM-------RALMA----TVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~-------~~~~~----~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.||+|+| |.||++. +|+|. ........+.+.+|+.+|++++|||||++++++.+.+..++
T Consensus 4 ~dy~i~~~lG~G~f--g~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSF--GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCcC--cEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 57888899999999 9999981 11111 12222345668899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
|||||.+|+|..++.. ...+++...+.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 vmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp EECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999999986 56789999999999999999999999 99999999999999999999999999997643
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
++.|+|||++.+..++.++||||+||++|+|++|+.||.... .. .+. ....+. ....|
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~---~~-~~~----~~i~~~-------~~~~p 221 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TM-KTY----EKILNA-------ELRFP 221 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HH-HHH----HHHHHC-------CCCCC
T ss_pred ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC---HH-HHH----HHHHcC-------CCCCC
Confidence 778999999999899999999999999999999999996431 11 110 001111 11344
Q ss_pred HHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
...++++.+++.+||+.||++|| |++++++
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 55667899999999999999996 8999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=335.77 Aligned_cols=229 Identities=23% Similarity=0.291 Sum_probs=184.3
Q ss_pred cccCCCCCCCCcchhHHHH---------HHHHHhcCC---CCCCcHHHHHHHHhcCCCCccceEeEEEEe-CCcceEEEE
Q 048314 27 SSLNDRNSPRSKSVWSCMR---------ALMATVNSP---YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR-GSKPSTEAA 93 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~~~---------~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 93 (274)
+.+||+|+| |.||+|.. +++|.+... ...++|.+|+++|++++|||||+++|+|.+ ++..++|||
T Consensus 32 ~~~iG~G~f--g~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHF--GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETT--EEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCC--eEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 467999999 99999821 123333221 234568899999999999999999999876 467899999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
||++|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++...
T Consensus 110 ~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999999986 456688999999999999999999999 99999999999999999999999999997532
Q ss_pred -----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 170 -----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 170 -----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
++.|+|||.+....++.++||||||+++|||++|..||........ +.. ...++. .
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---~~~----~i~~g~------~ 252 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQGR------R 252 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHH----HHHTTC------C
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCC------C
Confidence 4579999999999999999999999999999998888764321111 001 111110 1
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
...|..+++.+.+|+.+||+.||++|||+.||++.|
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 124455677899999999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=333.03 Aligned_cols=235 Identities=17% Similarity=0.135 Sum_probs=186.4
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC-CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP-YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
.++|.....||+|+| |.||+|. ..++|.+... .+...+.+|+++|++++|||||++++++.+++..++|||
T Consensus 4 ~~rY~i~~~lG~G~f--g~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEF--GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCC--eEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 356777889999999 9999982 1122333322 223346799999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC--CCcEEEeccccceecC--
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE--FWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~--~~~~kl~d~g~~~~~~-- 169 (274)
||++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++. ...+|++|||++....
T Consensus 82 ~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 82 FISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred cCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999975 344699999999999999999999999 9999999999999974 4589999999987643
Q ss_pred --------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCcc
Q 048314 170 --------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEV 241 (274)
Q Consensus 170 --------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (274)
++.|+|||.+.+..++.++||||+||++|+|++|..||.... ....+ ....+... .-+...
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~---~~~~~-----~~i~~~~~---~~~~~~ 226 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQII-----ENIMNAEY---TFDEEA 226 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH-----HHHHHTCC---CCCHHH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC---HHHHH-----HHHHhCCC---CCChhh
Confidence 677999999998899999999999999999999999996441 11111 10111100 000001
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 242 DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 242 ~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+.++.+|+.+||+.||++|||+.|+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1134567899999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=330.51 Aligned_cols=234 Identities=20% Similarity=0.205 Sum_probs=182.9
Q ss_pred hhccccccCCCCCCCCcchhHHHH-------------HHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEEe
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-------------ALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMR 84 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-------------~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 84 (274)
++|...+.||+|+| |.||+|.. .++|..... ....++.+|...+.++ +|||||+++++|.+
T Consensus 13 ~~~~l~~~iG~G~f--g~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 13 DRLVLGKPLGEGAF--GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGEEEEEECC-------CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHeEEeeEEeecCC--cEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 56666788999999 99999821 112222222 1234567899999888 79999999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceE
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNIL 150 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil 150 (274)
++..++|||||.+|+|.+++.... ...+++.+++.++.|++.||.|||+. +++||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence 999999999999999999997542 24589999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhh-cCCCccccCCChhh
Q 048314 151 MDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETIC-CWENMEIDASKPEE 216 (274)
Q Consensus 151 ~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~-g~~p~~~~~~~~~~ 216 (274)
++.++.+||+|||+++... ++.|+|||.+..+.++.++||||||+++|||++ |..||... ....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~--~~~~ 245 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEE 245 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC--CHHH
Confidence 9999999999999987542 457999999999999999999999999999998 67777532 1111
Q ss_pred HHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 217 IILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+ .....++. ..+.|...+..+.+|+.+||+.||++|||+.||+++|
T Consensus 246 --~----~~~i~~~~------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 246 --L----FKLLKEGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp --H----HHHHHTTC------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --H----HHHHHcCC------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 1 11111111 1134455677899999999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-47 Score=330.40 Aligned_cols=229 Identities=16% Similarity=0.110 Sum_probs=189.9
Q ss_pred hhccccccCCCCCCCCcchhHH-------HHHHH----HHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC-------MRALM----ATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPST 90 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~-------~~~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 90 (274)
++|...+.||+|+| |.||++ .+|+| .........+.+.+|+++|++++|||||++++++.+....++
T Consensus 41 d~y~i~~~lG~G~f--g~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSF--GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEEEEeecCcC--cEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 56788889999999 999998 11221 112222345568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC-
Q 048314 91 EAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS- 169 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~- 169 (274)
||||+.+|+|.+++.. .+.+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 119 v~e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999999986 35799999999999999999999999 99999999999999999999999999997654
Q ss_pred -------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcCCccC
Q 048314 170 -------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRGTEVD 242 (274)
Q Consensus 170 -------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (274)
++.|+|||++.+..++.++|||||||++|||++|..||... .. ..+. ...... ....+
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~-~~~~----~~i~~~-------~~~~p 258 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QP-IQIY----EKIVSG-------KVRFP 258 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SH-HHHH----HHHHHC-------CCCCC
T ss_pred ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CH-HHHH----HHHhcC-------CCCCC
Confidence 67899999999999999999999999999999999999643 11 1111 111111 11244
Q ss_pred HHHHHHHHHHHHHhhccCCCCCC-----ChhhHHh
Q 048314 243 KKNLENLVKVGLWCVQDEPALRP-----SMKCVVM 272 (274)
Q Consensus 243 ~~~~~~~~~li~~cl~~dp~~Rp-----s~~evl~ 272 (274)
...++++.+++.+||+.||.+|+ |++|+++
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 55677899999999999999994 8999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-46 Score=328.91 Aligned_cols=233 Identities=21% Similarity=0.206 Sum_probs=185.2
Q ss_pred hhhccccccCCCCCCCCcchhHH-------HHHHH----HHhcCCCCCCcHH---HHHHHHhcCCCCccceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSC-------MRALM----ATVNSPYSPSRPL---TLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~-------~~~~~----~~~~~~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
.++|...+.||+|+| |.||+| .+|+| ...........+. +|+++++.++|||||++++++.+.+
T Consensus 3 lddy~i~~~lG~G~f--g~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGF--GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp STTEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred HHhCeeeeEEecCCC--eEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 367888999999999 999998 11111 1111112222333 4577888889999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
..++|||||++|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999999986 45789999999999999999999999 99999999999999999999999999997
Q ss_pred ec---------CCCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhh
Q 048314 167 LL---------SDKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLV 236 (274)
Q Consensus 167 ~~---------~~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (274)
.. +|+.|+|||++.. ..++.++|||||||++|||++|+.||.......... + ... ...
T Consensus 156 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~--------~~~---~~~ 223 (364)
T d1omwa3 156 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I--------DRM---TLT 223 (364)
T ss_dssp ECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-H--------HHH---SSS
T ss_pred ecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-H--------HHh---ccc
Confidence 54 3778999999875 468999999999999999999999997542221110 0 000 001
Q ss_pred cCCccCHHHHHHHHHHHHHhhccCCCCCCC-----hhhHHh
Q 048314 237 RGTEVDKKNLENLVKVGLWCVQDEPALRPS-----MKCVVM 272 (274)
Q Consensus 237 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~evl~ 272 (274)
.+...+...++++.+||.+||+.||++||| ++|+++
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111345556788999999999999999999 678765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.4e-47 Score=321.02 Aligned_cols=233 Identities=16% Similarity=0.183 Sum_probs=186.6
Q ss_pred hhccccccCCCCCCCCcchhHHHH------HHHHHhcCC-CC----------CCcHHHHHHHHhcCC-CCccceEeEEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR------ALMATVNSP-YS----------PSRPLTLTSIVSRVS-WTTDIEVSSVAM 83 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~------~~~~~~~~~-~~----------~~~~~~e~~~l~~l~-h~niv~l~~~~~ 83 (274)
++|...+.||+|+| |.||+|.. .++|.+... .. .+.+.+|+.++++++ |||||++++++.
T Consensus 3 ~~y~~~~~iG~G~~--g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 3 ENYEPKEILGRGVS--SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred ccCEEceEEecCcC--eEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 56777899999999 99999921 112222211 11 124778999999997 999999999999
Q ss_pred eCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccc
Q 048314 84 RGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFG 163 (274)
Q Consensus 84 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g 163 (274)
+++..+||||||++|+|.+++.. .+.+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999986 45799999999999999999999999 99999999999999999999999999
Q ss_pred cceecC----------CCCcCCCccccc------CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHH
Q 048314 164 LAKLLS----------DKGCMAPECYKR------TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCF 227 (274)
Q Consensus 164 ~~~~~~----------~~~~~ape~~~~------~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (274)
+++... ++.|+|||.+.. ..++.++||||+||++|+|++|+.||.... ... .. ...
T Consensus 156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~-~~----~~i 227 (277)
T d1phka_ 156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QML-ML----RMI 227 (277)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-HH----HHH
T ss_pred heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHH-HH----HHH
Confidence 997643 567999998853 346889999999999999999999997431 111 11 111
Q ss_pred hhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 228 INRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.++... .+.+.....++++.+++.+||+.||++|||++||++
T Consensus 228 ~~~~~~---~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGNYQ---FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTCCC---CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCCCC---CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111 111233456788999999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=330.01 Aligned_cols=237 Identities=14% Similarity=0.119 Sum_probs=183.2
Q ss_pred hhhcccc-ccCCCCCCCCcchhHHHH------HHHHHhcCCCCCCcHHHHHHHHhcC-CCCccceEeEEEEe----CCcc
Q 048314 21 LRNFCRS-SLNDRNSPRSKSVWSCMR------ALMATVNSPYSPSRPLTLTSIVSRV-SWTTDIEVSSVAMR----GSKP 88 (274)
Q Consensus 21 ~~~f~~~-~~~g~g~~~~g~vy~~~~------~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~ 88 (274)
.++|... .+||+|+| |.||+|.. .++|.+. ..+.+.+|+.++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~f--g~Vy~a~~~~~~~~vAiK~i~---~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGIN--GKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSS--CEEEEEEETTTCCEEEEEEEE---CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccC--eEEEEEEECCCCCEEEEEEEC---CcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3577654 57999999 99999921 1122222 345577999987654 79999999999865 4568
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC---CCcEEEeccccc
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKISDFGLA 165 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~d~g~~ 165 (274)
++|||||++|+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||+++. .+.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999875456799999999999999999999999 9999999999999975 567999999999
Q ss_pred eecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh
Q 048314 166 KLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL 235 (274)
Q Consensus 166 ~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (274)
+... ++.|+|||++.+..|+.++|||||||++|+|++|+.||...........+ .... .....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----~~~i---~~~~~ 234 (335)
T d2ozaa1 162 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRI---RMGQY 234 (335)
T ss_dssp EECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CC---CSCSS
T ss_pred eeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----HHHH---hcCCC
Confidence 7532 77899999999989999999999999999999999999754221110000 0000 00000
Q ss_pred hcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 VRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
-.+.......++++.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0011112345678999999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-47 Score=322.38 Aligned_cols=234 Identities=16% Similarity=0.172 Sum_probs=183.8
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCC-----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCC----
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP-----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS---- 86 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 86 (274)
++|...+.||+|+| |.||+|. ..++|.+... ...+++.+|+.+|++++|||||++++++.+.+
T Consensus 7 drY~i~~~lG~G~f--g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 7 DRYELGEILGFGGM--SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ceeEEeEEEeeCCC--eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 56888899999999 9999992 1122322221 11235779999999999999999999987643
Q ss_pred cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccce
Q 048314 87 KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAK 166 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~ 166 (274)
.+++|||||++|+|.+++.. .+.+++..++.++.|++.||.|||++ +++||||||+||+++.++..+++|||.+.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred eEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 37899999999999999976 45799999999999999999999999 99999999999999999999999999875
Q ss_pred ec--------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhh
Q 048314 167 LL--------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINREL 232 (274)
Q Consensus 167 ~~--------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (274)
.. +++.|+|||++.+..++.++||||+||++|||++|..||... .....+ ........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~----~~~~~~~~- 231 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---SPVSVA----YQHVREDP- 231 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHH----HHHHHCCC-
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc---CHHHHH----HHHHhcCC-
Confidence 43 267899999999889999999999999999999999999643 111111 11111111
Q ss_pred hhhhcCCccCHHHHHHHHHHHHHhhccCCCCCC-ChhhHHhh
Q 048314 233 NKLVRGTEVDKKNLENLVKVGLWCVQDEPALRP-SMKCVVMM 273 (274)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~evl~~ 273 (274)
..+.......++++.+++.+||+.||++|| |++++++.
T Consensus 232 ---~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~ 270 (277)
T d1o6ya_ 232 ---IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270 (277)
T ss_dssp ---CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred ---CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHH
Confidence 111122334567899999999999999999 78888764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=325.08 Aligned_cols=229 Identities=18% Similarity=0.128 Sum_probs=186.4
Q ss_pred hhccccccCCCCCCCCcchhHH-------HHHHHH----HhcCCCCCCcHHHHHHHHh-cCCCCccceEeEEEEeCCcce
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSC-------MRALMA----TVNSPYSPSRPLTLTSIVS-RVSWTTDIEVSSVAMRGSKPS 89 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~-------~~~~~~----~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~ 89 (274)
++|...+.||+|+| |.||+| .+|+|. ........+.+..|..++. .++|||||++++++.+++..+
T Consensus 2 ddy~i~~~iG~G~f--g~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSF--GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSS--SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCeEEeeEEecCCC--cEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 46777889999999 999999 112211 1122234456677887766 689999999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC
Q 048314 90 TEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS 169 (274)
Q Consensus 90 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~ 169 (274)
+|||||++|+|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+|||++.++.+|++|||+++...
T Consensus 80 ivmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999999986 45789999999999999999999999 99999999999999999999999999987432
Q ss_pred -----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhhhcC
Q 048314 170 -----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKLVRG 238 (274)
Q Consensus 170 -----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (274)
++.|+|||++.+..++.++||||+||++|+|++|+.||... .... +. ..... ..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~---~~~~-~~----~~i~~-------~~ 219 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEE-LF----HSIRM-------DN 219 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHH-HH----HHHHH-------CC
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC---CHHH-HH----HHHHc-------CC
Confidence 67799999999999999999999999999999999999643 1111 11 11111 11
Q ss_pred CccCHHHHHHHHHHHHHhhccCCCCCCChh-hHHh
Q 048314 239 TEVDKKNLENLVKVGLWCVQDEPALRPSMK-CVVM 272 (274)
Q Consensus 239 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-evl~ 272 (274)
...|...++.+.+|+.+||+.||++|||+. |+++
T Consensus 220 ~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 134555677899999999999999999995 6754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=329.46 Aligned_cols=236 Identities=17% Similarity=0.199 Sum_probs=187.7
Q ss_pred hhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEEeCC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRGS 86 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 86 (274)
++|...+.||+|+| |.||+|. ..++|.+... .....|.+|+.+++++ +|||||+++|+|.+.+
T Consensus 23 ~~~~l~~~iG~G~f--g~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAF--GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGEEEEEEEEECSS--EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCC--eEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 56666789999999 9999982 1223333221 2234578999999999 6999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceE
Q 048314 87 KPSTEAALDLPWDLAYIIFCSA----------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNIL 150 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil 150 (274)
..++|||||++|+|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccc
Confidence 9999999999999999998642 22589999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhH
Q 048314 151 MDEFWTAKISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEI 217 (274)
Q Consensus 151 ~~~~~~~kl~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~ 217 (274)
++.++.++++|||.++... ++.|+|||.+....++.++||||||+++|||+++..|+.........
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~- 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 9999999999999997543 56799999999999999999999999999999955554322122111
Q ss_pred HHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 218 ILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+.. ....+ . ....+...+..+.+||.+||+.||++|||++||+++|
T Consensus 257 -~~~----~i~~~-----~-~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 257 -FYK----MIKEG-----F-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp -HHH----HHHHT-----C-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HHH----HHhcC-----C-CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111 11111 1 1124445678899999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=324.09 Aligned_cols=235 Identities=22% Similarity=0.291 Sum_probs=188.4
Q ss_pred hhhccccccCCCCCCCCcchhHHHH-----------HHHHHhcCCCC---CCcHHHHHHHHhcCCCCccceEeEEEEeCC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR-----------ALMATVNSPYS---PSRPLTLTSIVSRVSWTTDIEVSSVAMRGS 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~-----------~~~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 86 (274)
.++|...+.||+|+| |.||+|.. .++|.+..... ...|.+|++++++++|||||+++|+|...+
T Consensus 19 ~~~~~l~~~lG~G~f--G~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSF--GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSS--SEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCC--eEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 367777888999999 99998821 22333332211 234789999999999999999999999999
Q ss_pred cceEEEEeCCCCCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEE
Q 048314 87 KPSTEAALDLPWDLAYIIFCS--------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 158 (274)
Q Consensus 87 ~~~lv~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~k 158 (274)
..++|||||++|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEE
Confidence 999999999999999998743 113479999999999999999999999 999999999999999999999
Q ss_pred EeccccceecC-------------CCCcCCCcccccCCCccccceeehhHhHHHHhhcC-CCccccCCChhhHHHHHHHH
Q 048314 159 ISDFGLAKLLS-------------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCW-ENMEIDASKPEEIILTNWVY 224 (274)
Q Consensus 159 l~d~g~~~~~~-------------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~ 224 (274)
|+|||+++... ++.|+|||.+....++.++||||||+++|||++|. .||... .. .+ .+
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~-~~-~~----- 245 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SN-EQ-VL----- 245 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CH-HH-HH-----
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-CH-HH-HH-----
Confidence 99999987432 57799999999999999999999999999999985 555422 11 11 00
Q ss_pred HHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 225 KCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
....++.. ...+..++..+.+++.+||+.||++|||+.+|+++|
T Consensus 246 ~~i~~~~~------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 246 RFVMEGGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289 (308)
T ss_dssp HHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCC------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 11111111 124556678899999999999999999999999865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-48 Score=328.57 Aligned_cols=236 Identities=17% Similarity=0.195 Sum_probs=179.0
Q ss_pred hhhccccccCCCCCCCCcchhHHH-----------HHHHHHhcCC---CCCCcHHHHHHHHhcC-CCCccceEeEEEEeC
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM-----------RALMATVNSP---YSPSRPLTLTSIVSRV-SWTTDIEVSSVAMRG 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~-----------~~~~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 85 (274)
.++|...+.||+|+| |.||+|. ..++|.+... ...+.+.+|..++.++ +|+|||++++++.+.
T Consensus 12 ~~~y~~~~~iG~G~f--G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAF--GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSS--CEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCC--eEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 357888899999999 9999982 1122222211 2234567888888877 589999999998764
Q ss_pred -CcceEEEEeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceE
Q 048314 86 -SKPSTEAALDLPWDLAYIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNIL 150 (274)
Q Consensus 86 -~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil 150 (274)
+..++|||||++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence 46899999999999999997532 23489999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeccccceec-------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcC-CCccccCCChhh
Q 048314 151 MDEFWTAKISDFGLAKLL-------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCW-ENMEIDASKPEE 216 (274)
Q Consensus 151 ~~~~~~~kl~d~g~~~~~-------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~-~p~~~~~~~~~~ 216 (274)
++.++.+||+|||+++.. +++.|+|||++....++.++|||||||++|||++|. .||........
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~- 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 999999999999998643 256799999999999999999999999999999875 56654322111
Q ss_pred HHHHHHHHHHHhhhhhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 217 IILTNWVYKCFINRELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
+. .....+. . ...+...++++.+++.+||+.||++|||++||+++|
T Consensus 246 --~~----~~~~~~~-----~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L 291 (299)
T d1ywna1 246 --FC----RRLKEGT-----R-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291 (299)
T ss_dssp --HH----HHHHHTC-----C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HH----HHHhcCC-----C-CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 11 1111111 1 124556678899999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=327.80 Aligned_cols=246 Identities=18% Similarity=0.140 Sum_probs=177.8
Q ss_pred hccccccCCCCCCCCcchhHHH----HHHHHHhcCCCCCCcHHH--HHHHHhcCCCCccceEeEEEEeCC----cceEEE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM----RALMATVNSPYSPSRPLT--LTSIVSRVSWTTDIEVSSVAMRGS----KPSTEA 92 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~----~~~~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 92 (274)
++--...||+|+| |.||+|. .+++|.+.. ...+.+.. |+..+.+++|||||+++|+|.+.+ .+++||
T Consensus 4 ~~~l~~~iG~G~f--g~Vy~~~~~g~~vAvK~~~~-~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRF--GEVWRGKWRGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSS--SEEEEEEETTEEEEEEEECG-GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCC--eEEEEEEECCEEEEEEEECc-cchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3444567999999 9999982 222232222 12333444 455556789999999999997643 579999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC-----EPPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-----~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
|||++|+|.+++.+ ..++|..++.++.|++.||.|+|+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999986 36999999999999999999999621 13899999999999999999999999998864
Q ss_pred c---------------CCCCcCCCcccccC------CCccccceeehhHhHHHHhhcCCCccccCCChh---hHHHHHHH
Q 048314 168 L---------------SDKGCMAPECYKRT------PISVKADVYGYGIVLLETICCWENMEIDASKPE---EIILTNWV 223 (274)
Q Consensus 168 ~---------------~~~~~~ape~~~~~------~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~---~~~~~~~~ 223 (274)
. +++.|+|||++... .++.++|||||||++|||++|..|+........ ........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 3 26789999988654 257789999999999999999988754311110 00000000
Q ss_pred HHHHhhhhhhhhhcCC----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhhC
Q 048314 224 YKCFINRELNKLVRGT----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMML 274 (274)
Q Consensus 224 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~L 274 (274)
.............++. ..+......+.+++.+||+.||++|||+.||+++|
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 0000111111112211 12345667899999999999999999999998865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=318.21 Aligned_cols=235 Identities=18% Similarity=0.123 Sum_probs=177.8
Q ss_pred cccCCCCCCCCcchhHH------HHHHHHHhcC-------CCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEEE
Q 048314 27 SSLNDRNSPRSKSVWSC------MRALMATVNS-------PYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEAA 93 (274)
Q Consensus 27 ~~~~g~g~~~~g~vy~~------~~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 93 (274)
..+||+|+| |.||+| ...++|.+.. ....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 3 l~~lG~G~f--g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 3 LDFLGEGQF--ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEETT--EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred ceEeccCcC--eEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 357999999 999998 1111221111 1124567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC----
Q 048314 94 LDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS---- 169 (274)
Q Consensus 94 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~---- 169 (274)
||.++++..... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||.++...
T Consensus 81 ~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 81 FMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 999877766654 356799999999999999999999999 99999999999999999999999999986432
Q ss_pred -------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhhhh------
Q 048314 170 -------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELNKL------ 235 (274)
Q Consensus 170 -------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 235 (274)
++.|+|||++... .++.++|||||||++|||++|..||... .. ......+............
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~---~~-~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD---SD-LDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SH-HHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC---CH-HHHHHHHHHhcCCCChhhccchhcc
Confidence 6789999988754 5799999999999999999999999643 11 1111111111100000000
Q ss_pred ---hc--CC-cc-----CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 ---VR--GT-EV-----DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ---~~--~~-~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. .. .. ....++++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 00 01 1233578999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=318.72 Aligned_cols=242 Identities=18% Similarity=0.153 Sum_probs=183.6
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
++|...+.||+|+| |.||+|. ..++|.+. .....+.+.+|+++|++++|||||++++++.+++..++|
T Consensus 2 d~Y~~~~~lG~G~f--g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTY--GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSS--SEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcC--eEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 57888899999999 9999991 11222221 112356678999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec---
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~--- 168 (274)
|||+.+ ++.+++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+|++|||.++..
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 999975 556666554667799999999999999999999999 9999999999999999999999999998543
Q ss_pred --------CCCCcCCCcccccCC-CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHh--hhhhhhh--
Q 048314 169 --------SDKGCMAPECYKRTP-ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFI--NRELNKL-- 235 (274)
Q Consensus 169 --------~~~~~~ape~~~~~~-~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-- 235 (274)
+++.|+|||.+.... ++.++|+||+||++|+|++|+.||.... ....+......... .......
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS---EIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC---HHHHHHHHHHhcCCCchhhcccccc
Confidence 267899999877665 4789999999999999999999996431 11111111100000 0000000
Q ss_pred ----hcC---C------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 236 ----VRG---T------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 236 ----~~~---~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
... . ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 0 011133468899999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=314.05 Aligned_cols=223 Identities=22% Similarity=0.230 Sum_probs=181.4
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcC--------CCCCCcHHHHHHHHhcCC--CCccceEeEEEEeC
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNS--------PYSPSRPLTLTSIVSRVS--WTTDIEVSSVAMRG 85 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~--------~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~ 85 (274)
++|...+.||+|+| |.||+|. ..++|.+.. .....++.+|+.+|++++ |||||++++++.++
T Consensus 4 ~~Y~i~~~lG~G~f--g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGF--GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CeEEEeEEEeeCCC--eEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 46788899999999 9999982 112222211 123455789999999987 89999999999999
Q ss_pred CcceEEEEeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-CCcEEEeccc
Q 048314 86 SKPSTEAALDLP-WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKISDFG 163 (274)
Q Consensus 86 ~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~d~g 163 (274)
+..++||||+.+ +++.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CeEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 999999999965 688888875 45799999999999999999999999 9999999999999985 4799999999
Q ss_pred cceecC---------CCCcCCCcccccCCC-ccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 164 LAKLLS---------DKGCMAPECYKRTPI-SVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 164 ~~~~~~---------~~~~~ape~~~~~~~-~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
++.... |+.|+|||++....+ +.++||||+||++|||++|+.||... .. ....
T Consensus 157 ~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~----------i~~~--- 219 (273)
T d1xwsa_ 157 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EE----------IIRG--- 219 (273)
T ss_dssp TCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HH----------HHHC---
T ss_pred cceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----hH----------Hhhc---
Confidence 987543 678999999987665 67899999999999999999999632 10 0000
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....+...++++.+++.+||+.||++|||++|+++
T Consensus 220 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 ----QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01233345678999999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=316.45 Aligned_cols=243 Identities=16% Similarity=0.140 Sum_probs=183.5
Q ss_pred HhhhccccccCCCCCCCCcchhHHH-------HHHHHHhc----CCCCCCcHHHHHHHHhcC---CCCccceEeEEEEe-
Q 048314 20 KLRNFCRSSLNDRNSPRSKSVWSCM-------RALMATVN----SPYSPSRPLTLTSIVSRV---SWTTDIEVSSVAMR- 84 (274)
Q Consensus 20 ~~~~f~~~~~~g~g~~~~g~vy~~~-------~~~~~~~~----~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~- 84 (274)
.-++|...+.||+|+| |.||+|. .+++|.+. .......+.+|+.+|+.+ +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~f--g~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAY--GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGGTEEEEEEEEEETT--EEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CcCCEEEEEEEecccC--eEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 4568888999999999 9999982 11223222 112344567888887765 79999999999853
Q ss_pred ----CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEe
Q 048314 85 ----GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKIS 160 (274)
Q Consensus 85 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~ 160 (274)
....+++|||+.++++...... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|++
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccccCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeec
Confidence 3467999999988766555443 567799999999999999999999999 99999999999999999999999
Q ss_pred ccccceecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh-
Q 048314 161 DFGLAKLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN- 229 (274)
Q Consensus 161 d~g~~~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 229 (274)
|||.+.... |+.|+|||++....++.++||||+||++|||++|..||... .....+.... .....
T Consensus 159 dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~-~~~~~~ 234 (305)
T d1blxa_ 159 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS---SDVDQLGKIL-DVIGLP 234 (305)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHH-HHHCCC
T ss_pred chhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC---CHHHHHHHHH-HhhCCC
Confidence 999986532 78899999999999999999999999999999999999643 1111111111 11000
Q ss_pred --hhhh-------hhh-cCC-----ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 230 --RELN-------KLV-RGT-----EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 230 --~~~~-------~~~-~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.... ... ... ..+...++.+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 000 000 123344678899999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.4e-45 Score=309.19 Aligned_cols=240 Identities=18% Similarity=0.145 Sum_probs=183.9
Q ss_pred hhccccccCCCCCCCCcchhHHHH-----HHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCMR-----ALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTEA 92 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~~-----~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 92 (274)
++|...+.||+|+| |.||+|.. .++|.+... ...+++.+|+.+|++++|||||++++++.+.+..++++
T Consensus 2 ~~Y~~~~~iG~G~f--g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTY--GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETT--EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCC--cEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 46777888999999 99999921 122222221 23456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC---
Q 048314 93 ALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS--- 169 (274)
Q Consensus 93 e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~--- 169 (274)
|++.++.+..+.. ..+.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+|++|||.+....
T Consensus 80 e~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 80 EHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp ECCSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EeehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9998776666654 356799999999999999999999999 99999999999999999999999999986432
Q ss_pred --------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh---hhhh---h
Q 048314 170 --------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN---RELN---K 234 (274)
Q Consensus 170 --------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~ 234 (274)
++.|+|||.+... .++.++|+||+||++|||++|+.||.... ....+.... ..... .... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~---~~~~~~~i~-~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIF-RILGTPNSKNWPNVTE 230 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHH-HHHCCCCTTTSTTGGG
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC---HHHHHHHHH-HhhCCCChhhccchhh
Confidence 5679999998754 56899999999999999999999996431 111111111 10000 0000 0
Q ss_pred h------hc---C---CccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 235 L------VR---G---TEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 235 ~------~~---~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
. .. + .......+..+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 0 0122344578899999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=310.46 Aligned_cols=240 Identities=16% Similarity=0.083 Sum_probs=176.7
Q ss_pred hccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeEEEEeC------CcceE
Q 048314 23 NFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMRG------SKPST 90 (274)
Q Consensus 23 ~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 90 (274)
+|...++||+|+| |.||+|. ..++|.+.. +.....+|+++|++++|||||++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~f--g~Vy~a~~~~~~~~vAiK~i~~--~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSF--GVVYQAKLCDSGELVAIKKVLQ--DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETT--EEEEEEEETTTCCEEEEEEEEC--CSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcC--eEEEEEEECCCCCEEEEEEECc--cchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5777889999999 9999982 122233322 334456899999999999999999998643 34789
Q ss_pred EEEeCCCCCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC-cEEEeccccceec
Q 048314 91 EAALDLPWDLAYIIFC-SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKISDFGLAKLL 168 (274)
Q Consensus 91 v~e~~~~gsL~~~l~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~d~g~~~~~ 168 (274)
|||||+++.+...... .....+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987644443321 1456799999999999999999999999 999999999999998765 8999999998754
Q ss_pred C----------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH------Hhhhh
Q 048314 169 S----------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC------FINRE 231 (274)
Q Consensus 169 ~----------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~ 231 (274)
. +..|+|||.+.. ..++.++||||+||++|||++|..||.... ....+....... .....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~---~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS---GVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS---HHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC---HHHHHHHHHHHhCCChHHhhhhh
Confidence 3 567999998765 468999999999999999999999996441 111111111000 00000
Q ss_pred hhhhhc---CC--------ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 232 LNKLVR---GT--------EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 232 ~~~~~~---~~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.....+ +. ......++++.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00 112234677999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-43 Score=300.34 Aligned_cols=238 Identities=14% Similarity=0.060 Sum_probs=181.0
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcCCCCccceEeE-EEEeCCcceEEEEe
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRVSWTTDIEVSS-VAMRGSKPSTEAAL 94 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~~~lv~e~ 94 (274)
+.|...+.||+|+| |.||+|. ..++|........+++..|++++++++|+|+|..++ +..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~f--G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSF--GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSS--SEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCC--cEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 45888899999999 9999982 223444444456678899999999999877655554 45677888999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEc---CCCcEEEeccccceec---
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD---EFWTAKISDFGLAKLL--- 168 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~---~~~~~kl~d~g~~~~~--- 168 (274)
+. +++.+.+.. ....+++..+..++.|++.||.|||++ +|+||||||+||++. .+..++++|||+++..
T Consensus 85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 LG-PSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred cC-Cchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 84 677777665 456799999999999999999999999 999999999999875 4567999999999753
Q ss_pred ---------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhhhh
Q 048314 169 ---------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRELN 233 (274)
Q Consensus 169 ---------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (274)
+++.|+|||.+.+..++.++|||||||++|||++|..||................... ......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~ 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-MSTPIE 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-HHSCHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-CCCChh
Confidence 3678999999999899999999999999999999999997542222111111111000 000001
Q ss_pred hhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 234 KLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
......++++.+++..||+.||++||+++++.+.
T Consensus 239 ------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~ 272 (299)
T d1ckia_ 239 ------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272 (299)
T ss_dssp ------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHH
T ss_pred ------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1222455789999999999999999999887654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=308.52 Aligned_cols=240 Identities=15% Similarity=0.135 Sum_probs=176.0
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCC----CCcHHHHHHHHhcCCCCccceEeEEEEeCC----
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYS----PSRPLTLTSIVSRVSWTTDIEVSSVAMRGS---- 86 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 86 (274)
.++|...+.||+|+| |.||+|. ..++|.+..... .+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~f--g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAY--GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC--------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCcEEEEEEEecCCC--eEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 457777889999999 9999992 112222222211 235679999999999999999999997654
Q ss_pred --cceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 87 --KPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 87 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
..++||||| +.+|..++.. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|++|||.
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 5688888764 5699999999999999999999999 999999999999999999999999999
Q ss_pred ceecC--------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH---------
Q 048314 165 AKLLS--------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC--------- 226 (274)
Q Consensus 165 ~~~~~--------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 226 (274)
++... ++.|+|||.+.+. .++.++||||+||++|+|++|+.||.... ....+.......
T Consensus 168 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 168 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD---HLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHHHHH
T ss_pred eeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC---hHHHHHHHHhccCCCcHHHHh
Confidence 97654 6779999998764 56899999999999999999999996441 111111111000
Q ss_pred -Hhh---hhhhhhh---cCC---ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 227 -FIN---RELNKLV---RGT---EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 227 -~~~---~~~~~~~---~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
... ....... ... ......++.+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000000 000 122344577899999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=306.58 Aligned_cols=239 Identities=18% Similarity=0.183 Sum_probs=175.5
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCCC---CCCcHHHHHHHHhcCCCCccceEeEEEEeCC----cc
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPY---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGS----KP 88 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 88 (274)
.+|...+.||+|+| |.||+|. ..++|.+.... ..+++.+|+.+|++++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~f--g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAY--GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---C--CCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccC--eEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 45777899999999 9999992 12233333221 1235679999999999999999999997643 23
Q ss_pred eEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 89 STEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 89 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
+++++|+.+|+|.+++.. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 86 ~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 455566789999999975 4699999999999999999999999 9999999999999999999999999998653
Q ss_pred C--------------CCCcCCCccccc-CCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh---h
Q 048314 169 S--------------DKGCMAPECYKR-TPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN---R 230 (274)
Q Consensus 169 ~--------------~~~~~ape~~~~-~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~ 230 (274)
. ++.|+|||.+.. ..++.++||||+||++|+|++|..||..... .... ......... .
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~---~~~~-~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY---LDQL-NHILGILGSPSQE 235 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH-HHHHHHHCSCCHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH---HHHH-HHHhhhccCCChh
Confidence 2 567999999855 4578899999999999999999999964311 1111 100000000 0
Q ss_pred -----------h-hhhhhcCCcc-----CHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 231 -----------E-LNKLVRGTEV-----DKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 231 -----------~-~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
. .......... ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000000011 1123457899999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-43 Score=301.09 Aligned_cols=242 Identities=15% Similarity=0.114 Sum_probs=179.9
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhc----CCCCCCcHHHHHHHHhcCCCCccceEeEEEEe------
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVN----SPYSPSRPLTLTSIVSRVSWTTDIEVSSVAMR------ 84 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 84 (274)
.++|...+.||+|+| |.||+|. ..++|.+. .....+++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~f--g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTF--GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSS--SEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcC--eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 477888899999999 9999992 11222211 22334557899999999999999999999855
Q ss_pred --CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecc
Q 048314 85 --GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDF 162 (274)
Q Consensus 85 --~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~ 162 (274)
.+..++||||+.++.+..+.. ....++...++.++.|++.||.|||+. +|+||||||+||+++.++.+|++||
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred ccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 346799999998776654443 456799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecC---------------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHH
Q 048314 163 GLAKLLS---------------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKC 226 (274)
Q Consensus 163 g~~~~~~---------------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (274)
|++.... |+.|+|||.+... .++.++||||+||++|||++|+.||.... ....+ ......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~---~~~~~-~~i~~~ 237 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT---EQHQL-ALISQL 237 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH-HHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC---HHHHH-HHHHHh
Confidence 9986432 5679999998754 68999999999999999999999996431 11111 111111
Q ss_pred Hhh---hhhhh--------h---hcCCccC-------HHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 227 FIN---RELNK--------L---VRGTEVD-------KKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 227 ~~~---~~~~~--------~---~~~~~~~-------~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
... ..... . ......+ ....+.+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 100 00000 0 0000011 1224577899999999999999999999863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=300.73 Aligned_cols=241 Identities=15% Similarity=0.157 Sum_probs=185.8
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCCC----CCCcHHHHHHHHhcCCCCccceEeEEEEeCCcceEE
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPY----SPSRPLTLTSIVSRVSWTTDIEVSSVAMRGSKPSTE 91 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 91 (274)
++|...+.||+|+| |.||+|. ..++|.++... ..+++.+|+.+|++++||||+++++++.+....+++
T Consensus 2 ~ry~~i~~LG~G~f--g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTY--GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSS--SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcC--eEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 46778889999999 9999992 12233332221 134567999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccceecC--
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLAKLLS-- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~~-- 169 (274)
+|++.+++|..++.. .+.+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.++...
T Consensus 80 ~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 80 FEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999998888764 56789999999999999999999999 99999999999999999999999999997644
Q ss_pred ---------CCCcCCCcccccCC-CccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh---hhh---h
Q 048314 170 ---------DKGCMAPECYKRTP-ISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN---REL---N 233 (274)
Q Consensus 170 ---------~~~~~ape~~~~~~-~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---~ 233 (274)
+..|+|||.+.... ++.++||||+||++|||++|+.||.......... ..+...... ... .
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL---KRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH---HHHHHHHCCCCTTTCTTGG
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH---HHHHhhcCCCChhhhhhhh
Confidence 34588999887654 6899999999999999999999986432211111 111111000 000 0
Q ss_pred hhh------------cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 234 KLV------------RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 234 ~~~------------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
... .........++.+.+|+.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000233345678899999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-42 Score=293.08 Aligned_cols=238 Identities=12% Similarity=0.013 Sum_probs=188.9
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcCCC-CccceEeEEEEeCCcceEEEEe
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRVSW-TTDIEVSSVAMRGSKPSTEAAL 94 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~ 94 (274)
++|...+.||+|+| |.||+|. ..++|........+.+.+|+++++.++| +|++++++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~f--G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSF--GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSS--CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCC--eEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 56788899999999 9999992 1223444444566778999999999986 8999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcC-----CCcEEEeccccceec-
Q 048314 95 DLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-----FWTAKISDFGLAKLL- 168 (274)
Q Consensus 95 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-----~~~~kl~d~g~~~~~- 168 (274)
+ +++|.+++.. ....+++.+...++.|++.||.|||+. +++||||||+||+++. ++.++++|||+++..
T Consensus 83 ~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 8 6899999976 456799999999999999999999999 9999999999999964 567999999999753
Q ss_pred -----------------CCCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhhh
Q 048314 169 -----------------SDKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINRE 231 (274)
Q Consensus 169 -----------------~~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (274)
+|+.|+|||.+.+..++.++||||||+++|||++|..||.................. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~-~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-KQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-HHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc-cCCCC
Confidence 367899999999989999999999999999999999999754333222211111100 00001
Q ss_pred hhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHhh
Q 048314 232 LNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVMM 273 (274)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~~ 273 (274)
... .....++++.+++..|+..+|++||++..+.+.
T Consensus 237 ~~~------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~ 272 (293)
T d1csna_ 237 LRE------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 272 (293)
T ss_dssp HHH------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred hHH------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 111 122345679999999999999999998776553
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=303.87 Aligned_cols=234 Identities=15% Similarity=0.104 Sum_probs=187.4
Q ss_pred hhhccccccCCCCCCCCcchhHHHH---------HHHHHhc------CCCCCCcHHHHHHHHhcCCC-CccceEeEEEEe
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCMR---------ALMATVN------SPYSPSRPLTLTSIVSRVSW-TTDIEVSSVAMR 84 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~~---------~~~~~~~------~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~ 84 (274)
.++|...+.||+|+| |.||+|.. .++|.+. .....+.+.+|+++|++++| |||+++++++.+
T Consensus 23 l~~y~~~~~IG~G~f--g~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAY--GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp GGGEEEEEEEEETTT--EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred hhceEEEEEEecCCC--eEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 367888999999999 99999721 2233221 11345667899999999977 899999999999
Q ss_pred CCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEecccc
Q 048314 85 GSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGL 164 (274)
Q Consensus 85 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~ 164 (274)
....+++|||+.+|+|.+++.. .+.++....+.++.|++.||.|+|+. +++||||||+||+++.++.+||+|||+
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred CCceeeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence 9999999999999999999986 45678899999999999999999999 999999999999999999999999999
Q ss_pred ceecC------------CCCcCCCcccccC--CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhhh
Q 048314 165 AKLLS------------DKGCMAPECYKRT--PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFINR 230 (274)
Q Consensus 165 ~~~~~------------~~~~~ape~~~~~--~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
++... ++.|++||.+... .++.++||||+||++|+|++|..||...........+.. .
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~--------~ 247 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------R 247 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--------H
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--------h
Confidence 87543 5679999998764 467899999999999999999999975532221111111 0
Q ss_pred hhhhhhcCCccCHHHHHHHHHHHHHhhccCCCCCCC-----hhhHHh
Q 048314 231 ELNKLVRGTEVDKKNLENLVKVGLWCVQDEPALRPS-----MKCVVM 272 (274)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~evl~ 272 (274)
.. -.....+...+..+.+++.+||+.||++||| ++|+++
T Consensus 248 ~~---~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 248 IL---KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HH---HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cc---cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 00 0111345567789999999999999999995 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-42 Score=299.82 Aligned_cols=241 Identities=13% Similarity=0.151 Sum_probs=180.8
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCCCCCCcHHHHHHHHhcCC-CCccceEeEEEEe--CCcceEE
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSPYSPSRPLTLTSIVSRVS-WTTDIEVSSVAMR--GSKPSTE 91 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 91 (274)
.++|...+.||.|+| |.||+|. ..++|.+. ....+++.+|+.+|++++ ||||+++++++.. ....++|
T Consensus 34 ~d~y~i~~~LG~G~f--g~V~~a~~~~~~~~vAiK~i~-~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKY--SEVFEAINITNNEKVVVKILK-PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSS--EEEEEEEETTTTEEEEEEEEC-SSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcC--eEEEEEEECCCCCEEEEEEEC-HHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 357888899999999 9999982 11222222 234566789999999996 9999999999874 4568999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCC-cEEEeccccceecC-
Q 048314 92 AALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKISDFGLAKLLS- 169 (274)
Q Consensus 92 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~d~g~~~~~~- 169 (274)
||||.+++|.++. +.+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .+|++|||++....
T Consensus 111 ~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 111 FEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999987664 3599999999999999999999999 999999999999998654 68999999997543
Q ss_pred ---------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHH-HHHHHH-----HHHhhh---
Q 048314 170 ---------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEII-LTNWVY-----KCFINR--- 230 (274)
Q Consensus 170 ---------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~-~~~~~~-----~~~~~~--- 230 (274)
++.|+|||.+... .++.++||||+||+++++++|+.||........... ...... ......
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 5679999998765 478999999999999999999999975432221111 000000 000000
Q ss_pred ---hhhhhhc-----------CCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 231 ---ELNKLVR-----------GTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 231 ---~~~~~~~-----------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....... ........++++.+|+.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 00122234578899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=299.93 Aligned_cols=238 Identities=18% Similarity=0.119 Sum_probs=175.8
Q ss_pred hhccccccCCCCCCCCcchhHHH------HHHHHHhcCC----CCCCcHHHHHHHHhcCCCCccceEeEEEEe------C
Q 048314 22 RNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP----YSPSRPLTLTSIVSRVSWTTDIEVSSVAMR------G 85 (274)
Q Consensus 22 ~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~ 85 (274)
+.|...+.||+|+| |.||+|. ..++|.+... ...+++.+|+.+|++++|||||++++++.. .
T Consensus 17 ~~Y~i~~~LG~G~f--g~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQ--GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC----CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCcC--eEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 56888899999999 9999981 1223333322 112346799999999999999999999964 3
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
...|+|||||.++ +.+.+. ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++++|||++
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 6789999999765 444443 3689999999999999999999999 9999999999999999999999999987
Q ss_pred eecC----------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHH----------
Q 048314 166 KLLS----------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYK---------- 225 (274)
Q Consensus 166 ~~~~----------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---------- 225 (274)
+... ++.|+|||.+.+..++.++||||+||++++|++|+.||.... ...........
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~---~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHHHHT
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC---HHHHHHHHHHhccCCCHHHHH
Confidence 6533 678999999999899999999999999999999999996431 11111000000
Q ss_pred --------HHhhh----------hhhhhhcCC--ccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 226 --------CFINR----------ELNKLVRGT--EVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 226 --------~~~~~----------~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
..... ...+...+. ..+...+..+.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 000000000 123345778999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=295.46 Aligned_cols=240 Identities=16% Similarity=0.149 Sum_probs=176.4
Q ss_pred hhhccccccCCCCCCCCcchhHHH------HHHHHHhcCC-C---CCCcHHHHHHHHhcCCCCccceEeEEEEeC-----
Q 048314 21 LRNFCRSSLNDRNSPRSKSVWSCM------RALMATVNSP-Y---SPSRPLTLTSIVSRVSWTTDIEVSSVAMRG----- 85 (274)
Q Consensus 21 ~~~f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~-~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 85 (274)
.++|...+.||+|+| |.||+|. ..++|.+... . ..+++.+|+.+|++++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~f--g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAY--GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTT--SSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCC--eEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 346888899999999 9999992 1222333221 1 123467999999999999999999998643
Q ss_pred CcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEeccccc
Q 048314 86 SKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKISDFGLA 165 (274)
Q Consensus 86 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d~g~~ 165 (274)
...+++++|+.+|+|.+++.. +.+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+|++|||.+
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred CceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 345677788899999999964 5699999999999999999999999 9999999999999999999999999998
Q ss_pred eecC--------CCCcCCCcccccC-CCccccceeehhHhHHHHhhcCCCccccCCChhhHHHHHHHHHHHhh-------
Q 048314 166 KLLS--------DKGCMAPECYKRT-PISVKADVYGYGIVLLETICCWENMEIDASKPEEIILTNWVYKCFIN------- 229 (274)
Q Consensus 166 ~~~~--------~~~~~ape~~~~~-~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 229 (274)
.... +..|+|||..... .++.++||||+||++|+|++|..||..... . .....+......
T Consensus 169 ~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~---~-~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 169 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---I-DQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp -CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---H-HHHHHHHHHHCCCCHHHHT
T ss_pred cccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH---H-HHHHHHHHhcCCCChHHhh
Confidence 6654 4569999987665 468899999999999999999999964311 1 111111110000
Q ss_pred ----hhhhhhh----cCCc-----cCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 230 ----RELNKLV----RGTE-----VDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 230 ----~~~~~~~----~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
....... .... .....++.+.+||.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000000 0000 11234567899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.8e-37 Score=268.69 Aligned_cols=244 Identities=17% Similarity=0.156 Sum_probs=173.7
Q ss_pred ccccccCCCCCCCCcchhHHH------HHHHHHhcCC-CCCCcHHHHHHHHhcCC-----------CCccceEeEEEEe-
Q 048314 24 FCRSSLNDRNSPRSKSVWSCM------RALMATVNSP-YSPSRPLTLTSIVSRVS-----------WTTDIEVSSVAMR- 84 (274)
Q Consensus 24 f~~~~~~g~g~~~~g~vy~~~------~~~~~~~~~~-~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~- 84 (274)
|.....||.|+| |.||+|. ..++|.++.. ...+.+.+|++++++++ |+||+++++++..
T Consensus 15 Y~i~~~LG~G~f--g~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 15 YILVRKLGWGHF--STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp EEEEEEEEECSS--EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred EEEEEEEeeCCC--eEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 777899999999 9999992 1222333322 12345678999988875 4789999998864
Q ss_pred -CCcceEEEEeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCceEEcCCC------
Q 048314 85 -GSKPSTEAALDLP-WDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFW------ 155 (274)
Q Consensus 85 -~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~------ 155 (274)
....+++++++.. ++............+++..++.++.|++.||.|||+ . +|+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccc
Confidence 3456677776644 344555555456679999999999999999999998 6 999999999999997554
Q ss_pred cEEEeccccceecC--------CCCcCCCcccccCCCccccceeehhHhHHHHhhcCCCccccCCChhh---HHHHHHHH
Q 048314 156 TAKISDFGLAKLLS--------DKGCMAPECYKRTPISVKADVYGYGIVLLETICCWENMEIDASKPEE---IILTNWVY 224 (274)
Q Consensus 156 ~~kl~d~g~~~~~~--------~~~~~ape~~~~~~~~~~~Di~s~G~~l~el~~g~~p~~~~~~~~~~---~~~~~~~~ 224 (274)
.++++|||.+.... ++.|+|||.+....++.++|+||+||++++|++|+.||......... ..+...+.
T Consensus 170 ~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp EEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred eeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 38999999987543 66799999999889999999999999999999999999754322111 11111110
Q ss_pred HH-------Hhhhh-hhhhh----------------------cCCccCHHHHHHHHHHHHHhhccCCCCCCChhhHHh
Q 048314 225 KC-------FINRE-LNKLV----------------------RGTEVDKKNLENLVKVGLWCVQDEPALRPSMKCVVM 272 (274)
Q Consensus 225 ~~-------~~~~~-~~~~~----------------------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~evl~ 272 (274)
.. ..... ..... .....+...+..+.+|+.+||+.||++|||++|+++
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000 00000 011345677889999999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.72 E-value=5.3e-20 Score=145.38 Aligned_cols=148 Identities=12% Similarity=0.065 Sum_probs=104.2
Q ss_pred ccccCCCCCCCCcchhHHH-----HHHHHHhcC--------CC----CC--------CcHHHHHHHHhcCCCCccceEeE
Q 048314 26 RSSLNDRNSPRSKSVWSCM-----RALMATVNS--------PY----SP--------SRPLTLTSIVSRVSWTTDIEVSS 80 (274)
Q Consensus 26 ~~~~~g~g~~~~g~vy~~~-----~~~~~~~~~--------~~----~~--------~~~~~e~~~l~~l~h~niv~l~~ 80 (274)
..+.||+|+| |.||+|. ..++|..+. .. .. .....|...+.++.|.++++.++
T Consensus 4 vg~~IG~G~~--g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 4 IGKLMGEGKE--SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEECSS--EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hCCEeeeCcc--eEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3577999999 9999981 111111110 00 00 11235788899999999999886
Q ss_pred EEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCceEEcCCCcEEEe
Q 048314 81 VAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKIS 160 (274)
Q Consensus 81 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~ 160 (274)
+. ..+++|||+++..+.+ ++......++.|++.++.|||+. +++||||||+|||++++ .++++
T Consensus 82 ~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 53 2489999998755432 34455678899999999999999 99999999999999865 58999
Q ss_pred ccccceecCCCCcCCCcccc----------cCCCccccceeehh
Q 048314 161 DFGLAKLLSDKGCMAPECYK----------RTPISVKADVYGYG 194 (274)
Q Consensus 161 d~g~~~~~~~~~~~ape~~~----------~~~~~~~~Di~s~G 194 (274)
|||.+.....+. +.+++. ...|+.++|+||..
T Consensus 145 DFG~a~~~~~~~--~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~ 186 (191)
T d1zara2 145 DFPQSVEVGEEG--WREILERDVRNIITYFSRTYRTEKDINSAI 186 (191)
T ss_dssp CCTTCEETTSTT--HHHHHHHHHHHHHHHHHHHHCCCCCHHHHH
T ss_pred ECCCcccCCCCC--cHHHHHHHHHHHHHHHcCCCCCcccHHHHH
Confidence 999987765332 111111 23567888999864
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.80 E-value=9e-06 Score=65.11 Aligned_cols=105 Identities=10% Similarity=-0.100 Sum_probs=73.7
Q ss_pred CCCcHHHHHHHHhcCC-CCccceEeEEEEeCCcceEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 048314 56 SPSRPLTLTSIVSRVS-WTTDIEVSSVAMRGSKPSTEAALDLPWDLAYIIFCSAERNPYWNQRVRIALDVAKGILYLHDE 134 (274)
Q Consensus 56 ~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~ 134 (274)
....+.+|..++..+. +=-+.+++.++.+++..++||++.++.++.+.... ... ...++.+++..++.||+.
T Consensus 52 ~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~----~~~---~~~~~~~l~~~l~~lH~~ 124 (263)
T d1j7la_ 52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED----EQS---PEKIIELYAECIRLFHSI 124 (263)
T ss_dssp STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT----CSC---HHHHHHHHHHHHHHHHTS
T ss_pred chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc----ccc---HHHHHHHHHHHHHHHhcc
Confidence 4556778998887765 33368889888888999999999999887655421 111 223345555555556643
Q ss_pred CC--------------------------------------------------------CCcccCCCCCCceEEcCCCcEE
Q 048314 135 CE--------------------------------------------------------PPILHCDIKPQNILMDEFWTAK 158 (274)
Q Consensus 135 ~~--------------------------------------------------------~~i~h~dl~~~nil~~~~~~~k 158 (274)
.. ..++|+|+.+.||+++++..+.
T Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~ 204 (263)
T d1j7la_ 125 DISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSG 204 (263)
T ss_dssp CCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEE
T ss_pred CccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEE
Confidence 10 1378999999999999877778
Q ss_pred Eecccccee
Q 048314 159 ISDFGLAKL 167 (274)
Q Consensus 159 l~d~g~~~~ 167 (274)
++||+.+..
T Consensus 205 lIDwe~a~~ 213 (263)
T d1j7la_ 205 FIDLGRSGR 213 (263)
T ss_dssp ECCCTTCEE
T ss_pred Eeechhccc
Confidence 999987643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.04 E-value=0.00034 Score=55.17 Aligned_cols=46 Identities=13% Similarity=-0.112 Sum_probs=35.4
Q ss_pred CCCCcHHHHHHHHhcCCCCc--cceEeEEEEeCCcceEEEEeCCCCCH
Q 048314 55 YSPSRPLTLTSIVSRVSWTT--DIEVSSVAMRGSKPSTEAALDLPWDL 100 (274)
Q Consensus 55 ~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL 100 (274)
.....+..|+..++.+.... +.+++.++.+.+..++||++++|.++
T Consensus 46 ~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 46 GALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 44556778999888775433 57888888888889999999987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=94.89 E-value=0.029 Score=46.96 Aligned_cols=30 Identities=23% Similarity=0.276 Sum_probs=25.5
Q ss_pred CcccCCCCCCceEEcCCCcEEEeccccceec
Q 048314 138 PILHCDIKPQNILMDEFWTAKISDFGLAKLL 168 (274)
Q Consensus 138 ~i~h~dl~~~nil~~~~~~~kl~d~g~~~~~ 168 (274)
.++|+|+.+.||+++.+. ++++|+..+...
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence 589999999999998764 899999887553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=89.79 E-value=0.054 Score=43.43 Aligned_cols=31 Identities=19% Similarity=0.205 Sum_probs=27.4
Q ss_pred CCcccCCCCCCceEEcCCCcEEEecccccee
Q 048314 137 PPILHCDIKPQNILMDEFWTAKISDFGLAKL 167 (274)
Q Consensus 137 ~~i~h~dl~~~nil~~~~~~~kl~d~g~~~~ 167 (274)
.+++|+|+.+.|++++++....+.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999999988789999998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=88.00 E-value=0.17 Score=42.01 Aligned_cols=35 Identities=6% Similarity=-0.136 Sum_probs=24.7
Q ss_pred HHHHHHHhcCCCCcc-ceEeEEEEeCCcceEEEEeCCCCC
Q 048314 61 LTLTSIVSRVSWTTD-IEVSSVAMRGSKPSTEAALDLPWD 99 (274)
Q Consensus 61 ~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 99 (274)
.+|..+++.+.-.++ .++++++.+ .+|+||+++.+
T Consensus 92 ~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~ 127 (395)
T d1nw1a_ 92 VAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 127 (395)
T ss_dssp HHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred HHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEecccc
Confidence 478888888763344 688887642 68899987643
|